<SEC-DOCUMENT>0001655759-23-000079.txt : 20230808
<SEC-HEADER>0001655759-23-000079.hdr.sgml : 20230808
<ACCEPTANCE-DATETIME>20230808160940
ACCESSION NUMBER:		0001655759-23-000079
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		89
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20230808
DATE AS OF CHANGE:		20230808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARVINAS, INC.
		CENTRAL INDEX KEY:			0001655759
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472566120
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38672
		FILM NUMBER:		231151355

	BUSINESS ADDRESS:	
		STREET 1:		395 WINCHESTER AVE
		STREET 2:		5 SCIENCE PARK
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06511
		BUSINESS PHONE:		203-535-1456

	MAIL ADDRESS:	
		STREET 1:		395 WINCHESTER AVE
		STREET 2:		5 SCIENCE PARK
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARVINAS INC.
		DATE OF NAME CHANGE:	20181001

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARVINAS HOLDING COMPANY, LLC
		DATE OF NAME CHANGE:	20151015
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>arvn-20230630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:3ad84450-03f4-4a08-908c-03680fffbb5d,g:5431e377-e1a3-4379-9dba-d87e2214df03,d:76f5890a52dc4f2f9f2eb730676d3f66--><html xmlns:srt="http://fasb.org/srt/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:arvn="http://www.arvinas.com/20230630" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>arvn-20230630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-26">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-27">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-28">Q2</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-29">0001655759</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" id="f-30">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="c-78" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="f-397">6</ix:nonNumeric><ix:nonNumeric contextRef="c-79" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-398">1</ix:nonNumeric><ix:nonNumeric contextRef="c-80" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-399">1</ix:nonNumeric><ix:nonNumeric contextRef="c-81" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-400">1</ix:nonNumeric><ix:nonNumeric contextRef="c-82" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-401">1</ix:nonNumeric><ix:nonNumeric contextRef="c-83" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-402">1</ix:nonNumeric><ix:nonNumeric contextRef="c-84" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="f-403"></ix:nonNumeric><ix:nonNumeric contextRef="c-120" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-528">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="arvn-20230630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-08-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:CollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:RegulatoryAndSalesBasedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:RegulatoryMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SalesBasedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:RegulatoryMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SalesBasedMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:CollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:CollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:ResearchFundingPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:ResearchFundingPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:ResearchFundingPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:DevelopmentMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SalesBasedMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SalesBasedMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:DevelopmentMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:OptionPaymentsToLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:DevelopmentMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SalesBasedMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:GenentechIncorporationAndFHoffmanLaRocheLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-01</xbrli:startDate><xbrli:endDate>2017-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:DevelopmentMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:GenentechIncorporationAndFHoffmanLaRocheLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:GenentechIncorporationAndFHoffmanLaRocheLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:RegulatoryMilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:GenentechIncorporationAndFHoffmanLaRocheLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:CommercialMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:GenentechIncorporationAndFHoffmanLaRocheLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:CommercialMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-07-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2028-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2029-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">arvn:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">arvn:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PledgingPurposeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PledgingPurposeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndEighteenAssistanceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndEighteenAssistanceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndEighteenAssistanceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndEighteenAssistanceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndEighteenAssistanceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndFourteenAssistanceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndFourteenAssistanceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PiperSandlerAndCantorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arvn:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:EquityDistributionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PiperSandlerAndCantorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arvn:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:EquityDistributionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arvn:EmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arvn:EmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerCropScienceLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerCropScienceLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerCropScienceLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001655759</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:FoundationMedicineIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SuccessBasedMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-04</xbrli:startDate><xbrli:endDate>2022-06-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________ </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________ </span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#253;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 25.5pt;text-align:left;text-indent:-24.5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">June 30, 2023</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38672</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________ </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">ARVINAS, INC.</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________ </span></div><div style="margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">47-2566120</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">incorporation or organization</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Identification No.)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">5 Science Park</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-10">395 Winchester Ave</ix:nonNumeric>. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">New Haven</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">Connecticut</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">06511</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Zip Code)</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">203</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">535-1456</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________ </span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:39.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.896%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Trading</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Symbol(s)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">ARVN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Nasdaq </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Stock </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Market LLC</span></ix:nonNumeric></div></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-19">Yes</ix:nonNumeric> </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-20">Yes</ix:nonNumeric> </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-21">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#253;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-22">o</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-23">o</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#253;</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of August&#160;4, 2023, the registrant had <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-25">53,485,023</ix:nonFraction> shares of common stock, $0.001 par value per share, outstanding.</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span><br/></span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_13">PART I.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_13">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_13">2</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_16">Item 1.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_16">2</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_19">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_19">2</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_22">Condensed Consolidated Statements of Operations and Comprehensive Loss</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_22">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.15pt;text-indent:-0.15pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_28">Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_28">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_34">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_34">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_37">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_37">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_103">Item 2.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_103">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_103">19</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_124">Item 3.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_124">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_124">32</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_127">Item 4.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_127">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_127">32</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_130">PART II.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_130">OTHER INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_130">34</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_133">Item 1.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_133">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_133">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_136">Item 1A.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_136">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_136">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_139">Item 2.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_139">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_139">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_475">Item 5.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_475">Other </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_475">Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_139">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_142">Item 6.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_142">Exhibits</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_142">35</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_145">Signatures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i76f5890a52dc4f2f9f2eb730676d3f66_145">36</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this Quarterly Report on Form 10-Q, including statements regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;potential,&#8221; &#8220;goals,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;continue&#8221; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements in this Quarterly Report on Form 10-Q include, among other things, statements about:</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the initiation, timing, progress and results of our current and future clinical trials of vepdegestrant (ARV-471), bavdegalutamide (ARV-110) and ARV-766, including statements regarding the period during which the results of the clinical trials will become available;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the timing of, and our ability to obtain, marketing approval of vepdegestrant (ARV-471), bavdegalutamide (ARV-110) and ARV-766, and the ability of vepdegestrant (ARV-471), bavdegalutamide (ARV-110), ARV-766 and our other product candidates to meet existing or future regulatory standards;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the potential achievement of milestones and receipt of payments under our collaborations, including our collaboration with Pfizer Inc., or Pfizer, entered into in July 2021, or the Vepdegestrant (ARV-471) Collaboration;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">our plans to pursue research and development of other product candidates;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">our plans to submit Investigational New Drug Applications and/or Clinical Trial Applications;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the potential advantages of our platform technology and our product candidates;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">the extent to which our scientific approach and platform technology may potentially address a broad range of diseases and disease targets;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">the potential receipt of revenue from future sales of our product candidates;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">the rate and degree of market acceptance and clinical utility of our product candidates;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">our estimates regarding the potential market opportunity for our product candidates;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">our sales, marketing and distribution capabilities and strategy;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">our ability to establish and maintain arrangements for manufacture of our product candidates;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">our ability to enter into additional collaborations with third parties;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">our intellectual property position;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">our estimates regarding expenses, future revenues, capital requirements and needs for additional financing;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">the impact of government laws and regulations; and</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">our competitive position.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. We have included important factors in the cautionary statements included in our Annual Report on Form 10-K for the year ended December&#160;31, 2022, filed on February 23, 2023, and this Quarterly Report on Form 10-Q, particularly in the &#8220;Risk Factors&#8221; sections, that we believe could cause actual results or events to differ materially from the forward-looking statements that we make. Our forward-looking statements do </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ii</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should read this Quarterly Report on Form 10-Q and the documents that we have filed as exhibits to this Quarterly Report on Form 10-Q completely and with the understanding that our actual future results may differ materially from what we expect. We do not assume any obligation to update any forward-looking statements except as required by applicable law.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout this Quarterly Report on Form 10-Q, references to the &#8220;Company,&#8221; &#8220;Arvinas,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our,&#8221; refer to Arvinas, Inc. and its consolidated subsidiaries, except where the context requires otherwise, or any one or more of them as the context may require, and &#8220;our board of directors&#8221; refers to the board of directors of Arvinas, Inc.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Arvinas name and logo are our trademarks. We also own the service mark and the registered U.S. trademark for PROTAC&#174;. This Quarterly Report on Form 10-Q contains references to our trademarks and service marks and to those belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Quarterly Report on Form 10-Q, including logos, artwork and other visual displays, may appear without the &#174; or &#8482; symbols, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other entities&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other entity.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">iii</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_16"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements.</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_19"></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARVINAS, INC. AND SUBSIDIARIES</span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets (unaudited)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars and shares in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-31">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-32">81.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-33">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-34">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="f-35">948.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-36">1,124.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-37">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-38">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="f-39">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="f-40">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-41">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-42">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-43">1,056.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-44">1,240.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Property, equipment and leasehold improvements, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-45">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-46">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating lease right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-47">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-48">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Collaboration contract asset and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="arvn:CollaborationContractAssetAndOtherAssets" scale="6" id="f-49">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="arvn:CollaborationContractAssetAndOtherAssets" scale="6" id="f-50">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total assets</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-51">1,083.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-52">1,268.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Liabilities and stockholders' equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="f-53">74.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="f-54">74.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-55">230.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-56">218.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current portion of long term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-57">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="f-58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-59">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-60">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="f-61">306.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="f-62">295.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-63">310.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-64">405.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Long term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-65">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-66">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-67">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-68">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:Liabilities" scale="6" id="f-69">619.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Liabilities" scale="6" id="f-70">703.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Commitments and Contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-71"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-72"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-73"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-74">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-75"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-76">53.4</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-77"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-78">53.2</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of June&#160;30, 2023 and December&#160;31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-79">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-80">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-81">1,113.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-82">965.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-83">1,589.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="f-84">1,549.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-85">12.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-86">19.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-87">463.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-88">564.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-89">1,083.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-90">1,268.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARVINAS, INC. AND SUBSIDIARIES</span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">For the Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">For the Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars and shares in millions, except per share amounts)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-91">54.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-92">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-93">87.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-94">60.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-95">103.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-96">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-97">198.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-98">139.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-99">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-100">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-101">50.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-102">44.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-103">129.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-104">99.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-105">249.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-106">183.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-107">74.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-108">65.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-109">162.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-110">123.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Other income (expenses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="f-111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-112">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-113">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-114">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="f-115">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="f-116">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="f-117">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="f-118">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total other income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-119">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-120">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-121">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-122">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net loss before income taxes and loss from equity method investment</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-123">65.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-124">64.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-125">146.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="f-126">120.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-127">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-128">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-129">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-130">7.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Loss from equity method investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-131">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-132">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-133">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-134">4.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-135">66.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-136">70.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-137">148.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-138">133.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net loss per common share, basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-139"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-140">1.25</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-141"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-142">1.32</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-143"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-144">2.78</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-145"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-146">2.51</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Weighted average common shares outstanding, basic and diluted</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-147"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-148">53.4</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-149"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-150">53.2</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-151"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-152">53.4</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-153"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-154">53.1</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_25"></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">For the Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">For the Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-155">66.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-156">70.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-157">148.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-158">133.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Unrealized gain (loss) on available-for-sale securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-159">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-160">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-161">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-162">17.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-163">66.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-164">73.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-165">141.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-166">150.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARVINAS, INC. AND SUBSIDIARIES</span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity (unaudited)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.027%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:114%">(dollars and shares in millions)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Common</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Accumulated <br/>Other <br/>Comprehensive <br/>(Loss) Income </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Total <br/>Stockholders' <br/>Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:115%">For the Three Months Ended June 30, 2023 and 2022</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-167">53.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-168">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">0.1</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-169">1,047.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-170">1,570.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-171">12.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-172">511.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-173">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-174">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-175">66.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-176">66.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Issuance of common stock under equity incentive plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-177">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-178">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22.22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Unrealized gain (loss) on available-for-sale securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-179">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-180">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of June&#160;30, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-181">53.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-182">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-183">1,113.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-184">1,589.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-185">12.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-186">463.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-187">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="6" id="f-188">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-189">746.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-190">1,488.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-191">18.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-192">723.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-193">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-194">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-195">70.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-196">70.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Issuance of common stock under equity incentive plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-197">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-198">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-199">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-200">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Unrealized loss on available-for-sale securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-201">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-202">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-203">53.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-204">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-205">816.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-206">1,508.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-207">22.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-208">670.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.028%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:114%">(dollars and shares in millions)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Common</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Accumulated <br/>Deficit </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Additional <br/>Paid-in <br/>Capital </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Accumulated <br/>Other <br/>Comprehensive <br/>Income (Loss) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Total <br/>Stockholders' <br/>Equity </span></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:115%">For the Six Months Ended June 30, 2023 and 2022</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-209">53.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-210">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-211">965.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-212">1,549.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-213">19.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-214">564.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-215">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-216">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-217">148.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-218">148.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Issuance of common stock under equity incentive plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-40" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-219">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-220">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-221">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;padding-left:21.22pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Unrealized gain (loss) on available-for-sale securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-5" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-222">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-223">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of June&#160;30, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-224">53.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-225">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-226">1,113.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-227">1,589.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-228">12.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-229">463.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-42" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-230">53.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="6" id="f-231">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-232">682.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-233">1,469.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-234">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-235">781.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-236">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-237">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-238">133.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-239">133.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Issuance of common stock under equity incentive plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-49" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="f-240">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-241">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-242">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-243">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;padding-left:21.22pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Unrealized loss on available-for-sale securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-244">17.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-245">17.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-246">53.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-247">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-248">816.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-249">1,508.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-250">22.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-251">670.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARVINAS, INC. AND SUBSIDIARIES</span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows (unaudited)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-252">148.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-253">133.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="f-254">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="f-255">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net accretion of bond discounts/premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="6" id="f-256">7.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="6" id="f-257">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Loss on sale of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleGainLoss" scale="6" id="f-258">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleGainLoss" scale="6" id="f-259">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-260">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-261">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Amortization of collaboration contract asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="f-262">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="f-263">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-264">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-265">36.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-266">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-267">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="f-268">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="6" id="f-269">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-270">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-271">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-272">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-273">12.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="f-274">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="f-275">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-276">83.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-277">52.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-278">179.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-279">135.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-280">492.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-281">469.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Maturities of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="arvn:ProceedsFromMaturitiesOfMarketableSecurities" scale="6" id="f-282">638.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="arvn:ProceedsFromMaturitiesOfMarketableSecurities" scale="6" id="f-283">555.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Sales of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="arvn:ProceedsFromSaleOfMarketableSecurities" scale="6" id="f-284">42.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="arvn:ProceedsFromSaleOfMarketableSecurities" scale="6" id="f-285">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Purchases of property, equipment and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-286">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-287">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-288">187.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-289">117.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Proceeds from exercise of stock options and issuance of ESPP shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="arvn:ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares" scale="6" id="f-290">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="arvn:ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares" scale="6" id="f-291">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-292">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-293">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-294">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-295">15.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash, cash equivalents and restricted cash, beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-296">86.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-297">112.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Cash, cash equivalents and restricted cash, end of the period</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-298">96.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-299">97.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Purchases of property, equipment and leasehold improvements </span><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">unpaid at period end</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-300">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-301">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Cash paid for taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-302">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" format="ixt:fixed-zero" scale="6" id="f-303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARVINAS, INC. AND SUBSIDIARIES</span></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_40"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="f-304" continuedAt="ie14c162b6868450280c61cc4ec0af639" escape="true">Nature of Business and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="ie14c162b6868450280c61cc4ec0af639"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arvinas, Inc. and its subsidiaries (&#8220;Arvinas&#8221; or the "Company&#8221;) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-305" escape="true">The accompanying unaudited condensed consolidated financial statements include the accounts of Arvinas, Inc. and its subsidiaries. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission (&#8220;SEC&#8221;) rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December&#160;31, 2022 has been derived from the Company's audited consolidated financial statements as of that date. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December&#160;31, 2022, forming part of Arvinas&#8217; 2022 Annual Report on Form 10-K filed with the SEC on February&#160;23, 2023.</ix:nonNumeric> </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed in the Company's 2022 Annual Report on Form 10-K, the Company revised the accounting for its investment in Oerth Bio LLC ("Oerth Bio"). Accordingly, Arvinas recorded an adjustment to the unaudited condensed consolidated financial statements for the three and six months ended June&#160;30, 2022 that were previously included in the Company's Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2022. See Note 12,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Equity Method Investments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-306" escape="true">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amount of assets, liabilities, revenue and expenses. These estimates include assumptions and judgments based on historical experience, current conditions, future expectations and other factors the Company considers reasonable. These estimates are reviewed on an ongoing basis and revised as necessary. Actual results could differ from these estimates.</ix:nonNumeric></span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-307" continuedAt="i188126b2ac6247c182f27c6581a97df6" escape="true">Risks and Uncertainties</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i188126b2ac6247c182f27c6581a97df6">The Company is subject to a number of risks similar to other biotechnology companies in the early stage, including, but not limited to, the need to obtain adequate additional funding, possible failure of preclinical testing or clinical trials, the need to obtain marketing approval for its product candidates, competitors developing new technological innovations, the need to successfully commercialize and gain market acceptance of the Company&#8217;s products and protection of proprietary technology. If the Company does not successfully obtain regulatory approval, it will be unable to generate revenue from product sales or achieve profitability.</ix:continuation> </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, the Company has not generated any revenue from product sales and expects to incur additional operating losses and negative operating cash flows for the foreseeable future. The Company has financed its operations primarily through sales of equity interests, proceeds from collaborations, grant funding and debt financing. The Company had cash, cash equivalents, restricted cash and marketable securities of approximately $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-8" name="arvn:CashCashEquivalentsRestrictedCashAndMarketableSecurities" format="ixt:num-dot-decimal" scale="9" id="f-308">1.0</ix:nonFraction> billion as of June&#160;30, 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-309" continuedAt="iaa42e68a01f3482cae173bba8e3367ea" escape="true">Accounting Pronouncements and Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="iaa42e68a01f3482cae173bba8e3367ea"><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-310" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reviews</span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">new accounting standards as issued. As of June&#160;30, 2023, the Company has not identified any new standards that it believes will have a material impact on the Company&#8217;s financial statements.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to the Company&#8217;s significant accounting policies during the six months ended June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-311" continuedAt="ic89cef12964e4e99aa50bf470db2aa34" escape="true">Cash, Cash Equivalents and Restricted Cash</ix:nonNumeric> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-312" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="f-313" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the total amounts shown in the consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-314">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-315">93.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-316">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:RestrictedCashCurrent" scale="6" id="f-317">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-318">96.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-319">97.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic89cef12964e4e99aa50bf470db2aa34">Restricted cash represents a letter of credit collateralized by a certificate of deposit in the same amount as required under the terms of the Company's laboratory and office space lease entered into in May 2021 and amended in August 2022.</ix:continuation></span></div></ix:continuation><div id="i76f5890a52dc4f2f9f2eb730676d3f66_46"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-320" continuedAt="id9aa63aef6a74a8e9c9ebb4e2aa80d2a" escape="true">Research Collaboration and License Agreements </ix:nonNumeric></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%"><ix:continuation id="id9aa63aef6a74a8e9c9ebb4e2aa80d2a" continuedAt="i7e16e8323414453ea8c16f4717195939"> </ix:continuation></span></div><ix:continuation id="i7e16e8323414453ea8c16f4717195939" continuedAt="i0873a3de6ca64e8ba2b8399a547820b5"><div style="margin-top:6pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vepdegestrant (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ARV-471) Collaboration Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company entered into a Collaboration Agreement with Pfizer Inc. (&#8220;Pfizer&#8221;) (the &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vepdegestrant (</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARV-471) Collaboration Agreement&#8221;) pursuant to which the Company granted Pfizer worldwide co-exclusive rights to develop and commercialize products containing the Company&#8217;s proprietary compound ARV-471 (the &#8220;Licensed Products&#8221;). Under the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vepdegestrant (</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARV-471) Collaboration Agreement, the Company received an upfront, non-refundable payment of $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-321">650.0</ix:nonFraction> million. In addition, the Company is eligible to receive up to an additional $<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-8" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="9" id="f-322">1.4</ix:nonFraction> billion in contingent payments based on specific regulatory and sales-based milestones for the Licensed Products. Of the total contingent payments, $<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-323">400.0</ix:nonFraction> million in regulatory milestones are related to marketing approvals and $<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-8" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="9" id="f-324">1.0</ix:nonFraction> billion are related to sales-based milestones. There were <ix:nonFraction unitRef="usd" contextRef="c-55" decimals="INF" name="us-gaap:ProceedsFromCollaborators" format="ixt:fixed-zero" scale="0" id="f-325"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="INF" name="us-gaap:ProceedsFromCollaborators" format="ixt:fixed-zero" scale="0" id="f-326">no</ix:nonFraction></ix:nonFraction> regulatory or sales-based milestone payments received through </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and Pfizer share equally all development costs, including costs of conducting clinical trials, for the Licensed Products, subject to certain exceptions. Except for certain regions described below, the parties will also share equally all profits and losses in commercialization and medical affairs activities for the Licensed Products in all other countries, subject to certain exceptions. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will be the marketing authorization holder in the United States and, subject to marketing approval, book sales in the United States, while Pfizer will hold marketing authorizations outside the United States. The parties will determine which, if any, regions within the world will be solely commercialized by one party, and in such region the parties will adjust their share of profits and losses for the Licensed Products based on the role each party will be performing.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a direct result of the Company&#8217;s entry into the Vepdegestrant (ARV-471) Collaboration Agreement, the Company incurred direct and incremental costs to obtain the contract, paid to a financial advisor, totaling $<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="arvn:DirectAndIncrementalCostsIncurredToObtainTheContract" format="ixt:num-dot-decimal" scale="6" id="f-327">12.9</ix:nonFraction> million. In accordance with ASC 340, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recognized an asset of $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="arvn:CollaborationContractAssetAndOtherAssets" format="ixt:num-dot-decimal" scale="6" id="f-328">12.9</ix:nonFraction> million in collaboration contract asset and other assets in the condensed consolidated balance sheet at inception of the agreement, which is being amortized as general and administrative expense over the total estimated period of performance under the Vepdegestrant (ARV-471) Collaboration Agreement.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><ix:continuation id="i0873a3de6ca64e8ba2b8399a547820b5" continuedAt="i73a9cb7e099d464ea2883ca432cbdeab"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bayer Collaboration Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, the Company and Bayer AG entered into a Collaboration and License Agreement (the &#8220;Bayer Collaboration Agreement&#8221;) setting forth the Company&#8217;s collaboration with Bayer AG to identify or optimize proteolysis targeting chimeras ("PROTAC&#174; targeted protein degraders") that mediate the degradation of target proteins. Under the terms of the Bayer Collaboration Agreement, the Company received an upfront, non-refundable payment of $<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-329">17.5</ix:nonFraction> million in exchange for the use of the Company&#8217;s technology license. Bayer AG was committed to fund an additional $<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-330">12.0</ix:nonFraction> million through 2023, all of which was received as of June&#160;30, 2023, including $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="f-331">1.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="f-332">3.0</ix:nonFraction>&#160;million in the six months ended June&#160;30, 2023 and 2022, respectively. These payments are being recognized over the total estimated period of performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-333">197.5</ix:nonFraction>&#160;million in development milestone payments and up to $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-334">490.0</ix:nonFraction>&#160;million in sales-based milestone payments for all designated targets. In addition, the Company is eligible to receive, on net sales of PROTAC targeted protein degrader-related products, mid-single digit to low-double digit tiered royalties, which may be subject to reductions. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-65" decimals="INF" name="us-gaap:ProceedsFromCollaborators" format="ixt:fixed-zero" scale="0" id="f-335"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="INF" name="us-gaap:ProceedsFromCollaborators" format="ixt:fixed-zero" scale="0" id="f-336">no</ix:nonFraction></ix:nonFraction> development or sales-based milestone payments or royalties received through June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pfizer Research Collaboration Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Company entered into a Research Collaboration and License Agreement with Pfizer (the &#8220;Pfizer Research Collaboration Agreement&#8221;). Under the terms of the Pfizer Research Collaboration Agreement, the Company received an upfront, non-refundable payment and certain additional payments totaling $<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="f-337">28.0</ix:nonFraction> million in 2018 in exchange for use of the Company&#8217;s technology license and to fund Pfizer-related research as defined within the Pfizer Research Collaboration Agreement. These payments are being recognized as revenue over the total estimated period of performance. The Company is eligible to receive up to an additional $<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-338">37.5</ix:nonFraction>&#160;million in non-refundable option payments if Pfizer exercises its options for all targets under the Pfizer Research Collaboration Agreement. The Company is also entitled to receive up to $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-339">225.0</ix:nonFraction>&#160;million in development milestone payments and up to $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-340">550.0</ix:nonFraction>&#160;million in sales-based milestone payments for all designated targets under the Pfizer Research Collaboration Agreement, as well as tiered royalties based on sales. During the six months ended June&#160;30, 2023 and 2022, the Company received payments totaling $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="f-341">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="f-342">3.5</ix:nonFraction> million which were included in accounts receivable as of December 31, 2022 and 2021, respectively, for additional targets and services which are being recognized as revenue over the total period of performance. There were <ix:nonFraction unitRef="usd" contextRef="c-56" decimals="INF" name="us-gaap:ProceedsFromCollaborators" format="ixt:fixed-zero" scale="0" id="f-343">no</ix:nonFraction> sales-based milestone payments or royalties received through June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restated Genentech Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, the Company entered into an Amended and Restated Option, License, and Collaboration Agreement (the &#8220;Restated Genentech Agreement&#8221;) with Genentech, Inc. and F. Hoffman-La Roche Ltd. (together "Genentech"), amending a previous Genentech agreement entered into in September 2015. Under the Restated Genentech Agreement, the Company received additional upfront, non-refundable payments of $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="f-344">34.5</ix:nonFraction> million (in addition to $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="arvn:AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement" format="ixt:num-dot-decimal" scale="6" id="f-345">11.0</ix:nonFraction> million received under the previous agreement in 2015) to fund Genentech-related research. Upfront non-refundable payments were recognized as revenue over the performance period. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-346">44.0</ix:nonFraction>&#160;million per target in development milestone payments, $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-347">52.5</ix:nonFraction>&#160;million in regulatory milestone payments and $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-348">60.0</ix:nonFraction>&#160;million in commercial milestone payments based on sales as well as tiered royalties based on sales. There were <ix:nonFraction unitRef="usd" contextRef="c-77" decimals="INF" name="us-gaap:ProceedsFromCollaborators" format="ixt:fixed-zero" scale="0" id="f-349">no</ix:nonFraction> development, regulatory or commercial milestone payments or royalties received through June&#160;30, 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><ix:continuation id="i73a9cb7e099d464ea2883ca432cbdeab"><ix:nonNumeric contextRef="c-1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-350" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company's contract balances for the six months ended June&#160;30, 2023 and 2022 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Accounts receivable related to collaborations</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-351">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-352">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions" scale="6" id="f-353">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions" scale="6" id="f-354">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Payments received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived" scale="6" id="f-355">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived" scale="6" id="f-356">15.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-357">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-358">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Accounts payable related to collaborations</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="arvn:AccountsPayableContractBalancesCurrent" scale="6" id="f-359">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="arvn:AccountsPayableContractBalancesCurrent" format="ixt:fixed-zero" scale="6" id="f-360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="arvn:AccountsPayableContractBalancesCurrentAdditions" scale="6" id="f-361">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="arvn:AccountsPayableContractBalancesCurrentAdditions" format="ixt:fixed-zero" scale="6" id="f-362">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Payments made</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="arvn:AccountsPayableContractBalancesCurrentPayments" scale="6" id="f-363">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="arvn:AccountsPayableContractBalancesCurrentPayments" format="ixt:fixed-zero" scale="6" id="f-364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="arvn:AccountsPayableContractBalancesCurrent" format="ixt:fixed-zero" scale="6" id="f-365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="arvn:AccountsPayableContractBalancesCurrent" format="ixt:fixed-zero" scale="6" id="f-366">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Contract assets: Collaboration contract asset</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="f-367">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="f-368">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="arvn:ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements" format="ixt:fixed-zero" scale="6" id="f-369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="arvn:ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements" format="ixt:fixed-zero" scale="6" id="f-370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="arvn:CapitalizedContractCostAmortizationDuringPeriod" scale="6" id="f-371">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="arvn:CapitalizedContractCostAmortizationDuringPeriod" scale="6" id="f-372">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="f-373">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="f-374">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Contract liabilities: Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-375">623.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-376">740.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue recognized from balances held at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-377">84.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-378">55.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions to collaboration agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="arvn:ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements" scale="6" id="f-379">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="arvn:ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements" scale="6" id="f-380">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-381">540.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-382">688.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2023, the Company recorded cumulative catch-up adjustments from contract modifications totaling <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" format="ixt:fixed-zero" scale="6" id="f-383">zero</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" scale="6" id="f-384">8.2</ix:nonFraction>) million, respectively, relating to performance obligations which were satisfied in prior periods. During the three and six months ended June&#160;30, 2022, the Company recorded <ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" format="ixt:fixed-zero" scale="6" id="f-385"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" format="ixt:fixed-zero" scale="6" id="f-386">no</ix:nonFraction></ix:nonFraction> cumulative catch-up adjustments.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" id="f-387" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amount of the transaction price allocated to performance obligations that were unsatisfied as of June&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="f-388">540.6</ix:nonFraction> million, which is expected to be recognized in the following periods:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-389">110.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-390">200.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-391">90.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-392">55.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-393">34.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-394">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-395">38.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-396">540.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i76f5890a52dc4f2f9f2eb730676d3f66_52"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-404" continuedAt="i354fc48c68ac4d03b8cbb6a6db15ae45" escape="true">Marketable Securities and Fair Value Measurements </ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i354fc48c68ac4d03b8cbb6a6db15ae45" continuedAt="i651bd8583c3c45c1989afbc14a608fb7">The Company&#8217;s marketable securities consist of corporate bonds and government securities which are adjusted to fair value as of each balance sheet date based on quoted prices, which are considered Level 2 inputs. </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><ix:continuation id="i651bd8583c3c45c1989afbc14a608fb7"><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="f-405" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s available-for-sale marketable securities measured at fair value on a recurring basis. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Valuation</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Hierarchy</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amortized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross </span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-406">888.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-407">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-408">12.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-409">876.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-410">71.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-411">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-412">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-413">71.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-414">960.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-415">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-416">12.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-417">948.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Valuation</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Hierarchy</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amortized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-418">1,008.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-419">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-420">18.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-421">989.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-422">135.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-424">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-425">134.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-426">1,143.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-427">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-428">19.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-429">1,124.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not intend to sell any investments prior to recovery of their amortized cost basis for any investment in an unrealized loss position. As such, the Company has classified these losses as temporary in nature.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of accounts receivable and accounts payable and accrued liabilities approximate their </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair values due to the short-term nature of these assets and liabilities.</span></div></ix:continuation><div id="i76f5890a52dc4f2f9f2eb730676d3f66_55"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-430" continuedAt="i996c031d9c46476cba3ca0eb70c5104e" escape="true">Property, Equipment and Leasehold Improvements </ix:nonNumeric></span></div><ix:continuation id="i996c031d9c46476cba3ca0eb70c5104e"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-431" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment and leasehold improvements consist of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-432">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-433">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-434">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-435">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-436">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-437">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total property, equipment and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-438">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-439">30.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="f-440">18.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="f-441">16.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Property, equipment and leasehold improvements, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-442">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-443">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense totaled $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-444">1.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-445">1.5</ix:nonFraction> million for the three months ended June&#160;30, 2023 and 2022, respectively, and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-446">2.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-447">3.0</ix:nonFraction> million for the six months ended June&#160;30, 2023 and 2022, respectively.</span></div></ix:continuation><div id="i76f5890a52dc4f2f9f2eb730676d3f66_61"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-448" continuedAt="ic857f6b02d8b4508aa12b5941c04fa55" escape="true">Right-of-Use Assets and Liabilities</ix:nonNumeric></span></div><ix:continuation id="ic857f6b02d8b4508aa12b5941c04fa55" continuedAt="iec7d7b7a47b84c34bea02efacde7c7fb"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities in the condensed consolidated balance sheets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As the Company&#8217;s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><ix:continuation id="iec7d7b7a47b84c34bea02efacde7c7fb"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the present value of lease payments, which ranges from <ix:nonFraction unitRef="number" contextRef="c-97" decimals="3" name="arvn:PercentageOfIncrementalBorrowingForLeasePayments" scale="-2" id="f-449">3.0</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-98" decimals="3" name="arvn:PercentageOfIncrementalBorrowingForLeasePayments" scale="-2" id="f-450">7.5</ix:nonFraction>%. Lease expense is recognized on a straight-line basis over the lease term. The Company considers options to extend or terminate leases in recognizing ROU assets and lease liabilities when it is reasonably certain that such options will be exercised.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into a lease arrangement, which was amended in August 2022, for approximately <ix:nonFraction unitRef="sqft" contextRef="c-99" decimals="-3" name="us-gaap:LandSubjectToGroundLeases" format="ixt:num-dot-decimal" scale="0" id="f-451">160,000</ix:nonFraction> square feet of laboratory and office space, expected to be occupied in 2025. In connection with the signing of the lease and the related amendment, and at the Company&#8217;s election to increase the landlord&#8217;s contribution to the tenant improvement allowance, the Company initially issued a letter of credit totaling $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:DebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-452">4.5</ix:nonFraction>&#160;million, which was subsequently increased to $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:DebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-453">5.5</ix:nonFraction> million, collateralized by a certificate of deposit in the same amount, which is presented as restricted cash in the consolidated balance sheets. Once occupied, the base rent will range from $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-454">7.7</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-455">8.8</ix:nonFraction> million annually over a <ix:nonNumeric contextRef="c-104" name="arvn:BaseLeaseRentPeriod" format="ixt-sec:durwordsen" id="f-456">ten-year</ix:nonNumeric> lease term.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for its corporate office, laboratories and certain equipment, which expire no later than January 2026. The leases have a weighted average remaining term of <ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-457">1.8</ix:nonNumeric> years.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-458" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease cost</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="f-459">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="f-460">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="f-461">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="f-462">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="arvn:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" id="f-463" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="3" style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-464">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-465">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Supplemental non-cash information:</span></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Right-of-use assets obtained in exchange for new lease obligations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="6" id="f-466">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-467">2.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-468" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities as of June&#160;30, 2023, were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="6" id="f-469">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-470">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-471">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:fixed-zero" scale="6" id="f-472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="f-473">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-474">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-475">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="f-476" continuedAt="i4682519b8b074047bb560786a7f70061" escape="true">Accounts Payable and Accrued Liabilities </ix:nonNumeric></span></div><ix:continuation id="i4682519b8b074047bb560786a7f70061"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-477" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts payable</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-478">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="f-479">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="arvn:AccruedResearchAndDevelopmentExpenseCurrent" scale="6" id="f-480">51.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="arvn:AccruedResearchAndDevelopmentExpenseCurrent" scale="6" id="f-481">35.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Employee expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-482">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-483">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Professional fees and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="f-484">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedProfessionalFeesCurrent" scale="6" id="f-485">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-486">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-487">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="f-488">74.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="f-489">74.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i76f5890a52dc4f2f9f2eb730676d3f66_70"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-490" continuedAt="i27bde5e0ecd84046a297c467f570b04a" escape="true">Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="i27bde5e0ecd84046a297c467f570b04a"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="f-491" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt obligations consisted of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2018 Assistance Agreement Debt</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-105" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-492">3.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-493">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-494">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: current installments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-495">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="f-496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-497">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-498">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company entered into an additional assistance agreement with the State of Connecticut (the "2018 Assistance Agreement") to provide funding for the expansion and renovation of laboratory and office space. The Company borrowed $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-499">2.0</ix:nonFraction> million under the 2018 Assistance Agreement in September 2018, of which $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="arvn:DebtInstrumentLoanForgiveness" format="ixt:num-dot-decimal" scale="6" id="f-500">1.0</ix:nonFraction> million was forgiven upon meeting certain employment conditions. Borrowings under the agreement bear an interest rate of <ix:nonFraction unitRef="number" contextRef="c-109" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-501">3.25</ix:nonFraction>% per annum, with interest-only payments required for the first <ix:nonNumeric contextRef="c-108" name="arvn:DebtInstrumentInterestPaymentsTerm" format="ixt-sec:durmonth" id="f-502">60</ix:nonNumeric> months, and mature in September 2028. The 2018 Assistance Agreement requires that the Company be located in the State of Connecticut through September 2028, with a default penalty of repayment of the full original funding amount of $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-503">2.0</ix:nonFraction> million plus liquidated damages of <ix:nonFraction unitRef="number" contextRef="c-108" decimals="INF" name="arvn:PercentageOfLiquidatedDamages" scale="-2" id="f-504">7.5</ix:nonFraction>% of the total amount of funding received.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with an assistance agreement with the State of Connecticut entered into in 2014 under which all the borrowings by the Company were forgiven, the Company is required to be located in the State of Connecticut through January 2024, with a default penalty of repayment of the full original funding amount of $<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-505">2.5</ix:nonFraction> million plus liquidated damages of <ix:nonFraction unitRef="number" contextRef="c-111" decimals="INF" name="arvn:PercentageOfLiquidatedDamages" scale="-2" id="f-506">7.5</ix:nonFraction>%. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-507" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Minimum future principal payments on long-term debt for the years ending December&#160;31 are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="6" id="f-508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="f-509">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="f-510">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="f-511">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="f-512">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="arvn:LongTermDebtMaturityYearSix" scale="6" id="f-513">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-514">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2023 and 2022, interest expense was <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="0" id="f-515"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="0" id="f-516"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="0" id="f-517"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="0" id="f-518">immaterial</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-519" continuedAt="i3fef7b4f11ac46cc8cc42207ab59e6c4" escape="true">Equity</ix:nonNumeric></span></div><ix:continuation id="i3fef7b4f11ac46cc8cc42207ab59e6c4" continuedAt="i065ecd77c6444b8793b2fcd1c5733e26"><div style="margin-top:6pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Distribution Agreements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company entered into an Equity Distribution Agreement with Piper Sandler &amp; Company (&#8220;Piper Sandler&#8221;) and Cantor Fitzgerald &amp; Co. (&#8220;Cantor&#8221;), as agents, pursuant to which the Company may offer and sell from time to time, through the agents, up to $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="arvn:MaximumAggregateOfferingPriceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-520">300.0</ix:nonFraction> million </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the common stock registered under the Company's universal shelf registration statement pursuant to one or more &#8220;at-the-market" offerings. During the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> June&#160;30, 2023, <ix:nonFraction unitRef="shares" contextRef="c-113" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:fixed-zero" scale="0" id="f-521">no</ix:nonFraction> shares were issued under this agreement.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the Company adopted the 2018 Employee Stock Purchase Plan (the &#8220;2018 ESPP&#8221;), with the first offering period under the 2018 ESPP commencing on January 1, 2020, by initially providing participating employees with the opportunity to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-114" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-522">311,850</ix:nonFraction> shares of the Company&#8217;s common stock. The number of shares of the Company&#8217;s common stock reserved for issuance under the 2018 ESPP increased, pursuant to the terms of the 2018 ESPP, by additional shares equal to <ix:nonFraction unitRef="number" contextRef="c-115" decimals="2" name="arvn:IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock" scale="-2" id="f-523">1</ix:nonFraction>% of the Company&#8217;s then-outstanding common stock, effective as of January 1 of each year. As of June&#160;30, 2023, <ix:nonFraction unitRef="shares" contextRef="c-116" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-524">2,495,756</ix:nonFraction> shares remained available for purchase. During the six months ended June&#160;30, 2023 and 2022, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-117" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-525">23,206</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-118" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-526">5,749</ix:nonFraction> shares of common stock, respectively, of common stock under the 2018 ESPP.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Share Plan</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Fourth Amendment to the Company&#8217;s Incentive Share Plan (the &#8220;Incentive Plan&#8221;) adopted in March 2018, the Company was authorized to issue up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-119" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-527">6,199,477</ix:nonFraction> incentive units pursuant to the terms of the Incentive Plan. Generally, incentive units were granted at no less than fair value as determined by the board of managers and had vesting periods ranging from <span style="-sec-ix-hidden:f-528">one</span> to <ix:nonNumeric contextRef="c-121" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-529">four years</ix:nonNumeric>. The Incentive Plan was terminated in September 2018. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Stock Incentive Plan</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the Company&#8217;s board of directors adopted, and the Company&#8217;s stockholders approved, the 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), which became effective upon the effectiveness of the registration statement on Form S-1 for the Company&#8217;s initial public offering. The number of shares of common stock initially available for issuance under the 2018 Plan equaled the sum of (1) <ix:nonFraction unitRef="shares" contextRef="c-122" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-530">4,067,007</ix:nonFraction> shares of common stock; plus (2) the number of shares of common stock (up to <ix:nonFraction unitRef="shares" contextRef="c-123" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-531">1,277,181</ix:nonFraction> shares) issued in respect of incentive units granted under the Incentive Plan that were subject to vesting immediately prior to the effectiveness of the registration statement that expire, terminate or are otherwise surrendered, cancelled, forfeited or repurchased by the Company at their original issuance price pursuant to a contractual repurchase right; plus (3) an annual increase on the first day of each fiscal year beginning with the fiscal year ended December 31, 2019 and continuing to, and including, the fiscal year ending December 31, 2028, equal to the lesser of <ix:nonFraction unitRef="shares" contextRef="c-124" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-532">4,989,593</ix:nonFraction> shares of the Company&#8217;s common stock, <ix:nonFraction unitRef="number" contextRef="c-125" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="f-533">4</ix:nonFraction>% of the number of shares of the Company&#8217;s common stock outstanding on the first day of the year or an amount determined by the Company&#8217;s board of directors. As of June&#160;30, 2023, <ix:nonFraction unitRef="shares" contextRef="c-126" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-534">1,987,423</ix:nonFraction> shares remained available for issuance under the 2018 Plan. Shares of common stock subject to outstanding equity awards that expire or are terminated, surrendered, or canceled without having been fully exercised or are forfeited in whole or in part are available for future grants of awards.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><ix:continuation id="i065ecd77c6444b8793b2fcd1c5733e26" continuedAt="i6f7ca8daf398442c86c94ccbe314abcd"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Expense</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, the Company recognized compensation expense of $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-535">18.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-536">20.0</ix:nonFraction> million, respectively, related to the issuance of incentive awards, including $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-537">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-538">0.1</ix:nonFraction> million, respectively, related to the 2018 ESPP. During the six months ended June&#160;30, 2023 and 2022, the Company recognized compensation expense of $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-539">38.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-540">36.6</ix:nonFraction> million, respectively, relating to the issuance of incentive awards, including $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-541">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-542">0.3</ix:nonFraction> million, respectively, related to the 2018 ESPP.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-543">83.8</ix:nonFraction> million of total unrecognized compensation expense that is expected to be amortized over a weighted average period of approximately <ix:nonNumeric contextRef="c-136" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-544">1.8</ix:nonNumeric> years.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-545" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the stock options granted during the six months ended June&#160;30, 2023 and 2022 was determined using the Black-Scholes option pricing model with the following assumptions:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-137" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-546">72.3</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="c-137" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-547">74.2</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-138" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-548">73.2</ix:nonFraction> - <ix:nonFraction unitRef="number" contextRef="c-138" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-549">76.0</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-139" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-550">5.5</ix:nonNumeric> - <ix:nonNumeric contextRef="c-140" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-551">7.0</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-141" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-552">5.5</ix:nonNumeric> - <ix:nonNumeric contextRef="c-142" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-553">7.0</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-137" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-554">3.4</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-137" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-555">4.2</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-138" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-556">1.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-138" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-557">3.3</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-137" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-558">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-138" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-559">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercise price</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-143" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="f-560">23.23</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-144" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="f-561">36.27</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-145" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="f-562">36.79</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-146" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="f-563">78.91</ix:nonFraction></span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the Company&#8217;s common stock has not been trading for a sufficient period of time, the Company calculates volatility of its common stock by utilizing a weighted average of a collection of peer company volatilities and its own common stock volatility. The expected term is calculated utilizing the simplified method. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-564" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the stock option activity under the 2018 Plan during the six months ended June&#160;30, 2023 is presented below. These amounts include stock options granted to employees and directors.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions, <br/>except weighted average exercise price)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Options </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Remaining Contractual</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Term (Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Outstanding as of December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-147" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-565">6,814,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-147" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-566">49.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-148" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-567">7.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-568">34.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-149" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-569">1,653,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-149" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-570">33.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-149" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-571">71,321</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-149" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-572">18.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-149" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-573">212,677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-149" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-574">56.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Outstanding as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-126" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-575">8,183,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-576">46.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-149" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-577">7.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-578">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Vested and exercisable as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-126" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-579">4,417,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-580">41.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-149" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-581">6.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="f-582">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Vested and expected to vest as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-126" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-583">7,825,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-584">45.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-149" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-585">7.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="f-586">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><ix:continuation id="i6f7ca8daf398442c86c94ccbe314abcd"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value per share of options granted during the six months ended June&#160;30, 2023 and 2022 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-587">22.79</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-588">41.41</ix:nonFraction>, respectively. The total intrinsic value of options exercised during the six months ended June&#160;30, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-589">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-590">7.1</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units (RSUs)</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="f-591" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU activity under the 2018 Plan during the six months ended June&#160;30, 2023 is presented below. These amounts include RSUs granted to employees. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Grant Date</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Fair Value Per</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Share</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unvested RSUs as of December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-150" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-592">489,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-150" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-593">51.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-151" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-594">778,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-151" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-595">33.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-151" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-596">94,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-151" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-597">44.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-151" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-598">28,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-151" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-599">44.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unvested RSUs as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-152" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-600">1,144,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-152" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-601">40.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span id="ifd63f0d1bf8c4ee6838c66e23863a083_5558"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RSUs vested during the six months ended June&#160;30, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-602">4.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-603">0.7</ix:nonFraction> million, respectively.</span></div></ix:continuation><div id="i76f5890a52dc4f2f9f2eb730676d3f66_82"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-604" continuedAt="ifa75fd310d904a188f8d32dca489e485" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="ifa75fd310d904a188f8d32dca489e485" continuedAt="i8214888438934372ba0d23ab0bc78e56"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2023, the Company recognized income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-605">0.3</ix:nonFraction> million resulting in an effective tax rate of <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-606">0.4</ix:nonFraction>%, as compared to income tax expense of $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-607">3.4</ix:nonFraction> million resulting in an effective tax rate of (<ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-608">5.4</ix:nonFraction>)% in the same period for 2022. The primary reconciling items between the federal statutory rate of <ix:nonFraction unitRef="number" contextRef="c-5" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-609">21.0</ix:nonFraction>% for the three months ended June&#160;30, 2023 and the Company&#8217;s overall effective tax rate of <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-610">0.4</ix:nonFraction>% was the effect of expected benefits from state net operating loss carryback claims offset by equity compensation and the valuation allowance recorded against the full amount of its net deferred tax assets. The primary reconciling items between the federal statutory rate of <ix:nonFraction unitRef="number" contextRef="c-6" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-611">21.0</ix:nonFraction>% for the three months ended June&#160;30, 2022 and the Company&#8217;s overall effective tax rate of (<ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-612">5.4</ix:nonFraction>)% was the effect of equity compensation, deferred state income taxes and the valuation allowance recorded against the full amount of its net deferred tax assets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2023, the Company recognized income tax expense of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-613">0.7</ix:nonFraction> million resulting in an effective tax rate of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-614">0.4</ix:nonFraction>%, as compared to income tax expense of $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-615">7.9</ix:nonFraction> million resulting in an effective tax rate of (<ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-616">6.5</ix:nonFraction>)% in the same period for 2022. The primary reconciling items between the federal statutory rate of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-617">21.0</ix:nonFraction>% for the six months ended June&#160;30, 2023 and the Company&#8217;s overall effective tax rate of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-618">0.4</ix:nonFraction>% was the effect of expected benefits from state net operating loss carryback claims offset by equity compensation and the valuation allowance recorded against the full amount of its net deferred tax assets. The primary reconciling items between the federal statutory rate of <ix:nonFraction unitRef="number" contextRef="c-7" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-619">21.0</ix:nonFraction>% for the six months ended June&#160;30, 2022 and the Company&#8217;s overall effective tax rate of (<ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-620">6.5</ix:nonFraction>)% was the effect of equity compensation, generation of tax credits, deferred state income taxes and the valuation allowance recorded against the full amount of its net deferred tax assets.</span></div></ix:continuation><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8214888438934372ba0d23ab0bc78e56">A valuation allowance is established when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The realization of deferred tax assets depends on the generation of future taxable income during the period in which related temporary differences become deductible. The Company continues to establish a full valuation allowance against its net deferred tax assets since it is more likely than not that benefits will not be realized, including those benefits created in the current year. This assessment is based on the Company's historical cumulative losses which provide strong objective evidence that cannot be overcome with projections of income, as well as the fact the Company expects continuing losses in the future.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-621" continuedAt="i06e68f3d55fc46d2a5abcef2459b8ad0" escape="true">Net Loss Per Share </ix:nonNumeric></span></div><ix:continuation id="i06e68f3d55fc46d2a5abcef2459b8ad0"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-622" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted loss per common share was calculated as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars and shares in millions, except per share amounts)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net loss</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-623">66.6</ix:nonFraction>)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-624">70.0</ix:nonFraction>)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-625">148.5</ix:nonFraction>)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-626">133.4</ix:nonFraction>)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average number of common shares outstanding</span><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;- basic and diluted</span></div></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-627"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-628">53.4</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-629"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-630">53.2</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-631"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-632">53.4</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-633"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-634">53.1</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net loss per common share </span><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">-  basic and diluted</span></div></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-635"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-636">1.25</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-637"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-638">1.32</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-639"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-640">2.78</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-641"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-642">2.51</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-643" escape="true"><div style="margin-top:12pt;text-indent:34.7pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reported net losses for each of the three and six months ended June&#160;30, 2023 and 2022, and therefore excluded all stock options and restricted stock units from the calculation of diluted net loss per common share as their inclusion would have had an anti-dilutive effect, as summarized below:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three and Six Months Ended<br/>June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(shares in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-155" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-644"><ix:nonFraction unitRef="shares" contextRef="c-156" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-645">8.2</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-157" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-646"><ix:nonFraction unitRef="shares" contextRef="c-158" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-647">6.5</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-159" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-648"><ix:nonFraction unitRef="shares" contextRef="c-160" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-649">1.1</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-161" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-650"><ix:nonFraction unitRef="shares" contextRef="c-162" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-651">0.3</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-652"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-653">9.3</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-654"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-655">6.8</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i76f5890a52dc4f2f9f2eb730676d3f66_94"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="c-1" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="f-656" continuedAt="i9cdd00ae308046b59b9aa1e1abd7a278" escape="true">Equity Method Investments</ix:nonNumeric></span></div><ix:continuation id="i9cdd00ae308046b59b9aa1e1abd7a278" continuedAt="i4c8c3a7c914948e387186467578b27f6"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Company and Bayer CropScience LP (&#8220;Bayer LP&#8221;) formed Oerth Bio, a joint venture to research, develop and commercialize PROTAC targeted protein degraders for applications in the field of agriculture. The Company and Bayer LP each held an initial ownership interest in Oerth Bio of <ix:nonFraction unitRef="number" contextRef="c-163" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-657">50</ix:nonFraction>%. A <ix:nonFraction unitRef="number" contextRef="c-164" decimals="2" name="arvn:FutureGrantOfIncentiveUnitsToServiceProvidersPercentage" scale="-2" id="f-658">15</ix:nonFraction>% ownership interest of Oerth Bio was reserved for the future grants of incentive units to employees and service providers and, as a result, the Company's ownership interest totaled <ix:nonFraction unitRef="number" contextRef="c-165" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-659">45.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-166" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-660">47.5</ix:nonFraction>% as of June&#160;30, 2023 and 2022, respectively, as a result of vested incentive units.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the preparation of the Company's consolidated financial statements for the yea</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r ended December 31, 2022, the Company identified a prior period error related to the accounting of its investment in Oerth Bio in 2019. Previously, the Company disclosed that revenue of $<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-661">24.7</ix:nonFraction>&#160;million was deferred and would be recognized if and when Oerth Bio recognized revenue associated with the license. The Company has determined that the consideration received for the amounts associated with the deferred revenue should have been constrained, because at the time Bayer LP had contributed only a portion of its full cash commitment to Oerth Bio, and Bayer LP had the right to all the cash contributed, but not yet spent, upon liquidation of Oerth Bio. The constrained revenue should have been recognized upon both cash being contributed by Bayer LP and the related cash spent by Oerth Bio on research and development activities. As such, for each period presented, the revenue recognized is accompanied by corresponding equity method losses of the same amount. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company ev</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aluated the error</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nd determined that the related impact did not materially misstate the previously issued unaudited condensed consoli</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dated financial statements for the three and six months ended June&#160;30, 2022. Although the Company concluded that the error was not material to its previously issued unaudited condensed consolidated financial statements, the Company has</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> determined it is appropriate to adjust its previously issued unaudited condensed consolidated financial statements for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended June&#160;30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to correct</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the error and improve comparability</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><ix:continuation id="i4c8c3a7c914948e387186467578b27f6"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" id="f-662" escape="true"><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following illustrates the effect of the correction of the immaterial error for the period presented. There was no impact to the balance sheets, net loss per common share, statements of cash flows or changes in stockholders&#8217; equity.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:23.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.898%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as previously reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as adjusted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as previously reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as adjusted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-663">31.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-664">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-665">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-666">55.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-667">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-668">60.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-669">68.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-670">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-671">65.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-672">128.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-673">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-674">123.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from equity method investment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-675">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-676">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-677">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="f-678">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-679">4.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="f-680">4.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-681">70.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="f-682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-683">70.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-684">133.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="f-685">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-686">133.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share - basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-168" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-687"><ix:nonFraction unitRef="usdPerShare" contextRef="c-168" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-688">1.32</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-169" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="0" id="f-689"><ix:nonFraction unitRef="usdPerShare" contextRef="c-169" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="0" id="f-690">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-691"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-692">1.32</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-170" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-693"><ix:nonFraction unitRef="usdPerShare" contextRef="c-170" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-694">2.51</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-171" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="0" id="f-695"><ix:nonFraction unitRef="usdPerShare" contextRef="c-171" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="0" id="f-696">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-697"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-698">2.51</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-699">73.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:fixed-zero" scale="6" id="f-700">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-701">73.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-702">150.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:fixed-zero" scale="6" id="f-703">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-704">150.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss of Oerth Bio for the three months ended June&#160;30, 2023 and 2022 totaled $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-705">2.8</ix:nonFraction> million</span><span style="color:#ff0000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-706">5.3</ix:nonFraction> million, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized equity method losses of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-707">1.3</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-708">2.5</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended June&#160;30, 2023 and 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. Net loss of Oerth Bio for the six months ended June&#160;30, 2023 and 2022 totaled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-709">5.2</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-710">10.2</ix:nonFraction> million, respectively. The Company recognized equity method losses of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-711">2.4</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="f-712">4.8</ix:nonFraction> million for the six</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended June&#160;30, 2023 and 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company&#8217;s </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">carrying value of t</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he investment was <ix:nonFraction unitRef="usd" contextRef="c-180" decimals="INF" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="0" id="f-713"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="INF" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="0" id="f-714">zero</ix:nonFraction></ix:nonFraction>.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provides Oerth Bio with compensated research, development and administrative services through a separate agreement. The services rendered by the Company during the three and six months ended June&#160;30, 2023 and 2022 were immaterial.</span></div></ix:continuation><div id="i76f5890a52dc4f2f9f2eb730676d3f66_100"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-715" continuedAt="i8394c15739af4fcd98e71f72bba8593d" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i8394c15739af4fcd98e71f72bba8593d" continuedAt="i932bfbdaa13948f1b306a6d5c96e7a3b"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may be subject to legal proceedings, claims and disputes that arise in the&#160;ordinary&#160;course&#160;of business. The Company accrues a liability for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount, which could differ materially. Legal fees and other costs associated with such actions are expensed as incurred.&#160;The Company's accrual for such matters totaled $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-716">10.0</ix:nonFraction>&#160;million as of June&#160;30, 2023, primarily related to a contract dispute that is in early stages. Due to the early stage of the dispute, the means of resolution are unknown and could involve contract modification and, or payment of consideration.&#160;An estimate of the possible range of loss associated with the dispute cannot be made at this time and the Company has accrued its best estimate as of June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical and Preclinical Development and Licensing Arrangements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into contracts in the normal course of business with various third parties who support its clinical trials, preclinical research studies, and other services related to its development activities. The scope of the services under these agreements can generally be modified at any time, and the agreement can be terminated by either party after a period of notice and receipt of written notice.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, under licensing and related arrangements to which the Company is a party, the Company may be obligated to make milestone payments to third parties. The payment obligations under these arrangements are contingent upon future events, such as achievement of specified milestones or generation of product sales, and the amount, timing and likelihood of such payments are not known.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">FMI Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company entered into a Master In Vitro Diagnostics Agreement (the "FMI Agreement") with Foundation Medicine, Inc. ("Foundation Medicine") for the development and commercialization of one or more of Foundation Medicine&#8217;s companion in vitro diagnostic assays for use with one or more of the Company's therapeutic products.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><ix:continuation id="i932bfbdaa13948f1b306a6d5c96e7a3b"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FMI Agreement does not have a fixed duration, and the Company may terminate the FMI Agreement for convenience by providing adequate written notice to Foundation Medicine, subject to payment of applicable termination fees. Either party may terminate the FMI Agreement in its entirety for an uncured material breach by the other party, upon the bankruptcy or insolvency of the other party or by the mutual written agreement of both parties. Additionally, Foundation Medicine may terminate the FMI Agreement with respect to an applicable program, (a) if a reasonably necessary third party license is not secured by Foundation Medicine or if the Company does not consent to payments for such license, (b) if Foundation Medicine reasonably determines that further development of the applicable assay is not technically feasible or (c) following a certain number of years after the first commercial launch of the applicable assay for use with the applicable therapeutic product. Certain license and other rights and certain obligations of Foundation Medicine survive termination of the FMI Agreement. If the FMI Agreement is terminated in its entirety or with respect to any program, the Company has certain payment obligations remaining to Foundation Medicine and may also be required to pay a termination fee, if applicable.  </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bavdegalutamide</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In exchange for the development of FoundationOne&#174; Liquid CDx as a companion diagnostic for use with bavdegalutamide for androgen receptor protein (&#8220;AR&#8221;) metastatic castration-resistant prostate cancer (&#8220;mCRPC&#8221;) in the United States and European Union, pursuant to the terms of the FMI Agreement, the Company is subject to success-based milestone payments of up to low to mid tens of millions of dollars, in addition to certain validation fees per sample and related pass-through costs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ARV-766</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the development of FoundationOne&#174; Liquid CDx as a companion diagnostic for use with ARV-766 for AR mCRPC in the United States and European Union, pursuant to the terms of the FMI Agreement, the Company is subject to success-based milestone payments of up to low <ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-6" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt-sec:numwordsen" scale="6" id="f-717">ten</ix:nonFraction>s of millions of dollars in addition to certain validation fees per sample and related pass-through costs.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis is meant to provide material information relevant to an assessment of the financial condition and results of operations of our company, including an evaluation of the amount and certainty of cash flows from operations and from outside sources, so as to allow investors to better view our company from management&#8217;s perspective. You should read the following discussion and analysis of financial condition and results of operations together with our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q and the consolidated financial statements and the related notes and discussion and analysis of financial condition and results of operations in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed on February&#160;23, 2023. This discussion contains forward-looking statements that involve risks and uncertainties. As a result of many factors, such as those set forth in the section titled &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December&#160;31, 2022, filed on February&#160;23, 2023 and elsewhere in this Quarterly Report on Form 10-Q, our actual results may differ materially from those anticipated in or implied by these forward-looking statements. </span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_106"></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Business</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins. We use our PROTAC Discovery Engine, our proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body&#8217;s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. We believe that our targeted protein degradation approach is a therapeutic modality that may provide distinct advantages over existing modalities, including traditional small molecule therapies and gene-based medicines. We have a robust preclinical pipeline of PROTAC protein degraders targeting a broad range of intracellular disease targets, including those representing proteins that currently cannot be addressed by existing small molecule therapies, commonly referred to as &#8220;undruggable&#8221; targets. We are using our PROTAC Discovery Engine to build an extensive pipeline of protein degradation product candidates to target diseases in areas of unmet need, including oncology (including immuno-oncology), neuroscience and other therapeutic areas. We have three investigational clinical stage programs:  Vepdegestrant (ARV-471), a novel PROTAC estrogen receptor, or ER, protein degrader for the treatment of patients with locally advanced or metastatic ER positive / human epidermal growth factor receptor 2, or HER2, negative, or ER+/HER2-, breast cancer and bavdegalutamide (ARV-110) and ARV-766, each an oral PROTAC protein degrader that targets the androgen receptor protein, or AR, for the treatment of men with metastatic castration-resistant prostate cancer, or mCRPC.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vepdegestrant (ARV-471)</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vepdegestrant (ARV-471) is an investigational orally bioavailable PROTAC protein degrader designed to target and degrade the ER for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer. We are co-developing vepdegestrant with Pfizer, Inc., or Pfizer, pursuant to a collaboration agreement that we and Pfizer entered into in July 2021. We granted Pfizer worldwide co-exclusive rights to develop and commercialize vepdegestrant. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preclinical studies, vepdegestrant demonstrated near-complete ER degradation in tumor cells, induced robust tumor shrinkage when dosed as a single agent in multiple ER-driven xenograft models and showed superior anti-tumor activity when compared to a standard of care agent, fulvestrant, both as a single agent and in combination with a cyclin-dependent kinase, or CDK, 4/6 inhibitor. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the first quarter of 2023, we and Pfizer gained alignment with the U.S. Food and Drug Administration, or the FDA, on an approach for the planned first-line, metastatic ER+/HER2- breast cancer Phase 3 trial (VERITAC-3) of vepdegestrant in combination with IBRANCE&#174; (palbociclib) and in the second quarter of 2023, we, along with Pfizer, initiated the study-lead in of the VERITAC-3 Phase 3 clinical trial in combination with palbociclib as a first-line treatment in patients with ER+/HER2- locally advanced or metastatic breast cancer. Moving forward, we expect to continue enrollment in the study-lead in of the VERITAC-3 Phase 3 clinical trial to evaluate the dose of palbociclib (100 mg or 75 mg) in combination with 200 mg vepdegestrant once daily. The </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">objective of this trial is to select a dose of palbociclib (100 mg or 75 mg) that, when dosed with vepdegestrant 200 mg, results in a similar exposure and safety profile as palbociclib 125 mg in combination with aromatase inhibitors. This approach follows the recent analysis of data from the ongoing Phase 1b/2 combination study of vepdegestrant with palbociclib, in which an increase in palbociclib exposure was observed relative to historical palbociclib pharmacokinetic data.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the fsecond quarter of 2023, we continued enrollment in VERITAC-2, a Phase 3-second-line clinical trial of vepdegestrant as a monotherapy, TACTIVE-E, a clinical trial of vepdegestrant in combination with everolimus, and TACTIVE-N, a clinical trial of vepdegestrant as a monotherapy in the neoadjuvant setting, in each case, for the treatment of patients with ER+/HER2- metastatic breast cancer. We expect to complete enrollment for VERITAC-2 in the second half of 2024. Also in the second quarter of 2023, we continued enrollment in two arms of TACTIVE-U, a Phase 1b/2 clinical trial of vepdegestrant in combination with abemaciclib in one arm, and in combination with ribociclib in a second arm. In the second quarter of 2023, we entered into a collaboration agreement with Pfizer and Carrick Therapeutics, Inc. to evaluate samuraciclib in combination with vepdegestrant as part of the TACTIVE-U study. We expect to initiate a Phase 1b/2 trial with vepdegestrant in combination with Pfizer's CDK4 inhibitor during the second half of 2023 and initiate an additional arm of TACTIVE-U, a Phase 1b/2 combination umbrella trial of vepdegestrant with Carrick Therapeutics&#8217; CDK7 inhibitor, during the second half of 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluated and announced preliminary data from Part C of the ongoing Phase 1b/2 ARV-471-mBC-101 trial in the second quarter of 2023. Preliminary results from the Part C dose escalation trial (November 2022 data cutoff from the Phase 1b combination of vepdegestrant with palbociclib at 125 mg) demonstrate an observed clinical benefit rate (CBR; rate of confirmed complete response, confirmed partial response, or stable disease &#8805;24 weeks) of 60.7% (95% CI, 40.6 &#8211; 78.5) across all dose cohorts (17 of 28 CBR-evaluable patients; patients are CBR-evaluable if they received their first dose &gt;24 weeks prior to the cut-off).  We expect, with Pfizer, to present additional data from the Phase 1b combination trial of vepdegestrant in combination with palbociclib at a medical congress in the second half of 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2023, we presented vepdegestrant preclinical data at American Association for Cancer Research (AACR) annual meeting demonstrating the potential utility of vepdegestrant as an endocrine therapy backbone for combination with other targeted agents in early and late-stage ER+/HER2- breast cancer and the potential mechanisms of acquired resistance to vepdegestrant that may be associated with alterations within Receptor Tyrosine Kinase/MAPK signaling pathways rather than ER signaling or E3 ligase machinery. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in the second quarter of 2023, we announced the inclusion of vepdegestrant in the I-SPY-2 (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2) trial sponsored by Quantum Leap. The I-SPY-2 Endocrine Optimization Platform study will include a vepdegestrant monotherapy arm and a vepdegestrant plus letrozole arm. We were also awarded Innovation Passport Designation for vepdegestrant by the U.K. Innovative Licensing and Access Pathway Steering Group in the second quarter of 2023. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bavdegalutamide (ARV-110)</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bavdegalutamide (ARV-110) is an investigational orally bioavailable PROTAC protein degrader designed to target and degrade the AR for the treatment of men with mCRPC. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preclinical studies, bavdegalutamide demonstrated activity of AR mutation or overexpression, both common mechanisms of resistance to currently available AR-targeted therapies. In 2019, we initiated a Phase 1/2 clinical trial of bavdegalutamide designed to assess the safety, tolerability and pharmacokinetics of bavdegalutamide and which trial also included measures of anti-tumor activity as secondary endpoints, including reduction in prostate specific antigen, or PSA, a well-recognized biomarker of prostate cancer progression. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We expect to initiate a global Phase 3 clinical trial of bavdegalutamide for the treatment of men with mCRPC with AR T878/H875 tumor mutations in the second half of 2023 and present updated data, including radiographic progression free survival, from the ongoing Phase 1/2 clinical trial of bavdegalutamide at the European Society for Medical Oncology congress in Madrid in October 2023. Also in the second half of 2023, we expect to complete enrollment in the Phase 1b clinical trial of bavdegalutamide in combination with abiraterone for the treatment of men with mCRPC.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ARV-766</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARV-766 is an investigational orally bioavailable PROTAC protein degrader designed to target AR with a different profile than bavdegalutamide, as a potential treatment for men with mCRPC. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preclinical studies, ARV-766 degraded all tested resistance-driving point mutations of AR, including L702H, a mutation associated with treatment with abiraterone and other AR-pathway therapies.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2023, we presented ARV-766 preclinical data and compound structure at the AACR annual meeting and in June 2023, we shared data from the Phase 1/2 dose escalation and expansion trial of ARV-766 for the treatment of men with mCRPC. The Phase 1 dose escalation portion of the ARV-766 trial was designed to assess its safety, tolerability, and pharmacokinetics in men with mCRPC who have progressed on standard of care therapies, as well as to identify recommended Phase 2 doses for further dose optimization. The Phase 2 expansion cohort was designed to evaluate the antitumor activity of ARV-766 at the two recommended doses (100 mg and 300 mg) and determine the appropriate dose for future development.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Data from the Phase 1/2 dose escalation and expansion trial (data cut off April 2023) showed that ARV-766 was well-tolerated and demonstrated promising activity in a heavily pre-treated, post-receipt of novel hormonal agents, or NHAs, all-comers patient population. In both the Phase 1 dose escalation and Phase 2 dose expansion, 100% of patients were previously treated with at least one or more NHAs. Patients had a median of four prior lines of therapy in the Phase 1 trial and five prior lines of therapy in the Phase 2 trial. Multiple prior therapies have been associated with a decreased responsiveness to AR-directed therapies and an increase in tumor heterogeneity. AR ligand binding domain, or LBD, mutations were present in 28% (13 of 47) of patients&#8217; tumors in the Phase 1/2 trial as determined by plasma DNA analysis. Overall, 42% of patients with AR LBD mutations achieved reductions in PSA levels of greater than or equal to 50%, or PSA50. TIn all patients with L702H mutations, three of five patients with achieved PSA50, and three of three patients with co-occurring T878/H875/L702 mutations achieved PSA50. Response Evaluation Criteria in Solid Tumors, or RECIST, partial responses were observed. Of four patients with AR LBD mutations where RECIST was evaluable, one achieved a confirmed partial response, and one achieved an unconfirmed partial response.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ARV-766 was well tolerated and the majority of treatment related adverse events, or TRAEs, have been Grade 1 or 2, with no Grade &#8805;4 TRAEs and no dose limiting toxicities. Forty seven patients across the Phase 1 and 2 trials were evaluable for safety and, of these patients, one patient discontinued treatment due to a TRAE in Phase 2 and two of 47 patients, both in Phase 1, were dose reduced due to TRAE.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the second half of 2023, we also anticipate initiating a Phase 1b/2 trial for ARV-766 in combination with abiraterone in patients with AR-dependent tumors who have not previously received NHAs. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pipeline</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are further diversifying our pipeline by developing new PROTAC targeted protein degraders against targets for which we believe protein degradation offers advantages to existing therapeutic modalities, including PROTAC degraders that are designed to reach targets in deep brain regions and are capable of being delivered through multiple routes of administration, including oral delivery. We have engineered PROTAC targeted protein degraders that, in preclinical studies, have successfully achieved blood-brain barrier penetration, a key step in developing drugs with the potential to treat neurodegenerative diseases. We believe there are many other indications for which our PROTAC technology may be advantageous. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In April 2023, we presented in-vivo and in-vitro data at AACR - Targeting RAS Special Conference demonstrating our G12D PROTAC degraders are potent, selective and led to tumor stasis in a mouse xenograft model with intermittent dosing and degradation of KRAS G12D provides an advantage vs. inhibition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">in vitro </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">in vivo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">. We also presented new preclinical data at the CHDI Foundation&#8217;s Annual Huntington&#8217;s Disease Therapeutics Conference showing our PROTAC degraders potently and selectively degraded soluble mutant huntingtin (mHTT) in multiple cellular readouts, including rodent neurons, while sparing wild-type HTT.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By year-end 2023, we expect to submit an investigational new drug, or IND, application or clinical trial application, or CTA, for our PROTAC degrader designed to target each of the BCL6 protein, a protein mutated in patients with different forms of Non-Hodgkins Lymphoma, including Diffuse Large B-Cell Lymphoma, and the LRRK2 protein, a protein kinase that has been genetically linked to some forms of Parkinson's Disease. We also expect to progress at least two additional PROTAC protein degrader programs into IND-enabling or CTA-enabling studies by year-end 2023.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Operations</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We commenced operations in 2013. Our operations to date have been limited to organizing and staffing our company, business planning, raising capital, conducting discovery and research activities, filing patent applications, identifying potential product candidates, undertaking preclinical studies and clinical trials and establishing arrangements with third parties for the manufacture of initial quantities of our product candidates. To date, we have not generated any revenue from product sales and have financed our operations primarily through sales of our equity interests, proceeds from our collaborations, grant funding and debt financing. Since inception through June&#160;30, 2023, we raised approximately $1.3&#160;billion in gross proceeds from the sale of equity instruments and the exercise of stock options and had received an aggregate of $783.0&#160;million in payments primarily from collaboration partners.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage company. Vepdegestrant (ARV-471), bavdegalutamide (ARV-110) and ARV-766 are each in Phase 1/2 clinical trials, vepdegestrant is also in a Phase 3 clinical trial and our other drug discovery activities are at the research and preclinical development stages. Our ability to generate revenue from product sales sufficient to achieve profitability will depend heavily on the successful development and eventual commercialization of one or more of our product candidates. Since inception, we have incurred significant operating losses and expect to incur increasing operating losses for at least the next several years due to costs associated with our ongoing and anticipated clinical activities for vepdegestrant, bavdegalutamide and ARV-766, development activities associated with our other product candidates, research activities in oncology, neurological and other disease areas to expand our pipeline, hiring additional personnel in research, clinical trials, quality and other functional areas, increased expenses incurred with contract manufacturing organizations to supply us with product for our preclinical studies and clinical trials and contract research organizations for the synthesis of compounds in our preclinical development activities, as well as other associated costs including the management of our intellectual property portfolio. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not expect to generate revenue from sales of any product for many years, if ever. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on attractive terms, we could be forced to delay, reduce or eliminate our research or product development programs or any future commercialization efforts, or to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us.</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_109"></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Operations Overview</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not generated any revenue from product sales and do not expect to generate any revenue from the sale of products in the foreseeable future. Our revenues to date have been generated through research collaboration and license agreements. Revenue is recognized ratably over our expected performance period under each agreement. We expect that any revenue for the next several years will be derived primarily from our current collaboration agreements and any additional collaborations that we may enter into in the future. To date, we have not received any sales-based milestone payments or royalties under any of the collaboration agreements. </span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Genentech License Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, we entered into an Option and License Agreement with Genentech, Inc. and F. Hoffmann-La Roche Ltd, collectively referred to as Genentech, focused on PROTAC targeted protein degrader discovery and research for target proteins, or Targets, based on our proprietary platform technology, other than excluded Targets as described below. This collaboration was expanded in November 2017 through an Amended and Restated Option, License and Collaboration Agreement, which we refer to as the Restated Genentech Agreement.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Restated Genentech Agreement, Genentech has the right to designate up to ten Targets for further discovery and research utilizing our PROTAC platform technology. Genentech may designate as a Target any protein to which a PROTAC targeted protein degrader, by design, binds to achieve its mechanism of action, subject to certain exclusions. Genentech also has the right to remove a Target from the collaboration and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">substitute a different Target that is not an excluded Target at any time prior to us commencing research on such Target or in certain circumstances following commencement of research by us.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time we entered into the original agreement with Genentech, we received an upfront payment of $11.0 million, and at the time we entered into the Restated Genentech Agreement, we received an additional $34.5 million in upfront and expansion target payments. We are eligible to receive payments aggregating up to $44.0 million per Target upon the achievement of specified development milestones; payments aggregating up to $52.5 million per Target (assuming approval of two indications) subject to the achievement of specified regulatory milestones; and payments aggregating up to $60.0 million per PROTAC targeted protein degrader directed against the applicable Target, subject to the achievement of specified sales milestones. These milestone payments are subject to reduction if we do not have a valid patent claim covering the licensed PROTAC targeted protein degrader at the time the milestone is achieved. We are also eligible to receive, on net sales of licensed PROTAC targeted protein degraders, mid-single digit royalties, which may be subject to reductions. </span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfizer Research Collaboration Agreement </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, we entered into a Research Collaboration and License Agreement with Pfizer, setting forth our collaboration to identify or optimize PROTAC targeted protein degraders that mediate for degradation of Targets, using our proprietary platform technology that are identified in the agreement or subsequently selected by Pfizer, subject to certain exclusions. We refer to this agreement as the Pfizer Research Collaboration Agreement.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Pfizer Research Collaboration Agreement, Pfizer has designated a number of initial Targets. For each identified Target, we and Pfizer will conduct a separate research program pursuant to a research plan. Pfizer may make substitutions for any of the initial Target candidates, subject to the stage of research for such Target. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the year ended December 31, 2018, we received an upfront non-refundable payment and certain additional payments totaling $28.0 million in exchange for use of our technology license and to fund Pfizer-related research, as defined within the Pfizer Research Collaboration Agreement. We are eligible to receive up to an additional $37.5 million in non-refundable option payments if Pfizer exercises its options for all targets under the Pfizer Research Collaboration Agreement. We are also entitled to receive up to $225.0 million in development milestone payments and up to $550.0 million in sales-based milestone payments for all designated targets under the Pfizer Research Collaboration Agreement, as well as mid- to high-single digit tiered royalties, which may be subject to reductions, on net sales of PROTAC targeted protein degrader-related products. In the six months ended June&#160;30, 2023 and 2022, we received payments totaling $1.0 million and $3.5 million which were included in accounts receivable as of December 31, 2022 and 2021, respectively, for additional targets and services.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bayer Collaboration Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, we entered into a Collaboration and License Agreement, or the Bayer Collaboration Agreement, with Bayer AG, or, together with its controlled affiliates, Bayer, setting forth our collaboration to identify or optimize PROTAC targeted protein degraders that mediate for degradation of Targets, using our proprietary platform technology, that are selected by Bayer, subject to certain exclusions and limitations. The Bayer Collaboration Agreement became effective in July 2019. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Bayer Collaboration Agreement, we and Bayer conduct a research program pursuant to separate research plans mutually agreed to by us and Bayer and tailored to each Target selected by Bayer. Bayer may make substitutions for any such initial Target candidates, subject to certain conditions and based on the stage of research for such Target. During the term of the Bayer Collaboration Agreement, we are not permitted, either directly or indirectly, to design, identify, discover or develop any small molecule pharmacologically-active agent whose primary mechanism of action is, by design, directed to the inhibition or degradation of any Target selected or reserved by Bayer, or grant any license, covenant not to sue or other right to any third party in the field of human disease under the licensed intellectual property for the conduct of such activities.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the terms of the Bayer Collaboration Agreement, we received an aggregate upfront non-refundable payment of $17.5 million. Bayer was committed to fund a total of $12.0 million in research funding payments through 2023, all of which was received from inception through March 31, 2023. We are also eligible to receive up to $197.5 million in development milestone payments and up to $490.0 million in sales-based milestone payments for all designated Targets. In addition, we are eligible to receive, on net sales of PROTAC targeted protein degrader-related products, mid-single digit to low-double digit tiered royalties, which may be subject to reductions.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfizer </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vepdegestrant (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ARV-471) Collaboration Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we entered into a Collaboration Agreement with Pfizer, or the Vepdegestrant (ARV-471) Collaboration Agreement, pursuant to which we granted Pfizer worldwide co-exclusive rights to develop and commercialize products containing our proprietary compound ARV-471, or the Licensed Products.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Vepdegestrant (ARV-471) Collaboration Agreement, we received an upfront, non-refundable payment of $650.0 million. In addition, we are eligible to receive up to an additional $1.4 billion in contingent payments based on specified regulatory and sales-based milestones for the Licensed Products. Of the total contingent payments, $400 million in regulatory milestones are related to marketing approvals and $1.0 billion are related to sales-based milestones.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and Pfizer share equally (50/50) all development costs (including costs for conducting any clinical trials) for the Licensed Products, subject to certain exceptions. Except for certain regions described below, we will also share equally (50/50) all profits and losses in commercialization and medical affairs activities for the Licensed Products in all other countries, subject to certain exceptions.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be the marketing authorization holder and, subject to marketing approval, book sales in the United States, while Pfizer will hold marketing authorizations outside the United States. We will determine with Pfizer which, if any, regions within the world will be solely commercialized by one party, and in such region the parties will adjust their share of all profits and losses for the Licensed Products based on the role each party will be performing.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated in accordance with its terms, the Vepdegestrant (ARV-471) Collaboration Agreement will expire on a Licensed Product-by-Licensed Product and country-by-country basis when such Licensed Products are no longer commercialized or developed for commercialization in such country. Pfizer may terminate the Vepdegestrant (ARV-471) Collaboration Agreement for convenience in its entirety or on a region-by-region basis subject to certain notice periods. Either party may terminate the Vepdegestrant (ARV-471) Collaboration Agreement for the other party&#8217;s uncured material breach or insolvency. Subject to applicable terms of the Vepdegestrant (ARV-471) Collaboration Agreement, including certain payments to Pfizer upon termination for our uncured material breach, effective upon termination of the Vepdegestrant (ARV-471) Collaboration Agreement, we are entitled to retain specified licenses to be able to continue to exploit the Licensed Products.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to specified exceptions, we and Pfizer have each agreed not to directly or indirectly research, develop, or commercialize any competing products outside of the Vepdegestrant (ARV-471) Collaboration Agreement anywhere in the world during the term of the Vepdegestrant (ARV-471) Collaboration Agreement.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses since inception have consisted solely of research and development costs and general and administrative costs. </span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist primarily of costs incurred for our research activities, including our discovery efforts, and the development of our product candidates, and include: </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">salaries, benefits and other related costs, including stock-based compensation expense, for personnel engaged in research and development functions; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">expenses incurred under agreements with third parties, including CROs and other third parties that conduct research and preclinical activities on our behalf as well as third parties that manufacture our product candidates for use in our preclinical studies and clinical trials; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">costs of outside consultants, including their fees, stock-based compensation and related travel expenses; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">the costs of laboratory supplies and developing preclinical studies and clinical trial materials; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">facility-related expenses, which include direct depreciation costs of equipment and allocated expenses for rent and maintenance of facilities and other operating costs; and </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">third-party licensing fees. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development costs as incurred.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically use our employee and infrastructure resources across our development programs, and as such, do not track all of our internal research and development expenses on a program-by-program basis. The following table summarizes our research and development expenses for our AR program, which includes bavdegalutamide and ARV-766, ER program, which includes vepdegestrant, and all other platform and exploratory research and development costs:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Six Months Ended<br/>June 30,</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(in millions)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AR program development costs</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.3&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38.4&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">27.4&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">ER program development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">59.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other research and development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">49.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="2" style="background-color:#CFF0FC;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">43.9&#160;</span></td><td style="background-color:#CFF0FC;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="2" style="background-color:#CFF0FC;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100.5&#160;</span></td><td style="background-color:#CFF0FC;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="2" style="background-color:#CFF0FC;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">76.9&#160;</span></td><td style="background-color:#CFF0FC;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total research and development costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">103.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">75.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">198.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">139.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development activities are central to our business model. We expect that our research and development expenses will continue to increase substantially for the foreseeable future as we continue to conduct our ongoing clinical trials for vepdegestrant, bavdegalutamide and ARV-766, including our Phase 3 clinical trial for vepdegestrant, and continue to discover and develop additional product candidates. Research and development expenses related to vepdegestrant are shared equally with Pfizer since July 22, 2021, the effective date of the Vepdegestrant (ARV-471) Collaboration Agreement. The ER program development costs in the table above reflect the cost sharing with Pfizer.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot determine with certainty the duration and costs of future clinical trials of vepdegestrant, bavdegalutamide and ARV-766 or any other product candidate we may develop or if, when, or to what extent we will generate revenue from the commercialization and sale of any product candidate for which we obtain marketing approval. We may never succeed in obtaining marketing approval for any product candidate. The successful development and commercialization of our product candidates is highly uncertain. This is due to the numerous risks and uncertainties associated with developing drugs, including the uncertainty of: </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">successful completion of preclinical studies and clinical trials; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">receipt and related terms of marketing approvals from applicable regulatory authorities; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">obtaining and maintaining patent and trade secret protection and regulatory exclusivity for our product candidates; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">making arrangements with third-party manufacturers, or establishing manufacturing capabilities, for both clinical and commercial supplies of our product candidates; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">establishing sales, marketing and distribution capabilities and launching commercial sales of our products, if and when approved, whether alone or in collaboration with others; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">acceptance of our products, if and when approved, by patients, the medical community and third-party payors;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">obtaining and maintaining third-party coverage and adequate reimbursement; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">maintaining a continued acceptable safety profile of the products following approval; and </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">effectively competing with other therapies. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change in the outcome of any of these variables with respect to the development of a product candidate could mean a significant change in the costs and timing associated with the development of that product candidate. For example, if the FDA or another regulatory authority were to require us to conduct clinical trials beyond those that we anticipate will be required for the completion of clinical development of a product candidate, or if we experience significant delays in our clinical trials due to patient enrollment or other reasons, we would be required to expend significant additional financial resources and time on the completion of clinical development. </span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and other related costs, including stock-based compensation for personnel in our executive, finance, business development and administrative functions. General and administrative expenses also include legal fees relating to intellectual property and corporate matters; professional fees for accounting, auditing, tax and consulting services; insurance costs; travel expenses; and facility-related expenses, which include direct depreciation costs and allocated expenses for rent and maintenance of facilities and other operating costs. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our general and administrative expenses will increase in the future as we increase our personnel headcount to support increased research and development activities relating to our product candidates. We also expect to incur increased expenses associated with being a public company, including costs of accounting, audit, legal, regulatory and tax-related services associated with maintaining compliance with the Nasdaq Stock Market and Securities and Exchange Commission requirements; director and officer insurance costs; and investor and public relations costs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in 2013 through December&#160;31, 2022, we have not recorded any U.S. federal or state income tax benefits for the net losses we have incurred in any year or for our federal or state earned research and development tax credits, due to our uncertainty of realizing a benefit from those items. During the year ended December&#160;31, 2022, we fully utilized our previously held federal net operating loss and federal credit carryforwards due to taxable income resulting from revenue recognition for tax purposes from our Vepdegestrant (ARV-471) Collaboration Agreement and the mandatory capitalization of qualified research and development expenses incurred on or after January 1, 2022 under the Tax Cuts and Jobs Act. For the six months ended June&#160;30, 2023 we recorded a tax benefit related to expected benefits from state net operating loss carryback claims. We expect to generate federal and state net operating losses and credit carryforwards in 2023 and future periods. The revenue recognition and capitalization of research expenses are timing differences for tax purposes and deferred tax assets were established. We have provided a valuation allowance against the full amount of the deferred tax assets since, in the opinion of management, based upon our earnings history, it is more likely than not that the benefits will not be realized.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, Arvinas, Inc. had four wholly-owned subsidiaries organized as C-corporations: Arvinas Operations, Inc., Arvinas Androgen Receptor, Inc., Arvinas Estrogen Receptor, Inc., and Arvinas Winchester, Inc.</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_112"></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of financial condition and results of operations is based on our unaudited condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of our unaudited condensed consolidated financial statements and related disclosures requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, costs and expenses and the disclosure of contingent assets and liabilities in our unaudited condensed consolidated financial statements. We base our estimates on </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our critical accounting estimates from those described in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Annual Report on Form 10-K for the year ended December&#160;31, 2022, filed with the Securities and Exchange Commission on February&#160;23, 2023.</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_115"></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three and Six Months Ended June&#160;30, 2023 and 2022</span></div><div style="margin-top:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Six Months Ended<br/>June 30,</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">I</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the three months ended June&#160;30, 2023 totaled $54.5&#160;million, compared to $33.8&#160;million for the three months ended June&#160;30, 2022. The increase of $20.7&#160;million was primarily due to an increase in revenue from the Vepdegestrant (ARV-471) Collaboration Agreement with Pfizer totaling $24.2&#160;million, partially offset by a decrease of $1.8&#160;million of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue under the Genentech Amended and Restated Option, License, and Collaboration Agreement as the performance period has concluded and a decrease of $1.2&#160;million of previously constrained deferred revenue related to our Oerth Bio joint venture and changes in revenue recognition rates under both the Pfizer Research Collaboration Agreement and Bayer Collaboration Agreement due to project extensions. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the six months ended June&#160;30, 2023 totaled $87.0&#160;million, compared to $60.3&#160;million for the six months ended June&#160;30, 2022. The increase of $26.7&#160;million was primarily due to an increase in revenue from the Vepdegestrant (ARV-471) Collaboration Agreement with Pfizer totaling $40.1&#160;million, partially offset by a decrease of $2.4&#160;million of previously constrained deferred revenue related to our Oerth Bio joint venture, a decrease of $1.8&#160;million of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue under the Genentech Amended and Restated Option, License, and Collaboration Agreement as the performance period has concluded and a net decrease in revenue totaling $8.2&#160;million due to extensions of the period of revenue recognition under both the Pfizer Research Collaboration Agreement and Bayer Collaboration Agreement.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended June&#160;30, 2023 totaled $103.4&#160;million, compared to $75.3&#160;million for the three months ended June&#160;30, 2022. The increase of $28.1&#160;million was primarily due to an increased investment in our platform and exploratory programs of $5.4&#160;million as well as increases in our AR and ER programs of $7.4&#160;million and $15.3&#160;million, respectively. The increase over all of our programs was primarily driven by clinical trial costs and related drug manufacturing costs of $17.3&#160;million within </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our AR and ER programs. Expenses related to our platform and exploratory targets increased by $5.3&#160;million as we continued to expand the number of protein targets in the exploratory and lead optimization phases and continued to make investments into our platform discovery efforts. Additionally, personnel and infrastructure related costs increased by $5.5&#160;million.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the six months ended June&#160;30, 2023 totaled $198.6&#160;million, compared to $139.2&#160;million for the six months ended June&#160;30, 2022. The increase of $59.4&#160;million was primarily due to an increased investment in our platform and exploratory programs of $23.6&#160;million as well as increases in our AR and ER programs of $11.0&#160;million and $24.8&#160;million, respectively. The increase over all of our programs was primarily driven by clinical trial costs and related drug manufacturing costs of $24.5&#160;million as we expanded our AR and ER programs into additional clinical trials. Expenses related to our platform and exploratory targets also increased by $18.8&#160;million as we continued to expand the number of protein targets in the exploratory and lead optimization phases and continued to make investments into our platform discovery efforts. Additionally, personnel and infrastructure related costs increased by $16.1&#160;million. </span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses totaled $25.7&#160;million for the three months ended June&#160;30, 2023, compared to $24.3&#160;million for the three months ended June&#160;30, 2022. The increase of $1.4&#160;million was primarily due to an increase in professional fees of $2.0&#160;million and increased spending in developing our commercial operations of $0.9&#160;million, offset in part by reduced personnel and infrastructure related costs of $1.1&#160;million and reduced insurance costs of $0.3&#160;million. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses totaled $50.7&#160;million for the six months ended June&#160;30, 2023, compared to $44.5&#160;million for the six months ended June&#160;30, 2022. The increase of $6.2&#160;million was primarily due to an increase in professional fees of $4.0&#160;million,  increased spending in developing our commercial operations of $0.8&#160;million and personnel and infrastructure related costs of $2.0&#160;million, offset in part by reduced insurance costs of $0.6&#160;million.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income totaled $9.0&#160;million for the three months ended June&#160;30, 2023, compared to $1.7&#160;million for the three months ended June&#160;30, 2022. The increase of $7.3&#160;million was primarily due to higher interest income from higher interest rates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income totaled $15.5&#160;million for the six months ended June&#160;30, 2023, compared to $2.7&#160;million for the six months ended June&#160;30, 2022. The increase of $12.8&#160;million was primarily due to higher interest income of $13.7&#160;million from higher interest rates, offset in part by higher realized losses on our marketable securities of $1.0&#160;million.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit totaled $0.3 million for the three months ended June&#160;30, 2023, compared to an income tax expense of $3.4 million for the three months ended June&#160;30, 2022. Current year tax benefit was driven by expected benefits from state net operating loss carryback claims. Prior year tax expense was driven by revenue recognition for tax purposes from our Vepdegestrant (ARV-471) Collaboration Agreement and the capitalization of research and development expenses incurred on or after January 1, 2022.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit totaled $0.7&#160;million for the six months ended June&#160;30, 2023, compared to an income tax expense of $7.9&#160;million for the six months ended June&#160;30, 2022. Current year tax benefit was driven by expected benefits from state net operating loss carryback claims. Prior year tax expense was driven by revenue recognition for tax purposes from our Vepdegestrant (ARV-471) Collaboration Agreement and the capitalization of research and development expenses incurred on or after January 1, 2022. Under the Tax Cuts and Jobs Act of 2017, qualified research expenses incurred after 2021 are no longer immediately deductible for tax purposes and instead must be amortized over 5 years for tax purposes. As a result of these items, we fully utilized our federal net operating loss and credit carryforwards in 2022, which resulted in income tax expense for the prior period.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss from Equity Method Investment </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from equity method investment totaled $1.3 million for the three months ended June&#160;30, 2023, compared to $2.5 million for the three months ended June&#160;30, 2022. The decrease of $1.2 million was due to lower net losses incurred by Oerth Bio for the three months ended June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from equity method investment totaled $2.4 million for the six months ended June&#160;30, 2023, compared to $4.8 million for the six months ended June&#160;30, 2022. The decrease of $2.4 million was due to lower net losses incurred by Oerth Bio for the six months ended June&#160;30, 2023.</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_121"></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have any approved products and have never generated any revenue from product sales. To date, we have financed our operations primarily through the sale of equity interests and through payments from collaboration partners, grant funding and loans from the State of Connecticut. Since inception through June&#160;30, 2023, we had received an aggregate of $783.0&#160;million in payments from collaboration partners, grant funding and forgivable and partially forgivable loans from the State of Connecticut, and raised approximately $1.3&#160;billion in gross proceeds from the sale of equity interests and the exercise of stock options, including: </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">October 2018: completion of our initial public offering in which we issued and sold an aggregate of 7,700,482 shares of common stock, for aggregate gross proceeds of $123.2 million before fees and expenses; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">July 2019: sale of 1,346,313 shares of common stock to Bayer AG for aggregate gross proceeds of $32.5 million; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">November 2019: completion of a follow-on offering in which we issued and sold 5,227,273 shares of common stock for aggregate gross proceeds of $115.0 million before fees and expenses; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">September &#8211; December 2020: sale of 2,593,637 shares of common stock in an &#8220;at-the-market offering&#8221; for aggregate gross proceeds of $65.6 million before fees and expenses;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">December 2020: completion of a follow-on offering in which we issued and sold 6,571,428 shares of common stock for aggregate gross proceeds of $460.0 million before fees and expenses; and</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">September 2021: issuance of 3,457,815 shares of common stock to Pfizer for aggregate gross proceeds of $350.0 million.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we entered into a lease, which was amended in August 2022, for approximately 160,000 square feet of laboratory and office space, expected to be occupied in 2025. In connection with the signing of the lease and the related amendment, and at our election to increase the landlord&#8217;s contribution to the tenant improvement allowance, we initially issued a letter of credit totaling $4.5&#160;million, which was subsequently increased to $5.5 million, collateralized by a certificate of deposit in the same amount. Once occupied, the base rent will range from $7.7 million to $8.8 million annually over a ten-year lease term.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we entered into an Equity Distribution Agreement with Piper Sandler &amp; Company and Cantor Fitzgerald &amp; Co., as agents, pursuant to which we may offer and sell from time to time, through the agents, up to $300.0 million of the common stock registered under our universal shelf registration statement pursuant to one or more &#8220;at-the-market" offering. As of June&#160;30, 2023, no shares have been issued under this agreement.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents, restricted cash and marketable securities totaled $1.0 billion as of June&#160;30, 2023 and $1.2 billion as of December&#160;31, 2022. We had an outstanding loan balance of $1.0 million as of June&#160;30, 2023 and December&#160;31, 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our sources and uses of cash for the period presented: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Six Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(179.9)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(135.7)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(44.2)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">187.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">117.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">69.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#CFF0FC;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.0)</span></td><td style="background-color:#CFF0FC;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(15.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities for the six months ended June&#160;30, 2023 increased by $44.2 million, compared with the six months ended June&#160;30, 2022, primarily due to an increase in our net loss of $15.1 million, increased reduction in deferred revenue of $30.6 million and decreased cash inflows from accounts receivable of $12.7 million, partially offset by changes in prepaid expenses and other current assets of $14.1 million and account payable and accrued expenses of $12.1 million. Non-cash charges decreased by $10.4 million, primarily due to net accretion of bond discounts/premiums of $12.8 million, partially offset by increased changes in stock compensation expense $1.6 million.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities for the six months ended June&#160;30, 2023 increased by $69.6 million, compared with the six months ended June&#160;30, 2022, due to an increase in net sales and maturities of marketable securities in excess of purchases of $67.8 million and a decrease in purchases of property and equipment of $1.8 million.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the six months ended June&#160;30, 2023 decreased by $1.0 million, compared with the six months ended June&#160;30, 2022, due to decreased proceeds from the exercise of stock options.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding Requirements </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have incurred significant operating losses. We expect to continue to incur significant expenses and increasing operating losses for the foreseeable future as we advance the preclinical and clinical development of our product candidates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, we anticipate that our expenses will increase substantially if, and as we:</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.02pt">continue clinical trials of our product candidate vepdegestrant (ARV-471) to treat patients with locally advanced or metastatic ER+/HER2- breast cancer, including progressing the study-lead in trial of VERITAC-3, a Phase 3 clinical trial of vepdegestrant in combination with palbociclib, VERITAC-2, a Phase 3 monotherapy clinical trial, and a Phase 1b combination trial of vepdegestrant in combination with palbociclib, as well as initiating a Phase 1b/2 study with vepdegestrant with Pfizer's CDK4 inhibitor and an additional arm of the Phase 1b/2 combination umbrella clinical trial of vepdegestrant with Carrick Therapeutics, Inc.'s CDK7 inhibitor;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue clinical trials of our product candidate bavdegalutamide (ARV-110) for the treatment of men with mCRPC, including progressing a Phase 1/2 clinical trial of bavdegalutamide and a Phase 1b clinical trial of bavdegalutamide in combination with abiraterone, and initiating a global Phase 3 clinical trial of bavdegalutamide for patients with AR T878/H875 tumor mutations;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">continue clinical trials of our product candidate ARV-766 for the treatment of men with mCRPC, including progressing the Phase 1/2 dose escalation and expansion trial of ARV-766 and initiating </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:63pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a Phase 1b/2 dose escalation trial of ARV-766 in combination with abiraterone in patients who have not previously received novel hormonal agents;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">submit IND and CTA applications for our BCL6 and our LRRK2 PROTAC protein degraders, respectively, with regulators;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">progress additional PROTAC protein degrader programs into IND- or CTA-enabling studies;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">apply our PROTAC Discovery Engine to advance additional product candidates into preclinical and clinical development;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">expand the capabilities of our PROTAC Discovery Engine; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">seek marketing approvals for any product candidates that successfully complete clinical trials; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">ultimately establish a sales, marketing and distribution infrastructure and scale up external manufacturing capabilities to commercialize any products for which we may obtain marketing approval; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">expand, maintain and protect our intellectual property portfolio; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">hire additional development, including clinical and regulatory, and scientific personnel; and </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">add operational, financial and management information systems and personnel to support our research, product development and future commercialization efforts and support our operations as a public company.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash, cash equivalents, restricted cash and marketable securities totaling approximately $1.0 billion as of June&#160;30, 2023. We believe that our cash, cash equivalents, restricted cash and marketable securities as of June&#160;30, 2023 will enable us to fund our planned operating expenses and capital expenditure requirements into 2026. We have based this estimate on assumptions that may prove to be wrong and we could use our capital resources sooner than we currently expect. Our future capital requirements will depend on many factors, including: </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the progress, costs and results of our ongoing clinical trials for vepdegestrant (ARV-471), bavdegalutamide (ARV-110), and ARV-766 and any future clinical development of vepdegestrant, bavdegalutamide and ARV-766;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">the scope, progress, costs and results of preclinical and clinical development for our other product candidates and development programs, including BCL6 and LRRK2; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">the number of, and development requirements for, other product candidates that we pursue, including our other oncology and neurodegenerative research programs; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the success of our collaborations with Pfizer, Genentech and Bayer;</span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">the costs, timing and outcome of regulatory review of our product candidates; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">the costs and timing of future commercialization activities, including product manufacturing, marketing, sales and distribution, for any of our product candidates for which we receive marketing approval; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">the revenue, if any, received from commercial sales of our product candidates for which we receive marketing approval; </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims; and </span></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.8pt">our ability to establish additional collaboration arrangements with other biotechnology or pharmaceutical companies on favorable terms, if at all, for the development or commercialization of our product candidates. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of these anticipated expenditures, we will need to obtain substantial additional financing in connection with our continuing operations. Until such time, if ever, as we can generate substantial revenue from product sales, we expect to finance our cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. Although we may receive potential future payments under our collaborations with Pfizer, Genentech and Bayer, we do not currently have any committed external source of funds. Adequate additional funds may not be available to us on acceptable terms, or at all. If we are unable to raise capital when needed or on attractive terms, we may be required to delay, limit, reduce or terminate our research, product development programs or any future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we raise additional capital through the sale of equity or convertible debt securities, the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, we entered into an additional assistance agreement with the State of Connecticut, or the 2018 Assistance Agreement, to provide funding for the expansion and renovation of laboratory and office space.  We borrowed $2.0 million under the 2018 Assistance Agreement in September 2018, of which $1.0 million was forgiven upon meeting certain employment conditions. Borrowings under the agreement bear an interest rate of 3.25% per annum, with interest only payments required for the first 60 months, and mature in September 2028. The 2018 assistance agreement requires that we be located in the State of Connecticut through September 2028 with a default penalty of repayment of the full original funding amount of $2.0 million plus liquidated damages of 7.5% of the total amount of funding received. As of June&#160;30, 2023, $1.0 million remains outstanding under the 2018 Assistance Agreement.</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_124"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate sensitivities. Our interest-earning assets consist of cash, cash equivalents, restricted cash and marketable securities. Interest income earned on these assets totaled $16.6&#160;million and $2.9&#160;million for the six months ended June&#160;30, 2023 and 2022, respectively. Our interest income is sensitive to changes in the general level of interest rates, primarily U.S. interest rates. As of June&#160;30, 2023, our cash equivalents consisted of bank deposits and money market funds, and our marketable securities included interest-earning securities. Our outstanding debt totaled $1.0 million as of June&#160;30, 2023 and December&#160;31, 2022 and carries a fixed interest rate of 3.25% per annum.</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_127"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively), evaluated the effectiveness of our disclosure controls and procedures as of June&#160;30, 2023. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of June&#160;30, 2023, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the fiscal quarter ended June&#160;30, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_133"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in litigation or other legal proceedings arising in the ordinary course of business and regardless of outcome, litigation can have an adverse impact on our business, financial condition, results of operations and prospects because of defense and settlement costs, diversion of management resources and other factors. We are not currently a party to any material legal proceedings.</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_136"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing in our common stock involves a high degree of risk. You should carefully consider the those risks and uncertainties discussed in &#8220;Part I, Item 1A, Risk Factors,&#8221; in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed with the SEC on </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;23, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> together with all of the other information contained in this Quarterly Report on Form 10-Q, including our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q. The risk factor disclosure in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 is qualified by the information that is described in this Quarterly Report on Form 10-Q. If any of the risks described in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 actually occur, our business, prospects, operating results and financial condition could suffer materially. In such event, the trading price of our common stock could decline and you might lose all or part of your investment.</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_139"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not issue any securities that were not registered under the Securities Act during the three and six months ended June&#160;30, 2023.</span></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_475"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Director and Officer Trading Arrangements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-718"><ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-719"><ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-720"><ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-721">None of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K)</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> during the quarterly period covered by this Quarterly Report on Form 10-Q.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_142"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits.</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.459%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Description</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1655759/000119312518289513/d615527dex31.htm">Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K (File No. 001-38672) filed with the SEC on October 1, 2018).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1655759/000165575923000073/exhibit31-secondamendeda.htm">Second Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K (File No. 001-38672) filed with the SEC on June 21, 2023).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="arvinassixthleaseamendme.htm">Sixth Amendment to Lease between Arvinas Operations, Inc. (formerly Arvinas, Inc.) and Science Park Development Corporation, dated June 13, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="bayer_arvinasxamendmentx.htm">First Amendment to Collaboration and License Agreement between Arvinas Operations, Inc. and Bayer AG, dated June 30, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="arvn-20230630x10qex311.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="arvn-20230630x10qex312.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="arvn-20230630x10qex321.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="arvn-20230630x10qex322.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="background-color:#ffffff;color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inline </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Schema Document.</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="background-color:#ffffff;color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inline </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="background-color:#ffffff;color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inline </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Definition Linkbase Document.</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="background-color:#ffffff;color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inline </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Label Linkbase Document.</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="background-color:#ffffff;color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inline </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104.00</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Date File (formatted as Inline XBRL and contained in Exhibit 101). </span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35</span></div></div></div><div id="i76f5890a52dc4f2f9f2eb730676d3f66_145"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Table of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i76f5890a52dc4f2f9f2eb730676d3f66_7">Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Arvinas, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: August&#160;8, 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ John Houston, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">John Houston, Ph.D.</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">President and Chief Executive Officer</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Executive Officer)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: August&#160;8, 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Sean Cassidy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Sean Cassidy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer <br/>(Principal Financial Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: August&#160;8, 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David K. Loomis</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">David K. Loomis</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vice President and Chief Accounting Officer <br/>(Principal Accounting Officer)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">36</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>arvinassixthleaseamendme.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>arvinassixthleaseamendme</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1058;"><!-- arvinassixthleaseamendme001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="arvinassixthleaseamendme001.jpg" title="slide1" width="1058" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">SIXTH AMENDMENT TO LEASE  :Wl THIS SIXTH AMENDMENT TO LEASE (the &quot;Agreement&quot;) is entered into as of this \:!_ day of June, 2023 by and between SCIENCE PARK DEVELOPMENT CORPORATION, a Connecticut non stock corporation having its office at 5 Science Park, New Haven, Connecticut  06511 (the &quot;Landlord&quot;), and ARVINAS OPERATIONS, INC., f/k/a Arvinas, Inc., a Delaware  corporation having a principal place of business at 5 Science Park, 1st Floor, New Haven,  Connecticut 06511 (the &quot;Tenant&quot;) in modification of that certain Lease between the Landlord and  the Tenant executed on or about January 2, 2018 (the &quot;Original Lease&quot;), as amended by the First  Amendment to Lease between Landlord and Tenant and dated as of May 23, 2018 (the &quot;First  Amendment&quot;), as further modified by the Second Amendment to Lease between Landlord and  Tenant and dated as of September 4, 2018 (the &quot;Second Amendment&quot;), as further modified by  the Third Amendment to Lease between Landlord and Tenant and dated as of March 12, 2019 (the  &quot;Third Amendment&quot;), as further modified by the Fourth Amendment to Lease between Landlord  and Tenant and dated as of January 31, 2020 (the &quot;Fourth Amendment&quot;), and as further modified  by the Fifth Amendment to Lease between Landlord and Tenant and dated as of January 4, 2021  (the &quot;Fifth Amendment&quot;). The Original Lease as modified by the First Amendment, the Second  Amendment, the Third Amendment,the Fourth Amendment, and the Fifth Amendment are  collectively referred to herein as the &quot;Lease&quot;.  WHEREAS, the Landlord and the Tenant are parties to the Lease which is in full force  and effect; and  WHEREAS, the Landlord and the Tenant wish to modify the Lease as more fully set forth  herein; and  NOW, THEREFORE, the Landlord and the Tenant agree as follows:  1. Amendments to Lease. As of June 1, 2023, the following modifications are made to the Lease:  26247570.2  a) Section l . l(a) of the Lease is amended and restated to read, in full, as follows: Landlord is the owner of the real property located at Science Park, New  Haven, Connecticut as described on Exhibit A attached hereto (the  &quot;Property&quot;). The Tenant shall lease from Landlord the following premises  located in Science Park Building 5 (&quot;Building 5&quot;), which is located on the  Property: (i) approximately 7,873 rentable square feet on the first floor of  Building 5, as shown on the floor plan attached hereto as Schedule A-1 (the  &quot;First Floor Premises&quot;); (ii) approximately 10,249 rentable square feet on  the second floor of Building 5, as shown on the floor plan attached hereto  as Schedule A-2 (the &quot;Second Floor Premises&quot;); approximately 9,456  rentable square feet on the third floor of Building 5, as shown on the floor  plan attached hereto as Schedule A-3 (the &quot;Third Floor Premises&quot;); (iii)  as of May 15, 2018, approximately 2,632 rentable square feet on the first  floor of Building 5, as shown on the floor plan attached hereto as Schedule  A-4 (the &quot;Part A Space&quot;); (iv) as of May 1, 2019, or earlier as provided in Exhibit 10.1 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- arvinassixthleaseamendme002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="arvinassixthleaseamendme002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    26247570.2  2  Section 2.4.G. of the Lease, approximately 3,600 rentable square feet  (reduced from approximately 3,705 rentable square feet) on the first floor  of Building 5, as shown on the floor plan attached hereto as Schedule A-4  (the &#8220;Part B Space&#8221;); (v) as of September 1, 2018, approximately 84  rentable square feet on the first floor of Building 5 as shown on the floor  plan attached hereto as Schedule A-5 (the &#8220;September 2018 Space&#8221;); (vi)  as of March 1, 2019 approximately 1,264 rentable square feet (reduced from  approximately 1,468 rentable square feet) on the second floor of Building 5  as shown on the floor plan attached hereto as Schedule A-6 (the &#8220;March  2019 Space&#8221;); (vii) as of April 1, 2019 approximately 3,719 rentable square  feet on the first floor of Building 5 as shown on the floor plan attached  hereto as Schedule A-7 (the &#8220;April 2019 Space&#8221;); (viii) as of February 1,  2020 approximately 9,889 rentable square feet on the third floor of Building  5 as shown on the floor plan attached hereto as Schedule A-8 (the  &#8220;February 2020 Space&#8221;); as of February 1, 2021 approximately 10,708  rentable square feet on the second floor of Building 5 as shown on the floor  plan attached hereto as Schedule A-9 (the &#8220;February 2021 Space&#8221;); and  as of June 1, 2023 approximately 3,067 rentable square feet on the third  floor of Building 5 as shown on the floor plan attached hereto as Schedule  A-10 (the &#8220;June 2023 Space&#8221;).  Tenant shall have exclusive use of the  Landlord&#8217;s fixtures, equipment, furniture and other personalty as set forth  in Schedule A-1 attached hereto (&#8220;Landlord&#8217;s Additional Property&#8221;).   The First Floor Premises, the Second Floor Premises, the Third Floor  Premises, the Part A Space, the Part B Space, the September 2018 Space,  the March 2019 Space, the April 2019 Space, the February 2020 Space, the  February 2021 Space, the June 2023 Space, and the Landlord&#8217;s Additional  Property shall be referred to herein collectively as the &#8220;Leased Premises&#8221;.  Landlord&#8217;s Additional Property shall be considered part of the Leased  Premises but shall remain property of the Landlord.      b) Section 1.2 of the Lease is amended and restated to read in full as follows:    1.2 Parking.  The rental of the Leased Premises will include the  use of up to one hundred forty (149) parking spaces (&quot;Tenant's Parking  Spaces&quot;), in parking lots in common with other tenants and in locations in  reasonable proximity to Building 5 as designated by Landlord.  c) A new Section 2.4.M. is added to the Lease to provide, in full, as follows:    M.  Landlord shall deliver the June 2023 Space to Tenant in a broom  clean condition, free of any personal property of any prior tenants, except  as otherwise agreed. The June 2023 Space shall be leased to Tenant in its  then &#8220;as is&#8221; condition and Landlord shall not be required to construct any  additional improvements in, or contribute anything of value in connection  with any Tenant&#8217;s Work with respect to the June 2023 Space, excepting  only the following: consistent with Schedule A-10 (i) construction of any  needed partition or demising walls; and (ii) installation of tenant space  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- arvinassixthleaseamendme003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="arvinassixthleaseamendme003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    26247570.2  3  doors.  Tenant shall be responsible for installing any security locks and/or  key card security access devices for the door(s) to the June 2023 Space.    d) Section 2.1(a) of the Lease is modified by amending and restating the last sentence  thereof to read in full as follows:  Unless sooner cancelled or terminated or extended in accordance  with the terms of this Lease, the Term will expire with respect to the  entire Leased Premises as of December 31, 2024 (the &quot;Expiration  Date&quot;).     e) Section 3.1.A. of the Lease is modified by deleting the last line of the Base Rent  chart (for the months of February 2021 through December 2024) and substituting  therefor the following:          Months of Term  Base Rent  Rate  (Annually per  RSF)  Applicable  RSF    Monthly Base  Rent  February, 2021 - December, 2022 $21.00 59,474 $104,079.50  January, 2023 &#8211; May 31, 2023  $23.50 59,474 $116,469.91  June 1, 2023 - December, 2024  $23.50 62,541 $122,476.13           f) Section 3.2.A. of the Lease is modified to add the following provisions:    &quot;2023 Base Year&quot; shall mean the calendar year 2023.    &quot;2023 Operating Expenses&quot; shall mean the amount of Operating Expenses  attributable to the 2023 Base Year.    &quot;2023 Property Taxes&quot; shall mean the amount of Property Taxes attributable to  the 2023 Base Year.    g) The last paragraph of Section 3.2.A. of the Lease is amended and restated to read,  in full, as follows:  &#8220;Tenant&#8217;s 2018 Proportionate Share&#8221;, &#8220;Tenant's 2019 Proportionate Share&#8221; ,  &#8220;Tenant&#8217;s 2021 Proportionate Share&#8221;, and &#8220;Tenant&#8217;s 2023 Proportionate  Share&#8221; shall mean, respectively, those fractions, the numerator of which is: (i)  with respect to Tenant&#8217;s 2018 Proportionate Share, 38,877  rentable square feet  (the &#8220;Initial Premises&#8221;) (the &#8220;2018 Numerator&#8221;); (ii) with respect to Tenant&#8217;s  2019 Proportionate Share, 9,889 rentable square feet (the &#8220;2019 Numerator&#8221;), (iii)  with respect to Tenant&#8217;s 2021 Proportionate Share, 10,708 rentable square feet (the  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- arvinassixthleaseamendme004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="arvinassixthleaseamendme004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    26247570.2  4  &#8220;2021 Numerator&#8221;), and (iv) with respect to Tenant&#8217;s 2023 Proportionate Share,  3,067 rentable square feet (the &#8220;2023 Numerator&#8221;), and the denominator for each  of which (the &quot;Denominator&quot;) is the average of the total rentable square feet of  floor space in Building 5 actually under lease to tenants during the calendar year in  question (as such number is determined by leases, whether verbal or in writing,  and pursuant to the terms of which leases rent has commenced to be payable), (said  average being referred to as the &quot;Average Occupancy Figure&quot;). Notwithstanding  the foregoing, in the event that the Average Occupancy Figure is less than ninety  five percent (95%) of the total rentable square footage in Building 5 during any  calendar year, then in such event (i) the Denominator described hereinabove shall  be then established during such period in question at ninety five percent (95%) of  the total rentable square footage in Building 5, and (ii) those components of  Operating Expenses which relate to and are incurred as a consequence of Building  5 tenant use and occupancy (including Building 5 maintenance and repair,  janitorial and cleaning expenses. Building 5 management fees and costs and  Building 5 tenant electric expenses) shall be increased on a pro rata basis from the  actual levels at which they are incurred during any given calendar year in question  to the levels at which they would have been incurred had the Average Occupancy  Figure been ninety five percent (95%) of the total square footage in Building 5  during the calendar year in question.    &#8220;Tenant&#8217;s 2018, 2019, 2021, and 2023 Proportionate Shares&#8221; shall mean  Tenant&#8217;s 2018 Proportionate Share, Tenant's 2019 Proportionate Share, Tenant's  2021 Proportionate Share, and Tenant's 2023 Proportionate Share.    h) Section 3.2.B. of the Lease is amended and restated to read, in full, as follows:    B. Expense and Tax Increases.   In addition to the Base Rent, Tenant shall  pay to Landlord, as Additional Rent, as hereinafter provided, (I) Tenant's 2018  Proportionate Share of (i) increases in Operating Expenses over the Base Operating  Expenses, and (ii) increases in Property Taxes over Base Property Taxes; (II)  Tenant's 2019 Proportionate Share of (a) increases in Operating Expenses over 2019  Operating Expenses, and (b) increases in Property Taxes over 2019 Property Taxes;   (III) Tenant's 2021 Proportionate Share of (1) increases in Operating Expenses over  2021 Operating Expenses, and (2) increases in Property Taxes over 2021 Property  Taxes, and (IV) Tenant's 2023 Proportionate Share of (1) increases in Operating  Expenses over 2023 Operating Expenses, and (2) increases in Property Taxes over  2023 Property Taxes (collectively referred to as the &quot;Expense and Tax Increases&quot;).  In advance of each calendar year during the Term, Landlord shall furnish Tenant  with an estimate (which estimate may be changed by Landlord from time to time)  of Tenant's 2018, 2019, 2021, and 2023 Proportionate Shares of the Expense and  Tax Increases for the ensuing calendar year (or portion thereof). Commencing with  the monthly installment of Base Rent payable for January, 2019, and thereafter on  the first (1st) day of each month of calendar year 2019, Tenant shall pay to Landlord  one-twelfth (1/12th) of the amount of Landlord's then current estimate of Expense  and Tax Increases.  Commencing with the monthly installment of Base Rent payable  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- arvinassixthleaseamendme005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="arvinassixthleaseamendme005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    26247570.2  5  for January, 2020 (as to the Initial Premises) and February, 2020 (as to the February  2020 Space) and thereafter on the first (1st) day of each month of through December  31, 2021, Tenant shall pay to Landlord one-twelfth (1/12th) of the amount of  Landlord's then current estimate of Expense and Tax Increases. Commencing with  the monthly installment of Base Rent payable for January, 2022, and thereafter on  the first (1st) day of each month of the Term, as to the entire Leased Premises,  Tenant shall pay to Landlord one-twelfth (1/12th) of the amount of Landlord's then  current estimate of Expense and Tax Increases.  Commencing with the monthly  installment of Base Rent payable for January, 2024, and thereafter on the first (1st)  day of each month of the Term, as to the entire Leased Premises, Tenant shall pay  to Landlord one-twelfth (1/12th) of the amount of Landlord's then current estimate  of Expense and Tax Increases.  Within 180 days after the end of each calendar year  and within 180 days after the end of the Term, Landlord shall submit to Tenant a  statement, prepared by Landlord, of the actual Expense and Tax Increases for the  preceding calendar year (or partial calendar year in the event the Term shall end on  a date other than a December 31st), and the figures used for computing Tenant's  2018, 2019, 2021, and 2023 Proportionate Shares for the preceding calendar year,  and if Tenant's 2018, 2019, 2021, and 2023 Proportionate Shares of Expense and  Tax Increases so stated for such period is (i) more than the amount paid for such  period, Tenant shall pay to Landlord the deficiency within thirty (30) days after  submission of such statement, or (ii) less than the amount paid for such period, at  Landlord's sole election, Tenant shall be entitled to a credit in the amount of such  excess against amounts next coming due under this Paragraph or Landlord shall  refund the amount of such overpayment to Tenant (or a refund of such excess in the  case of the end of the term of this Lease). Any such adjustment shall survive the  expiration or earlier termination of the Term. If Landlord shall furnish such estimate  subsequent to the commencement of any such calendar year, then, until the first (1st)  day of the month following the month in which such estimate is furnished to Tenant,  Tenant shall pay to Landlord on the first (1st) day of each month an amount equal  to Tenant's monthly payment with respect to Tenant's 2018, 2019, 2021, and 2023  Proportionate Shares of Expense and Tax Increases for the last month of the  preceding calendar year.    i) Section 3.4 of the Lease is modified by substituting therefor the following:           Months of Term  Electricity Charge   (Annually per RSF)  Applicable  RSF    Monthly  Electricity  Charge  February, 2020 - January, 2021 $2.50 48,766    $10,159.58  February, 2021 &#8211; May 2023  $2.50 59,474    $12,390.42  June 2023 - December, 2024 $2.50 62,540 $13,029.17      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- arvinassixthleaseamendme006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="arvinassixthleaseamendme006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    26247570.2  6  2. Schedules. Schedule A-10 attached hereto is hereby made a part of the Lease  as amended by this Agreement.    3. Extended Term. Tenant shall continue to retain its right to an Extended Term  under and subject to the provisions of Article 35 of the Lease as to the entire Leased Premises  (inclusive of the Mandatory Expansion Premises), which Extended Term would commence  immediately following the Expiration Date of the Lease as extended by this Agreement.     4. Reaffirmation of Lease.   In all other respects, the Lease, as hereby amended,  is reaffirmed by the Parties and shall be and remain in full force and effect.      5. Landlord and Tenant Remain Obligated.     Nothing herein shall constitute a  waiver or release by the Landlord or the Tenant of any unperformed obligations of the other under  the Lease as modified by this Agreement.      6. Brokerage. Landlord shall pay an agreed commission to Colliers International  by way of a separate agreement. Landlord represents to Tenant that no other broker has any right  to lease space at the Property and Landlord agrees to indemnify and hold Tenant harmless from  and against the claims, losses, damages, costs and expenses (including, but not limited to,  reasonable attorneys&#8217; fees) incurred by Tenant as a result of any party asserting a right to a fee or  commission claiming to have acted by, under, through or on behalf of the Landlord. Tenant agrees  to indemnify and hold Landlord harmless from and against the claims, losses, damages, costs and  expenses (including, but not limited to, reasonable attorneys&#8217; fees) incurred by Landlord as a result  of any party other than Colliers International claiming a fee or commission by, under or through  Tenant on account of this Agreement and/or the extension of the Term of the Lease provided for  in this Agreement.        7. Later Provision Controls. In case of any inconsistency between the provisions  of the Lease and this Agreement, the provisions of this Agreement shall govern and control.   Without limiting the meaning or application of the foregoing sentence in any manner, the  provisions of Paragraph 5 of this Agreement supersede and replace Article 29 with respect to this  Agreement.    8. Capitalized Terms. Capitalized terms used but not otherwise defined herein shall  have the same meaning as set forth in the Lease.    9. Entire Agreement.  This Agreement sets forth the entire agreement between the  parties with respect to the matters set forth herein.  There have been no additional oral or written  representations or agreements.      10. Counterparts. This Agreement may be executed in one or more counterparts, each  of which shall be deemed an original, but all of which together shall constitute one and the same  instrument. Signatures to this Agreement transmitted by telecopy or otherwise electronically shall  be valid and effective to bind the party so signing.  Each party agrees promptly to deliver an  execution original to this Agreement with its actual signature to the other party, but a failure to do  so shall not affect the enforceability of this Agreement, it being expressly agreed that each party  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- arvinassixthleaseamendme007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="arvinassixthleaseamendme007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    26247570.2  7  to this Agreement shall be bound by its own telecopied or electronic signature and shall accept the  telecopied or electronic signature of the other party to this Agreement.    [The Signature Page(s) Follow.]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- arvinassixthleaseamendme008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="arvinassixthleaseamendme008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- arvinassixthleaseamendme009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="arvinassixthleaseamendme009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- arvinassixthleaseamendme010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="arvinassixthleaseamendme010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>bayer_arvinasxamendmentx.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>bayer_arvinasxamendmentx</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:965;"><!-- bayer_arvinasxamendmentx001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="bayer_arvinasxamendmentx001.jpg" title="slide1" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">DocuSign Envelope ID: 3068EFB8-4880-47C5-9C04-FDB1E1D99439 i  l  I : 5CDF20A 1ADD-4EFA-AEA6-F65D3EE 9750  -1-      Exhibit 10.2    FIRST AMENDMENT  TO  COLLABORATION AND LICENSE AGREEMENT    This FIRST AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT (&quot;First  Amendment&quot;), effective as of the date of last signature hereunder (the &quot;First Amendment Date&quot;),  is between Arvinas Operations, Inc., a corporation organized and existing under the laws of  Delaware, located at 5 Science Park, 395 Winchester Ave., New Haven, CT 06511, USA  (&#8220;Arvinas&#8221;) , and Bayer AG, a corporation having offices at M&uuml;llerstrasse 178, 13353 Berlin,  Germany (&#8220;Bayer&#8221;). This First Amendment amends that certain Collaboration and License  Agreement between Bayer and Arvinas effective as of June 3, 2019 (the &quot;Original Agreement&quot;).  Each of Arvinas and Bayer may be referred to herein as a &#8220;Party&#8221; and both collectively as the  &#8220;Parties.&#8221; All capitalized terms not otherwise defined in this First Amendment shall be as  defined in the Original Agreement.    WHEREAS, the Parties agree that the Research Term under the Original Agreement is to  be extended as specified below.    NOW, THEREFORE, in consideration of the mutual covenants and promises contained  in this First Amendment and for other good and valuable consideration, the receipt and  sufficiency of which are hereby acknowledged, the Parties, intending to be legally  bound, agree as follows:    1. The last sentence of Section 2.3.1 of the Original Agreement is hereby deleted in  its entirety and replaced with the following sentence:    &#8220;Notwithstanding any other provision, the Research Term shall not exceed five  (5) years, and the Research Program shall terminate at such time with respect to  all Collaboration Targets, unless otherwise agreed by the Parties in writing, such  agreement to not be unreasonably withheld.&#8221;    2. The Parties agree that no additional research funding payments shall be due in  connection with the extension of the Research Term contemplated herein and that  Arvinas shall utilize any remaining balance of any research funding payments  already received in support of any Research Program activities to be conducted  after the fourth anniversary of the Effective Date.    3. From and after the First Amendment Date, the term &quot;Agreement&quot; as used in the  Original Agreement shall mean the Original Agreement as amended by this First  Amendment.    4. This First Amendment may be executed in one or more counterparts, each of  which shall be deemed an original and all of which shall constitute one and the  same instrument.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- bayer_arvinasxamendmentx002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="bayer_arvinasxamendmentx002.jpg" title="slide2" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">DocuSign Envelope ID: 3068EFB8-4880-47C5-9C04-FDB1E1D99439 i  l  I : 5CDF20A 1ADD-4EFA-AEA6-F65D3EE 9750  -2-      The Parties hereby accept the terms and conditions of this First Amendment, as  evidenced by the signatures of their respective authorized representatives below:              On behalf of,  ARVINAS OPERATIONS, INC.  On behalf of,  BAYER AG        By:  By:   Sean Cassidy  Name:    Name: ppa. Dr. Friedemann Janus  SVP, Acting Head of Business  Title:    Date:  CFO and Treasurer  6/27/2023  Title:    Date:  Development &amp; Open Innovation  6/30/2023        By:     Name:  Title:  Date:  Dr. Andrea Haegebarth  Head of Research and Early  Development Precision Medicine    6/30/2023  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>arvn-20230630x10qex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2462dadee2b84ed69e1f7b1879ba61a3_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:18pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, John Houston, Ph.D., certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this Quarterly Report on Form 10-Q of Arvinas, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.979%"><tr><td style="width:1.0%"></td><td style="width:48.217%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August&#160;8, 2023</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John Houston, Ph.D.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">John Houston, Ph.D.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">President and Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>arvn-20230630x10qex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i6ea802c1d68e48d588ea8799291c0fb8_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:18pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Sean Cassidy, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this Quarterly Report on Form 10-Q of Arvinas, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-bottom:0.05pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August&#160;8, 2023</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sean Cassidy</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sean Cassidy</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Financial Officer and Treasurer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Principal Financial Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>arvn-20230630x10qex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i790b85918e894938995df3db1647f56d_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:18pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Arvinas, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="margin-bottom:0.05pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.979%"><tr><td style="width:1.0%"></td><td style="width:48.217%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August&#160;8, 2023</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John Houston, Ph.D.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">John Houston, Ph.D.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">President and Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>arvn-20230630x10qex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ied2248ef239e48848eee1bd67f8c9a55_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt;text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:18pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Arvinas, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="margin-bottom:0.05pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August&#160;8, 2023</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sean Cassidy</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sean Cassidy</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Financial Officer and Treasurer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Principal Financial Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>arvn-20230630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3ad84450-03f4-4a08-908c-03680fffbb5d,g:5431e377-e1a3-4379-9dba-d87e2214df03-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:arvn="http://www.arvinas.com/20230630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.arvinas.com/20230630">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="arvn-20230630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="arvn-20230630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="arvn-20230630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="arvn-20230630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.arvinas.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunaudited" roleURI="http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited">
        <link:definition>0000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunauditedParenthetical" roleURI="http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited" roleURI="http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited">
        <link:definition>0000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited" roleURI="http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsunaudited" roleURI="http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessandBasisofPresentation" roleURI="http://www.arvinas.com/role/NatureofBusinessandBasisofPresentation">
        <link:definition>0000007 - Disclosure - Nature of Business and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingPronouncementsandSignificantAccountingPolicies" roleURI="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Accounting Pronouncements and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchCollaborationandLicenseAgreements" roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreements">
        <link:definition>0000009 - Disclosure - Research Collaboration and License Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesandFairValueMeasurements" roleURI="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurements">
        <link:definition>0000010 - Disclosure - Marketable Securities and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyEquipmentandLeaseholdImprovements" roleURI="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovements">
        <link:definition>0000011 - Disclosure - Property, Equipment and Leasehold Improvements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLiabilities" roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilities">
        <link:definition>0000012 - Disclosure - Right-of-Use Assets and Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableandAccruedLiabilities" roleURI="http://www.arvinas.com/role/AccountsPayableandAccruedLiabilities">
        <link:definition>0000013 - Disclosure - Accounts Payable and Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.arvinas.com/role/LongTermDebt">
        <link:definition>0000014 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://www.arvinas.com/role/Equity">
        <link:definition>0000015 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.arvinas.com/role/IncomeTaxes">
        <link:definition>0000016 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.arvinas.com/role/NetLossPerShare">
        <link:definition>0000017 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestments" roleURI="http://www.arvinas.com/role/EquityMethodInvestments">
        <link:definition>0000018 - Disclosure - Equity Method Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.arvinas.com/role/CommitmentsandContingencies">
        <link:definition>0000019 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingPronouncementsandSignificantAccountingPoliciesPolicies" roleURI="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesPolicies">
        <link:definition>9954701 - Disclosure - Accounting Pronouncements and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingPronouncementsandSignificantAccountingPoliciesTables" roleURI="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesTables">
        <link:definition>9954702 - Disclosure - Accounting Pronouncements and Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchCollaborationandLicenseAgreementsTables" roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTables">
        <link:definition>9954703 - Disclosure - Research Collaboration and License Agreements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesandFairValueMeasurementsTables" roleURI="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsTables">
        <link:definition>9954704 - Disclosure - Marketable Securities and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyEquipmentandLeaseholdImprovementsTables" roleURI="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsTables">
        <link:definition>9954705 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLiabilitiesTables" roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesTables">
        <link:definition>9954706 - Disclosure - Right-of-Use Assets and Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableandAccruedLiabilitiesTables" roleURI="http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesTables">
        <link:definition>9954707 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.arvinas.com/role/LongTermDebtTables">
        <link:definition>9954708 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTables" roleURI="http://www.arvinas.com/role/EquityTables">
        <link:definition>9954709 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.arvinas.com/role/NetLossPerShareTables">
        <link:definition>9954710 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsTables" roleURI="http://www.arvinas.com/role/EquityMethodInvestmentsTables">
        <link:definition>9954711 - Disclosure - Equity Method Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessandBasisofPresentationDetails" roleURI="http://www.arvinas.com/role/NatureofBusinessandBasisofPresentationDetails">
        <link:definition>9954712 - Disclosure - Nature of Business and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails" roleURI="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails">
        <link:definition>9954713 - Disclosure - Accounting Pronouncements and Significant Accounting Policies - Cash Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails" roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails">
        <link:definition>9954714 - Disclosure - Research Collaboration and License Agreements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails" roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails">
        <link:definition>9954715 - Disclosure - Research Collaboration and License Agreements - Summary of Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails" roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails">
        <link:definition>9954716 - Disclosure - Research Collaboration and License Agreements - Transaction Price Allocated to Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails_1" roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails_1">
        <link:definition>9954716 - Disclosure - Research Collaboration and License Agreements - Transaction Price Allocated to Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails" roleURI="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails">
        <link:definition>9954717 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Available-for-Sale Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" roleURI="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails">
        <link:definition>9954718 - Disclosure - Property, Equipment and Leasehold Improvements - Schedule of Property, Equipment and Leasehold Improvements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyEquipmentandLeaseholdImprovementsAdditionalInformationDetails" roleURI="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsAdditionalInformationDetails">
        <link:definition>9954719 - Disclosure - Property, Equipment and Leasehold Improvements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLiabilitiesAdditionalInformationDetails" roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails">
        <link:definition>9954720 - Disclosure - Right-of-Use Assets and Liabilities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLiabilitiesComponentsofLeaseExpenseDetails" roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesComponentsofLeaseExpenseDetails">
        <link:definition>9954721 - Disclosure - Right-of-Use Assets and Liabilities - Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLiabilitiesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails" roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails">
        <link:definition>9954722 - Disclosure - Right-of-Use Assets and Liabilities - Schedule of Supplemental Cash Flow Information Related to Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>9954723 - Disclosure - Right-of-Use Assets and Liabilities - Schedule of Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>9954723 - Disclosure - Right-of-Use Assets and Liabilities - Schedule of Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableandAccruedLiabilitiesDetails" roleURI="http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails">
        <link:definition>9954724 - Disclosure - Accounts Payable and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofLongTermDebtDetails" roleURI="http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails">
        <link:definition>9954725 - Disclosure - Long-Term Debt - Schedule of Long Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtAdditionalInformationDetails" roleURI="http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails">
        <link:definition>9954726 - Disclosure - Long-Term Debt - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails" roleURI="http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails">
        <link:definition>9954727 - Disclosure - Long-Term Debt - Schedule of Minimum Future Payments on Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityAdditionalInformationDetails" roleURI="http://www.arvinas.com/role/EquityAdditionalInformationDetails">
        <link:definition>9954728 - Disclosure - Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails" roleURI="http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails">
        <link:definition>9954729 - Disclosure - Equity - Schedule of Assumptions Used to Determine Fair Value of and Stock Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquitySummaryofStockOptionActivityDetails" roleURI="http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails">
        <link:definition>9954730 - Disclosure - Equity - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquitySummaryofRestrictedStockDetails" roleURI="http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails">
        <link:definition>9954731 - Disclosure - Equity - Summary of Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.arvinas.com/role/IncomeTaxesDetails">
        <link:definition>9954732 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareBasicandDilutedLossperCommonShareDetails" roleURI="http://www.arvinas.com/role/NetLossPerShareBasicandDilutedLossperCommonShareDetails">
        <link:definition>9954733 - Disclosure - Net Loss Per Share - Basic and Diluted Loss per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails" roleURI="http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails">
        <link:definition>9954734 - Disclosure - Net Loss Per Share - Securities Excluded From Computation of Diluted Net Loss Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsAdditionalInformationDetails" roleURI="http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails">
        <link:definition>9954735 - Disclosure - Equity Method Investments- Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails" roleURI="http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails">
        <link:definition>9954736 - Disclosure - Equity Method Investments - Schedule of Correction of Immaterial Error for the Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.arvinas.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9954737 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="arvn_ResearchCollaborationAndLicenseAgreementsAbstract" abstract="true" name="ResearchCollaborationAndLicenseAgreementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement" abstract="false" name="AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_DebtInstrumentLoanForgiveness" abstract="false" name="DebtInstrumentLoanForgiveness" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_ProceedsFromSaleOfMarketableSecurities" abstract="false" name="ProceedsFromSaleOfMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" abstract="false" name="ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="arvn_CollaborationAgreementMember" abstract="true" name="CollaborationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_SalesBasedMilestonePaymentsMember" abstract="true" name="SalesBasedMilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares" abstract="false" name="ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract" abstract="true" name="IncomeStatementAndStatementOfComprehensiveIncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived" abstract="false" name="AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_ChangeInContractWithCustomerLiabilityRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="arvn_TwoThousandEighteenStockIncentivePlanMember" abstract="true" name="TwoThousandEighteenStockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_FoundationMedicineIncMember" abstract="true" name="FoundationMedicineIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions" abstract="false" name="AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_PercentageOfLiquidatedDamages" abstract="false" name="PercentageOfLiquidatedDamages" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="arvn_SalesBasedMilestonesMember" abstract="true" name="SalesBasedMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_AccruedResearchAndDevelopmentExpenseCurrent" abstract="false" name="AccruedResearchAndDevelopmentExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_SupplementalNonCashInformationRelatedToLeasesAbstract" abstract="true" name="SupplementalNonCashInformationRelatedToLeasesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="arvn_EquityDistributionAgreementMember" abstract="true" name="EquityDistributionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage" abstract="false" name="FutureGrantOfIncentiveUnitsToServiceProvidersPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="arvn_PercentageOfIncrementalBorrowingForLeasePayments" abstract="false" name="PercentageOfIncrementalBorrowingForLeasePayments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="arvn_ProceedsFromMaturitiesOfMarketableSecurities" abstract="false" name="ProceedsFromMaturitiesOfMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" abstract="true" name="CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="arvn_PiperSandlerAndCantorMember" abstract="true" name="PiperSandlerAndCantorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_BayerCropScienceLPMember" abstract="true" name="BayerCropScienceLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_RegulatoryAndSalesBasedMilestonesMember" abstract="true" name="RegulatoryAndSalesBasedMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_RegulatoryMilestonePaymentsMember" abstract="true" name="RegulatoryMilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward" abstract="true" name="ChangeInCollaborationContractAssetAndOtherAssetsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="arvn_ResearchFundingPaymentsMember" abstract="true" name="ResearchFundingPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward" abstract="true" name="ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock" abstract="false" name="IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="arvn_LaboratoryEquipmentMember" abstract="true" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_CommercialMilestonesMember" abstract="true" name="CommercialMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_EmployeesMember" abstract="true" name="EmployeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_TwoThousandAndFourteenAssistanceAgreementMember" abstract="true" name="TwoThousandAndFourteenAssistanceAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_DevelopmentMilestonePaymentsMember" abstract="true" name="DevelopmentMilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_PfizerIncorporationMember" abstract="true" name="PfizerIncorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_CapitalizedContractCostAmortizationDuringPeriod" abstract="false" name="CapitalizedContractCostAmortizationDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities" abstract="false" name="CashCashEquivalentsRestrictedCashAndMarketableSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_LongTermDebtMaturityYearSix" abstract="false" name="LongTermDebtMaturityYearSix" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_MaximumAggregateOfferingPriceOfCommonStock" abstract="false" name="MaximumAggregateOfferingPriceOfCommonStock" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_StockIncentivePlanMember" abstract="true" name="StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_ResearchCollaborationAndLicenseAgreementsTable" abstract="true" name="ResearchCollaborationAndLicenseAgreementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="arvn_BaseLeaseRentPeriod" abstract="false" name="BaseLeaseRentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="arvn_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="arvn_AccountsPayableContractBalancesCurrent" abstract="false" name="AccountsPayableContractBalancesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_AggregateIntrinsicValueAbstract" abstract="true" name="AggregateIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="arvn_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="arvn_CollaborationContractAssetAndOtherAssets" abstract="false" name="CollaborationContractAssetAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_OerthBioLimitedLiabilityCorporationMember" abstract="true" name="OerthBioLimitedLiabilityCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember" abstract="true" name="GenentechIncorporationAndFHoffmanLaRocheLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_SuccessBasedMilestonePaymentsMember" abstract="true" name="SuccessBasedMilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward" abstract="true" name="ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements" abstract="false" name="ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_AccountsPayableContractBalancesCurrentAdditions" abstract="false" name="AccountsPayableContractBalancesCurrentAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_OptionPaymentsToLicenseAgreementMember" abstract="true" name="OptionPaymentsToLicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_BayerAGMember" abstract="true" name="BayerAGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_AccountsPayableContractBalancesCurrentPayments" abstract="false" name="AccountsPayableContractBalancesCurrentPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_ResearchCollaborationAndLicenseAgreementsLineItems" abstract="true" name="ResearchCollaborationAndLicenseAgreementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="arvn_DirectAndIncrementalCostsIncurredToObtainTheContract" abstract="false" name="DirectAndIncrementalCostsIncurredToObtainTheContract" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_TwoThousandAndEighteenAssistanceAgreementMember" abstract="true" name="TwoThousandAndEighteenAssistanceAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements" abstract="false" name="ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="arvn_DebtInstrumentInterestPaymentsTerm" abstract="false" name="DebtInstrumentInterestPaymentsTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>arvn-20230630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3ad84450-03f4-4a08-908c-03680fffbb5d,g:5431e377-e1a3-4379-9dba-d87e2214df03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="arvn-20230630.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:calculationLink xlink:role="http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_77717002-b78b-40ee-a47e-b305b5a6caa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fc432282-081a-4f62-b9b4-baa29e476170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77717002-b78b-40ee-a47e-b305b5a6caa7" xlink:to="loc_us-gaap_CommonStockValue_fc432282-081a-4f62-b9b4-baa29e476170" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b2fac20f-ea47-476d-b9d1-bb4bcd606bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77717002-b78b-40ee-a47e-b305b5a6caa7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b2fac20f-ea47-476d-b9d1-bb4bcd606bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b22e480f-260a-4207-b26d-ae0986cac6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77717002-b78b-40ee-a47e-b305b5a6caa7" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b22e480f-260a-4207-b26d-ae0986cac6e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_94015f70-f240-4d13-b0ff-2065e2bbee95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_77717002-b78b-40ee-a47e-b305b5a6caa7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_94015f70-f240-4d13-b0ff-2065e2bbee95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_db5d5cef-200e-4d83-a752-8e5248a2b2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_714331c3-bba8-4139-b16a-0bbd6854a777" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_db5d5cef-200e-4d83-a752-8e5248a2b2cb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_714331c3-bba8-4139-b16a-0bbd6854a777" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_825806a7-3871-4df6-9aca-0fd5f3ab9d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_db5d5cef-200e-4d83-a752-8e5248a2b2cb" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_825806a7-3871-4df6-9aca-0fd5f3ab9d5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d233a2cf-ef09-4947-bd63-e7378fcabaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_db5d5cef-200e-4d83-a752-8e5248a2b2cb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d233a2cf-ef09-4947-bd63-e7378fcabaf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5172511a-80c7-4b94-9843-f370d2c5bc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_db5d5cef-200e-4d83-a752-8e5248a2b2cb" xlink:to="loc_us-gaap_LongTermDebtCurrent_5172511a-80c7-4b94-9843-f370d2c5bc9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a588b46a-f5ac-440f-a0b7-cd9fa5930e29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4260d4d4-580d-43e1-afc7-8afcf8789f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a588b46a-f5ac-440f-a0b7-cd9fa5930e29" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4260d4d4-580d-43e1-afc7-8afcf8789f8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_423cbc02-e9db-4c85-851b-7559178f2060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a588b46a-f5ac-440f-a0b7-cd9fa5930e29" xlink:to="loc_us-gaap_RestrictedCashCurrent_423cbc02-e9db-4c85-851b-7559178f2060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_c779fe53-f113-4404-9781-6dbbaf2898fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a588b46a-f5ac-440f-a0b7-cd9fa5930e29" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_c779fe53-f113-4404-9781-6dbbaf2898fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ddd6c1cd-5665-4fdb-9116-696eaed35ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a588b46a-f5ac-440f-a0b7-cd9fa5930e29" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ddd6c1cd-5665-4fdb-9116-696eaed35ebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_c0d72b18-ee47-46b4-90f7-b63a6e4cac33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a588b46a-f5ac-440f-a0b7-cd9fa5930e29" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_c0d72b18-ee47-46b4-90f7-b63a6e4cac33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8191dac9-e442-4fd1-ad46-a41ed45b0520" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a588b46a-f5ac-440f-a0b7-cd9fa5930e29" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8191dac9-e442-4fd1-ad46-a41ed45b0520" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1d8394ab-41da-409b-9648-01476f07aa51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_efb07cd4-1fe9-4ef1-95c7-9c485e6f82c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1d8394ab-41da-409b-9648-01476f07aa51" xlink:to="loc_us-gaap_LiabilitiesCurrent_efb07cd4-1fe9-4ef1-95c7-9c485e6f82c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_99696e62-86ba-4acf-a0ec-e58eb0d7c809" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1d8394ab-41da-409b-9648-01476f07aa51" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_99696e62-86ba-4acf-a0ec-e58eb0d7c809" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b4d51bf5-b98e-4042-a3c5-453e450a0d59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1d8394ab-41da-409b-9648-01476f07aa51" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b4d51bf5-b98e-4042-a3c5-453e450a0d59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0cfaaf7a-6816-49fa-add9-305fadcf0093" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1d8394ab-41da-409b-9648-01476f07aa51" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0cfaaf7a-6816-49fa-add9-305fadcf0093" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2b3f240f-d6e9-450c-abfe-e93d71140e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_33287d68-f417-4d26-ad80-d419881b32dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2b3f240f-d6e9-450c-abfe-e93d71140e7a" xlink:to="loc_us-gaap_Liabilities_33287d68-f417-4d26-ad80-d419881b32dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a0ac8200-f997-4bcf-acb1-2d5cf796462a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2b3f240f-d6e9-450c-abfe-e93d71140e7a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a0ac8200-f997-4bcf-acb1-2d5cf796462a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_28676a08-e350-4c31-9ab8-926e9823e3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2b3f240f-d6e9-450c-abfe-e93d71140e7a" xlink:to="loc_us-gaap_StockholdersEquity_28676a08-e350-4c31-9ab8-926e9823e3d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6e8a535e-3b07-4133-92d3-53f31e9d0263" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f2ad5062-701d-4e4e-aa5a-99476faa8aca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e8a535e-3b07-4133-92d3-53f31e9d0263" xlink:to="loc_us-gaap_AssetsCurrent_f2ad5062-701d-4e4e-aa5a-99476faa8aca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_91ab80e8-a0c3-4738-bbc8-aa926c3a0c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e8a535e-3b07-4133-92d3-53f31e9d0263" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_91ab80e8-a0c3-4738-bbc8-aa926c3a0c4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f4355391-00a4-448a-acf9-5c618731cd00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e8a535e-3b07-4133-92d3-53f31e9d0263" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f4355391-00a4-448a-acf9-5c618731cd00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CollaborationContractAssetAndOtherAssets_db5064de-2838-481f-8d4d-7d4126c833a2" xlink:href="arvn-20230630.xsd#arvn_CollaborationContractAssetAndOtherAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6e8a535e-3b07-4133-92d3-53f31e9d0263" xlink:to="loc_arvn_CollaborationContractAssetAndOtherAssets_db5064de-2838-481f-8d4d-7d4126c833a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="simple" xlink:href="arvn-20230630.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"/>
  <link:calculationLink xlink:role="http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b54e66e8-d4d6-4db3-b267-e5457492a8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_1722077d-9081-4c0d-9b78-a77b71321c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b54e66e8-d4d6-4db3-b267-e5457492a8f3" xlink:to="loc_us-gaap_InvestmentIncomeInterest_1722077d-9081-4c0d-9b78-a77b71321c7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d4fd0df1-595c-467f-a8e3-7c4770604798" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b54e66e8-d4d6-4db3-b267-e5457492a8f3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d4fd0df1-595c-467f-a8e3-7c4770604798" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0a8f4a17-6d4f-428b-8ce5-ed32210e9097" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8decfbf2-cb4a-4073-bff9-ea00f51da499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0a8f4a17-6d4f-428b-8ce5-ed32210e9097" xlink:to="loc_us-gaap_NetIncomeLoss_8decfbf2-cb4a-4073-bff9-ea00f51da499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3a79287e-8f67-4365-8e14-3a3b3f5b3589" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0a8f4a17-6d4f-428b-8ce5-ed32210e9097" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3a79287e-8f67-4365-8e14-3a3b3f5b3589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_4735dad9-1610-409b-9002-1f7cc013af63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_91279014-0fe6-48c8-a03f-9aaa72077123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4735dad9-1610-409b-9002-1f7cc013af63" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_91279014-0fe6-48c8-a03f-9aaa72077123" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2edad92d-b82a-48c8-a203-50cb03181d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4735dad9-1610-409b-9002-1f7cc013af63" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2edad92d-b82a-48c8-a203-50cb03181d4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0663b9ca-a77b-408f-aaf5-b57cb8470508" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a68391be-199e-4995-8b17-6b59846b32c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0663b9ca-a77b-408f-aaf5-b57cb8470508" xlink:to="loc_us-gaap_OperatingIncomeLoss_a68391be-199e-4995-8b17-6b59846b32c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_95507db9-e822-42ab-95be-9e7c07bd3ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0663b9ca-a77b-408f-aaf5-b57cb8470508" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_95507db9-e822-42ab-95be-9e7c07bd3ab8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5ff6fb52-77f5-4640-ba99-cdfb65ff4a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b5404392-c800-4e5e-990c-474258b07d03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5ff6fb52-77f5-4640-ba99-cdfb65ff4a44" xlink:to="loc_us-gaap_Revenues_b5404392-c800-4e5e-990c-474258b07d03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_be38b4af-f235-4b01-aa38-774a0fe51867" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5ff6fb52-77f5-4640-ba99-cdfb65ff4a44" xlink:to="loc_us-gaap_OperatingExpenses_be38b4af-f235-4b01-aa38-774a0fe51867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_792578be-b537-4fe2-8e26-91f15b25d744" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bec48f3d-e1ab-45b9-91a3-44e573d6df23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_792578be-b537-4fe2-8e26-91f15b25d744" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bec48f3d-e1ab-45b9-91a3-44e573d6df23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ead6083d-6b8b-431e-8851-68880e9aaf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_792578be-b537-4fe2-8e26-91f15b25d744" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ead6083d-6b8b-431e-8851-68880e9aaf6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0363cec0-ae6c-42e7-9dce-c5868928ea09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_792578be-b537-4fe2-8e26-91f15b25d744" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0363cec0-ae6c-42e7-9dce-c5868928ea09" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="arvn-20230630.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:calculationLink xlink:role="http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db8246b1-f847-4b75-b8fc-0884f13b72ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c6e77ed5-63dd-4213-89a6-6eb99c3480e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db8246b1-f847-4b75-b8fc-0884f13b72ee" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c6e77ed5-63dd-4213-89a6-6eb99c3480e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3b8f5010-6bb7-4a0f-a3c2-48b0e56a82db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db8246b1-f847-4b75-b8fc-0884f13b72ee" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3b8f5010-6bb7-4a0f-a3c2-48b0e56a82db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_02ca3d4a-bc72-49e8-b603-23b680c5ab2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db8246b1-f847-4b75-b8fc-0884f13b72ee" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_02ca3d4a-bc72-49e8-b603-23b680c5ab2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_c57c4c60-0119-464d-801c-55e49b9fb585" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_c57c4c60-0119-464d-801c-55e49b9fb585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_73a6fcea-b8b8-40ee-aa1c-71e0793b0bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_73a6fcea-b8b8-40ee-aa1c-71e0793b0bbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_35f1ee41-6ecf-4ba7-987e-dc08abdca281" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_35f1ee41-6ecf-4ba7-987e-dc08abdca281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_b491b3c8-53ba-4b8f-8121-e59a1cc79ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_b491b3c8-53ba-4b8f-8121-e59a1cc79ca5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_76dea309-2704-4225-b87a-afaf5ccca7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_76dea309-2704-4225-b87a-afaf5ccca7c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_3d6bcfc4-805d-422a-93fa-2fd95d299d81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_3d6bcfc4-805d-422a-93fa-2fd95d299d81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3fd5f26a-18f7-43b2-97d2-9e75083d79cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_ShareBasedCompensation_3fd5f26a-18f7-43b2-97d2-9e75083d79cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_c4cedcef-8725-4ed1-8c17-b564688ba953" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_c4cedcef-8725-4ed1-8c17-b564688ba953" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLoss_2a99402f-faf3-424d-bdb2-d767c99b04ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLoss"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLoss_2a99402f-faf3-424d-bdb2-d767c99b04ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d8d2126a-7f3a-4cc6-a75a-26078322b937" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_DepreciationAndAmortization_d8d2126a-7f3a-4cc6-a75a-26078322b937" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ead52ecf-2d5b-459d-bb5e-f9fa1c2020e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ead52ecf-2d5b-459d-bb5e-f9fa1c2020e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7bcd8be6-6a7f-4ff6-98b6-dae332b52f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_NetIncomeLoss_7bcd8be6-6a7f-4ff6-98b6-dae332b52f0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f2204d99-217b-4099-b518-2ff9e0e0e5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_25914c79-60bb-4743-a7df-e127df17fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f2204d99-217b-4099-b518-2ff9e0e0e5b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_356e14ad-9e27-4a5d-9893-9ae729d3904e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares_de16442e-3f5e-4d36-b617-76468cb71a3c" xlink:href="arvn-20230630.xsd#arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_356e14ad-9e27-4a5d-9893-9ae729d3904e" xlink:to="loc_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares_de16442e-3f5e-4d36-b617-76468cb71a3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_98205f33-9790-4d14-a9de-4220ccd59384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ProceedsFromMaturitiesOfMarketableSecurities_f86fd508-3de6-4063-9d33-f1aae42a68f8" xlink:href="arvn-20230630.xsd#arvn_ProceedsFromMaturitiesOfMarketableSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_98205f33-9790-4d14-a9de-4220ccd59384" xlink:to="loc_arvn_ProceedsFromMaturitiesOfMarketableSecurities_f86fd508-3de6-4063-9d33-f1aae42a68f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_e2d20ea3-2417-4fca-aa4b-4064b5be2228" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_98205f33-9790-4d14-a9de-4220ccd59384" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_e2d20ea3-2417-4fca-aa4b-4064b5be2228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7eb501f5-f6de-4369-ae18-1f15986e795b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_98205f33-9790-4d14-a9de-4220ccd59384" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7eb501f5-f6de-4369-ae18-1f15986e795b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ProceedsFromSaleOfMarketableSecurities_21d90a0b-7440-42e3-93ee-6c2739cbfa65" xlink:href="arvn-20230630.xsd#arvn_ProceedsFromSaleOfMarketableSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_98205f33-9790-4d14-a9de-4220ccd59384" xlink:to="loc_arvn_ProceedsFromSaleOfMarketableSecurities_21d90a0b-7440-42e3-93ee-6c2739cbfa65" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c060785f-eb1e-4a0f-85da-567ad4875b96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6c4b9f5-f2d4-4017-a517-2887a5fe88cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c060785f-eb1e-4a0f-85da-567ad4875b96" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6c4b9f5-f2d4-4017-a517-2887a5fe88cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_898eb900-7822-4ec5-9c3f-422ae8a37e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c060785f-eb1e-4a0f-85da-567ad4875b96" xlink:to="loc_us-gaap_RestrictedCashCurrent_898eb900-7822-4ec5-9c3f-422ae8a37e6c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_046d1090-ceed-47bb-a7b8-56f2237d28f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_319083fc-60b9-443e-af15-dd94cacd2212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_046d1090-ceed-47bb-a7b8-56f2237d28f6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_319083fc-60b9-443e-af15-dd94cacd2212" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b2dc8365-8109-4951-94e7-0efa32f81ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_046d1090-ceed-47bb-a7b8-56f2237d28f6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b2dc8365-8109-4951-94e7-0efa32f81ff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2df4d986-eea0-47ac-9223-47ff3921526e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_046d1090-ceed-47bb-a7b8-56f2237d28f6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2df4d986-eea0-47ac-9223-47ff3921526e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"/>
  <link:calculationLink xlink:role="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7e132dec-72df-4aec-902f-431b17df0886" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c047725d-2f8b-4126-bad8-0c341d6aa6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_7e132dec-72df-4aec-902f-431b17df0886" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c047725d-2f8b-4126-bad8-0c341d6aa6bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0461c266-6004-4e8b-9dd6-a40bbbc87f29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_7e132dec-72df-4aec-902f-431b17df0886" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0461c266-6004-4e8b-9dd6-a40bbbc87f29" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9fca85c-04f6-43fd-a32c-d4a58780eebd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4e3e037a-25da-4158-9c0b-b3600da92fef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9fca85c-04f6-43fd-a32c-d4a58780eebd" xlink:to="loc_us-gaap_OperatingLeaseLiability_4e3e037a-25da-4158-9c0b-b3600da92fef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c67d2f9d-9537-403a-9e6e-da24a8ba588e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9fca85c-04f6-43fd-a32c-d4a58780eebd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c67d2f9d-9537-403a-9e6e-da24a8ba588e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="arvn-20230630.xsd#RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2efc424e-7b8e-4aa3-b76f-7fb52afa7290" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3862e9e6-35fa-47e4-83ab-a6c8e59ce0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2efc424e-7b8e-4aa3-b76f-7fb52afa7290" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3862e9e6-35fa-47e4-83ab-a6c8e59ce0ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_189943fd-097a-49d2-8e27-a00fa1eb78af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2efc424e-7b8e-4aa3-b76f-7fb52afa7290" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_189943fd-097a-49d2-8e27-a00fa1eb78af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7174d454-4c44-4925-978d-b0ac07e2f5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2efc424e-7b8e-4aa3-b76f-7fb52afa7290" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7174d454-4c44-4925-978d-b0ac07e2f5d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_6a41205f-9cab-4d45-9a74-10290d618e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2efc424e-7b8e-4aa3-b76f-7fb52afa7290" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_6a41205f-9cab-4d45-9a74-10290d618e6d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#AccountsPayableandAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_61d4f284-95ed-48c4-9856-0df296421e85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_eea2307d-3f93-4877-a025-38a5f1d54dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_61d4f284-95ed-48c4-9856-0df296421e85" xlink:to="loc_us-gaap_AccountsPayableCurrent_eea2307d-3f93-4877-a025-38a5f1d54dbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccruedResearchAndDevelopmentExpenseCurrent_5cb276e6-7bd3-4d64-aeca-8127ee049cee" xlink:href="arvn-20230630.xsd#arvn_AccruedResearchAndDevelopmentExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_61d4f284-95ed-48c4-9856-0df296421e85" xlink:to="loc_arvn_AccruedResearchAndDevelopmentExpenseCurrent_5cb276e6-7bd3-4d64-aeca-8127ee049cee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_12b9c7f6-7c66-4c73-bf01-ac5937f32b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_61d4f284-95ed-48c4-9856-0df296421e85" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_12b9c7f6-7c66-4c73-bf01-ac5937f32b52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ac14832b-825e-475d-a0f3-8f69b49d8c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_61d4f284-95ed-48c4-9856-0df296421e85" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ac14832b-825e-475d-a0f3-8f69b49d8c9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_4a20666b-8a94-4ac2-9abe-0128ec9317c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_61d4f284-95ed-48c4-9856-0df296421e85" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_4a20666b-8a94-4ac2-9abe-0128ec9317c0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_748c64f3-1a24-4ea8-a81d-53e76234612e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_4ee76b3e-cff0-4fd9-a591-05ba3b7506db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_748c64f3-1a24-4ea8-a81d-53e76234612e" xlink:to="loc_us-gaap_LongTermDebtCurrent_4ee76b3e-cff0-4fd9-a591-05ba3b7506db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_06e3cd2a-690a-4860-bb72-a87848547341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_748c64f3-1a24-4ea8-a81d-53e76234612e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_06e3cd2a-690a-4860-bb72-a87848547341" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ca089f4c-345c-4b87-92e6-5be8aa742a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_54ce5842-7369-4245-b097-a600007623e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ca089f4c-345c-4b87-92e6-5be8aa742a0b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_54ce5842-7369-4245-b097-a600007623e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_6a2b2a98-28c7-4a13-b77d-d28bb30a69dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ca089f4c-345c-4b87-92e6-5be8aa742a0b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_6a2b2a98-28c7-4a13-b77d-d28bb30a69dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4293535f-2e98-4459-ba4d-653ef5371a78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ca089f4c-345c-4b87-92e6-5be8aa742a0b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4293535f-2e98-4459-ba4d-653ef5371a78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_LongTermDebtMaturityYearSix_e2f0e100-b190-4782-bb59-b96b052176b4" xlink:href="arvn-20230630.xsd#arvn_LongTermDebtMaturityYearSix"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ca089f4c-345c-4b87-92e6-5be8aa742a0b" xlink:to="loc_arvn_LongTermDebtMaturityYearSix_e2f0e100-b190-4782-bb59-b96b052176b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c4684a51-6bd5-41c2-a414-72de9849c2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ca089f4c-345c-4b87-92e6-5be8aa742a0b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c4684a51-6bd5-41c2-a414-72de9849c2ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_70ee9875-e376-48da-a856-bd90cc941a39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ca089f4c-345c-4b87-92e6-5be8aa742a0b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_70ee9875-e376-48da-a856-bd90cc941a39" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>arvn-20230630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3ad84450-03f4-4a08-908c-03680fffbb5d,g:5431e377-e1a3-4379-9dba-d87e2214df03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited" xlink:type="simple" xlink:href="arvn-20230630.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited" xlink:type="extended" id="ifb6a690f826e4a67818c6dcd6c62aaf2_CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b4b3d47f-131e-4d98-8d5e-f2a4a8061c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b4b3d47f-131e-4d98-8d5e-f2a4a8061c8d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cb218ad8-b9fd-4ae6-b6d8-cebd63b4f406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cb218ad8-b9fd-4ae6-b6d8-cebd63b4f406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a037544a-3e21-4c6e-8f0c-42feb1f9d062" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_StockholdersEquity_a037544a-3e21-4c6e-8f0c-42feb1f9d062" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7feb3259-b32d-4453-a767-c91df0cdc0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7feb3259-b32d-4453-a767-c91df0cdc0b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_043c008c-4abf-47e4-900f-3545c05eb100" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_NetIncomeLoss_043c008c-4abf-47e4-900f-3545c05eb100" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_72bbd422-d6c8-4312-8dec-fba5eff73083" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_72bbd422-d6c8-4312-8dec-fba5eff73083" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_bd10442d-39c2-4be4-b3fe-ab5703c3fc84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_bd10442d-39c2-4be4-b3fe-ab5703c3fc84" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_8e29ae94-77b8-4b3d-b19c-f1435df42e70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_8e29ae94-77b8-4b3d-b19c-f1435df42e70" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_559fda4f-8d2a-4875-abf9-f9eacb7b88be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5da28bda-a2e9-4eeb-8eb3-ccd89b331284" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b8e8dbd0-d7b0-431a-a856-c439a6faba33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b4b3d47f-131e-4d98-8d5e-f2a4a8061c8d" xlink:to="loc_us-gaap_StatementTable_b8e8dbd0-d7b0-431a-a856-c439a6faba33" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a5273d04-f090-4fb0-a239-705dc9d804d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b8e8dbd0-d7b0-431a-a856-c439a6faba33" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a5273d04-f090-4fb0-a239-705dc9d804d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a5273d04-f090-4fb0-a239-705dc9d804d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a5273d04-f090-4fb0-a239-705dc9d804d7" xlink:to="loc_us-gaap_EquityComponentDomain_a5273d04-f090-4fb0-a239-705dc9d804d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a5273d04-f090-4fb0-a239-705dc9d804d7" xlink:to="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_24160901-ccea-48e9-8808-654ad2b2978f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:to="loc_us-gaap_CommonStockMember_24160901-ccea-48e9-8808-654ad2b2978f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b3058516-c921-4c53-a799-abc7b621123d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:to="loc_us-gaap_RetainedEarningsMember_b3058516-c921-4c53-a799-abc7b621123d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0b32cbf0-ef3e-411b-bd57-d30e6945c8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0b32cbf0-ef3e-411b-bd57-d30e6945c8f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_25953b08-c2ae-4f12-86e9-56b16d0022f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_25953b08-c2ae-4f12-86e9-56b16d0022f2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails" xlink:type="extended" id="iaca6bf2510b04aa889f74d8d1fc1bb94_ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_60d56911-73c1-45e0-aa5c-d7fd67705411" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_60d56911-73c1-45e0-aa5c-d7fd67705411" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_85218138-69cf-4433-90a2-ab7d5f54aee4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_us-gaap_ProceedsFromCollaborators_85218138-69cf-4433-90a2-ab7d5f54aee4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract_923bafc9-7c90-4158-b269-a61b07e1522a" xlink:href="arvn-20230630.xsd#arvn_DirectAndIncrementalCostsIncurredToObtainTheContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract_923bafc9-7c90-4158-b269-a61b07e1522a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CollaborationContractAssetAndOtherAssets_a37a45bb-2f43-48d2-a518-20d24682e2be" xlink:href="arvn-20230630.xsd#arvn_CollaborationContractAssetAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_arvn_CollaborationContractAssetAndOtherAssets_a37a45bb-2f43-48d2-a518-20d24682e2be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement_b761444b-82f3-446c-8fbc-d70caa6b965a" xlink:href="arvn-20230630.xsd#arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement_b761444b-82f3-446c-8fbc-d70caa6b965a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_11054993-1587-495f-982d-a7c4d1d02988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_11054993-1587-495f-982d-a7c4d1d02988" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_278144a9-3c51-482f-9ef7-da597218ec8f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:to="loc_srt_CounterpartyNameAxis_278144a9-3c51-482f-9ef7-da597218ec8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_278144a9-3c51-482f-9ef7-da597218ec8f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_278144a9-3c51-482f-9ef7-da597218ec8f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_278144a9-3c51-482f-9ef7-da597218ec8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_873a9c9b-89c3-42f1-96bf-08b0ec8f2176" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_278144a9-3c51-482f-9ef7-da597218ec8f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_873a9c9b-89c3-42f1-96bf-08b0ec8f2176" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PfizerIncorporationMember_4698a4d5-0824-460b-9923-81356670fa3c" xlink:href="arvn-20230630.xsd#arvn_PfizerIncorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_873a9c9b-89c3-42f1-96bf-08b0ec8f2176" xlink:to="loc_arvn_PfizerIncorporationMember_4698a4d5-0824-460b-9923-81356670fa3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_BayerAGMember_baeda139-49bf-402d-8509-299bba50e1b8" xlink:href="arvn-20230630.xsd#arvn_BayerAGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_873a9c9b-89c3-42f1-96bf-08b0ec8f2176" xlink:to="loc_arvn_BayerAGMember_baeda139-49bf-402d-8509-299bba50e1b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember_e8667356-0227-4cd5-a67b-a83e65e3f179" xlink:href="arvn-20230630.xsd#arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_873a9c9b-89c3-42f1-96bf-08b0ec8f2176" xlink:to="loc_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember_e8667356-0227-4cd5-a67b-a83e65e3f179" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_723f1292-01a9-41c1-a8d4-c95a70bfcbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:to="loc_us-gaap_TypeOfArrangementAxis_723f1292-01a9-41c1-a8d4-c95a70bfcbc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_723f1292-01a9-41c1-a8d4-c95a70bfcbc9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_723f1292-01a9-41c1-a8d4-c95a70bfcbc9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_723f1292-01a9-41c1-a8d4-c95a70bfcbc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_723f1292-01a9-41c1-a8d4-c95a70bfcbc9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_RegulatoryAndSalesBasedMilestonesMember_3c60a8e8-2199-43aa-902a-60e1c1fdd52b" xlink:href="arvn-20230630.xsd#arvn_RegulatoryAndSalesBasedMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_RegulatoryAndSalesBasedMilestonesMember_3c60a8e8-2199-43aa-902a-60e1c1fdd52b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CollaborationAgreementMember_693d9acd-8afd-4944-a303-5789bc365f95" xlink:href="arvn-20230630.xsd#arvn_CollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_CollaborationAgreementMember_693d9acd-8afd-4944-a303-5789bc365f95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_RegulatoryMilestonePaymentsMember_f38c3d28-fde8-493a-b91f-03b246a17c21" xlink:href="arvn-20230630.xsd#arvn_RegulatoryMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_RegulatoryMilestonePaymentsMember_f38c3d28-fde8-493a-b91f-03b246a17c21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_SalesBasedMilestonesMember_aaeb8a94-eb5c-49f1-9d96-fa171dc7b544" xlink:href="arvn-20230630.xsd#arvn_SalesBasedMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_SalesBasedMilestonesMember_aaeb8a94-eb5c-49f1-9d96-fa171dc7b544" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchFundingPaymentsMember_599b53c6-6fb9-42c0-b289-588ff72f2f8f" xlink:href="arvn-20230630.xsd#arvn_ResearchFundingPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_ResearchFundingPaymentsMember_599b53c6-6fb9-42c0-b289-588ff72f2f8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DevelopmentMilestonePaymentsMember_a13f9f61-9518-407b-9643-430e0b886d47" xlink:href="arvn-20230630.xsd#arvn_DevelopmentMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_DevelopmentMilestonePaymentsMember_a13f9f61-9518-407b-9643-430e0b886d47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_SalesBasedMilestonePaymentsMember_a1adc59d-5231-48c2-bb1e-5baaf7f19433" xlink:href="arvn-20230630.xsd#arvn_SalesBasedMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_SalesBasedMilestonePaymentsMember_a1adc59d-5231-48c2-bb1e-5baaf7f19433" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_OptionPaymentsToLicenseAgreementMember_572dfd18-c86c-4a9e-80c1-cd69216826b5" xlink:href="arvn-20230630.xsd#arvn_OptionPaymentsToLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_OptionPaymentsToLicenseAgreementMember_572dfd18-c86c-4a9e-80c1-cd69216826b5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CommercialMilestonesMember_1067d174-3060-4f9d-8190-e78e584c799e" xlink:href="arvn-20230630.xsd#arvn_CommercialMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_CommercialMilestonesMember_1067d174-3060-4f9d-8190-e78e584c799e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c039db36-ad5e-4aa0-b321-16cde430ab71" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:to="loc_srt_RangeAxis_c039db36-ad5e-4aa0-b321-16cde430ab71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c039db36-ad5e-4aa0-b321-16cde430ab71_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c039db36-ad5e-4aa0-b321-16cde430ab71" xlink:to="loc_srt_RangeMember_c039db36-ad5e-4aa0-b321-16cde430ab71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6807e5e3-12ef-4d84-8156-c0c67bcc6cdc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c039db36-ad5e-4aa0-b321-16cde430ab71" xlink:to="loc_srt_RangeMember_6807e5e3-12ef-4d84-8156-c0c67bcc6cdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_90a09966-d3ac-4fc4-b7ab-5c853e47aa6a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6807e5e3-12ef-4d84-8156-c0c67bcc6cdc" xlink:to="loc_srt_MaximumMember_90a09966-d3ac-4fc4-b7ab-5c853e47aa6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_2ad073dc-b17b-490c-bfe9-0ae09ce69527" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:to="loc_srt_StatementScenarioAxis_2ad073dc-b17b-490c-bfe9-0ae09ce69527" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_2ad073dc-b17b-490c-bfe9-0ae09ce69527_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_2ad073dc-b17b-490c-bfe9-0ae09ce69527" xlink:to="loc_srt_ScenarioUnspecifiedDomain_2ad073dc-b17b-490c-bfe9-0ae09ce69527_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_49b930e3-e7ab-4d93-b51a-12af5a970d40" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_2ad073dc-b17b-490c-bfe9-0ae09ce69527" xlink:to="loc_srt_ScenarioUnspecifiedDomain_49b930e3-e7ab-4d93-b51a-12af5a970d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_79d2dc4d-5c2b-41d6-94b7-e9e9077e17ec" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_49b930e3-e7ab-4d93-b51a-12af5a970d40" xlink:to="loc_srt_ScenarioForecastMember_79d2dc4d-5c2b-41d6-94b7-e9e9077e17ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5d4398b3-04aa-4e39-ba59-8f841be3845e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5d4398b3-04aa-4e39-ba59-8f841be3845e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5d4398b3-04aa-4e39-ba59-8f841be3845e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5d4398b3-04aa-4e39-ba59-8f841be3845e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5d4398b3-04aa-4e39-ba59-8f841be3845e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c9e3f0f5-010f-4a82-980d-685b5f91d232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5d4398b3-04aa-4e39-ba59-8f841be3845e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c9e3f0f5-010f-4a82-980d-685b5f91d232" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e08d25f5-cc09-491e-8028-31b44df7546a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c9e3f0f5-010f-4a82-980d-685b5f91d232" xlink:to="loc_us-gaap_SubsequentEventMember_e08d25f5-cc09-491e-8028-31b44df7546a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails" xlink:type="extended" id="i944b63fc0ad74bbbaa1d55c138bbb44b_ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_c0fc6ac3-52dd-4204-a50a-c961aaf0c2da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_c0fc6ac3-52dd-4204-a50a-c961aaf0c2da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_63a5164e-1a40-4cca-9aad-056eafb83e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_63a5164e-1a40-4cca-9aad-056eafb83e8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c9aa9e07-b64d-4f9d-a363-2ec243828e02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c9aa9e07-b64d-4f9d-a363-2ec243828e02" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_c05b4198-b461-4b8f-8c92-5bcedd322827" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c9aa9e07-b64d-4f9d-a363-2ec243828e02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_c05b4198-b461-4b8f-8c92-5bcedd322827" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="arvn-20230630.xsd#ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails_1"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails_1" xlink:type="extended" id="i610231b4af754472a952730befac6107_ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_c0fc6ac3-52dd-4204-a50a-c961aaf0c2da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_c0fc6ac3-52dd-4204-a50a-c961aaf0c2da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_63a5164e-1a40-4cca-9aad-056eafb83e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_63a5164e-1a40-4cca-9aad-056eafb83e8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c9aa9e07-b64d-4f9d-a363-2ec243828e02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c9aa9e07-b64d-4f9d-a363-2ec243828e02" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails" xlink:type="extended" id="i551a47e4f7a642f4bac28302a6b8cb2d_MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3b7f793d-0366-4c5e-8415-8767b1004223" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3b7f793d-0366-4c5e-8415-8767b1004223" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_373bae02-4d43-41d9-bdb9-16d639b645ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_373bae02-4d43-41d9-bdb9-16d639b645ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e97e71ee-8f87-477c-aa95-ff42a7361286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e97e71ee-8f87-477c-aa95-ff42a7361286" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_129dd981-57a8-4e7a-bc81-2545187f737a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_129dd981-57a8-4e7a-bc81-2545187f737a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f03d389-8cdf-4495-a514-f4c6c6dd08de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f03d389-8cdf-4495-a514-f4c6c6dd08de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c9f22879-f5f8-4ea4-8448-c336800494fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f03d389-8cdf-4495-a514-f4c6c6dd08de" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c9f22879-f5f8-4ea4-8448-c336800494fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9f22879-f5f8-4ea4-8448-c336800494fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c9f22879-f5f8-4ea4-8448-c336800494fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c9f22879-f5f8-4ea4-8448-c336800494fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab6c2c39-cfb4-4874-bc13-5d6268d7dae0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c9f22879-f5f8-4ea4-8448-c336800494fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab6c2c39-cfb4-4874-bc13-5d6268d7dae0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6de5b35b-3185-46aa-9838-88f79faf1f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab6c2c39-cfb4-4874-bc13-5d6268d7dae0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6de5b35b-3185-46aa-9838-88f79faf1f8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8ed8e18d-fd5c-444c-a2db-c5c0258b4739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f03d389-8cdf-4495-a514-f4c6c6dd08de" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8ed8e18d-fd5c-444c-a2db-c5c0258b4739" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8ed8e18d-fd5c-444c-a2db-c5c0258b4739_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8ed8e18d-fd5c-444c-a2db-c5c0258b4739" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8ed8e18d-fd5c-444c-a2db-c5c0258b4739_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_04b1af8f-4d4a-4246-938c-f319bccab8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8ed8e18d-fd5c-444c-a2db-c5c0258b4739" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_04b1af8f-4d4a-4246-938c-f319bccab8c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a894d974-8754-40bb-93fd-6cf85353983b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_04b1af8f-4d4a-4246-938c-f319bccab8c5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a894d974-8754-40bb-93fd-6cf85353983b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_dee07cc1-ce83-434d-b3f3-38250d2cf09e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f03d389-8cdf-4495-a514-f4c6c6dd08de" xlink:to="loc_us-gaap_FinancialInstrumentAxis_dee07cc1-ce83-434d-b3f3-38250d2cf09e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dee07cc1-ce83-434d-b3f3-38250d2cf09e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dee07cc1-ce83-434d-b3f3-38250d2cf09e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dee07cc1-ce83-434d-b3f3-38250d2cf09e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dd7b71a7-c1b6-43f7-8516-08cd61d128c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dee07cc1-ce83-434d-b3f3-38250d2cf09e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dd7b71a7-c1b6-43f7-8516-08cd61d128c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_a12f3d5f-cc74-4215-982f-58d84b73b747" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dd7b71a7-c1b6-43f7-8516-08cd61d128c9" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_a12f3d5f-cc74-4215-982f-58d84b73b747" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_ab50bd7b-94fc-4b1b-ac4a-4d0bfcbee57e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dd7b71a7-c1b6-43f7-8516-08cd61d128c9" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_ab50bd7b-94fc-4b1b-ac4a-4d0bfcbee57e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" xlink:type="extended" id="i471a6394037e46ecb9b02353576c7b4e_PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_53267d5a-08c8-42cf-b789-4e2870dde45e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_24db3196-4717-4e81-b45f-dfa3724d8d48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_53267d5a-08c8-42cf-b789-4e2870dde45e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_24db3196-4717-4e81-b45f-dfa3724d8d48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2e9aae01-18e5-4143-aaf9-612eff700a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_53267d5a-08c8-42cf-b789-4e2870dde45e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2e9aae01-18e5-4143-aaf9-612eff700a4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9159cdb9-3ba7-4cc5-9ba9-cb09ebf6622b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_53267d5a-08c8-42cf-b789-4e2870dde45e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9159cdb9-3ba7-4cc5-9ba9-cb09ebf6622b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eeaa3c5-1204-4a68-8111-240f14d7c96f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_53267d5a-08c8-42cf-b789-4e2870dde45e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eeaa3c5-1204-4a68-8111-240f14d7c96f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_638f632c-c43b-4160-a277-d18ba547c6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eeaa3c5-1204-4a68-8111-240f14d7c96f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_638f632c-c43b-4160-a277-d18ba547c6cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_638f632c-c43b-4160-a277-d18ba547c6cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_638f632c-c43b-4160-a277-d18ba547c6cf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_638f632c-c43b-4160-a277-d18ba547c6cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_55b96ea9-3446-4c1e-a5b3-62dc52a2a702" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_638f632c-c43b-4160-a277-d18ba547c6cf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_55b96ea9-3446-4c1e-a5b3-62dc52a2a702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_LaboratoryEquipmentMember_b8d77bec-99d0-4b39-8994-5fbde4a41ad1" xlink:href="arvn-20230630.xsd#arvn_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_55b96ea9-3446-4c1e-a5b3-62dc52a2a702" xlink:to="loc_arvn_LaboratoryEquipmentMember_b8d77bec-99d0-4b39-8994-5fbde4a41ad1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_39a721ec-874e-4d1d-9e29-2a6b26400ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_55b96ea9-3446-4c1e-a5b3-62dc52a2a702" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_39a721ec-874e-4d1d-9e29-2a6b26400ef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_1aa3ed7b-8f12-499d-8da0-e0350dd12090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_55b96ea9-3446-4c1e-a5b3-62dc52a2a702" xlink:to="loc_us-gaap_OfficeEquipmentMember_1aa3ed7b-8f12-499d-8da0-e0350dd12090" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#RightofUseAssetsandLiabilitiesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails" xlink:type="extended" id="i4f0ae2972e1f4011b2c907ea9b1a5f9a_RightofUseAssetsandLiabilitiesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PercentageOfIncrementalBorrowingForLeasePayments_52462759-0e61-41e2-ab4a-383b5259a609" xlink:href="arvn-20230630.xsd#arvn_PercentageOfIncrementalBorrowingForLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_arvn_PercentageOfIncrementalBorrowingForLeasePayments_52462759-0e61-41e2-ab4a-383b5259a609" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandSubjectToGroundLeases_22bbee40-c910-4ed2-9078-72c3549be796" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandSubjectToGroundLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_us-gaap_LandSubjectToGroundLeases_22bbee40-c910-4ed2-9078-72c3549be796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecurities_f7686281-ee0a-4e37-8a7c-f2d4f656e596" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_us-gaap_DebtSecurities_f7686281-ee0a-4e37-8a7c-f2d4f656e596" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_7d3be5a7-571e-4f76-a908-f3a162d0519e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_us-gaap_LeaseCost_7d3be5a7-571e-4f76-a908-f3a162d0519e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_BaseLeaseRentPeriod_54c73ae6-5574-4fca-a5c5-60ece6ca8ef5" xlink:href="arvn-20230630.xsd#arvn_BaseLeaseRentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_arvn_BaseLeaseRentPeriod_54c73ae6-5574-4fca-a5c5-60ece6ca8ef5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_89f1046d-ec0d-425d-9534-c76e717a178a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_89f1046d-ec0d-425d-9534-c76e717a178a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_58055d09-e9de-469a-889d-026a239803aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_58055d09-e9de-469a-889d-026a239803aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_812b777d-7261-4d6c-af1e-a56d25fed1f8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_58055d09-e9de-469a-889d-026a239803aa" xlink:to="loc_srt_RangeAxis_812b777d-7261-4d6c-af1e-a56d25fed1f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_812b777d-7261-4d6c-af1e-a56d25fed1f8_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_812b777d-7261-4d6c-af1e-a56d25fed1f8" xlink:to="loc_srt_RangeMember_812b777d-7261-4d6c-af1e-a56d25fed1f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5b836532-bea9-4abb-9d9d-039527ffaee1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_812b777d-7261-4d6c-af1e-a56d25fed1f8" xlink:to="loc_srt_RangeMember_5b836532-bea9-4abb-9d9d-039527ffaee1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_415a720b-897e-4ff8-a9da-da162dd8f6fc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5b836532-bea9-4abb-9d9d-039527ffaee1" xlink:to="loc_srt_MinimumMember_415a720b-897e-4ff8-a9da-da162dd8f6fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3142b410-232a-415d-a3e0-7f3181b68363" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5b836532-bea9-4abb-9d9d-039527ffaee1" xlink:to="loc_srt_MaximumMember_3142b410-232a-415d-a3e0-7f3181b68363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgingPurposeAxis_a3502844-319d-410d-aecf-fd19dec1bd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgingPurposeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_58055d09-e9de-469a-889d-026a239803aa" xlink:to="loc_us-gaap_PledgingPurposeAxis_a3502844-319d-410d-aecf-fd19dec1bd5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgingPurposeDomain_a3502844-319d-410d-aecf-fd19dec1bd5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgingPurposeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PledgingPurposeAxis_a3502844-319d-410d-aecf-fd19dec1bd5c" xlink:to="loc_us-gaap_PledgingPurposeDomain_a3502844-319d-410d-aecf-fd19dec1bd5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgingPurposeDomain_1ca72ccb-4a74-4b97-ab2d-eecb155b1ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgingPurposeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PledgingPurposeAxis_a3502844-319d-410d-aecf-fd19dec1bd5c" xlink:to="loc_us-gaap_PledgingPurposeDomain_1ca72ccb-4a74-4b97-ab2d-eecb155b1ea4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_6c9af49a-ea26-47b1-bc06-24e2790f3dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PledgingPurposeDomain_1ca72ccb-4a74-4b97-ab2d-eecb155b1ea4" xlink:to="loc_us-gaap_LetterOfCreditMember_6c9af49a-ea26-47b1-bc06-24e2790f3dc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusAxis_15ffbb77-d6cb-46a3-b114-f5b94fc9994f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_58055d09-e9de-469a-889d-026a239803aa" xlink:to="loc_us-gaap_PledgedStatusAxis_15ffbb77-d6cb-46a3-b114-f5b94fc9994f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain_15ffbb77-d6cb-46a3-b114-f5b94fc9994f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PledgedStatusAxis_15ffbb77-d6cb-46a3-b114-f5b94fc9994f" xlink:to="loc_us-gaap_PledgedStatusDomain_15ffbb77-d6cb-46a3-b114-f5b94fc9994f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain_a79ea2f4-1f6d-46df-8581-f5fdc32aee83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PledgedStatusAxis_15ffbb77-d6cb-46a3-b114-f5b94fc9994f" xlink:to="loc_us-gaap_PledgedStatusDomain_a79ea2f4-1f6d-46df-8581-f5fdc32aee83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetPledgedAsCollateralMember_72b298ae-0bc5-4a67-93bf-73d8e72b8220" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetPledgedAsCollateralMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PledgedStatusDomain_a79ea2f4-1f6d-46df-8581-f5fdc32aee83" xlink:to="loc_us-gaap_AssetPledgedAsCollateralMember_72b298ae-0bc5-4a67-93bf-73d8e72b8220" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended" id="i9560d963f7814ef2be53ff8a1cc2876d_LongTermDebtScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_12f7532b-5881-49ab-af15-3c10fb2f1a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_12f7532b-5881-49ab-af15-3c10fb2f1a7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b47af406-6d97-4359-906c-9f01402385b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:to="loc_us-gaap_LongTermDebt_b47af406-6d97-4359-906c-9f01402385b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d7ff3fa5-44c1-40e1-8922-d5714a2b982b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:to="loc_us-gaap_LongTermDebtCurrent_d7ff3fa5-44c1-40e1-8922-d5714a2b982b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_86a7118f-7c69-46da-85f4-bd3c1fe1c936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_86a7118f-7c69-46da-85f4-bd3c1fe1c936" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a0b11bfe-41c5-4432-9598-5a9e8f8419cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:to="loc_us-gaap_DebtInstrumentTable_a0b11bfe-41c5-4432-9598-5a9e8f8419cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3450ca9d-154c-47dc-9ab6-32f43342a08a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a0b11bfe-41c5-4432-9598-5a9e8f8419cf" xlink:to="loc_us-gaap_DebtInstrumentAxis_3450ca9d-154c-47dc-9ab6-32f43342a08a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3450ca9d-154c-47dc-9ab6-32f43342a08a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3450ca9d-154c-47dc-9ab6-32f43342a08a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3450ca9d-154c-47dc-9ab6-32f43342a08a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_429e10d8-46c2-44e8-82ce-29ff73f8f794" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3450ca9d-154c-47dc-9ab6-32f43342a08a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_429e10d8-46c2-44e8-82ce-29ff73f8f794" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandAndEighteenAssistanceAgreementMember_6b3644ed-6e4d-4d08-8d92-d5101f3548b2" xlink:href="arvn-20230630.xsd#arvn_TwoThousandAndEighteenAssistanceAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_429e10d8-46c2-44e8-82ce-29ff73f8f794" xlink:to="loc_arvn_TwoThousandAndEighteenAssistanceAgreementMember_6b3644ed-6e4d-4d08-8d92-d5101f3548b2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#LongTermDebtAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="extended" id="i1975cbcdcf8640e39c8aa6c1b6ba2dfd_LongTermDebtAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4e39df38-607c-4151-91cd-d7e44317ec10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4e39df38-607c-4151-91cd-d7e44317ec10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DebtInstrumentLoanForgiveness_b5e33590-86c3-4561-9bda-3e91bac3e042" xlink:href="arvn-20230630.xsd#arvn_DebtInstrumentLoanForgiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_arvn_DebtInstrumentLoanForgiveness_b5e33590-86c3-4561-9bda-3e91bac3e042" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0710a64-5265-4e90-9d81-6e826a71b83f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0710a64-5265-4e90-9d81-6e826a71b83f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DebtInstrumentInterestPaymentsTerm_29f34a87-1750-4003-a8dd-80c933e581c4" xlink:href="arvn-20230630.xsd#arvn_DebtInstrumentInterestPaymentsTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_arvn_DebtInstrumentInterestPaymentsTerm_29f34a87-1750-4003-a8dd-80c933e581c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PercentageOfLiquidatedDamages_38dc5eaa-6c34-4fe5-b32a-4c8167f46ce9" xlink:href="arvn-20230630.xsd#arvn_PercentageOfLiquidatedDamages"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_arvn_PercentageOfLiquidatedDamages_38dc5eaa-6c34-4fe5-b32a-4c8167f46ce9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e10b5a58-c86d-4654-868c-29f304144f38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_us-gaap_InterestExpense_e10b5a58-c86d-4654-868c-29f304144f38" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c134c040-b2d5-4cfe-8e76-13256224d6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_us-gaap_DebtInstrumentTable_c134c040-b2d5-4cfe-8e76-13256224d6b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_081041f7-f983-42f7-a7d0-ce2da0beab0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c134c040-b2d5-4cfe-8e76-13256224d6b3" xlink:to="loc_us-gaap_DebtInstrumentAxis_081041f7-f983-42f7-a7d0-ce2da0beab0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_081041f7-f983-42f7-a7d0-ce2da0beab0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_081041f7-f983-42f7-a7d0-ce2da0beab0e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_081041f7-f983-42f7-a7d0-ce2da0beab0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dacfc468-a140-448d-b0fd-e729be300df9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_081041f7-f983-42f7-a7d0-ce2da0beab0e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dacfc468-a140-448d-b0fd-e729be300df9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandAndEighteenAssistanceAgreementMember_20071692-8117-46fd-b28f-c53bcf646790" xlink:href="arvn-20230630.xsd#arvn_TwoThousandAndEighteenAssistanceAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dacfc468-a140-448d-b0fd-e729be300df9" xlink:to="loc_arvn_TwoThousandAndEighteenAssistanceAgreementMember_20071692-8117-46fd-b28f-c53bcf646790" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandAndFourteenAssistanceAgreementMember_2317e545-b990-449e-9633-d11fefa1166d" xlink:href="arvn-20230630.xsd#arvn_TwoThousandAndFourteenAssistanceAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dacfc468-a140-448d-b0fd-e729be300df9" xlink:to="loc_arvn_TwoThousandAndFourteenAssistanceAgreementMember_2317e545-b990-449e-9633-d11fefa1166d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3c7256ee-5c63-424c-81bf-ca03f51caa5b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c134c040-b2d5-4cfe-8e76-13256224d6b3" xlink:to="loc_srt_StatementGeographicalAxis_3c7256ee-5c63-424c-81bf-ca03f51caa5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3c7256ee-5c63-424c-81bf-ca03f51caa5b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_3c7256ee-5c63-424c-81bf-ca03f51caa5b" xlink:to="loc_srt_SegmentGeographicalDomain_3c7256ee-5c63-424c-81bf-ca03f51caa5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2671025a-a9fe-486a-b8e1-2086138e96a1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_3c7256ee-5c63-424c-81bf-ca03f51caa5b" xlink:to="loc_srt_SegmentGeographicalDomain_2671025a-a9fe-486a-b8e1-2086138e96a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT_ff29aa26-a4cc-4aee-beaa-ee15efcdc266" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_CT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2671025a-a9fe-486a-b8e1-2086138e96a1" xlink:to="loc_stpr_CT_ff29aa26-a4cc-4aee-beaa-ee15efcdc266" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquityAdditionalInformationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/EquityAdditionalInformationDetails" xlink:type="extended" id="i1fbb647b3ec44f5cabc27be580f16332_EquityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_MaximumAggregateOfferingPriceOfCommonStock_65073744-95c5-4353-a449-174c5f1b3f75" xlink:href="arvn-20230630.xsd#arvn_MaximumAggregateOfferingPriceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_arvn_MaximumAggregateOfferingPriceOfCommonStock_65073744-95c5-4353-a449-174c5f1b3f75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e454f59e-dc10-4352-95c6-b0c96f7201fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e454f59e-dc10-4352-95c6-b0c96f7201fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b8c3e126-465e-4e3d-ae45-b9f86f9f3a79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b8c3e126-465e-4e3d-ae45-b9f86f9f3a79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock_36b175d9-037a-4cfc-9224-007eace040b1" xlink:href="arvn-20230630.xsd#arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock_36b175d9-037a-4cfc-9224-007eace040b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6605d7b5-cac3-4dbe-ac83-957111292f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6605d7b5-cac3-4dbe-ac83-957111292f5d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c53ca706-71a6-49d2-8b56-41a5f154c936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c53ca706-71a6-49d2-8b56-41a5f154c936" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_449d858d-1770-436f-8a1e-d44d13615efb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_449d858d-1770-436f-8a1e-d44d13615efb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8891fd70-6e99-4ece-89b0-55b2eb4be5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8891fd70-6e99-4ece-89b0-55b2eb4be5e6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_5025e563-0a66-476d-bb40-8033096d90d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_5025e563-0a66-476d-bb40-8033096d90d9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_0aba78eb-beee-4284-9eb9-a80e640d91df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_0aba78eb-beee-4284-9eb9-a80e640d91df" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_784c60dd-2a23-41cc-8467-699fe6515fca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_784c60dd-2a23-41cc-8467-699fe6515fca" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_5d35e1cf-7071-40a7-a7c8-12959808e0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_5d35e1cf-7071-40a7-a7c8-12959808e0b8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_260359f9-c1be-4883-8191-5e8cb88e2ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_260359f9-c1be-4883-8191-5e8cb88e2ca2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f6248e28-de86-450c-b7cc-a4086664f028" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f6248e28-de86-450c-b7cc-a4086664f028" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2a11ea6b-4023-4874-be41-61f7918ba1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2a11ea6b-4023-4874-be41-61f7918ba1fc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_27e12453-ada2-4128-986c-2cbef900a550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_27e12453-ada2-4128-986c-2cbef900a550" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_82a32c91-550e-4803-8d82-f6a96de986db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_82a32c91-550e-4803-8d82-f6a96de986db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_82a32c91-550e-4803-8d82-f6a96de986db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_82a32c91-550e-4803-8d82-f6a96de986db" xlink:to="loc_us-gaap_EquityComponentDomain_82a32c91-550e-4803-8d82-f6a96de986db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f4929178-fff7-4a1d-b7cf-314a49308e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_82a32c91-550e-4803-8d82-f6a96de986db" xlink:to="loc_us-gaap_EquityComponentDomain_f4929178-fff7-4a1d-b7cf-314a49308e1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d1e36d09-82d2-43a3-9911-cafc1896e245" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f4929178-fff7-4a1d-b7cf-314a49308e1c" xlink:to="loc_us-gaap_CommonStockMember_d1e36d09-82d2-43a3-9911-cafc1896e245" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_8f4c46ab-160b-4a1e-8483-55a5029a017b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_8f4c46ab-160b-4a1e-8483-55a5029a017b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8f4c46ab-160b-4a1e-8483-55a5029a017b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8f4c46ab-160b-4a1e-8483-55a5029a017b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8f4c46ab-160b-4a1e-8483-55a5029a017b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_15a039bf-f0dc-4106-873b-9b4760d9d367" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8f4c46ab-160b-4a1e-8483-55a5029a017b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_15a039bf-f0dc-4106-873b-9b4760d9d367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_EquityDistributionAgreementMember_62f6c78e-f80f-406b-b58e-1522cf231d1f" xlink:href="arvn-20230630.xsd#arvn_EquityDistributionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_15a039bf-f0dc-4106-873b-9b4760d9d367" xlink:to="loc_arvn_EquityDistributionAgreementMember_62f6c78e-f80f-406b-b58e-1522cf231d1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b6b890bd-e43c-4303-abe9-f151220ba41c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b6b890bd-e43c-4303-abe9-f151220ba41c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b6b890bd-e43c-4303-abe9-f151220ba41c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b6b890bd-e43c-4303-abe9-f151220ba41c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b6b890bd-e43c-4303-abe9-f151220ba41c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f5499638-fff6-4fca-a05e-ce18b6bf556a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b6b890bd-e43c-4303-abe9-f151220ba41c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f5499638-fff6-4fca-a05e-ce18b6bf556a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AtTheMarketOfferingMember_c763e01f-02da-4018-b34a-4076a6593514" xlink:href="arvn-20230630.xsd#arvn_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f5499638-fff6-4fca-a05e-ce18b6bf556a" xlink:to="loc_arvn_AtTheMarketOfferingMember_c763e01f-02da-4018-b34a-4076a6593514" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_76206bdd-ac1e-48b7-8db4-39ab70c7ba9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f5499638-fff6-4fca-a05e-ce18b6bf556a" xlink:to="loc_us-gaap_EmployeeStockMember_76206bdd-ac1e-48b7-8db4-39ab70c7ba9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a9ff23de-32d6-4a1c-9f05-26adaf2937bf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_srt_CounterpartyNameAxis_a9ff23de-32d6-4a1c-9f05-26adaf2937bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a9ff23de-32d6-4a1c-9f05-26adaf2937bf_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_a9ff23de-32d6-4a1c-9f05-26adaf2937bf" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a9ff23de-32d6-4a1c-9f05-26adaf2937bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d7c2960-b3d0-4923-bc2e-1acf28e5b7e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_a9ff23de-32d6-4a1c-9f05-26adaf2937bf" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d7c2960-b3d0-4923-bc2e-1acf28e5b7e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PiperSandlerAndCantorMember_cb04bd76-f87b-4066-a93f-6857fb53821b" xlink:href="arvn-20230630.xsd#arvn_PiperSandlerAndCantorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d7c2960-b3d0-4923-bc2e-1acf28e5b7e6" xlink:to="loc_arvn_PiperSandlerAndCantorMember_cb04bd76-f87b-4066-a93f-6857fb53821b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_00d6634a-b9f3-4125-9d7c-5ac2c62746c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_PlanNameAxis_00d6634a-b9f3-4125-9d7c-5ac2c62746c6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_00d6634a-b9f3-4125-9d7c-5ac2c62746c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_00d6634a-b9f3-4125-9d7c-5ac2c62746c6" xlink:to="loc_us-gaap_PlanNameDomain_00d6634a-b9f3-4125-9d7c-5ac2c62746c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1cd04944-8701-4ba2-82eb-0099a5f178a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_00d6634a-b9f3-4125-9d7c-5ac2c62746c6" xlink:to="loc_us-gaap_PlanNameDomain_1cd04944-8701-4ba2-82eb-0099a5f178a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_StockIncentivePlanMember_83f31d62-2caf-4310-8c4e-b4a8d6a8ed02" xlink:href="arvn-20230630.xsd#arvn_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1cd04944-8701-4ba2-82eb-0099a5f178a9" xlink:to="loc_arvn_StockIncentivePlanMember_83f31d62-2caf-4310-8c4e-b4a8d6a8ed02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_938342c5-9e8c-4775-ac96-000c42628ec5" xlink:href="arvn-20230630.xsd#arvn_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1cd04944-8701-4ba2-82eb-0099a5f178a9" xlink:to="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_938342c5-9e8c-4775-ac96-000c42628ec5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9a5ba3a0-6a3c-4b9a-a6ad-887285c67a64" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_srt_RangeAxis_9a5ba3a0-6a3c-4b9a-a6ad-887285c67a64" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9a5ba3a0-6a3c-4b9a-a6ad-887285c67a64_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9a5ba3a0-6a3c-4b9a-a6ad-887285c67a64" xlink:to="loc_srt_RangeMember_9a5ba3a0-6a3c-4b9a-a6ad-887285c67a64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e64acacd-a142-4d32-b03a-1255d6f298d4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9a5ba3a0-6a3c-4b9a-a6ad-887285c67a64" xlink:to="loc_srt_RangeMember_e64acacd-a142-4d32-b03a-1255d6f298d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e1990a18-9cb6-4342-9da1-51dd29c11819" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e64acacd-a142-4d32-b03a-1255d6f298d4" xlink:to="loc_srt_MinimumMember_e1990a18-9cb6-4342-9da1-51dd29c11819" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_971bc85e-cfa2-422a-ba12-3541e48948db" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e64acacd-a142-4d32-b03a-1255d6f298d4" xlink:to="loc_srt_MaximumMember_971bc85e-cfa2-422a-ba12-3541e48948db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_1b120e4b-36eb-4c40-b531-4a66f6adc780" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_GranteeStatusAxis_1b120e4b-36eb-4c40-b531-4a66f6adc780" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_1b120e4b-36eb-4c40-b531-4a66f6adc780_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_1b120e4b-36eb-4c40-b531-4a66f6adc780" xlink:to="loc_us-gaap_GranteeStatusDomain_1b120e4b-36eb-4c40-b531-4a66f6adc780_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_a04e777e-a27f-4487-8e86-f7a081069ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_1b120e4b-36eb-4c40-b531-4a66f6adc780" xlink:to="loc_us-gaap_GranteeStatusDomain_a04e777e-a27f-4487-8e86-f7a081069ddf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_678580f2-495f-4dcc-86a9-7990605f9521" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_a04e777e-a27f-4487-8e86-f7a081069ddf" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_678580f2-495f-4dcc-86a9-7990605f9521" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b98553a0-aa12-4e0b-ab2f-6d5bb74db146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_AwardTypeAxis_b98553a0-aa12-4e0b-ab2f-6d5bb74db146" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b98553a0-aa12-4e0b-ab2f-6d5bb74db146_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b98553a0-aa12-4e0b-ab2f-6d5bb74db146" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b98553a0-aa12-4e0b-ab2f-6d5bb74db146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5b5eb1e-87d4-4fa5-8bdc-12938114a8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b98553a0-aa12-4e0b-ab2f-6d5bb74db146" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5b5eb1e-87d4-4fa5-8bdc-12938114a8b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_3e320059-3bd0-458b-9e7e-a2464fc86f15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5b5eb1e-87d4-4fa5-8bdc-12938114a8b5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_3e320059-3bd0-458b-9e7e-a2464fc86f15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e1bd808c-4290-4844-9f9c-0b932ab97bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5b5eb1e-87d4-4fa5-8bdc-12938114a8b5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e1bd808c-4290-4844-9f9c-0b932ab97bf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_80b147fc-dac4-4c09-b0ad-ded8e2036bba" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_srt_TitleOfIndividualAxis_80b147fc-dac4-4c09-b0ad-ded8e2036bba" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_80b147fc-dac4-4c09-b0ad-ded8e2036bba_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_80b147fc-dac4-4c09-b0ad-ded8e2036bba" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_80b147fc-dac4-4c09-b0ad-ded8e2036bba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b7e30f5-ece9-44af-b96b-02fe1eb1c929" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_80b147fc-dac4-4c09-b0ad-ded8e2036bba" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b7e30f5-ece9-44af-b96b-02fe1eb1c929" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_EmployeesMember_d78ad64c-eb62-460c-aa45-6ffbdab5be17" xlink:href="arvn-20230630.xsd#arvn_EmployeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b7e30f5-ece9-44af-b96b-02fe1eb1c929" xlink:to="loc_arvn_EmployeesMember_d78ad64c-eb62-460c-aa45-6ffbdab5be17" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails" xlink:type="extended" id="i1fd6977061cb4b47b196ac0bb2d3fa34_EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_cadc8d76-9450-4cd7-bd92-e673da576f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_cadc8d76-9450-4cd7-bd92-e673da576f33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_342da05b-87c6-4a94-bb01-6c54c460eb66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_342da05b-87c6-4a94-bb01-6c54c460eb66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_795db98c-1afe-4285-a688-797dd88fe44a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_795db98c-1afe-4285-a688-797dd88fe44a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_82cbe0ec-13e5-4ce3-8b34-06fef28de0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_82cbe0ec-13e5-4ce3-8b34-06fef28de0a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_fdf81b80-d03a-401e-b11f-100ea271c8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_fdf81b80-d03a-401e-b11f-100ea271c8fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4a54471e-fd6e-42c8-b2e2-482e6ca590d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4a54471e-fd6e-42c8-b2e2-482e6ca590d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c435acea-d64b-4e13-8f98-ba4a9cf135cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c435acea-d64b-4e13-8f98-ba4a9cf135cc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e5a6d47-5a5a-441f-a613-29d07339c865" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e5a6d47-5a5a-441f-a613-29d07339c865" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_639ee70e-78ce-4291-9646-3118db2e4eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e5a6d47-5a5a-441f-a613-29d07339c865" xlink:to="loc_us-gaap_AwardTypeAxis_639ee70e-78ce-4291-9646-3118db2e4eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_639ee70e-78ce-4291-9646-3118db2e4eb4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_639ee70e-78ce-4291-9646-3118db2e4eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_639ee70e-78ce-4291-9646-3118db2e4eb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40abfeb9-1e31-4f16-8e05-9de740a4906b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_639ee70e-78ce-4291-9646-3118db2e4eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40abfeb9-1e31-4f16-8e05-9de740a4906b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_396b3daf-e663-4ddd-9d01-bee9b1b16b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40abfeb9-1e31-4f16-8e05-9de740a4906b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_396b3daf-e663-4ddd-9d01-bee9b1b16b6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7131b0f1-fe7d-4907-92ce-9453c6b9125a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e5a6d47-5a5a-441f-a613-29d07339c865" xlink:to="loc_srt_RangeAxis_7131b0f1-fe7d-4907-92ce-9453c6b9125a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7131b0f1-fe7d-4907-92ce-9453c6b9125a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7131b0f1-fe7d-4907-92ce-9453c6b9125a" xlink:to="loc_srt_RangeMember_7131b0f1-fe7d-4907-92ce-9453c6b9125a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_795f2b22-c5d6-49a0-99e8-81bcdcee8ca9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7131b0f1-fe7d-4907-92ce-9453c6b9125a" xlink:to="loc_srt_RangeMember_795f2b22-c5d6-49a0-99e8-81bcdcee8ca9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_820f3bf8-2833-405b-a22f-cf7e1846e55e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_795f2b22-c5d6-49a0-99e8-81bcdcee8ca9" xlink:to="loc_srt_MinimumMember_820f3bf8-2833-405b-a22f-cf7e1846e55e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e88da4d9-642c-413a-a155-927aa017eba2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_795f2b22-c5d6-49a0-99e8-81bcdcee8ca9" xlink:to="loc_srt_MaximumMember_e88da4d9-642c-413a-a155-927aa017eba2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquitySummaryofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails" xlink:type="extended" id="ica48e2199dc2425ea236f309233075fb_EquitySummaryofStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a6a4d032-d919-45b5-acc8-5006d8e94577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a6a4d032-d919-45b5-acc8-5006d8e94577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_67325836-5dc5-497e-bb02-0dbb9ad882d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_67325836-5dc5-497e-bb02-0dbb9ad882d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1f012efd-c0cf-499c-8d62-6c4d3b52d4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1f012efd-c0cf-499c-8d62-6c4d3b52d4cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_392645fe-568e-4e16-86ee-10f689eba951" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_392645fe-568e-4e16-86ee-10f689eba951" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_275b0a14-efdc-418d-a138-c2d6887f7ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_76263bd7-3f55-4f47-8c70-d9e09d1b3e64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_76263bd7-3f55-4f47-8c70-d9e09d1b3e64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_d52b3178-fd76-4199-8bd8-01a6591e3bff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_d52b3178-fd76-4199-8bd8-01a6591e3bff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0fa3675d-7274-46df-95e5-7669f7a85dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0fa3675d-7274-46df-95e5-7669f7a85dd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ccc9ad1b-5cf6-4a8d-b89f-3c5f4ea395bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ccc9ad1b-5cf6-4a8d-b89f-3c5f4ea395bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_efd58e60-0afa-471b-80f5-bfeafa7ba117" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_efd58e60-0afa-471b-80f5-bfeafa7ba117" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c1e347ea-a86b-44df-894f-257f1a1b6bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c1e347ea-a86b-44df-894f-257f1a1b6bfa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6c746847-bcdb-451c-b004-9db6afd3b0af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f6d38bc6-d7fc-4a64-a982-7c996ceda476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f6d38bc6-d7fc-4a64-a982-7c996ceda476" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_4b021cda-fa4b-4329-b3cc-6233e4d230a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_4b021cda-fa4b-4329-b3cc-6233e4d230a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2f31eade-1a7d-456a-8564-c9a222a66f19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2f31eade-1a7d-456a-8564-c9a222a66f19" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_73ee8fd1-21cd-42b7-9085-1028400a55a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2f31eade-1a7d-456a-8564-c9a222a66f19" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_73ee8fd1-21cd-42b7-9085-1028400a55a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40d883ea-4e7b-4bf0-ab29-506fe01bcb40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2f31eade-1a7d-456a-8564-c9a222a66f19" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40d883ea-4e7b-4bf0-ab29-506fe01bcb40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dc7ade0b-febd-40e3-898a-832cad68ff00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2f31eade-1a7d-456a-8564-c9a222a66f19" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dc7ade0b-febd-40e3-898a-832cad68ff00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AggregateIntrinsicValueAbstract_75afe749-2b48-43cb-a38c-686d1f80922b" xlink:href="arvn-20230630.xsd#arvn_AggregateIntrinsicValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_arvn_AggregateIntrinsicValueAbstract_75afe749-2b48-43cb-a38c-686d1f80922b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8871326a-2c9a-4011-9a8b-4f6337fc1673" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_arvn_AggregateIntrinsicValueAbstract_75afe749-2b48-43cb-a38c-686d1f80922b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8871326a-2c9a-4011-9a8b-4f6337fc1673" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_942fa402-14fb-4c2e-9770-9f077a92de42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_arvn_AggregateIntrinsicValueAbstract_75afe749-2b48-43cb-a38c-686d1f80922b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_942fa402-14fb-4c2e-9770-9f077a92de42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_e388ffac-16d6-4e89-be82-9eca5ae79ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_arvn_AggregateIntrinsicValueAbstract_75afe749-2b48-43cb-a38c-686d1f80922b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_e388ffac-16d6-4e89-be82-9eca5ae79ea0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e255df6-e773-4b47-b10b-4be513ac573c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e255df6-e773-4b47-b10b-4be513ac573c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_90de6278-761f-4783-827b-ccdf46a2c31f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e255df6-e773-4b47-b10b-4be513ac573c" xlink:to="loc_us-gaap_PlanNameAxis_90de6278-761f-4783-827b-ccdf46a2c31f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_90de6278-761f-4783-827b-ccdf46a2c31f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_90de6278-761f-4783-827b-ccdf46a2c31f" xlink:to="loc_us-gaap_PlanNameDomain_90de6278-761f-4783-827b-ccdf46a2c31f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6e0fca1a-0223-4eeb-965b-8056baea9fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_90de6278-761f-4783-827b-ccdf46a2c31f" xlink:to="loc_us-gaap_PlanNameDomain_6e0fca1a-0223-4eeb-965b-8056baea9fcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_ac98c4a2-baec-4ac4-9ab2-7b9811f3484c" xlink:href="arvn-20230630.xsd#arvn_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6e0fca1a-0223-4eeb-965b-8056baea9fcd" xlink:to="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_ac98c4a2-baec-4ac4-9ab2-7b9811f3484c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquitySummaryofRestrictedStockDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails" xlink:type="extended" id="ia207eb317bae4cffa8abf49984be5552_EquitySummaryofRestrictedStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0831000e-6fcd-41a0-9372-172b0cf6d335" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0831000e-6fcd-41a0-9372-172b0cf6d335" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_91f7ccb9-4a66-44d5-a237-567737d8601e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_91f7ccb9-4a66-44d5-a237-567737d8601e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0ba4097e-b778-4759-852d-7130f87cb037" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0ba4097e-b778-4759-852d-7130f87cb037" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_57dd3895-2d1b-441f-b8e6-d60bee42ed0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_57dd3895-2d1b-441f-b8e6-d60bee42ed0e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_42eb0f97-e443-4895-9c05-2d15e1c6617e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_42eb0f97-e443-4895-9c05-2d15e1c6617e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9140e328-0b3e-45cd-9f68-202bfe150034" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0831000e-6fcd-41a0-9372-172b0cf6d335" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4db95704-7b2b-4967-a2d3-735bb0365ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4db95704-7b2b-4967-a2d3-735bb0365ccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_59289163-b757-4886-9fd6-285c53284523" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_59289163-b757-4886-9fd6-285c53284523" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f53dc957-8aaa-4555-8593-ee2c39308d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f53dc957-8aaa-4555-8593-ee2c39308d4f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_ac159267-5980-409e-8a5f-5e6181d9e726" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_ac159267-5980-409e-8a5f-5e6181d9e726" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bd00ee30-4829-4946-9f4b-638471d9b443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c6fd8d-5af4-4c10-9a1a-0821cd148ede" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0831000e-6fcd-41a0-9372-172b0cf6d335" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c6fd8d-5af4-4c10-9a1a-0821cd148ede" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3f9f0e5f-7db6-4923-bbfe-7bb56daed349" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c6fd8d-5af4-4c10-9a1a-0821cd148ede" xlink:to="loc_us-gaap_PlanNameAxis_3f9f0e5f-7db6-4923-bbfe-7bb56daed349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3f9f0e5f-7db6-4923-bbfe-7bb56daed349_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3f9f0e5f-7db6-4923-bbfe-7bb56daed349" xlink:to="loc_us-gaap_PlanNameDomain_3f9f0e5f-7db6-4923-bbfe-7bb56daed349_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b6e603d7-8578-467d-bf25-5afe39aa18ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3f9f0e5f-7db6-4923-bbfe-7bb56daed349" xlink:to="loc_us-gaap_PlanNameDomain_b6e603d7-8578-467d-bf25-5afe39aa18ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_b7d7df44-2fc0-4925-9666-12ebc8e5eff3" xlink:href="arvn-20230630.xsd#arvn_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b6e603d7-8578-467d-bf25-5afe39aa18ed" xlink:to="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_b7d7df44-2fc0-4925-9666-12ebc8e5eff3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_244a3272-2037-4d78-831d-7ed6d1781b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c6fd8d-5af4-4c10-9a1a-0821cd148ede" xlink:to="loc_us-gaap_AwardTypeAxis_244a3272-2037-4d78-831d-7ed6d1781b1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_244a3272-2037-4d78-831d-7ed6d1781b1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_244a3272-2037-4d78-831d-7ed6d1781b1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_244a3272-2037-4d78-831d-7ed6d1781b1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_350adb15-3dea-4cf8-9433-2709e4919d98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_244a3272-2037-4d78-831d-7ed6d1781b1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_350adb15-3dea-4cf8-9433-2709e4919d98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bbdadbc6-2add-4033-b720-c3a1236926f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_350adb15-3dea-4cf8-9433-2709e4919d98" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bbdadbc6-2add-4033-b720-c3a1236926f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_c3b5cc81-8082-4eba-9cbd-2dd12b4bec90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c6fd8d-5af4-4c10-9a1a-0821cd148ede" xlink:to="loc_us-gaap_GranteeStatusAxis_c3b5cc81-8082-4eba-9cbd-2dd12b4bec90" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_c3b5cc81-8082-4eba-9cbd-2dd12b4bec90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_c3b5cc81-8082-4eba-9cbd-2dd12b4bec90" xlink:to="loc_us-gaap_GranteeStatusDomain_c3b5cc81-8082-4eba-9cbd-2dd12b4bec90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_aab883b3-3231-419d-bf37-49f95d15fef4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_c3b5cc81-8082-4eba-9cbd-2dd12b4bec90" xlink:to="loc_us-gaap_GranteeStatusDomain_aab883b3-3231-419d-bf37-49f95d15fef4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_d74a2416-150b-4e6a-be40-72b3417ca7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_aab883b3-3231-419d-bf37-49f95d15fef4" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_d74a2416-150b-4e6a-be40-72b3417ca7ed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails" xlink:type="extended" id="i8d6e65d01f364e64ad81b8d4e327f37b_NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0194aa4e-fd26-4584-b5dd-97a624fe6c17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ce0fe2b7-b3a5-40d2-8553-d93e1711e937" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0194aa4e-fd26-4584-b5dd-97a624fe6c17" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ce0fe2b7-b3a5-40d2-8553-d93e1711e937" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4e3bf920-59e0-43bb-9083-d43fe5b0dee1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0194aa4e-fd26-4584-b5dd-97a624fe6c17" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4e3bf920-59e0-43bb-9083-d43fe5b0dee1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f432a448-de61-4286-b9ac-460f49d34d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4e3bf920-59e0-43bb-9083-d43fe5b0dee1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f432a448-de61-4286-b9ac-460f49d34d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f432a448-de61-4286-b9ac-460f49d34d3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f432a448-de61-4286-b9ac-460f49d34d3f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f432a448-de61-4286-b9ac-460f49d34d3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d26cf91c-f171-4fd4-bd88-9eb04fffb228" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f432a448-de61-4286-b9ac-460f49d34d3f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d26cf91c-f171-4fd4-bd88-9eb04fffb228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_292f47ed-b592-4ea4-a15d-c8f88f1437b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d26cf91c-f171-4fd4-bd88-9eb04fffb228" xlink:to="loc_us-gaap_EmployeeStockOptionMember_292f47ed-b592-4ea4-a15d-c8f88f1437b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e080067a-309e-47ed-b861-203569f1ca64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d26cf91c-f171-4fd4-bd88-9eb04fffb228" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e080067a-309e-47ed-b861-203569f1ca64" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquityMethodInvestmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails" xlink:type="extended" id="i14e36714969e49b28204f136bd3ce95d_EquityMethodInvestmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_573854c0-71c6-4eac-a1b4-379587b146ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_573854c0-71c6-4eac-a1b4-379587b146ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage_e37e1806-c254-441d-b703-d89ef5d5a0b3" xlink:href="arvn-20230630.xsd#arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage_e37e1806-c254-441d-b703-d89ef5d5a0b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_222a790f-d9c5-47eb-b273-5d0a5fd62c39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_us-gaap_ContractWithCustomerLiability_222a790f-d9c5-47eb-b273-5d0a5fd62c39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1b6caecd-5e3e-46a7-9475-79ca6f277aad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_us-gaap_NetIncomeLoss_1b6caecd-5e3e-46a7-9475-79ca6f277aad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e9e7f591-ec8a-4252-aeae-370588e18e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e9e7f591-ec8a-4252-aeae-370588e18e8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_4aba30d5-b75f-421a-a19e-58f6b46b4c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_us-gaap_EquityMethodInvestments_4aba30d5-b75f-421a-a19e-58f6b46b4c9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ab5db015-7abb-4df4-aac5-52c2106c2316" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ab5db015-7abb-4df4-aac5-52c2106c2316" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_984fad32-fc38-4b33-9476-d4e893356535" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ab5db015-7abb-4df4-aac5-52c2106c2316" xlink:to="loc_srt_CounterpartyNameAxis_984fad32-fc38-4b33-9476-d4e893356535" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_984fad32-fc38-4b33-9476-d4e893356535_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_984fad32-fc38-4b33-9476-d4e893356535" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_984fad32-fc38-4b33-9476-d4e893356535_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_44421421-b442-4c22-906a-2660d8942db0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_984fad32-fc38-4b33-9476-d4e893356535" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_44421421-b442-4c22-906a-2660d8942db0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_BayerCropScienceLPMember_f90e3275-eb41-461a-98ee-76c5bbff531e" xlink:href="arvn-20230630.xsd#arvn_BayerCropScienceLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_44421421-b442-4c22-906a-2660d8942db0" xlink:to="loc_arvn_BayerCropScienceLPMember_f90e3275-eb41-461a-98ee-76c5bbff531e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_609ba1cd-b788-4ec2-a015-0c3e708d9b6a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ab5db015-7abb-4df4-aac5-52c2106c2316" xlink:to="loc_dei_LegalEntityAxis_609ba1cd-b788-4ec2-a015-0c3e708d9b6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_609ba1cd-b788-4ec2-a015-0c3e708d9b6a_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_609ba1cd-b788-4ec2-a015-0c3e708d9b6a" xlink:to="loc_dei_EntityDomain_609ba1cd-b788-4ec2-a015-0c3e708d9b6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5bfdb294-cfa5-4f94-9cfd-ccf338f2655c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_609ba1cd-b788-4ec2-a015-0c3e708d9b6a" xlink:to="loc_dei_EntityDomain_5bfdb294-cfa5-4f94-9cfd-ccf338f2655c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_OerthBioLimitedLiabilityCorporationMember_6bfe2537-931e-464a-912d-170382146a34" xlink:href="arvn-20230630.xsd#arvn_OerthBioLimitedLiabilityCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5bfdb294-cfa5-4f94-9cfd-ccf338f2655c" xlink:to="loc_arvn_OerthBioLimitedLiabilityCorporationMember_6bfe2537-931e-464a-912d-170382146a34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3430805d-4aa0-4925-9436-b874259e4e96" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ab5db015-7abb-4df4-aac5-52c2106c2316" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3430805d-4aa0-4925-9436-b874259e4e96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3430805d-4aa0-4925-9436-b874259e4e96_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3430805d-4aa0-4925-9436-b874259e4e96" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3430805d-4aa0-4925-9436-b874259e4e96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3f77d7cb-0c44-4fd3-bc46-b8bff3a543eb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3430805d-4aa0-4925-9436-b874259e4e96" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3f77d7cb-0c44-4fd3-bc46-b8bff3a543eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_OerthBioLimitedLiabilityCorporationMember_2da4da0c-de08-47e9-bd47-4d73d11e8d67" xlink:href="arvn-20230630.xsd#arvn_OerthBioLimitedLiabilityCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3f77d7cb-0c44-4fd3-bc46-b8bff3a543eb" xlink:to="loc_arvn_OerthBioLimitedLiabilityCorporationMember_2da4da0c-de08-47e9-bd47-4d73d11e8d67" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails" xlink:type="extended" id="i5323713015744dd7b2b88695fbe37e16_EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9f9f4da8-ac48-4002-acf0-2bec2e541b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_Revenues_9f9f4da8-ac48-4002-acf0-2bec2e541b7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e5fbdd8e-da3e-451a-89a2-1e5808ee457e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_OperatingIncomeLoss_e5fbdd8e-da3e-451a-89a2-1e5808ee457e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_950a0611-b4d7-45b9-bfec-381e0607ee54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_950a0611-b4d7-45b9-bfec-381e0607ee54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5d4c3447-8a11-421b-955c-e5b101138ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_NetIncomeLoss_5d4c3447-8a11-421b-955c-e5b101138ffd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_12f658b8-bff5-449f-be90-56bcb32d64b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_EarningsPerShareBasic_12f658b8-bff5-449f-be90-56bcb32d64b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_74c409a7-9598-4c79-996b-e883060a73d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_EarningsPerShareDiluted_74c409a7-9598-4c79-996b-e883060a73d7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9fde82c6-c136-424b-9bec-f84592f21cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_9fde82c6-c136-424b-9bec-f84592f21cfb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_88adcf7d-636b-4e3d-bc47-ce7a29c42920" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_88adcf7d-636b-4e3d-bc47-ce7a29c42920" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_475ef39e-1037-418b-a1ab-a93ea1d332ed" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_88adcf7d-636b-4e3d-bc47-ce7a29c42920" xlink:to="loc_srt_RestatementAxis_475ef39e-1037-418b-a1ab-a93ea1d332ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_475ef39e-1037-418b-a1ab-a93ea1d332ed_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_475ef39e-1037-418b-a1ab-a93ea1d332ed" xlink:to="loc_srt_RestatementDomain_475ef39e-1037-418b-a1ab-a93ea1d332ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c23a9213-5a84-4f3e-9bb3-75a1d4a5ceec" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_475ef39e-1037-418b-a1ab-a93ea1d332ed" xlink:to="loc_srt_RestatementDomain_c23a9213-5a84-4f3e-9bb3-75a1d4a5ceec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_8eee4838-d2c7-4f22-803f-95aae1d6346b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_c23a9213-5a84-4f3e-9bb3-75a1d4a5ceec" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_8eee4838-d2c7-4f22-803f-95aae1d6346b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_9ba42456-5fc2-4bc3-9d3a-72ce4a1a3499" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_c23a9213-5a84-4f3e-9bb3-75a1d4a5ceec" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_9ba42456-5fc2-4bc3-9d3a-72ce4a1a3499" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.arvinas.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i5b8c9679dc7743e5a78742942342c932_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CommitmentsAndContingenciesLineItems_ffbe0589-ebdf-4a33-8de6-19b628e208c8" xlink:href="arvn-20230630.xsd#arvn_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_25c849fe-e7cd-4723-87a9-71a45580e159" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_arvn_CommitmentsAndContingenciesLineItems_ffbe0589-ebdf-4a33-8de6-19b628e208c8" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_25c849fe-e7cd-4723-87a9-71a45580e159" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_6282f2ec-a95f-4708-a903-0cdf7be90905" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_arvn_CommitmentsAndContingenciesLineItems_ffbe0589-ebdf-4a33-8de6-19b628e208c8" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_6282f2ec-a95f-4708-a903-0cdf7be90905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CommitmentsAndContingenciesTable_3b3e663c-6c0b-440c-a958-ca8acb4f5b91" xlink:href="arvn-20230630.xsd#arvn_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_arvn_CommitmentsAndContingenciesLineItems_ffbe0589-ebdf-4a33-8de6-19b628e208c8" xlink:to="loc_arvn_CommitmentsAndContingenciesTable_3b3e663c-6c0b-440c-a958-ca8acb4f5b91" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_aeac2f1f-d31f-4366-8af7-34d873c75421" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_arvn_CommitmentsAndContingenciesTable_3b3e663c-6c0b-440c-a958-ca8acb4f5b91" xlink:to="loc_srt_CounterpartyNameAxis_aeac2f1f-d31f-4366-8af7-34d873c75421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aeac2f1f-d31f-4366-8af7-34d873c75421_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_aeac2f1f-d31f-4366-8af7-34d873c75421" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aeac2f1f-d31f-4366-8af7-34d873c75421_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_002c889d-653c-47a4-8e94-89b23b23dbca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_aeac2f1f-d31f-4366-8af7-34d873c75421" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_002c889d-653c-47a4-8e94-89b23b23dbca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_FoundationMedicineIncMember_492e5e79-414a-4ca3-b353-d32a70e79146" xlink:href="arvn-20230630.xsd#arvn_FoundationMedicineIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_002c889d-653c-47a4-8e94-89b23b23dbca" xlink:to="loc_arvn_FoundationMedicineIncMember_492e5e79-414a-4ca3-b353-d32a70e79146" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1fffa5d1-f48a-4398-9e7c-69429cc1aa6c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_arvn_CommitmentsAndContingenciesTable_3b3e663c-6c0b-440c-a958-ca8acb4f5b91" xlink:to="loc_srt_RangeAxis_1fffa5d1-f48a-4398-9e7c-69429cc1aa6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1fffa5d1-f48a-4398-9e7c-69429cc1aa6c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1fffa5d1-f48a-4398-9e7c-69429cc1aa6c" xlink:to="loc_srt_RangeMember_1fffa5d1-f48a-4398-9e7c-69429cc1aa6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2856e453-30eb-41e6-8db9-c6633b6e6399" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1fffa5d1-f48a-4398-9e7c-69429cc1aa6c" xlink:to="loc_srt_RangeMember_2856e453-30eb-41e6-8db9-c6633b6e6399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e998c966-dc1d-4d97-98e4-4c8d494f28b8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2856e453-30eb-41e6-8db9-c6633b6e6399" xlink:to="loc_srt_MaximumMember_e998c966-dc1d-4d97-98e4-4c8d494f28b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e51f7296-35dc-4d9c-a3d4-876b293978af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_arvn_CommitmentsAndContingenciesTable_3b3e663c-6c0b-440c-a958-ca8acb4f5b91" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e51f7296-35dc-4d9c-a3d4-876b293978af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e51f7296-35dc-4d9c-a3d4-876b293978af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e51f7296-35dc-4d9c-a3d4-876b293978af" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e51f7296-35dc-4d9c-a3d4-876b293978af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a833e86e-a3db-4f92-8a09-cae544158b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e51f7296-35dc-4d9c-a3d4-876b293978af" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a833e86e-a3db-4f92-8a09-cae544158b7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_SuccessBasedMilestonePaymentsMember_4c21e4c2-34ce-48be-8b52-7aebe8604e2f" xlink:href="arvn-20230630.xsd#arvn_SuccessBasedMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a833e86e-a3db-4f92-8a09-cae544158b7c" xlink:to="loc_arvn_SuccessBasedMilestonePaymentsMember_4c21e4c2-34ce-48be-8b52-7aebe8604e2f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>arvn-20230630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3ad84450-03f4-4a08-908c-03680fffbb5d,g:5431e377-e1a3-4379-9dba-d87e2214df03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_108fe00d-5694-4d75-b01f-a39f5f69b64a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collaborators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollaborators" xlink:to="lab_us-gaap_ProceedsFromCollaborators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandSubjectToGroundLeases_7829502e-e84e-4a43-abca-5d736a60efae_terseLabel_en-US" xlink:label="lab_us-gaap_LandSubjectToGroundLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease for laboratory and office space</link:label>
    <link:label id="lab_us-gaap_LandSubjectToGroundLeases_label_en-US" xlink:label="lab_us-gaap_LandSubjectToGroundLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land Subject to Ground Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandSubjectToGroundLeases" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandSubjectToGroundLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandSubjectToGroundLeases" xlink:to="lab_us-gaap_LandSubjectToGroundLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_8e17d92a-df8c-4999-85b4-3b9cdeb93fda_terseLabel_en-US" xlink:label="lab_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:href="arvn-20230630.xsd#arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:to="lab_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_ff14377c-4520-403d-a6cc-c92f3ceb8481_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PledgingPurposeDomain_041f5394-6b91-43b3-932f-8470df449925_terseLabel_en-US" xlink:label="lab_us-gaap_PledgingPurposeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledging Purpose [Domain]</link:label>
    <link:label id="lab_us-gaap_PledgingPurposeDomain_label_en-US" xlink:label="lab_us-gaap_PledgingPurposeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledging Purpose [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgingPurposeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgingPurposeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PledgingPurposeDomain" xlink:to="lab_us-gaap_PledgingPurposeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_7d91d791-78fa-46ee-8d5c-a4307b4c921e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_70946df8-6a85-4e6a-a512-3da20047026f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3d5e2f88-feca-44fa-b69a-03bff932c876_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f20557f5-cfb0-4ae3-aabf-cc5ad3044659_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_c1162b6a-72df-4a26-88c1-f148febbadbc_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_1b30234c-1591-44e0-90ac-61518f8d7373_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_70ca8880-b5ef-4116-b68f-5394a5881bd0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_441930f7-f3ef-4413-af56-1e2db5920b26_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_cf60dc80-abdc-451f-b208-f1cca37f88d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_678a39e1-d8e6-4624-99a0-e9ebf0cfe4c2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_cd32457e-241a-4d6b-aebc-4513d26c4457_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_d8e82e52-8d60-4544-af51-b56a79064cb7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_7a469a0d-f98e-4e3d-8877-8badcc7b8df9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6d62b450-78ec-44b3-aea4-4e9deb24a17c_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_d1e96541-d249-4825-9a82-58dd307276d5_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e264f469-0f75-451f-aa30-56c09202ae71_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal statutory rate, percentage</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_999c9088-1be7-4b58-9722-18953da57269_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_e812ce8d-988f-4d19-9132-197fa1f4b09b_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">as previously reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_759aeac2-de82-4aee-bbaf-865c0862a9ea_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement And Statement Of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_documentation_en-US" xlink:label="lab_arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement And Statement Of Comprehensive Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract" xlink:href="arvn-20230630.xsd#arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract" xlink:to="lab_arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_a69e6a32-3fbb-4085-8538-184ab2863917_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Grant Activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2d1c0d5c-ae2c-4367-ab30-aa8d08cc25e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c3e4badb-409b-4559-9b3a-d877a715aaf3_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_35742718-33d8-458d-9145-23109b106529_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_27a0742a-5eb6-4f18-9bc7-cf65c24c5c38_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_9fe5563d-f92c-490d-ab67-0a30b4cf55ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_777950d9-f301-4bcd-b890-f6175e241b7d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Business and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_70b59379-cf67-4a99-842f-8c2785419eb3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bb2f36c1-e533-4c19-ac69-9e401c348abe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9544d2c0-54cc-4fdc-924e-b2b14ded19d4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_CommitmentsAndContingenciesTable_7534ac2a-ae60-444c-95bd-7809d08429c7_terseLabel_en-US" xlink:label="lab_arvn_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_arvn_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_arvn_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_arvn_CommitmentsAndContingenciesTable_documentation_en-US" xlink:label="lab_arvn_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CommitmentsAndContingenciesTable" xlink:href="arvn-20230630.xsd#arvn_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_CommitmentsAndContingenciesTable" xlink:to="lab_arvn_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c11cac2a-604b-40b6-a368-98a19d6d294e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_6f4a096e-bee0-45e4-bbac-6128a2ee2474_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_d1e81345-c1a6-4a03-9d84-595ad5c16ab6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e1ebe447-00f7-44d7-9999-9fe1f88ac88f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8abe6f2a-9bbd-4872-a30a-9c6b15680d65_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1180ab3f-a474-4fc3-ad6c-dc612c456b4a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_f18a0f33-b6db-4956-8cae-80da469f1c4a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e73fe5bf-772c-4968-bf51-ae51d72b892a_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_fe141cd7-fd01-4dd7-8c7d-5d6bf7c4b58a_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_482c3350-199c-41a5-acda-ceee56050bec_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c2721269-0929-4e7a-aa1a-b05c9fc3b51e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_SalesBasedMilestonePaymentsMember_db1063d2-691b-4def-8889-4eec35bbc861_terseLabel_en-US" xlink:label="lab_arvn_SalesBasedMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Based Milestone Payments</link:label>
    <link:label id="lab_arvn_SalesBasedMilestonePaymentsMember_label_en-US" xlink:label="lab_arvn_SalesBasedMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Based Milestone Payments [Member]</link:label>
    <link:label id="lab_arvn_SalesBasedMilestonePaymentsMember_documentation_en-US" xlink:label="lab_arvn_SalesBasedMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-based milestone payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_SalesBasedMilestonePaymentsMember" xlink:href="arvn-20230630.xsd#arvn_SalesBasedMilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_SalesBasedMilestonePaymentsMember" xlink:to="lab_arvn_SalesBasedMilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_90e4d930-6787-4aaa-bf9c-d73f7c3d1351_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expenses)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_86d4881e-b10a-434f-9112-5cfa7c0a3389_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage_7b161273-4e58-4980-b6d7-726c28880107_terseLabel_en-US" xlink:label="lab_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future grant of incentive units to service providers percentage</link:label>
    <link:label id="lab_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage_label_en-US" xlink:label="lab_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Grant Of Incentive Units To Service Providers Percentage</link:label>
    <link:label id="lab_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage_documentation_en-US" xlink:label="lab_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future grant of incentive units to service providers, percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage" xlink:href="arvn-20230630.xsd#arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage" xlink:to="lab_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8b13cf09-fc9f-4517-8361-27b7f3d21ca2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9e459290-4ba9-49c8-8eeb-01b8e841916a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value of options (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_841b0a1c-fe7a-4ba8-ba08-bdb6e6ab61fd_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e7d66fce-9ca7-4060-864a-00eb91d91db7_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b33489e9-9cb6-4c57-a48d-ef26bfc70fbd_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_03e80bf5-4124-4772-bef7-cccb02445e5e_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_22979267-0ac3-4bd1-848b-36b03bbf63ba_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_5bb22054-38d7-4b15-936b-6a55743d9866_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares_e126e277-7a60-4f03-9e02-1968d5461ec5_terseLabel_en-US" xlink:label="lab_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options and issuance of ESPP shares</link:label>
    <link:label id="lab_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares_label_en-US" xlink:label="lab_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Exercise Of Stock Options And Issuance Of Employee Stock Shares</link:label>
    <link:label id="lab_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares_documentation_en-US" xlink:label="lab_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Exercise Of Stock Options And Issuance Of Employee Stock Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares" xlink:href="arvn-20230630.xsd#arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares" xlink:to="lab_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_95ffc6e5-d0d9-47e1-81da-83835f64f96f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_5db08993-321e-4f40-8801-a936153f81d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_f1ca62bd-2bc5-4e9d-bad6-05da34ef8e13_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dc604d6c-5fa4-4cd2-aab8-3f7a026e4992_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_1c51d27e-cc5c-402c-81af-ac8f9935bfc0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_18a7f00d-2658-49e7-a635-4745f963d739_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions_9eed5670-5537-4ed7-9482-2459a2cfe686_terseLabel_en-US" xlink:label="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions_label_en-US" xlink:label="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, After Allowance For Credit Loss, Current, Additions</link:label>
    <link:label id="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions_documentation_en-US" xlink:label="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, After Allowance For Credit Loss, Current, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions" xlink:href="arvn-20230630.xsd#arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions" xlink:to="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_54a89234-e5f0-4035-97b0-e6815f825f32_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4fc0156e-652d-4b21-a56a-6cb47339bb44_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_da8afbd0-b29e-456a-b08b-da1717da0692_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_4eddde3f-3ee4-46a6-8893-19304bfc2ede_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_41a9396a-6042-4ff0-b1a5-49f96523df3f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_b1965a4b-dc38-41c7-8569-435844342654_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ee2347f8-9b58-472c-b7bc-c0f9fcfc43a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Basic and Diluted Loss per Common Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e5e5a5bc-05de-454a-b1af-134c2f75289b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based award, vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_AccountsPayableContractBalancesCurrent_b0f72241-bc15-4b21-96e2-1f1fc1f7826b_periodStartLabel_en-US" xlink:label="lab_arvn_AccountsPayableContractBalancesCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_arvn_AccountsPayableContractBalancesCurrent_d04410dc-41f5-4686-b4cd-f1358d497aa3_periodEndLabel_en-US" xlink:label="lab_arvn_AccountsPayableContractBalancesCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_arvn_AccountsPayableContractBalancesCurrent_label_en-US" xlink:label="lab_arvn_AccountsPayableContractBalancesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Contract Balances, Current</link:label>
    <link:label id="lab_arvn_AccountsPayableContractBalancesCurrent_documentation_en-US" xlink:label="lab_arvn_AccountsPayableContractBalancesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Contract Balances, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccountsPayableContractBalancesCurrent" xlink:href="arvn-20230630.xsd#arvn_AccountsPayableContractBalancesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_AccountsPayableContractBalancesCurrent" xlink:to="lab_arvn_AccountsPayableContractBalancesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_127666f9-9ea1-4cc1-9cd1-2c3bf3139239_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_4fd77971-7b00-4ad0-bb01-dea8bb1eceb5_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_66c7e872-998b-49e9-ae63-7c7146551bd3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_b7e89c0e-006f-447f-ad33-b2c1eb548041_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_OerthBioLimitedLiabilityCorporationMember_29409234-a759-4702-a3cf-5f989b188fc0_terseLabel_en-US" xlink:label="lab_arvn_OerthBioLimitedLiabilityCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oerth</link:label>
    <link:label id="lab_arvn_OerthBioLimitedLiabilityCorporationMember_label_en-US" xlink:label="lab_arvn_OerthBioLimitedLiabilityCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oerth Bio Limited Liability Corporation [Member]</link:label>
    <link:label id="lab_arvn_OerthBioLimitedLiabilityCorporationMember_documentation_en-US" xlink:label="lab_arvn_OerthBioLimitedLiabilityCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oerth Bio LLC.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_OerthBioLimitedLiabilityCorporationMember" xlink:href="arvn-20230630.xsd#arvn_OerthBioLimitedLiabilityCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_OerthBioLimitedLiabilityCorporationMember" xlink:to="lab_arvn_OerthBioLimitedLiabilityCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_8ddc6548-15dc-4f1c-ac8b-e15a91636777_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Equipment and Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_46525ffd-9bc3-4634-bef8-96d1042953a0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7f99a0f-e908-4216-b243-1b133152c341_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement_b3b16430-3ee9-4dd3-9c93-80e6640f454c_terseLabel_en-US" xlink:label="lab_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional upfront non-refundable amount received under previous agreement</link:label>
    <link:label id="lab_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement_label_en-US" xlink:label="lab_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Upfront Non Refundable Amount Received Under Previous Agreement</link:label>
    <link:label id="lab_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement_documentation_en-US" xlink:label="lab_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional upfront non-refundable amount received under previous agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement" xlink:href="arvn-20230630.xsd#arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement" xlink:to="lab_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_13b36cb3-cfae-4dd1-823c-4b332136ef68_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_be1248e0-4b07-444e-a119-fe71d86dd0a4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares remained available for purchase (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_70cb0387-e8c6-46bc-950a-390d0c07f883_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4e795196-55a8-4a31-8b98-763e3885f1f7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6d79d461-0771-43a6-8de8-7866dc16c5ec_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_9d08434b-5e15-49fe-96df-055afbe6b4f6_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_DebtInstrumentInterestPaymentsTerm_8af7659d-13cb-46c5-86f2-155757e7a15e_terseLabel_en-US" xlink:label="lab_arvn_DebtInstrumentInterestPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument interest payments term (in months)</link:label>
    <link:label id="lab_arvn_DebtInstrumentInterestPaymentsTerm_label_en-US" xlink:label="lab_arvn_DebtInstrumentInterestPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Interest Payments Term</link:label>
    <link:label id="lab_arvn_DebtInstrumentInterestPaymentsTerm_documentation_en-US" xlink:label="lab_arvn_DebtInstrumentInterestPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument interest payments term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DebtInstrumentInterestPaymentsTerm" xlink:href="arvn-20230630.xsd#arvn_DebtInstrumentInterestPaymentsTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_DebtInstrumentInterestPaymentsTerm" xlink:to="lab_arvn_DebtInstrumentInterestPaymentsTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2017e15b-0d69-4b66-8636-3acf728f66ef_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_3b0f6975-2289-4bbe-8bcc-f161df1e55a7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_d303a341-9575-45eb-be4b-434a81022417_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_d167a125-48a5-418b-9720-262bdac3443f_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_babbe6e5-9fce-4c18-859c-01bcb24fbb89_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_DevelopmentMilestonePaymentsMember_da1f6232-1f39-445e-8906-51590f8b07ec_terseLabel_en-US" xlink:label="lab_arvn_DevelopmentMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Milestone Payments</link:label>
    <link:label id="lab_arvn_DevelopmentMilestonePaymentsMember_label_en-US" xlink:label="lab_arvn_DevelopmentMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Milestone Payments [Member]</link:label>
    <link:label id="lab_arvn_DevelopmentMilestonePaymentsMember_documentation_en-US" xlink:label="lab_arvn_DevelopmentMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development milestone payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DevelopmentMilestonePaymentsMember" xlink:href="arvn-20230630.xsd#arvn_DevelopmentMilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_DevelopmentMilestonePaymentsMember" xlink:to="lab_arvn_DevelopmentMilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2e5216b1-5ff9-454a-8a00-a2c90fbfff3a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_EquityDistributionAgreementMember_8a13e9d9-8632-46b1-ad01-bd1fff624862_terseLabel_en-US" xlink:label="lab_arvn_EquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Distribution Agreement</link:label>
    <link:label id="lab_arvn_EquityDistributionAgreementMember_label_en-US" xlink:label="lab_arvn_EquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Distribution Agreement [Member]</link:label>
    <link:label id="lab_arvn_EquityDistributionAgreementMember_documentation_en-US" xlink:label="lab_arvn_EquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity distribution agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_EquityDistributionAgreementMember" xlink:href="arvn-20230630.xsd#arvn_EquityDistributionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_EquityDistributionAgreementMember" xlink:to="lab_arvn_EquityDistributionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_f3b03c32-7e77-479f-b28c-bc751a15bf8e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_796a8ced-5732-4e3c-a24d-31379ea027f0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ChangeInContractWithCustomerLiabilityRollForward_f123fea9-8ec7-44af-8b8e-210676bc90b2_terseLabel_en-US" xlink:label="lab_arvn_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities: Deferred revenue</link:label>
    <link:label id="lab_arvn_ChangeInContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_arvn_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_arvn_ChangeInContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_arvn_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ChangeInContractWithCustomerLiabilityRollForward" xlink:href="arvn-20230630.xsd#arvn_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ChangeInContractWithCustomerLiabilityRollForward" xlink:to="lab_arvn_ChangeInContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_CapitalizedContractCostAmortizationDuringPeriod_18814d20-180f-4080-bbd0-4a7de7c7615b_negatedLabel_en-US" xlink:label="lab_arvn_CapitalizedContractCostAmortizationDuringPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_arvn_CapitalizedContractCostAmortizationDuringPeriod_label_en-US" xlink:label="lab_arvn_CapitalizedContractCostAmortizationDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization During Period</link:label>
    <link:label id="lab_arvn_CapitalizedContractCostAmortizationDuringPeriod_documentation_en-US" xlink:label="lab_arvn_CapitalizedContractCostAmortizationDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CapitalizedContractCostAmortizationDuringPeriod" xlink:href="arvn-20230630.xsd#arvn_CapitalizedContractCostAmortizationDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_CapitalizedContractCostAmortizationDuringPeriod" xlink:to="lab_arvn_CapitalizedContractCostAmortizationDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_BaseLeaseRentPeriod_be7fa66d-b9eb-4db3-af8e-1ac33f7bc927_terseLabel_en-US" xlink:label="lab_arvn_BaseLeaseRentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base rent lease term (in years)</link:label>
    <link:label id="lab_arvn_BaseLeaseRentPeriod_label_en-US" xlink:label="lab_arvn_BaseLeaseRentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Lease Rent Period</link:label>
    <link:label id="lab_arvn_BaseLeaseRentPeriod_documentation_en-US" xlink:label="lab_arvn_BaseLeaseRentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base lease rent period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_BaseLeaseRentPeriod" xlink:href="arvn-20230630.xsd#arvn_BaseLeaseRentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_BaseLeaseRentPeriod" xlink:to="lab_arvn_BaseLeaseRentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ca5a9684-9b49-437e-b329-8afd77f508bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7ef3c1c8-7482-4fe4-a9fc-7f8c40e2aac4_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetPledgedAsCollateralMember_b0f80d1b-2356-4ebe-82d4-037e99f4c361_terseLabel_en-US" xlink:label="lab_us-gaap_AssetPledgedAsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Pledged as Collateral</link:label>
    <link:label id="lab_us-gaap_AssetPledgedAsCollateralMember_label_en-US" xlink:label="lab_us-gaap_AssetPledgedAsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Pledged as Collateral [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetPledgedAsCollateralMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetPledgedAsCollateralMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetPledgedAsCollateralMember" xlink:to="lab_us-gaap_AssetPledgedAsCollateralMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_db1cfb0b-4a01-4c96-bbbd-f9a041b30a31_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_LongTermDebtMaturityYearSix_50d3ff8c-1b1d-4ad9-942c-804e71ccd1a6_terseLabel_en-US" xlink:label="lab_arvn_LongTermDebtMaturityYearSix" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_arvn_LongTermDebtMaturityYearSix_label_en-US" xlink:label="lab_arvn_LongTermDebtMaturityYearSix" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Six</link:label>
    <link:label id="lab_arvn_LongTermDebtMaturityYearSix_documentation_en-US" xlink:label="lab_arvn_LongTermDebtMaturityYearSix" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Six</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_LongTermDebtMaturityYearSix" xlink:href="arvn-20230630.xsd#arvn_LongTermDebtMaturityYearSix"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_LongTermDebtMaturityYearSix" xlink:to="lab_arvn_LongTermDebtMaturityYearSix" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_b5202b29-1ccb-441b-b452-93bcc9c4b95e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PledgedStatusAxis_c6274038-34de-47e3-b712-711eff20dad7_terseLabel_en-US" xlink:label="lab_us-gaap_PledgedStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Axis]</link:label>
    <link:label id="lab_us-gaap_PledgedStatusAxis_label_en-US" xlink:label="lab_us-gaap_PledgedStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PledgedStatusAxis" xlink:to="lab_us-gaap_PledgedStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_16ae3c39-c40f-4be0-8076-e9765fa1a4bb_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_0e791937-bf23-4d4c-8d8f-3a1c69cb8257_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_4a3e936f-21dc-4b6f-9650-d80e5307dd78_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Securities Excluded From Computation of Diluted Net Loss Per Common Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_b5e7c540-d4c4-451f-bca4-aee4a310cfab_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_b3137846-1c98-488d-b428-aa357d519ded_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Lease Expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_825468dc-86d3-4b2d-ae47-1f5af70f2b7f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c3b461d6-a52f-4f64-9de9-012d6e0fd7fc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_PiperSandlerAndCantorMember_0ecfecec-c8eb-42e7-8758-9022664ff85d_terseLabel_en-US" xlink:label="lab_arvn_PiperSandlerAndCantorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Piper Sandler and Cantor</link:label>
    <link:label id="lab_arvn_PiperSandlerAndCantorMember_label_en-US" xlink:label="lab_arvn_PiperSandlerAndCantorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Piper Sandler And Cantor [Member]</link:label>
    <link:label id="lab_arvn_PiperSandlerAndCantorMember_documentation_en-US" xlink:label="lab_arvn_PiperSandlerAndCantorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Piper sandler and cantor.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PiperSandlerAndCantorMember" xlink:href="arvn-20230630.xsd#arvn_PiperSandlerAndCantorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_PiperSandlerAndCantorMember" xlink:to="lab_arvn_PiperSandlerAndCantorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7895a0bc-7fb3-4d24-a276-8aea1fdafdb1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of diluted net loss per common share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_52b53b11-6b12-465f-b40d-9768c9eb4711_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1ee8f06b-4d8a-461a-beb9-b7e7b28c1161_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_6b74ba00-360c-44bc-8407-1228452d29ab_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_c851ebc5-dd63-49dd-9825-e3352191e5da_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_8bbbc25e-6b7d-4819-b08c-583ccd496aa1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments (up to low)</link:label>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_a3412064-1513-4f26-9874-a1d8bc74cb77_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_6ddc5b64-166d-4ac5-8606-81e9c0a1d742_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, equipment and leasehold improvements unpaid at period end</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_42b77054-035b-4c97-b70c-9569e7ded69d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b4529ba7-b5c5-4685-901d-42f3a393e634_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive units authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_60ae61eb-3730-49a8-add2-41863288b2d7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, equipment and leasehold improvements</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_083ac6be-c85c-4fe4-8914-59ffd5c6dc77_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_42117b77-845b-4aed-9d58-c7dc7b008d41_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8ca25bf1-76be-4556-b8c7-2accc5d36c76_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_3d52c960-cc71-480e-8241-95f65ac261fe_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ad73eba6-04f5-459d-9493-04e6e5ab4f1a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_80b87519-e567-4ff1-b3fd-544c3d0ae2ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_72e06c79-c2e9-49ec-84b6-521e0a264c0e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c2757251-7d68-4067-9e09-91899287c939_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_36fa31a2-6cd6-4fc1-83eb-04677cdfd9b1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract_47ea1c12-9ad5-4144-a189-57c5ec912780_terseLabel_en-US" xlink:label="lab_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement direct and incremental costs incurred</link:label>
    <link:label id="lab_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract_label_en-US" xlink:label="lab_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct And Incremental Costs Incurred To Obtain The Contract</link:label>
    <link:label id="lab_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract_documentation_en-US" xlink:label="lab_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct and incremental costs incurred to obtain the contract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract" xlink:href="arvn-20230630.xsd#arvn_DirectAndIncrementalCostsIncurredToObtainTheContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract" xlink:to="lab_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_61313783-8c54-4d88-826c-0790863ffa03_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_AggregateIntrinsicValueAbstract_2e650c78-0f94-4753-9b69-aaf1c1ce1102_terseLabel_en-US" xlink:label="lab_arvn_AggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_arvn_AggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_arvn_AggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value [Abstract]</link:label>
    <link:label id="lab_arvn_AggregateIntrinsicValueAbstract_documentation_en-US" xlink:label="lab_arvn_AggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AggregateIntrinsicValueAbstract" xlink:href="arvn-20230630.xsd#arvn_AggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_AggregateIntrinsicValueAbstract" xlink:to="lab_arvn_AggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_15c08368-62a3-4f7a-804d-75ac68edc4c1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c89f6fe3-2d53-4508-a404-8fd949da96d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_8e01d33f-5993-4e5b-a570-403d273666bc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant And Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_86a5bad8-cc52-4877-9c72-883a5aacdca4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_f3f555c5-0d32-4582-9292-38691ffa9456_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities_7329dba8-9bd8-4c59-be0b-21f927548394_terseLabel_en-US" xlink:label="lab_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and marketable securities</link:label>
    <link:label id="lab_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities_label_en-US" xlink:label="lab_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Marketable Securities</link:label>
    <link:label id="lab_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities_documentation_en-US" xlink:label="lab_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities" xlink:href="arvn-20230630.xsd#arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities" xlink:to="lab_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_35ff9266-4400-4526-a94e-beee3689f619_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e99e3ba-05e0-4b00-890a-a1d79395a8af_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4139a271-24ce-4a14-bcfe-39eaf418bd10_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e4269f9c-6885-42a6-a55a-969be3d95f66_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_4e11544b-ef57-4e30-8ac6-96c7cdef85a5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_1d5f9ce5-f7cf-40f7-af9d-fde05d491b2a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_80a6b0ef-a713-41d3-9175-bfcc61eb4e33_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_56a981a3-593c-404a-8ec8-f9a5a8a3d2b1_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_ccac09a8-436e-4fe6-8c80-7c46d046de1c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_9ef0908f-3e5a-4c4c-8bf6-5ed1851f5fe8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used to Determine Fair Value of Stock Options Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_247be2c6-a62e-42e2-95a3-c4cb1e275295_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_aa735705-40a1-43c9-a444-b1478bb0fc0a_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLoss_e60b37f0-617d-4600-a6b8-5c158257b7c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of marketable securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f6670178-7a3b-444e-ab31-34369b98b75e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a873e3a4-2ee6-4893-84f4-68cebb67fa33_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_688c04b3-f249-465f-ace7-70deb7835522_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Collaboration and License Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_32f3f73e-1607-49e5-880a-110c02164073_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_a99ee79c-b37e-4d40-a6e1-4140021cfa66_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense not yet recognized, period of recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_f42a8d94-02f2-4f72-afb5-b9f75e9a5bf6_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_bf7a8a25-3fd1-4e67-b64b-6db83b4d5629_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_a2abe5eb-09d1-4a1b-b643-b6b74e35733a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_48e768f5-f57d-4203-b3b4-7e8f16bc9887_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_dee42714-6515-4a4e-9074-465e3ba580bc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue adjustments arising from contract modifications</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Modification of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0bf7ea9c-3c83-49cf-962d-a19015316c64_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_384df35d-0771-4938-a57d-b9604a8d3392_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_2ed142eb-7005-422d-8c48-52750538ba89_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_FoundationMedicineIncMember_a194d6b6-a633-469d-b7ae-7c8ceafe5aa4_terseLabel_en-US" xlink:label="lab_arvn_FoundationMedicineIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foundation Medicine, Inc.</link:label>
    <link:label id="lab_arvn_FoundationMedicineIncMember_label_en-US" xlink:label="lab_arvn_FoundationMedicineIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foundation Medicine, Inc. [Member]</link:label>
    <link:label id="lab_arvn_FoundationMedicineIncMember_documentation_en-US" xlink:label="lab_arvn_FoundationMedicineIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foundation Medicine, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_FoundationMedicineIncMember" xlink:href="arvn-20230630.xsd#arvn_FoundationMedicineIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_FoundationMedicineIncMember" xlink:to="lab_arvn_FoundationMedicineIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_b584b964-e31d-4a63-94a8-b0056beb0aea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_6d080e7b-55e5-40a6-9693-d529ee4b9127_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0f775eac-9a1b-4b17-b789-b9206fbaa48f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_TwoThousandAndEighteenAssistanceAgreementMember_5bfd9a39-37e2-4485-be57-cfe10f9989fa_terseLabel_en-US" xlink:label="lab_arvn_TwoThousandAndEighteenAssistanceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Assistance Agreement</link:label>
    <link:label id="lab_arvn_TwoThousandAndEighteenAssistanceAgreementMember_label_en-US" xlink:label="lab_arvn_TwoThousandAndEighteenAssistanceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Eighteen Assistance Agreement [Member]</link:label>
    <link:label id="lab_arvn_TwoThousandAndEighteenAssistanceAgreementMember_documentation_en-US" xlink:label="lab_arvn_TwoThousandAndEighteenAssistanceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand and eighteen assistance agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandAndEighteenAssistanceAgreementMember" xlink:href="arvn-20230630.xsd#arvn_TwoThousandAndEighteenAssistanceAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_TwoThousandAndEighteenAssistanceAgreementMember" xlink:to="lab_arvn_TwoThousandAndEighteenAssistanceAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0acd0341-5fd8-4e69-ba10-2b3af97714e7_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_4afd7c55-6475-4334-86ee-71da654bbc85_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_09689764-9d94-4e10-87f2-687955821efb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_be7a65a0-7ed6-49d7-a1fa-bfc068339272_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_38527c7a-ad7b-4297-b2bd-9f4b9a46fe5a_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued and sold (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_f14dff56-03f2-4c10-a2a9-d918afdad327_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a0da0dfa-3156-4a8b-a40f-5ca8b5a2cb4b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_CommercialMilestonesMember_98edd298-128e-4d31-9237-bb0c9b9c4c51_terseLabel_en-US" xlink:label="lab_arvn_CommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Milestones</link:label>
    <link:label id="lab_arvn_CommercialMilestonesMember_label_en-US" xlink:label="lab_arvn_CommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Milestones [Member]</link:label>
    <link:label id="lab_arvn_CommercialMilestonesMember_documentation_en-US" xlink:label="lab_arvn_CommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CommercialMilestonesMember" xlink:href="arvn-20230630.xsd#arvn_CommercialMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_CommercialMilestonesMember" xlink:to="lab_arvn_CommercialMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_CollaborationContractAssetAndOtherAssets_d26bfbec-195c-491a-892b-e65880fdff73_terseLabel_en-US" xlink:label="lab_arvn_CollaborationContractAssetAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration contract asset and other assets</link:label>
    <link:label id="lab_arvn_CollaborationContractAssetAndOtherAssets_label_en-US" xlink:label="lab_arvn_CollaborationContractAssetAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Contract Asset And Other Assets</link:label>
    <link:label id="lab_arvn_CollaborationContractAssetAndOtherAssets_documentation_en-US" xlink:label="lab_arvn_CollaborationContractAssetAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration contract asset and other assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CollaborationContractAssetAndOtherAssets" xlink:href="arvn-20230630.xsd#arvn_CollaborationContractAssetAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_CollaborationContractAssetAndOtherAssets" xlink:to="lab_arvn_CollaborationContractAssetAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward_34749fb0-a226-4f93-a951-4ecc786f5098_terseLabel_en-US" xlink:label="lab_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable related to collaborations</link:label>
    <link:label id="lab_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward_label_en-US" xlink:label="lab_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounts Payable, after Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward_documentation_en-US" xlink:label="lab_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounts Payable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward" xlink:href="arvn-20230630.xsd#arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward" xlink:to="lab_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_SuccessBasedMilestonePaymentsMember_221afffb-3204-44da-8269-185237bdffc5_terseLabel_en-US" xlink:label="lab_arvn_SuccessBasedMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Success-Based Milestone Payments</link:label>
    <link:label id="lab_arvn_SuccessBasedMilestonePaymentsMember_label_en-US" xlink:label="lab_arvn_SuccessBasedMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Success-Based Milestone Payments [Member]</link:label>
    <link:label id="lab_arvn_SuccessBasedMilestonePaymentsMember_documentation_en-US" xlink:label="lab_arvn_SuccessBasedMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Success-Based Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_SuccessBasedMilestonePaymentsMember" xlink:href="arvn-20230630.xsd#arvn_SuccessBasedMilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_SuccessBasedMilestonePaymentsMember" xlink:to="lab_arvn_SuccessBasedMilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1c080c4d-3fd4-47de-bdc7-fa7ce92f46de_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_da778752-78b6-4d12-bc9b-197fb2f82ee2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b72fcada-98b4-4453-b084-29245a724c1c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under equity incentive plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_9ca29f7c-bf21-403d-88f6-1306670c400d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_debd7855-5cae-4d17-8067-72dbbe5f374d_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5257124b-5b7c-45ed-bad0-3157b076f72e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_91cd46f1-0bb2-4e99-bfff-262d19d2f429_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_TwoThousandEighteenStockIncentivePlanMember_40bf1823-0007-4a2c-9caa-d5e94a653bd6_terseLabel_en-US" xlink:label="lab_arvn_TwoThousandEighteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Plan</link:label>
    <link:label id="lab_arvn_TwoThousandEighteenStockIncentivePlanMember_4c1edcf3-54fc-45b0-997a-6613a1996767_verboseLabel_en-US" xlink:label="lab_arvn_TwoThousandEighteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Plan</link:label>
    <link:label id="lab_arvn_TwoThousandEighteenStockIncentivePlanMember_label_en-US" xlink:label="lab_arvn_TwoThousandEighteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_arvn_TwoThousandEighteenStockIncentivePlanMember_documentation_en-US" xlink:label="lab_arvn_TwoThousandEighteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand eighteen stock incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandEighteenStockIncentivePlanMember" xlink:href="arvn-20230630.xsd#arvn_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_TwoThousandEighteenStockIncentivePlanMember" xlink:to="lab_arvn_TwoThousandEighteenStockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_dddf093b-4667-46aa-8b6f-2ad1d5d232ad_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of collaboration contract asset</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_69dfa21b-8227-4e8c-a179-b1e724bef50c_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base rent</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_0aa04f0b-6897-4a1e-9cf8-926e9ea05d24_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f1bdae41-fc69-4779-b403-bbf1dc2eca03_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements_e997a1b2-24db-41e9-9b9b-6c269034514d_terseLabel_en-US" xlink:label="lab_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to collaboration agreements</link:label>
    <link:label id="lab_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements_label_en-US" xlink:label="lab_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase (Decrease) For Additions To Collaboration Agreements</link:label>
    <link:label id="lab_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements_documentation_en-US" xlink:label="lab_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase (Decrease) For Additions To Collaboration Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:href="arvn-20230630.xsd#arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:to="lab_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_dfc0a510-96fe-4538-be6b-63b554220a6a_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_2cc06f58-9886-4752-9715-52313f70c380_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_797fb834-8a63-4354-a71a-f2470aba0a2f_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ed0607a-da84-41d8-8dac-581548f7377d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_18119b24-ed89-4289-b23f-6096e36464cc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f2122033-8fa4-4e8e-b170-11ae1c92b0e0_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_9df495a2-0522-4e3f-ae13-5d3dbf5f5c5e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_52475989-93eb-4364-bc1c-922705e3e1ed_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ae443cbe-d89c-4b3b-9820-10f3ed6c82be_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_b7217912-b1ee-40dd-be2c-fd5475b1658d_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CT_ea443695-f816-41c6-964b-2b62f6704ab7_terseLabel_en-US" xlink:label="lab_stpr_CT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Connecticut</link:label>
    <link:label id="lab_stpr_CT_label_en-US" xlink:label="lab_stpr_CT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONNECTICUT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_CT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CT" xlink:to="lab_stpr_CT" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6ea3a54f-8509-4500-a94b-9beae24dc197_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_1ac7e1a1-830e-48cf-8b45-940597a9a5ed_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_32ff9d61-38ce-47fc-a143-4ae6e159a7e1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d2c700df-acf2-4813-a004-69e9383654c2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract_e1570662-5e3c-4ae7-b11e-fb02b9fe2379_terseLabel_en-US" xlink:label="lab_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental non-cash information:</link:label>
    <link:label id="lab_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract_label_en-US" xlink:label="lab_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Non Cash Information Related To Leases [Abstract]</link:label>
    <link:label id="lab_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract_documentation_en-US" xlink:label="lab_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental non-cash information related to leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract" xlink:href="arvn-20230630.xsd#arvn_SupplementalNonCashInformationRelatedToLeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract" xlink:to="lab_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_c1609f2c-f882-454f-ad0a-da204b17cd5e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_af8b43ef-e1a7-4fe3-823d-7fdba6b33b4f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_59b84c12-c331-4c16-92d7-4c618bc8f2d9_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f6faf919-47f5-4062-b9ad-e537377a7465_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ResearchFundingPaymentsMember_4e5526d8-e906-4b10-b0fe-b5d2c2147390_terseLabel_en-US" xlink:label="lab_arvn_ResearchFundingPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Funding Payments</link:label>
    <link:label id="lab_arvn_ResearchFundingPaymentsMember_label_en-US" xlink:label="lab_arvn_ResearchFundingPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Funding Payments [Member]</link:label>
    <link:label id="lab_arvn_ResearchFundingPaymentsMember_documentation_en-US" xlink:label="lab_arvn_ResearchFundingPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research funding payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchFundingPaymentsMember" xlink:href="arvn-20230630.xsd#arvn_ResearchFundingPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ResearchFundingPaymentsMember" xlink:to="lab_arvn_ResearchFundingPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_4ecf819a-d2dc-446b-b1d4-b9d238554852_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ProceedsFromMaturitiesOfMarketableSecurities_0c4e4507-1cb4-41b8-9f7a-49d609f9b417_terseLabel_en-US" xlink:label="lab_arvn_ProceedsFromMaturitiesOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of marketable securities</link:label>
    <link:label id="lab_arvn_ProceedsFromMaturitiesOfMarketableSecurities_label_en-US" xlink:label="lab_arvn_ProceedsFromMaturitiesOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Maturities Of Marketable Securities</link:label>
    <link:label id="lab_arvn_ProceedsFromMaturitiesOfMarketableSecurities_documentation_en-US" xlink:label="lab_arvn_ProceedsFromMaturitiesOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ProceedsFromMaturitiesOfMarketableSecurities" xlink:href="arvn-20230630.xsd#arvn_ProceedsFromMaturitiesOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ProceedsFromMaturitiesOfMarketableSecurities" xlink:to="lab_arvn_ProceedsFromMaturitiesOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_1e8db46f-e021-49e3-99b8-f9e0822d7861_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_3b236508-1906-4835-8505-bb82a7e3cf02_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_StockIncentivePlanMember_7d81c980-396b-40c2-908e-f87820533a54_terseLabel_en-US" xlink:label="lab_arvn_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Plan</link:label>
    <link:label id="lab_arvn_StockIncentivePlanMember_label_en-US" xlink:label="lab_arvn_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_arvn_StockIncentivePlanMember_documentation_en-US" xlink:label="lab_arvn_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_StockIncentivePlanMember" xlink:href="arvn-20230630.xsd#arvn_StockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_StockIncentivePlanMember" xlink:to="lab_arvn_StockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_963a009b-cc34-41dc-b1fc-2019d6b2fabb_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6054d7e4-a6e8-4bce-bbda-4bfa7eee734c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_afbc1af3-f5aa-4110-b8aa-f9b25fb127f7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_e178e04a-f8f0-4875-804a-f5e3d93a2b40_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Correction of the Immaterial Error for the Period</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e2fac7aa-712c-4460-9706-47aa36e300d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate, percentage</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_63167eea-7f78-487a-a47e-2077beb7e13e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecurities_53b264fc-1842-445c-8abd-401478f4c4d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit for collateralized by certificate of deposit</link:label>
    <link:label id="lab_us-gaap_DebtSecurities_label_en-US" xlink:label="lab_us-gaap_DebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecurities" xlink:to="lab_us-gaap_DebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_42d7b1df-1d4e-4ce1-9c75-a8816430e455_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Minimum Future Payments on Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_39d2cba0-dd5e-47c7-b0d7-176e2a422777_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_d664be85-dec7-45f8-bd51-33803c82ac20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3293855f-d370-42bf-8104-8c1e43c4336d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b1d0427b-8b07-4e98-99e9-874e509c92e4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_4503a243-d258-4486-813e-f17567e32e19_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2748e2ac-1c19-4220-b9a8-103d3613bbdd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_01121ba5-3ead-449b-a146-54d63d121c67_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_95a4b663-ec09-4dff-8d7d-beb3e4baf43d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Equipment and Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_1a06b85f-5910-4e15-8c93-288582eabb16_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_ebec2ad9-65b5-493b-b99a-0ac8d1f7fdaa_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_DebtInstrumentLoanForgiveness_a514e586-c0fe-4e05-8cb1-f20a5e3ed52e_terseLabel_en-US" xlink:label="lab_arvn_DebtInstrumentLoanForgiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan forgiveness</link:label>
    <link:label id="lab_arvn_DebtInstrumentLoanForgiveness_label_en-US" xlink:label="lab_arvn_DebtInstrumentLoanForgiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Loan Forgiveness</link:label>
    <link:label id="lab_arvn_DebtInstrumentLoanForgiveness_documentation_en-US" xlink:label="lab_arvn_DebtInstrumentLoanForgiveness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument loan forgiveness.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DebtInstrumentLoanForgiveness" xlink:href="arvn-20230630.xsd#arvn_DebtInstrumentLoanForgiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_DebtInstrumentLoanForgiveness" xlink:to="lab_arvn_DebtInstrumentLoanForgiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember_36e21c81-d351-47d1-8862-43a995446f9f_terseLabel_en-US" xlink:label="lab_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genentech, Inc. and F. Hoffman-La Roche Ltd.</link:label>
    <link:label id="lab_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember_label_en-US" xlink:label="lab_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genentech Incorporation And F Hoffman La Roche Limited [Member]</link:label>
    <link:label id="lab_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember_documentation_en-US" xlink:label="lab_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genentech, Incorporation. and F. Hoffman-La Roche Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember" xlink:href="arvn-20230630.xsd#arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember" xlink:to="lab_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_457ff2f1-2e14-4355-9895-1fce698a70db_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_70a46a01-75de-4bb2-8fed-62d5465ac2bf_terseLabel_en-US" xlink:label="lab_arvn_ResearchCollaborationAndLicenseAgreementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Collaboration And License Agreements [Line Items]</link:label>
    <link:label id="lab_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_label_en-US" xlink:label="lab_arvn_ResearchCollaborationAndLicenseAgreementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Collaboration And License Agreements [Line Items]</link:label>
    <link:label id="lab_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_documentation_en-US" xlink:label="lab_arvn_ResearchCollaborationAndLicenseAgreementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research collaboration and license agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems" xlink:to="lab_arvn_ResearchCollaborationAndLicenseAgreementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_043a6aa7-4e2d-4646-9f4e-8301747e97d8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_1019ff7e-d8af-4231-8b2a-ed4e440d54ff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_PercentageOfLiquidatedDamages_94ce2449-c0c3-4d5e-8bf2-a1249a87c83f_terseLabel_en-US" xlink:label="lab_arvn_PercentageOfLiquidatedDamages" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of liquidated damages</link:label>
    <link:label id="lab_arvn_PercentageOfLiquidatedDamages_label_en-US" xlink:label="lab_arvn_PercentageOfLiquidatedDamages" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Liquidated Damages</link:label>
    <link:label id="lab_arvn_PercentageOfLiquidatedDamages_documentation_en-US" xlink:label="lab_arvn_PercentageOfLiquidatedDamages" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of liquidated damages.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PercentageOfLiquidatedDamages" xlink:href="arvn-20230630.xsd#arvn_PercentageOfLiquidatedDamages"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_PercentageOfLiquidatedDamages" xlink:to="lab_arvn_PercentageOfLiquidatedDamages" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_66f4fac1-1417-4f07-a4fb-28aef4d190b0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_07e83d0a-ac9c-427f-b7ef-e22fb3f00d05_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_456c729d-2b91-4451-a3be-41039c119fe7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 53.4 and 53.2 shares issued and outstanding as of June&#160;30, 2023 and December&#160;31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_1ddcde3e-2dca-4dfb-abb1-b46fbd0c719b_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_6fc69338-1733-4734-a30b-5ed61a748cbc_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_60a09f16-1342-48e4-809c-8ef8e09de13e_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_a154e91c-bf55-4c91-9aed-bb0a3f2db599_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees and other</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_08c15835-7595-4dd1-9500-948840d4a2e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_62bd9cd3-273d-468e-991c-cce5f92e10b3_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_332db63c-b675-472f-a929-3ae4e282b8bd_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PledgingPurposeAxis_74852109-3944-4c73-982a-a5c72c5f5f03_terseLabel_en-US" xlink:label="lab_us-gaap_PledgingPurposeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledging Purpose [Axis]</link:label>
    <link:label id="lab_us-gaap_PledgingPurposeAxis_label_en-US" xlink:label="lab_us-gaap_PledgingPurposeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledging Purpose [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgingPurposeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgingPurposeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PledgingPurposeAxis" xlink:to="lab_us-gaap_PledgingPurposeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_a30db64d-a009-4c96-abc3-fcdbf7bd8d0d_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3ba15538-b2dd-4a7f-a390-50735c6701c4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_2d75ebd0-d99b-48ff-b24b-76e225c7bed3_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_8f50d657-974b-4d1a-8b02-a40527915b40_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5ed9f90e-f667-4470-bdcf-9ce10a31f48f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_029f9770-f698-41c6-9fc6-e91f86a4d5a4_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_CollaborationAgreementMember_4d46baa4-dc63-47f2-845f-d4a5bcc08e16_terseLabel_en-US" xlink:label="lab_arvn_CollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement</link:label>
    <link:label id="lab_arvn_CollaborationAgreementMember_label_en-US" xlink:label="lab_arvn_CollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement [Member]</link:label>
    <link:label id="lab_arvn_CollaborationAgreementMember_documentation_en-US" xlink:label="lab_arvn_CollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CollaborationAgreementMember" xlink:href="arvn-20230630.xsd#arvn_CollaborationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_CollaborationAgreementMember" xlink:to="lab_arvn_CollaborationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_ab24a152-faa0-4e40-a319-3b3f56c49510_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_CommitmentsAndContingenciesLineItems_8401dad8-f51d-401d-bb71-a03c4d242ef3_terseLabel_en-US" xlink:label="lab_arvn_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_arvn_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_arvn_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_arvn_CommitmentsAndContingenciesLineItems_documentation_en-US" xlink:label="lab_arvn_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CommitmentsAndContingenciesLineItems" xlink:href="arvn-20230630.xsd#arvn_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_CommitmentsAndContingenciesLineItems" xlink:to="lab_arvn_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_27e30cc2-4181-494c-82d1-a9d104182937_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_671086b8-622e-402e-a966-5beaa6541361_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_AccountsPayableContractBalancesCurrentPayments_b720bcfe-3ab9-4025-b5b3-3672c8bf8829_negatedTerseLabel_en-US" xlink:label="lab_arvn_AccountsPayableContractBalancesCurrentPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments made</link:label>
    <link:label id="lab_arvn_AccountsPayableContractBalancesCurrentPayments_label_en-US" xlink:label="lab_arvn_AccountsPayableContractBalancesCurrentPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Contract Balances, Current Payments</link:label>
    <link:label id="lab_arvn_AccountsPayableContractBalancesCurrentPayments_documentation_en-US" xlink:label="lab_arvn_AccountsPayableContractBalancesCurrentPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Contract Balances, Current Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccountsPayableContractBalancesCurrentPayments" xlink:href="arvn-20230630.xsd#arvn_AccountsPayableContractBalancesCurrentPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_AccountsPayableContractBalancesCurrentPayments" xlink:to="lab_arvn_AccountsPayableContractBalancesCurrentPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_MaximumAggregateOfferingPriceOfCommonStock_88bf25df-51ed-4a2f-934a-1928dd073c79_terseLabel_en-US" xlink:label="lab_arvn_MaximumAggregateOfferingPriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock aggregate offering price</link:label>
    <link:label id="lab_arvn_MaximumAggregateOfferingPriceOfCommonStock_label_en-US" xlink:label="lab_arvn_MaximumAggregateOfferingPriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Aggregate Offering Price Of Common Stock</link:label>
    <link:label id="lab_arvn_MaximumAggregateOfferingPriceOfCommonStock_documentation_en-US" xlink:label="lab_arvn_MaximumAggregateOfferingPriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum aggregate offering price of common stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_MaximumAggregateOfferingPriceOfCommonStock" xlink:href="arvn-20230630.xsd#arvn_MaximumAggregateOfferingPriceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_MaximumAggregateOfferingPriceOfCommonStock" xlink:to="lab_arvn_MaximumAggregateOfferingPriceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c174c8ef-37e3-4be9-bd80-4f4b06da4d77_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_3ab82959-f5c0-48fe-aaa0-e21c574d7cd5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_4998e59c-0a32-4f12-8b12-7d64c6a76d3b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1b5705f4-acbc-4299-8334-2bde2692ae46_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_dd6021ec-ef10-4e8e-ae1f-588b2fe93b2f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument bearing interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ff973dfc-6b0b-4b4d-85a5-bb40a8baf369_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_a990a3f1-2ea1-4191-ab00-f9f010b7333e_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_2ebe4049-a54d-4776-a8e5-66c6858fae4a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_2df1e0cf-3703-42dd-af0f-8337001032d8_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f1dea6c3-3e68-42a5-af58-df5cacc2c6c0_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e6d46aca-fd48-40ba-884e-d0765c9c01c5_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a92d5453-2ca8-4490-b226-bcdeb09cacb2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_04d0c1eb-b9a5-4894-91a7-ea2dc96b2fb6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized from balances held at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_de0bb734-454f-427e-84f9-cdbd323c4798_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_1fe3d4e4-4dd0-4475-b90a-e132e510421f_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ProceedsFromSaleOfMarketableSecurities_8c5cb468-a188-48fd-9110-a73a52ae7786_terseLabel_en-US" xlink:label="lab_arvn_ProceedsFromSaleOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of marketable securities</link:label>
    <link:label id="lab_arvn_ProceedsFromSaleOfMarketableSecurities_label_en-US" xlink:label="lab_arvn_ProceedsFromSaleOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Marketable Securities</link:label>
    <link:label id="lab_arvn_ProceedsFromSaleOfMarketableSecurities_documentation_en-US" xlink:label="lab_arvn_ProceedsFromSaleOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of marketable securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ProceedsFromSaleOfMarketableSecurities" xlink:href="arvn-20230630.xsd#arvn_ProceedsFromSaleOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ProceedsFromSaleOfMarketableSecurities" xlink:to="lab_arvn_ProceedsFromSaleOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4299faa9-9737-4b7f-8efd-162dedbcbd61_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_e2a6bf0b-e0b7-4964-9331-ee37ff017856_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_4cd45a79-0b86-49ed-a0d7-dedc32f8c580_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_e8474bdc-2115-4293-a539-9f6adda514f3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_label_en-US" xlink:label="lab_arvn_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Collaboration And License Agreements [Abstract]</link:label>
    <link:label id="lab_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_documentation_en-US" xlink:label="lab_arvn_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Collaboration And License Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:to="lab_arvn_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3a371fb8-862a-4437-a614-62856a0c664d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_df6918a3-5be6-4995-b29e-825964c9ffd4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived_bd5178cb-845a-4af5-a0fd-e86c94b8e544_negatedTerseLabel_en-US" xlink:label="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments received</link:label>
    <link:label id="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived_label_en-US" xlink:label="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, After Allowance For Credit Loss, Current, Payments Received</link:label>
    <link:label id="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived_documentation_en-US" xlink:label="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, After Allowance For Credit Loss, Current, Payments Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived" xlink:href="arvn-20230630.xsd#arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived" xlink:to="lab_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d2a02000-dc35-4115-acff-67218f5bad58_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_c9167c67-a4bd-4750-92e4-b0c396c7422e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ea21e71e-dc1c-4e24-a188-be05412feb2c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_7bb64184-edb3-45dd-bfd3-6cb12db2b214_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3939c181-5853-4e44-a4f3-4be61e90225b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e9c27f4a-292a-4be9-8e93-39ceed91fb48_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_04fe567f-964e-433f-ad6f-14857b1c1a7e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9ea97a6d-09d7-49b9-a04c-3a7555986fdc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ff407530-c4c5-41fb-9c25-7c6f4c671b0b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward_24dcb0ad-8bf2-4d07-a525-5f9477bbadea_terseLabel_en-US" xlink:label="lab_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets: Collaboration contract asset</link:label>
    <link:label id="lab_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward_label_en-US" xlink:label="lab_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Collaboration Contract Asset And Other Assets [Roll Forward]</link:label>
    <link:label id="lab_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward_documentation_en-US" xlink:label="lab_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Collaboration Contract Asset And Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward" xlink:href="arvn-20230630.xsd#arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward" xlink:to="lab_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_b9a60bc2-cbba-4bed-81d3-5cc24288621c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0a6ae39b-a5bf-4fae-9faf-3cf9cfa037f9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_335effcb-3c84-48ba-b359-f7802cd7e12b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_6efc4758-1864-411e-8183-edc3b840695c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual increase in reserved shares of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Other Increases (Decreases) in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_4be3754a-f8d9-41ea-94c5-bf29b5f2418d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_1639f214-a649-49f4-9e69-a0ef33c5d349_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest in joint venture (percentage)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_1d2a294d-4148-4d9d-8587-33c6a0d5948a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_8b401f71-6b5a-4f01-897f-646909717877_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_b891a5ae-9f71-4ffb-8231-f98affc8b48a_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_797efc67-64ad-4437-a09a-95e1109bb419_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, equipment and leasehold improvements, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1739cf0c-69c8-4b35-8361-bf249693340d_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, equipment and leasehold improvements, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_edd8be72-4b2d-4e26-9fcc-f3250c9ef21c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_BayerCropScienceLPMember_78388c44-96b4-41b7-a335-3ac1e6799c94_terseLabel_en-US" xlink:label="lab_arvn_BayerCropScienceLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer LP</link:label>
    <link:label id="lab_arvn_BayerCropScienceLPMember_label_en-US" xlink:label="lab_arvn_BayerCropScienceLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer Crop Science L P [Member]</link:label>
    <link:label id="lab_arvn_BayerCropScienceLPMember_documentation_en-US" xlink:label="lab_arvn_BayerCropScienceLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer CropScience LP.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_BayerCropScienceLPMember" xlink:href="arvn-20230630.xsd#arvn_BayerCropScienceLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_BayerCropScienceLPMember" xlink:to="lab_arvn_BayerCropScienceLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_AccruedResearchAndDevelopmentExpenseCurrent_cb2c6134-e86a-416b-836d-833a7d472e3c_terseLabel_en-US" xlink:label="lab_arvn_AccruedResearchAndDevelopmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_arvn_AccruedResearchAndDevelopmentExpenseCurrent_label_en-US" xlink:label="lab_arvn_AccruedResearchAndDevelopmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development Expense Current</link:label>
    <link:label id="lab_arvn_AccruedResearchAndDevelopmentExpenseCurrent_documentation_en-US" xlink:label="lab_arvn_AccruedResearchAndDevelopmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued research and development expense current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccruedResearchAndDevelopmentExpenseCurrent" xlink:href="arvn-20230630.xsd#arvn_AccruedResearchAndDevelopmentExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_AccruedResearchAndDevelopmentExpenseCurrent" xlink:to="lab_arvn_AccruedResearchAndDevelopmentExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_eed33b81-0e2e-48ee-afd8-035ed0c6d15f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_OptionPaymentsToLicenseAgreementMember_6a412892-43f8-4bd4-a150-b7481d9e4174_terseLabel_en-US" xlink:label="lab_arvn_OptionPaymentsToLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Payments To License Agreement</link:label>
    <link:label id="lab_arvn_OptionPaymentsToLicenseAgreementMember_label_en-US" xlink:label="lab_arvn_OptionPaymentsToLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Payments To License Agreement [Member]</link:label>
    <link:label id="lab_arvn_OptionPaymentsToLicenseAgreementMember_documentation_en-US" xlink:label="lab_arvn_OptionPaymentsToLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option payments to license agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_OptionPaymentsToLicenseAgreementMember" xlink:href="arvn-20230630.xsd#arvn_OptionPaymentsToLicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_OptionPaymentsToLicenseAgreementMember" xlink:to="lab_arvn_OptionPaymentsToLicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_c0ec9200-ded6-4f49-967d-a46b7c5c10f3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward_03fe48ff-4c59-403a-b9f9-2726663e421d_terseLabel_en-US" xlink:label="lab_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable related to collaborations</link:label>
    <link:label id="lab_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward_label_en-US" xlink:label="lab_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounts Receivable, after Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward_documentation_en-US" xlink:label="lab_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward" xlink:href="arvn-20230630.xsd#arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward" xlink:to="lab_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_RegulatoryAndSalesBasedMilestonesMember_f45aa22c-cb66-4319-aa5f-5c968174f92d_terseLabel_en-US" xlink:label="lab_arvn_RegulatoryAndSalesBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Sales-Based Milestones</link:label>
    <link:label id="lab_arvn_RegulatoryAndSalesBasedMilestonesMember_label_en-US" xlink:label="lab_arvn_RegulatoryAndSalesBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory And Sales Based Milestones [Member]</link:label>
    <link:label id="lab_arvn_RegulatoryAndSalesBasedMilestonesMember_documentation_en-US" xlink:label="lab_arvn_RegulatoryAndSalesBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and sales-based milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_RegulatoryAndSalesBasedMilestonesMember" xlink:href="arvn-20230630.xsd#arvn_RegulatoryAndSalesBasedMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_RegulatoryAndSalesBasedMilestonesMember" xlink:to="lab_arvn_RegulatoryAndSalesBasedMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_6dd799e9-2b8d-4beb-b24c-0a19ca32c497_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_401ba045-2758-411e-a18e-bbb85779e6da_terseLabel_en-US" xlink:label="lab_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Cash Flow Information Related to Leases</link:label>
    <link:label id="lab_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_label_en-US" xlink:label="lab_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Supplemental Cash Flow Information Related To Leases [Table Text Block]</link:label>
    <link:label id="lab_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_documentation_en-US" xlink:label="lab_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information related to leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:href="arvn-20230630.xsd#arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="lab_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_2eae6c0e-6dd2-4105-b353-a8add754588e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f27e64b5-88e8-4f44-bf01-348de4ffded0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_BayerAGMember_64fde46b-9007-4431-be8d-95cc7df1d6da_terseLabel_en-US" xlink:label="lab_arvn_BayerAGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer Collaboration Agreement</link:label>
    <link:label id="lab_arvn_BayerAGMember_label_en-US" xlink:label="lab_arvn_BayerAGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer A G [Member]</link:label>
    <link:label id="lab_arvn_BayerAGMember_documentation_en-US" xlink:label="lab_arvn_BayerAGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bayer AG.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_BayerAGMember" xlink:href="arvn-20230630.xsd#arvn_BayerAGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_BayerAGMember" xlink:to="lab_arvn_BayerAGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_EmployeesMember_536726f3-5914-4134-b66f-82d586015cc2_terseLabel_en-US" xlink:label="lab_arvn_EmployeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees</link:label>
    <link:label id="lab_arvn_EmployeesMember_label_en-US" xlink:label="lab_arvn_EmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees [Member]</link:label>
    <link:label id="lab_arvn_EmployeesMember_documentation_en-US" xlink:label="lab_arvn_EmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_EmployeesMember" xlink:href="arvn-20230630.xsd#arvn_EmployeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_EmployeesMember" xlink:to="lab_arvn_EmployeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_bd813f79-98d9-471d-a5b0-1b994e9a4be0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_91b4ef09-1ace-409f-a314-6963173afecc_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_8c68e96a-432d-4730-8d65-6f38043effb6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_d301fa31-5c71-44cf-ab0e-c99c9f0fe2dd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_fcb04089-b33a-4f70-8e9a-67291ad7651e_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current installments</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b83e637f-a3e6-48db-81f5-4b0b3b2f7eb4_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accretion of bond discounts/premiums</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_eba866ae-c6e5-4fab-a037-e248e939db44_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_721bcb89-c15b-48ef-a8b9-72abc915307b_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ac8a841c-8710-4968-a975-f3a76d74fc0a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_05307abb-6b99-4720-abab-6e6c758516d8_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9954d55d-d18c-4571-9f0f-70698b8650fb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right of use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_fd9587e9-f807-4090-9997-b9c9fabdbd33_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_b3a11f50-ec03-4f64-8797-cf2afcbaaa08_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_43b20d8b-0cdc-4ddb-a380-f9c1edbeb5cf_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_eeb1ab79-6cb9-47da-af57-dfee147a7dec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_60279e9f-3592-4a8f-8e74-428449be80dc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1ab4a3ec-f87b-4ed0-882b-d263d4adb0f0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a9c7710c-5543-45aa-ab71-aef999719dd8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_877fa2c4-77a3-4405-bf5d-8cb65eb9b34f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_0e2aafa0-f9c1-42ff-bb37-c5f16c83661a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restrictions on Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_811dd59c-0e93-4735-a992-b36b14d00edc_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">adjustments</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Error Correction, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_d13bf474-32c6-44ad-8401-46151468a702_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5d2d513d-fba5-4f43-ad30-732897bfb494_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_3a3858bd-8afa-4f36-a546-1c1d61ce843d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_ca0a424b-29c4-4260-9b57-46ea6438f397_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e974df2b-449b-425c-b735-5a7afa393939_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_22b80778-9bbc-49b8-8c69-3ab6a74975d9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_SalesBasedMilestonesMember_6469f2d7-44d7-4763-9dd9-d2a51b1880b8_terseLabel_en-US" xlink:label="lab_arvn_SalesBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Based Milestones</link:label>
    <link:label id="lab_arvn_SalesBasedMilestonesMember_label_en-US" xlink:label="lab_arvn_SalesBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Based Milestones [Member]</link:label>
    <link:label id="lab_arvn_SalesBasedMilestonesMember_documentation_en-US" xlink:label="lab_arvn_SalesBasedMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-based milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_SalesBasedMilestonesMember" xlink:href="arvn-20230630.xsd#arvn_SalesBasedMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_SalesBasedMilestonesMember" xlink:to="lab_arvn_SalesBasedMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0e8ab04b-71c6-4ea3-a498-a9d81cc5d9bf_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_907cdea1-703c-4219-b326-7309d81c4b96_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock_eed47893-5198-45b4-9bf1-272d7f5bc143_terseLabel_en-US" xlink:label="lab_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock reserved for issuance represented as percentage on outstanding common stock</link:label>
    <link:label id="lab_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock_label_en-US" xlink:label="lab_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Capital Shares Reserved For Future Issuance Represented As Percentage On Outstanding Common Stock</link:label>
    <link:label id="lab_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock_documentation_en-US" xlink:label="lab_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in capital shares reserved for future issuance represented as percentage on outstanding common stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock" xlink:href="arvn-20230630.xsd#arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock" xlink:to="lab_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_cb936fb0-20d8-4a9d-bee8-42918c5243ee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual increase in reserved shares as percentage of outstanding common stock</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_9c2f96cf-91a6-4604-aab9-051607c8b10d_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_AccountsPayableContractBalancesCurrentAdditions_083bd5c7-a60d-4253-ab02-b1a0d68c00a4_terseLabel_en-US" xlink:label="lab_arvn_AccountsPayableContractBalancesCurrentAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_arvn_AccountsPayableContractBalancesCurrentAdditions_label_en-US" xlink:label="lab_arvn_AccountsPayableContractBalancesCurrentAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Contract Balances, Current Additions</link:label>
    <link:label id="lab_arvn_AccountsPayableContractBalancesCurrentAdditions_documentation_en-US" xlink:label="lab_arvn_AccountsPayableContractBalancesCurrentAdditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Contract Balances, Current Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccountsPayableContractBalancesCurrentAdditions" xlink:href="arvn-20230630.xsd#arvn_AccountsPayableContractBalancesCurrentAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_AccountsPayableContractBalancesCurrentAdditions" xlink:to="lab_arvn_AccountsPayableContractBalancesCurrentAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_563ddd07-ce5f-4ca6-8c21-9bc385bc1bc1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Transaction Price Allocated to Performance Obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b9d703ff-890e-4d06-b85f-6490897c6e43_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of RSUs vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_0b8f5f7e-14f2-4c66-bce8-4a14bffe5208_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_267a1c17-741b-467c-a2f5-d181380a9fe0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_38f0817c-ccb4-4ba4-907d-bacbcedb1260_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_53f60af3-c5b1-4d26-8691-b9259ec8a6b0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_80bef63d-30cd-4b72-afde-0df6ea68be06_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PledgedStatusDomain_767fdf42-dc4a-45c7-bf22-2da6bc9fe984_terseLabel_en-US" xlink:label="lab_us-gaap_PledgedStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Domain]</link:label>
    <link:label id="lab_us-gaap_PledgedStatusDomain_label_en-US" xlink:label="lab_us-gaap_PledgedStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pledged Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PledgedStatusDomain" xlink:to="lab_us-gaap_PledgedStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_6334ea57-e3fe-4b8b-8a82-502a074a689d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2ae8f9e1-c11f-4688-812f-171e17c130a9_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9fd961c3-b9b2-473f-b6c9-3e0b9ae08d9b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_85b76cfd-8f8c-4307-928d-ff0495a0a6f7_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2e88267a-f3cd-4dd4-a741-68b5db89a6d1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f5be01dc-3b06-457e-8d88-f6413c3df29d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a6dea243-1a21-4cea-820b-4891d3cda7b5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under equity incentive plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_PfizerIncorporationMember_d53fa1cf-9ed4-44a0-8a23-4f3f662033a7_terseLabel_en-US" xlink:label="lab_arvn_PfizerIncorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer, Inc.</link:label>
    <link:label id="lab_arvn_PfizerIncorporationMember_label_en-US" xlink:label="lab_arvn_PfizerIncorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer Incorporation [Member]</link:label>
    <link:label id="lab_arvn_PfizerIncorporationMember_documentation_en-US" xlink:label="lab_arvn_PfizerIncorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer, Incorporation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PfizerIncorporationMember" xlink:href="arvn-20230630.xsd#arvn_PfizerIncorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_PfizerIncorporationMember" xlink:to="lab_arvn_PfizerIncorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bb12614d-8c86-4f6d-b5fc-defc0fc8f66c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ResearchCollaborationAndLicenseAgreementsTable_eedf3f56-47f9-4979-9703-87761a3866d9_terseLabel_en-US" xlink:label="lab_arvn_ResearchCollaborationAndLicenseAgreementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Collaboration And License Agreements [Table]</link:label>
    <link:label id="lab_arvn_ResearchCollaborationAndLicenseAgreementsTable_label_en-US" xlink:label="lab_arvn_ResearchCollaborationAndLicenseAgreementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Collaboration And License Agreements [Table]</link:label>
    <link:label id="lab_arvn_ResearchCollaborationAndLicenseAgreementsTable_documentation_en-US" xlink:label="lab_arvn_ResearchCollaborationAndLicenseAgreementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research collaboration and license agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable" xlink:to="lab_arvn_ResearchCollaborationAndLicenseAgreementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3db1de4d-99d9-4653-8a5b-905e26958e8e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ad4f11fa-4143-4e9a-8b73-4da97b1125f1_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2587519b-b8e3-43ba-b334-0f121afa26ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_6cfc351b-d4ca-40f8-af0b-d87010d3e74c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_1b6a47b9-4264-41c7-beff-68d6577a0138_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_c87688e1-b72d-4d0f-89d7-2e0fe61430b9_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f8cee792-ab89-4514-870c-c3bc29b61805_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ebfd3099-13ca-45d7-acd4-8ced7bd92d19_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_e0ff40ee-91d6-45a7-b82d-0f87af4e643b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_312deea0-beb9-4cfb-a356-4cb653f9ebf3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities and Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_659c312c-4b0d-47a4-ad08-9fb8d784bef7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_e3025019-6a0f-4355-90fc-14142fe11173_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_d736aa39-ea48-42ac-ab5d-a7ecba28fa4d_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c76b2f75-8284-436a-96b4-8c72aa119cdf_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_2d60f397-2229-41cd-bad9-fcccbe8cad13_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe1121b1-3aca-4598-a4d0-8d2d3db03a21_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_7997dafe-ec99-4ad8-91c2-89dcd730b49a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_7b2fac1a-86fd-47b1-aa9f-8b43063d1df9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_7cdefb1f-95f2-4147-9432-5d25140536d1_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_RegulatoryMilestonePaymentsMember_fed09f37-677a-4977-825c-0a2d1db7fb8f_terseLabel_en-US" xlink:label="lab_arvn_RegulatoryMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Milestone Related to Marketing Approvals</link:label>
    <link:label id="lab_arvn_RegulatoryMilestonePaymentsMember_label_en-US" xlink:label="lab_arvn_RegulatoryMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Milestone Payments [Member]</link:label>
    <link:label id="lab_arvn_RegulatoryMilestonePaymentsMember_documentation_en-US" xlink:label="lab_arvn_RegulatoryMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory milestone payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_RegulatoryMilestonePaymentsMember" xlink:href="arvn-20230630.xsd#arvn_RegulatoryMilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_RegulatoryMilestonePaymentsMember" xlink:to="lab_arvn_RegulatoryMilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_149b5c44-faac-4251-a174-55048bccb2a4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5f5e385b-a58c-4d2b-9a05-905a21e163f9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_8a76f8b5-1215-4c58-ab2d-f10e33394a0e_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_22d4dd5d-761f-40c8-9af1-c5c7cffc3bc5_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contract Balances</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_d9b5e2be-62be-4124-9b7e-5eb6792ffad7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bdc9dd09-8035-4b7b-ba65-9d248cfc14ca_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, equipment and leasehold improvements</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_58e8a803-1900-4ed5-b37b-e825e7158d7b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_PercentageOfIncrementalBorrowingForLeasePayments_6384d71e-d664-4469-9fdc-210c490bb479_terseLabel_en-US" xlink:label="lab_arvn_PercentageOfIncrementalBorrowingForLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of incremental borrowing for lease payments</link:label>
    <link:label id="lab_arvn_PercentageOfIncrementalBorrowingForLeasePayments_label_en-US" xlink:label="lab_arvn_PercentageOfIncrementalBorrowingForLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Incremental Borrowing For Lease Payments</link:label>
    <link:label id="lab_arvn_PercentageOfIncrementalBorrowingForLeasePayments_documentation_en-US" xlink:label="lab_arvn_PercentageOfIncrementalBorrowingForLeasePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of incremental borrowing for lease payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PercentageOfIncrementalBorrowingForLeasePayments" xlink:href="arvn-20230630.xsd#arvn_PercentageOfIncrementalBorrowingForLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_PercentageOfIncrementalBorrowingForLeasePayments" xlink:to="lab_arvn_PercentageOfIncrementalBorrowingForLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_9c3be183-0818-44a0-ad69-7c4643be55e7_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_a35ed8dc-c067-411b-9a67-3c9836646f09_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from equity method investment</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_78c9f0a4-cc61-4a6b-bb1f-f9960244945e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from equity method investment</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_1395f494-6dc4-4cff-8eb1-f9fd448817df_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_954ec229-5742-4a2f-a15e-8821da68afb9_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_b962ad85-23b6-4971-a90b-3f91b55b065c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_30b3cd6f-a70c-4c61-b78d-70657f576c44_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_fb3be875-9416-46e9-893b-aa9dca453655_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_11728e82-8f28-4638-868b-bce79f22406e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements_eec41847-d737-47c0-bb0d-d34f3352d5ad_terseLabel_en-US" xlink:label="lab_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements_label_en-US" xlink:label="lab_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Assets, Increase (Decrease) For Additions To Collaboration Agreements</link:label>
    <link:label id="lab_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements_documentation_en-US" xlink:label="lab_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Assets, Increase (Decrease) For Additions To Collaboration Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:href="arvn-20230630.xsd#arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:to="lab_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_75107d92-a11f-46f1-81c5-103dcd5f74f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3cd0b07b-d409-4e70-b233-13222426b9eb_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_1ae535cd-a3cf-4c45-bf04-4626fc474d34_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_338dee02-5d3e-4ce8-b074-687711adc7c8_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_TwoThousandAndFourteenAssistanceAgreementMember_e9ae2459-ef34-4c48-b75b-5fcd38c3377d_terseLabel_en-US" xlink:label="lab_arvn_TwoThousandAndFourteenAssistanceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Assistance Agreement</link:label>
    <link:label id="lab_arvn_TwoThousandAndFourteenAssistanceAgreementMember_label_en-US" xlink:label="lab_arvn_TwoThousandAndFourteenAssistanceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Fourteen Assistance Agreement [Member]</link:label>
    <link:label id="lab_arvn_TwoThousandAndFourteenAssistanceAgreementMember_documentation_en-US" xlink:label="lab_arvn_TwoThousandAndFourteenAssistanceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand and fourteen assistance agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandAndFourteenAssistanceAgreementMember" xlink:href="arvn-20230630.xsd#arvn_TwoThousandAndFourteenAssistanceAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_TwoThousandAndFourteenAssistanceAgreementMember" xlink:to="lab_arvn_TwoThousandAndFourteenAssistanceAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c637617d-74e4-4522-b15f-743f48aa317c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_LaboratoryEquipmentMember_d0bbb03c-2da6-44b8-837c-3bd0bf211cc7_terseLabel_en-US" xlink:label="lab_arvn_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_arvn_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_arvn_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_arvn_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_arvn_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_LaboratoryEquipmentMember" xlink:href="arvn-20230630.xsd#arvn_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_LaboratoryEquipmentMember" xlink:to="lab_arvn_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d26355e5-2bed-48d0-aa5f-482c373f273b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_144d349a-1aa0-45d5-adef-44b586042d2d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_36c1c8ed-32d9-4f2d-94ed-e08481799174_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss before income taxes and loss from equity method investment</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_arvn_AtTheMarketOfferingMember_d9fbfae9-dd97-44e3-89fd-cc2660e4a6f1_terseLabel_en-US" xlink:label="lab_arvn_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-the-Market Offering</link:label>
    <link:label id="lab_arvn_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_arvn_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering [Member]</link:label>
    <link:label id="lab_arvn_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_arvn_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At the market offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AtTheMarketOfferingMember" xlink:href="arvn-20230630.xsd#arvn_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_arvn_AtTheMarketOfferingMember" xlink:to="lab_arvn_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_f5296749-32f6-4781-8abc-510d1dfafef6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_6208e5a7-5cd3-4f39-907f-7cfbed524185_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_1b883641-07e9-43f0-954b-ce6833df4056_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue receivable if milestones achieved</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_35a8ae12-6f2f-4af3-9702-34fd5050766b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_9376de3b-e3ce-41eb-af30-d5b9d530e8d3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_5e436fc3-0151-4c37-a491-58a72fc296f1_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_49d02675-5875-4cde-a1d2-9f24b5146a77_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dcb3ab25-c10b-4856-8dd3-032d9a3748d1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_8594dc9d-bcd1-43d9-b37c-bbbde7155f50_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f5c231cd-5b09-442b-9907-ca01f66ed20b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f5909243-2a25-460c-84b2-39cbb40ea72e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_d970c3b6-44ce-4518-947d-8723d4153522_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_9875b7be-d32a-48e5-8399-9350bc7e8ca3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0ccf3b1d-c751-4f6d-a291-f52031a18067_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_f57f07e2-0239-4a99-8ac7-1fd86705e1f2_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2b534c7e-b58a-4691-9c5e-f75cc76de730_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_da1c29a6-2536-4ca1-9a0a-1c35d742a61c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Marketable Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>arvn-20230630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:3ad84450-03f4-4a08-908c-03680fffbb5d,g:5431e377-e1a3-4379-9dba-d87e2214df03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.arvinas.com/role/CoverPage" xlink:type="simple" xlink:href="arvn-20230630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_64dd414d-0d1f-4b72-8b21-85abe2da6655" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_DocumentType_64dd414d-0d1f-4b72-8b21-85abe2da6655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_e9f4c72f-e7b0-4d64-855e-33522c093b99" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_DocumentQuarterlyReport_e9f4c72f-e7b0-4d64-855e-33522c093b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9e9d244c-a17a-4faa-9076-e4ed63876a20" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_DocumentPeriodEndDate_9e9d244c-a17a-4faa-9076-e4ed63876a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e6661902-9dc5-4e52-8873-a3bd980c039a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_DocumentTransitionReport_e6661902-9dc5-4e52-8873-a3bd980c039a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8652556f-f78c-437d-b885-b6e0cc2637cd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityFileNumber_8652556f-f78c-437d-b885-b6e0cc2637cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4112a357-1172-49f7-a3ea-39b5daecc603" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityRegistrantName_4112a357-1172-49f7-a3ea-39b5daecc603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7ff12cd2-3818-4369-b633-3a744bafb8d1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7ff12cd2-3818-4369-b633-3a744bafb8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ea029aa2-5e09-4137-a10d-288ac307765a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityTaxIdentificationNumber_ea029aa2-5e09-4137-a10d-288ac307765a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d6395f81-c5e4-4a8e-881e-5fcf7b4789e8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityAddressAddressLine1_d6395f81-c5e4-4a8e-881e-5fcf7b4789e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_d6da4ab6-5ff8-43f4-b33a-69913715e0af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityAddressAddressLine2_d6da4ab6-5ff8-43f4-b33a-69913715e0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_830c2dc4-b1be-43cb-85a8-cba7018d9cf3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityAddressCityOrTown_830c2dc4-b1be-43cb-85a8-cba7018d9cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d8561bbc-80bf-4fb0-997b-4ba960125a82" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityAddressStateOrProvince_d8561bbc-80bf-4fb0-997b-4ba960125a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_46743935-ca45-4cbe-81f2-5361b0223f5f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityAddressPostalZipCode_46743935-ca45-4cbe-81f2-5361b0223f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_60b8917d-9e6d-4cd8-8f93-d499cbf8a8b4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_CityAreaCode_60b8917d-9e6d-4cd8-8f93-d499cbf8a8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b91bad1b-9a80-4a05-8f5a-8075091a88a9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_LocalPhoneNumber_b91bad1b-9a80-4a05-8f5a-8075091a88a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_77eeed02-b8ce-4a11-adab-8410a8b0f452" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_Security12bTitle_77eeed02-b8ce-4a11-adab-8410a8b0f452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_0765302a-b9b2-466f-a247-7b22b738c891" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_TradingSymbol_0765302a-b9b2-466f-a247-7b22b738c891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fb31775a-e65a-452d-b20f-99a91eca3635" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_SecurityExchangeName_fb31775a-e65a-452d-b20f-99a91eca3635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6be9eb87-2982-4c3f-a049-3a6f2faa2916" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityCurrentReportingStatus_6be9eb87-2982-4c3f-a049-3a6f2faa2916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ff2a5fc0-5479-40ca-b16d-cc3a4b4be8c5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityInteractiveDataCurrent_ff2a5fc0-5479-40ca-b16d-cc3a4b4be8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f45ce7a3-3a47-4751-9ff5-300808d59442" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityFilerCategory_f45ce7a3-3a47-4751-9ff5-300808d59442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_15c54ec4-d470-4e29-a60c-41f494a80895" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntitySmallBusiness_15c54ec4-d470-4e29-a60c-41f494a80895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bb02f92f-e9da-4739-a98b-4f902d5bce96" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityEmergingGrowthCompany_bb02f92f-e9da-4739-a98b-4f902d5bce96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b7755434-606b-41fa-8204-9f4750acf22b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityShellCompany_b7755434-606b-41fa-8204-9f4750acf22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_09c6e2e2-7c21-42df-8f34-a96f9b6e9fe7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_09c6e2e2-7c21-42df-8f34-a96f9b6e9fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a0f2d237-3ad4-4fb9-a859-c78441c17655" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_AmendmentFlag_a0f2d237-3ad4-4fb9-a859-c78441c17655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_540c4002-1612-47c9-a2dc-9bbd9c9a601c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_DocumentFiscalYearFocus_540c4002-1612-47c9-a2dc-9bbd9c9a601c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_ac976cdd-b215-47f6-8a7a-35500fde725e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_DocumentFiscalPeriodFocus_ac976cdd-b215-47f6-8a7a-35500fde725e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e909b575-b81b-4611-b6c6-66f94a0e5746" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_EntityCentralIndexKey_e909b575-b81b-4611-b6c6-66f94a0e5746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_89e1e209-5b62-4882-bea8-a0fe593ed1e2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d4dbd2cf-1688-45bd-9104-85fcc189d56d" xlink:to="loc_dei_CurrentFiscalYearEndDate_89e1e209-5b62-4882-bea8-a0fe593ed1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="arvn-20230630.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e43b59a4-0283-41fd-8c69-dbf99e3e5625" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_73a9c404-1252-4478-b6a6-b485aa28ed3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e43b59a4-0283-41fd-8c69-dbf99e3e5625" xlink:to="loc_us-gaap_AssetsAbstract_73a9c404-1252-4478-b6a6-b485aa28ed3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_589b1013-ced9-4959-bdaf-2b8cc28cf4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_73a9c404-1252-4478-b6a6-b485aa28ed3e" xlink:to="loc_us-gaap_AssetsCurrentAbstract_589b1013-ced9-4959-bdaf-2b8cc28cf4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8b65a645-59bb-464e-a9d0-b6b1f44abd63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_589b1013-ced9-4959-bdaf-2b8cc28cf4d1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8b65a645-59bb-464e-a9d0-b6b1f44abd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_d72230ed-9012-4857-a2f6-985b19de9a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_589b1013-ced9-4959-bdaf-2b8cc28cf4d1" xlink:to="loc_us-gaap_RestrictedCashCurrent_d72230ed-9012-4857-a2f6-985b19de9a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_ba6e029f-fbcc-490f-9a62-5931c1ad04c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_589b1013-ced9-4959-bdaf-2b8cc28cf4d1" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_ba6e029f-fbcc-490f-9a62-5931c1ad04c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b8b6ea86-7521-45c6-bd3c-f423a08c6f10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_589b1013-ced9-4959-bdaf-2b8cc28cf4d1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b8b6ea86-7521-45c6-bd3c-f423a08c6f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_9bf89f4e-5eac-4f09-9945-996792cdda7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_589b1013-ced9-4959-bdaf-2b8cc28cf4d1" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_9bf89f4e-5eac-4f09-9945-996792cdda7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ff6e024e-ec98-4a18-a0b6-6db40618fab7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_589b1013-ced9-4959-bdaf-2b8cc28cf4d1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ff6e024e-ec98-4a18-a0b6-6db40618fab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a6a7030f-cce3-4606-b94d-704422aa21da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_589b1013-ced9-4959-bdaf-2b8cc28cf4d1" xlink:to="loc_us-gaap_AssetsCurrent_a6a7030f-cce3-4606-b94d-704422aa21da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_93723e95-001d-40fc-b98b-c58d90ee90de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_73a9c404-1252-4478-b6a6-b485aa28ed3e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_93723e95-001d-40fc-b98b-c58d90ee90de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6513849f-bb68-42f5-9b6d-2385814f9374" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_73a9c404-1252-4478-b6a6-b485aa28ed3e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6513849f-bb68-42f5-9b6d-2385814f9374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CollaborationContractAssetAndOtherAssets_76c3cb11-e360-4b96-bd2f-413bed8e99df" xlink:href="arvn-20230630.xsd#arvn_CollaborationContractAssetAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_73a9c404-1252-4478-b6a6-b485aa28ed3e" xlink:to="loc_arvn_CollaborationContractAssetAndOtherAssets_76c3cb11-e360-4b96-bd2f-413bed8e99df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_62303c78-055f-4e8c-8e95-2938cd99fdff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_73a9c404-1252-4478-b6a6-b485aa28ed3e" xlink:to="loc_us-gaap_Assets_62303c78-055f-4e8c-8e95-2938cd99fdff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cdf7de77-d4d6-4f18-8e99-b4d3303dde1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e43b59a4-0283-41fd-8c69-dbf99e3e5625" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cdf7de77-d4d6-4f18-8e99-b4d3303dde1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3eaa7fd1-7eb5-492d-919c-26cedebc7368" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cdf7de77-d4d6-4f18-8e99-b4d3303dde1a" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3eaa7fd1-7eb5-492d-919c-26cedebc7368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_a04cb0a1-fe47-41dc-b3b4-e36fd698c1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3eaa7fd1-7eb5-492d-919c-26cedebc7368" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_a04cb0a1-fe47-41dc-b3b4-e36fd698c1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f7b1a2ec-10b3-4325-8815-cc1892d889a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3eaa7fd1-7eb5-492d-919c-26cedebc7368" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f7b1a2ec-10b3-4325-8815-cc1892d889a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_40a4ba87-1d08-4097-859e-3d7623b989c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3eaa7fd1-7eb5-492d-919c-26cedebc7368" xlink:to="loc_us-gaap_LongTermDebtCurrent_40a4ba87-1d08-4097-859e-3d7623b989c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b6f639b5-696b-4377-a6c5-4f62baaaf404" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3eaa7fd1-7eb5-492d-919c-26cedebc7368" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b6f639b5-696b-4377-a6c5-4f62baaaf404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cc62351a-1757-4daa-9616-3bff20b869f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3eaa7fd1-7eb5-492d-919c-26cedebc7368" xlink:to="loc_us-gaap_LiabilitiesCurrent_cc62351a-1757-4daa-9616-3bff20b869f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ac416878-dafa-4e85-b81c-85f820e0ede2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cdf7de77-d4d6-4f18-8e99-b4d3303dde1a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ac416878-dafa-4e85-b81c-85f820e0ede2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4f5b43fe-d598-4d48-bed9-daf420776fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cdf7de77-d4d6-4f18-8e99-b4d3303dde1a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4f5b43fe-d598-4d48-bed9-daf420776fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9188b8fb-a838-4013-83cb-6260f1a759e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cdf7de77-d4d6-4f18-8e99-b4d3303dde1a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9188b8fb-a838-4013-83cb-6260f1a759e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f6ff345b-f79c-4cda-941b-77044f984993" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cdf7de77-d4d6-4f18-8e99-b4d3303dde1a" xlink:to="loc_us-gaap_Liabilities_f6ff345b-f79c-4cda-941b-77044f984993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_783fd892-13f5-455e-b2b4-5956e7c6464d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cdf7de77-d4d6-4f18-8e99-b4d3303dde1a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_783fd892-13f5-455e-b2b4-5956e7c6464d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_09652b89-8d44-457c-9429-26ced92b4231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cdf7de77-d4d6-4f18-8e99-b4d3303dde1a" xlink:to="loc_us-gaap_StockholdersEquityAbstract_09652b89-8d44-457c-9429-26ced92b4231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_eec6edeb-5a38-4f36-9c4a-589a6ee928a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09652b89-8d44-457c-9429-26ced92b4231" xlink:to="loc_us-gaap_CommonStockValue_eec6edeb-5a38-4f36-9c4a-589a6ee928a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_96cb6c8f-3161-442c-b91f-eda1201a656f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09652b89-8d44-457c-9429-26ced92b4231" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_96cb6c8f-3161-442c-b91f-eda1201a656f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e73e90ce-2d9d-4710-933e-c59e5bf54275" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09652b89-8d44-457c-9429-26ced92b4231" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e73e90ce-2d9d-4710-933e-c59e5bf54275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_43b1b90c-8b88-47a6-ad07-a894ccf1b5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09652b89-8d44-457c-9429-26ced92b4231" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_43b1b90c-8b88-47a6-ad07-a894ccf1b5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_68f77268-ffd5-4193-86cc-c02568f84b59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09652b89-8d44-457c-9429-26ced92b4231" xlink:to="loc_us-gaap_StockholdersEquity_68f77268-ffd5-4193-86cc-c02568f84b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_20f96e8c-2077-40f9-8f51-598fb2f2d96b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cdf7de77-d4d6-4f18-8e99-b4d3303dde1a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_20f96e8c-2077-40f9-8f51-598fb2f2d96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="arvn-20230630.xsd#CondensedConsolidatedBalanceSheetsunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0375a8d9-5d85-4e38-b1fe-41f2922563c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ea270833-592f-4ec6-a759-7f0dcac6e56f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0375a8d9-5d85-4e38-b1fe-41f2922563c3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ea270833-592f-4ec6-a759-7f0dcac6e56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_c1ac787a-68fd-4135-8866-8e76c7e2d247" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0375a8d9-5d85-4e38-b1fe-41f2922563c3" xlink:to="loc_us-gaap_CommonStockSharesIssued_c1ac787a-68fd-4135-8866-8e76c7e2d247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0a6aa55e-5397-4324-a4c0-c20d09306ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0375a8d9-5d85-4e38-b1fe-41f2922563c3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0a6aa55e-5397-4324-a4c0-c20d09306ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="simple" xlink:href="arvn-20230630.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_7d2a9219-c644-4ac0-81dd-54198ed7c182" xlink:href="arvn-20230630.xsd#arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_7d2a9219-c644-4ac0-81dd-54198ed7c182" xlink:to="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a30f0954-565f-47c7-8e82-1437ca0b9676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_Revenues_a30f0954-565f-47c7-8e82-1437ca0b9676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_60942fc9-64af-41da-a3c9-ab82be83b75b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_OperatingExpensesAbstract_60942fc9-64af-41da-a3c9-ab82be83b75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a37efc97-5910-4027-b54f-b90aea91c5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60942fc9-64af-41da-a3c9-ab82be83b75b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a37efc97-5910-4027-b54f-b90aea91c5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_68c55955-a8dc-47d9-96f5-2fd6f3cfb725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60942fc9-64af-41da-a3c9-ab82be83b75b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_68c55955-a8dc-47d9-96f5-2fd6f3cfb725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a4d1f6bf-a56c-41f9-889b-9b0927345689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_60942fc9-64af-41da-a3c9-ab82be83b75b" xlink:to="loc_us-gaap_OperatingExpenses_a4d1f6bf-a56c-41f9-889b-9b0927345689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c070fff3-b903-4de4-bb62-1e2527554934" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_OperatingIncomeLoss_c070fff3-b903-4de4-bb62-1e2527554934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_aaefa1d0-2e7d-406c-9ed5-64ef02fef3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_aaefa1d0-2e7d-406c-9ed5-64ef02fef3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ec70a3d9-9427-4552-aa9c-1bc633250a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_aaefa1d0-2e7d-406c-9ed5-64ef02fef3ac" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ec70a3d9-9427-4552-aa9c-1bc633250a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_72825137-b87b-448b-b680-72c22a7b3668" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_aaefa1d0-2e7d-406c-9ed5-64ef02fef3ac" xlink:to="loc_us-gaap_InvestmentIncomeInterest_72825137-b87b-448b-b680-72c22a7b3668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_71697c75-0b6c-4b40-a177-42a2fc984277" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_aaefa1d0-2e7d-406c-9ed5-64ef02fef3ac" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_71697c75-0b6c-4b40-a177-42a2fc984277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b770ee0e-e77a-41aa-a5ab-9262a7bfd122" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b770ee0e-e77a-41aa-a5ab-9262a7bfd122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_757111f6-90b8-4203-8c6a-04d4549eb933" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_757111f6-90b8-4203-8c6a-04d4549eb933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_94e94935-8094-4cfe-9161-b560aca304bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_94e94935-8094-4cfe-9161-b560aca304bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_281b8a76-5976-46b4-8d7f-77ace3135b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_NetIncomeLoss_281b8a76-5976-46b4-8d7f-77ace3135b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1a6eb8ba-09c7-4740-a70c-1ec5edc97282" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_EarningsPerShareBasic_1a6eb8ba-09c7-4740-a70c-1ec5edc97282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_93aeeefe-64fe-4728-84fd-77dc72fe4428" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_93aeeefe-64fe-4728-84fd-77dc72fe4428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8b5b287d-2c9b-49c0-aef1-3b25f2954ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8b5b287d-2c9b-49c0-aef1-3b25f2954ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_581e1c34-09ce-4c06-a2c5-4726d446ba7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2e9af751-56eb-4686-bffa-47b6d8b3437b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_581e1c34-09ce-4c06-a2c5-4726d446ba7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c619ed28-3c2d-4392-a88c-ba768b129f64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract_7d2a9219-c644-4ac0-81dd-54198ed7c182" xlink:to="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c619ed28-3c2d-4392-a88c-ba768b129f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0e02e53f-777f-4c4c-84f1-30833feec9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c619ed28-3c2d-4392-a88c-ba768b129f64" xlink:to="loc_us-gaap_NetIncomeLoss_0e02e53f-777f-4c4c-84f1-30833feec9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_5ebb8c07-0223-449a-a7b1-20e53645556e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c619ed28-3c2d-4392-a88c-ba768b129f64" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_5ebb8c07-0223-449a-a7b1-20e53645556e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_63335045-871b-494a-b2fd-3ae013b06572" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_5ebb8c07-0223-449a-a7b1-20e53645556e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_63335045-871b-494a-b2fd-3ae013b06572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d47f6a3e-da8c-4176-a879-180013659f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c619ed28-3c2d-4392-a88c-ba768b129f64" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d47f6a3e-da8c-4176-a879-180013659f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited" xlink:type="simple" xlink:href="arvn-20230630.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c050c2c7-c3e8-4094-ae25-1ccfcdfd2b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b8e8dbd0-d7b0-431a-a856-c439a6faba33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c050c2c7-c3e8-4094-ae25-1ccfcdfd2b1e" xlink:to="loc_us-gaap_StatementTable_b8e8dbd0-d7b0-431a-a856-c439a6faba33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a5273d04-f090-4fb0-a239-705dc9d804d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b8e8dbd0-d7b0-431a-a856-c439a6faba33" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a5273d04-f090-4fb0-a239-705dc9d804d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a5273d04-f090-4fb0-a239-705dc9d804d7" xlink:to="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_24160901-ccea-48e9-8808-654ad2b2978f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:to="loc_us-gaap_CommonStockMember_24160901-ccea-48e9-8808-654ad2b2978f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b3058516-c921-4c53-a799-abc7b621123d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:to="loc_us-gaap_RetainedEarningsMember_b3058516-c921-4c53-a799-abc7b621123d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0b32cbf0-ef3e-411b-bd57-d30e6945c8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0b32cbf0-ef3e-411b-bd57-d30e6945c8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_25953b08-c2ae-4f12-86e9-56b16d0022f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a9704325-4d3d-4e5c-bee4-04375a794d31" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_25953b08-c2ae-4f12-86e9-56b16d0022f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b4b3d47f-131e-4d98-8d5e-f2a4a8061c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b8e8dbd0-d7b0-431a-a856-c439a6faba33" xlink:to="loc_us-gaap_StatementLineItems_b4b3d47f-131e-4d98-8d5e-f2a4a8061c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b4b3d47f-131e-4d98-8d5e-f2a4a8061c8d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cb218ad8-b9fd-4ae6-b6d8-cebd63b4f406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cb218ad8-b9fd-4ae6-b6d8-cebd63b4f406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a037544a-3e21-4c6e-8f0c-42feb1f9d062" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_StockholdersEquity_a037544a-3e21-4c6e-8f0c-42feb1f9d062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7feb3259-b32d-4453-a767-c91df0cdc0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7feb3259-b32d-4453-a767-c91df0cdc0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_043c008c-4abf-47e4-900f-3545c05eb100" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_NetIncomeLoss_043c008c-4abf-47e4-900f-3545c05eb100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_72bbd422-d6c8-4312-8dec-fba5eff73083" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_72bbd422-d6c8-4312-8dec-fba5eff73083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_bd10442d-39c2-4be4-b3fe-ab5703c3fc84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_bd10442d-39c2-4be4-b3fe-ab5703c3fc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_8e29ae94-77b8-4b3d-b19c-f1435df42e70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_8e29ae94-77b8-4b3d-b19c-f1435df42e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_559fda4f-8d2a-4875-abf9-f9eacb7b88be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_559fda4f-8d2a-4875-abf9-f9eacb7b88be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5da28bda-a2e9-4eeb-8eb3-ccd89b331284" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_33239da8-ac26-44bc-a972-0d51c502d58a" xlink:to="loc_us-gaap_StockholdersEquity_5da28bda-a2e9-4eeb-8eb3-ccd89b331284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="arvn-20230630.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_e666ccc9-3376-47b8-ad9f-f2ca9e87caba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_77f30f4c-b1e2-418d-b8bc-ee133b21901e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e666ccc9-3376-47b8-ad9f-f2ca9e87caba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_77f30f4c-b1e2-418d-b8bc-ee133b21901e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e87cd81f-0f3a-4596-b40b-b2c6ba619c75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_77f30f4c-b1e2-418d-b8bc-ee133b21901e" xlink:to="loc_us-gaap_NetIncomeLoss_e87cd81f-0f3a-4596-b40b-b2c6ba619c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ea24717-7910-4fee-9b8e-9d073e1014ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_77f30f4c-b1e2-418d-b8bc-ee133b21901e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ea24717-7910-4fee-9b8e-9d073e1014ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_9e136ab7-dbfe-4220-a156-6e099a5b7e10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ea24717-7910-4fee-9b8e-9d073e1014ca" xlink:to="loc_us-gaap_DepreciationAndAmortization_9e136ab7-dbfe-4220-a156-6e099a5b7e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_2915a56a-79cc-4516-a0d0-8867057ca4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ea24717-7910-4fee-9b8e-9d073e1014ca" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_2915a56a-79cc-4516-a0d0-8867057ca4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLoss_1dd398a0-984e-4148-ac52-38e82df6f48f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ea24717-7910-4fee-9b8e-9d073e1014ca" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleGainLoss_1dd398a0-984e-4148-ac52-38e82df6f48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_f3a8729c-2ef8-401d-9b72-b4a3e6a14dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ea24717-7910-4fee-9b8e-9d073e1014ca" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_f3a8729c-2ef8-401d-9b72-b4a3e6a14dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_7ebecdbc-5aa6-44ae-936e-b8bde0cebb83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ea24717-7910-4fee-9b8e-9d073e1014ca" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_7ebecdbc-5aa6-44ae-936e-b8bde0cebb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c858d4ff-4eea-473f-89ba-b46a8adf3e66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ea24717-7910-4fee-9b8e-9d073e1014ca" xlink:to="loc_us-gaap_ShareBasedCompensation_c858d4ff-4eea-473f-89ba-b46a8adf3e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e7231948-37b3-4648-9fec-a1ea3b563ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ea24717-7910-4fee-9b8e-9d073e1014ca" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e7231948-37b3-4648-9fec-a1ea3b563ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c3e87768-727f-4f65-88c5-4698a252ff1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e7231948-37b3-4648-9fec-a1ea3b563ee2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c3e87768-727f-4f65-88c5-4698a252ff1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_97e22ffe-e144-4774-9904-520c5d4d6593" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e7231948-37b3-4648-9fec-a1ea3b563ee2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_97e22ffe-e144-4774-9904-520c5d4d6593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a5c89007-c3fd-48dd-95d6-f2b101d80027" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e7231948-37b3-4648-9fec-a1ea3b563ee2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a5c89007-c3fd-48dd-95d6-f2b101d80027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7e2db32e-87c3-4742-af3f-b3c4607727c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e7231948-37b3-4648-9fec-a1ea3b563ee2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7e2db32e-87c3-4742-af3f-b3c4607727c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5425e1d6-a7c7-43d5-9d2d-3c9a41686bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e7231948-37b3-4648-9fec-a1ea3b563ee2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5425e1d6-a7c7-43d5-9d2d-3c9a41686bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1e013428-dfb2-4f8c-bd4a-4779f0853984" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e7231948-37b3-4648-9fec-a1ea3b563ee2" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1e013428-dfb2-4f8c-bd4a-4779f0853984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c254ecdc-0c7f-4d28-b3fb-c619a35c4667" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_77f30f4c-b1e2-418d-b8bc-ee133b21901e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c254ecdc-0c7f-4d28-b3fb-c619a35c4667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e7f94518-e294-4f5f-8cd5-c4859e829487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e666ccc9-3376-47b8-ad9f-f2ca9e87caba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e7f94518-e294-4f5f-8cd5-c4859e829487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_38a45b61-bb82-421f-bb97-4dca17ab1b75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e7f94518-e294-4f5f-8cd5-c4859e829487" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_38a45b61-bb82-421f-bb97-4dca17ab1b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ProceedsFromMaturitiesOfMarketableSecurities_96c989d7-d1a6-499e-bd14-2aad079c9be7" xlink:href="arvn-20230630.xsd#arvn_ProceedsFromMaturitiesOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e7f94518-e294-4f5f-8cd5-c4859e829487" xlink:to="loc_arvn_ProceedsFromMaturitiesOfMarketableSecurities_96c989d7-d1a6-499e-bd14-2aad079c9be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ProceedsFromSaleOfMarketableSecurities_8bf075f5-37ef-44f0-bd1b-ea40ac0a0a44" xlink:href="arvn-20230630.xsd#arvn_ProceedsFromSaleOfMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e7f94518-e294-4f5f-8cd5-c4859e829487" xlink:to="loc_arvn_ProceedsFromSaleOfMarketableSecurities_8bf075f5-37ef-44f0-bd1b-ea40ac0a0a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_57bb2738-0c7e-4c78-9794-6561b27c0c89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e7f94518-e294-4f5f-8cd5-c4859e829487" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_57bb2738-0c7e-4c78-9794-6561b27c0c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0c5b2cc0-39cb-478e-96c0-1cc85b6e295c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e7f94518-e294-4f5f-8cd5-c4859e829487" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0c5b2cc0-39cb-478e-96c0-1cc85b6e295c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8e1165ee-a623-4731-92b5-4e523a1876a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e666ccc9-3376-47b8-ad9f-f2ca9e87caba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8e1165ee-a623-4731-92b5-4e523a1876a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares_d7627a5a-13da-4ccd-9121-6935efac8d6a" xlink:href="arvn-20230630.xsd#arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8e1165ee-a623-4731-92b5-4e523a1876a6" xlink:to="loc_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares_d7627a5a-13da-4ccd-9121-6935efac8d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d9b421ab-26ed-440d-9e88-44adc1f8add4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8e1165ee-a623-4731-92b5-4e523a1876a6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d9b421ab-26ed-440d-9e88-44adc1f8add4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d797fb34-2647-44aa-8170-5bffea328201" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e666ccc9-3376-47b8-ad9f-f2ca9e87caba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d797fb34-2647-44aa-8170-5bffea328201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ef625f5-0396-4e10-a582-ed40cc6f758d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e666ccc9-3376-47b8-ad9f-f2ca9e87caba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ef625f5-0396-4e10-a582-ed40cc6f758d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eb2bd95b-c279-4761-807c-c01448108f22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e666ccc9-3376-47b8-ad9f-f2ca9e87caba" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eb2bd95b-c279-4761-807c-c01448108f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_46e63a40-c801-464c-971d-ae1f01cf835b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e666ccc9-3376-47b8-ad9f-f2ca9e87caba" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_46e63a40-c801-464c-971d-ae1f01cf835b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_7148a540-a25f-4e53-9e01-6ada3df0fdc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_46e63a40-c801-464c-971d-ae1f01cf835b" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_7148a540-a25f-4e53-9e01-6ada3df0fdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_34c7cd8d-1359-488a-8b96-5d6be0a1a2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_46e63a40-c801-464c-971d-ae1f01cf835b" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_34c7cd8d-1359-488a-8b96-5d6be0a1a2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/NatureofBusinessandBasisofPresentation" xlink:type="simple" xlink:href="arvn-20230630.xsd#NatureofBusinessandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/NatureofBusinessandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4478d81d-6a0c-42f1-a36d-16f7ecb36cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_941f5a28-5181-43b6-9a90-7692dc68808b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4478d81d-6a0c-42f1-a36d-16f7ecb36cf1" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_941f5a28-5181-43b6-9a90-7692dc68808b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPolicies" xlink:type="simple" xlink:href="arvn-20230630.xsd#AccountingPronouncementsandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_57daa146-3d10-45fa-8e09-6d99d09c38bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3762624b-93eb-4e43-8b5e-e2ce9e1ce262" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_57daa146-3d10-45fa-8e09-6d99d09c38bf" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3762624b-93eb-4e43-8b5e-e2ce9e1ce262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreements" xlink:type="simple" xlink:href="arvn-20230630.xsd#ResearchCollaborationandLicenseAgreements"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_38e0a535-de43-488f-a6a6-b928f8b09c7f" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_fda27af4-03b6-471c-8972-05a7a338815c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_38e0a535-de43-488f-a6a6-b928f8b09c7f" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_fda27af4-03b6-471c-8972-05a7a338815c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurements" xlink:type="simple" xlink:href="arvn-20230630.xsd#MarketableSecuritiesandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bf9f1c3a-cc7e-4e67-a411-6673c4ff35ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_5344dde1-47e1-4673-8d2e-ff15dc1da6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bf9f1c3a-cc7e-4e67-a411-6673c4ff35ab" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_5344dde1-47e1-4673-8d2e-ff15dc1da6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovements" xlink:type="simple" xlink:href="arvn-20230630.xsd#PropertyEquipmentandLeaseholdImprovements"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0274a737-7ab2-4ae4-a654-3c9eed61689f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_32d00645-d2aa-46ce-bcb8-7a0ae2fc6f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0274a737-7ab2-4ae4-a654-3c9eed61689f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_32d00645-d2aa-46ce-bcb8-7a0ae2fc6f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilities" xlink:type="simple" xlink:href="arvn-20230630.xsd#RightofUseAssetsandLiabilities"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/RightofUseAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_76e8afc0-2f78-480f-b45e-1b29aaf59a40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_8efaf626-8e54-4c61-9e33-5f1ad04bc47f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_76e8afc0-2f78-480f-b45e-1b29aaf59a40" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_8efaf626-8e54-4c61-9e33-5f1ad04bc47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/AccountsPayableandAccruedLiabilities" xlink:type="simple" xlink:href="arvn-20230630.xsd#AccountsPayableandAccruedLiabilities"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/AccountsPayableandAccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_67552c94-1f7c-4f00-9edd-0d2d85e4de74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_9940cf39-8a19-498c-a34c-c266d1765d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_67552c94-1f7c-4f00-9edd-0d2d85e4de74" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_9940cf39-8a19-498c-a34c-c266d1765d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/LongTermDebt" xlink:type="simple" xlink:href="arvn-20230630.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ba347ebb-9bb2-4ced-8ecf-04ae7616a654" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_9f0ecac0-7b1f-4827-a848-59fa28cab5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ba347ebb-9bb2-4ced-8ecf-04ae7616a654" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_9f0ecac0-7b1f-4827-a848-59fa28cab5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/Equity" xlink:type="simple" xlink:href="arvn-20230630.xsd#Equity"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e24b2425-bea1-41bd-a7e1-37e146e57ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6b918381-f676-4ab7-96bc-d6c1449791c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e24b2425-bea1-41bd-a7e1-37e146e57ed3" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6b918381-f676-4ab7-96bc-d6c1449791c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/IncomeTaxes" xlink:type="simple" xlink:href="arvn-20230630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_22abbc99-d266-4660-afd3-940a29024856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_55d81edb-d773-442d-8023-a3f2cd035da6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_22abbc99-d266-4660-afd3-940a29024856" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_55d81edb-d773-442d-8023-a3f2cd035da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/NetLossPerShare" xlink:type="simple" xlink:href="arvn-20230630.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d8a6dfe3-8255-4268-add7-1cb81737c4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_ba793c89-7916-4bef-942c-cfb107cdbfad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d8a6dfe3-8255-4268-add7-1cb81737c4d5" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_ba793c89-7916-4bef-942c-cfb107cdbfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquityMethodInvestments" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquityMethodInvestments"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/EquityMethodInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2bb2cb7c-2054-4464-be83-2cbc5dc427ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_7389d64c-30c4-44c1-bd6d-51b964e0a828" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2bb2cb7c-2054-4464-be83-2cbc5dc427ab" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_7389d64c-30c4-44c1-bd6d-51b964e0a828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="arvn-20230630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_52ef66ca-ff43-4bc8-b474-55cc49d0897b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6f3a5e09-ce8f-490c-9a14-97e9f2b9490f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_52ef66ca-ff43-4bc8-b474-55cc49d0897b" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6f3a5e09-ce8f-490c-9a14-97e9f2b9490f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="arvn-20230630.xsd#AccountingPronouncementsandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7de9cb15-4671-42d4-8f33-ba5460519fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_79755584-276a-4e18-afab-5e69797a5cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7de9cb15-4671-42d4-8f33-ba5460519fe4" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_79755584-276a-4e18-afab-5e69797a5cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_3e16640c-9324-44e5-a61e-612a3bc0a0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7de9cb15-4671-42d4-8f33-ba5460519fe4" xlink:to="loc_us-gaap_UseOfEstimates_3e16640c-9324-44e5-a61e-612a3bc0a0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_e58c7318-fd60-4c27-905c-f7d953d8250f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7de9cb15-4671-42d4-8f33-ba5460519fe4" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_e58c7318-fd60-4c27-905c-f7d953d8250f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ce992513-d816-41e6-b2b6-a1622ba9cb45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7de9cb15-4671-42d4-8f33-ba5460519fe4" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ce992513-d816-41e6-b2b6-a1622ba9cb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_863862f3-2f23-46b8-93f9-d7def73a4e94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7de9cb15-4671-42d4-8f33-ba5460519fe4" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_863862f3-2f23-46b8-93f9-d7def73a4e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="arvn-20230630.xsd#AccountingPronouncementsandSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3f9d492b-379b-426e-b7b3-cc5e18c228c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_c2ecaec2-764f-44a8-8006-8d378cc0a60d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f9d492b-379b-426e-b7b3-cc5e18c228c5" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_c2ecaec2-764f-44a8-8006-8d378cc0a60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_4ae9b3de-ee26-4203-bc33-7d88c0e41f78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3f9d492b-379b-426e-b7b3-cc5e18c228c5" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_4ae9b3de-ee26-4203-bc33-7d88c0e41f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTables" xlink:type="simple" xlink:href="arvn-20230630.xsd#ResearchCollaborationandLicenseAgreementsTables"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_e6aecf8e-a54a-4907-ba56-4609b1c7e107" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3a5c6adf-c66c-49f9-963b-7892fb2e57a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_e6aecf8e-a54a-4907-ba56-4609b1c7e107" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3a5c6adf-c66c-49f9-963b-7892fb2e57a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_b790fdca-3b87-4e16-b16d-1da6eb0c864e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_e6aecf8e-a54a-4907-ba56-4609b1c7e107" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_b790fdca-3b87-4e16-b16d-1da6eb0c864e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="arvn-20230630.xsd#MarketableSecuritiesandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_12de0df1-2d86-4339-bf80-c011d860e7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_90664d15-696d-4830-b136-1c9d57951277" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_12de0df1-2d86-4339-bf80-c011d860e7d3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_90664d15-696d-4830-b136-1c9d57951277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsTables" xlink:type="simple" xlink:href="arvn-20230630.xsd#PropertyEquipmentandLeaseholdImprovementsTables"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d157c0e5-fe3f-4245-b29b-49e6e9b158ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_803c7cdf-2a8c-4c87-8b8c-04e5f4291cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d157c0e5-fe3f-4245-b29b-49e6e9b158ef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_803c7cdf-2a8c-4c87-8b8c-04e5f4291cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesTables" xlink:type="simple" xlink:href="arvn-20230630.xsd#RightofUseAssetsandLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0850dd59-553b-44fb-9431-65648ebdf7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_7449badd-0f90-4a60-a20e-1c2111513826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0850dd59-553b-44fb-9431-65648ebdf7ea" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_7449badd-0f90-4a60-a20e-1c2111513826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_8b24b042-6ca8-40ac-af01-3e289aedaba4" xlink:href="arvn-20230630.xsd#arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0850dd59-553b-44fb-9431-65648ebdf7ea" xlink:to="loc_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_8b24b042-6ca8-40ac-af01-3e289aedaba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_70492186-f330-4364-b2ea-61d5ddca393a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0850dd59-553b-44fb-9431-65648ebdf7ea" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_70492186-f330-4364-b2ea-61d5ddca393a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesTables" xlink:type="simple" xlink:href="arvn-20230630.xsd#AccountsPayableandAccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_77baf536-12ed-4a45-a3a5-78e6919e9077" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_a2457790-93b8-4348-843f-d990bb3c59cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_77baf536-12ed-4a45-a3a5-78e6919e9077" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_a2457790-93b8-4348-843f-d990bb3c59cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="arvn-20230630.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ec0be384-22bd-4e22-b24c-c6e02e45ac2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_4435d14c-f8be-4b10-81df-a9b2e5ce6bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ec0be384-22bd-4e22-b24c-c6e02e45ac2b" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_4435d14c-f8be-4b10-81df-a9b2e5ce6bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_c3a2cef4-3b37-4196-99ac-3d4830a60fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ec0be384-22bd-4e22-b24c-c6e02e45ac2b" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_c3a2cef4-3b37-4196-99ac-3d4830a60fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquityTables" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquityTables"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/EquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_052f843e-f7e7-42e5-9a9b-b7200ef7ce9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a9446764-8527-44c4-a5fc-cd9b28687c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_052f843e-f7e7-42e5-9a9b-b7200ef7ce9e" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a9446764-8527-44c4-a5fc-cd9b28687c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_73066224-7f1a-4eeb-81d2-69154008f527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_052f843e-f7e7-42e5-9a9b-b7200ef7ce9e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_73066224-7f1a-4eeb-81d2-69154008f527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_523191b6-b243-4016-87f6-8977f6c832bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_052f843e-f7e7-42e5-9a9b-b7200ef7ce9e" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_523191b6-b243-4016-87f6-8977f6c832bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="arvn-20230630.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a3fd8497-ffe2-4e13-9981-b19152df8ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_fc03a60d-1c32-49b5-b8dd-39e22bf08a97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a3fd8497-ffe2-4e13-9981-b19152df8ea7" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_fc03a60d-1c32-49b5-b8dd-39e22bf08a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_cf42c8b3-2de3-40e7-a33c-b45602b06ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a3fd8497-ffe2-4e13-9981-b19152df8ea7" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_cf42c8b3-2de3-40e7-a33c-b45602b06ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquityMethodInvestmentsTables" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquityMethodInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/EquityMethodInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_cdfd0fa3-20d4-46c2-b120-ef053f0c79c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_d6fde31a-0b42-43c4-8d07-3d03105d00b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_cdfd0fa3-20d4-46c2-b120-ef053f0c79c8" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_d6fde31a-0b42-43c4-8d07-3d03105d00b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/NatureofBusinessandBasisofPresentationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#NatureofBusinessandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/NatureofBusinessandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_98f0c5c1-578f-4c2d-acc9-b4408b700c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities_10764367-39c1-4126-a41f-e972cf476670" xlink:href="arvn-20230630.xsd#arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_98f0c5c1-578f-4c2d-acc9-b4408b700c9b" xlink:to="loc_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities_10764367-39c1-4126-a41f-e972cf476670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a0309ca4-c483-4469-b34f-bbb54f4f6702" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_36c438af-9b0b-4102-8558-3f21e9e89e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a0309ca4-c483-4469-b34f-bbb54f4f6702" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_36c438af-9b0b-4102-8558-3f21e9e89e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_1de7a265-4bc5-4ac5-b522-abe0bf0a1532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a0309ca4-c483-4469-b34f-bbb54f4f6702" xlink:to="loc_us-gaap_RestrictedCashCurrent_1de7a265-4bc5-4ac5-b522-abe0bf0a1532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dfee317a-4d61-4981-8b64-63e87154d3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a0309ca4-c483-4469-b34f-bbb54f4f6702" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dfee317a-4d61-4981-8b64-63e87154d3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_3fa26181-f23b-44d4-b187-f5858fefc2aa" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_3fa26181-f23b-44d4-b187-f5858fefc2aa" xlink:to="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_278144a9-3c51-482f-9ef7-da597218ec8f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:to="loc_srt_CounterpartyNameAxis_278144a9-3c51-482f-9ef7-da597218ec8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_873a9c9b-89c3-42f1-96bf-08b0ec8f2176" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_278144a9-3c51-482f-9ef7-da597218ec8f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_873a9c9b-89c3-42f1-96bf-08b0ec8f2176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PfizerIncorporationMember_4698a4d5-0824-460b-9923-81356670fa3c" xlink:href="arvn-20230630.xsd#arvn_PfizerIncorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_873a9c9b-89c3-42f1-96bf-08b0ec8f2176" xlink:to="loc_arvn_PfizerIncorporationMember_4698a4d5-0824-460b-9923-81356670fa3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_BayerAGMember_baeda139-49bf-402d-8509-299bba50e1b8" xlink:href="arvn-20230630.xsd#arvn_BayerAGMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_873a9c9b-89c3-42f1-96bf-08b0ec8f2176" xlink:to="loc_arvn_BayerAGMember_baeda139-49bf-402d-8509-299bba50e1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember_e8667356-0227-4cd5-a67b-a83e65e3f179" xlink:href="arvn-20230630.xsd#arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_873a9c9b-89c3-42f1-96bf-08b0ec8f2176" xlink:to="loc_arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember_e8667356-0227-4cd5-a67b-a83e65e3f179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_723f1292-01a9-41c1-a8d4-c95a70bfcbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:to="loc_us-gaap_TypeOfArrangementAxis_723f1292-01a9-41c1-a8d4-c95a70bfcbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_723f1292-01a9-41c1-a8d4-c95a70bfcbc9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_RegulatoryAndSalesBasedMilestonesMember_3c60a8e8-2199-43aa-902a-60e1c1fdd52b" xlink:href="arvn-20230630.xsd#arvn_RegulatoryAndSalesBasedMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_RegulatoryAndSalesBasedMilestonesMember_3c60a8e8-2199-43aa-902a-60e1c1fdd52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CollaborationAgreementMember_693d9acd-8afd-4944-a303-5789bc365f95" xlink:href="arvn-20230630.xsd#arvn_CollaborationAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_CollaborationAgreementMember_693d9acd-8afd-4944-a303-5789bc365f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_RegulatoryMilestonePaymentsMember_f38c3d28-fde8-493a-b91f-03b246a17c21" xlink:href="arvn-20230630.xsd#arvn_RegulatoryMilestonePaymentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_RegulatoryMilestonePaymentsMember_f38c3d28-fde8-493a-b91f-03b246a17c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_SalesBasedMilestonesMember_aaeb8a94-eb5c-49f1-9d96-fa171dc7b544" xlink:href="arvn-20230630.xsd#arvn_SalesBasedMilestonesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_SalesBasedMilestonesMember_aaeb8a94-eb5c-49f1-9d96-fa171dc7b544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchFundingPaymentsMember_599b53c6-6fb9-42c0-b289-588ff72f2f8f" xlink:href="arvn-20230630.xsd#arvn_ResearchFundingPaymentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_ResearchFundingPaymentsMember_599b53c6-6fb9-42c0-b289-588ff72f2f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DevelopmentMilestonePaymentsMember_a13f9f61-9518-407b-9643-430e0b886d47" xlink:href="arvn-20230630.xsd#arvn_DevelopmentMilestonePaymentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_DevelopmentMilestonePaymentsMember_a13f9f61-9518-407b-9643-430e0b886d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_SalesBasedMilestonePaymentsMember_a1adc59d-5231-48c2-bb1e-5baaf7f19433" xlink:href="arvn-20230630.xsd#arvn_SalesBasedMilestonePaymentsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_SalesBasedMilestonePaymentsMember_a1adc59d-5231-48c2-bb1e-5baaf7f19433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_OptionPaymentsToLicenseAgreementMember_572dfd18-c86c-4a9e-80c1-cd69216826b5" xlink:href="arvn-20230630.xsd#arvn_OptionPaymentsToLicenseAgreementMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_OptionPaymentsToLicenseAgreementMember_572dfd18-c86c-4a9e-80c1-cd69216826b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CommercialMilestonesMember_1067d174-3060-4f9d-8190-e78e584c799e" xlink:href="arvn-20230630.xsd#arvn_CommercialMilestonesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_24379470-65d2-4cb4-9760-4352964f64b4" xlink:to="loc_arvn_CommercialMilestonesMember_1067d174-3060-4f9d-8190-e78e584c799e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c039db36-ad5e-4aa0-b321-16cde430ab71" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:to="loc_srt_RangeAxis_c039db36-ad5e-4aa0-b321-16cde430ab71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6807e5e3-12ef-4d84-8156-c0c67bcc6cdc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c039db36-ad5e-4aa0-b321-16cde430ab71" xlink:to="loc_srt_RangeMember_6807e5e3-12ef-4d84-8156-c0c67bcc6cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_90a09966-d3ac-4fc4-b7ab-5c853e47aa6a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6807e5e3-12ef-4d84-8156-c0c67bcc6cdc" xlink:to="loc_srt_MaximumMember_90a09966-d3ac-4fc4-b7ab-5c853e47aa6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_2ad073dc-b17b-490c-bfe9-0ae09ce69527" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:to="loc_srt_StatementScenarioAxis_2ad073dc-b17b-490c-bfe9-0ae09ce69527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_49b930e3-e7ab-4d93-b51a-12af5a970d40" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_2ad073dc-b17b-490c-bfe9-0ae09ce69527" xlink:to="loc_srt_ScenarioUnspecifiedDomain_49b930e3-e7ab-4d93-b51a-12af5a970d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_79d2dc4d-5c2b-41d6-94b7-e9e9077e17ec" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_49b930e3-e7ab-4d93-b51a-12af5a970d40" xlink:to="loc_srt_ScenarioForecastMember_79d2dc4d-5c2b-41d6-94b7-e9e9077e17ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5d4398b3-04aa-4e39-ba59-8f841be3845e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5d4398b3-04aa-4e39-ba59-8f841be3845e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c9e3f0f5-010f-4a82-980d-685b5f91d232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5d4398b3-04aa-4e39-ba59-8f841be3845e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c9e3f0f5-010f-4a82-980d-685b5f91d232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e08d25f5-cc09-491e-8028-31b44df7546a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c9e3f0f5-010f-4a82-980d-685b5f91d232" xlink:to="loc_us-gaap_SubsequentEventMember_e08d25f5-cc09-491e-8028-31b44df7546a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsTable_9269778e-72cd-4681-8a67-7a0df0c98de5" xlink:to="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_60d56911-73c1-45e0-aa5c-d7fd67705411" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_60d56911-73c1-45e0-aa5c-d7fd67705411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_85218138-69cf-4433-90a2-ab7d5f54aee4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_us-gaap_ProceedsFromCollaborators_85218138-69cf-4433-90a2-ab7d5f54aee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract_923bafc9-7c90-4158-b269-a61b07e1522a" xlink:href="arvn-20230630.xsd#arvn_DirectAndIncrementalCostsIncurredToObtainTheContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract_923bafc9-7c90-4158-b269-a61b07e1522a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CollaborationContractAssetAndOtherAssets_a37a45bb-2f43-48d2-a518-20d24682e2be" xlink:href="arvn-20230630.xsd#arvn_CollaborationContractAssetAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_arvn_CollaborationContractAssetAndOtherAssets_a37a45bb-2f43-48d2-a518-20d24682e2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement_b761444b-82f3-446c-8fbc-d70caa6b965a" xlink:href="arvn-20230630.xsd#arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement_b761444b-82f3-446c-8fbc-d70caa6b965a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_11054993-1587-495f-982d-a7c4d1d02988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsLineItems_0bc35492-4002-4c39-a2dd-9d313827c262" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract_11054993-1587-495f-982d-a7c4d1d02988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_82bfe09c-e978-496d-a1dd-0ba8bda168c9" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward_893acc6a-bc0b-4680-bea2-27e6086bf477" xlink:href="arvn-20230630.xsd#arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_82bfe09c-e978-496d-a1dd-0ba8bda168c9" xlink:to="loc_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward_893acc6a-bc0b-4680-bea2-27e6086bf477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7e1e8422-0352-4a55-8b35-05f795af3ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward_893acc6a-bc0b-4680-bea2-27e6086bf477" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7e1e8422-0352-4a55-8b35-05f795af3ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions_3b66478c-b44a-48dc-97a8-ffa4b18b5a5d" xlink:href="arvn-20230630.xsd#arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward_893acc6a-bc0b-4680-bea2-27e6086bf477" xlink:to="loc_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions_3b66478c-b44a-48dc-97a8-ffa4b18b5a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived_d58877bd-0230-4ea2-9f65-debe179998ed" xlink:href="arvn-20230630.xsd#arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward_893acc6a-bc0b-4680-bea2-27e6086bf477" xlink:to="loc_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived_d58877bd-0230-4ea2-9f65-debe179998ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a29cfa14-1820-45c5-913b-e6b3db719a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward_893acc6a-bc0b-4680-bea2-27e6086bf477" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a29cfa14-1820-45c5-913b-e6b3db719a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward_7ba9bb87-b8aa-4cde-9c74-4e303a3de9b0" xlink:href="arvn-20230630.xsd#arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_82bfe09c-e978-496d-a1dd-0ba8bda168c9" xlink:to="loc_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward_7ba9bb87-b8aa-4cde-9c74-4e303a3de9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccountsPayableContractBalancesCurrent_ec6cbb03-94ec-4713-92c0-0a4742804cee" xlink:href="arvn-20230630.xsd#arvn_AccountsPayableContractBalancesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward_7ba9bb87-b8aa-4cde-9c74-4e303a3de9b0" xlink:to="loc_arvn_AccountsPayableContractBalancesCurrent_ec6cbb03-94ec-4713-92c0-0a4742804cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccountsPayableContractBalancesCurrentAdditions_efea8ed6-870b-463f-aa1b-db5875446b9e" xlink:href="arvn-20230630.xsd#arvn_AccountsPayableContractBalancesCurrentAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward_7ba9bb87-b8aa-4cde-9c74-4e303a3de9b0" xlink:to="loc_arvn_AccountsPayableContractBalancesCurrentAdditions_efea8ed6-870b-463f-aa1b-db5875446b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccountsPayableContractBalancesCurrentPayments_e0626186-45a4-4197-98b7-fb590e353b2c" xlink:href="arvn-20230630.xsd#arvn_AccountsPayableContractBalancesCurrentPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward_7ba9bb87-b8aa-4cde-9c74-4e303a3de9b0" xlink:to="loc_arvn_AccountsPayableContractBalancesCurrentPayments_e0626186-45a4-4197-98b7-fb590e353b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccountsPayableContractBalancesCurrent_493ccffc-ea2c-4ca0-b244-952fcde14564" xlink:href="arvn-20230630.xsd#arvn_AccountsPayableContractBalancesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward_7ba9bb87-b8aa-4cde-9c74-4e303a3de9b0" xlink:to="loc_arvn_AccountsPayableContractBalancesCurrent_493ccffc-ea2c-4ca0-b244-952fcde14564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward_7f81f245-7bf9-4df2-8c14-3898ddec0923" xlink:href="arvn-20230630.xsd#arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_82bfe09c-e978-496d-a1dd-0ba8bda168c9" xlink:to="loc_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward_7f81f245-7bf9-4df2-8c14-3898ddec0923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_dd342a0f-caf5-4763-93cb-adfac49efa1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward_7f81f245-7bf9-4df2-8c14-3898ddec0923" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_dd342a0f-caf5-4763-93cb-adfac49efa1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements_3795c326-dc0b-4431-98f8-4aab78447fd5" xlink:href="arvn-20230630.xsd#arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward_7f81f245-7bf9-4df2-8c14-3898ddec0923" xlink:to="loc_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements_3795c326-dc0b-4431-98f8-4aab78447fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CapitalizedContractCostAmortizationDuringPeriod_0c16161a-41f0-4b38-9837-96e0981ab7f3" xlink:href="arvn-20230630.xsd#arvn_CapitalizedContractCostAmortizationDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward_7f81f245-7bf9-4df2-8c14-3898ddec0923" xlink:to="loc_arvn_CapitalizedContractCostAmortizationDuringPeriod_0c16161a-41f0-4b38-9837-96e0981ab7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_0db47268-ab2f-4c92-a8aa-3ac81a4a5325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward_7f81f245-7bf9-4df2-8c14-3898ddec0923" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_0db47268-ab2f-4c92-a8aa-3ac81a4a5325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ChangeInContractWithCustomerLiabilityRollForward_85bafbdf-390c-4d9d-a776-fa95ae32a79f" xlink:href="arvn-20230630.xsd#arvn_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_82bfe09c-e978-496d-a1dd-0ba8bda168c9" xlink:to="loc_arvn_ChangeInContractWithCustomerLiabilityRollForward_85bafbdf-390c-4d9d-a776-fa95ae32a79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_a6671bb6-560a-4093-8b5c-3c2dcc4c9c92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInContractWithCustomerLiabilityRollForward_85bafbdf-390c-4d9d-a776-fa95ae32a79f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_a6671bb6-560a-4093-8b5c-3c2dcc4c9c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_cbf98a52-3f03-4245-8f84-7b428a5cee4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInContractWithCustomerLiabilityRollForward_85bafbdf-390c-4d9d-a776-fa95ae32a79f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_cbf98a52-3f03-4245-8f84-7b428a5cee4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements_8d38bfb6-c87a-4d76-abd4-2ad1e71c96d0" xlink:href="arvn-20230630.xsd#arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInContractWithCustomerLiabilityRollForward_85bafbdf-390c-4d9d-a776-fa95ae32a79f" xlink:to="loc_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements_8d38bfb6-c87a-4d76-abd4-2ad1e71c96d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_73406c78-3663-4982-8952-edb5527fe4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ChangeInContractWithCustomerLiabilityRollForward_85bafbdf-390c-4d9d-a776-fa95ae32a79f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_73406c78-3663-4982-8952-edb5527fe4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_0935ee6b-4936-49fb-831e-6b0fe9139002" xlink:href="arvn-20230630.xsd#arvn_ResearchCollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c9aa9e07-b64d-4f9d-a363-2ec243828e02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_ResearchCollaborationAndLicenseAgreementsAbstract_0935ee6b-4936-49fb-831e-6b0fe9139002" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c9aa9e07-b64d-4f9d-a363-2ec243828e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_c05b4198-b461-4b8f-8c92-5bcedd322827" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c9aa9e07-b64d-4f9d-a363-2ec243828e02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_c05b4198-b461-4b8f-8c92-5bcedd322827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_c9aa9e07-b64d-4f9d-a363-2ec243828e02" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_c0fc6ac3-52dd-4204-a50a-c961aaf0c2da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_c0fc6ac3-52dd-4204-a50a-c961aaf0c2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_63a5164e-1a40-4cca-9aad-056eafb83e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_512fb32b-e0c1-4eae-80c1-b14be78ecd8b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_63a5164e-1a40-4cca-9aad-056eafb83e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="arvn-20230630.xsd#ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4ab2ba72-7b7e-4731-bb73-1298bbb6d5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f03d389-8cdf-4495-a514-f4c6c6dd08de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4ab2ba72-7b7e-4731-bb73-1298bbb6d5cb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f03d389-8cdf-4495-a514-f4c6c6dd08de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c9f22879-f5f8-4ea4-8448-c336800494fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f03d389-8cdf-4495-a514-f4c6c6dd08de" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c9f22879-f5f8-4ea4-8448-c336800494fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab6c2c39-cfb4-4874-bc13-5d6268d7dae0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c9f22879-f5f8-4ea4-8448-c336800494fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab6c2c39-cfb4-4874-bc13-5d6268d7dae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6de5b35b-3185-46aa-9838-88f79faf1f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab6c2c39-cfb4-4874-bc13-5d6268d7dae0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6de5b35b-3185-46aa-9838-88f79faf1f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8ed8e18d-fd5c-444c-a2db-c5c0258b4739" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f03d389-8cdf-4495-a514-f4c6c6dd08de" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8ed8e18d-fd5c-444c-a2db-c5c0258b4739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_04b1af8f-4d4a-4246-938c-f319bccab8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_8ed8e18d-fd5c-444c-a2db-c5c0258b4739" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_04b1af8f-4d4a-4246-938c-f319bccab8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a894d974-8754-40bb-93fd-6cf85353983b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_04b1af8f-4d4a-4246-938c-f319bccab8c5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a894d974-8754-40bb-93fd-6cf85353983b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_dee07cc1-ce83-434d-b3f3-38250d2cf09e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f03d389-8cdf-4495-a514-f4c6c6dd08de" xlink:to="loc_us-gaap_FinancialInstrumentAxis_dee07cc1-ce83-434d-b3f3-38250d2cf09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dd7b71a7-c1b6-43f7-8516-08cd61d128c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dee07cc1-ce83-434d-b3f3-38250d2cf09e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dd7b71a7-c1b6-43f7-8516-08cd61d128c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_a12f3d5f-cc74-4215-982f-58d84b73b747" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dd7b71a7-c1b6-43f7-8516-08cd61d128c9" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_a12f3d5f-cc74-4215-982f-58d84b73b747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_ab50bd7b-94fc-4b1b-ac4a-4d0bfcbee57e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dd7b71a7-c1b6-43f7-8516-08cd61d128c9" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_ab50bd7b-94fc-4b1b-ac4a-4d0bfcbee57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6f03d389-8cdf-4495-a514-f4c6c6dd08de" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3b7f793d-0366-4c5e-8415-8767b1004223" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3b7f793d-0366-4c5e-8415-8767b1004223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_373bae02-4d43-41d9-bdb9-16d639b645ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_373bae02-4d43-41d9-bdb9-16d639b645ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e97e71ee-8f87-477c-aa95-ff42a7361286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e97e71ee-8f87-477c-aa95-ff42a7361286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_129dd981-57a8-4e7a-bc81-2545187f737a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6297812d-3ba0-4e09-b32d-daff6ee0d7c6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_129dd981-57a8-4e7a-bc81-2545187f737a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_521782d6-4fb9-46ba-9cc4-7fb37254d7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eeaa3c5-1204-4a68-8111-240f14d7c96f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_521782d6-4fb9-46ba-9cc4-7fb37254d7c8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eeaa3c5-1204-4a68-8111-240f14d7c96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_638f632c-c43b-4160-a277-d18ba547c6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eeaa3c5-1204-4a68-8111-240f14d7c96f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_638f632c-c43b-4160-a277-d18ba547c6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_55b96ea9-3446-4c1e-a5b3-62dc52a2a702" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_638f632c-c43b-4160-a277-d18ba547c6cf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_55b96ea9-3446-4c1e-a5b3-62dc52a2a702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_LaboratoryEquipmentMember_b8d77bec-99d0-4b39-8994-5fbde4a41ad1" xlink:href="arvn-20230630.xsd#arvn_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_55b96ea9-3446-4c1e-a5b3-62dc52a2a702" xlink:to="loc_arvn_LaboratoryEquipmentMember_b8d77bec-99d0-4b39-8994-5fbde4a41ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_39a721ec-874e-4d1d-9e29-2a6b26400ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_55b96ea9-3446-4c1e-a5b3-62dc52a2a702" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_39a721ec-874e-4d1d-9e29-2a6b26400ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_1aa3ed7b-8f12-499d-8da0-e0350dd12090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_55b96ea9-3446-4c1e-a5b3-62dc52a2a702" xlink:to="loc_us-gaap_OfficeEquipmentMember_1aa3ed7b-8f12-499d-8da0-e0350dd12090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_53267d5a-08c8-42cf-b789-4e2870dde45e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eeaa3c5-1204-4a68-8111-240f14d7c96f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_53267d5a-08c8-42cf-b789-4e2870dde45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_24db3196-4717-4e81-b45f-dfa3724d8d48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_53267d5a-08c8-42cf-b789-4e2870dde45e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_24db3196-4717-4e81-b45f-dfa3724d8d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2e9aae01-18e5-4143-aaf9-612eff700a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_53267d5a-08c8-42cf-b789-4e2870dde45e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2e9aae01-18e5-4143-aaf9-612eff700a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9159cdb9-3ba7-4cc5-9ba9-cb09ebf6622b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_53267d5a-08c8-42cf-b789-4e2870dde45e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9159cdb9-3ba7-4cc5-9ba9-cb09ebf6622b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsAdditionalInformationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#PropertyEquipmentandLeaseholdImprovementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1348b04d-068a-4e27-8117-0517138801f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d1555a33-f055-4650-9886-1234a0e1286e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1348b04d-068a-4e27-8117-0517138801f1" xlink:to="loc_us-gaap_DepreciationAndAmortization_d1555a33-f055-4650-9886-1234a0e1286e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#RightofUseAssetsandLiabilitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d232b57a-5c70-4475-b878-9bb531b6ccfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_58055d09-e9de-469a-889d-026a239803aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d232b57a-5c70-4475-b878-9bb531b6ccfb" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_58055d09-e9de-469a-889d-026a239803aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_812b777d-7261-4d6c-af1e-a56d25fed1f8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_58055d09-e9de-469a-889d-026a239803aa" xlink:to="loc_srt_RangeAxis_812b777d-7261-4d6c-af1e-a56d25fed1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5b836532-bea9-4abb-9d9d-039527ffaee1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_812b777d-7261-4d6c-af1e-a56d25fed1f8" xlink:to="loc_srt_RangeMember_5b836532-bea9-4abb-9d9d-039527ffaee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_415a720b-897e-4ff8-a9da-da162dd8f6fc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5b836532-bea9-4abb-9d9d-039527ffaee1" xlink:to="loc_srt_MinimumMember_415a720b-897e-4ff8-a9da-da162dd8f6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3142b410-232a-415d-a3e0-7f3181b68363" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5b836532-bea9-4abb-9d9d-039527ffaee1" xlink:to="loc_srt_MaximumMember_3142b410-232a-415d-a3e0-7f3181b68363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgingPurposeAxis_a3502844-319d-410d-aecf-fd19dec1bd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgingPurposeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_58055d09-e9de-469a-889d-026a239803aa" xlink:to="loc_us-gaap_PledgingPurposeAxis_a3502844-319d-410d-aecf-fd19dec1bd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgingPurposeDomain_1ca72ccb-4a74-4b97-ab2d-eecb155b1ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgingPurposeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgingPurposeAxis_a3502844-319d-410d-aecf-fd19dec1bd5c" xlink:to="loc_us-gaap_PledgingPurposeDomain_1ca72ccb-4a74-4b97-ab2d-eecb155b1ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_6c9af49a-ea26-47b1-bc06-24e2790f3dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgingPurposeDomain_1ca72ccb-4a74-4b97-ab2d-eecb155b1ea4" xlink:to="loc_us-gaap_LetterOfCreditMember_6c9af49a-ea26-47b1-bc06-24e2790f3dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusAxis_15ffbb77-d6cb-46a3-b114-f5b94fc9994f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_58055d09-e9de-469a-889d-026a239803aa" xlink:to="loc_us-gaap_PledgedStatusAxis_15ffbb77-d6cb-46a3-b114-f5b94fc9994f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PledgedStatusDomain_a79ea2f4-1f6d-46df-8581-f5fdc32aee83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgedStatusAxis_15ffbb77-d6cb-46a3-b114-f5b94fc9994f" xlink:to="loc_us-gaap_PledgedStatusDomain_a79ea2f4-1f6d-46df-8581-f5fdc32aee83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetPledgedAsCollateralMember_72b298ae-0bc5-4a67-93bf-73d8e72b8220" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetPledgedAsCollateralMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgedStatusDomain_a79ea2f4-1f6d-46df-8581-f5fdc32aee83" xlink:to="loc_us-gaap_AssetPledgedAsCollateralMember_72b298ae-0bc5-4a67-93bf-73d8e72b8220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_58055d09-e9de-469a-889d-026a239803aa" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PercentageOfIncrementalBorrowingForLeasePayments_52462759-0e61-41e2-ab4a-383b5259a609" xlink:href="arvn-20230630.xsd#arvn_PercentageOfIncrementalBorrowingForLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_arvn_PercentageOfIncrementalBorrowingForLeasePayments_52462759-0e61-41e2-ab4a-383b5259a609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandSubjectToGroundLeases_22bbee40-c910-4ed2-9078-72c3549be796" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandSubjectToGroundLeases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_us-gaap_LandSubjectToGroundLeases_22bbee40-c910-4ed2-9078-72c3549be796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecurities_f7686281-ee0a-4e37-8a7c-f2d4f656e596" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_us-gaap_DebtSecurities_f7686281-ee0a-4e37-8a7c-f2d4f656e596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_7d3be5a7-571e-4f76-a908-f3a162d0519e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_us-gaap_LeaseCost_7d3be5a7-571e-4f76-a908-f3a162d0519e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_BaseLeaseRentPeriod_54c73ae6-5574-4fca-a5c5-60ece6ca8ef5" xlink:href="arvn-20230630.xsd#arvn_BaseLeaseRentPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_arvn_BaseLeaseRentPeriod_54c73ae6-5574-4fca-a5c5-60ece6ca8ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_89f1046d-ec0d-425d-9534-c76e717a178a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a32fdb4c-e93e-4dd3-adae-7ce6d4f8398b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_89f1046d-ec0d-425d-9534-c76e717a178a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#RightofUseAssetsandLiabilitiesComponentsofLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cd6b066e-07c4-4f9f-9540-5983c228e51f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_2dbfba3f-7dbf-4148-bfc7-37d6165b38ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cd6b066e-07c4-4f9f-9540-5983c228e51f" xlink:to="loc_us-gaap_OperatingLeaseCost_2dbfba3f-7dbf-4148-bfc7-37d6165b38ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#RightofUseAssetsandLiabilitiesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_985697c2-6495-4b8c-856e-5e31479e332b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_2ce74ab2-4074-4f32-9a8f-fa99242efb80" xlink:href="arvn-20230630.xsd#arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_985697c2-6495-4b8c-856e-5e31479e332b" xlink:to="loc_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_2ce74ab2-4074-4f32-9a8f-fa99242efb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_e1b9a025-fcfd-454c-986e-95c5e67b749d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract_2ce74ab2-4074-4f32-9a8f-fa99242efb80" xlink:to="loc_us-gaap_OperatingLeasePayments_e1b9a025-fcfd-454c-986e-95c5e67b749d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract_4490075c-cb00-49e0-83fb-a34787cfe7ae" xlink:href="arvn-20230630.xsd#arvn_SupplementalNonCashInformationRelatedToLeasesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_985697c2-6495-4b8c-856e-5e31479e332b" xlink:to="loc_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract_4490075c-cb00-49e0-83fb-a34787cfe7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3adbc735-2594-4cb6-907e-7f2db26c88b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract_4490075c-cb00-49e0-83fb-a34787cfe7ae" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3adbc735-2594-4cb6-907e-7f2db26c88b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4cf0a9a2-8dd6-4bbc-b556-ac5742deecc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_61594ee5-e849-40b6-88c2-ee6266f0bdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4cf0a9a2-8dd6-4bbc-b556-ac5742deecc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_61594ee5-e849-40b6-88c2-ee6266f0bdfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_06f01205-7957-4a02-b2cc-7ca574de22ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4cf0a9a2-8dd6-4bbc-b556-ac5742deecc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_06f01205-7957-4a02-b2cc-7ca574de22ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a45f6d3a-4e7e-4e12-94b9-fda3dfaabbff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4cf0a9a2-8dd6-4bbc-b556-ac5742deecc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a45f6d3a-4e7e-4e12-94b9-fda3dfaabbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_aea638df-7cdd-4731-86b8-53a5ad8e47da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4cf0a9a2-8dd6-4bbc-b556-ac5742deecc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_aea638df-7cdd-4731-86b8-53a5ad8e47da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_50e0f759-7d3d-4c03-983a-ce317ae62920" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4cf0a9a2-8dd6-4bbc-b556-ac5742deecc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_50e0f759-7d3d-4c03-983a-ce317ae62920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e21389d0-4b88-4089-8126-e95bbf55e1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4cf0a9a2-8dd6-4bbc-b556-ac5742deecc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e21389d0-4b88-4089-8126-e95bbf55e1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7d63ce4c-977f-4026-ba3b-046a6c5a43a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4cf0a9a2-8dd6-4bbc-b556-ac5742deecc1" xlink:to="loc_us-gaap_OperatingLeaseLiability_7d63ce4c-977f-4026-ba3b-046a6c5a43a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="arvn-20230630.xsd#RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#AccountsPayableandAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_1f126c95-3f2c-4f49-bdf9-be5fc92792fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3f51d9d6-af75-41c8-8030-976304d2e93d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1f126c95-3f2c-4f49-bdf9-be5fc92792fb" xlink:to="loc_us-gaap_AccountsPayableCurrent_3f51d9d6-af75-41c8-8030-976304d2e93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_d8f33c38-cce3-411f-975e-766735e6e0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1f126c95-3f2c-4f49-bdf9-be5fc92792fb" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_d8f33c38-cce3-411f-975e-766735e6e0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AccruedResearchAndDevelopmentExpenseCurrent_372db724-386b-4ad4-9c97-44e6b7758297" xlink:href="arvn-20230630.xsd#arvn_AccruedResearchAndDevelopmentExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_d8f33c38-cce3-411f-975e-766735e6e0d8" xlink:to="loc_arvn_AccruedResearchAndDevelopmentExpenseCurrent_372db724-386b-4ad4-9c97-44e6b7758297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e4d3e4ff-05f2-4765-9f53-4f5d3c0dd3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_d8f33c38-cce3-411f-975e-766735e6e0d8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e4d3e4ff-05f2-4765-9f53-4f5d3c0dd3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_5117692d-2522-4a1f-9e6d-fbc01ed76e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_d8f33c38-cce3-411f-975e-766735e6e0d8" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_5117692d-2522-4a1f-9e6d-fbc01ed76e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_63175548-e9fa-4242-a98b-80227f64e31b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_d8f33c38-cce3-411f-975e-766735e6e0d8" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_63175548-e9fa-4242-a98b-80227f64e31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_24c5db80-34bf-4f38-8f09-9fc956681c10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1f126c95-3f2c-4f49-bdf9-be5fc92792fb" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_24c5db80-34bf-4f38-8f09-9fc956681c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6f8acee3-a940-4f9f-94e0-caee60435b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a0b11bfe-41c5-4432-9598-5a9e8f8419cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6f8acee3-a940-4f9f-94e0-caee60435b52" xlink:to="loc_us-gaap_DebtInstrumentTable_a0b11bfe-41c5-4432-9598-5a9e8f8419cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3450ca9d-154c-47dc-9ab6-32f43342a08a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a0b11bfe-41c5-4432-9598-5a9e8f8419cf" xlink:to="loc_us-gaap_DebtInstrumentAxis_3450ca9d-154c-47dc-9ab6-32f43342a08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_429e10d8-46c2-44e8-82ce-29ff73f8f794" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3450ca9d-154c-47dc-9ab6-32f43342a08a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_429e10d8-46c2-44e8-82ce-29ff73f8f794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandAndEighteenAssistanceAgreementMember_6b3644ed-6e4d-4d08-8d92-d5101f3548b2" xlink:href="arvn-20230630.xsd#arvn_TwoThousandAndEighteenAssistanceAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_429e10d8-46c2-44e8-82ce-29ff73f8f794" xlink:to="loc_arvn_TwoThousandAndEighteenAssistanceAgreementMember_6b3644ed-6e4d-4d08-8d92-d5101f3548b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a0b11bfe-41c5-4432-9598-5a9e8f8419cf" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_12f7532b-5881-49ab-af15-3c10fb2f1a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_12f7532b-5881-49ab-af15-3c10fb2f1a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b47af406-6d97-4359-906c-9f01402385b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:to="loc_us-gaap_LongTermDebt_b47af406-6d97-4359-906c-9f01402385b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d7ff3fa5-44c1-40e1-8922-d5714a2b982b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:to="loc_us-gaap_LongTermDebtCurrent_d7ff3fa5-44c1-40e1-8922-d5714a2b982b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_86a7118f-7c69-46da-85f4-bd3c1fe1c936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c926d3ac-f405-4945-acc2-f14c21ba82be" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_86a7118f-7c69-46da-85f4-bd3c1fe1c936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#LongTermDebtAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0f899982-52f0-4843-9af0-396c876cd749" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c134c040-b2d5-4cfe-8e76-13256224d6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0f899982-52f0-4843-9af0-396c876cd749" xlink:to="loc_us-gaap_DebtInstrumentTable_c134c040-b2d5-4cfe-8e76-13256224d6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_081041f7-f983-42f7-a7d0-ce2da0beab0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c134c040-b2d5-4cfe-8e76-13256224d6b3" xlink:to="loc_us-gaap_DebtInstrumentAxis_081041f7-f983-42f7-a7d0-ce2da0beab0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dacfc468-a140-448d-b0fd-e729be300df9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_081041f7-f983-42f7-a7d0-ce2da0beab0e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dacfc468-a140-448d-b0fd-e729be300df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandAndEighteenAssistanceAgreementMember_20071692-8117-46fd-b28f-c53bcf646790" xlink:href="arvn-20230630.xsd#arvn_TwoThousandAndEighteenAssistanceAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dacfc468-a140-448d-b0fd-e729be300df9" xlink:to="loc_arvn_TwoThousandAndEighteenAssistanceAgreementMember_20071692-8117-46fd-b28f-c53bcf646790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandAndFourteenAssistanceAgreementMember_2317e545-b990-449e-9633-d11fefa1166d" xlink:href="arvn-20230630.xsd#arvn_TwoThousandAndFourteenAssistanceAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dacfc468-a140-448d-b0fd-e729be300df9" xlink:to="loc_arvn_TwoThousandAndFourteenAssistanceAgreementMember_2317e545-b990-449e-9633-d11fefa1166d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3c7256ee-5c63-424c-81bf-ca03f51caa5b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c134c040-b2d5-4cfe-8e76-13256224d6b3" xlink:to="loc_srt_StatementGeographicalAxis_3c7256ee-5c63-424c-81bf-ca03f51caa5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2671025a-a9fe-486a-b8e1-2086138e96a1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_3c7256ee-5c63-424c-81bf-ca03f51caa5b" xlink:to="loc_srt_SegmentGeographicalDomain_2671025a-a9fe-486a-b8e1-2086138e96a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT_ff29aa26-a4cc-4aee-beaa-ee15efcdc266" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_CT"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2671025a-a9fe-486a-b8e1-2086138e96a1" xlink:to="loc_stpr_CT_ff29aa26-a4cc-4aee-beaa-ee15efcdc266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c134c040-b2d5-4cfe-8e76-13256224d6b3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4e39df38-607c-4151-91cd-d7e44317ec10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4e39df38-607c-4151-91cd-d7e44317ec10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DebtInstrumentLoanForgiveness_b5e33590-86c3-4561-9bda-3e91bac3e042" xlink:href="arvn-20230630.xsd#arvn_DebtInstrumentLoanForgiveness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_arvn_DebtInstrumentLoanForgiveness_b5e33590-86c3-4561-9bda-3e91bac3e042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0710a64-5265-4e90-9d81-6e826a71b83f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0710a64-5265-4e90-9d81-6e826a71b83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_DebtInstrumentInterestPaymentsTerm_29f34a87-1750-4003-a8dd-80c933e581c4" xlink:href="arvn-20230630.xsd#arvn_DebtInstrumentInterestPaymentsTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_arvn_DebtInstrumentInterestPaymentsTerm_29f34a87-1750-4003-a8dd-80c933e581c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PercentageOfLiquidatedDamages_38dc5eaa-6c34-4fe5-b32a-4c8167f46ce9" xlink:href="arvn-20230630.xsd#arvn_PercentageOfLiquidatedDamages"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_arvn_PercentageOfLiquidatedDamages_38dc5eaa-6c34-4fe5-b32a-4c8167f46ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e10b5a58-c86d-4654-868c-29f304144f38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8381e19e-330a-4033-932e-63ba9918731f" xlink:to="loc_us-gaap_InterestExpense_e10b5a58-c86d-4654-868c-29f304144f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0d8a621d-2481-419c-a15c-bf5c65462200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_528c1589-4b58-4ca4-863a-397b77074b19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0d8a621d-2481-419c-a15c-bf5c65462200" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_528c1589-4b58-4ca4-863a-397b77074b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_e512c66b-ef77-47a6-820f-574f1f951f40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0d8a621d-2481-419c-a15c-bf5c65462200" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_e512c66b-ef77-47a6-820f-574f1f951f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c3e23d46-2c99-49d9-8c3d-7bd97aba31aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0d8a621d-2481-419c-a15c-bf5c65462200" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c3e23d46-2c99-49d9-8c3d-7bd97aba31aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2587d55e-491e-47cb-9466-4d57d8b646fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0d8a621d-2481-419c-a15c-bf5c65462200" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2587d55e-491e-47cb-9466-4d57d8b646fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_9d5bbdca-2d00-4372-b86d-68ee1368a70a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0d8a621d-2481-419c-a15c-bf5c65462200" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_9d5bbdca-2d00-4372-b86d-68ee1368a70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_LongTermDebtMaturityYearSix_8709d287-c4aa-4dcf-bab2-31508507a5fc" xlink:href="arvn-20230630.xsd#arvn_LongTermDebtMaturityYearSix"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0d8a621d-2481-419c-a15c-bf5c65462200" xlink:to="loc_arvn_LongTermDebtMaturityYearSix_8709d287-c4aa-4dcf-bab2-31508507a5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_073336eb-7039-4ffe-bc70-4d4f005aae92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0d8a621d-2481-419c-a15c-bf5c65462200" xlink:to="loc_us-gaap_LongTermDebt_073336eb-7039-4ffe-bc70-4d4f005aae92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquityAdditionalInformationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/EquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_090fdf67-7f91-4bb9-a046-3be2bac360fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_090fdf67-7f91-4bb9-a046-3be2bac360fa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_82a32c91-550e-4803-8d82-f6a96de986db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_82a32c91-550e-4803-8d82-f6a96de986db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f4929178-fff7-4a1d-b7cf-314a49308e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_82a32c91-550e-4803-8d82-f6a96de986db" xlink:to="loc_us-gaap_EquityComponentDomain_f4929178-fff7-4a1d-b7cf-314a49308e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d1e36d09-82d2-43a3-9911-cafc1896e245" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f4929178-fff7-4a1d-b7cf-314a49308e1c" xlink:to="loc_us-gaap_CommonStockMember_d1e36d09-82d2-43a3-9911-cafc1896e245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_8f4c46ab-160b-4a1e-8483-55a5029a017b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_8f4c46ab-160b-4a1e-8483-55a5029a017b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_15a039bf-f0dc-4106-873b-9b4760d9d367" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8f4c46ab-160b-4a1e-8483-55a5029a017b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_15a039bf-f0dc-4106-873b-9b4760d9d367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_EquityDistributionAgreementMember_62f6c78e-f80f-406b-b58e-1522cf231d1f" xlink:href="arvn-20230630.xsd#arvn_EquityDistributionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_15a039bf-f0dc-4106-873b-9b4760d9d367" xlink:to="loc_arvn_EquityDistributionAgreementMember_62f6c78e-f80f-406b-b58e-1522cf231d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b6b890bd-e43c-4303-abe9-f151220ba41c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b6b890bd-e43c-4303-abe9-f151220ba41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f5499638-fff6-4fca-a05e-ce18b6bf556a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b6b890bd-e43c-4303-abe9-f151220ba41c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f5499638-fff6-4fca-a05e-ce18b6bf556a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AtTheMarketOfferingMember_c763e01f-02da-4018-b34a-4076a6593514" xlink:href="arvn-20230630.xsd#arvn_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f5499638-fff6-4fca-a05e-ce18b6bf556a" xlink:to="loc_arvn_AtTheMarketOfferingMember_c763e01f-02da-4018-b34a-4076a6593514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_76206bdd-ac1e-48b7-8db4-39ab70c7ba9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f5499638-fff6-4fca-a05e-ce18b6bf556a" xlink:to="loc_us-gaap_EmployeeStockMember_76206bdd-ac1e-48b7-8db4-39ab70c7ba9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a9ff23de-32d6-4a1c-9f05-26adaf2937bf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_srt_CounterpartyNameAxis_a9ff23de-32d6-4a1c-9f05-26adaf2937bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d7c2960-b3d0-4923-bc2e-1acf28e5b7e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_a9ff23de-32d6-4a1c-9f05-26adaf2937bf" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d7c2960-b3d0-4923-bc2e-1acf28e5b7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_PiperSandlerAndCantorMember_cb04bd76-f87b-4066-a93f-6857fb53821b" xlink:href="arvn-20230630.xsd#arvn_PiperSandlerAndCantorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d7c2960-b3d0-4923-bc2e-1acf28e5b7e6" xlink:to="loc_arvn_PiperSandlerAndCantorMember_cb04bd76-f87b-4066-a93f-6857fb53821b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_00d6634a-b9f3-4125-9d7c-5ac2c62746c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_PlanNameAxis_00d6634a-b9f3-4125-9d7c-5ac2c62746c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1cd04944-8701-4ba2-82eb-0099a5f178a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_00d6634a-b9f3-4125-9d7c-5ac2c62746c6" xlink:to="loc_us-gaap_PlanNameDomain_1cd04944-8701-4ba2-82eb-0099a5f178a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_StockIncentivePlanMember_83f31d62-2caf-4310-8c4e-b4a8d6a8ed02" xlink:href="arvn-20230630.xsd#arvn_StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1cd04944-8701-4ba2-82eb-0099a5f178a9" xlink:to="loc_arvn_StockIncentivePlanMember_83f31d62-2caf-4310-8c4e-b4a8d6a8ed02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_938342c5-9e8c-4775-ac96-000c42628ec5" xlink:href="arvn-20230630.xsd#arvn_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1cd04944-8701-4ba2-82eb-0099a5f178a9" xlink:to="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_938342c5-9e8c-4775-ac96-000c42628ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9a5ba3a0-6a3c-4b9a-a6ad-887285c67a64" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_srt_RangeAxis_9a5ba3a0-6a3c-4b9a-a6ad-887285c67a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e64acacd-a142-4d32-b03a-1255d6f298d4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9a5ba3a0-6a3c-4b9a-a6ad-887285c67a64" xlink:to="loc_srt_RangeMember_e64acacd-a142-4d32-b03a-1255d6f298d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e1990a18-9cb6-4342-9da1-51dd29c11819" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e64acacd-a142-4d32-b03a-1255d6f298d4" xlink:to="loc_srt_MinimumMember_e1990a18-9cb6-4342-9da1-51dd29c11819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_971bc85e-cfa2-422a-ba12-3541e48948db" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e64acacd-a142-4d32-b03a-1255d6f298d4" xlink:to="loc_srt_MaximumMember_971bc85e-cfa2-422a-ba12-3541e48948db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_1b120e4b-36eb-4c40-b531-4a66f6adc780" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_GranteeStatusAxis_1b120e4b-36eb-4c40-b531-4a66f6adc780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_a04e777e-a27f-4487-8e86-f7a081069ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_1b120e4b-36eb-4c40-b531-4a66f6adc780" xlink:to="loc_us-gaap_GranteeStatusDomain_a04e777e-a27f-4487-8e86-f7a081069ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_678580f2-495f-4dcc-86a9-7990605f9521" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_a04e777e-a27f-4487-8e86-f7a081069ddf" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_678580f2-495f-4dcc-86a9-7990605f9521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b98553a0-aa12-4e0b-ab2f-6d5bb74db146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_AwardTypeAxis_b98553a0-aa12-4e0b-ab2f-6d5bb74db146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5b5eb1e-87d4-4fa5-8bdc-12938114a8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b98553a0-aa12-4e0b-ab2f-6d5bb74db146" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5b5eb1e-87d4-4fa5-8bdc-12938114a8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_3e320059-3bd0-458b-9e7e-a2464fc86f15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5b5eb1e-87d4-4fa5-8bdc-12938114a8b5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_3e320059-3bd0-458b-9e7e-a2464fc86f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e1bd808c-4290-4844-9f9c-0b932ab97bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b5b5eb1e-87d4-4fa5-8bdc-12938114a8b5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e1bd808c-4290-4844-9f9c-0b932ab97bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_80b147fc-dac4-4c09-b0ad-ded8e2036bba" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_srt_TitleOfIndividualAxis_80b147fc-dac4-4c09-b0ad-ded8e2036bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b7e30f5-ece9-44af-b96b-02fe1eb1c929" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_80b147fc-dac4-4c09-b0ad-ded8e2036bba" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b7e30f5-ece9-44af-b96b-02fe1eb1c929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_EmployeesMember_d78ad64c-eb62-460c-aa45-6ffbdab5be17" xlink:href="arvn-20230630.xsd#arvn_EmployeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b7e30f5-ece9-44af-b96b-02fe1eb1c929" xlink:to="loc_arvn_EmployeesMember_d78ad64c-eb62-460c-aa45-6ffbdab5be17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_87462b7b-e9ff-4afb-9020-3987f67f974f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_MaximumAggregateOfferingPriceOfCommonStock_65073744-95c5-4353-a449-174c5f1b3f75" xlink:href="arvn-20230630.xsd#arvn_MaximumAggregateOfferingPriceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_arvn_MaximumAggregateOfferingPriceOfCommonStock_65073744-95c5-4353-a449-174c5f1b3f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e454f59e-dc10-4352-95c6-b0c96f7201fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e454f59e-dc10-4352-95c6-b0c96f7201fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b8c3e126-465e-4e3d-ae45-b9f86f9f3a79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b8c3e126-465e-4e3d-ae45-b9f86f9f3a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock_36b175d9-037a-4cfc-9224-007eace040b1" xlink:href="arvn-20230630.xsd#arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock_36b175d9-037a-4cfc-9224-007eace040b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6605d7b5-cac3-4dbe-ac83-957111292f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6605d7b5-cac3-4dbe-ac83-957111292f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c53ca706-71a6-49d2-8b56-41a5f154c936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c53ca706-71a6-49d2-8b56-41a5f154c936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_449d858d-1770-436f-8a1e-d44d13615efb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_449d858d-1770-436f-8a1e-d44d13615efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8891fd70-6e99-4ece-89b0-55b2eb4be5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8891fd70-6e99-4ece-89b0-55b2eb4be5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_5025e563-0a66-476d-bb40-8033096d90d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_5025e563-0a66-476d-bb40-8033096d90d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_0aba78eb-beee-4284-9eb9-a80e640d91df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_0aba78eb-beee-4284-9eb9-a80e640d91df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_784c60dd-2a23-41cc-8467-699fe6515fca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_784c60dd-2a23-41cc-8467-699fe6515fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_5d35e1cf-7071-40a7-a7c8-12959808e0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_5d35e1cf-7071-40a7-a7c8-12959808e0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_260359f9-c1be-4883-8191-5e8cb88e2ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_260359f9-c1be-4883-8191-5e8cb88e2ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f6248e28-de86-450c-b7cc-a4086664f028" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f6248e28-de86-450c-b7cc-a4086664f028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2a11ea6b-4023-4874-be41-61f7918ba1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2a11ea6b-4023-4874-be41-61f7918ba1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_27e12453-ada2-4128-986c-2cbef900a550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad13f67c-a485-4091-b156-75c3a4d51c53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_27e12453-ada2-4128-986c-2cbef900a550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_969b55f8-28c4-4663-a93c-c30f1557a1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e5a6d47-5a5a-441f-a613-29d07339c865" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_969b55f8-28c4-4663-a93c-c30f1557a1dd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e5a6d47-5a5a-441f-a613-29d07339c865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_639ee70e-78ce-4291-9646-3118db2e4eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e5a6d47-5a5a-441f-a613-29d07339c865" xlink:to="loc_us-gaap_AwardTypeAxis_639ee70e-78ce-4291-9646-3118db2e4eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40abfeb9-1e31-4f16-8e05-9de740a4906b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_639ee70e-78ce-4291-9646-3118db2e4eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40abfeb9-1e31-4f16-8e05-9de740a4906b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_396b3daf-e663-4ddd-9d01-bee9b1b16b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40abfeb9-1e31-4f16-8e05-9de740a4906b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_396b3daf-e663-4ddd-9d01-bee9b1b16b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7131b0f1-fe7d-4907-92ce-9453c6b9125a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e5a6d47-5a5a-441f-a613-29d07339c865" xlink:to="loc_srt_RangeAxis_7131b0f1-fe7d-4907-92ce-9453c6b9125a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_795f2b22-c5d6-49a0-99e8-81bcdcee8ca9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7131b0f1-fe7d-4907-92ce-9453c6b9125a" xlink:to="loc_srt_RangeMember_795f2b22-c5d6-49a0-99e8-81bcdcee8ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_820f3bf8-2833-405b-a22f-cf7e1846e55e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_795f2b22-c5d6-49a0-99e8-81bcdcee8ca9" xlink:to="loc_srt_MinimumMember_820f3bf8-2833-405b-a22f-cf7e1846e55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e88da4d9-642c-413a-a155-927aa017eba2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_795f2b22-c5d6-49a0-99e8-81bcdcee8ca9" xlink:to="loc_srt_MaximumMember_e88da4d9-642c-413a-a155-927aa017eba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e5a6d47-5a5a-441f-a613-29d07339c865" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_cadc8d76-9450-4cd7-bd92-e673da576f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_cadc8d76-9450-4cd7-bd92-e673da576f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_342da05b-87c6-4a94-bb01-6c54c460eb66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_342da05b-87c6-4a94-bb01-6c54c460eb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_795db98c-1afe-4285-a688-797dd88fe44a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_795db98c-1afe-4285-a688-797dd88fe44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_82cbe0ec-13e5-4ce3-8b34-06fef28de0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_82cbe0ec-13e5-4ce3-8b34-06fef28de0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_fdf81b80-d03a-401e-b11f-100ea271c8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_fdf81b80-d03a-401e-b11f-100ea271c8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4a54471e-fd6e-42c8-b2e2-482e6ca590d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4a54471e-fd6e-42c8-b2e2-482e6ca590d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c435acea-d64b-4e13-8f98-ba4a9cf135cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_102cf94d-aa32-400c-b5a1-8399a4d97186" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c435acea-d64b-4e13-8f98-ba4a9cf135cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquitySummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0050d579-03e1-4b72-9034-5dd930aa2b60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e255df6-e773-4b47-b10b-4be513ac573c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0050d579-03e1-4b72-9034-5dd930aa2b60" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e255df6-e773-4b47-b10b-4be513ac573c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_90de6278-761f-4783-827b-ccdf46a2c31f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e255df6-e773-4b47-b10b-4be513ac573c" xlink:to="loc_us-gaap_PlanNameAxis_90de6278-761f-4783-827b-ccdf46a2c31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6e0fca1a-0223-4eeb-965b-8056baea9fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_90de6278-761f-4783-827b-ccdf46a2c31f" xlink:to="loc_us-gaap_PlanNameDomain_6e0fca1a-0223-4eeb-965b-8056baea9fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_ac98c4a2-baec-4ac4-9ab2-7b9811f3484c" xlink:href="arvn-20230630.xsd#arvn_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6e0fca1a-0223-4eeb-965b-8056baea9fcd" xlink:to="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_ac98c4a2-baec-4ac4-9ab2-7b9811f3484c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e255df6-e773-4b47-b10b-4be513ac573c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a6a4d032-d919-45b5-acc8-5006d8e94577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a6a4d032-d919-45b5-acc8-5006d8e94577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_67325836-5dc5-497e-bb02-0dbb9ad882d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_67325836-5dc5-497e-bb02-0dbb9ad882d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1f012efd-c0cf-499c-8d62-6c4d3b52d4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1f012efd-c0cf-499c-8d62-6c4d3b52d4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_392645fe-568e-4e16-86ee-10f689eba951" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_392645fe-568e-4e16-86ee-10f689eba951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_275b0a14-efdc-418d-a138-c2d6887f7ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a2c72b7d-5b30-4f74-9f22-43ffac25be7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_275b0a14-efdc-418d-a138-c2d6887f7ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_76263bd7-3f55-4f47-8c70-d9e09d1b3e64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_76263bd7-3f55-4f47-8c70-d9e09d1b3e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_d52b3178-fd76-4199-8bd8-01a6591e3bff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_d52b3178-fd76-4199-8bd8-01a6591e3bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0fa3675d-7274-46df-95e5-7669f7a85dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0fa3675d-7274-46df-95e5-7669f7a85dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ccc9ad1b-5cf6-4a8d-b89f-3c5f4ea395bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ccc9ad1b-5cf6-4a8d-b89f-3c5f4ea395bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_efd58e60-0afa-471b-80f5-bfeafa7ba117" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_efd58e60-0afa-471b-80f5-bfeafa7ba117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c1e347ea-a86b-44df-894f-257f1a1b6bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c1e347ea-a86b-44df-894f-257f1a1b6bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6c746847-bcdb-451c-b004-9db6afd3b0af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84907429-362b-40bc-87d8-9db9df0cb3ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6c746847-bcdb-451c-b004-9db6afd3b0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f6d38bc6-d7fc-4a64-a982-7c996ceda476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f6d38bc6-d7fc-4a64-a982-7c996ceda476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_4b021cda-fa4b-4329-b3cc-6233e4d230a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_4b021cda-fa4b-4329-b3cc-6233e4d230a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2f31eade-1a7d-456a-8564-c9a222a66f19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2f31eade-1a7d-456a-8564-c9a222a66f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_73ee8fd1-21cd-42b7-9085-1028400a55a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2f31eade-1a7d-456a-8564-c9a222a66f19" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_73ee8fd1-21cd-42b7-9085-1028400a55a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40d883ea-4e7b-4bf0-ab29-506fe01bcb40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2f31eade-1a7d-456a-8564-c9a222a66f19" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40d883ea-4e7b-4bf0-ab29-506fe01bcb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dc7ade0b-febd-40e3-898a-832cad68ff00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2f31eade-1a7d-456a-8564-c9a222a66f19" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dc7ade0b-febd-40e3-898a-832cad68ff00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_AggregateIntrinsicValueAbstract_75afe749-2b48-43cb-a38c-686d1f80922b" xlink:href="arvn-20230630.xsd#arvn_AggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cb155ec3-c702-428c-9cdb-2257ea4b7a5d" xlink:to="loc_arvn_AggregateIntrinsicValueAbstract_75afe749-2b48-43cb-a38c-686d1f80922b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8871326a-2c9a-4011-9a8b-4f6337fc1673" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_AggregateIntrinsicValueAbstract_75afe749-2b48-43cb-a38c-686d1f80922b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8871326a-2c9a-4011-9a8b-4f6337fc1673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_942fa402-14fb-4c2e-9770-9f077a92de42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_AggregateIntrinsicValueAbstract_75afe749-2b48-43cb-a38c-686d1f80922b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_942fa402-14fb-4c2e-9770-9f077a92de42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_e388ffac-16d6-4e89-be82-9eca5ae79ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_AggregateIntrinsicValueAbstract_75afe749-2b48-43cb-a38c-686d1f80922b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_e388ffac-16d6-4e89-be82-9eca5ae79ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquitySummaryofRestrictedStockDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_63cc14cd-e9d7-4f18-b651-852f6a285950" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c6fd8d-5af4-4c10-9a1a-0821cd148ede" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_63cc14cd-e9d7-4f18-b651-852f6a285950" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c6fd8d-5af4-4c10-9a1a-0821cd148ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3f9f0e5f-7db6-4923-bbfe-7bb56daed349" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c6fd8d-5af4-4c10-9a1a-0821cd148ede" xlink:to="loc_us-gaap_PlanNameAxis_3f9f0e5f-7db6-4923-bbfe-7bb56daed349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b6e603d7-8578-467d-bf25-5afe39aa18ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3f9f0e5f-7db6-4923-bbfe-7bb56daed349" xlink:to="loc_us-gaap_PlanNameDomain_b6e603d7-8578-467d-bf25-5afe39aa18ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_b7d7df44-2fc0-4925-9666-12ebc8e5eff3" xlink:href="arvn-20230630.xsd#arvn_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b6e603d7-8578-467d-bf25-5afe39aa18ed" xlink:to="loc_arvn_TwoThousandEighteenStockIncentivePlanMember_b7d7df44-2fc0-4925-9666-12ebc8e5eff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_244a3272-2037-4d78-831d-7ed6d1781b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c6fd8d-5af4-4c10-9a1a-0821cd148ede" xlink:to="loc_us-gaap_AwardTypeAxis_244a3272-2037-4d78-831d-7ed6d1781b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_350adb15-3dea-4cf8-9433-2709e4919d98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_244a3272-2037-4d78-831d-7ed6d1781b1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_350adb15-3dea-4cf8-9433-2709e4919d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bbdadbc6-2add-4033-b720-c3a1236926f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_350adb15-3dea-4cf8-9433-2709e4919d98" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bbdadbc6-2add-4033-b720-c3a1236926f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_c3b5cc81-8082-4eba-9cbd-2dd12b4bec90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c6fd8d-5af4-4c10-9a1a-0821cd148ede" xlink:to="loc_us-gaap_GranteeStatusAxis_c3b5cc81-8082-4eba-9cbd-2dd12b4bec90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_aab883b3-3231-419d-bf37-49f95d15fef4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_c3b5cc81-8082-4eba-9cbd-2dd12b4bec90" xlink:to="loc_us-gaap_GranteeStatusDomain_aab883b3-3231-419d-bf37-49f95d15fef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_d74a2416-150b-4e6a-be40-72b3417ca7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_aab883b3-3231-419d-bf37-49f95d15fef4" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_d74a2416-150b-4e6a-be40-72b3417ca7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0831000e-6fcd-41a0-9372-172b0cf6d335" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c6fd8d-5af4-4c10-9a1a-0821cd148ede" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0831000e-6fcd-41a0-9372-172b0cf6d335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0831000e-6fcd-41a0-9372-172b0cf6d335" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_91f7ccb9-4a66-44d5-a237-567737d8601e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_91f7ccb9-4a66-44d5-a237-567737d8601e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0ba4097e-b778-4759-852d-7130f87cb037" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0ba4097e-b778-4759-852d-7130f87cb037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_57dd3895-2d1b-441f-b8e6-d60bee42ed0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_57dd3895-2d1b-441f-b8e6-d60bee42ed0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_42eb0f97-e443-4895-9c05-2d15e1c6617e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_42eb0f97-e443-4895-9c05-2d15e1c6617e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9140e328-0b3e-45cd-9f68-202bfe150034" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e34b0743-573c-4e60-b8db-949a844947c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9140e328-0b3e-45cd-9f68-202bfe150034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0831000e-6fcd-41a0-9372-172b0cf6d335" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4db95704-7b2b-4967-a2d3-735bb0365ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4db95704-7b2b-4967-a2d3-735bb0365ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_59289163-b757-4886-9fd6-285c53284523" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_59289163-b757-4886-9fd6-285c53284523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f53dc957-8aaa-4555-8593-ee2c39308d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f53dc957-8aaa-4555-8593-ee2c39308d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_ac159267-5980-409e-8a5f-5e6181d9e726" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_ac159267-5980-409e-8a5f-5e6181d9e726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bd00ee30-4829-4946-9f4b-638471d9b443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63964458-a27c-487c-bb76-45cb3a7e74a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bd00ee30-4829-4946-9f4b-638471d9b443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8a97d79d-e8a0-41f0-bf3c-0227d16d7562" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_80f02ece-db39-48af-be15-bbdf5dbfca10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8a97d79d-e8a0-41f0-bf3c-0227d16d7562" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_80f02ece-db39-48af-be15-bbdf5dbfca10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5b30b0b7-6c8d-491b-9b84-0ce8dd589e49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8a97d79d-e8a0-41f0-bf3c-0227d16d7562" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5b30b0b7-6c8d-491b-9b84-0ce8dd589e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_39f9a941-5e78-4d8e-a5a5-59e8a33a06c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8a97d79d-e8a0-41f0-bf3c-0227d16d7562" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_39f9a941-5e78-4d8e-a5a5-59e8a33a06c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/NetLossPerShareBasicandDilutedLossperCommonShareDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#NetLossPerShareBasicandDilutedLossperCommonShareDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/NetLossPerShareBasicandDilutedLossperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_38b407ca-84fb-488d-97f9-fad5e17b26c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_55e42bcd-593f-43e5-8746-7ad61fa937a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38b407ca-84fb-488d-97f9-fad5e17b26c5" xlink:to="loc_us-gaap_NetIncomeLoss_55e42bcd-593f-43e5-8746-7ad61fa937a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c42eb162-77e3-46d8-a52b-2c1e23f03f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38b407ca-84fb-488d-97f9-fad5e17b26c5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c42eb162-77e3-46d8-a52b-2c1e23f03f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7c16ed67-7a4b-4e5a-9dbe-65e3b7abad6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38b407ca-84fb-488d-97f9-fad5e17b26c5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7c16ed67-7a4b-4e5a-9dbe-65e3b7abad6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2d547ff2-ba4d-466e-ad36-ad7545261ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38b407ca-84fb-488d-97f9-fad5e17b26c5" xlink:to="loc_us-gaap_EarningsPerShareBasic_2d547ff2-ba4d-466e-ad36-ad7545261ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6c05a8b5-87e1-48c1-8a99-8012df4b3125" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38b407ca-84fb-488d-97f9-fad5e17b26c5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6c05a8b5-87e1-48c1-8a99-8012df4b3125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9372796f-0cd6-4e96-a0cc-2e2c2ee0330c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4e3bf920-59e0-43bb-9083-d43fe5b0dee1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9372796f-0cd6-4e96-a0cc-2e2c2ee0330c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4e3bf920-59e0-43bb-9083-d43fe5b0dee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f432a448-de61-4286-b9ac-460f49d34d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4e3bf920-59e0-43bb-9083-d43fe5b0dee1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f432a448-de61-4286-b9ac-460f49d34d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d26cf91c-f171-4fd4-bd88-9eb04fffb228" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f432a448-de61-4286-b9ac-460f49d34d3f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d26cf91c-f171-4fd4-bd88-9eb04fffb228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_292f47ed-b592-4ea4-a15d-c8f88f1437b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d26cf91c-f171-4fd4-bd88-9eb04fffb228" xlink:to="loc_us-gaap_EmployeeStockOptionMember_292f47ed-b592-4ea4-a15d-c8f88f1437b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e080067a-309e-47ed-b861-203569f1ca64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d26cf91c-f171-4fd4-bd88-9eb04fffb228" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e080067a-309e-47ed-b861-203569f1ca64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0194aa4e-fd26-4584-b5dd-97a624fe6c17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4e3bf920-59e0-43bb-9083-d43fe5b0dee1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0194aa4e-fd26-4584-b5dd-97a624fe6c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ce0fe2b7-b3a5-40d2-8553-d93e1711e937" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0194aa4e-fd26-4584-b5dd-97a624fe6c17" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ce0fe2b7-b3a5-40d2-8553-d93e1711e937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquityMethodInvestmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_535941d7-c67d-4639-87a7-b170a2655e62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ab5db015-7abb-4df4-aac5-52c2106c2316" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_535941d7-c67d-4639-87a7-b170a2655e62" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ab5db015-7abb-4df4-aac5-52c2106c2316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_984fad32-fc38-4b33-9476-d4e893356535" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ab5db015-7abb-4df4-aac5-52c2106c2316" xlink:to="loc_srt_CounterpartyNameAxis_984fad32-fc38-4b33-9476-d4e893356535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_44421421-b442-4c22-906a-2660d8942db0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_984fad32-fc38-4b33-9476-d4e893356535" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_44421421-b442-4c22-906a-2660d8942db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_BayerCropScienceLPMember_f90e3275-eb41-461a-98ee-76c5bbff531e" xlink:href="arvn-20230630.xsd#arvn_BayerCropScienceLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_44421421-b442-4c22-906a-2660d8942db0" xlink:to="loc_arvn_BayerCropScienceLPMember_f90e3275-eb41-461a-98ee-76c5bbff531e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_609ba1cd-b788-4ec2-a015-0c3e708d9b6a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ab5db015-7abb-4df4-aac5-52c2106c2316" xlink:to="loc_dei_LegalEntityAxis_609ba1cd-b788-4ec2-a015-0c3e708d9b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5bfdb294-cfa5-4f94-9cfd-ccf338f2655c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_609ba1cd-b788-4ec2-a015-0c3e708d9b6a" xlink:to="loc_dei_EntityDomain_5bfdb294-cfa5-4f94-9cfd-ccf338f2655c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_OerthBioLimitedLiabilityCorporationMember_6bfe2537-931e-464a-912d-170382146a34" xlink:href="arvn-20230630.xsd#arvn_OerthBioLimitedLiabilityCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5bfdb294-cfa5-4f94-9cfd-ccf338f2655c" xlink:to="loc_arvn_OerthBioLimitedLiabilityCorporationMember_6bfe2537-931e-464a-912d-170382146a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3430805d-4aa0-4925-9436-b874259e4e96" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ab5db015-7abb-4df4-aac5-52c2106c2316" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3430805d-4aa0-4925-9436-b874259e4e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3f77d7cb-0c44-4fd3-bc46-b8bff3a543eb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3430805d-4aa0-4925-9436-b874259e4e96" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3f77d7cb-0c44-4fd3-bc46-b8bff3a543eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_OerthBioLimitedLiabilityCorporationMember_2da4da0c-de08-47e9-bd47-4d73d11e8d67" xlink:href="arvn-20230630.xsd#arvn_OerthBioLimitedLiabilityCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3f77d7cb-0c44-4fd3-bc46-b8bff3a543eb" xlink:to="loc_arvn_OerthBioLimitedLiabilityCorporationMember_2da4da0c-de08-47e9-bd47-4d73d11e8d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_ab5db015-7abb-4df4-aac5-52c2106c2316" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_573854c0-71c6-4eac-a1b4-379587b146ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_573854c0-71c6-4eac-a1b4-379587b146ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage_e37e1806-c254-441d-b703-d89ef5d5a0b3" xlink:href="arvn-20230630.xsd#arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage_e37e1806-c254-441d-b703-d89ef5d5a0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_222a790f-d9c5-47eb-b273-5d0a5fd62c39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_us-gaap_ContractWithCustomerLiability_222a790f-d9c5-47eb-b273-5d0a5fd62c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1b6caecd-5e3e-46a7-9475-79ca6f277aad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_us-gaap_NetIncomeLoss_1b6caecd-5e3e-46a7-9475-79ca6f277aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e9e7f591-ec8a-4252-aeae-370588e18e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e9e7f591-ec8a-4252-aeae-370588e18e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_4aba30d5-b75f-421a-a19e-58f6b46b4c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_00cc0616-caa4-4c6b-8d8b-5182ad40c819" xlink:to="loc_us-gaap_EquityMethodInvestments_4aba30d5-b75f-421a-a19e-58f6b46b4c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f1606d9b-9850-46ef-be4d-b6d6c9b76c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_88adcf7d-636b-4e3d-bc47-ce7a29c42920" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f1606d9b-9850-46ef-be4d-b6d6c9b76c9f" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_88adcf7d-636b-4e3d-bc47-ce7a29c42920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_475ef39e-1037-418b-a1ab-a93ea1d332ed" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_88adcf7d-636b-4e3d-bc47-ce7a29c42920" xlink:to="loc_srt_RestatementAxis_475ef39e-1037-418b-a1ab-a93ea1d332ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c23a9213-5a84-4f3e-9bb3-75a1d4a5ceec" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_475ef39e-1037-418b-a1ab-a93ea1d332ed" xlink:to="loc_srt_RestatementDomain_c23a9213-5a84-4f3e-9bb3-75a1d4a5ceec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_8eee4838-d2c7-4f22-803f-95aae1d6346b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_c23a9213-5a84-4f3e-9bb3-75a1d4a5ceec" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_8eee4838-d2c7-4f22-803f-95aae1d6346b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_9ba42456-5fc2-4bc3-9d3a-72ce4a1a3499" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_c23a9213-5a84-4f3e-9bb3-75a1d4a5ceec" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_9ba42456-5fc2-4bc3-9d3a-72ce4a1a3499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_88adcf7d-636b-4e3d-bc47-ce7a29c42920" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9f9f4da8-ac48-4002-acf0-2bec2e541b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_Revenues_9f9f4da8-ac48-4002-acf0-2bec2e541b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e5fbdd8e-da3e-451a-89a2-1e5808ee457e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_OperatingIncomeLoss_e5fbdd8e-da3e-451a-89a2-1e5808ee457e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_950a0611-b4d7-45b9-bfec-381e0607ee54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_950a0611-b4d7-45b9-bfec-381e0607ee54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5d4c3447-8a11-421b-955c-e5b101138ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_NetIncomeLoss_5d4c3447-8a11-421b-955c-e5b101138ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_12f658b8-bff5-449f-be90-56bcb32d64b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_EarningsPerShareBasic_12f658b8-bff5-449f-be90-56bcb32d64b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_74c409a7-9598-4c79-996b-e883060a73d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_EarningsPerShareDiluted_74c409a7-9598-4c79-996b-e883060a73d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9fde82c6-c136-424b-9bec-f84592f21cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_65c752bb-b1e1-45dd-86ab-f9bf9c758b42" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_9fde82c6-c136-424b-9bec-f84592f21cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.arvinas.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="arvn-20230630.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.arvinas.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1336e0ec-3a97-4360-a6dd-5ce5d285bd57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CommitmentsAndContingenciesTable_3b3e663c-6c0b-440c-a958-ca8acb4f5b91" xlink:href="arvn-20230630.xsd#arvn_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1336e0ec-3a97-4360-a6dd-5ce5d285bd57" xlink:to="loc_arvn_CommitmentsAndContingenciesTable_3b3e663c-6c0b-440c-a958-ca8acb4f5b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_aeac2f1f-d31f-4366-8af7-34d873c75421" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_CommitmentsAndContingenciesTable_3b3e663c-6c0b-440c-a958-ca8acb4f5b91" xlink:to="loc_srt_CounterpartyNameAxis_aeac2f1f-d31f-4366-8af7-34d873c75421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_002c889d-653c-47a4-8e94-89b23b23dbca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_aeac2f1f-d31f-4366-8af7-34d873c75421" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_002c889d-653c-47a4-8e94-89b23b23dbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_FoundationMedicineIncMember_492e5e79-414a-4ca3-b353-d32a70e79146" xlink:href="arvn-20230630.xsd#arvn_FoundationMedicineIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_002c889d-653c-47a4-8e94-89b23b23dbca" xlink:to="loc_arvn_FoundationMedicineIncMember_492e5e79-414a-4ca3-b353-d32a70e79146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1fffa5d1-f48a-4398-9e7c-69429cc1aa6c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_CommitmentsAndContingenciesTable_3b3e663c-6c0b-440c-a958-ca8acb4f5b91" xlink:to="loc_srt_RangeAxis_1fffa5d1-f48a-4398-9e7c-69429cc1aa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2856e453-30eb-41e6-8db9-c6633b6e6399" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1fffa5d1-f48a-4398-9e7c-69429cc1aa6c" xlink:to="loc_srt_RangeMember_2856e453-30eb-41e6-8db9-c6633b6e6399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e998c966-dc1d-4d97-98e4-4c8d494f28b8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2856e453-30eb-41e6-8db9-c6633b6e6399" xlink:to="loc_srt_MaximumMember_e998c966-dc1d-4d97-98e4-4c8d494f28b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e51f7296-35dc-4d9c-a3d4-876b293978af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_CommitmentsAndContingenciesTable_3b3e663c-6c0b-440c-a958-ca8acb4f5b91" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e51f7296-35dc-4d9c-a3d4-876b293978af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a833e86e-a3db-4f92-8a09-cae544158b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e51f7296-35dc-4d9c-a3d4-876b293978af" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a833e86e-a3db-4f92-8a09-cae544158b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_SuccessBasedMilestonePaymentsMember_4c21e4c2-34ce-48be-8b52-7aebe8604e2f" xlink:href="arvn-20230630.xsd#arvn_SuccessBasedMilestonePaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a833e86e-a3db-4f92-8a09-cae544158b7c" xlink:to="loc_arvn_SuccessBasedMilestonePaymentsMember_4c21e4c2-34ce-48be-8b52-7aebe8604e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_arvn_CommitmentsAndContingenciesLineItems_ffbe0589-ebdf-4a33-8de6-19b628e208c8" xlink:href="arvn-20230630.xsd#arvn_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_CommitmentsAndContingenciesTable_3b3e663c-6c0b-440c-a958-ca8acb4f5b91" xlink:to="loc_arvn_CommitmentsAndContingenciesLineItems_ffbe0589-ebdf-4a33-8de6-19b628e208c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_25c849fe-e7cd-4723-87a9-71a45580e159" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_CommitmentsAndContingenciesLineItems_ffbe0589-ebdf-4a33-8de6-19b628e208c8" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_25c849fe-e7cd-4723-87a9-71a45580e159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_6282f2ec-a95f-4708-a903-0cdf7be90905" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_arvn_CommitmentsAndContingenciesLineItems_ffbe0589-ebdf-4a33-8de6-19b628e208c8" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_6282f2ec-a95f-4708-a903-0cdf7be90905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>arvinassixthleaseamendme001.jpg
<TEXT>
begin 644 arvinassixthleaseamendme001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!"(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN(VDADBWG[5_=V$G'(R>?[I'6MU-9\5MIFK:C%8Z?=0QAQID4(<277("NW)
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MVR""ZELHHY5F6%RNXK\YSM#^@Z5SWQ%<+^SC8C(^>SL /?\ U9_I6MX.L/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1X,@UR"?P[%<W+RQV]E):3#S63<=H?SNI",?N]JH>!I%C_9GNG+ ;=/U#O\
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M^/)-8\%:?XA\,/9M]HNX+6:*[1F,322+&5.UA@J7!]QTZBK;ZA8>(-8\-7
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M:BPU*PU2V^TZ?>V]W!N*^9;RK(N1U&0<9H I/X5T!YK&9M'LO,L%"VC"$ P
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MUO8HCE$N(@ZJ<8R :XCQ'X@\8Z9X&\1:E*;:SU+2;L"%HH"8;F#;&=P#Y/\
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M_:I0PPX! $:M[J@5?J#7 ^)M1TY_$GC*V6ZM-,F33(X;N:\.^2Y!C=D2%&(
M W<G!R3C'>O5JJOIEA+?+?26-L]XJ[%N&B4R!?0-C..3Q0!Y'8KI6I_\*C6<
MVEV?LSQR!RK\K:?=/T;'![U'K;O8VWQ2BT=0B1SV3216W&V,QIYQ '0E=^?Q
MKUI=!T=#"4TFP4P8$)%L@\O!S\O''))X[U+;Z5IUI/)/;6%K#-("'DCA56;)
MR<D#)YH X#5=9\-W/CCP#<:??Z<R;KE8C%(@VQM 0J\= 3@ >O%:7Q-CM9;/
MPVE]'%):-K]JLJR@%"I#CYL\8Y[UU$&A:1:E#;Z58PE)#*ICMT7:YZL,#@G
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M 'M3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M".>>2.:(W# ++9^6%7;G@J#NS[DYZT =I<:OIEH]LESJ-I"UU_Q[B295,O\
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M&(,#R"$*\'IT[5C^(8/"7C'6]1\/Z_'!!?Z=Y;6USYXCFVN@;<C<8PV01R.
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M/@!;R:5- U*!C_PB<CVRS.H"S,1B%U]Q"3G_ 'Q5GXT7$,'PKU=)940R^2B
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MFDCO;V<3.O&-H^48P1]TCKG-4?AW<ZE-;>(8=3U*;4);36I[=)I@ =BJF!@
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MW;VD#7*#"S-&"X^C8S3+K2]/OI%DN[&UN'485IH5<@>Q(KRRZEU.3X^'P_\
MVWJD>E3V1N_L\=TP"M@\ YR!D9Q_2K_A/Q+JZ_%G6_")OWU;2+2 3)<RA3)
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MF7/4=1P<\8TZ /,?$1&J_$N>SLW837/A>YM(IMC!/-D960;\8SC)K/\ "/\
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M0@OQ;1&22#Y F[:.2ORHV1GH1Z9]"M_%-GJ-Y#;:9#=7A=OWLBP.D<*XZL[
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MBPZPM_$]A.0(98\MYC$X"J!RS9R-H&<CI3+/Q1HM_875[#?QK#:,5N?.!B:
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MC9WUU9:I%<16(S<^6K,T8]2H&['N!CK5AO$^C)#I4S7H\G565;*38VV8L,J
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M1_8HL9*N[ #)8 8!]3T'(!>\,ZGIMGX.CO&\2MJUFDCC^T;AN7)D("^^"=H
MZ\8[5;B\8^'Y=/O;[^THXX+$@77G(T3PYZ;D8!AGMQS7DEE(K?"W2;V$7-Q:
M:=XAENM0CL9&6:.$O+AQM(;C<C?3GI6Y<W7A"Y\,>+-9T.6\NFGT:6WFU*ZG
MF979D(CA'FGYFSV XR!WH [^R\9^'-1U2#3;/5K>:[N(_,A1<XD&,G:V,$@<
MD9R/2EO?&&@Z=>-:W6H"-TD$4DGEN8HW.,*\@&Q&.1PQ!Y%<%<ZCIJ6WPLVW
M5NH1XR<.!M7[.R'/H-_R_7BH="US1]-TG5/!GBK3IKG5!?SR"S:U>0Z@'E,B
M.I P<DCDD8QS0!Z/JOBG1=$E,>H7HB95#N%C=_*4]&?:#L7@\M@<&M6*6.>)
M)8G62-U#(ZG(8'D$'N*\@O;K1M+\:^([/QE+JEBFJ.DMJ\-Q.(+F(PJC18BZ
ME2".G.?I7IWARUMK+PY86UG9S65K'"!%;3L2\:=@V23G';/'2@#)^(]U?Z?X
M"U74=-OYK*[LXC-')&JG./X2&!X-86H:KK/A35O"C?VQ/JEIK-S'9SVUVD>]
M"R@^9&R*I '<'(Y[5H?%R^MK+X8:V+B=(VGA\F(,<%W)&% [GJ?P-7O#&A>'
M9K+2]<LHDNYA;*(+N2=YV0%0#M+L=OH<8]* +LOC#08+\V4FH*LHG%LS^6YB
M68_\LS)C8'Y'RDYJ._\ '/A?2[NXM+W6[2"XMB@EC9^5+' 'U_EWKR/7]9LK
M_P +:\AEEL)H-9$DNDVML=L6+E=TT[;226 +9R%S@ $BNUTJ_P!'U/XR:N!-
M:SM-I%LL:O@EL,SLN#SD#82.HXH N>'M?;3;SQD^NZP[V.FZ@JI-<X B1HT(
M7Y0.,M@<5VUK<Q7EK%<P,6AE4,C%2,@]#@\UX>VK16WBSQ+XDAN8M1TC3M81
M[ZP ##88T07"?WF1P>#D<$C!YKU0^./#O]H:39)J222:LI:S:-2R28[;@, Y
MXP><\4 =#7(?$R^UC2O FHZEHNHK97-JGF%S )"RY P,\+UZX-=?7$_%N\MK
M3X8ZT+B>.(S1"*,.P!=R1A1ZG@\>QH TO%FH:E8Z1:R:<7,C29G6!H_M!B",
M6,2R JS X.".@;'.*R?#&J76J>-[F4:Q-<Z?)HME<PPM$(U8N9,N%QE<[<]_
MO8SP .HDM-'\1Z7;M/;V>I63@2Q&1%E0\8##.1T)Y]S5A=,L$O4O4LK9;M(A
M LXB4.L8.0@;&0N>W2@"U7G^G-J=UXX\5Z?=^)M0BL-.6VE@V^2OEB1&9@28
M^0"O'M7H%>4Z3;^%_%WQ0\:07L-AJ*O#:1P>8%?<%C82&,^QP"1T- &CKTNN
MZ/I6@2?\)#-<B;Q!;Q+,BH#<6LL@PLF%'('&5P#78:KXDTC1)5BU"\6*5D,G
MEJC.P0<%B%!(7W/%<A\2KG3]$T7PM;SW4<,<6M6.WS7 /EQL-S'V ZFGZ=JE
MMH'Q*\4#7;J&T348[:>PN;APD<L21E616/&5;)QU^;- '8S:YI=OI*:K)?P?
M8'"E)U?<K[N%VX^\2>@'6H+7Q3H=Y8W=Y%J4(AL_^/DRYC,'?YU;!7\1S7E>
MGVUQH-AX9UBYAEA\.P:]>W!CD4C[/!+O6"1E_A49)SVW@UT-S/8W/CW6=?LK
MJ%M*A\/-;WEXD@\EIC)N0;NA8*#GT# =Z .RTKQ7H.N77V72]5MKN?R!<&.)
M\D1DX#'T[>_(]:V*\Y\"ZWX?T#X0:3KES+;QV]I9I%<3Q)O9&+<J=H)SN;D>
MIS7?V5Y;ZA8V][:2K+;7$:RQ2+T96&0?R- &!X[FU>S\+7-]H=ZUO?V^TQ1^
M6CI,Q8*$;<#C.>H(ZTWPQXBE\4Z)<V\_F:5KEH?L]] H4O;2XX90P(*GJIY!
M'KBCX@ZE::7X/N9[RYB@3S80ID8#<?,4X'J< G\#57Q5I=Q!/%XR\.A9=2M(
M?WT*-\NH6W4QDC^(=4;UXZ&@"?POK,EKX"TK5?$.K&:>[A25I9(U4EG7(1%1
M1GV !)YJZ_C3P['HLFKOJD2V$4ODRRE6_=/_ '7&,J?J!U'K7GFKSI9>%_AQ
MK5X;Z/1;6S47D]D[JUN9+=520[>< [@?][WQ70Z#HOA3Q'I?B*/21>75GJT:
MQ75_/+(ZSOM890N>2F1R!C.!DX. #K6\0Z3'J5GISWT27EZGF6T+9#2KC.1^
M JS:ZE9WMS=6]M<))-:.(YT7K&Q&0#^&#7D4L^OW'A+3/%,]M<1W_@^4PO$0
M,WJH?+N6'?!0#!XY#\=*]3\/V\L6E)-<QF.[NV-U.IZJ[\[3Z[1A/HHH M:D
MEQ)IEREK.T%P8F\J5 I*MC@X8$=?45RGPWO]6\2?#FSU+5-4GDOKY9,S)'$A
MBP[*-@"8Z 'D'FNKU&]MM.TZXO+N>."WA0L\LK!54>Y->8?"K2?#%U\+]/OK
MDP[XDD-W(;ME$1#M][# +Q@]N* -SP#K=VO@RZUOQ-KS7"K=31&6>..-(ECD
M:,8V*,EL#KGD@#WZ.+Q;H<UI?7*WP5+ !KM9(G1X0>A9& 8 ^N,<&O)=$US2
MK3X,[(8[6[@@UHQ.TI+I:*UR62=U!#%0,$<C/YUT?A2_L+CXJZHHU2?4?MVD
MP&.:XA"K< ,^XH JJ4 QR,CD\F@#NO\ A*-%.A1ZV-0C;39&"I<*"58EMH P
M,\MQ]:;J/BO0M)NOLU]J44,@*A\@E8RW3>P&$SD8W$5POA.QO8]>;P5<6\HT
MWP[>F^AN"?EEA;+6\?N59F/_ &R%9/VCP]:ZSXHT+QC<ZM;SWFHS3Q6R2S>7
M?02$;-BIPQP N/8#UP >GWWB[P_IM[-9WFKVL-U#$)GA9_G"$@ XZG.1@=3F
MKVE:K8:WIT6H:9=1W5I*"4EC.0<'!^A!XQ7G]C<:9:_%[3+4-';M;>&?)6":
M4-)"PD5@C')^8("3SG&3TYJ#P9XR\/>'O#.KWM_J4,5H_B&ZC1HP7 \R1F0X
M4'"E02#TP* /4Z*0$,H8$$'D$=Z6@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJIJFHP:1I
M-YJ5T2(+2%YY,==J@D_RKD_"NFW'B70K7Q%K5_?_ &K4(Q<106UY+!%;1MRB
MJJ, QVXR6R2<]N* .WP,YQS1CG-<KID]SX3TB\_X2/4YKP&_9+.5AYDTR/CR
MT"J,ELY& .Q/2KMIXNTF[BOSON(9M/3S+JVFMG6:-<9#>7C<P(Z%0: *_A[P
M[J.DZ]KFIWVHVUT-4E27RXK8Q^444(!DNV1M _&NEQGK7*VGQ%\-7TNFK;W<
M[Q:BPCMK@VLHA:0]$WE=H<X/RYS3KOX@^'[.ZU*T::[ENM.(%S!#93.Z @G=
M@+RN!G=]WISR* .HQQBC QC%8\GBC2ETVROX9I+F*_3?:);1-)),,;LJH&>!
MUSC'?%10>,=$N-&EU5;ME@AF^SRH\3+*DV0OE&/&[?D@;<9.1B@#=HKE9_'V
MF1:?K$R6]\UYI4/G7%BUN4F"D$AL'C:0.N>*RKKQ'IFM>%O#.H:U=ZGI,ES=
M6LD?V:.2,2SE00A.#F(E^YYQUXH [_ /445B:OXJTW1IY8)A<SRP0_:)TM8&
ME,,7/SOCH.#[G!P#BD@\7:/<W^E6D%P\C:M"TUE(L3>7*JKN;YL8! ['F@#<
MHKD=:\?V&GZ#KU_:6]U<W&CDQ30>0R[9-NY2<X^3H2P[&M_1M1.JZ3;WA@FA
M:1 626,H<XYX/;TH O8'H*7 ]*\OAU#4-:\"ZSXW@O[J.[B>XN-.C6=A"D,#
M, C1@[6WA&W$@GYN",#%[6O'BW4^AZ7IE\EA+J=DNHSW3IO:WMB 1L7!W2,3
M@9! P3@T >A45R4U^NG^ ;O4/#4UYKDK(S0.LQNI'D/RY&3_  GDJ,#@C K.
M^'?]EW4]U=6?B;Q#J5W"@AN;+6)B&MV)SDQ%1M/& >1U /6@#OJJ:I8_VGI-
MY8>?+;_:87B\Z$X=-P(RI]1FN5LY=2@^+]Y8S:K<7%A)HXNH[9PH2%C-MP
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MCW"C&:[1+WROBY'?M9WYM=1T2&&"06<F-_G.Q#_+\F 03NQBN_HH \62QO\
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MPZX/?MF@#L=4UFPT:*)[V5E,S[(HXXFEDE;&<*B LQP">!5)?&&@MHMSJ_\
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MR2WT/*P*\114+?WBS [>H"GBN<2>"Z^"LO@V6W;_ (2**+[%_9I'[TS!_ED
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MU1^)(% '3(ZR(KHP9& *L#P15/5-7L=%MDN+^?RDDD6*,*C.TCMT554$LQ]
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M9KN>,R0HH;$B@9.UL;6('4 Y'>L;X@^*+2Q\,:Y;VNJ75KJ-M:NZS6L+L(I
MNY$>0*50MP,$@X(QC(H [>BJ&AO))H&FO,[22M:Q%W8Y+-M&2:Y?QI!KNGZ#
MXCUR#Q%=VQMK=IK*WMXXO+0(@/S;D)8E@V>>A% ';T5R>A6&L+%HVJR>([JZ
MMI+8/>P72Q;&W1Y#(50$$-CJ<8)K1LO%VAZAJ"6-O?9N)4,D(>)T6=1U,;,
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MVY['/'L:YOPK>>$-:N=%$=KK,VN:>06MKRXNB-.95P[-O;8%&,#UX&/3UD
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M%::*Y1@ZJMTS,6R.RD%O3/-=5KDIO_B5KUGIES&+^?PLUM 5;'[_ 'NP7/\
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M#\Q5@/7'%<K=S+J6G>-7TL27J6WB2"^FMK.0K++ GE[RFT@]5)!'=<BO<J*
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MOE% $5O.MS;17"*ZK*@<"1"K $9Y!Y!]C4M%% !1110 4444 %%%% !1110
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M1D #OC.*\TURQ\/C7M,UOP'?00>(I;R)9K&RDP+B)F'F>="/N #))(&._.,
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MYMK6[:TGEC9$N$7<T1(QN /<5Y_?:7);?$K1-&37-;^Q7.GW$LL9U&7+NA4
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M,,Z=R0,CIUSCFJ/A7X@6>A_"OP[K'BJ^N7:\+Q-=-&TI+[WQN(!/0?I0!Z8
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M#?EC\O3#I]?P-?3=% 'DOBBWOK?X\>&/$$>F7]UIW]G-!YMM 7PY\[ /9?\
M6+RV!^1KUJBB@#B/B;$U[INAZ;#DW-WK-J(P.H",79OH%4DUN:9XGM=4U_4]
M&2UO8+FPP6:XAV),IR-T9S\PR.O%6ET>$ZX^K3RR3W 3RK=7QLMT.-P0>K$9
M).3T'05-;Z;;6U]<WJ!VN;C >21RQ"CHJY^ZHY.!QDD]30!S/Q%O+JRTK37@
MM9)(#J,0N;B&U^T2VD?)\V-,-\P. &P<9Z5Q]HMI#JGCA+OP_KU[I^HVUDPC
MG@F>2XB *.P8Y(8;LA>#\O &./8:* //? R7MKXDO+.VU*^U70$M%:&YU"!E
MFMY=^/)\QE!<;>2#]WCIWL_%N=T^'U[;P6]S<7$\D(CCMX'D)VRHQSM!QPIZ
MXKN:* . \67\']M>#/$R0W5QIEK<7'G206SR-&)(6124 W8W<=.*YO4);J:W
M^*,TFE:G#_:-O$MH)+-_WO\ H^P 8!&<D<=1GG&#CV.B@#SKQ6DE_P#!RU-E
M:W$IC6R<PI WF 1RQE_DQNX"GC':GW6I1W_Q2\+W<=K?1P_V?= M-:2(%+E=
M@;(^4G83@X/3/6O0J* /$IK6[U70_$\MCIEU=FW\4C4S9M$\3W5NH0'9D DG
M:Q&.>/7%='ID^@7-KJ>JZ3X9U"T*Z=)%+>WEO*LN3C$*JV6?G)..!@=<\>E4
M4 <K\-6Q\.M#A,4L4L%JD,L<L31LKJ,,"& /7O5#QS(1XI\&8M[F58M1:61X
MK=Y%C7RV4%BH('S,.O\ 2NYHH \_TJX2V^(?CJYG@N4@>WM2DK6S[9/+C97V
MG'S8+#@9SVKF/#L5[IV@_#S6Y+.\>TTE+BUU"$6[^9 95VB39C<0"!D@'@U[
M/10!Y1XCT&_\67OBW4=%AECBN=$CL(7=#']KE#L[;0V.-N$R>.>O!J74O$RZ
MW-X.D@T;64DL]41KR)M.E_T8^3(I!.WG!8<KGCTKU*B@#@-!N4M?B9XWO)H+
MM('BM-DIM)=LGE(P?:=OS8)' SGMFL71KEH_@;K5C+9W\5Z(;Z+[.]G*LA:9
MY3& I7)R'7GMWQ7K-% 'D&IPBTD\(Z]?:/?ZAHZ:0+&Y6VCD$MK)\A#E!AL9
M4J?_ -69]1LE@TO2M>T#PS=V^G66M+>SVJQ,+BYC\LHTWEGYL@L< \D#/%>L
M44 >?Z7K$>J_%9+ZUL=2%E/H@BCNI;&6.,L)F;!+*,<9ZXSVZC._X\L[G4/
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M]+7TS&QE,5TL=G,S0$=2X"Y"C^\>/>M:]\1:=96]I*9)+@WB[K:*UB:629<
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M>2^7"I"YP6))( 4 <DDD  <DFLRS\7Z->)?DW$EJ^GQ^;=17D+P/%'@G>5<
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M5M %N)/+8(9/.+[=V,9VD'K0!N>"_$X\6^'+?5/LLUNTH+%7B95P2<;2>&X
MR1QFGZKXRT;1[JZM[F6=WLXUENS!;22BV1LX:0J#M& 3ZX&>E8WPFN0WP_TV
MP>"ZAN;&+R9UGMWCVODY + ;L=\9ZUSGBB\:[UKQEID]IJ%O,]D%M8-.M'W:
MA^Y.)))57D*3M"E@,<$'.* .\OO&GA_3KVUL[F_(GNX/M%NJ0R/YR8S\A52&
M/L,GVJ33_%VB:EHEQJ\-YLL[9VCN#-&T;1.N,HRL 0W(XQDY%<#HM]!<>(OA
MSY<=R%MM(F@E:2UD01N8XU4$E1C)1L>N/<5FW N[JU\276GVMS<BU\50:H]L
MD+![FW01YV @;N5)X_N_2@#J8-:.H_%O38[>XU6&!M+GDFL;J.2%,AT"N$8
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MX[+W..@R1SGD:9XR\ :[X:T.UU)"\!D:ZOK9H?/N&8ODE@"S%ER2!@ CIP*
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MK:*\Y/QJ\+_V.^IK;ZN\,,ODW*K9'-L2<#S#G:,GI@D^U=-J_C'2])M],?\
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ML\[RLS9/]XG'T% ':45A:IXH@T[5TTF"QO-0U%K8W9M[0)N6(-MW$NRCD\
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MAJL=Q;Q&W.YT+JV?P"'/U'K6]XL\,ZY+IWP_U^TT>ZO3H]O%'>Z<N5F VIG
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M'7B;9H>H7D>L6UN;:>W0&(,D;(P=B0$ZC\*Y[2[?4[/2_AO#=:'JL<FF2O\
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MW*?E4COTKTFB@#RWQ3;:CJ=QX?\ %-[X2.JV< N8KG27@62>.*1AY<@C;@N
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MS7KE% &;X?:5O#NG>?;36THMT5X9@ Z$* 0<$^E:5%% !1110 4444 %%%%
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M-3VOC/3KC5K73IK:^LY;U&DLFNH-BW2J,G9R3D @[6 /M575K";Q/\+;G3[
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MST (Z]/0G!QJ_$&YU&VMM)-I:7<UFU\HO9+&#SKB&/:V#& "02>"PY /')H
MNQ^-])_LS5+RX6YM&TJ01WEO/'^]C9L;1@$@[MPP02#GK5W2O$$>J7]U8/8W
MMC=VT<<KPW2*"4<L%(*LP(RC=#7G%E:BVN/&T-UX0UJYT[4'LW6WF5Y'FBPB
M.P?+%G&6?&=PV\[3TZ'P);7UEK>HVUO>:K>>'E@C-M)JL#I-%+N;=$ID569
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M3KZ()JEP+(L S]2#&@5L81CM'J.M79+2_B^-GB?5VTC4WL)-&>WAG2RD99)
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MY,L^GNC1RLN]N0."3TQCG#<4 >IM\0-)BTO5[RX@O8)-'*B_M)(U\Z ,,JQ
M8@@CG*DU5T_XI^&M1U'2;.$WR?VL#]DGFM'CBD8<%0QZG/'&1DCFN8U2SAO_
M  )XHO\ 2O!VKV=YJ-HL)^TI(]W<R$XQL)9MJ\?,>O/85@2Z9J1_X5.JZ)JW
M_$JPU\?L$N(/G0'=\O'*,?I@]"* .Y3XB37'Q9F\*PZ9>FUM+8^>Z0Y)E9H]
MKGTC"D\]]W3I4/\ PAFM+X5FT^'5]?2X75#/8S/?HTL:8"@S-T:/=N?8,G!
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MH02<AE(4?=S_ (]WIRW:Z? +]H3=[<R^2"$#'LN><#ID]<59HH XG3[+6_\
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MOB*WTR22ZLM._LW4-.\^,2;"%^9&W;"0RYP6&01T-0ZUX;UG4-,\::BFF/\
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M;K=V4]LQ(6:-HR1V!&*XCP7;W%Q\)FT0HJZA9P7&F2QYQME3<@S]1M;/HP-
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MHS6[W0B1E15C4A22S$#))  'Z5#X5,\R7%RWAR+0K=PJQ0%4$SD9RS[#@#D
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MA+2('8$QX)!^[LW'(SDY]JJ^-]'76-6F,^@:G]HM[=3IFL:4X699#NRA.X$
M''4;>3TI%L?$EEXG\)ZI>:=+J,Z:2]E?26[Q@1S,8R6;<1\ORMR,].!TH ]$
MKS74M:U*R\>:7XC:Y_XIRXN'T0PXX5B>)SVYE4IG^Z <_-77^++W4[+P]<-H
M]C/=W\O[J(0[<QEN/,.XCA>N.YP.^:YOQ)X!TN7X?7FG6%KJ<CI;9M(!>RNR
MR@90A7?:"&P3^- '0>)_%EKX473GO+.]GCOKI+1&M8A)L=NFX9SSST!)Q6;'
M\0%DU.]TG_A'-9&JV\:S)9^7&6EB8X#A@^Q1Q_$P/89/%8>K2^(]:\+^$GNO
M#U^-2M-5M;B_C'E_*(CEW'S8(;.0/KZ5LPP7T7Q6U'4VTVZ_L]M(CMUN %*M
M(CLY4#.>C<<=0: +<'CS2[CPSI^M11SXOY3;V]K)M24R@L&0[F"C&QLDG''T
MJF/B5IZ:;K<\UA=B[T55>\LXGBD<(PR'5@^UEQ[Y&.E<?;>'->_X0O1[A- ,
M]]H^JW-S)IEZ% NH96DR%SD;MKC&>X/MG<U.#4M5\"Z_%9>#3I9O+,VUO:JL
M2SR.P(+-M(54&1C)SU.!QD W[+QQ#=:YING3:1J-I'JD326-S<*@68JN]EVA
MBRG;S\P&<&N;^).MQZU\/O$*6VD7%[IT"/']N1T"B9#@E5+!BJL""P]#@$<U
M=O+75)=>\!7*:/>F+3ED-XWR?N=\!B /S<D'DXSQ6"=-\2Z7\.M;\#CP[>7D
MHCN$L[Z&2/RIHY'9@6+,"'&X_+@]/QH [*?QC;Z/JVG^'1I6IW5Y-8^? ;>)
M2D@4 %0Q88/NV ..>:H_\+0M#HUWJ2Z!K3+I\SPZC&L*9M"GWMQ+ -US\A/'
M)Q34AU6?XA^'=0DT2\AMH=*D@GD9HR(I'*D*=K'.-G49ZBLE=.U<>"OB!9MH
MMZMQJ=[=26<>U295F0*IX/&".<]!0!V6J>+K6RGM[6TA-]>7%O\ :DB6:.("
M+( 8L[ #). .2>?0FLL?$[2'T?2M3AL]0G@U"]^P8BC5F@GSC8X#9SU^[NSC
MW%<_?:5JMEJVC>(/^$5_MFT?28K"[L)$C,]LZ$D.H;@_>(.#[U=UVSUBZT[P
MVT/AEK<PZW#?R6MIY?\ H\"9'SG< 7.<X7CMVR0#;A\;23_VU:C0KR#5-,@6
MX^QW,D:^=&V=K!U9E_A.?2K/@36=0U_P?IVI:E;F*>>!)"^Y<2Y .X =!['F
ML@Z?J5Q\1-?N/[-N([.ZTE+.&Y?;L:12Y/0Y ^<<X[&J.C:[K7@_X;:4+OPG
M?NVGI';7*>=$"J*OSR@!CE1C@<$^U 'H-]/-;6,\]O;&YF1"R0APF\^F3P*\
MBUO6;GQ-\(])U[5[$I.NH6L\4BX;<#. =JKSPO&",FO8Y%+Q.HZE2*\>73?$
M,?PETK0)/#=^+RQN[97"M&V]8Y?,9QAONX  S@DGICF@#OM-\9VU[KMWI%WI
M]]IEQ!;?;%-ZJJLL&=I<$,<8/4'!&:HP?$?39;[2XYK6:"SU5Q'8W;21L)'8
M94,BL63=VR/KBL_6--OM8^(L^-/O(K"Y\/3:=]M:,;%DD8-ZYX'MUXJKX0MM
M8M(]/T>\\"V=K?612.;5BL1A=$Q^\4CYR[ <#L3D],4 =9XZ@UFY\$ZK#H#,
MNIM#^YV'#$9&X*>S%=P!]2*XOPW+X2\2:AI<GA^&/0==TZX5[S3G0P3.@!#H
MX&/,Z@[CGISC)KOO$S:NFA2OH40EU%)(FCB+*HD42*74EN "FX9_+FN2U[29
M/%?B#0;NVT&]TW4M.OHYYK^X1$V0KDO'N5CYF[@ #(Y)R.X!J:S\0[#26OI%
MM)KJTTZ3RKV>*6(>4V 2%1F#/MW#.![#)!%7;GQ="]PEKHUG+JUPUHMZRP.J
M*D+?<)9B.6P<#J<'I7'PZ7JGA[Q'K-M+X*AUV#4+V6]LK]/*^0R')CE+\J%/
M?GCH#5ZXM?$?A7QE)K-EHO\ :]EJ=C!!=PV+K&T$T0(!57/W"">,\=^G(!N0
M>.K"]T;2+VPM+NXN-6WBTLMJI*=F=Y;<0%"XY.?3&<BD3QS:_8=:>?3KV*_T
M9!)>:?\ (90A&X.AW;64@$YSV/&>*R]3L?$(USP[XLET[S9K7SX;S3K9PSQ0
MRXVE22 [+M7=CKVZ5#?Z3J5]<^+=>32[A3?:4NG65KA1-*</EV!.%&7 &3G"
MDXZ4 :EE\0+>[N]%5]'U*VL]95?LEY.J!&<IO"%0Q8<9Y(P2.,CFJ7C?6X]4
M\+>);&VTBXU&SM;::&YN(W0+'*J9PH+ L4."2.G09((JA/I^KG1/A[ -%O3)
MI<T$EZHV?N0D+1G/S<\G(QGC\JBCL_$&@Z5XJ\.+H%WJ"7[WES8WMO)'L83
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M^-T8JRG'H0:V* "BO-?']]JB7::_IL["R\+7$<MU @_X^=XQ*/\ @$3@_P#
MV]*ZWQ'XG@\/^%)O$*VTU_:QQK+BW*Y*'&&Y(XY![_2@#=HKBW^(#PZQ8V$_
MAO5(SJ4+R:>W[LM.RJ&92N[]WP0<L1[XJ>T\?61T76=0U2SN--DT>;R;NWE9
M&8,0I7:P.T[MP Y')_&@#K:*XS3?B%;7NOG1);1!?26[7%JEM>13K.%ZIN!
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MI752RQH0"Y Z#) R?<@5R/AWPXNH6MQJGB'2)+?5[V=WN(Y+@, N<1J-C%2
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MPNWA@RW6F36BBYCO(A%/'#(K!DR<Y(09! Q^E>M4P2QF5H@ZF10"4!Y /?%
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M#\B12;B0=^#D=,>^<=](:?XC\.>*-7:T\+P:YIVJW'VR&;SXXGMI&50R/O\
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M[4 :%WXZ,-K?ZE::/<WFC:?(\=S>12(#\AQ(R(>753G)R.AQFL[67LK[XE>
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M$R8.=V1CL#G%=%IUEJ:?%+5]2ETN>/3I[&&WBNFDB*LR,Q/RARP!W<9'8]*
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M;Q)J,B.J&,R' V*?OX/7I^-<AX+\#Z]X4GOM!N?"6E:I:R7?FVNL7!B98T.
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MH M45#://+9P27,(AG:-6DB#;@C$<KGO@\9J:@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L[7="T_P 2
M://I6J0F:SFV[T5V0G!##E2#U K1HH K:?I]II6GP6%A D%K @2*)!PH%6:*
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZE>H'(YJ>@ HHJ*:Y@M@#//'$#P#(X7/YT 2T4R*6.>,212+(AZ,AR#^-/H
M**** "BJ_P#:%E]L>S^UV_VJ./S'A\P;U3^\5SD#D<TMI>VNH6XN+*YAN822
MHDAD#J2#@C(XX/% $]%%% !15>>^M+6:&&XNH(99VV0I)(%:1O10>I^E6* "
MBBB@ HHJ"TOK2_C:2SNH+A$<HS0R!P&'4$CO[4 3T45!%?6D]U-:PW4$EQ
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M@SW48"%49-HP3G.[.?3'?H 7M#M=!\5ZJ;:'2$LY= -C/%<-9^1-YI#,RX8
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MQTR.-N?7VYK @\'>)1HZW,=G!!JUAK\VK6T,LX:.>.0MF,LN=K8;&<8SCUX
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MRN8C%A>?FZ[OI[]+_A[3=4M?'?BC4KNQ\FSU(V_V>3SE8_NDV'(!R,YR/UH
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M/4@CC&: .VMKF"\M8KJVE2:"9!)'(ARKJ1D$'N"*EK!\$J%\!>'0.@TRV_\
M12UO4 %%%% !1110!'%!#!O\F)(][EVV*!N8]2<=2?6I*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH R-7\,Z5KEW9W6HP2RS63B2W*W,D8C<?Q *P&??K6O
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$N[2UCMW$$A=3L4*#D@=0,XQQZGK6S110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQDYS@ '4?\);I'FZ)%YTN[6D$EE^X?#@IOY;&%..Q.:W*\QE $'PI Z!D_\
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MB9X(^4C@<&MRRUKQ%IOBOP]IFI/I\MAK%M+Y<=O&P>V>*,/RY/S@@]<+]!W
M.[HKAOBLU]'X2B>ROVM0;VVCE"QAO,5ID&,GH!UXZ].E6IM5U:[\3#PQ8ZA#
M%/:V2W=Y?/;ABQ9BJ(J9 '0DDY[#OD '7T5S/@_7[W5_[6T_5(HEU'2;LVLT
MD(*I,,!DD ))7*D<9.*PFUSQC?:]XNTNTN=(MTTCRGMYFMG<LKQEPA7>!G&
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MR,#SR -IX[YKJ;V\U_0?&6B)>:C;7&D:E(]M+*;0(Z2A6:)-P/1N0,YY!]>
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M[K:VW[D%  " QR25<#D\'..M5TF\06WB#XAW6ASV$!MKB*=C=1-(9"MLIV
MC:#C[V3].] 'JU%9OA[5#K?AO2]5:,1M>VD5P4!R%+*&(_6M*@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 0GE\_-\WR@>G-=C10!PMMX%O[.P\-36VI6Z:QH4'V5)O()BN("H4HZ[LC@
MY!X/;FI[WP9>WNG>)'DO[?\ M;7;<6LDODMY4$04J%5=V3PS')/)/3'%=G10
M!R&H^#+C5_!.G:/<ZD+?4M.,4MK?6L9 CEB&$?:3SQG(SW-:'A_2M=M9&N=?
MUM-0N/+\N-+>#R8D&<EBN3N8X')Z#@ 9.=^B@#DO$_AO6=7\1Z'JNGZA90QZ
M5(\JP3P,QD9E*ME@W VGCCKZT^^\-:J?&/\ ;NF:K!:K<6B6EY%);^8VU&9@
MT9R &^8CD$=\'I7544 >;_\ "N-7M_ =CX:MM<M7:UOQ>"XEM",@2&4+@/R=
MYY/IQBMZ[\/ZG+X\T_Q&;ZT2TM+-[9[?R6+,'(+$-GCE5QQT!KJJ* . T5M!
M\9^/(_%>C2O<06-F;9[@(Z)+*Q^488#<44OS_P!-!Z5VVHV\UYIEW;6]RUM/
M-"\<<ZC)B8J0&'3D'G\*GCCCA0)&BH@Z*HP*=0!Q+>"+G5]6@O?$5Q8SM#93
M6;/9V[1/<K*@1C(2QX SA1W.<]J/#OA+Q'HYM;"\\4F[T:R8&WB6V\N=U7[B
M22 \J..@^;&#QD5VU% '->'/#5]H&L:S-_:44VG:A>27J6_V?:Z22;<Y?=R!
MMX&!UJ+Q+X?U?5]>T74+&[LX8M*F,ZQRHQ:9F4HRE@?E&TGL>:ZJB@#D_P#A
M&=3TOQ/J6LZ%=6BKJJH;NVNU8JLJ# D0J>XZKWP.16?<^ ;R+3O#UGIFHVZ_
MV7?G49I+B L;B8EBW"L-H)D;CG''I7>44 <SXA\-7VJ:_HNL:?J45G<:<)HV
M$EOYH=)0H; W#!&WCKUK/B\(ZU"_BYQJ-B7UTYB8P-^X^3RQD;OF^4#TY_*N
MVHH R/"^E7&A^%]-TFZFBFDLK=+?S(E*A@HP#@]\ 5KT44 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %>-^%/$6N>&?AMI.H16%A)HL=])#/NE;SV62[=-R #:,%@,$G..U>
MPRF00N851I0IV!V(4MVR0#@?@:\S_P"$&\3CX6P>%0VD&[2\\YYC/)L*>?Y_
M'[O(.[Y<>G.>U &EKWCF_AU;5=/T: -+I@4,'T^YN1<2%-_EJT0PG!7DYY/3
M R677C7Q')?^&[6PT*WAEUJTGD\G4)'BDMY8T!(<;?NY([9/MUJ6Y\.>+--\
M47NL^&[W2UBU18VOK/4!(R1RJH7?&R $\ <'&<?E/=^'-??Q7X8U-;BSNXM*
MBG2YEGD:.29I@ Q550J -N0,]\<8S0!0OO'&LQW-QIL5M!'JEA;0O=A;&YNX
MY)W3>8D,0^4 8^9B?O=.,U--XQU"1_!EQ-H26PU>X,,T-XK+/:R;6SM! _NG
MD]01QS4VI>&_$UAXON]=\+7VG;-22-;ZTU)7V;D7:LB%.<[>"/\ (?K'AG7;
MVZ\,3+=6EU)I5T;JYEN&:,S.0P(554A5&XXR>  />@"O)XF\576N>)]*TZST
MA6T?RGCFN))")%="X!4 <X &<@#WK3TWQ!K&O>'O#FKZ7I]L8[\QO?)-*08(
MBIW%/[Q!Z?YQ6L_#^NVOB'Q7J9&G,NKI$MNGG."AC0H-_P G<')QT(QSUK/M
MX/$O@[PEX;T>TETF6[@E6WEB8R.US&",^7@ A@"221@ 9)Q0!W5_/+:Z=<W%
MO;-<S11,\<"$ RL 2%!/0D\?C7#Z3XWU&7Q1I.C7SZ7<2ZE;2R/'9A@UE,BA
MC'(VY@W7'&#D=*Z[Q#IT^K^'-1TZUNFM9[JW>*.=>J,00#Q7&6?A+Q7#?>%[
MQY=!B&BI+ ;6!)0A1T"E@W]X[>F !GO0!4D\?>*D\)ZCXA.FZ0+?2KV6WNHO
M-D+3+')L;9QA3[G.?05U4^N:AJ7B*ZT;0WM(GL(8IKN>[C:09DR4C559>2%)
M+$\9'!SQSC^!_$$OP^UWP\\FF"YU2\EG$HEDV1K(^\C&S)(/ ]<]L<Z1\-^(
MM/\ %,FO:/-IBOJ-O##J=K<ER@>,$+)&P&20#C:0,^OH .^%2R+X)_?(B3&_
MO/,6,Y4-]H?('M7:US/@?0M4\/:+-8ZK<6D\C7<TZ-;*P&)'+G.[W8__ %ZZ
M:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HQ110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%0W=Q]DM9)_)EF\L9
M\N%=SM]!W-8/A?QYX<\8M.FBZ@)IH #+"\;1NH/?# 9'N,T =)161I/B2QUF
MXU""V2Y1K"4PW!G@:-5<#)&3P>"#QV(/>LU/B!H<\-S<V?VV]L;9BLUY:VDD
MD*$=<,!\P'<KG% '4T5BW/BO1[?PRWB);K[3I2IYAGM4,ORYP3A<GCOZ8.>E
M9]O\0]!NO"DGB:$WKZ5&Y1IEM')&.K;<9VCH3TH ZJBL#2O&&E:SX9E\16?V
MEM-C5V\QH&!=4^\57&2!@CCT-:VG7\&JZ;;:A:ES;W,:RQET*$J1D'!Y'% %
MFBLS7->L?#UE'=7QFVRS+!&D,+2N\C=%"J"23BN>7XH^'WUF71TAU9M2B7?)
M:+ITID48!R5VYZ$?F* .THKBM1^*GAG3-$L=9N'O/[/O2R13+:MC>K,I4@\A
M@5/!]*O:QX]T7P_HUGJNKB]LK2[.$:6T?*GD@, "5) )P: .GHKC];^).B>'
MM(LM5U&#48;*].(93:D<]0"#@C(&1D<BIT\>:;]IL(9['5K47\J0V\EQ8NL;
M.WW1NZ#/O0!U-%<I=?$/1+/Q.WAR5+]M5 W+!'9NY=<$[EP#D8!.:T='\5Z-
MKMW<65E=G[=;?Z^TFC:&:/W*. <<CG&.10!M45Q4/Q/T6XU^ZT*&RU:34[7<
M9K=+,LR $ G@].1S[BM.R\9Z?J%EJ=Q;VNHE]-8+<VSVK),I(SPC8)XYH Z*
MBN'TWXIZ)K&FRZCIMAK5W:1.4DE@L'<*P )'&>Q!_&MN;QCH-MX9MO$-S?I!
MIMRBO#)("&?<,A0O4M[ 9H W:*YU/&VD+=VEM>B[TV2\.+8W]L\*RM_=#$8#
M?[)P?:H_$?CO1?"NHV=CJOVM)KTXM_+MVD$K9 V@CODCCW% '345@6GC+1+K
M6$TAYY;34I%W1VM[;O \@]4W@!NAZ9Z&L_6/B-HVA^)8O#]Y;ZB=1G"F".*V
M+B4'(!4@\\@C\#0!U]%8&E^+K#5-;?1UMM0M;Y8#<>7=VCQ;HPP4D$C!Y8=*
MWZ "BFM(BMM+#<06"]R!UP/Q'YUE>'O$=EXFL9[NQ2X1(;B2V=;B/RV#H<,,
M'D?C0!KT444 %%85KXNTR]\1W.@PK>&_M<>>IM) D8(RI+XV@$=.>:W: "BB
MB@ HJGJNI0Z/I5UJ-RDSP6T9D<0QEWP.N .M9/\ PFFF^5X>D\F[V:]L^R-Y
M7"EDW@.<X!QVYZ&@#HJ*** "B@G S61X>\1V7B6UNKBRCN(UMKI[21;B+RV$
MB8W?*>1U[X- &O1110 445CW_B2RT[Q#I>B3QW)NM3\SR'6(F/Y%+'+=,X'3
MD]* -BBD=UC1G=@JJ,EB< "LB]\265AXCTS0IDN/M6I+(T#K$3'\BEF!;IG
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ!YF.3C![<]>, ":KXBUK4O$=UI&D1:E'':6<$\DM@ELS^9+N*AO/8#8 O\
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M6.MR07D]L4@RWE;?WBDX*-D'@@]L'WK,\26FH1>+/ -M;ZDTMWOO=MU=Q*Q
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !116+HWBK2]>U/4]/T^25YM-9$N-\3( 6SC&X#/W3STZ4 ;5%%%
M!1110 4444 %%%95[XCTS3_$&FZ)<3[;[45D:W3'4(,G/I[>N#0!JT444 %%
M%% !110>!TS0 45S?A?QKI_BJ]U6RM;:\MKK2I1#=172*"KDL, JS \H>]=)
M0 4444 %%%07EY;V%G+=W<R0V\2EI)'. HH GHHHH **@CO+>:ZGMHYD>>#;
MYJ \IN&1GZ@9J>@ HJKJ5Z=.TZ>\^S3W(A0N8H-N\@=<;B!T]ZPO!GCBP\<V
M4][I=E?Q6D3^7YURB*&? )4 ,3P".V.: .GHHHH **** "BBB@ HHHH **S-
M(U_3M=>_33YQ*;"Z:TG_ -F10,CZ<]?8UIT %%%% !16)K'B+^SKLV%G8S:C
MJ MFNVMH656$0.,Y8]2> .^#Z5;@U0W&A1ZI'87I+P"86C1A)^1G:58@!O8F
M@#0HK!\)>*K;QCHPU:RLKVVM'8K$UVJ*9,$@D!6;@$$<XK>H **** "BBL/3
MO%>GZIXDU#0K>.[6[L$5YC- 8U()(&W=@MTZXP>Q- &Y116%K_BB'0Y([=-.
MU'4[R13(+73X?,=4'&YLD!1G@9/)Z9P: -VBN?TOQGHNJ^&[G7HYW@L[3>+I
M;A"DENR?>5UZAAZ?E3].\3Q7E_!975A=Z=/=0FXM5NMG[Y!C=C:QPPRI*G!P
M?K@ W:*XN3XEZ3!>0+<6&JP:;/*(8=6DM<6CL3@8;.=I/1B,'KG'-:/B'QE:
M>'93$VGZIJ$B1^;.NGVWF^1'S\SG( '!XSG@\4 ='1573=1M=7TRVU&RE$MK
M<QK+$X&,J1D<=JM4 %%8&M>*[31AI#^1-=P:I>QV44]L5:-'=L L<].O0'I6
M_0 4455U+4;72-,N=1O91%:VT9EE<C.% ST[_2@"U16)I7B";4=4GT^YT74=
M/DCB6=)+A%,<B'T=20&!ZJ>?K5K7M670=!O=6DMI[F.TA:9XH-N\JHR2-Q X
M&3U[<9Z4 :-%<W<^,+>V'AQFL;IH]==$AD79MB9DW@/SG.,] >AKI* "BBB@
M HK-N=5FM]>L=-73;N6*YCD=[Q%S%"5' <]B>U:5 !1110 4444 %%%% !16
M#:^*(KKQ)JVB+87:7&G0),S.%VS!\XV8)S]T]<4Z+Q-#'X0/B+5+.ZTR)(6E
MFM[E,2Q@$C!7U.!@>XH W**Y6#Q??MKT&DW'A+6H#,XQ=!$>!$(SN9U;"D'@
MK_.NJH ***CDGBA>)))41I6V1AFP7;!.!ZG )^@- $E%9MMJLT^OWVFMIMW%
M%;1QNEXZXBF+9RJ'N1W_ ,YTJ "BBB@ HHHH **** "BBB@ HHHH **Q/%?B
M6+PGH4FK7%G<W4,;HC+;A<KN(4$[B.,D#C/7I6W0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7&^'1_Q<WQJ?5+#_ -%O795SND>&KK3?
M%6KZW)JOVA=3$8>W^SA0GE@A-K9SP"0<]: .BHK/L["ZMM4U&ZFU*:X@NFC,
M-LZ@+;;5P0I'7)YYK0H **** "BBB@!"0 22 !U)KYT^(UXNHI:?$#2WOCJ-
MG?@P@VLPB2T0XC.XKLP6&_KSYI'.!7O6OZ2VN:+<Z:+^YLEN$,;S6VW?M/!
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M?;+9VD2Z4*K[T$[!L 8Z@9XQ5"'Q=XVB\*^"=<'B622?5KY[1X)K:,Q;?,*
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M8I8G'F(R,'5\X^]N /3UJK#X%\K6HM:;Q#J\FJ)9M9M<.T1#JQW9*;-HP<$
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MW5MY@B;:8_\ 5K]P<#GW/?MC2G\%6]YXEU#5[V^GNHK^Q^P364B)Y?D\G (
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$R><I  ;H!GDD]\9&;%!I6F:QX@T;Q1X>U>[N+O4)[FT-NLTD-['(VY5PK;
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M24+\-M:A"R/+<0&&*..-G9W/0  'T- &_P"'X&M]!L@]S<7,CQ*[RW$A=V)
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M$GQ,\+1VT]Q]MN&BMIS;W++93'[.PP#YGR?(.1R<9YQG!KE_"<N@:E/I$/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %4[#38-.\]HC(\EQ(99997+,[8 ')Z    #@8JY10 4444 %%%% !111
M0!3U+38-6M/LMT9#;LV9(T<J)!_=;'53W'?H>.*N444 %%%% !1110 4444
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MZ:*<1[0^  5VJ#]T =>WK6'-\+-/DTN\T>+6M8MM'N)!(EA#,@2!MX<["5+
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M;J.[C4''SIG&?4')!'H: .$\-ZUJVH:/J'AZ\U._BUY=32..678)EMGQ*CX
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MA(LDT>]7#?,"3@E>A)(]JTKKX>65YHRV<^J:G)>K=1WBZF\JM<"6/[A!*[0
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MO@*,A0,S8*.I!Y8\]?3%1Q>#M-:PU6WU!I=1DU90M]/<;0\H"[5'R@!0HZ8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:=</$)YY02S!UPQ1=HP.AR<YXJ;X8PM;^'=1@:9YFCUB^0RR8W.1,PW''<T
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M"/;&PR "#D$<D]:;IQ3PYK?Q(UF)[R=]-*S1Q274CJY^S!\,"QSST)Z#ITH
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MW&5O%*/Y8!9&8+\IVDD9'.TBNCT74?[7T'3M3,7E&\MH[CR]V=F]0V,]\9H
MPKCP);7-II-O+K.KL=+N!<P2-,CNT@&%9BR'H"0 ,#D\4FJ_#_3-3U^36HK[
M5=-O)T5+HZ==F$7*C@;\#G XR,&NLJKJ5X=.TRZO!;S7!@B:00PKN>0@9VJ/
M4]* ,;5/!>GZB-),%S>Z;)I2M':R6,H1EC8 ,AR#D$*/?CK55?AWHJ:5KNF^
M=?M;:TYDN5>Y+E7./F4G.#P.3G.!FH9O&>L6_B"PT27PP5O+V"2>(?;T*@)C
M<"=O!Y'YUT&AZI<:K:S/=:=+87$$[0R0R,&Y !!##@@@@YH GTRP&F:?%:?:
MKJZV9S-=2;Y'^I_P %+JFFVVL:5=Z;>(7MKJ)H95!P2K#!P>QJW10!QMK\.;
M"VN-'N6UC6Y[G26/V>66[R=A4*8R H&W '0 GN:L67@6TM/L$+ZIJ5U8Z?,+
MBUL[AHRD<@SM.X('(7)P"V!^%=510 5C>(_#-CXGLX8;MYX9;:43VUS;2;)8
M)!T96_'H016C-?6UO=6UM+,JS73,L*'JY52QQ] #5B@#E[#P+86>J7>HSWVI
M7\UY:BTNEO)PZ3( 1RH '<\#CDX'-0Z#\.],\/W43P:AJUQ:V[%[6QNKLR06
MQ.>47';)QDG&?7FM3Q9KDWAOPO?ZS!9"]:TC,K0F7R\J.IS@]!STK3L[C[78
MV]SMV^=&LFW.<9&<4 <Y:>!;2V^Q0OJFI7-A8W N;>SG:,QI("2IW! Y"DY
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC#-R<Y;. ,'(]JLR>--;U^Z^'>FWA98-3MC+>*9VMQ=R LBAG49 )4-@#!W
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M/7!(S[GUKE-1D:U^,VB&'(^V:3<13^ZHZLOY$G\S7<5S.E:5/?\ B:Y\3:A
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M27!\UHE)*Q@CHN2> .<G.:DD\&6$U_HUZ]W?F?1T*6I\_@ C!W#&"2ORD^E
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MA'<* NTX;)8#&,\D@YKVXZ;9R-=2O;();R,1W#?Q.H! 7/H,GIZGUH QM/\
M%Z74.DSW=C-90:H-D+RMRD_.8G'8G:=IY#8QP< ]+7$?%&&.S^%NIFV18?L4
M<4MMY8V^4T<B%-OIC KL[>1I;:*1AM9D#$>A(H DHKC?B59WC>&1JVGW%W'<
MZ3*MXT5O</'Y\2D&2-MI&05!/X<=36!/XJM]-^(%KX@.H7+^%M1LVMEE-V[0
M+=*/,RJ9VC*#;Q_$&'!SD ['5O$DVE^+-!T;[!YD&JM*OVKSL>4R(7QLQSG
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MUFZ)\/?#V@2%K6"XE4(T<4=S<O,D*,,,J*Q(7(X]<<9KJ%8,H92"",@CO2T
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M_P ]#(3NW<#G/3CIQ5KP_P"%]/\ #<<HM&NIYI0HDN+NX::1E7.U=S'A1DX
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MY(1"\3EC(LB%@6R!@XQP/?D]:/$OB"\T35?#]O#:P2VVI7PLY9'<AXR59@5
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MY(@W^:V",'C 0<#COC-)I.GVOC'3_%-_JSR)J5MJ-S:PS>:R/8+&!Y>S!^7
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MX5T?2_#TF@VMJW]ER(\;6\LSR#:PPR@L20#D\#UH X'7O#]KH_A/PSXKTZR
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M..,C!41@[?3MV'H*I)X(T%(]7C6WN%CU=VDOD6\F"RLQRQP'^7/0XQD<=.*
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M3D_.&#')Y.3R:?>^!_#VH:19:5-8NMC8R"6WBAN)(@K]=V58$MDDY.3DD]Z
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M==IE20KN/GJH;@\'' /6@";6O$WB/P]X!_MO4=+L%U&.=$N+=)V**C2A%*D
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M$T1'J201@=!U.:UH--30_%W@.YL[F\\W4H9H;WS;EW$ZK;;URI.!A@,8  H
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MBT*,QNGOTEP1T&T*#S7+>$(I(_VA/&Q8''V6(Y^HC(H ]99E1"[L%51DDG
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MMK=!VYQS6IJNDV6MZ;)I^HP^=:R%2R;V7E6# Y4@C! /![51\7:K?:%X8O\
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M;4M<;6;K28WO7(,C!W592.F] =K_ (@TNN^+ET?Q#HND1VC7#ZA<B"60-A8
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M?1_"]M)!I%IY"R$&1FD:1WQP,LQ)('89P*UZ 0>AS10 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ+XJU'6E U:WO[J!;ASB2P6/_5B,]4P,-QC)))S5"SCE\0ZI\-;K5VG:XO\
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M93(@7MR0.>M:5<CX"GGMO#=Q!?WYN;>SOY[6TO)Y,F:%7VH2QZG.5SWVUUU
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MWB*T61KN;P]K,YTB25BS&.+:WE%CRP^^G/H/2I[GQ/80>+-(^($*X\/7MO\
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MIL4][ GEI*Q/*YSM8 X89YP0:S/!?B*]U2RU+^VY[,75MJUQ8(85\M7\L@#
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MX7MII%E!<KG;)'"H*9Z[?[N>^.M 'BTR+KGQ/\>:+K^JV6GM<P+%;RWT ?9
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MNY!/?.:]Q"* H"@!>G'2L[3O#^C:3,TVG:79VDC+M+0PJAVYS@8' SS@5I4
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MB:P+<:EI%E>"VXA^T0*_ECC@9' X'Y5/J&CZ;JMA]AU"PMKJT&,0S1!D&.F
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MMZT ,_X1W1?[(_LG^RK/^SAR+4PKY8.<\+C YJS8Z98Z9;M!8V<%M$S%F6)
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6]NI[AQ;H2#Y1\TXW$Y.!G&"?3(!UWB+7+?P[H%[JERT8%O"\B([A?,95+!
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M$9;622VD2*X 7<P1R &(')Q6IK&LV.A:>;V_E,<6]8U"J69W8X554<DDG&*
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M?A7344 >&>(I;K5?#OB."YTG5TU&'4Q(+*SM'CMHXUG0^:2H F9E!))+'/(
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M;<G+ ].G4X%4[RT:TL/!&M7NAZAJ&EVFD_8+R"&&03VK[8_G\OAB,H0?;\*
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M=#S7=4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>-.]S(WWG?,:;>@  R  !P!72T4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>arvinassixthleaseamendme002.jpg
<TEXT>
begin 644 arvinassixthleaseamendme002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY;[-K;L8Y[<\X-=S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB.Y@ATR6XF\^%IXY#;2+&55MI&XC&>1QUYKHJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X;
MPA ]AX]\;VTX(::YM[R,G^.-XR 1[ HP_"NYJE<:;#-J$%^I,5W"I02+_'&2
M"4;U&0#['IWR <1X4L[B\TKQU8K%<6L]]JEX]N\\#QAED151P6 R,@]/2J/A
M*>QO[71](U#PGJ":[IK1"474#^3 \> 9ED/R] 2N.23CIS7J5% 'C23W>F_#
M?Q7X3U#3]0;6!]M:)H[221;M9"SK(KJ"O\6.3GCUXK::X?3/%GA/6+JRU!;-
MM&DLF*6<KO',3&0K(JEESM.,CM7I=% 'BXMM8&@:C?VNCW[3:=XPDU5[-H2'
MN( QSL[.>2>">5^E=/KL\GCGP?K0T'2[F*:6T"K/=VQMWF=6#"(;@"1PP)Z9
M88)YQZ#10!YSI5SI_BD1M8^'-0L=8AMY5:XOX)$^PN\94A7;J2<#Y>W)QC%<
MU/>W#_"&R\-R:/J<>LZ;-:0SVJV4C?ZN=,NK!=K @9&#SFO:Z* &QN)(U<!@
M& (#*0?Q!Y%<+X=G\GQUXWN9;>[C@GDMFAD>UD"RA( K;3M^;!!'%=Y10!Y'
M9:'JFJ?L\)HMG:SPZI'",VT\31,S)-YA3# ?> QZ'-;NK/\ \)GJ/A*;3[>Z
MADLK];Z[::!XS;HJ,&C;<!\Q8JN![GH,UW]% 'DT<<Y\"_$BW^Q7OG7E_?/;
M1FTDW3*\:JA0;>02#R*T;TR/JGPXD6UO"MMO-PPM9/W(-N4&_P"7Y?FXYKTB
MB@#-\02W,'AS4Y;.R6^N4M9#%:NNX3-M.$([@],=Z\XTV:6X\8^"M26SUB5/
ML=S#<22V4D4<,C)'A F L:C!&0 #C[S$&O6:1MQ1@A ;'!(R ?I0!X_I,\-[
M\-?%>B16TUQ?W=_J$$$"PL?,=Y&"L#C& 2"6S@8YQ6I8M%X=^*5A9WTK$P>$
MX;=I@C,"RS$9) XSCO\ 3K78>%O#K>&K&YM#>?:EFNI+K<8MA5I&+,.IR,GC
M^M(/#L@\;MXE^W LUD+'[/Y/'EAR^=V[[V3UZ8[4 ><W^CW5IX9O+@6%WMU+
MQ6FI0VT=L[.D D3+L@!*Y"EL''!'?BNK\2K=6/CSPYXC\F>?28X)[2X,4;.;
M<R;2LA4#."5 )QQWKN:* .!LB;#Q1XJ\6BTNY+"X@MX((HK=R]TZ*<L$QG'S
M!0Q&.">G-5/"5G<^"/%,VBRV;RZ=JR?:X)[:V=H[.4D[H"V.(\DE<XQD^M>D
MT4 >42I.VB?%",65Z7O7F^RK]EDS/NMP@V?+\WS#'%7;WS&N/ANZVEX1:MNN
M"+63]R/LY3Y_E^7YN.:]*HH \IU*?4+35?B/>66C37SS1V7V>*:S=XYPL>R0
MJ",/MR3@=<5;T1V?XJ6VH10:S/:W.AF$7EW;2(&D\X,<@@",8[84>@.>?2Z*
M /%[*UU2/X6:)#%H^H2W6@:G]HO;(PO&\R"24,L9.-YVN&&W(Z=^*ZNQN-(U
M*PU;5M*T*]MRU@\+W5S:R)-(2.(U5LLP!ZXXSC&><=[10!YSI_A^;7/@MI>F
MA9;35+2SADMVFC,;P740!4X8 CD8/L370>"'N]1T1=?U& 0WNK*D[1 Y$<84
M!%!],9;ZN:MZ]H%QKDUL%UF]LK1 ZW-M;[0+E6Q\K,02O0C(YY.,'FME$6.-
M8T4*B@!5 P !VH S]:UBST:UCDOHKAX)I!"3#;/,%R#RP4$A>,9]ZYKP_I%K
MIWBO7?$&F64MII5Q:1 PI 8_/F0N6=8\ _=*@<?,<_4]O2,"RD!BI(QD=10!
MD:/XDL]:\/'68(;J&!0Y>*XA*2H4SD%?7BL*+PU<:O\ #"^TVY'DZAK$$UQ-
MO_@FFRX!]E)5?HM==:6D-E;B"!=J ECDDDL2222>222234] 'FEY:W?BG0_"
M.B?8[B&YM+NVGU,2Q,JP+ IW+N(P2S !<9R#GIS6YKFL6&O:?K7ATZ9?SW;(
M]L();*14D)&%<2$; N<'=GC'KBNOHH IZ19/INBV%A)*97MK>.%I#_&54#/X
MXKE-'WK\6O$4K6]RL4UE:QQ3- XC=DW[@'(P<;AWKMZ* /(M*%M8+J/A7Q#X
M8U&_O#>3O;LL+R6]ZDDK2*Q;[BX+<[NF/6NBTHFU^*&OSR6UQ';'3;6-)1;R
M>6S)OW*K8P<9'2N[HH \8TRVO+3X<> Y)M.OP=,UE9+N(6DAEB3,PW% NXCY
MEZ#O6AXJNKW5/^$RT^32=2A>33A]ACM;-Q]LS"<M+*H^8J3MV%L<8PQ->KT4
M >9P2O;>(?!>KW-G>PV,>D2VTLKVS_NI"(\!P!E<[3@D"JNL:1=/X<^(FJPV
M5R$UM52RME@8R2;(@F_8!D;FR>1G !/6O5J* /+=5F?2?$6BZ[>Z7J%YHL^D
M)92FVAD,EK*K;@S(,-@YQTZBNW\+06<6ER2V&DMIEM<3-,L4B%)'R!EW4\AB
M1T/.,9P>*VZ* ///&EDLVORWNGWVI:/KMK8J;>\@A:2"[7<Y\EUVE7((SCK\
MX(S52TU+4]!\966KZ_I-VL.IZ+;V[&RMGF6UN$)9HBJ D EN/I[9KTZD.<'!
M /;- 'C#076H?#KQB]K9SR2IXIEN3;HFZ3:EQ$[# SD@ \#TKH&U.6^^)D6K
M6&EW\]J?#\T4+RVDD:22>:K*IW %0=I&6 SVS75^&O#K^'AJ0-[]I%_?2WS?
MNMFQY#E@.3\O''?W-;M 'C=E<W-W>^!-2?3=7\VVN)%O(5L)(H;1FA91&D>
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M4D ]:R/%%K<P:WJ^J^&IK^TUQ98TET^2!I+75AL0 X(QG!VE@>-ISCK7J5%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)KR/1H[:TM;OPEXA\+ZA?:BMU+Y)\EWMKQ&D+HY?[B@9&<],9Z\5ZYD1QY/
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M6 [+5X_,63L<I_%@9..^,5R&C2,_Q0T[48K?6;BUN-$>#[7=VLB R>:C$%2
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MR8P,^N>!F@#JO&GB*UB\-^((+::]%Q9VLGF7%FK_ .C2;"R9=>A^Z3CH""<
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MTZ#2M*OM-CGO$O\ 48K'*P-F%BX#AUQD. & 7&2<<8K=N?$5E;RK ([J:Y,
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M:VELEF:.498^6WEG_:QSTV]@<U?;39_"/QCTS5I=-O1HLVD)90F")[G[,RJ
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M;7%T\49*06\32/(V.% 4$\GOVKR[Q_X&N=6^&)*ZA=WEY;L;R&);/#23,29
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M/ESP.,MC..: .\HKEUU-M&\=P:%([-9ZK;27%H&.?*EC(\Q!_LE6# =B#V(
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M8<"NUH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO?C4+N,$PZ=HGERN.@DEE)5?^^4)_*NW/(ZXJK96$%@LOE M),YDFE<Y>1\
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MGA69+>S9\"0G#?[HQR?<8S74UQ>@Q7$?Q.\57,EG=1VUW#:+!.\#+'(8U<.
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M7#Q1EA''C)_,CC\:Y7PO=6VK7UM<)X&ET:ZMU;S[B[LDB,9(P5B8<MD]P ,
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M,,"I ;RP=I()'S+V)SVJ_=_%+2K9C<)97<^EIJ0TM[Z+:5$^,G"YR4'3=Z]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMO4C(Z#)YJ+7O#&K7/AGQ9=6^FSO>ZYJ-O-!9J5W)%$T>"V3@$A&;&>X'7-
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MT^:5"\L<?#*2#M5B"V.<<#D9X?J'AG_A+?%?]I7$5W9V":7)8LQ_=2RF1@2
M.H"@'D]2W&10!GZE?7FH_$7P7?":2/39[BZ6U@!P)$%NY\UAWW$_+Z* >K$#
ML?$_B&W\*^'[G6+JWN)[>W +K;A2P!.,\D<9(KB=8^'5TWBGPU+:ZOXAGM89
MIS<3R:B2UN#$0I0GD9.%..QKH_B387NJ_#_5M.TZUDNKNYC$<44>,D[@>22
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^V1L)8T1UW[.I/ SGD\\< U#;>/;*X\+6.LFTFCEO+P6$=FQ&_[29#'L+=,
M@G/H,^U '6T5SNG^*9+OQ5=^'9]+FBN[6-)I)DE1X=C [2"2&.2"/N\'\Z@\
M>P:O>>'Q::5I0U-)90+NV^U"W,D(Y*A^Q8@#Z9H ZFBN*^&O_".?V1=_V#I,
MNDSI<>5?V5PS&6*51T8L3Q@\$<<^N:[6@ HHHH **** "BBB@ HHHH ****
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MOC*RT+5XX-/VRW/B-[Z6&"\57N;1VRZ(^1M)P.25./2O2K&TCL+&"TA+F*%
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MAK7XOAO<> YK LP5K2+4A)'Y+0,^1(5W;PP4XV[>H'.#D>FT4 <79:-?Z?\
M$62_CTZ9M+CT6*PBE\V/+.CLW3=GD$#)'7\ZYBS\)^)K#P]X?O(--SJFB:I<
MW1LGGC N(9G<D*P8J&"N.N.<UZW10!Q.D6FM3?$B[URZT:2RL+G3(K<&:>-G
M5U=V(*H3Z]B1TY["QX\T[4M3@T5--L)+HVNK6UY+MDC3;'&V6^\PR?05UU%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2&=(RL0YVC+*<LP4''\);G.*X3XD?#[5+K5-#UOPC;W4VKV$P8R7-\74H#N
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MUEX>N].%O+J&GKJ%G-%.95>-@3A@54JV%/KTK-'Q6N;B^U[3M.\)WU_J&CW
MADAMI@P<;F4L#C. 5'&"3GI@$C#T#P5XIL_B+X:\076CPQQPZ<;>_D^W"60R
MD.&D<D99B6!XW=AGBM_X?>&]9T3QKXSU'4M/:"UU>[6>U?S8V^4-(<,%8D'#
MC]: +NL_$46-UK,&FZ1)J+:)#%+J 6784WGA$ 5MS 9)Z 8ZUQWB_43-\7_
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MB2W2>)IXP"\:N"R_4=17F5O;CP<OQ"U;08EM]*@MPUM @_="Z2-O,*+T !*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML<E?0[N._'2H-.T?5;7Q#XQOY+(>5JOE&U E7)*0B,AO3)&>_%=G53^U-/\
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MZC=A2V<8P0,YS7>T4 <IXLTK4M2UGPY<65J)8M-OOM4Y,BJ2NQEPH/4_-GG
M]ZW-5:Y:U,5MIT=W(X^43NJQ*>Q?J<?0&K,MW;0.$EN(HW(R%=P#4U &'X8\
M.)X=L9P\WVF^O)VN;RY*[?-E;T'\*@8 '8"N>US0/$-]XBUIEMK.]L;VP$%C
M+<3E?L+;&5\)M.2Q8'(P> "<5WM% 'E!M]6T;6OAA9W5E$][9VMU \$,X.0E
MNBDAB ,\9QT[9[T_QOHEQ!X0\>>(+R,0SZE:Q1QP!@QBBBX&XCC<26)QD#@9
M->@WGA_3;_5K/5+F&1KVSW?9Y!/(OE[AAL ,!R.#QS4FL:-8:]ILNG:E"TUI
M+_K(A(R!AZ':02/:@#GI]*O_ !!J/AZYO;+[);Z2YNG!E5S--L*J$P?NC<3E
ML'@#'7%?0?"UZWAOQ/HVKPBWCU>\O)4>.0/B.?./HPS]/>NMAELK.2'3$N4$
MPCS'#)-ND*#O\Q+$#UJW0!Y[_P (SKFK>"].\(ZO;11Q6KP)<7R3!DFAA967
M8OW@[!%!R !DG)Z5;\4>&]4\2QWMQM>UO]/8/H;QRC"R#!\QO]XC:0<X7IR2
M*[>B@#B=>T[Q!KEGX7DETZ*.\L-3AO;U$G79A%96"$]<[LC..G)J?3M+U2S\
M:^)]6>RW6VHPVZ6^V5=Q,2L#N&>,EN.O3G%=?10!YC%X1UZ+X:^'= ^QQ&^T
MZ]@GF/GKL*QR[SM/4DC@<=<_BOB#PMXGU=/%ELUI9W/]I1XL+N>XPUO'L \D
M)M.WY@>00#G))QBO3:* .)?1=?7Q7H&MI:6;&'3I+*[C-R0(2S(P8';\_P!W
M&..?SJIHFE>,_#4ESH-E;6%SH[W$DMIJ,EP5>U21BQ5H]IWD%CCD ]R.WH-%
M '*1:3J*?$ZXUQ[<?V>^E)9"0R+NWK(S[BO]W#8]<]JH6GA]?^%H7UW;7(.F
MF**^N+8#Y1>%7C5L].8\DCUVGTKM;FWAO+6:VN(Q)#,C1R(>C*1@C\JS=%T[
M0?#<4>AZ3':V?RF5;5'^=AP"Y!.X]AD^PH N:G+>P:=-+IUK'=W:KF."2;RE
M<YZ;L''&>U8B:7>:UXATG6M2L4L#ID<WE1>:)':210IR1P% S[DD=,<]-10!
MA:#JNJWVHZO::G806PM)PL$D$WF"2,Y*[O1\ $CT84_P_IUS:-J=Y>J%N[^]
M>9@&SMC7"1#/^XBGZL:V(XHXEVQHJ+DG"C R3DFL^;Q!HMO<2V\^KV$4T0S)
M&]R@9!G'()R.: ,:\TK4I?B5IVM1VH-A;V,MH[^8H;<[*P(7T&WGO[5IZ[%J
M-W ;73K:%9V'R7MQM9+<G^)5^\S#L.![UL44 9GA[0K/PUH=MI-B&\F!3\[G
M+2,3EF8]R223]:Q_#VDZC9>+O%%_=VJI::I+#) PE#$!(PA# =,XR,9KJZ*
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M4<S;HY'1"C(2/X6#-S].E=M10!B:#/XAO UQKEC;:=A=B6D$_GDGN[/M&/0
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MK>--D[90-&7! *?,3N&>1C '..<[7?"5[K>J+>KID=EK5O?*]KK-O,J_Z.)
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M1- U#3X(;ZZMGN+!X[DM%<%/O(6* JPR#T/'/M6-)\2)8O!UMXADTB&)3?\
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M&76[#S)-T<@8M^[<CD95F!_#GT[70)_$-YNN-<L;73L+L2U@G\\L>[LVT8]
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MT11R!FBW9P& Z$X/!]*N5YK%/JMK\2/'#Z-:6LUP+6Q<FYE*(,1R<?*"23^
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MY)(!8^W'Y5?T_P ?B^\-:/>O:K#J&I3RVP@+,Z1O$7$C$@9*C8< #)R!QR0
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M<3R*LDF=B$\MCDX'M4E<7X*OY]>&OZZ"C327\MI:>9G:D,/RJ/;+;F/NWL*
M.TJJ-1LCJ;:8+J(WRPB<V^X;Q&3MW8],\9KE]'\87VJ>%9KYK.WAU:*_:P>R
MWL0DPD";2V,]"&SC@'VJW#K=PWQ!N=#DTZT62/2ENTNED):0&0J$/R_*,@G'
M- &K_P )!I']F7.I_P!I6WV&V=DFG\P;(V4X8$]B#Q5V.Z@EE,4<T;2! ^T,
M"=IZ'Z'UKS]_&4P^&NMZ[_8-@6L[JXBFLC+^[?9(59B=GS$GGD#/M6A\0-0?
M1_"MOXH@&VXTN:&8A?XXG=4DC/L5;/U53U H [6BD#!E##D$9%<1%XWOX=3T
M*WU&QM[8ZO.\/V(R?Z3:\,49QT((7G@8SU- '<45R-EXNGU36+VSL/L3265_
M]EN+*1RMPL88*9@.ZX.0,8QWSQ72:EJ%OI.EW>HW;[+:UA::5@,X51D_RH C
MU?1['7=-ET_4H6FM)>)(Q(R!AZ':02/:H[G4-*\.6$:WEY':V\:$*9Y23M'4
MY8DD#C)[5SMUXRO]+T_1]9U*Q@32=2DBC<1N3+:>;]QF)X<<@-C&,\;JI[M3
MG^,]S;R+9O;C14&QV8CRFG;/&,;C@9'3@4 =NVHV*6*WSWENMFRAUN#*HC*G
MD$-G&*I#Q1X>8@+KNF$DX %W'S^M-UBTM[/P?J-I;01PVT5C*B11J%55"'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOG@84G)H YB;0-:@\76OBJU6R>[DLC9:A9&9E0KNW(T;[3EE/'(&1Z5I^&]
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M].9?WXN2!'M!SEL\#D U6M-2T&QTO3%L[FR@L+HK!8",A8Y"02JH!P<X.,4
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M@,313@A)%=>HW?/G/WL]Z](M=#G;Q?+XEN+>"WG^P?8Q%#)N,HWA]SM@#C
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M\\L"!@  #GKGCL:* //7\)>+;VS\.VM]J6DDZ+?17"SK%(6G5$9067( ;!Y
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ME2<+M [ GGG%:FJZM8:'ITM_J=U':VL0R\DAX'^)]A5N.198UD0Y1P&4^H-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6B;<#!."3PO.!TXK(TWX4:Y97GA*[?6=.9]"9P46U8!E8Y)SNRS')R3CM[Y
M-&X\<^)-8N?$A\*6%I=#0KN.U%M*I,EVVXB0AMP"@8..#G'X5+K7Q"NX_%-_
MH%B+2TN-/TW[7,;I#*9)B 4A4*P[,,MSUX%)9> O$'ASQQJVL>&]5L(].UA_
M-NK:]A=S&^22R!2,\LV,D=<<XS4FI^!=<MOB"GB_PWJ=FES/;+;7T-_&Q28
M ;ODQSA5XXY7T.* -K0O(\7V&A>)[NP^RW<4;2+%)%B2.3#(PW$9VC+8'&<@
MTNH>&+2V\):W:6J)%)="2ZWPH(PDP4;'4#[I78F/=<]:Z&SCGAM(TN9Q/.!E
MY FT$GDX'8>@R>.YZUG^*+I[7PY?>0ADNYH6AMHEZR2L"%4?CU] "3P* ,KP
MUK>M>(O#GAC5K5++R+J(-J7G;@X^7'[H#C.\'KVKK*XFUT[6?"FE^$M%TF>S
MD@M]D%]#(C&29?E#O&1]T+EV.?\ 9'?![:@#@?$'C35]!6ZNKB&QBCAU".".
MQ?+SSV[.J>=N5\)DL2 5[8ZFK.K^,+B#Q+?:#:W&GVE_% DEE#?QM_IS,"<(
M^Y0,'Y<<G.:R]0\ ^(+K2-=TM-4T\PW^I#4(II87,I(E5PCG.,+M !&> !Q6
MKXD\*:EXEL-0TW45TN[M[E5^SW$BLLEE)L"LZ#!S\P+ ;AZ$G- ':5S/]N:A
MJWB#5])T9[2%M*2(337432!Y9%+!0%9< #&3D\GIQ70VT/V>UBA\QY/+0)O<
MY9L#&3[US(\.:CI7C#4==T:2UDBU6.,7EK<NR 21C:LB,H;^'@KCGKF@#DO%
MGB6[\3_""[OXECLIH[N.TOK=E+E95N(U*JP(XSSR#D''%>GVEL\8\ZZ^SR7C
M+MDFAA\O< 25&"6.!GU/?UKC-2\!7,G@&;P[875O]IN[K[9=74P(#2F82L0H
MSP2, 9X&.M=S$93$IF5%DQ\P1BP'T) _E0!Y]\0Y9(/&7@26*VDN9%OY\11E
M0S?NN@+$#\R*V9_$0LM,UGQ#JNC2V<FEAXHDD9#))&4C?&5++\SD#J<8^M'B
M;P[J6L>)/#VI6LEHD6D3O.4E9MTNY=N.!\N!GGFMC7]%@\1^'K[1[LLD5Y"8
MF9.JD]"/H<'\* ,.S\0:[_PDUA93V!NM/NXW\VXAT^>W^QR*,@,9.'5N0" .
M1TKB/#6O>)/#/PLL]9M++3KC1[*:X:YA9G^T/']IDW,A^ZN,]#G(&<]J[OPY
MIGB^V:"'Q!K%A=6UH,1O:PNDMR<8!E).!ZX4<G'/'.99>!]3B\(R>#[BZM&T
MEY9-]U'N$[Q/(9&381A2=Q7=N/';- $EUXF\37OBN]T30[?2<)I\-]!-=M)@
MJ[D8;;SD@=AQZGI3X_%NK-I/C&9DLOM&@22+$1&VR4+$)/F&[()SC(-:%IX>
MO;7Q]<ZZ&M192V$=DL*LV]0C,P;IC^+&/UK*O?!NN&X\5P6%]8)I^OHSDS(Y
MEBD:+RR..-IP#GJ.>#0!>/B+59[+1;E%L;&VO;!;F:]N!O19F52L*H'5B3N)
MZGA<=36.OQ U>X\'>&-:M=/LS-JNHQV,\4CL I,C(2OI]P]<XST-7+7PAK]A
MJ>@WL&IZ?*;#2QITJ30/M7D?O8P&^\0H!R1D"J-KX!URU\+Z'H_V[3Y3I6K+
MJ"R%77>JR.X4]>3OZ]L=#UH T;C7_%&AZKH4.NC1_L6H7;VLL]K'+^[8Y,0^
M9OX\8]CZYKH=+O[N_P!4U16\DV%M,((65"'=PH+Y.<$ G;P!R#Z5C^/IM(O?
M#5]H=[>0)J-S &M+59E$[2Y_=&->I_> 8..WUK?T33?[(T:UL3(99(T_>RGK
M+(3EW/NS$G\: +S*KJ58!E(P01D$5Q/PT18[+Q&B*%5?$-\  , #S*[9MP4[
M0"V. 3@$_6N<\(:#?:!%JL=X]O)]MU&>^4PLWR^:V=AR!T]>_H* .DJM=6%M
M?/;M<PK+Y$GFQJXR ^" <>H!-9/A*YUNYTZY.N2V<\R7++#<6:,L<L>%((!]
M"67/?;WZF7Q/::Y?:8+;0KJTM9G8>;)<AS\G=5V$$$],Y! Z<\@ Y&6V.F:A
MX[\6:3&((!IQBC\L86>XA1V>3'?!(3/<JU9.L9TGX#>&]1M21=6G]GWD3CJ9
M7=2Q]\^8^?7)KM]'TKQ%A[37I]&?2_LQ@2TTZV>,'.!\Q=CP%R,#'6J$/@FZ
M?1])\/7MS#+HVF7"2HPSYMPD9S%&XQA0/ER03NV]!F@"]XLTS2X_"^LI)81W
M,VH*R",J&>XG8;8P">X.T _P@9X ID^D'3/A7)I5XRW,EIH[0N[#(9EA()&:
M@U'2_&LOB&6_LKS0/LZ I:17=O,YA'<_*ZC<>YQP.!WSKSZ?JUUX1N-/N;FV
MGU*XMY(I)@ICB#.",@<G SP.IQR>] $7@3_DGWAS_L&6W_HM:T-=N[^QT2ZN
M=+LA>WJ)^Y@9P@8Y Y)[#J?I4/AC3;C1O#.FZ7=-$\ME;1V^^(DAPBA=W(&,
MXZ5!XRT.Y\1^%;S2K.[6UGFV%7<$H=K!BK <E6 P?8T 8^G^+KZX\1:IHRR:
M=?M;Z<M[;W,"M'&Q+,I0_,^<$=0?;K6$/B#XG@\):1XON].TO^Q+@QB\BB9_
M/C5VV^8I)VX!(^7D^XSQN1>'-;A\4S>(;R\T[8^D_8YK>"%QMVLS#82>G/4_
MEWK"\&Z'?>)?A-X>TF\-JFE.D4LSHS&26-'WB/;C"Y*@%MQX!X&> #8D\1>+
MM0\0^(]'T>TT=9=*\@QR7+2,)!(A<*0,<G@9X QWSQ2M_B'JVJ:;X4NM/TZT
MC?6;B6TGCN';,,J!]V,=LIGUQQC-2Z.VJ+\3_'7]G)9R9%B"+B1DVMY!P?E!
MR.O''UJPO@2ZL(?"T&G7%NZ:-<O=3/.2K7$CAM^  =N2['OC@4 7++7==N=7
M3P[*VF1:O;V?VJ^N(XY)(%W.5C5%+*V2!DDGCISGBG#XL\0:EX<UIM-L+-O$
M&BW+V]Q:.&:.<K@@QD$$;E.0#GGCWK3O_#E[#XS3Q/H\EN9Y+7['>6MRS(DR
M!MRL& )5@>.A!'I4=OX7O[*QOEM[F$7FK7QN=0F!9,(< QQD D80!0QYZG@G
M@ F\+>(KOQ3:-JMJ(/[*>)1!OB9)'E ^?/S'"JWR],Y![ $\[)X\UJ+X=W7B
M%++3_M5OJ+VCQ#?LVB<19'.2><]16YHOAB\\.>)=2FTLVD>A7H$GV#++Y4X&
M"Z8&%#8&5]L^U8S^ ]8?P%?>'?M-B);G4#>"?+[5!G$VW&.N1CK[T :$VO\
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M@R1G.T$;CVQD>O;!R_$&OZGJGPR\<Z5K:6XU32!Y$LMN"(YE8*R. <X)!Y%
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MU '956;3K%]034'L[=KU$\M+DQ*9%7^Z&QD#D\5YU/XI\6MH?BW48;G2H_\
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MK]HR:!<1O;^78D>9&B,@#Y?EL$#(( YX/;NY[J&V:)97VM,XCC7!)9NN ![
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MB! (&_[G)^4G)_O>O:44 <WI?A@VWBNY\1W)M4O)[06KI:1E%DPVXN^3RW
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M[>$K5_&LGB)I"?-M5ADML?(\B[@)#ZD([)]#5GP]XLT+Q7;RSZ'J4-XD3!9
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MR0 RX8;>N?\ Z^*/AU>#PI?Z*=;5GEU+^T+69K7_ %;>;YN' ;YLG@XV^PH
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M$0\1W5SX?GU+Q!932:-.9$=+%@TXV%,OF3[Q![8'U[=M,)&@<0LBR$$*74D
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MC]V0H^_OZ_+Z=ZA\%^ M8\';]-A\1B;0%G,T5N;;$RY.=GF;L!2>O'/.,9H
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M+3B$*3A 0"2<8'4<9S6G7%:C_P EDT+_ +!%U_Z''0!VM-=UC1G=@J*,LQ.
M!ZTZF30QW,$D$R!XI%*.C=&4C!!H YS3?'_AS5=9CTJWO)5NI@6MQ-;R1+<
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M"6R_>L@5F'D\9"@#(&!P!G'05WM !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@U:QN-3C;3-2V[[>2UWO#A%4^6^X 'Y<@E3@G-/MO"\UGXKGUR"_0>98I8K
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MZ((O$9B>_CD=/,C*YDCS\K,%X#8/(''% &G/>PP7=O:G<T\^XHBC)VKC<Q]
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M/M.T(-GD[MN_=G&,\8Z^U &0OPZMHOB!)XR@U2[AOY1MDBC5!%(NT+M88R>
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MUF^A-]:):7T400+.$!"G)4E3AB/EQ^%=4LB.SJKJS(=K@')4X!P?3@@_C3J
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MWZ1J]H6*#<DK;3AM^X9./EP1CJ?1^M<UJ?A$:K%JEG-J,O\ 9FIE?/M#&I"
M(JD1MU7(0=<X/(P:DM=,U"#QI/>1ZA=MI36@B-G+CR8Y!MVF/OG ?<>G('/8
M /&.MSZ'I-LUL/\ 2+R]@LHVX^0R. 6&[C(&<9XSC/%<_?ZOXD\)IK>KWBRW
M.B0:>9H8[N2,S+<@XV@QC_5L",YY!Z<5UGB+P_8^*-#N-)U /Y$V"'C;:\;
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M") KG9M*@^B@GU[5U!\%64=[X>FLKB6TAT%'2U@15*D,FQMQ(R>/<<\TL/A
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MQZ9;2PK/<0/"9)'( 4!@"0@#G/3,@QR#@ [.VBDAM8HI9WGD10&E< ,Y]2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "L0>&85\2W6O)?7B7EQ;"U8
M Q[%0$D8!3J"2>2>M;=<EK7CVWT+3[[4;K1-7;3K*8PR72+#L9MX3*@R!B-Q
MQG% ")\/=.C\,6'A]-0U$65C<+<0_/'O#*^]<G9R W-=:H(4 L6('4]37+W_
M (T.FVE[/=^'M7A^RV;WA#^00\:8W;2LI&1D'!YQZUT&G7BZCI=I?*A1;F%)
M@I.2H90<?K0!EW/AB*;Q!+KEOJ-]9WTD"0,874HR*6(!1E(/+'G&?0CFHXO!
MFD"UU>*\22^DU@ 7\]P1OF 7:H^4 *%'3 &.O7FNAHH Y/POX!LO"<'D66JZ
MO/ @;[/%<W =+?=G)10H&>3U!ZGU-92_!_P^GA6?PV+S4_[.FNQ>.OFIN,F,
M==G3@<>U='XC\56_AF33UN;"]N/[0NDM(#;B,@ROG:IW.N,X//3WJ:WUV275
M(;"YT;4;-ID9XY9O):,[<97*2-@\Y (YP?2@#(U[X=:5KUQI=[)>ZC::EIB"
M."_M)528J.S':0>_;N?6I=;\ :1KVDV=E=37JSV4XN(+Y)O](67J7W$$$G X
MQC@8 P,;NDWMQJ&GI<76GS6$I9E-O,RE@ Q .5)'(&?QJ[0!RFD^ -.TCQ9<
M>)DOM2N-3N81#,]Q,K!UPHY 4=U4\<#'  XK'F^#?AV:QU'3S>:LFGWMU]K:
MT2X41QR>JC;Z<?-FN_EGBA,8ED5#(^Q 3]YNN![\'\JDH Y.]\ :=J&KZ)J<
M]]J'VG1D"6I5XP.,<L-G).!G^E0GX:Z3'XHN]=LK[5+"6^.;RWM+GRX;@]26
M&,\\]".IZ9-:GB'Q5!X<N=.@N-/O;AM0N%M8#;B,@RMG"G<ZXZ'GI4D6OS/J
M LIM"U.WE:!YHVD\DK)M*@J&60@-\PP#COSQ0!LJJHBHBA548  P *S)=$6;
MQ%#K)O[P20PM"D *>4%8J6X*YR2J\YSQ4?A?Q!#XI\.VNLV\$D$5SOVQRD;E
MVNR\XX_AK8H Y+Q)\/=+\4:]8:U=WE_!>V&#;/;.B;"#N'5"3SSR3WKK%!5
M"Q8@8+'&3[\4M% '+:UX$L-=\2Z?KUU?Z@EYIYS:B)HPD?.>A0Y_'-=0H(4
MDD@=3WI:YO4O&$6F^);?01I&I75[<PM/#Y'D[61?O'+2+C'O0!8USPO:ZYJ6
MFZBUW>V=[IY?R9K20*2K@!E;<""#@=L\<&LW_A76C_V)J^D&YU%K75+DW4FZ
MXW-%)O#Y0D==R@Y.3ZDUJ^'_ !/IWB1+H69ECN+.4PW5M.FR6!_1A_(@D'UK
M9H YZY\(6EU?Z7?27^HB[TY)(UF6<!IE?!=7..A('W=N.V*S)?AGI,EE<V(U
M'5H[2:\^VQP)< );R[]Y*#;T)'1MV,\8/-=I10!RE_X!L+S6QJ]MJ6K:=>/$
ML-R]E=;/M2*,+YF022!QN&#[U=?PG9'6],U2*XNH7TR!K>VAC*>6$8 ,#E23
MG:.<]JU[V>2UL+BXAMGN98HV=((R TA R%&>,GIS2VDSW%G!-+ ]O))&KM"Y
M!:,D9*G'&1TXH YIOA_H\VE:SIMW+=W5MJUR;N<2NH*S''SH54;3\J^W'UJ;
M3O!-C::?=6=_?:EK*7,)MW?4[CS6$1ZHN  ,\9/4X'/ QTM% '&P_#FSCATN
M"76]:G@TJX6>RCDG3]U@%0N0@)&#W)(Q@$#.>RHHH Q(_#,,/B.]UV._O%N[
MN!8'7,9157.W *=B3U)Z\YK(?X:Z,_A:RT'[3J"QV$QGLKI)E6XMW)))5PH[
MD]0?T&.NEGB@V>;(J;W"+D_>8] />LC3O$<>H^)M7T,6<\,NFI"[R2%=L@DW
M8*X)X^7O@\]* *%SX#L;WPU<Z+>:GJEPMTR&YNI9U:>7:05!8K@ $=% [^IS
M<\0^$K'Q-I=O9ZA/=B:VD66WO8)!'/%(/XU8# /X8]JWJ* .9?P1I]QX:OM$
MOKS4+Y;Y0MQ=W,^Z=L'*X;&!M/( &.O')S)<^#[6XETV[^WWZ:GIX81:@)%,
MS*WWE?*E64^FWCMBN@D=(HVDD8*B@LS$X  ZFN7;QQ$-(&LC1=3?274/%=HL
M9#J?NOLW[PIXP2.AR<"@#:TK1[;21<M$TDL]U+YUQ<2D%Y7P!DX '
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M9M_EY4&0,1N.,XJ34?&ATNSOKB\\/:O#]DM'NRK^00Z+C=M99",C(R.N#T-
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MI5?+C5P8P1A#U&>>/4\UN2>!;.X\.7NCW>J:K="^4)<W<\ZO.Z#HF2N O)X
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MBI=BU9-LQ485B'5L,!QE<&@#@[/Q)KWB'3O =P^ISV,VHW5Q:7JVZJ%D\M9
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MRL&3"<?<48.1@5++X-TR]74_[3,NH/J5NEM<23[03$N2JC8% P6)SC.>_ P
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M^\.&QC.X8ZY[]AQ7?UD>&O#UMX6T.#2+.XN)K6#/E?:&4LH))QD 9Y)ZUKT
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M^TTG2WOET^017,GGK&/,*AMB9^\P!&<[1SUZXT-$U5=;TF+4$MIK82,Z^3.
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M35*YN;Z+4[&"#3_/M)O,^T7/G*OV?"Y7Y3RVX\<=* +:(D4:QQJJ(H"JJC
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M=I3& 1@Y ]N*[^B@#G;OP3HU]I$NG3I.1+="\>Y64K,9P01)O'1A@ 8X
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MHC\36MS?RJ,*SR.[,V.R[V 'MBNQUKP7IVNZHNHW5WJD4Z1^4OV6_DA55ZD
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MH_$7A._N_$-UXB\':T+#78@D%Y!*-UO=;5#*L@[':R_,,\'MUKO0 H    X
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MF8.0T!!_@YV[,=AWZ@'I%%>816=YXXC\2J-3BL[ZSU.:VBG^?S;)8R/+9<.
M 0-W^UDYS7HVGLSZ=:M)<+<2&%"TRKM$AP/F [ ]<4 +?WUMIME+>7<JQ01C
M+,?<X ^I)  ]ZQ[CQ%<0>.[+P\UG'Y%S9RW*W(E);*%05VXX^]UR:Q/B[:PW
M'@9FE3<8[VU*<D8)G13^A(_&J^L:3:S?%'0-//FI:_V3=@I'*REAOCX+ [L?
M0^W3B@#T.BO'K76+K2/#%QIRWLD=FGBZ32A--*S>3;;LA2^=P&<+G.<'K7;:
M#H%SHGB>[F_M.$6=Y;AETR)&"(ZD RKN8XR& ( &3@T ;6O:E+H^A7NIQ6RW
M'V2%YVB:7R]RJI8X.#SQ4?AO5Y=>\/6.K26JVPO(4G2(2^80K $9.!SS4'C)
MU'@K7D+#<=,N2%SR0(V_Q%<+;^9;>'_A2Z/)$\C6T,FUBN]#;,=K#N,@'!H
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MZ 7B,;8;@H=3C]YR0,#'.1VH Z+3/#^FZ1>7MW912I-?2>;<,T\CB1^F<,Q
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MF"TF%G83+/:Q"\F'E.IRI!WYX/3TJ*[^'_AF^DU%[G3F<:CS=)]HD"2-TW[
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MX3;AP "H!/&#DYS7:CPAI'GV\TGV^=K>198EN-2N94#J<J=KR%20>>15>^\
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M@'%>D+9VJ1PQK;0JD)W1*$&$//('8\G\ZS=/\+:5ICVC6\4S"R4I:K-<22B
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M2> 2S!1GW]#CG-'L_LOQ5GT]K2VL+:Y\/K))9V;D+D3;06("Y?!(R!TXR>M
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M08Y/O(P.&4_B*XW1+&[O_B1\0X;74Y;'<]DK/%&K,,P'D%@<$>M1>(?"6E:
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MJSJ4M=1O((D3[B(LPPJ#LHSP* /1M2\0WMCXQ\.:.MO ;755N"\I8[U,<>[
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M_?WFL6=AJ=GJ$S3W@M2;NR:.9BJA_,&%V  #&,'UR: /7:Y?QCXFO?#3:/\
M9;*"Z74M1AT\>9,8S&\F<-PIR.*Z=,[%R<G')QC]*X+XH]?!G_8T6/\ [/0!
MWD>_RU\S;OQ\VWIGVIU0W%S#:B,RN%\R18T'=F)X _ST!->3:+8#Q=X0AURX
MUFSL=4M;MIKB\2T)NK>59#F,MYG0C"A<8*D #I0!Z_17C7CIK:X\/^-=4T[,
ML]E=HKW]RX\RWF3R_P!W;X&549ZDCEFP#UK<\:PWL.JWNJC3+77](%DL-Y9[
M@MS9@;V,D.>.0V3C!)0<\< 'I.:*\QAN[;Q1XO?2Y9;)[&31K6XTZWU&U,HE
MC<,7=5WKAON GD\<8YS#;1C3]<\'^$;[56U72]MX?.G7"W,L9PD;9)#!,MQD
M\J.XH ['0O$%YJ?BCQ'I-U;P1)I<D"Q-$Q8N)(]^23CV[>O6NCK@O!5E:Z=\
M0?'5M9PI# LUFRQH,*N8,G [#)/%=[0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6)=^$="OM
M3.IW-@)+XKL\\ROO"YSM!!X'L.*VZX^Z\4:T/'DOABRTVPE9=/\ [06::Z>,
M%/,V;2 C8.>] &JGA'0$M+ZU_LR%H;]52Z63+^:%SM!))/&3CTIMMX,\.V=Q
M#<V^E017$,1ACF7(=5/7YLYS[]?>HO"/BR+Q5:7I:T>RO=/NGM+RV=P_ER+U
MPP^\/0X%=%D4 80\': -*ATL:>HL(9/-BMQ(X1'SG(&>#GGZ\U)>^$]"U'4H
MM1N].CEO(X_*$Q9@S)_=?!^<>S9K9SQGM1F@#!3P7X=CTVTTZ/2XH[2TE$T$
M2,RA)!T?@\L.Q/(JU>^'=*U"]2]N+8_:TC\D3Q2O'(4_N,RD%E]CD58U1M0&
MEW#:2MJ]_L_<"Z+"(M_M%><?2K2EMB[]H; SCIGVH S+OPWH][%913V*&.Q9
M6M41BBPLO *A2 ".Q[4:OX;TC7C;-J=DD\ELVZ"3<RO&>^&4@C/?GFM7( R3
MQ1G R: ,W2O#^D:&UPVF:?!:M</YDK1K@NWN:DU#1['5)+>6[B9I;<EH9$D:
M-XR1@X92",CBKU<YH7B"\U+Q/XCTJ[M[>)-+D@2)HF+%Q)'OR2<<\CM^= &W
M96-KIUL+>TA6*(,6(')+$Y+$GDDDDDGDDTW4=.M-6L9;*^B\ZVE&V2,L0''H
M<'D>U6JAN[N"QLYKNZE2&WA0R22.<!5 R2: $6SA2R%FH<0A-@'F-NQ_O9S^
MM95OX.\/6VBSZ-%I4 TRXYDM3DQD^H4G .><CT'I6M:7,=Y9P746?+FC61,C
M!P1D?SJ;(SB@##L/!WA[3+V"]M=+A6Z@C\J.9RSNJ^FYB3_G%5F^'WA1_.#:
M);%)I1,\?S>7O!SN"9V@Y'. ,]Z7P]X@O-5U_P 1:=>6]O"-+N(HHS$Q;>'C
M#Y)..>1VKI"0!DG% &;'H.F0ZN-5CM0E\(A )5=@1&.B8SC;GG&,9YJJ/!OA
MX65Y9+I4"VUZ_F7,2Y593G/.#TR2<=,]J@\;>(+SPSH U&SMX)B+B&)Q,Q&
M\BID =3\WJ*)_$%Y#\0;+P^;>#['<V,MT)MQ,FY&48QT ^;W_"@"_=^'=*OH
M;..XM2QLSFVD$KK+#QCY9 0PXXZTVX\,Z-=Z0=*GL$>Q9][PEFQ(V=VYN<L<
M\Y.>>>M:U&: ,QO#^F/J4&HO;E[R",Q1S/*[,J'JO)Z'N._>L^+P#X4@CBCC
MT*T"0S>?&NTD(_/3/0<GY>G/2NCR,9SQ10!GVNB:=9:G=:E;6^R\N\?:)=[$
MRXX7=DX.!P/0=*T*,Y&::Q)0E-I;'&3QF@#-L?#NE:;J-SJ%G:F*[N2#/+YK
MDRXX&[)^;&>,]*?J6A:;J\UM-?6_G26K^9 WF,OEO_>7!&#[]:ETIM1;2[<Z
MLMJM^5_?"U9C$&S_  EN<?6KE &?J6AZ=JTEO+>6^^:V8M!,CM')$2,':ZD,
M,]\'FN9\>^');SP,^B:'I/VCS+F&1HD=%!"S+(Y8NPR3@\\DD\UVU&<]* ,[
M3](L;*0W4-M(ES)&$9YY6ED51SLW,S8 /8'&:HVG@GPS8:Z^M6NC6L6HNQ8S
M*O1CU8#H"<GD#/)K?SF@'/2@#.T[0M-TJYNKBRM_*FNFWSMYC'S6_O-DG)]^
MM9EUIQ\,6LUSX6\-P7=W=7(:XA6X6WR"26?<P(X/.T>IKI,BC('4T 9>@:8^
MEZ<RSK$+NYFDNKHQ?=,KMN./4#A03R0HK4HS5--4M)-7ETM)0UW%"L\B#^!6
M)"Y^N#^5 %67PSI$UU/<26FY[B199D\U_+E=<89TSM8C Z@]!Z4X>'M+6_N[
M];=ENKQ0EQ*LSAI%'0'!Z#MZ=JU** ,!O!/AM[.RM&TF$V]B[/:H2W[DGJ%Y
MX![CH?2G?\(9X<^Q7MFND6Z6U]+YMU$@*K*W7Y@#R,\XZ9[5NYYQWKG=4UR\
M/B%?#VDBV74#8/?&2Z5FC"APBKA2#R2><\!>AS0!>D\.Z7->6-W);,]Q8@K:
MRM*Y:($8.#GN.#ZC@UJ5DG6&TSPQ_:WB!(K%X8/,ND23>J,!R%/?G@?7%4=3
M\07ECXWT'15MX#::G'<,TI8F13$@; '0?>'K0!HZAX?TO4[V*]N;8_:XE*)<
M12-%*%/)7>A!V^V<4ZXT'2;K13HT^G6[Z:5VFV,8V8SGIZYYSUSS6CUH!!Z&
M@#+T+PYH_AJS:TT:PBM(6;<P3)+'U).2?Q-:E<QXW\37GA73;6]M;*"[$]W%
M:E))3'@N< Y /&:Z2+S/*7SMGF8^;9G'X9H Q;?P7X;M=>?6X-'M8]1=BYF5
M?XCU8#H&Y/(&>34UWX8T:^OI;V>R!GG01SLCL@G4=%D"D"0=L,#6OD9QGFC(
M% &=<Z#IEW?V=]-:@W-D"+:0.R^2",': <#(X/J.*K-X2T-DO%:Q!%[(LMQF
M5SYCJ058\_>! P>O%;5<G!XFU.;Q%XHTP6EIC2K>":V/F-^]\Q7/SG''W1P!
M^- &N?#FE-9W=J]LTD=X MR9)7=YE QM9R2Q&.,$XY-17GA+0M0TRTTZZT])
M;:S(-LI9MT..FQ@=RXZ<'I1X1UF;Q%X1TO6+B..*:\@65TCSM4GL,UM Y&10
M!C6?A/0+ WIMM)M4-\NRZ)3=YRXQALYR,=?7J>:BTCP5X<T&&YBTK2HK1;D;
M93$S!F7TW9R![ XK>S7.77B"\M_'VG:#]GMS9W=I-/YVXF3=&5&,= /F]_PH
M TK+0=+T[2#I-K91IIY5E-L<M'M/5<'(P<GCIS570O"'A_PRTS:-I4%HT_$C
M("21Z9).![#BMNB@#FE^'WA-05&AVWEF83B([C&KYSE4SM7Z  &ND50JA5 "
M@8  X I:* .)\3:'>:MX^\-7@TR>;3[".Y$UQ'.D91I%0*5^</QM.2/7O703
M>&-%N='GTF?3XI;*=_,FCDRQD?.=S,3N+9 ^8G/'6M:B@#"C\&^'89VGBTJ"
M.9H/LYD3(8Q\Y&0<Y.3D]3DY-6H/#^DV^AOHL=E'_9CH8S;,2R;3U4 G@>PK
M3HH JZ=IUGI-C'96%ND%O&,(B]!_C3[RRMM1LY;.]MX[BVF4I)%*H96'H0:G
MHH SM/T'3M+8M:P,)/+$0DDE>1U0=$#,20OL#BDTW0=-TB:XFL+8PO<N9)R)
M&/F.>K,">6]^M:5% !6+)X2T&674)&TR'?J((NRN5\X'&0<'H<#/KCG-;5%
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MI)_,C\S>Q5PJL4W8(YQG-;^M>#/#GB*]AO-6TBVN[F$;4D<'./0X^\/8Y'-
M'#3Z%9W_ (S\)Z??7LVJV\NC74<T[.RBZ5?+ 8@'OG.0>>O-7-$\.:):_%+6
M[)=,M/L\.E6:QK)&&QS(N<MDDD  D\GO7;R^']+FU2VU-[4?;+5=D$H=AY:]
MU4 X /<=#27FB:>^I?VVNFP3ZM#"4AD8[6(&2%STZGJ1QF@#SO3+9=.EU'X:
MR19\Z\$]M(PR7L)"9'8GJ678T>[L2E>AZ_/<:7X4U.XTV$?:+6RE>VC5>-RH
M2H ^H'%4?#]MJ=]J#Z]KFF0Z=?&W%K%:I.)FB3=N8EP #N.W@= H[DUT= 'D
M6I0Q0_"SP]XGT7!UU392)=(?WMU)(Z)(DC=7W%FR#Z>U;;Z3ILGQQ)>PM6;^
MPA<9,*G][]I^_P!/O>_6NJL_"VB6%PLUK8)'LD,R1AV\J-SG+)&3M5N3R #R
M:F.@:8=:_MG[.?[1V>7]H$K[MF<[.OW<\[>E ',?&"W@G^%^L--#'(8E1T+J
M#L;>HR/0X)Y]ZJ>(])T]OB!X(TY+:..S\K4 T$(\M2#&A((7'![COGGK7>7]
MA:ZI836-] EQ:SH4DBD&0P/:LZ/PIHD,]C/%8*DM@I6U978>4#]['/?OZ]\T
M >8F];PWX<\4VEG)]DTNV\310-C)6VMG,1D  ((7YB, C[QQBNVT7P]!I?B[
M^TK;4[2-+VRVG3["V\J&8*P(FQO89&X+GN"*VX?#.C01W\:V$;1Z@2;M)&9U
MG)X)8,2"?>F:#X4T+PPDJZ+ID-GYQ!D*9);'09))P,GCIS0!S7Q;_P"19TS_
M +#-G_Z,KN+BYAM(UDF<(K.L:Y[LQ"J/Q)%4M9\/:5X@A2'5K1;J*-@ZQNS;
M0PZ' .,^]00>$M#M[R"[2P!GMVWQ.\COL;!&1N)YP30!YGJ[6TFG0:WI>74^
M)X]NHW#C[3(QGV.BX VQ 94 GD#H!S6]#H&F:S\4O%-IJ$!N;5["T=H7D8H2
MWF<XSCZ>G:NFD\!^%I?M7F:):-]JE\Z7*GE\AMPYX)(!.,9[U=B\-Z3!?3WL
M-J8KF>,12R1RNI9 ,!>#T'8=NU 'EOAS5IKO0OAEI6I3-)I]^+D7'FG(F:($
M0QL>XSC@]2HKH-$L;33O'_CZ"SA2"(V-F_EQC"@E)<X'0>OXUU3^#/#LFAIH
MKZ7"VG1OYD<!+8B;.<H<Y4Y)Z$=3ZTZV\(:!9RW$MOID4<US&(II06\QU Q@
MMG/UYY[T ><:)>,/#WPMTJY_Y!-^D@N@?N2.L1,4;>H+'..Y45H:G9G3O%'B
MW2+%6CT:;P\;Z2")BJ07.74%0/N[@I) ZD9KNO\ A%M$_L1-&.GQG3XV#10$
ML1&P.04.<J0>F",5*OA_3%L;JS^S%HKL8N"\KL\PQC#N3N;CCD]..E 'ELUI
M9^'OAAX=UBV$L%QJD.FV>I7PF?<MLVTMSG"\?+D<@''I71SZ5IVF?&+P^UA:
M06PETNZ#+"@16P8\' XS@]?8>E=@GA_2DT,Z)]BC?3"GE_99,NFW^Z <X [#
MM5.Q\%>'-.NK6ZMM*A6XM%*P2N6=HP<< L3Z<>G:@#<CDCE7=&ZNN2,J<C(X
M(IU4M+TC3]$M6M=-M4MH&D:4HF<%V.6//J:NT %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<O_ ,)!>P_$>;0[
ME[5=-72?MZR;2KJWF[,,Q.,8!/0=: .HHK,UC4)[#2GU*U1;F&!#-+$O+21@
M9.PYQN Y Z'IQG(NV=W!?V4%Y:RK+;SQK+%(O1E89!'X&@":BBN5'B"_U3Q9
MJVAZ5-86SZ4D1F-U$TKRM(NX;55UVJ 0-W/)Z<<@'545EZ#?7][IC3:K;0VM
MTD\L3QQ.63".5# G!(( /0=:T(+B&YC\RWFCE3.-T;!AGZB@"2BH4N[:3S=E
MQ$WE?ZS#@[/KZ5CKKG]O>%[C4/#E[9B0^8L$]SEHAL<J68 YVG:2#]#0!O45
M%)/';VXEN9HHU &YV;:N?QIQEC6+S3(@CQG>6&,>N: 'T5&D\4DCQI*C/'@.
MJL"5SZCM1,95A<P(CR@?*KN54GW(!Q^1H DHKGO!&OW/BCPE::O=P103SO,K
M11$E5V2N@Y/7A15W6[C6(XHH-$MK:2[E)_>W;,(8E'4MMY).0 HQGDYXH U*
M*Y7PCXDU35-0UC1M<LK>WU72GC$KVK$PS)(I9&7=R. <@UU$DB11M)(ZHBC)
M9C@ ?6@!U%1?:8/LWVD31F#&?,# KCZURGAK7-<\20Z5K5J^G_V1>!VGM65A
M- O/ED,"0QX&00.O% '845F/KEC_ &ZVB1W$?]H"W-P4)!V#(5=PSW)X'H#6
M5X+\1W.MZ1-/JKVL=TNH7%HBQ HK^6Y48!))/'K0!U%%13W,%LH:XFCB4G ,
MCA03Z<U+0 45R.B^(=6U'QWK^@SBR6VTE;=O,2)P\OFH6 Y;"XP?7/M77$X&
M30 45%!<P7*%[>:.5 <%HV##/IQ1!=6]SO\ (GBEV'#>6X;:?0XZ4 2T5$EU
M;R2M$D\32(<,BN"0?0B@7,!N#;B>,S@;C'O&X#UQUH EHJ&Z\\V<XM6C2X\M
MO*:4$H'QP6 YQGK4%I<O!I%K+J=U:><8D\V:,[8F<CDKD]">E %VBD5U==R,
M&7U!R*C:ZMTN%MVGB69AE8RX#'Z#K0!+14<D\,6?,E1,*7.Y@,*.I^E(;JW'
ME9GB'G?ZKYQ\_P!/7\* ):*BGN8+90UQ-'$I. 9&"@GTYI[2(A4,Z@L<*"<9
MXSQ^% #J*9%-%<1B2&1)$/1D8$'\17,:AXDN8/'>@:1:RV<UCJ N1/M!:1'B
M0,!D-@9W#C&>* .JHJ(W, N!;F>,3D;A'O&XCUQUJIK-\;#3)Y(I[:.Z$;-
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MQ+I3+#]NM'VR+N177>N?F0AL<XZ$9KO*R[OPYHU]<O<W.F6LEQ)]^;RP)&X
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MA96\S9NXSOSG'7 _N\=;X0LK;3?"MA96=_-?VT"M'%<S$%I%#$#D<$8X!'4
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M.WCM[:&.&&,;4CC4*JCT %9DWA3P]<37DTVAZ=)+>@"Y=[9"9N0?F..>0#^
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M8/\ ,L68T@48VKR"&S]XG /6O3[C0-'N].BTZYTNSFLHF#1V\D"M&I'0A2,
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MZ? UH6:W:.W4&(MC<5.."<#GVH \BO9+#5OV>;C4[H0RZF9Q+=32 >:MS]H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*K66HV6I0F:PO+>ZB5BI>"57 /ID'K5F@ HHHH **** "BBB@ HHHH ****
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M--BTXZ='IUHEB1@VRPJ(B/\ =QC]* /,ENK&;QIXT@U'6;;R[K0XUFGM,*
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MG;$:W96,MECP&*# )]2.]>F?V+I0\[_B66?[[B7]PO[SG/S<<\^M$NBZ5<6
ML)M,LY+,'<+=X%,8/KM(Q0!YWXOAT.U^&UV-!"BQ?6;>3>LA>.21KB,N4))&
MW.1QP"#6M-=VMA\:YI;NXAMXY/#J;7E<(&*W#$\GT!%=C-I>GW%M';3V-M+!
M%@1Q/"K*F.F 1@43Z5IUS);23V%K*]J<V[20JQA/^P2/EZ#I0!XMI>JP6WA'
MPL9YD&CKXDG_ +0)/RI^]E,7F>B[MIYXX%;VMW*_\+$\4'19X3J4WA3,/D."
M[SAI-N,=6QM_2O2_[+T_[%)9?8;;[))G?!Y*[&SR<KC!S26FD:;I[*UEI]I;
M,J>6IAA5"$R3M&!TR2<>YH \[\//X6\00^%+ZW\03SWUEM^RV430+)$2F)$=
M50-M !SGC ]QG9^*91/"UG+(55(]5LF9FZ*/.7))["NKMM)TVSNYKNUT^T@N
M9O\ 6S10JKR?[S 9/XU/<VT%Y;O;W4$<\+C#QRH&5A[@\&@#A+F.PU/XRZ=N
M6WN8!H$SIG#J2)T&1V/>N0AO5TGPC"YEDM]&M/&%PET\"JP@AWR;#@@C:'*'
MIZ5['_9.F^>L_P#9]IYRJ%63R5W  8 SC.,<41:3IT$$T$.GVL<,W$L:0J%?
M_> &#^- '.>&K30F\3ZEJNE:U+JEU=P1_:WCEB>$;>$)\M0-^,^^/PKKZK6.
MGV6F6_V?3[.WM( 2?*MXEC7/K@#%6: "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *HKK6EN;P+
MJ-H398^U 3+F#/3?S\O0]:O5YO%J=CI7Q&\<17]U%;R7=I9M;1R-AIP(W4[!
MU8YXP,T =RVMZ6ME!>?VA;-;7'^IE20,LO&?E(Z\ GBE_MG3/[.34!?VQLY#
MA)Q("CG.,*>_(/2O*O#JC4/!/@=M'\00:=KMO8S"U\T!X9@-@EBD&<Y^X>.1
M@FED\221CPAK>L1/H^F^;?6]U-:'=#%<,^%D!(/R/MDP>P8\XYH ]8T_4K+5
M;476GW<-U 25\R%PPR.HX[CTI]W>6UA 9[NXC@B!"[Y&"C)Z#ZGTKGO!MOH:
MG5+W0;F6[AO;CSI[HR;HYI<88I@ 'MDCC/'4'&;XRN7T_P <^#;^[;9H\<UQ
M%-*WW(IWCVQ,WIGYE![9H ZN'7-*N+"6^BU&U>UB8I+*)1MC8<$,>QY'!KDO
M!^LZCXOMM.UVUUZ)$9Y&O=+\N-U6,LPC ( =6&T'))!YX[4[245?BCXDU.UE
M1=*-A;I=2!AY;7(+=^F5CQGTW"G?"":.7X6Z)Y<BN5C<-M.<'S&ZT ==<:G8
M6EW;VMS>6\-Q<';#%)(%:0^B@\G\*A.O:0OVS=JEDOV+'VK,ZCR,YQOY^7.#
MU]*Y;XB3Q65_X0OKF1(;6#6D\V:0X6,&*0 L>@&<<FN:O-1L+_5/BH8+F&99
MM%A>(@@B0+;RY9?[P&1R..10!Z3;>)]"O=273K;6+&:]>,2K;I.I<J1D$#.>
MG/TYK2EEC@B>65U2-%+,S' 4#J37D]Q8:?J'AGX<?V.MN=22[LYD>WQO6-4S
M.6QSMX.[/? /)KUN@# \/>,-(\2:5-J-I=PK!$\H??( 51'90[ _=!"YY[5H
MV.LZ;J<LD5E?6\\L0!=$<%E!Z$CK@]CT->-P7Q7X26\,#^=_9NN&?5K:/YG2
MW6\=F#J.1_"<'L#V!KMM3\K5/B?X3O\ 1YXYA%:W37LL#A@;=E'EAB.Q?E1[
M$]C0!WE9UMKVD7MX+2VU*UEN&!98TE!+ =2OJ!WQTK/\=PZA<^ ]<ATH.;Y[
M.18@GWCQR%]R,@>]<AJ]Q9^(/#?@9M!DC-ZE_:/;K$1OA1%Q,& Y"JN0P^@]
M* .VN?%_ANS21[C7M.B6.7R7+7* *^,[3SUQV[5H7FIV.GP+/=W<,,;_ '&9
MA\W&>/7CGBO,(O[.9/BNQ^S$_.I/RYV_9AQ]-V?QJM:ZW!I5WX+O=6U*:RTF
MY\.1VT5ZA78EQ\C,KL00NY0.>/NT >MV5]::E9QW=C<Q7-M*,I+"X96'L17+
M>(M<O-(\=^&K=M02#2KN.[:Z215"CRH@P8N>0,GU'2KG@JST>TTFY;0I)I;&
MXNY)Q/(VY97;&YD_V<YZ<9!QQ6/XL:U;XH^!(IVB)'VY@CD=?*7:<'W''N*
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M=V;QG<&DC0;X\CKN7<I'J>>E=!X0G.L6<OB5XGB.J['@20?,ENHQ&#]<N_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2TMI8#!);Q/">L;("OY53M_$&CW=ZMG;ZE:RW#[MD:R E]OWMO\ >QWQT[U
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY Z$^F>/KT(!YYX%UO3O#VA:Q>ZM>QVEE?>);Q+)Y,[6#/@ >V5?GIP:]*.
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MD2*QZL% -24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6SE^+7C-2\+R/#8A.02VU&W >N#MSZ'%8&EW4-O\-/$GAC6B/[=5KV-K9_\
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M;M7GMX-A+2QFU W* .0"#D]!CG%.-[;?9?A26E5#'LWA_E*_Z,5YST&[CZT
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MX<;3Y+-[RV:5%MY6,;!F*8.T[-N>1D>U 'H<'B+1[G2&U:+4(&L4)5IMV K
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M$C6)=S#R2D7E#/'.1SV]/>MCPII-QH7A;3=(N9(I)+*W2#S(LX<*, X/3Z4
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MTQU[U>JCH\>IQ:3;IK$]O/J 4^=);H4C8Y., \],5>H **** "BBB@ HHHH
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M;:2F_*E5R1@;L9[4 =/17.Z%KL4?@O0;W5+HM<75A!(QVEWE<QJS$*H)/<G
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M:K@LC*&*DC 88R/?F@!:*\[\(^.["VTV2W\2>(8/M[ZE<P1&X949E64JN0H
M4<8[#K75:EXO\/:/<36^H:Q:0301>=+&TGS(F0,D#W(H VJ*R;OQ-HUBNZXO
MXU01K,S*"RQQMT=R 0JGL6P.*M7.J6-I;17$UR@BF($)4[C*2,@(!DL2.<#/
M% %RBLD>)]$_LJ?4VU2V2S@8I-+(^WRV'56!Y5O8\U"GC+PX]Y]D&LV@G\HS
M;6?'R 9)R>.!R1U'>@#<HK.TC7=+UZ"6;2[V*Z2*0QR;,Y1AV(/(K1H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ K@->T[3O%VK^*/#[7<'GSZ9:K'AP6CE1[A@<=<J=I/U]Z
M[^B@#QV\N]1U+X4:[KGB2,6NH'3)-,ABE(!+)D2,!_>>0=/1%KN=!\0Z39>%
M_#$<UZ@:^A@M;?8"^^7RP=N0#@\'KBNII" <9 ..E "T444 %%%% ",RHC.[
M!549))P *\M^'GB;0;"X\8+>ZSI]L9?$5U-&)[E$WH0H#+D\@X/(KU.B@#SO
MQ!XOTJYO/#EXGD16<][/%;ZU,N4@VQE25SQER612V1P3@\5Q5_>VH^&7Q"M'
MN'>9M==P)TV.X9X2"1@<G!.,#H>.*]Y(!ZBB@#SO6+NV;XJ:"MA=6PE;1[N.
M(JZXR2AC'';@D#VKC+G7=./P'?1+B81:Y920QW=E+_KTD%TA9RO7!SG=TYZY
MKW>DV+DG:,G&3B@#S^YO8)OC-:B"ZB$DGAV5(R6'WVF0J,>N!G'H*YJWFAN_
M@?=>%[H#_A(HE>U:P8_OVN?-+*P7J<DA]PXQDYX->S4FU=V[:-V,9QS0!YS8
M?9O^%QBUO9[>>Z7PU#!(6()>03,7'/<C!QZ&LRRUJTTRU^(&BZ[.EOJMQ=7<
M\,<_!NH'CQ$8_P"^ JXP,XQ7K5(45CDJ"<8Y% '-_#V9)OAWX=,9SLTZ!&XQ
MA@@!'YUSGC-FM?$5[J.C:_!I^LV^GH;BQO@&M[Z %RJX."""7&5_O =Z](I"
MJMC<H.#D9'2@#S2TU"WN?B=X8GNHHK*<^''9K61ANMY&:,[.>A W#UP#6%9:
MYI^G^';^21+6:+_A,IMEQ+\\5D&D+).0".!CCD#)'->TT$ C!&10!Y/I&HV:
M:Y\1]U^\PEMH)4GF39YB_9MN[A0N,X .,'C&:JS7UHOPS^&FZYA&S4M-WY<?
M+L'S9],=_2O8J* $!# $$$'D$5Y%:ZU::=H?Q T/7)TM]8EN+Z=(IN&NHGCQ
M&T8_C&T 8&< 5Z]2%%8Y*@G&.1VH \:M-9L]&?P;J>KSW4&AR^'HK(7<+2*L
M%P-A97*\@, !]5]N+?B9= L?AV9=&#PV-YK=O<I)/(Y^T,9HR\B[SG;P?;@D
M<'->M,JLI5@"#V(I: ."NKRT;XUZ4%N(26T291AQR3*C*/Q )'M55-.N].\=
M:IX:B@<Z1KCKJF\#Y8@"!<H?]\B,8])#7H]&!G/>@#S'5M7T[0/B/JZ^)[FZ
MLK'4K:W-C=+)(L3A%8/$2O?)) /]X^HS7FAT/2O$OPWLK.(6EA#)?-!#=.2R
M*T;;&.\[AN8@@'D9 ZC%>JLJMC< <'(R*6@!J(D:!(U5448"J, 5P>FZA:Z;
M\6_%,=[,L#75G920[^-ZHL@9A[#N>@KOJ* /"[.ZLHO@AX9_?P)(FL0NPW ,
M"+HDD^X7GZ5N3ZMHFG>+/$^E>+;FZMHM4E6>TD$DHBNX&A2,HNSJ1M(QU.>*
M]8I"JL02 2.1D=* *&A6MO8Z#8VMI;2VMM%"J102L2\: <*<Y.0,=>E<-XYU
M*T\1ZCI?A_39&EU/3]?LI+F H0RQ@,Y<9ZJ%SR./TKTFDVKNW;1N(QG'.* .
M N=2L]%^,EQ+J,ZVZ7FBQ1VQ<']\ZS/E%_O-R/E'/-<597MDWPT\'PSR1C9X
MH4R)+QA?M,K$D'MM()^M>Z%02"0"1T/I2@ # & .U 'E.O;]0\:^,[+2IXVO
MKGPTD<*QN-SR9D^4?[6"/ID59\-:IX1\47.AR6XOI];L/F%K)+,&L6V[9-X)
MV@#&.>O %>FT@5020 ">I ZT 1W%Q#:6TMS<2I%!$I>21S@*H&22:\\M?B#X
M2UC6[>^FU19)8G,6FV21.SEW^7>1C&]L[0/X03G!8@>D44 >?Z/+;^$?&'B_
M^U)EMX+Z6/4;61SCSE*;75?5E88VCGYE]:SO#VLV_P ./ASI%IK4T5KJM\TD
MRPS9Q&9'9\N!R H89[YXKU @'&0#CD4M '&>'/%/A2#1[^:QU3[1;VA^T:A?
M-$P!DD)RS' R20>!P  .!BL^WTW2;OXDZ5K_ (5N(9$EAF_M:2TEWPRH5_=[
ML';OWD$#K@$]J]#(R,&D"A1A0 /04 +7D7B2#PAXIT1O$L5^FB^)X(2\<UO+
MY5QYH'"%.L@)&!QD@C!KUVFF-"RL47*]#CI0!Y=<WLJ^*?AK=^)O)M[UK&Z-
MP9@%"3&*+KGA3G]>*H:D]KIDGCC78["&[T2\O;!(RREH/-0CS)R%Y958@DCJ
MRD9KOM6\/WFH>,M%UI)K=;?38YXS"ZDM*)0H//08V^AS71X&W;@8Z8H \;N9
MI-3\2>,;72M1EOKW4/#J"TF6/:)B/-SL*@#;S@-SR<9)KI_"_B7PUXFM]"BM
M;59=8L(MH@: A]/.S:^XD?*.-OOQCV[[ I J@D@ $]<#K0!XSX:NO#M_X>M?
M"WB-=0?Q%93[9-,,TP:297)61<'&T_>W=!DD\5[/2;5W;L#=C&<<TM 'C%VM
MU>>$/B3H>F[VU=M6N+@6JJ=[PDQ$_@RA@/7H*Z'6[VR\6WO@JX\/SQRW,&I)
M=/Y1&ZWMA&WFJX'W,_*F#CGBO1J0*JDD* 3R<#K0 M><^.+ZT@^)?@(2W,*&
M*XNC)N<#8&A 4GTR3@9KT:B@#@_B+=G2K[PWK-V+G^QK.ZD%[);%MT.^,HDA
MV\X!)!/HWO7->+7\,S_#KQAJNA/),NH1P++>R2R,MS(K !4WGDJ,9(]?4''L
M) (P>12 !0   !T H \]U.^L$^*/A V\]NR_V==JJQ.O((CV*,>N#@>U<@FO
M:==Z;X+NX94M(8-=7S-,MX3LL<B7Y7."WF$GN1G)PM>Y4F!Z#UH \KM[O3FU
M+XI.9[;YT09+#YE^RA2/INR/KQ56SU"UM(?A-J%Q.JVL-G+!)-U"R&U50AQ_
M$2",=<\5Z_10  Y /K7C\]]9'1OBRHN8#O:78 X^8FV"C'K\W'UKV"B@#RR:
M\L(]3^%ICN+955)!\KJ H-J5_#+<?7BO3YW,5O)((VD*H6V+U; Z"I** /#[
M77-.N8? =Y#.D$$.IE6T^VA/EV.8Y (V."QDSQR>>H4"O<*3 ]!ZTM 'CEFV
MFR?#?Q?H5PD4FJW%]?K'8$#SY)7=O)(3J>=I!QP!GH*U=,C@M?BII&GZC/;S
M7<'A5;:3>P;=*)%R.>Y&XX],UZ;M7=NVC=C&<<TM 'G7A[4+31?$/C/3O$<T
M-O)<WQNX6N2%6XM6C55"9^\%"[2!TSBN=\.6VH^%?^%?W.O>9#IT5M=V[O-P
M+225MT7F$_=RF$YZ<CBO9BJL02H)'(R.E! 8$$ @]0: /(M?CC9/B7J]M-'_
M &5=Z6D"2*PV3W*Q,#L/0D95>._'45;O[K33J/PO_?6NQ"Q'S+A1]F(!]OF
M'U]Z]2    & .PI: .$\)75M)\3/'213Q,6DLV"JP.<0X8_@>#[UW=%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %9FI>(=)TAG6^O4A**'DX+")2<!G(!V*<'EL#@UIUY?:
M:]I6A^)_%VA^+/D.IW7GVWG0LZWENT2H(UP#N(V[=OOQ0!T&JZG>P_$;PO:V
M^H.=.O[>[>2!0I1RB*58$#/\7KCI6W=>)='LKQ;6YOXHI&E$(+ [!(>B%\;0
MQX^4G/-<AJ<]I;_$;P% J1V8CL[M1;%@#"#'&$0CMT('TXKG=+NO#UQI-_X0
M\6+J#ZRM[-OT[S9A]L+3-)&\84X(.0<\8P2>.: /4+_Q-HVF32Q7E_'$T.TS
M$@E8=WW?,8#"9[;B,T7WB;0]-O#9WFJ6L-RL1F,32#<$R!G'N2 /7/%>7^,]
M6M+BR\?Z:N-/NXX!NMHX]TU]B)<2L2#^[ X^7&-N2><5M0:CIUW\2_"<ZW$+
M#^PYMK,<'<2F,9]0&QZC..* ._TK5K#6]/CO],NH[FU<D+)&>,@X(]B#V-/O
MM1M-.1&NIMAD;;&@4L\AQG"J 2QP"< =JX_X9W$$L?BE898W \0WC@(P/RL0
M01['G!J'Q5K$?ACXCZ-K.KEH]$DL)K,7)4E+>=G1LMCIN"@9H ZZ'7])N-*_
MM2+4(&LMVWSMW ;.W;Z[L\;>N>,4EOXBTBYBNY%OXD%GC[2)LQ-!D9!=6P5!
M'3(YK@?$$]E%!H&O:39>5X?@UW[7>R1Q%5D#J1]I(QG:&8\^P(XP:NW36][\
M1I]<L+J%].M]"D@O;J.0&)F+YC0L."P&X^P(]10!T]MXS\-W=W9VMOK%K)/>
M#-NJM_K.,X!]2.0.IH\1Z[9Z?I]]"=1-K=QV[2[XTWF$8.UV^5E4$CJW'!KR
M^UN;*'X5_#D>= C1ZQ9,XW %2';>3Z8SS]>:VM,UNSTG5/'6E:]<)!J%Y=2W
M-KYW_+U;M$%C$?\ ?P%QM&?YT :^@ZU]N\(^#9]2\1M::A=^3*4RF^^8J<H0
M1T).21C&*V;+QGIE[XFU715D*/IR1F21U*J68.S#)&,!5!ST.3Z5YU;W]H/
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M5(+'HNX+M!/TH Z1_$NE_P!AW.K0723VUON#[,DJZ]488RK9[$<5SW@NZO\
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MIVMM/(C2)'+* Q5069L>@ /-1^&[6:'2OM-TA2\OI#=W"GJK/T0_[JA4_P"
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MR,<_*J@;BW!XQD8/I0!JU@:KHNJ:KK"!]6C30BB^=8+; O*RMGF3/"G@$8Y
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "O'/&EZVH:?X[TXV=S:W2+^ZMK6T;_ $Q0B_OY) OS#@@#( "@
M')->QT4 >7:^T5Q>1ZMH^LW.BZW#I<3)]HA/D7T>7(B:-ARP(.,?, XX->@Z
M%-<W'A_3IKRT6SNI+:-I;91@0N5&4 [8/%:%% 'G'A^\C\/WGC#2O$"NLEUJ
M,][;[D)%Y!*H"K'_ 'V&W:5'/3BL?3M-OO"UO\,?[6BN#]B6ZCN62)I3$TD1
MV(0H)SSM_"O7Z* /,[6>'^W_ (E2/\JSQ0^66'^LQ;;"%_O8;CC//%8EG='1
M-/\ !&L:E!J#Z/'HO]GW3VAE#V<W[LY<1D-@[-I^@]J]GHH \F\1QZ./"MK<
M:1IT\%K=^(+6[9I4D,ER ZF28J_S <=3UQGN,]3\0;2:7P];ZYIR&:]T:X34
M(!'R9$7B1!CJ&C+?7BNPHH \O71M8M_& 1X9&M/%5N)-2!.1;/$P)0^QA81<
M=2,UL:W(@^+?A<\[8[.[1V X5GV;03T!.#@=Z[BB@#RK1_/TS7M+;P[?R7>F
M7MZWVK1+M-TFGE@Y>6-OO(H.>O!W<$[A5'1)-*&ES^#O$VE:K<ZQ%<R!;0FX
M,-YF4NDBD'8J\@DG&"":]CHH :Y*1,54L0N0H/7VKQ2/4UO;+P;>&TO+=[;6
ME-QI]O8.D-C\LHV!0O+9(YY/)/ .*]MHH \>UG4],TW6?&NC7%_)96^KE4E:
MXL9I3&SPJKNA12K#:1@$@@@]L9U;FXTI_%/PX?3+D76FVT-U&EP,L%7R1&A8
MX^4DKCG'((KHK?PQK>GWMVVG>)BEE=7#W#0W-DLSHSG)"R;AQZ9!P,"NAL+&
M+3K-;:(LP#,[.^-SNS%F8XP,EB3P .: /.]6O[7P[\1-6D\0Q:DFF:I! ;.[
MM#.8PR*5:)A$<Y).1QW-4[];/PIJWA_4WTC4;+PQ]AGM-EJTP>R9Y1(K.$.X
M!@.1S@\=J]9HH \FUB.UL;;1/$6C:3>+H<.MF^O<I(TDP:,J;DHWSX!)ZC)Q
MG'.:U=-U:TO?B[=ZA:K<2V;Z!&JSK;2;&(F=CSM]/SQCK7HE% %'1]5MM<TF
MVU*T$HM[A=R"6,HV,XY4\CI65X^D5?A_X@C)^>;3YXHD R7=HV"J!W)-='10
M!S?A"YAC^'>C.\@00:;"DN[@QLL:@@CL0>U><V9$/PC\"P,C+/;ZO:/+%L.^
M,),6<LO4  Y)/K[U[510!Y0;W3=)\2^)-(\4VNJ/#JET;BSDM_M#PWD4D:KY
M>V(X+#;MP1R,5Z7I-O'::/96T5K]DCB@1$M]V[R@  $SWQT_"KE% 'G%Q>IX
MM^(OA>ZTZ&X5-%GU!+Y9XBC1'8J+D'LQ/R^H!]#BA=7J:7J/Q'TZYBN/M5_&
M9[5$@=O.0VP7<"!C ((.3Q7JU% 'E&GS(=1^%6^.6,VVGS).)8F3RF-LB#=D
M<98$#/7MFJ5_#>75MXY?3();F6/6[6_6WB)5KF*/RBVPCD\H>1W'KBO9** .
M(\+WOAOQ!K4>JZ19:A+=0V[12W=[YX,"D@^5F0X))YPN0,$YZ9Z'Q'K]MX;T
MA[^YCFEP0D<4,;.SL>@PH)QZG' K6HH X3P_K.C:[)>V$!OKC4=2B=KVY>QE
MA1%"[0 9%'RKD!0,GDD\DFN<>QO+GX01>!/*9=>WKI[P[3\B+,"9C_TS\L;@
MW0Y Z\5Z]10!P7B7Q7HUM='PU=/?1VB1A;N2&RGE\Q<?ZI61".1]X]@<#DY7
M7/BSP^=%LY;M)+;3KYF@@6YLW5&"\?,NWY%..-V,BNFHH XKP/H4&DZWXCNM
M+A-MH=[+"UI %*)O5#YCHIZ*25 [';QQBM[Q!JPT>TMYI+66Y@EN%AF2*%I6
M",#EMJ@D@8!/!XS6O10!Y3::)I=A\2-)O? LVR"Y:3^V+:U8FU$84[68=$?=
M@!>OL,&HM)O=./AOXA:;.%ENKG5]02.U"9DN"P 4(/XCGCCIWQ7K1SM." >Q
M(S6!X7\.S^'?[5$M_'="_OY;X[;<Q[&D(ROWFR..* .*M#/HU[I?A[48)[>:
M'P_##]KM;8R2WD@R&@$@4[54C.!@\YR!UQ]"OY]$T#X?Z[<65ZVF:;!<6=_B
MW?=;LX4"3;C)4%2"0.Y[\5[;10!YIXJN$U#P]#KNA:/<O96^K0WUR+>%H)[V
M-5*NZKA7)&5P3@G8>P!.WX4N/#VL:M-K.B6EY(YMQ#-?W7G@GY@1$/-Y;').
M.!QZUV%% ')^.[6PO;338;V]N].D^U[K74+9MIM90CX9CTVD94YX^;%<5JEY
MJMUX-MH]8,-U/#XDMUCO+>#:+V&-T)GVCMC()''RU[#10!YOJMWY?Q*UFZM[
M07X'A@JD &4N)%D=O*ST)((XZX-8^FZA'=>*/ &H(+V6-;>YAE5+%XX;9VB0
M+$BA<* 01GG@<GBO8** /+M/FC&E?$S)(,UU</$,']XI@505_O L,#'>NR\#
M,#X#T!>C1Z?!&ZD8*LL:@@CL01C%;]% '!M=0:/\6M3O-1;[-;7.E01P3RJ0
MDC*[EE#8P6Y''6N3.EWWAS3M-UV?3[[^R5UV]O9K2VWI-;6TX*QOM4AAM')
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M!IGV11QQM([M@D@*H)/ )]@*XWP9=QW7Q \:3Q1W'D7$EH\4KV[HC@0 '!(
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MJ_A/1RIZ6<*D=P0@!!]"#QBN;TV>"'XL^)9Y6"1'3[5!(PPI*ERP!Z$C(R*
M.G'B+26TFTU1+Q9+2\V_9GC5F,Q;D!5 W$\'@#/!]#563Q?I"Z5J=_&\\O\
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M.X-K+FW?=%*&V%'&/E.[C)P/>I[/Q?I=]JEUIL2W@NX(/M(CDM70S19QOCW
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT.".X%9NC+=:)X:\3^&M3L+R:\DN+M[4I;NZWJ39*D,!MSEB&!(V]^*].HH
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M10!Q7AA)E^(GC.9[2[B@N7M#!++;.B2[(=K;6( .#QQ7:T44 %%%% !1110
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MD< GB@#M+KX@:':RZG%B_FETP@7<<-E*S1@KNW$;?N@<[NGIFM";Q1IB#3A
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MMI%24)"%;:Q&#@@CB@"KX+UQ=-T/5'U"XO+H_P!OW5G "7GE;$A"J.K' 'X
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MVPK@'C/.*V=5:3QH/"2VME>6US9ZG#?W8GMWB^S+&K;D)8 $EB% &<YST&:
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M2MBN)\"WNDW&I:S+!/=MJM],+JY2ZLI+7Y0 B[$?^$  $Y/)YZBNVH ****
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M8,<!U)(! S['&=9>+KFY\::YH[Z3=BVTV& ^8@1B2XD8L0&S@A5  !/!SC-
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MEO$DKRX7R\.2%&<YS\IXQV]QF]0 4444 %%%% !1110 4444 %%%% !1110
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MN&:W?8\ID#B,Y'<#^G7BN\HH \W\+Z1<Z+XCM#H0U:W\/RV\KWNFW\3[;-\
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MR@!(\, =HVDD].1[XYZQAUBXUGP/J\^A:RUS:-,NHR3H%V2/ 4PB;L+&&/&
M!C'4T ==;?$"ROKN:UL-)UF[E@O'LI?*M,".15W?,68!0>@)QSUP,$XJ^,;+
M7/A7=ZUXETN_BTZ7S/,6W()9/-8*%*-D8"J"3M!/L:U/ 4%S;77B@7-G<VXN
M=:FNH#-"R"2)E0!AD>JGCK7))IFL+\"M0\-/HM^NI1+) L?E9\UFG9@4P3E=
MN#N.!SWH [2_\475GXVTK0+?2KB6"XM9+AI5:/Y@NT #<P.!NYSSTQGFG:5K
M&@1:IXINXOM-M)9R(VI2W194&(\@J&/ VCL!GWJAJ<5ZGC[PWK$&F7EQ:?8)
M[9S''@Q.Q0KO#8VCY3R:Q=0\-ZEKX^(]A#;W%LVJ&!K*6:-D2;RXU!&2. 67
M'T.>E '9Q^+K/[?I]I=VE[8_VB#]CEN44),<9V\,2K$<@,%)^O%9UQ\2-*AM
M]4G33]7FCTN=H;PQVO\ J@ &+G)'R@'Z\'C'-4-1AO?&5MX7MVTV\LKFQU&"
M^OOM$#1K!Y0.55CPY9B -I/!).*H+97YT#XCP?V;?"74YKAK-3;OF8/ L:D<
M=V!Z_6@#TN">*YMXKB%P\4J!T8=&4C(-4]3UBVTM[6&19)KJ[D,=O;P@%Y2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#&-MK$=QGJ,^HP?0BIJ* (X((K6WCM[>-(H8E")&@PJJ!@ #L*DHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&!92
MQ4D8R.HI:* ,7PYX;@\-07D-O>7=RMU=27;_ &DH2)'.6QM5>">U;5%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6-
MKNO2:28X;/2;S5+R12XM[7:-JCJS,Q 4=ASD]AP<;-5;Z\@TZV>ZFSQA0J#+
MR-_"JCN23@#WH SO"_B>S\5:8]Y:13P/#,UO<6UPFV2"5?O(P]>1^=;=8/A;
M17TBSO)KD*M]J5W)?7*J<A'? " ]]JA1GN03WK>H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ***JZA->PVI;3[2.ZN"0%CEF\I/J6VL0/H": +5%<A'XY\W2;.9
M;"*._N;F>U\B:Z"0QM"S+(QEVGY 5X(7)+#CTM:WXBU31M";5O[(M;B"WMC<
MW92_P%4<D1G9^\..1G:#Q0!TM%<[K7BR/2K_ $JSBM'N9+V6)9/GV?9XY'"*
M[<'DL<!>^&YXIM]K^KV&NV%C)H]J\%]=&"&6._)DV!2Q<Q^5@ *I)&[T&>:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)
M\1V^L7>C26^B3P07<C!3+*Q7:G\6T@'#8X!P<=:UJ* .*E\*7IM=$DBTW1UF
MTEI$CLWE=X6C=0"=Y3<'R <[3GGGG-5V\):Y;Z5I&E0MIMUIUJ7GN;:61X5E
ME,A=5X1OW2$\+QG"YX&#WM% '&ZUX)N-4N1?0:O=VMS-=VMS<1HR-&OE%>$+
M1EN,$@'C))(Y-;2:3-)XLDUBYD1HHK46UG&N<IN.Z5C[MA!QV7WK8HH Y6R\
M/7S>*;;6+NUTNR^RQ2Q_Z"6+W)?;RY*K@#;G;\W)Z\<LD\)W<_AW489;F'^U
MKV^6_:;!,8DCD5XE]=JK'&OX$UUM% '-Z=I>M0:E>ZM/]@6]O9+>.2%'=XX[
M>/.=K%06<[W/( Y [9J+3-*UV+Q7<ZIJ4>G3I*6BBE2=]]O;]51$*8R2 6.[
MD^P '4T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/ %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>arvinassixthleaseamendme003.jpg
<TEXT>
begin 644 arvinassixthleaseamendme003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "L37-=L+*"[M7O9H;E(#([6T+2M ISAVPK!!P>6XX/I6W7FNEZM'
MH'B_Q?I^N"6*?4+@7-C*8F87,7E!0B$ Y*[<;>O- &OX(\0#_A7&@:AK%[)+
M=7<0&Y@TDDTA). H!+' )P!T!["NAL=?TO4;>ZGM[M=EHQ6Y$JF)H"!D[U<
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M#MV2Q+(LL97:R-YC'D=0>0?QKMZ "BBB@ HHHH **** "BBB@ HHHH ****
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M:5;YA@XP3SQGIC/8UE:[I5YJUK#%9:S=Z4\<PD:6V5"SK@@J=P(QS^E '/\
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MK$ 'IMZ]ZW?#-_I'B#5+&[M_#.H6NH6BOYLM_ Z&T+*0RJS_ 'B3@87MDG'
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M  XR 1WXSZ=10!R6EZCINBZ1]MM- O;2VU"_4)'%:MYLC28'G2)U4$@Y)YP
M>^*ZVBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** $)VJ2<X'/ S6)8>+=)U&SGNX995MH+MK*626%HPDJ
MX!# @%1DXR0.:J7.L76H>-9/#=E<FT2ULEN[F=$5G)=BJ(NX$ <$DD'L!CFL
M;X<V9N]!\4V.HE+CS=<OHK@A=JR9(#<=L\\4 >@45Q_POU6YU?X>Z9->2&2Y
MA#VTDAZOY;L@)]R%'XUV% &5?>(=/L+[[$YN)KH1B5H;6VDG9$)P&8(#@'!Q
MGK@XSBI]*UBQUNT-WIT_G0!VC+;2N&7@C! .0>/K7%^(=-\4:!XJO/%/A:.'
M5(;J../4=*D;:[&,?*T;=CM/3WZ'(P6GCRPN?#":AHEI-#>7^K+8RVLZ /;W
M+XWAE) S@$CD9)&<<T >A45Y_>^)/$GA>'7;_5+&:YT>ULA/:W%P84E\[<%\
MIA$Q!4Y!W8&!GK6]%:^)XM4M2=2M[BPFMW%V6C56@FP-C0@#E<YX8D\=: -?
M4=1ATS3+F_E662*W0NZP(9'..H"CDFK$4@FA250P5U# ,I!&?4'I7E&AZKKN
ME_!G5->AU3SKV%[R93<PA^5GDR>,<GWR!Z5UAU^[U#Q-IWARWN#;2OI7]I75
MPJ*7P6"*J!@5&6W$D@\#'?( .NHKRW6/&_B#3O#7B^%9K8:OX>FB7[08,K/#
M+@HVW.%?!.>HXZ<UT,>J:YI_Q#LM(O[VWNK/4K.:=(XX/+^SO&5X!R2P(;OW
M';I0!T^HZC::382WU].L%M$,N[9/4X  ')))  '))K-T#Q?H?B:6YATR\9[B
MVQYT$L+Q2(#T)1P#CWK8E@BG,9EC5S&^],]FP1G]37+V&G)J/Q$N_$L2A;>W
ML/[-20?\MW\S>Y]PN H/KN]* .IFFCMX7EF=4C099F. !5/1]9T_7],CU'3+
M@7%I(SJDH4@,58J>H!Z@U?KSSP!??V7\(YK\*&^RF_F"^NV:5L?I0!W<5[!/
M=S6T3%W@P)2H^5&(!"D_WL$''88SC(S-*_E1/)M9MH)VJ,D_05P_AJ74;/X/
MVFH6+VSZI/9?;3+>/MC,LO[QG=O0;B?PQQ4N@^(KN?QU/H;7DE]8G3$OHIYK
M<1-N\PH0N%4,AX(./Q- '7VEW;WUJES:RK+"X^5E_(CV(.01U!%35Q/AR[>U
M^)7BS10?]%(M[^)>R-(NV3\RH;ZD^M:.M:Y.OBO2?#=G+Y$M[%+<37&T,T<:
M8&%!XW%B.2"  >* .EK!M_%^E76J6=C$9S]M\P6EQY)\F<IG<%?IQ@GG ('&
M:Q;/6M5GU/Q+X8O+O%UI\*7%M?QQ*&DA<$X9?N[@01D  ]<"I/A3#-'\-]#>
M6Y:5'M$,:% /+'/ (Z_C0!V3.J]3S@G Y) ]JSM$U^P\0VUQ<:>TK1V]P]M)
MYD31D2)PPPP!&#ZBN7F_M"3XU10#4Y5MDT1IU@V*5&9T#+T[[1D]>*Y6WU+7
M-"\)>,-<TR]MXH]/\07LK6[P;_M \X;E9B?E&#Q@9]Z /9:*X^^UW4=1\07V
MCZ4+F+[%:PRO-;I"[>9+N*@B5@-H"]ADYZC'.SX8N=:N_#MI+XAL4LM5VD7$
M,;JRY!(!!4D8(P<9XSB@!L?BG29?$#Z"DTYU*-!(\/V67Y4)P&+;=NW/?.*V
M:X&R_P"2[ZI_V 8?_1IKI/%>N/X>T"6^BC$D[2Q00J>F^2144GD< MGJ.G44
M ;5%<?:W7B^WUV:-K.2YTM[-GCFO3!&T5P.B_NV.4;UQD>M9VE>*-3'BCPYI
M\]^E]'JEI.UT4A ACFC56/D2 #>F21U;H.: /0:*X#P_XMGU7Q#'IMUJ1LM5
MBN)1=Z1=0*F8@'V-"V,OT0YR<C)P!4*>(_%>LZ-;Z]X?L9KA9+D[+)O(6&6W
M$A4_.SAP^!G/3/&.] 'HM4M)U2'6=-COK>.>.*0L MQ$T3C:Q4Y5N1R*M2B1
MHG$3*DA!VLR[@#[C(S^8KS>R\;:M_P *UT;Q!?\ FMY]Y+'J-U9VX=K>%9)5
MWJF#P"B D@X!)Y- 'I=%8OA?41JNDM>1ZK!JEM)*QM[F$ 9CXP& Z,.0>!]!
MTK%O-3U^?XCS>'K74+:VLVTC[8DGV;<\;>;L[M@GCV'/0T =I17D\GBSQ7'\
M/KWQ&VH6?G:/=R6\T2VO%X(YMA+'/R9'9>XZ\X'7?VS=ZUXPU+0;&[:RCTVU
MAEFF2-6D>27<5 W C:%7)XR2>HQR =567%X@L)O$DV@(TOV^&W%RZM$RKY9;
M:"&(P>?3/0UQ=GX^U&XL8=+E2"/76UM]%>94/E90;FF"D_W,87/WCZ5-96U]
M!\9[Z.6_^TN?#R&&66)<J//;A@NT-SGIC@@>] '866N65YHKZN3+;6B"1G:Z
MC,10(2&)#<@?*3]*RU\=:4=8M]*:WU%+NY*&%6LWPR/G$F0,!>,$G!&>0*XO
M5M6U7Q%\ =2U.]NU6Z:.Y6;RH@JR*LSH%QS@8 ]ZZ/6-3UC08O"D<5_'-'?Z
ME#:7!DMP'*,C-@$' ^[CIGGK0!V](Q"J6.< 9X&37"7VN^(=7.N_\([%,)=,
MN&M;=%2!HYI41682EV# $MM^7&!SDYP+=IKVJ:UXA30SG2KBUTZ*[U#R]DCI
M-)P(E)W+@88DX.>,8YH WM$UZQ\0VL]SI[2-%#</;/YD;1D.APPPP!'/J*2/
MQ!82^)9- 5I?[0CMOM3*T3*OE[@N0Q&#R>V>AKF?A8LR:-K:W$BR3C7;T2.J
M[0S>9R0.PSVJKJUOJ5U\8VATN^BL9V\.C-Q)!YQ4?:#T7(!.<=?RH ]$HKRX
M^*O%;>#M8NO,A_M7P[J#6]]Y, *W4"[69T!^ZVQL^G!XY&.RM-4DU77[8:=>
MB33$L5N)B%4B0R']U@XX^4.3_P  Z9Y -^BL3Q/>7ME96KVES;VL;W2)<SS$
M;HXCG/E@@AG)V@#!Z]#7'/XPUM/"OC2>&X1KG0Y6^SSW-J5=X_+5P'3Y<-R1
MG [?+0!Z917GUQK'BBU\0>&K?^TK.2'7895:-K7 MG6+S X(.6[@@X!]NT<?
MC'5M&M/%5MJ,L6H76DWEO;VTXB$?F?: FS<H('RE^>1D#MUH ]%HKCK:?QA'
MK[0&&1]*EM6;[5>) &MYQT&V)P60CMU![US>G>+?%#^%?"GB6YO[5XM1OH;6
MYM%M@ RR2%-V_.0PX( &/7/6@#T^ZN8[.UEN9M_EQ*6;8C.V!Z*H)/X"LJW\
M5:==Z1I6J6ZW4MKJ<J16[1P,Q!;."P'W5XY)Z5D+JVH>)+OQ)#I]Z+*WTIS:
M)B)7,TP0,Y?</N#<%PN#P3GICF?#VL:EHWPW^'AL985AO;RVLKA7BW,4<L3@
MYP/NXZ=^U 'K%%<&=2\3ZEXN\3Z-:ZK:6D-A!;RV\HM-[+O5S@@M@\J,GVX
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MU'_T".@#MJ*\XU3Q5K6EW5K+)>0R2OKD=C+9P1"2".W>38NZ0#*RX(;!;O\
M=Q5C5/%L]MXKO-&NM2.CW)DC&F"X@7[/>H54M^\(^_N+KC(Q\O!YH [[<-VW
M(SC.*6N$T?\ M"7XM^)$DU.5[>"TM"D)1=H5O-.T<<8/.>IK9\9ZU=:#HT5[
M!%<- +E%NY;>+S9((#G=(%P<X( Z' ).#B@#HJ*X3_A+Y!HEI/I^IQ:P-4U-
M;.RN8E0,J%-QW+E1O&UQ@XY*\=JBOM6\9:5IGB>>6'%I9V+7=A>WB0ERRJ2T
M;I$^#TX; ]P: /0*0,"2 02.#[5Y_:Z]XAMM9\(->WUO<6FNPLLMNEN$\EQ!
MY@8-G).00>@YX K-T;6[_0=+\=:U=W\M\;/6)84BE55#/LA1,D 8 RHP.,"@
M#U.BN/M9_&$?B.WA,$LNE7$#B>>[2!3:S 94JL;Y9">-IR1Q\U<O:>+O%1\#
MZ1XJN-0M&5M06WN+1+7 E1KDQ$[LY4@8QCTYSF@#UBBN0?5-6U_4?$5GHUZE
MD^DE8(2T:MYTYC#_ #Y!PGS*.,'[QSTJ.?7-:GU:WT'RWAOX]-CO+V2P$;[9
M'8J%3S2!M!5B>">G2@#LZ*Q/"EQKUSH:'Q)9I:ZBDC(VQE(D4'Y7PK,%R.HS
MUS6W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '+ZKX3N9
MO%<'B31M473[\6_V6X66W\Z*XBSD KN4A@>A!J'2=)F\%:7J\AOGU.XOKV:[
MAA$*HSS2<A!@\Y('/ ')X KKJ* ,+P9X?_X1?PCIVD-())8(R9G'1I&)9R/;
M<QQ[5NT44 8#Z-JUOK%_?Z?J\*1WC(S6MS:F1$*H%W*5=2"<<]1P..]94_PZ
MM+OP]?V$]],+^]O?[1>_A4(T=R"-KHN3@#  &3QGG)S7823I$'R=SJF_8HRQ
M'L.M9_AW7[3Q/HD.K6*3);S-(JB9=K?([(<C)QRIH QX?!]Y?Z/>V'BG7)-8
M^U6[6VY+=;=40XR0JYR^0IR>F!@#G,GASPSJ^D_9TU7Q)+JL%FNVUC-LL1'&
MT&1@27(4D=ASD@G!'444 </'X N(O!VJ^&4UL_8KUIO*+6H)@21R[#[PW'+'
M!X'M5ZX\(3G4M)UBSU&.#5["V-H\IMRT5S"?X&3<",$9!#<'UKJJ* .,U7P#
M_:OA[6[!]16.]UN9);V\%OG(7:%5$W< ! !DGOZUHW'AR[NO%NE:])J,(:PM
MY(#"ML0)!)MW'._C[HQU_&N@DD2&)Y9'5(T4LS,<  =2:P].\5VVIZA:VL=C
MJ$<=Y;?:K6ZDA'DSQ\<@@DJ<$'#!3@T 6?$.FZAJVD266G:H=,ED(#7"P^8P
M7N!R,$^OUQSR,[0_#^NZ;>0-?^)_MME!&5CM(K".W4'&!DJ>0!GCIT]*Z0.A
MD,8=2Z@,5SR <X./P/Y&G4 9NEV>IV>FO#?:J+^[,CLMP]N$ 4L2JE5(S@8'
M7FLWPUX4_L/PO+H-U>+>V\AFRPA\LD2LS,#\Q[L<5TE% ' 67AB34?AS+X&O
MKN2UN[1! LZKG=&CAHI #]Y2%4$>NX5IVOA>]M/%4?B:_P#$ FE33_LEP@M5
MBC90^_(.3M&>N<GW XKK*.M '+>&M*D/B+7O$LZ,AU)XHK9&&"((EVJQ';<Q
M9L>FVK.O^&?[6U32]8L[O['JNFL_DS&/S$='&'C=<C*D>A!!Y%6O$GB&T\+:
M%<:O?1W$EM  7$$>]N3CV'4]S6J#D ^M &!;^&Y89-7O6O(WU74T6.2X\@^7
M&BJ5553=G R3RW))]@)O"FA2^&O#=EHSW:W26D8CCE$7EDJ.F1N/-7=,U'^T
MX9I?L=W:^5.\.VZB\MFVG&Y1W4]0>XJ[0!SU]X:FG\8VOB*TU(VTD=F;.:(P
MAQ+&7#C!)^4Y'7!X].M8\GP_N)?"FOZ$^L1[=8O);J2869!C,C;F4#S.>1Q_
M6NRO;RWTZQGO;N58;:WC:661NBJ!DG\JS=-\11ZCJCZ>VG:A:2B!;E'N(@(Y
M8R<95E)&<_PG!]J ,74_!6HRZU;ZYH_B Z7J@MEM;MQ:"6&Y13D9C9N",G!R
M:ZG3;-K"QCMWN)+F09:2>7&Z1B<DD#@<GH. , =*35-1ATG2[G4+A96AMHVE
M<1(6;:!DX%9$GC/38K#P_>-#=^5KKPI:XB'RF5=RASG XSW/0]: *<GA+55\
M:W7B:TUNVBFGM5M/(DL"Z"-6W#D2@YSW_2GW_@Z;7M,U2S\0:H;L7L:1Q&W@
M\@6VT[@R#<QW;L$DG^$"NKHH X^U\(:M/I-Y8>(/%$^IK-:R6L3QVRP&,.I4
MN<$[GP>IXZ\<U!9^!=1AO?#EW<^(S+)HD<D"!+)$62)D5<8R<-A1D\CT KMZ
MBN;B&TM9;FXD6."%#)([' 50,DGV H Y@>#[BZN-&DU;48;PZ3/Y]O,MKY<S
M$ @*S[S\O/. ,[1GWIZ?X"O](O+BVT_Q+/#X>N)FF;3/LZLR;CED24G*J23P
M!D9."#S6YIGB>#4M32Q&GZA;F6V%W!--"/*FC) R&4G!Y'RM@\]*U+Z\CT^Q
MGO)5D:.%"[+&A9B!Z =: )I YC81LJOCY2RY /N,C/YUR>B>$-2T#P]IFEV6
MN1[K&XDF\Q[0[9D<N2C*']7R"#_"*L-XXTM=%T/53#>&WUF:&&VQ$"5:4@+O
MYPO7U_.NFH Q/#?AR'P[#?B)D,E]=O=S"*/RXU=@!A5R<#"CN<G)J%O#ES_P
MG#>)%OXQFP^PBW-N3A=^_=NW]<^W3\ZZ&B@#A7^'MQ)X*U;PV^LQ[-1N9+AY
MQ9G*;WWL /,]>A]/6M.3PK=1>)$\0:=J,-OJ$EJMK>J]L7AN%7E6VAP58=CN
M/'%=/10!Q=]\.[:YT:."#4);;58M1;54U%8P3]J8Y+%.A7'R[<] .>*LV7A7
M5(O%A\1WFMQ3W3:<+%HH[+RX^'9PV-Y.,GIGUY' '5T4 <.G@"X3X=7/A#^V
M$,<YD!N?LGS!7<NPV[\9R3@^G:M'6/"]YK$.A*^J0QOI5Y'>;A:$B5T4J!C?
MP,,>YKIZ* .,N/!6I0>);W5= \22Z5%J+*][:FU297<#&]-Q^1B!Z'\>E2W7
M@N>'Q%:ZYH6J_8;M+5;.X6X@-Q'<Q+RI8;E.\?WLUUU% '/>$_#4OAFWU"*3
M46O?ME]->9:()L,C9(XZ_P">!27_ (<NI/%D7B+3M0BM[H67V&2*XMS+&\>_
M>",,I#9]R,=JZ*B@#E6FT#P'I9&KWX4ZG=N\TTL9)N9W&6^50<# P!Z #FG^
M O#T7ASPO%;I%+$T\C7!CF.7C5C\D9_W$"+_ ,!KIF56QN4'!R,CH:6@#G_%
M'AR;7FTN>TU$V-WIMV+J%VA\U&.TJ0R9&>&/.016+-\/KJ6U\3V[:^[)KX'F
M[[13Y9V!&(P1G@<=,=]W6NZHH Y:X\*7=QJ7AN].IPAM$#@*+4XF+1^6<_/\
MOR_7G\JJW'P_CU%_$ZZE?B:WU\Q,Z10^6T#1J%1E;<<D;0>1U'X5V=% '+Z+
MX=UZRC_XFOBAM4DBC*6I>S6-4)&-[A6S(V..HZGN<UFQ_#VXB\'Z+X>368]F
ME7<=RDQLSE_+?>JD>9Z]3_*NZHH Y >#;ZR\0:EJ.D:TMI;ZJ U]:R6OF@R!
M=IDC.X;&(]0P]C52'X?7,'AKPYHRZVK#1+R.[25[3/F%,[5P'&!\Q]3[UW5%
M '-VWAF\M?$NMZRFI0EM4ABB\IK4XB\L,%.=_/WCGI^%<7K>F1>%_#_ACPI=
M>(XK*"%Y'%_=62M;.$!VQRJS%2V7R,D#Y<]0*]8IKHDB%'4,IZAAD&@#C/!5
MQ??:I+5-9TK6=*$1<7.G68@2*3</DRK,C9!8G'(V\]16EKOAJYU/Q!I6M6.J
M&RN;!)8BKP"9)$DQN&"1M;Y1@_H:Z)55%"J JCH , 4M ' 'X;W/_"/WFCC7
MV:*XU/\ M$/):*2A\WS-O##)+ 9/ QT K9N?";WWBMM:N[V*2&33&TR6T%N0
M'C9MS'=OX.1Z=/SKIJ* //?^%<ZG_P ([;>'SXGW:997,4UGNL@9D6-PRHS[
M\,!C ^4?EQ7>R)*;5HXY5$VW D=-PSZD C/TR*EHH Y"P\!01?#L^#=0O#=V
MGEF)9HXO*<#=N4]2-P;!!]AQ3]*\+ZY!:20:OXKGU(I"\5JXM5A,992N]B"2
M[ 'KD=^_(ZRB@#FK;PM,_B'3];U.\@N;VQMY((Y8+7R6EWX!,AW-G&. , $D
M_3%B^&]U;>&]/TB#Q"Z_V7?K>6$C6BD1[6<[77=\_P!\\Y'08 YSW]% '&Q>
M!93=>)9;O6I9X]?M5@N$%NJ;&$1CW CM@\#\R:2?P3?W.@Z%ILVNH[Z3=P7*
MRFR #^2,(NT.,#UY))/&.E=G10!SEKX;O+3Q7JNNIJ4)>_@BA\EK4XC\O=M.
M=_/WCGI^%<5K.DQ^%/#'AKPI=>(H[.W2>1QJ%S9*;9E4$B.56)4DLX(R0/ES
MU KUBFNBR*5=0RGJ",@T <7X*N+X7KVL>M:3K6E")G^T:=9B!89=RX7*,R-N
M!8G'(VC/45K^)O#DFO/I<]O?_8KK3;P744AA$JGY64J5R.H8\YK>5510JJ%4
M= !@"EH YFS\,7EGXEU76EU2.1]0MXH"DEK]SRP0K$AQD_,<\#VQ6*OPTE@\
M-:'86FO26VJ:&[M8ZC';C(5_O*\98A@1P>1T'OGT"B@#+T33;S3[=VU+4WU&
M^E(\R<Q")<#HJH.% R>Y))//I3U/P[/J'BW1M<6^2)=,29%@,!;S!* &RVX8
M^Z,<?G7044 >>GX:WHTA=+C\2.MK!J0U&T!LU9D;S?,P[;LOR3@_+UYSTK5U
MKP==:]8W^F:AJD5QIMY(DFV6TS-#@*#L<, "2I.=O!8_2NMHH YZ/PS+;^-+
MG7[?4FCBN[>*&YM3"&WF/=M(<G@?,<C'/J*T=6LKZ\6T:POULY;><2DO%YBR
MKM92C#<O'S9SGJ!6A10!P]U\-K2[TK4(?MC6M]=:@NI1W-G%Y:VUPJA59$R>
MP.<GDL>G&+3>%-8O?#VI6&K^(_MMW>VKVGVC[&L:11L,-MC5N6/J3V' []=1
M0!R<G@^ZDE\+R?VK$#H(^7_1#^^_=^7S\_R_*??G\JB_X0&&5/$EG=:@\NE:
MY,\\EJ(@K1R.J@L'YSC:"!@8/K78T4 <KH'AK7=,$:ZGXIDU1+92MHKVBQ[3
M@J&D(.9" 2.HZDG)P1G+\/+E/ MMX8&M1^7!="Y%P;,[CB7S0,>9C[WZ?G7=
MT4 <;=^"]1C\37.MZ'XA;2Y+]$74(?LBS),R# = Q^1L<=_?-+K'@>XGU+3]
M6T+7)M+U6SM_LK7#Q"X6XASNVR*2,G=DYSU)_#L:* *6E6,NGV0BN+R2\N6)
M>:XD4*9&/?:.%&   .@ Z]:NT44 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1374O&RJ[(2,!EQD>XSD5QWP[U?5=:M-8FU2^-PUKJEQ91 1(@"1D
M$[0,D\^WM0!V=%<W;:C+9ZYKCZGJX33;)8F3SQ'&D89226; [].?SJY:^*]
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MECAB>65UCC12S.QP% ZDGL*S[/7])O[AX+:_A>9(_-,>[#>7_? /5?\ :'%
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M0"/45J?"Q+)OAQH$MNL!D6S6-WC R#U921[\D>M=@D4<48CCC5$'15&!^5.
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M)SP6 STY Z]1784V.-(D"1HJ(.BJ, 4Z@ HHHH **** "BBB@ HHHH ****
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M$ENEPB'RWB?.YAD*HQES_NYS3V\:>'8],O-0EU..&WLI/+N?.1XWB?\ NLC
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MI65FSQL921SP=WO7=> [W5+W2;S^UOLTT\-Z\*7ULFQ+U%"XE Z<\@XXRO%
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M;BZ2218V<*SP%4' )R3P*S+.YM?^$H^),KR1A98+<*S$#>!;E2!ZX;@X[\4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445C_ /"4Z+_:$%D;
MW;+<2&*!FB<1RN.JI(1L9N#P#G@T ;%%<U<>/_"UJER\FL1;;:7R9BB._EL
M"<[0>!D9;H,]:74_&-EIWB32M&\JXE>_CDF\V.!W0(JY^4J#N))7IG ZXR*
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MGO?LY*R?.VPD1J0N5V\<5H1^*-)F2=XYIF2"W6YD86LN%C9=P.=O.1S@<^U
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M>NT4 ><VFM:?JWQBL+W3Y6N;:309(EGCB<H6,Z,!NQCH#].G6ND\?2I'\/\
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MR+YRV['/$H92$ &6Y/4$8R3B@#N;NP\5F^NVBU"\$7_"2VTB $X^Q;$+J/\
M8RQ![94^];EQJKZ+XSL-,GE:2SUA)3;[SDPSQ@,5R?X64D@=BI X( Z6N'\9
MV[WWCCP1:P@F2*\FNW(_ACCCP2?8EE'XT =Q16?I>KPZM]L\F"ZB^R73VK_:
M(3'O9<99<_>4YX/>M"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *I0:;%%J,VH.3+=2J(P[?P1@Y"*.PSR>Y/7H +M% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDC'<T >A45R.B^*-0_X0W3;W4]"U8ZD6BM[JV2U;>KD[3)@X^3^(D9P#774
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M2 !W%8WA+S[6U\9?:+"_B-SJMS<P![20&6-D0*5^7G)!XZ^U<W;Z7JFG^#?
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M((&X#.""#C."*SO$_BF;0M7T*PAT^>X.HW)C:2,*0JA&8@9(RQP/;&>>E1^
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MM";20-*LK90@8Z'].^*V)H[F7QGX&N5L;[R+6QN8[B0VL@$3.D84-QQRI^E
M'1:=XPTK4='N=2'VB!+6X-K/#/$5ECF! $>T9RQ++@#.=PJ73_$UI?ZW<:+)
M!<V>I0PBX-M<JH+Q$X#J5)!&>.N0>M>=76C:O>:9XJ>STJXDN$\11ZI;VUS
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M,V=V"PQOV[2>_-+J?CS2]+U6[TMK74[F]M85G>&ULWD8HS;=RCN!W(X]\\4
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MNY+F&X1!ED99&;&0#@J0<UK:;XPMM3T32[ZWM;B>YU"T%TMI!M+JN!NR6(4
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M;YKZ5X[?[))O96NO,! QTV\__7KV*B@#AM9AGOOB1X?N8;:]%JMA=127(MI
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MQ:79(CI'(8UY!(VE@!P2:]1HH \FNM,UC5;?XEQ1:->Q/J<<368F0*)<0*N
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'(()X^AK @TG5M-O?!NOI87,R6.F?V;J%HJ_O8@57YU7/S89<'&3CIFMO1M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *RM>\/67B&W@BNVN(I+>436\]M,8I(G (W*P]B1SD<UJT4 9&F>'
MXM.E6:6^O]0G4$)+>S[R@/7:  H/OC/O6O110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 8^NW=_!+I5MI\T,,E
MY=F%I)HC(%40RR<*&7G,8'7O3?L7B/\ Z#=A_P""UO\ X[1K?_(7\-_]A%__
M $EN*VJ ,7[%XC_Z#=A_X+6_^.T?8O$?_0;L/_!:W_QVMJB@#%^Q>(_^@W8?
M^"UO_CM'V+Q'_P!!NP_\%K?_ !VMJB@#%^Q>(_\ H-V'_@M;_P".T?8O$?\
MT&[#_P %K?\ QVMJB@#%^Q>(_P#H-V'_ (+6_P#CM'V+Q'_T&[#_ ,%K?_':
MVJ* ,7[%XC_Z#=A_X+6_^.T?8O$?_0;L/_!:W_QVMJB@#%^Q>(_^@W8?^"UO
M_CM'V+Q'_P!!NP_\%K?_ !VMJB@#%^Q>(_\ H-V'_@M;_P".T?8O$?\ T&[#
M_P %K?\ QVMJB@#%^Q>(_P#H-V'_ (+6_P#CM'V+Q'_T&[#_ ,%K?_':VJ*
M,7[%XC_Z#=A_X+6_^.T?8O$?_0;L/_!:W_QVMJB@#%^Q>(_^@W8?^"UO_CM'
MV+Q'_P!!NP_\%K?_ !VMJB@#%^Q>(_\ H-V'_@M;_P".T?8O$?\ T&[#_P %
MK?\ QVMJB@#%^Q>(_P#H-V'_ (+6_P#CM'V+Q'_T&[#_ ,%K?_':VJ* ,7[%
MXC_Z#=A_X+6_^.T?8O$?_0;L/_!:W_QVMJB@#%^Q>(_^@W8?^"UO_CM'V+Q'
M_P!!NP_\%K?_ !VMJB@#%^Q>(_\ H-V'_@M;_P".T?8O$?\ T&[#_P %K?\
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M%R"'&/O-W[UJ_"3Q!J^I:IXIM;J_GU'0K&Z9+"_N&W%E#,,>8?O#:%.>WXT
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MZOI\AMXFD"'3F&[ Z9\VKWV+Q'_T&[#_ ,%K?_':/%__ "*&K?\ 7L_\JVJ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMJL76_\ D+^&_P#L(O\ ^DMQ6U0 4444 %%%% !1110 4444 %%%% !1110
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M^_B+39;M]*O],:.=X?(OH]CG;CYL>AS^AH 3Q?\ \BAJW_7L_P#*MJL7Q?\
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MC9$[M\S!1U8\<DG@&G?%;Q3#X@^#FF>)-&EN;83WB!&#%)$^^KJ2I]5^AP*
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MDMQ6U0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!BK_R.[_\ 8-7_ -&-
M6U6*O_([O_V#5_\ 1C5M4 >8?"ZUD\.7WC71[B.1I[?4VNT11EI(I%RC+ZY"
M_G6BOAC_ (27PSJC:TNJ6=QJ;2-<VFX$+VC  R&VJJ=#R1FNSETRTEU*'43%
MMNXD,:RH2I*'JK8^\N><'H>15N@#QWP'IWBO3?A=KOAC6=%NTF2VG33VRK"0
M2*1LX;@AB3SV;VK!/@[Q,/ '@73/[#NC=Z5J<EQ=Q@I\B>:7!SNP<ANWH:^@
M** /,+K1]6_X7K%XB72[EM*CTPVYN% ^_AC@#.>X'3K7->'O _B-/@5XC\-W
M&F2V^J3W)GAAD9?WBYB88(.,G81^5>Z44 >(V.A>)+GQ5\/-0E\.WMM::/8I
M:W3RLFX,$VD[0Q.W/3OUX'>'QEX=\;>)$\8VTV@.Z/-&=,:*>-(S&L@);:#E
MY&4#ENG(&.A]THH \=UO0->O-6^&ES'HMWLT9$-]RA,/^K'9N?N$\9K5\(Z-
MJNG_ !:\7:Q>:=/!IU^J_9[A]NUMN,YYR.G>O3:HZSI%IKVC7>E7RNUK=1F.
M0(VTX/H: //? O@ZZ\/_ !!\21(X_L&.=;RRA'19I4(./3:I*X]"IKK/B%_R
M3GQ)_P!@VX_]%FM31=&MM"TR.QM6E=$ !DF?>[X 4%CWX 'T I=:TF'7=&N]
M+N9)8[>[C,4IB(#%3P0"0<9'% 'A-MHFK>-?A3X*\.V.EW*1I=?:)[YRHA2(
M&0$@YSGYCQC/'T-=)?\ AG4='^*^KZI<>&9=?T/6H54B'8S1.% PP=@,<'KQ
M@CG@BO3/#F@6OAC0[?2+*6>2UMP1%YS LH))QD 9Y)ZUJT >3^*O#&I2>,/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"X__ !VC[%XB_P"@W9?^"X__ !VMJB@#%^Q>(O\ H-V7_@N/_P =H^Q>(O\
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M_P""X_\ QVMJB@#%^Q>(O^@W9?\ @N/_ ,=H^Q>(O^@W9?\ @N/_ ,=K:HH
MQ?L7B+_H-V7_ (+C_P#':/L7B+_H-V7_ (+C_P#':VJ* ,7[%XB_Z#=E_P""
MX_\ QVC[%XB_Z#=E_P""X_\ QVMJB@#%^Q>(O^@W9?\ @N/_ ,=K(MK/7O\
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M 8OV+Q%_T&[+_P %Q_\ CM'V+Q%_T&[+_P %Q_\ CM;5% &+]B\1?]!NR_\
M!<?_ ([67KUKK,=E:O=ZI:SP#4K'=&ED8R?]*BQ\WF''..U==6+XI_Y!$'_8
M2L/_ $KBH VJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%U
MO_D+^&_^PB__ *2W%;58NM_\A?PW_P!A%_\ TEN*VJ ,O4O$6DZ1<PVVH7J6
M\TY(A1P<R$=0O')^E.L=?TK4KUK.TO8Y+E(_-:+!#!,XW8(Z9-<=\1I)(?%/
M@:2&!IY%U.3;$K!2W[L\9) K8N?$,FGZ5K6OZOH[6K:6KK C.K/)&41C\RDC
MYGP/^ T =3)(D4;22,%1 68GL!5/2-8L->TV/4=,N!<6DC,J2!2 2K%3P0#U
M!%<[::YXA'B33K:2T^UZ==HXN)H[":W^QN!E>9#\ZMR.@(//M7$^'=9\3>'?
MA?'K>GPZ;/I=C<74EQ;2!_.EC^TR;V5P0JD<X&#TSGM0![-17!W/B3Q-J'BR
MXT70_P"RDC.EQ:A;S7<<AX=RNU@K>@[=,]ZDA\5:RUAXS+_8?M.A.P@987V2
M 0B3YEWY[XX(H [BBN.7Q%JUSIN@7>;*RMK_ $];BXNY%WXF9%*Q1Q[@Q)W,
M>_"XZG-8Z^/M;N/!/AO6K>TL?M.HZFEA<1.'"\RM&2O.5SM[YQGOB@#TFBN&
MO=;\5>'M1T0:W+H\FG7MZUI<3VUO(#$6SY/5^-QPI)! ..N:Z+3+Z\OM7U0%
MH#I]M*((2L9#LX4%R6W$$ G;P!R#Z4 :]8/_  FGAK^W?[$_MJS_ +2W^7Y'
MF<[_ .[GIN]LYK>KB/&_A^SU+P[8^&+&W1+F:YB:W91\UNJ.K239ZC"Y&>[.
M!WH ZJ_U6QTSRA=SA'E)$<:J7=\#)PJ@DX'4XXIMSKFEVFC_ -KSZA;1Z=L#
MBY,@V$'H0>^>WK7)Z9-)=_&G7O.)(L=+MX8 >RR,78CZD#\A4/PZABNQXAMI
MXQ)!I?B2[%F&Y6+.#@#V+O\ 3- '7:)XBT?Q):O<Z/J$%Y$C;7,3<H?0CJ/Q
MJ:WUC3KO4KC3K:]@FO+90T\,;AFC!Z;L=.G0USGA[2XY/'?B#Q%:H(K.YCBM
M%*# N)(RV^3WP2$![[6J'2D5?C%X@VJ!G2K0G Z_/)0!VU%0W=W;6%I+=7<\
M5O;Q+NDEE8*J#U)/ %5-*U[1]<65M)U2SOQ$0)#;3K)LSG&=I.,X/Y4 1:EX
MFT;2+R*TU"_CMKB;/E1R @R8Z[>.<9[5+8:_I&J7$EO8ZE;3W$8R\*2#S%'J
M5Z@?A7)>,/\ DJ7P]_ZZW_\ Z(%4OC(BZ=H>G>)K,"/5]-OX?L\J\,ZL<-&?
M52#R/:@#TNBN)U+Q5JES+K<6A(IFTN3R4C>PFG%S,$5RNY" @^8+SSG)Z=;-
MIXDU/6=3ATJV@33+Q-.CO;P749E,+2$A8@H9<D%6).>F..> #K:*XP^)]9MH
M-%T_5;.*SUN_69IA!$]RD:1$ LJH<G=N3 )XR<DXP<O4_&7BG2O"6KZA/IUN
MMQ87D44,\UO)%'=PR.J!U0G<K#=R"2./>@#T>L_6-<TW0+1;K4[I;>%G6-6*
MELL3@# !/4BN8GUOQ1;^-8] 9])9;^RDN;>40R?Z,4900PW?O>&'39D^E<WX
MEUW4-:^%^MIJ*6YO]-UN*Q=X 4CE*7,1# $DKD,.,F@#UNBN'/B;7M"\86FF
M>(ETZ2PU*&>6VGLD=6A:)=[(^XG<-O1AC)[5#;>+M?O8M$U2QT]KJRU"2,SV
MBV,J/;P2#(D$Q.UBN1D 8.>/6@#OJ*X?1M<\5ZSK^J6L?]D16NEZH+>8LDFZ
M2'8K';\W#C=U/!ST&.>XH Q-;\7^'O#D\4&L:O:V<LHRB2-SC.,D#H,]SQ6C
M-J5E;Z=_:$MW"MGM#B<N-A!Z$'OG(QCKFJ.L1:98:9J=W=6B3"Z3;-&5W-<'
M:$6,#OG@ >I]Z\]?2;O0(/AAX7NY-ZK=M+<<Y'F1H75<]P&;C_=% 'I]EJEE
MJ$4LEM.&$+;90P*-&<9PRM@J<$'D="#6;I/C/PWKNH26&EZS:75U&"3%&^20
M.I']X>XS7.3(DOQIO=+==UGJ'AQ9+J+/#LLY0$_\!8K]*O:WI$.K>.O#AM(D
M231V>YN)T7'EQLA1(L_[1.<>B'U&0#5U'QIX:TC54TO4-:L[:]? \J23!&>F
MX]%S[XK=KDO&FEV3^#=4TJ&RCEN=5WQ01$9,EQ)G#D_[)^8GL$]!71:79G3M
M)LK$RF4VT"0F1NK[5 R?KB@"@O\ R.[_ /8-7_T8U;58J_\ ([O_ -@U?_1C
M5M4 %%%% !1110!E:GXCTO2+B.WN[G$\F/W:*790<X8A02%X/)]*6[\2:+8Z
M,NL7.J6J:<^-ESY@*/GH%(ZGV%<)XNAU?PGXM?Q/;6[:EH]]-;M>6T2YN(7B
M5E#1C^)2I)(]:[31#H6KZ98:OI?E3VA\R6VD X4NQ+D ]#G(]1R/6@"WH^N:
M7X@L!>Z3?0WEL6*^9$V<$=CW!]C3[+6-.U&ZNK:RO8+B:T*K.L3AO+)S@''0
M\'BN<\':5'%KWB77K9!%8ZM<Q&W11@.(TVM*!_ML6.>X />H?"R*GQ*\=A5"
MCS+'@#_IWH [4D*"20 .236?8:[I>J3>597D<K[/,4#(WIG&]"?O+G^)<CWK
MFOBY>W%C\+=<EMG*2/&D)8=E>14;_P =8U6\: :3K?@)[(;&CU1;-0O_ #Q>
M,JR_3"K^0H ZZXU_2K6^^QS7L:3AE5@<X1F^Z&;HI;L"03VK1KR30?\ B9_!
M7Q9?7GS3WK:C<3$]0XW!?RV+CTP*]!\'WD^H^"M"O;IBUQ<:?!)(QZLQC!)_
M$T ;5%%% !1110!B^+_^10U;_KV?^5;58OB__D4-6_Z]G_E6U0 4444 %8EI
MXP\.WVLMH]IK%I/J*LR&WCDRX*YW#'M@UIW\-Q<:?<PVEP+:YDB98IRF_P M
MB,!MN1G!YQFN#\,/K'A7Q'8>&==MM/N8KJ!UT[5+.#RV8QKEHY5[-M&<@\X[
M\X .PG\1:1:WAM9KZ-)!(L3$@[$D;&U&?&U6.1@$@G(]:U*\:FOAI'PK\7:'
MXAM;M-1C-Z_F-;.R7!D9FCE$@&W&YE&2>"*]/T":>+PAI<^J/LN$L(GNGD.,
M,(P7)_'.: +=]JECIIMA>W,<)NIUMX QYDD;HH]ZH:SXO\/>'KE+;5]8M+*=
MT\Q8YI I*Y(SCTR#^5><>*=<TG5KSPSK<FJV)?\ MZU\B'[2A-M;?,2S#/RE
MB%+9Z *.H.?2=2.D:?IU]KT]O;RHEN9Y)MH8NB+D 'TQT XY]Z +.DZUINO6
M7VS2KV&\MMQ3S8FRNX=1G\:DM=4L;Z[O+6UN8Y9[-Q'<(ASY;$9 /OBN2MKM
M?"/A'2].N+NTLM6U'?(\D[JB1RN?,F<Y(!"E^!W.T<9XS_AS-I,'BSQA9:?>
MV\R&[A>+;.KM*! FY\Y^8[LY/J30!Z11110 5BVO_([:K_V#K/\ ]&7-;58M
MK_R.VJ_]@ZS_ /1ES0!M4444 %9FJ^(-,T9HTO;C;+(5VQ(I=R&8*&VKDXR0
M,UIUYIXYLM9T'7SXJTZ#^T-/G^QPW]D@S.OE3AD:+UR6P5]\_0 ] @U2PNM.
M_M""]MY++!/GK(-@ .#D]!@@@^F*73M2LM7L8[[3[F.YM9"VR:,Y5L$J<'OR
M#5'PUJ.D:UH4=_HS+)97#O*05P1(S%G# ]&W$Y%</X3O)M,_9\EO+0E9[>PO
M9(BO\+*\I!_"@#OX->TNZOOL<-[&\Y9D4#.'9?O*K=&*]P"2,<U/J.HV>DZ?
M/?W]PEO:0+ODE<X"BO+M=']E?!3PG=VG%Q:-IMQ"R]3(Q7<?QWMGUR:=\2]:
MTK6_"WB&)M4L_*L(9(H+8W"[Y[@<,VW.2$Y4#NVX]E- 'JZ.LB*ZG*L,@^HJ
MA>:_I=A=?9KJ]CCE 4N#DB,,<*7(X0$\ MC-2:1=6]YI%K/:SQ3PM& )(G#*
M<#!Y'N"*\_\ "@&K>%?'MQ?#>]WJ=_%+NZA$0(J_0** .XUKQ-HGAP0G6=4M
MK$3Y\KSWV[\8SCZ9'YTS3?%6@:Q9W-YI^K6EQ;6HS/,D@V1C&?F/0<"L7P L
M.J^ =!U;4X8IKO\ L](VGF4,=JYYR>F<9)[]^E<YJ6FW][\-+G5],LGFFU#4
MH]6DM(E^:6V612B =SY21G'<Y]: /1K#6M.U*>2"UN0T\:AVB=61PIZ-M8 [
M3V/0U>)"J68@ #))[5YM?ZU!JWQ6\&2:4MR&-M>&Z,EO)"?(*+M!# 9&\#Z&
MNU\2Z9=ZUX=O=-L;Y;*>Y3R_/:+S JD_,-N1U&1U[T 1:/XN\/>(+J2VTC5[
M6]FC3>Z0/N*KD#)_$BK*:_I<FH?84O8S<>88@.=ID R4#="P&25!R,=*XK2]
M;UG1CKFBZS86":M9Z;)?6E[81;([J)01RO\ "P;&1[_G@:D38?LV6%_ Y%W;
MQ6M]%+GYA,9U8MGU)8_F: /9:*1260$C!(SBEH *Q?%/_((@_P"PE8?^E<5;
M58OBG_D$0?\ 82L/_2N*@#:HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1H&&X+*T@4X/4ECD\8P.#UKJ_P#A%-+]=0_\&5S_ /'*/^$4TOUU#_P97/\
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M:-<D+V+98EB>,\#C'.?H^@>,[&2&*YU[2FMC,);IH;%Q-/R"V69R,G&,XX'
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MY_\ CE "^+_^10U;_KV?^5;5<;XI\,Z;!X5U25#?;EMW(W:A<,.GH7P:U_\
MA%-+]=0_\&5S_P#'* -NBL3_ (132_74/_!E<_\ QRC_ (132_74/_!E<_\
MQR@"_JD=_-ID\>EW$-O?%?W,LT9D13GNH(R.W6L^RTJ_N+ZTU'7)K62YM$80
M1VD;+&C,,,^6))..!TP">N<TO_"*:7ZZA_X,KG_XY1_PBFE^NH?^#*Y_^.4
M1:IH$WB&Y@35I(AIEO*)A91983NIRIE8@94'G8!C(&2>E)?MK#>,+&WAFM9M
M%EMW6\M&ARZ\-B0MTP2%7:>N6ZXXF_X132_74/\ P97/_P <H_X132_74/\
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M_@RN?_CE'_"*:7ZZA_X,KG_XY0 GA[0'\/:3<PQ2QSWEU<RWDSE=B-+(VXX
MSA1P .>E5?"7A>70O!D?AW49(+R)%E1G12HD21F8@@]/O$=:M_\ "*:7ZZA_
MX,KG_P".4?\ "*:7ZZA_X,KG_P".4 8]OX*N#IVC:+?7D<VDZ1.DT.%/FSB/
M/E(_8!>,XSNVC[O(JUXI\#:5K^@:E906&GVUY=QLJW?V52R,?XL@9S^-7O\
MA%-+]=0_\&5S_P#'*/\ A%-+]=0_\&5S_P#'* *-_;ZII$_A^ST%[*&S28)=
MV8M^98R5W,I'";078GN<#J<&*?PC=PC7K32[R*WL=<=I9]Z$O;R.H61H^QW
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M"@#(M)-1UWXQ6LTUI%;)HNF.MSY4YE"R3$;8RVT<X&['/&/6M*#_ )+9>_\
M8OP_^CY*O:;KG@W2+8V]EK.F1HSF1R;M6:1SU9F)RS'U)S51+[P?'XEDU\>)
M+4WTD MV)O4V&($L%V], DG/7WH [*BL3_A,/#7_ $'],_\  I/\:/\ A,/#
M7_0?TS_P*3_&@#;K%\4_\@B#_L)6'_I7%2?\)AX:_P"@_IG_ (%)_C69KWB3
M0]0LK6UL]7L;BX?4K';%%.K,V+J(G !] 30!UU%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!BZW_ ,A?PW_V$7_]);BMJL76_P#D+^&_^PB_
M_I+<5M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8J_\CN__ &#5_P#1
MC5M5BK_R.[_]@U?_ $8U;5 !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 8OB_\ Y%#5O^O9_P"5;58OB_\ Y%#5O^O9_P"5;5 !1110 4444 %%
M%% !1110 4444 %%%% !6+:_\CMJO_8.L_\ T9<UM5BVO_([:K_V#K/_ -&7
M- &U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6+XI_P"0
M1!_V$K#_ -*XJVJQ?%/_ ""(/^PE8?\ I7%0!M4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% &+K?_(7\-_\ 81?_ -);BMJL76_^0OX;_P"P
MB_\ Z2W%;5 !1110 5QNH:YJMO\ $W3M"2ZA73KFRENY-T(WJ4.,!LXQR.HK
MLB0 2>@KSFVOK7Q)\6-$UC2)UN]/71K@F= =HS*% .>AR#P?0^E ';?V[HXL
MGO3JMC]D1_+:?[0GEJW]TMG /M3KG6M+LW9+G4K.%UB,[+).JD1C&7.3]WD<
M].:\AO\ 4+*V^'?Q(T^:YA2\;5KXK;EAYA#%2"%ZXQSGI@'TKHXTTV_^*WAZ
M95MIP_A^1U<;6W$21X/OW_6@#OX-3L+G3AJ,%];2V)4N+E)5,>T=3NSC%)8:
MII^J)(^GWUM=K&VQS!*K[6]#@\&O'!>C3/"UW<I))%I5EXUF-VUNH;R8 [8;
M:01M5RC8P>@KOO#4?A^[\3WVL:1K$FJW=Q;(EU/'+&T0 /R!MB@;\9QWP#G'
M% &KXOU*^T?PEJFIZ=]G^TV=M).HG4LI"J6Q@$>GK5W1KJ2]T/3[N8@RSVT<
MCD# W,H)_G67X_8+\._$A8@#^S+@<_\ 7-J=IFJV&D> ]-U+4+N*WLHK& O,
MY^4950/U('XT =!7GGB/6?&?ARS7Q)-)ITNF+/&L^E+ 1+'$[A!B7=\T@W#(
MP!UQFN_AGBN+>.>&19(9%#HZG*LI&00?3%<)J/C+PCK&HK%>>(M*CT[3YQ(T
M;W2;KB9#E?ESG8K#(_O,!C@?, ;%WK=W?>-&\-:=,MO]FLQ=W=SL#L"S;8XU
M!XYP6).>, =<BKI7B'6?$6@S1Z>MK;ZO;7\NGWDTB%XH'C)W.$R"V1M(7/\
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MB\XZ$Y![8K)A\>W%_P"$O#%W;VT<&J>()EMXXW!9(2,^9)C@D *2!GG*U?\
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M2XRL,>X+O8=R2< =SD]%-=G7CGQ#L/%]GX%\2RWHT.2UN6$DTT;RF<IYBA%
M*[0%&!CZGJ23ZSIIU Z?#_:@MA>X/FBU+&/.3C;NYZ8ZT 9Z_P#([O\ ]@U?
M_1C5M5BK_P CN_\ V#5_]&-6U0 4444 %%%% '!ZEXGO;OQQ<>';6_CT][1[
M?:IC#R7(D5F9ADXV+P"!SGN.*VYCXHN=)MK:![&TU%V<7%XT+/%&JL0"D>[)
M+#! +8 SGL#@>-=-T+Q1=)#]I^QZQIEY'%]NA<)/;;H_,# Y^[AAUXX/UIVB
M^.?[/\ :?J7B6\M5OKAW@@DD=8%N]KE5DYX564!B>F#D=0* +GA77-?N;OQ#
MHFKQVEQJ>D-&([F$&.*Y61"R9'.TC'.,]?S+&]\46'CBWTG4[JSU*QO+26X\
MVWM3"UJR%1@_,V5.[ R<\'T-2>'-;\,P6^H3PZ_I][<$F\U*\BF4QJ3A1N8'
M"J  J@G.%[\FLVYT^ ?$C0]8\/ZC+,]X)!J4:7331/;!&*.020H#E0N,#+<=
MZ .YO;VWTZPN+V[D$=O;QM+*YZ*JC)/Y"N,\&:[K7BBZ74TUW0[G23EGL[2)
MC/#N!*H[%N".YQS@XKI9?$>B1Q:BTVIVJQZ<P2\+2 " G& WIG-<R-*TN3XC
MZ3J_AUK8.8)AJC69&R6(K^[+[>-V_!'<@'L. !C>+M4O=!UWQ+IQA^P:5/*D
M-JR9^U1P_P"M8MU!.&VXZ8&<YP.UT^^AU/3;6_MF+07,*31D]U8 C]#7ENEY
MT'X2^*]"N ?M]K+>6BQ?QRM,282HZG?YBX]?PKT7POILNC^$]'TR?_76EE#!
M)@_Q*@!_44 :U%%% !1110!B^+_^10U;_KV?^5;58OB__D4-6_Z]G_E6U0 4
M444 07U[;Z;87%]=RK%;6\;2RR-T50,D_E6)X<U+4?$%O'JTQ6RLY@)+:R"@
MRF(_=:5CG!8<[5 QZFJ7Q1T^\U3X::Y:6".]PT 8(GWF575F ]25!&*P[_3=
M,_M_P/JGA2&"&:>8^:UJH7S;(QDN9,?> .T9/1F'<T 6?%6L>,_#VG3^)Q+I
MSZ=;.&DTDP'S/)+ 9\W=_K,$'&,#ISCGT%3N4'!&1G!K@]6\7^$]7U V%[XA
MTJ'3[&</<1R7:!KB5#N5,9SL5@"?4@#H#GJH_$.DR:E:Z<+Z);ZZM_M,-LYV
MR/'_ 'MIY['\CZ&@#D!XJU+Q%XLN]-\.^(M"@CLYO)DM;B)I+B3;]]UPPXSD
M#K]W/>NH\3ZU)HND2RVL2SW[H_V:%CP2JEBS>BJ!DG\!R17*^+H/#WBG3+2^
MT*YL9]=CNHFT^YM'4RAQ(-P)7G:!NW9X YJ;Q+8>+TN-<U"U&ARV;VCQ1&X>
M42Q0A,LH 7;DMDD]_EST& #H/#&HW^L^!M)U)WA^WW=C%,S,GR;V4$G [<]*
MA\ ZY>>)/!.G:OJ B%U<B0R")<*,2,H 'T JG\,&OQ\.-%.H"U51:1>08"W^
MI\M=I?/\77..*A^$3J_PNT8JP(Q+T/\ TV>@#MJ*** "L6U_Y';5?^P=9_\
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M_P"A7U7_ +_6O_QZMJB@#%_MK4?^A7U7_O\ 6O\ \>H_MK4?^A7U7_O]:_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ(,*B* %'H .E 'GOB.]M;7XT>%6N+F&$"PNP3(X4#(&.OK@_E6OXLUN._\
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M!$J+@?\ 33/:O4+73[*Q+FTL[>W,AR_DQ*FX^IP.:GV)YGF;5WXV[L<X],T
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MQ1R>$]7C>-63[%-\K#(^X:\O;2M/NOAGX!ETJ& :Q]HL6MY80/,W@#SLD<X
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M,<LAA7!/N,>Y_.I/L%G]C%G]D@^RCI#Y8V=<_=QCKS0!8&,<=**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_+^?8T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS[UKBRN+?6+%(_$5Y*XWRR6L_E$31 ;3]U 1AG0]: -^BL)/&6@NE^RWK_\
M$OD2*Z4V\H:)V.%4KMSDGTIVH>+]!TJ[%I?:BD-SY'G^248OLR!]T#.<D<=?
M:@#;HK'T[Q3HFJZ(=8LM1BEL%;8TH!!5L@;2I&0V2!C&3D>M1KXOT(QW[/?>
M0=/4/=)<1/$\2D9#%' ;![$#% &Y16!9>-/#VH7]G96NHK)/>Q>;;#RW"RC;
MNP&(V[@.2N<CN*M-XCTM;M;8SR%VG^S!Q!(8S+G&S>%VYSD$9X(([4 :M%8V
MH>*M&TJ1UO;PQ+'(L4LWDNT43MC >0 JAY'WB.H]14E_XCTO3'G6ZGD'D*'F
M:."218@>FXJI"^O/:@#5HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "DP,YP,],TM% &!XO\2P^$
M?#D^HFVEN)5&RWMH4+-(YZ#CH.Y/8"N!\":U9>)(-6T&UTG58;O4;>>XU+4M
M0@$7FR. GR@$\#=PO95[GFO7:* /FX^&]0U+X::!X%\ATUF#7G^TV^.88OGS
M*?\ 8PXPW0]LUVWQ(\;:8NKQ>&KS3-6O=+A*RWXLK?>)F4@K"22!MS@MC/0#
MUKUNB@#@W\>:%/HVE1^(-+N+.RUI) B75MNAC16PJRGHI(P<=!Z]ZH_#/PF/
M#WB3Q5<Z;O3P]=31"P1B</A279<_P@MM![@=\9KTJB@#RCXQ>%M2O;WP_P"*
MM*M9+R71K@//;1#<[QAU<%1WP5.1[^U6OB/XCL_$7@&YTCP\_P#:>IZH$BAM
M;<;I$!8%C(.L8 !SNQ@UZ;10!\_^+M!/@W1_A;I5PWF/9ZD'G,:E\L9$=PH'
M)Y) XYK5BL;OQ/\ %GQ=JF@EC9MHCV2W8!5))VC4*H)ZD$<^FVNZ\:^!YO%V
MJ:#>1ZFEF-(N1=(C6QD\Q@RG!.\8'RBNP7.T;B"<<D#% 'AOPSM]*U+2M"T?
M5X]837M!O&>.R,;(D1WEMY.T +@\AFY(('49T_AO:6\_Q-^(,EU;HZ7%ROD&
M5,K*F]RVW/##(3I[5[!10!X/XYG>[\1^-]/L]$N[29M.7=-;VCR-J! 4Y9L%
M40#TP6(Z_P -5?$%O<S?";X>7*6MRT5A=P_:3Y#YC ZDC&<<=>E?05% 'D'B
MJX6[^-W@B]B63[,D#[Y&C90FX.%W9'RYR, XZBN:VM]L^+[>6^+N/%L=A_??
M,X^3^]R1T]17T)10!X!<?V99>"?ACJ-_?"RO]/N#Y0N%;RN"&=92!E/N* 0#
MR>F.1W/PV31)]=\2:Q8Z_9:CJ&JSK-/;VKG;;HN0H&<%OO<M@?05T?BCPHOB
M2XTV:2>$I9.[_9;NW%Q;S%EQEX\C)7G:<\9-0:#X&T_1/$$NMQP6,-V]M]E"
M:?9BVB";@Q)4$Y8D#G/0=* .*_:'5KOP5I]G;(TUS_:*2^3&I9M@CD!; [9(
M&?>MC2]3\->&%#Z$B-=ZNUK$+.V@;:LWW"[8&$&&!.<?=/<UZ/10!XI\7HDG
MUFS\1:)$EQJ.@M&MX@/^OC=\"( ??Q\VX#H&.<\X3XI:S:ZK/\.=6A$GD2:F
MLI0QDNOS1DJ5'.X=,5[97'>-? \WB[4]"O(]32S&D7(ND1K8R>8P93@G>,#Y
M: .%BL;OQ/\ %GQ;JF@EC9MHCV2W8!5))VC4*H)ZD$<^FVJ_PSM]*U+2M#T?
M5X]837M!O&>.R,;(D1WEMY.T +@\AFY(('49]R7.T;B"<<D#%+0!\[*C>5\8
M?W;_ .F2J;;Y#^^'F2#*?WOO+T]16G>Z'::Q\//!*MJLNBZU96,DEG?,2D<3
MIL#1R-_ 3D8/L>O0^[44 ?/FMW/B27PY\/O%>L65U&EE=3/?FUAVNH=QB8IC
M +*&.<8R>VZNBUCPUX1UCPK=M!=:I%;:MJ27 U25&PESL<^;M(!V=5)P!\W4
M8)'L-% 'GOPFN-<GT'4;?798[S[->-!!J"C/VQ%4#?N_C'& W<<=J]!P,YP,
MCC-+10!S_C:'3[CPI<PZHUPEI))"K2VQ(DA8RIMD!&<;6PV?:O/M3NM6/@CQ
MIIM_?P:S!'9)'9:K%&%>Y+!OW3;>'9?;^]SUKV&B@#SB]N;=O&WP\>*1#'';
M72NR]$W0H%!/;)&!GN,5R\^K1W^D>'K@VUS9R6GB2*2XTRWLG6*Q7S7SNPOS
M.<@DYY+' '->WT4 <'I=U /BYK\K2!(VTRV 9_E&5+EAD]P",CM4OPF<?\(%
M;Q'(D2YN2R,,,NZ=V&0>F00?QKMZ* .$@N($^-&HRO(BH-#BC\QC@;EE=F7/
M3(!!(]*XMWC_ .%":A;*/](.HN1"%^<_Z;O!"]?N\_2O;Z* /+;_ %73M%\>
MZRWB+^T%TO6(H)+"[M7G,3A8]C1'RCUSR./XO?F;[38:+KF@:7!I<VBV#:?*
M;>Y2W:6?F0$6ZDABA(^<CD] ,$5Z910!X;ITT:?#?P?9RQS1RVOB9&FCFB8%
M%%S*S$Y'("D$GH,\UW.G3Q-\9=69'4K)I%N@8=&=9') /<@$''I7<T4 <1\0
MG^S7WA*^D23[-;:RC3.B%_+!CD4$@ G&2!^-5])O;4?%7Q)<R2+'$VFV@#RC
M;]W>67GN,C([=Z[^B@#PS1IWTGP7X"U:[@OGTO3Q=6^HBU,BRVQD/R.P0AL#
M'/LWN*],\(+HDYO]3T*TN%M[QT:2[G,N;IP",@2?-@# W=^?2NGHH \V\3:D
MK^*==TR2WFLY'TI1!+;6I>7420^4WA3A4)Q@8/S$Y %8^EW<#VOPHW;E^S(R
MS>9&5V$6Q3)R.!NX!Z$]*]AHH \XTVXM4\8_$65Y(U26.VVN> X6W*M@]\-P
M<=^*P?#TLVEVWP[UFZ#_ -E6NGRV-TY!Q9S.JX9Q_"#MVY/3OUKV6B@#RG6-
M*N-5;XB:II:--9W^E);PF(9%U,D;99/[V 57(ZG([4HUVRU3Q)\.KBR%Q-!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR?7N9$\R-DWLF1C<IP1]*\WUZ+0/&L^D:GX<*2:Y!?P2+=Q0M')%&KCS/-R
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M&M2\,>)M:L=1TVRU*;4K1'$DEX;C-D&7#(3(=I8G P,]SVKOJ .$M/%#>)/
MEB='O+B'6+X_9E+;3);SK_K2X(QA.2<@9^4<%A74-=V^AV=O#>WEQ<S,"%8Q
M&6:8@9)"1KD^^!@5Q'@Y+"+XN>-9($C5)OLS6S 861C'F8H>A)8*6QW STJ?
MQK=KH7C;2=:U2.^.AM92V<L]HTH-M(SJP9O+.[:P7'?H* .JC\6:'-I46I17
MZO;2S?9X]J,7:7./+V8W;^#\N,\=*8WC#0(])O-4DU!8K2SD,-RTD;HT3CJK
M(1N!Y'&*XJ^O-'TK3M.O-*TF2WTV_P!9\Y]2N())7B<QG-P$D!968_(&88[X
M((SB74RCPW\3K0"]:6XDWPFX@=7EW0H!U4<DYPO7 Z8% 'K&D^(])UV>[@TV
M\%Q):%!, C#;N!*\D $$ \C-:E8*:[IND>&=,O)F?[-*(+>,P1,_S-A0,*.!
MGCVK>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#A[VW\12?%N$0:C<1:,VC2-Y8_U8F#[<XZ%OF4Y]L55\%V/BN]^&%K;7NLS
M0:O/+*);R<>9+#'O8?+GJV ,9Z!L]@*]"K%\5Z[+X=\/W%_;:==:C=*-L%K:
MPM(SN>F=H.%[D_UQ0!YYX%U#Q'H?Q#\3^'-7UFXUC2M-M!<_:KCEXV(5E7)S
MC*LW&<?+D8KG3\0=<B^']MX]:\G-S)KQA>U\P^3]FVG]T$^[V^]C=GO74> -
M6N]4GN]'G\)ZO8-?1RW&I:IJ$+1^>[#;A> !]X87/"K^-<8?!FLS?#>U\!&S
MG&J)KY9V\IO+$&T_OM^-NSGUSGCKQ0!W_P 3-/\ $D^A:AXATSQ7/IEO86_V
MBWM;8;1*H4,QD;.23R .G ]36IHTFM^)_AKI%S?ZK)I%Q<6PEN[J!564KV*E
MAA-PPQ...V,Y&!\0_$4\=_:^'8_"FN:KH\ 1[S[):N4G*X*1;MN"@P"V.N /
M6MQ/'.W1M*FUSPOJ=M;:HTJ-$+1I5M$5MJB9<9&X<_=Z?2@#,^#NHZO?6NOP
MW^M_VQ8VE^T%C=O('D=1G)/).#\I&?4XXKL/&;RP^"M;N8)YH)[>QGGBDBD*
M,KK&Q4\=>1T/%<MX!\'QZ)XU\3:QIMN]GHE]Y2VENR&/<P&78(<$*&) R.YQ
MQC/4>-]Q\#:[%'%-++-83Q11PQM(SNT;  !03R30!XD?%_B+3OA+H7BJ#Q#>
MR:U<:@\#03.)4N$#.,;".VU>1CKZD5Z]=?$/1M)U"STO66FL]3N+,77D^2S#
M&TD@$9R<JR@=21CO7.?!?P_:V?@BR;4-#6VUB"63?)=6/ES %R5^9E!/&.AJ
M'Q!8W,W[0_AO4/[/NY+&VL&CDN5MG:))")MH+ 8S\R]^] '5V_Q#T&ZTG2K^
MWDN)#JTC165L(L33,I(;"GH!CDD@>]2-X^T%?#U]K9FF^RV$Q@O$$1\RWD!V
ME73KP2.F:YGQKH]Y!\5/"/B?R99=*M!);W!B0OY!8-AV Y )8<]!CFN,NM%U
M"U\#?%+7+J"6"TU>\\RS25"C/&)F._:>0"'&,^E 'J5E\2?#M[J&EVBR747]
MJINL9Y[9XXISQ\JL1R>0/KQ5K5/'&B:3=WL$\LS_ -GK&U])#&72U#G"ES[]
M<#) Y(Q7DTMM=>*]'^%VF:79WAFL!#/=3-;NB01JL?S;R-IS@D8)SCUJW#I(
MTOXA^+],\3Z1K-WIFNS">VELEF:.498[&\LC^\!STV]@<T >EZKX_P##^BZU
M;:5?7,D=Q=0&>!EB+I(F"<J5SDG:0!U)QCJ*YG7/B]8Q:;H%QHUK>3_VO?+
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MC:39LW-C /!Z^E<]X36T_LK3_"^L^$[^36]/9(CYL#M;'8<+.)#\@7'/KG@
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M#>:=,9(UD:&160H\<BG#(RGE6'H:34=<L],N[:SE\R6\N@[0V\*%G<(,L?0
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M=GS<<9XR2>36M<7LFN?$R;0)))5T[3M.6XECBD9/-FD;"[BI!(502!ZG/84
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7]R%@,9[\_,>V>*ATJPU;P_J.HZ-/X.358YKR:XL=2'E>7LD<OB8M\R[2QZ
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M!X-4BU W%Y [WB?:95W3/DN1&'V_>)('3I4'A+4O$FD_#F*/5/#U[/J^G(L
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MU%P "#*)2^T#.>AZXQFN530M<7X/6NB'1[O^TH]1$S0?)D(+LS9SNQ]WWZT
M>LS.T<+ND3RLJDB-" S'T&2!D^Y KR/3M0L[K0M4\4^(-#OYI=+U:XN5NX7B
M$L:QR;5C!$@8JJC!7[IYZUZYYG[GS-K_ '=VW'S?3'K7F=CX?U>[^&/BG1)-
M.FMK^]GO9;>.8J XD<LG() SG'/2@#M)O$]M!KFCZ4]K=>9JT<DEO* FP;$#
ML&^;(.".Q%<1IUI#_8OQ.M]I\M;RX(&XY!^SH1SUZU;5=:U/Q1X)U'_A'+^W
MMM/CN8[GSFC#(7B5,XW?=S[Y.#QZOL=.U2.P\?H^EW2MJ4\TEF"%_?!H5C&.
M>.1WQQ0!TO@;_D0/#G_8,MO_ $4M:&M:O:Z!HUWJM[O^S6L9D<1KN8CT [DG
MBN8TK5K_ ,->&?".GW.AW;[XH+&[D#*!:/A(P6&?F!8]NP)K:\8G6E\)Z@?#
MJ;]5V#R0" 3\PW;=W&[;NQGOB@".W\5P-J]WI=_:7%C=6UD+\B4JRM#D@L"I
M/((((_+-2Z5XB_M6:S":=<Q07EJ;J"X9D9&0;.#M8D,0X..G!YXKCK+3]3@\
M<R:Q:>&;N.UGT%K<&[E1W:82%_WWSDDD8'4GIG':QX7\/7&D>*+6?0[;4=,T
M6:"1M1TR[;,,,IQL\H9/.2V=I*X';@4 :?Q0U:]T?X?ZI<6"3B8QB/SXF5?)
M#,JD\D'H2!MR0?2BT31]"UJ.2QT2XM=8U2(J;")XU!2+K(X5S&,;@-V<G(%/
M^)EC?:KX!U+3M-LY;N\N1&L<<>!TD5CDD@#@&JVKV6HP>.='\66EE<7%J+.2
MPO+90/-B5F#JX4GYOF&"!SCIF@!GB+7;+Q'X \76XAFM[S3K2=+FUFP)(9!&
M64_*2"#P00<&LK48D^S_  OFP?,^T0)G)Z?9F.,?4"K5[X>U"XM/'NK1V4PG
MUVS6UM+3CS"$A9 S<X7<S'J> !G!XI;[3M4DL? "II=TS:;/%)>* N80L+1G
M///)[9XH Z2\\5Q0OJ0LM/N]033#B\:VV?(VT,44,PW,%() ]0.O%1+XWTV6
M\T&*WAN;BWUQ6-I>1A/*R%+%6RP8-@'C'MU!K)T2UU3PGK/B6WDTRYOK34KY
M]1LYK<*VYY% :)\D;""HP3Q@]>U4F\#W^F?"73=*M-LNMZ.R7]MM/!N%<R%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $4EM#--%+)&'>(DQ
MD\[2>,@>N.,^Y]34M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME@AGV^=%')M.Y=Z@X/J,]Z\EU?Q1\0/"GC;04UB33+K2]9NA;BTM(SF EE&
MQ 8D;@<]#@\"M;6/&>I7GC77] TJY%HFB:2]X\HC5S+/A653N!&P!AG&#GN*
M /1G1)!AU5AZ$9H2-(\[$5<]=HQ7 Z5XF\1^./ &F:EX;^PV-_=*XN9[D%D@
M9#M(5>22QY&<@#.><5#\+O%WB'Q!#K^FZ_%!)J6C77V<SQC8DK?,"#@8X*]0
M.A'% 'H$5K;P2/)#!%&[\NR( 6^I'6I6177:RAAZ$9KSSP3XQUO7O'_BC1M4
M6TCATHK'%'; D9W$$ECR3@#T'M7;:R\\6BWLUM.T,T4+R(X4-@A21P0010!;
M2*.,Y2-5)]!BAHHW;<T:%O4J,UX79?$KQ=_PJQ_&KWUG++;W_P!GDLY+4!)$
M^4<%2"&^:O5;#QKHMQ9:5)>7L%A=:C:)=QVMQ(%;:R;CUZ@<\^U '021I+&T
M<B*Z,,%6&0?PK&\3Z+)J_A#4M%L!! UW;/;H6^5$##!. .V>E+%XN\/S:.NK
M1:O:O8-+Y"S*^0TF<;%[EO0#DU*OB71GTN?4UU&#[';L4GE+8$+#J''52.X.
M,4 9_@CPW)X9\+Z?IEX+66ZLXS$+B($[EW$]P".O2N@FMH+C;Y\,<NPY7>@;
M:?49K%M?&WAB]OK:RMM=L9;BZ&8$24'S/8'IGVZU;U/Q)HVCSB"_U"&";RS,
M4))98QP78#[JC^\<#WH TGCCDQO16QTW#-+M7;MVC;C&,<8K,U#Q)HNE6UM<
MWVIVL%O=$""5Y!LDR,C:W0Y'-9&L_$;PQH^E:I?'4X+DZ<PBFA@?<_FG.U/J
M2"/08.>E '3^1#M5?*3:HPHVC %)+:V\ZHLT$4@0Y4.@.T^V:\^UCQM<7_AO
M0+_1-?T?3I[JXA%U]L)*-E07B4X/S#<..#CN*[+4_$>CZ/,L.H7\4$K1F7RS
MDL(QU<@9(4=V/'O0!I/'')C>BMCID9I!#$K;A&@8=PHS6;J'B;1-*L[:\OM4
MM8+6ZP()WD&R3(R-K=#D<TFE^)]#UJ^N;+3-5M;NYMO]='%(&*CU]Q[B@#2\
MB+;M\I-N[=C:,9]?K3FC1F5F12R_=)'(^E9!\6Z NH0V)U6V$\TAAB&[Y7D!
MP4#?=+ \8SG-8^J_$;1=,\:VGAJ2XC$SH\ES*QPL("_*N>[$_D/K0!UKV\$D
MR3/#&TJ?=<J"R_0]J>RAE*L 5(P0>AK,O/$FC:?>_8[O48(IP4#*S?<WG";C
MT7<>!G&>U7KN?[+9SW&QG\J-GV+U; S@>]  ;2V:Y%R;>(S@8$I0;@/KUI[1
M1LVYHU+>I'->8>%?&&J>-/"EQJFD>(+;^WU21_[(>%#%'@G:N,"0Y&/GW$9/
M3M5KQ;XSU+P]\0?"VG&\A@TS4(V:\$Z* FT<G<>G_P!:@#T40Q+G;$@R,'"C
MD4"&,;,1H-GW/E'R_3TK.TKQ'HVMV$M]INI6US:PDK+*CC$9 R=V>G'/-,L?
M%.AZEJ(T^TU*"2[:/SDBR09(_P"\N?O+[C(H U%BC5MRQH&]0HS22V\$[(TT
M,<A0Y0NH.T^HSTK$N/&_ABT%X;C7+*(V3!+A7D :)B< $=<\'CVJS?>)M$TT
M1F[U*WC\R+SU^;/[KC]X<=$Y'S'CWH UJJ:G8_VEI\MGYIB28;7<*"P4]=N>
M ?0\XKE/$6H>*[;QIX?.D36,N@W9$4\)&978[B7!Q]U5 .0?KU%2?#^^\57,
M6K6WBJ2TGN+2[\N.>T&$8%02HX&=N0/Q(/(- '6VMM#9VD-K;QB."%%CC0=%
M4# 'Y"I:*QCXMT!=0AL3JML)YI##$-WRO(#@H&^Z6!XQG.>* -=XTD #HK8]
M1FA(TCSL15SZ#%9%_P"+?#^EWTEC?ZQ9VUU&GF-%+(%8+ZX/6IK+Q#H^HZ,V
ML6FI6TNG*&9KD2 (H7KDGICWH OBW@%P;@0QB8C!DVC<1Z9ZT>1"23Y29/7Y
M1S7F6K?$61_B'X6T_0=5@NM+U1F6X3RP2N,8*G (!SG/?M7;^+=>'AGPM?ZP
M4#_9D!P02 2P4$@<D#.3CL#0!K>1%LV^4FW.<;1C/K2F*,LS%%RPPQQU'O7
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MOQ[JMIJW@M-6N$N;?Q1:F1E$2I]FE."H3 R5.X+AB3WSVH ]12*./.Q%7/7
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M/I]Y?S%?1=G<6.J6T%]:O#<Q8)AG4!AZ$J?0^HZU8\F+RS'Y:;&ZKM&#^%/
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M\KU)'U->T;5V;-HVXQC'&*1(HX\[$5<]=HQ0!\U^5<6OP@\;Z-J63K\NO(#
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M,1F50L[*V6"DANO0-G^+%6_&EQIFI_#;7=1T.QQ;37-O<27,<!0W)6:,O)C
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M>.&!%$3/N\L!0-I8]<=,UYEI-_:-X.^)*_:8LR:AJ+H-PRZM&H4CU!/ (ZT
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MVC.S#<C( H ]6KG)/%UF?&3>&%$ZW M?.>40L0"S!5 ."#_$2>@P!ZU=\/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 A /44M9/_  DNDFZU"V%T3/IRA[N,1.3$
MIZ$\=",D>H!/2EB\2:3/IMKJ,5T7M+IUC@E6)R)&8X&..YZ'I0!JT5RR:_I5
MA-XDU+^V[B_BL]CW%K&OF"TPGW4"C/S8)/)Q[5@ZQXNGN])\&:U:7TUC;WNI
M6T=Y"R[$*/&TC LR@D# Y!P1GK0!Z/169I'B'2=>-R-,O$N&MG"3*%*LA(R,
M@@'!'0]#2:IXCT?1;F"WU'48+::X#&*-V^9@H))QZ8!H U**Q$\7:'+IEOJ,
M-[Y]M<1M+&T$+R,44X9MJJ6 !X)(P*L#Q#I3V=I=PW8N(;M2]N;9&F,JCJ0J
M D@=SCC/- &G16)+XP\/01VDDVKVT:W:NT&]MI<("6.#R -IY/I4FD>*=#UZ
MRN;S3=2@G@MB1.V2GE8&3N#8*\9Y/I0!KT5EV7B/2M0U!K"WNC]K$?G"&6)X
MV:/.-ZA@-R^XR*8GBC1I+Z&S6^7S9V9("48),R_>5'(VL1@\ D\&@#7HKG?#
MGB^R\27VJ6UM'.OV&Z:W!DA==^U4+'D8'S,1@\X&<<T:YXOLM#U_2-)FCF:;
M4&D^9(78(B(S$\ Y.0HP.Q)H Z*BLK4/$FDZ6\J7=WL,*AYBL;N(5/0R%00@
M]VQ6G%+'-$DL3J\;J&5U.0P/0@]Q0 ZBO-_%TWB7P]IVC3KXHO#<7VKV]I,@
MM[;RTCD8Y"9BSD# !)/K776D-WHLE]<ZIKLMWI_EQF-KM(D:)@6W\QHH(.4Q
MD9SF@#:J.>-IH7C65XBPQO3&1],@C]*RH_%FANEZS:@D)L5#W27*-"\2GHQ5
MP#@]CC!J.S\9>'K^^M+*UU2&2XO(O-MU 8>8NW=P2,9VG.WKCM0!KVEK#8V<
M-K;ILAA0(BYS@ 8')ZU-6//XIT6VNS;2WRJRSK;,^QC&DIQB-I -H;D<$YY%
M,O?%_A_3[NXM+G5(5N;= \L*Y9U!Z< $D\'@<\4 ;=(0<'&-V.,US&K^.])T
M[3-(OX)&O(-5NHH+>2"-G4AF 9B0.,#=QU)&,=<37J:Q<>)M%O=-U&5=,9&^
MU6;VHV.A4D.7.&5L[ %Z]?>@ \*^';KP^VK_ &B[AN1J&H2WX\N(IY9DQE>6
M.0,=>*Z+K67+XATN&[%L]RP?SEM]PB<H)6( 3>!M#<CC.>:MW_VLV,JV!C6Z
M8;8VE&50GC<1WQUQQG&.* +-%<#!)XD\.^/-'TV[UR36M.U>.?>)[>.-[9XU
M#;E* ?*<@8/3(J-/$&KZUHOB;Q!I]ZT$>ESSQ6-L$4QS" 98R9&3O(8<$8&,
M<Y- 'H5%</XI\37LGPFF\4:'<BTF>Q2[C+1B0J& .WGC(SC.#6GXOUF]T7P1
M<ZI9JSSQ)&SNJ;S&A91)(%[E5+-CIQSQ0!TO6BN0T36'O?$L,.EZFVK:-)8&
M>:X8JPAEW+L 90.64N2IZ;0>,\K\3=4U+0_ .IZMI5\]I>6BJZ,L:.#EU!!#
MJ>Q- %\Z'J5SXC:]O]9\_2XY%FM=/6V5/+<+C+/G+@$E@..<>@K5OK&/4(EA
MG9_)#AGC&,28.0&[XR!P,9Z'C(KAM0US6?"_BOPO:2ZI)JEEK3-#+%<Q1+)"
MP4'S%:-5&T9Y!!^OITEOXV\-7=_#8V^L6\MS-.]O&B$G=(HRPSC'3OT.#CI0
M!OT5D)XHT62[@MEOEWW$AB@<HPCF<=520C:S<'@$G@U5O_'?A?3'NTN]:MD>
MT95G527*%@2 0H/8'/IWQ0!T-%9[:YIBZ=;Z@+R-[6YV_9WBR_G$C("!<EB1
MG@ G@U OBC1&TVZU ZC#';6C%+EI<QM"P_A=6 93[$9H UZ*XS5_B;X=T_3+
MJYM+S[;-"(OW4,;G!E.$+'& /7\NN!6E/JFG7/B+1(TUN:WN)%F:/3PNW[4-
MO)=67< N"1T_&@#H:*R+WQ/HVG2RI=WJQB%U2:38QCA8XP)' VH>1]XCJ/6B
M_P#%&AZ9>K97FIV\5RT1F$1;+%!CG ^HP.^>,T :]%9%OXIT2ZT0ZQ#J,36
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M&P[9("YQ@$D' .,]LTEIXPLKOQA?^'T282V<4;/(T+A2[[^,XQ@!1ST.>.E
M'1=:*Q[3Q1HM_=P6EM?!I;E7:W/ELJSA?O&-B-KXZ_*37(>'?'-AI#:]#XF\
M0#S(M<GMK=KC&5B4(%SM4!5R3R0!G- 'H]%<?KNHWL/Q"\'P6VH2"POOM?G0
M+M\N39#N5LXR>3ZXZ5LWWB?1M-N/)O+U8L2+$TA1C&CMC"M(!M4G(X)'4>M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH X+Q3!J&D^-]-U;28#(VKV[Z3<87*H^"\,K#N%Q)GVJMX'TJ]TW5[CPS
M/'*=-\/W+S64S_\ +1)ES$,]]@:8'WV^E>C44 >80LMWKGQ3AMB)99[>(1*G
M)D(M-IV^N&XX[\5G3ZG87?@OX:HLRL+?4;$3!U(";(65R<]E8@$] :]@HH X
M70KB%OB[XJ5)4/F6=F!@_>91)N^I&1GTS3?'$]LGC3P0)Y(P([^5VWD?*/)8
M*Q]/FP ?6N\HH \SUW4['PS\1[FX\0M>6VE:A8P1VEY!),D<<D;2;HV\L]3O
MW#-17FE:);66@QZ'J-QX6N(TNIM+GG),;(60NLBRGH^58*2#QGKQ7J-% 'D,
M^K27+?#S4=>M[6S?^TKKS2@Q"Q"2 2KGHK'#@GUS2>(])N]6U#QMJWAV(W$$
MUA:Q'R#\MY-')OD"D?>(C&W([MCKFN]U[P]=ZOK^A:E!>0PII4SS>6\)<RED
M*$9##'!/8UT5 'F=G=^&O&/^E^'5OY]<ALIXXYKB:XS8EXRN&+G;G=@8Y]1T
MS3O!?B+0]4T+P_H4^FL^NZ4L43V4UJP:TDC78TI)&%&,D'/.0.IKTJB@#A/
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MR6!X.22<9P :UM-N=-M-/\?Z7J2I]LN]4NWCL77]]<HZ*$V)U<$YP1FO5**
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M^M+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8QR 0<GIT]1G=\/Z3HMG9Q7FEZ;9VSS1+ODAMUC=N.C' /X&O/?A79%/'/Q
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MX--O=6>]\8P^&[:1HUBM3>WLB'#;2VV.,$="QW$GKA??( .ACC2&)(HT5(T
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M-N^QHFA0*0V,')!& <^U>BT4 >/:7#?:=H?PVUE[:Y:STF.2#4(1$V^ R1[
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M75BRB>"ZA,3J&&5;![$ X^E-UOQ7IGA^]L;.^^T^??,RP+%;NX8A2<9 QGC
M7J<CBL;18YU^*?B2Y:TNTMKBTM$BG>W=8W9-^X!B,'&X4GC%)V\7^#IHK.[F
MBM;R62>2&W>18U:)D!8J"!R10!K1>+;2YLH9[:QU&::2$SFT%OMGCC#%<LK$
M8R5.!G+8. <4MKXOTK4;+3[G3&DOO[01Y+>.%0'94(#D[B -I(!R<Y.*Y7Q
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MN(4NH]@FC'4J<GD=U.&'I4*>--):ZT^,_:$@U*0Q65VT?[JX<#.%.<\X."0
MW8FN;T];/Q5:RQVG@ZXT?4/LDT,EW?60A-LSQE-L;]6))'(XV@YP< S>"M:U
M$Z/I/AZ]\-:A;ZGIR1V\\L]OBV18QM\Q9.C94<!<G)],F@#9\*^*Y/$=_K4+
M:?<6Z6-\]JC2*!PJ)G<0?O$L3CTQ1X@\5R:-XGT'2(]/N)_[1>4O)&@("I&S
M;5YY;.T_3-4?!4=UI^O>*K*ZL+N(SZO+>13M$1$\;(@4A^A.0>!DCO2^,(KJ
M'QEX/U6.QN[JUM)KI9S;1&1D\R$JI('09XST'>@#8O\ Q58V+WH$-U<K8 ->
MO;1;Q;@C=\W.2=O)"@D @D<BM6SO+;4;*"\LYDFMIT$D4B'(92,@BN%\/M=>
M%]6\4V6IV%]-%?ZA)J-I-#;/,LRR*H,>5!"LI7&&QZ]*W/A]H5UX:\":3I-Z
M1]I@B)D4'.QF8MMSWQNQ^% '+>-]-N=!TW0I(=:U@W5WK=M;W,@U&8!TD8[U
M"AL*.PP,@#K7816EMX8:\O9M1OI+.81(D-S<27!23<PPFXELN608'<"L'XGP
MW-U9Z!':65Y=/#K5K=2BWMGDV1(268[0>GIUJ[\0K&^U+PS;7.F69O9K*\@O
M39,,&X1#EDP>^#T/IZT 7?\ A-=+CEU&"[CN[2ZT^#[5/;RP%I/)_P">BA-V
MY>,9'3OBHK'Q[HU_=:5#&MZB:K&&M)Y;9EBD8IOV;^F['X9!&<UAQRV&JZ+K
M%]IG@^\T^4Z9-;F6XT[RKB1F'$2* 689R3VSC&><4&M[P>'/AI#_ &=J'FZ?
M/;&[06<N8 D#(Q;Y>,,0* .ON?&^D6LDQ?[0UK;WBV$]VL>8HIR0-AYW=64$
M@$ GK2WOC33+/6;G2!#?W&H6\ G:""T=F92<#;QST//3WS7GOB;^V-6T/7X+
MC1-7-_!JR/#!;6S" VZSH1(NW E9E!)/S,#V %=79M.?BM>ZB]A?Q6DFBPQ"
M5[5]OF+([E<@$$@,.A]J )=4^(%M'H>@ZII5M/>0:O?0VT;JF-@+X<$$@[L*
MR@>H]JTK[2KV_P#$VBZO;7NHVT4"-]HMC*%@="IX>/J7W%>>@"GOC/GUGI^I
M0?#;PR&TG4?.TWQ$MW<VXM'\U8OM$K;@F,M\KJ>,UZ_!(9H(Y3&\>]0VR089
M<]C[T 9+^)K-;AD2"ZEA6[6R>XC0&-9BP7:><\%@"<8SQG-:.H0W-Q8RPVEQ
M]GGD&U9L F/)Y8 \9 SC/&<9KS>]TZ\M_$,NJ^&5U6QU&75 E[ILL#M9WB>9
MM:;+#:IV#=O![8ZGGT75=0&EZ9<7OV6YNC$N1!:Q&220]@JCO^@[T <3#IFH
M>&?B+HEK8:UJE_8ZE#<-?6]_<F?RQ&H*RJ3]W+,JG''-5K74;_Q'X;\5>(XK
M^ZMY[.XN4TQ8YF6.-(!\I9 =K[F!+;@>#CM6AX?\1276KK)/X;UY=3OBJ2SW
M%BT4%O&,G8';HHY[99CVR ,^VTZ_\/>&?%7AN&QN9[B[N+E],:.%FCD2<?+N
M<#:NUBP;<1P,]Q0!M06DGC[0-+U275-1T^TN;*.80Z=<&!O-898LPY('  Z=
M2<\8=\/;C5;OPI-%J=[)<R07EQ:V]\P&^>)'*+(<C!/!Y[X[UG75W-X2T'1_
M"MOINM74<-FD5S>Z=9/)M55 (4CHS'//\(YZXKI?#FI17FDL8-&OM+L[7$,,
M%U;F)RJJ/NQC)V]AZX/'J 9/PXNKRZT74_MMY/=R0ZO=P++.VYMJ2%5'MP.@
MXIGQ7N+FQ^&^K7]E=W-K=VR(T4MO,T;*3(H/0C/!/6E^&\4]OIFKQW-I=6SO
MJ]W.BW%N\>Z-Y"RL-P&<BD^*]O<WWPWU:PLK2YNKNY1%BBMX6D9B)%)^Z#C@
M'K0!CZE?7GASQOX2L])U*]NX]4#K?6-Q</<XC"@^<"Q++CGH<''2NDL?'NCZ
MEJ'V.TCU"1A=26DDGV.0)#(@R=Y(^3OUQTK3T6QTVWLH[JSTV*TDDB&\BU\J
M0\=&& ?SKD?#.F7=[X?\;Z:T%U93:CJ5\UO)<6[Q I*H"."P&1^O% '0CQII
M/^A2O]HCL;Z40VM\\>(97/W0#G(SC@D 'L3D56O_ (@Z-8WFI6?DZE<76G;#
M<0V]E([*&!.[&/N@#);IR,$YKE)[*_\ $'PJL/!SZ;>VNL1BUM)?,MW6.$0N
MFZ428V%=J$C!.<XK3TG4X-.^*7C?SXKIPT=@08+9Y<XB;CY0<$YXSUYH ZB+
MQ9I%SI>G:A9SFZCU(XLTA7+S'!) !QC !SG &.<5#_PFFD+8:K=3&YA;2?\
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M(Y'#$9P?I3J* ,7PKX>3PKH$.D17<ES#"SE'E4!OF8L<XX/+&MJBB@ HHHH
M**** "BBB@ HHHH J3:=!+J,-^NZ.ZC7R_,3^-"<E&]1GD=P>F,G-NBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;S,GW].@[.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJKJ$U[#:EM/M([JX)
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M,K*3[XS6K10!5T_3K;3+;R+5"JEVD=F8LSNQR68GDDGO5JBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
>4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>arvinassixthleaseamendme004.jpg
<TEXT>
begin 644 arvinassixthleaseamendme004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1,/$I<1SPN&93=(V>1R=H)/IWKNGN('^--E+'(C1MH,D>]3E2QF1E7/3) )
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MD&8Y&!Y521@DXQN&<<TS3[J#3/$7B_QM>"7^S)5M[:T,<99IUC3#,BCE@7.
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M+-'',"5ECPN&VGAUR#SR* -W0OB+IEQX9T6]URXBL;_4+4S_ &<*QW;02Q4
M$X.,@=3D 9)K;7Q9HLEI;74-U)/'<P?:8A!;R2N8O[Y15+ =LD#GBN=\3-;0
M_$OP.N(UCMQ> X'RQ;HE5,]ER1@?I3;>Z_X1WXIZ]/K$@M['5;6U-C=2G;$/
M*5E>+<> V6+ =\T ='-XO\/6]A8WTNKVPM;]UCMI=V5D8G&..GOGI@YQ2Z+X
MMT+Q#/=0:7J"3S6N/.C*-&R ]#A@"1[CBO+KNQ;2/#6G7-Y&\5C=>-UO;>*2
M,YCMVD;;\N,@$ MC'1JV_$6DS^)_%>K7WAV1'_XIR>Q:ZB8;)9I&RD88<$@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !17$?$&UFAT2^U7_A)[W3)X(O]!C@G6*-I
M<?*K _?+-QR<8QP.2>MTTW1TNT-\4-YY*>>8_NF3:-V/;.: +5%<)8W=YXNU
MGQ2(KZYM(=+F^P67D2% LRIN>1@.'^8@;6RN!TY-9J_$N6[\$^&;F%K>#6->
M)A5Y!^[@,9(FEQW P<+W) H ]-HKF;#[-K'AV[AT+Q#-/.Y\B:]:8R21/_$=
MAX1\$X 4 ''&*Q+?0=0TOQQH]G%XKUZ_3RY;J[ANYT9/+4!5&%0<EW'?HK4
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M6:Y8@-(L2*JEF=V.%4 =23_G% %JBLE/$>G&ROKN9Y;:.QE\FX%Q$R%'VJP
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M;#,^_//0+A1@G&3G%6/%FNR:)IMLMMM-_J%W%8VF\9422'&XCN% 9L=\8[T
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M2=%W1/G'.X< ?,IR>,&LEM67QW%;7?AC4]2M3INIB*=0GE)(!M+B16&2NTG
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M8Q<RQ2-'),03L,I&TN<'C.>*]#H **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M" _S$+ZGCGC.#0!)K'BU=+\6Z3H7V.YD-ZDLKRI S@*B]%QU.67/8#ZU:O\
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M0T:(T3!.A&S'/4'TQ7HVD6Z6FCVEO'9I9)'$H6V0@B$8^[QQQTXH X.WOO\
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M-M<PO-YD5Q \3+NF=APP'4$&NUH **** "BBB@ HHHH **** "BBB@ HHHH
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M*OERH!G/#$C(((# 'VX- &W17.2>-=,AFL#+%=)9:A.+>UORB^1+(<[0#G<
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MU'?'(W(CR-B'H-HR< #O4]CX\TJ_O=)MUM[^)-5CWV=Q-;[8I#LW[-V?O8_
MXX)H ZBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH XJ\2X'Q=T^]%G=M9QZ5+;/<+;N8UD:1& W 8Z*>>E8&H^'=2U^3
MXDV$%O<V[:I]G-E+-$R),8XE4@,1C!9=OT.>E>J44 >>ZC'=^,K+PO;?V;>V
M5U9:C;WM[]HMVC6#R@=P5B,.2V%&TG@YJ#18+_P]I7B;P_>Z9>W4MQ=7,]E+
M#;M)'=)-D@%P-J,"2#O(]>E>DT4 >8Z;H-[H.O\ @&SDM[FX32].N+>ZN8X7
M:-)'5-HW8Z95A[8&<5Z'JA*Z3>D6WVHB!R+?&?-^4_)^/3\:MT4 >;>&M)N]
M&UV.+1'U5?#<MG*T]CJ<3J+*3Y=BQ,XR0?FRH) VYSR*PM&M9/%/P+T?PU:V
M=U]JNEA0RO;NL<2+,&:3S"-IPJG !R20,=:]AN8FGMI(DE:)G4J)% )7W&<B
MLWPSH$7AC0+71[>YFN+>V7;$T^W<%SG!V@ ]?2@#SWQC#KFL6?C/39]&U.64
MIC35M8\6\D>Q?G+ CS),@C:<D87 ZU?-UJWA[QA%K[:#JEYIFIZ9#;2);0^9
M/:RQEBNY >%(8_0]<5Z510!YOXI@U,WWA[Q+)X:>_M+87$5WI<<:RS1Q2[2K
MA>0SC8,@>N,]ZZKPNMO);SW=KX?&C0SL"L4ENL,TF!R[JO3T //'O6]10!Q=
M_%<#XM:9>BTNFM(M+G@>=8'9%=G1@,@>BFN2N=-U*7X2^*M-32]0-[=ZG<20
M0&U<-(KSAU(XZ;>?:O8:* (HYE:U6;;(%V;L&-@W3^[C.?;&:\X\%R'2[3Q/
M%JNB:FPO=;NKN&(Z=(XFA?;M_AP,X/#8KTRB@#QN'PAK]O\ "+Q%8FPE1[G4
M/MMAI0<.]O )D<1C!(SA3\H/ZDUTD=S>:E\3=)UB/1-4BT\:5/ TL]N8RK,Z
M-\RGD?=/!Y/88P3Z!10!Y.NGZ@_PT\<V0TR_%U?:A?26T)MG#2K*V4(&.A_3
MOBM"4:CHWC31/$9TR_NM,FT4:;.MO;N\MK('#[FC W8.,' [?2O2** /)C::
MG-X4^(T']BZBDFI74[V:/ =TH>)$7 &3U!YZ#UK7DANI/%?@*Y6PO?)L[.X2
MY<VS@0L\2*H;CCE2/:O0J* /)KVP:7PW\1(K[2K]XKV^\ZV3RS$TPVQJC(6
M!(=<@=3@#!S6EHFK6UWXOL;_ %BSUV'4%MC8VTUWI3VT&6(9LMEAO8J!U [
M<UVFO:%;>(=.%G<RW$.V5)HYK:39)'(ARK*?4'U!%5]/\/26LT<M_K6HZJT1
MW1"[,:JAZ9Q&BY/NV<=L4 6M:U4Z-8B[_L^^OE\Q4:.RB\V10?XMN<D#OC)]
MJR=/L1J/C(^)EM)K6-=/^Q+Y\9CDFRX?)0\@+C W8/S-Q@ GIZ* .5\;76J6
MRZ0;*SNI[-KT"^>RB\R>*/:<%!U&3@%AR 3C'6N%E\/ZY<Z;XQMM/T>]@N#J
M=OJ5FMT1MN!&(FV;RQW,=A[GD<D&O9** .9TG7;OQ)"^W0-0TU1 RRMJ,/E-
MO(X1!G)'4ENG QG/'#PV&K_\*D\/VIT341=Z)>VDMQ;F']Y((I<OY:YRW'(Q
MU[9KUZB@#S:2?6;CQYJNLZ?H-[MD\.>5:&[AV(\RR2,JN"01DXX///.,U0T^
M/4KCQ-X(U5]%UMGABN8K^6YBV^7(\2C 0D!$!!Q@!?3)KUBB@#S:QMKQ-.^(
MBMI]\K7UQ/):J;9\S*T"H-O'.6!_GTJU+H,NJ?![3K)@]EJ>GV,$T#SH8VM[
MF% 03GH,J03TP37?UB:UX:BUV]MIKC4=1BMHE9);*"?9!<J<<2+C+#C'4<$C
MO0!'X/CNY-"34]1B$6H:F1=W$8_Y9[E 1/\ @*!1]03WK(\7)=6GC;PIK:6%
MY=V=H+N&X^R0F5XS*B!"5'.,J03VKMJ* /'-2T_6+GP=\0[7^P]12XU+4#+:
MQ^3N,@*QCC&?[IR>GO74ZM%<7GQ!\+7<%I>BVAL[N.6?[,X$32*@3.1P?E/T
M[XKNJ* /%);?6H/@W?>"IO#^J/J]H/)5H;9GAN%\X,'23H>.HSGVK>U%)M(\
M<WNJ:CX2N]8TO5X(#&T%HMQ+:2HI4HR]@1@YSC/XX]-HH \[N[*:#Q/X&E@T
M*2RM+-[QYH+2V)CM5EC94#;!M#$D;L9&<GIS7H;$*I)S@#/ S2T4 >/KHFL3
M>"+MK?2)I;NR\1R:HMA<PE/M<)E8[1N&#E6)^H]:VVNI[KP_JVI^&O [:=J"
M6+1H+^P2&:5R0=BKU90 3SP3M SS7HM% 'F&G17G_"?Z7JT>BZV]O+H\UO)/
M?)\WFET;YP3\@X/& /[HIF@:'>6>K6,>@#5K'1KV";^T=+OH7$5BQ0[3"S@8
M.\XPI((R>E>I44 >5>$+=[>PL/#FJ> C_:U@4A-_)91M:LJ' F$IZG:,X'.?
M3J.X\:6-QJ?@?7;&SC,MS<6$T<48ZLQ0@ ?4UNT4 >:-%J::AX-\2KI6H?9;
M"VDLKRU:$F>,.BCS!&,L0&7! &<#(!%;NA:9-/X\UOQ+Y,T%K<VT%K LT9C>
M4IDLY5@"!R%&0#P>V,]=10!Q?BR"\B\;^$=6@T^ZN[:T-W'-]F3<4,D:A"1G
M@$@C)X'>N>M+9]$US6]*UCP1/K*WM_-=V5[#:1S1R)*V[9*[<)M)(R>,?AGU
M6B@#A;.VN+7XI&Z:PFCLX_#\=IYL%L_DB592Q1,#H%(Q^77BN>T@ZYI/A+2;
M8:3J:P'6;EK_ ,FU;[1'"[R,C(",@'< 67D G&#7K=% 'C=SI>ICPO\ $/3X
MM!U1'U"?S+17C,AD#1Q@#<"2QX))R<8Y.:ZC4([BX\<>";N.QO3;VMO=+<2?
M9G B,D:*H;CC)4_3O7>44 >8:=8R0^'/%&C:QX<O[NVFUF>5T6(XEAEG4AXR
M#EB%)?Y>1L['%;?@>RU73;_5+.2]U"]T-%B-A-J4;).K'=OCRP#,H^7!([X'
M0UVE% '!ZTNH:'\3[7Q$=/O+[2KG3#I\ILX6F>VD$F\,47)*GID ]*YNZTC6
M=1\%>/K:+1KZ.>\U8WMM'+&%,R Q'"C.2<1M^E>P44 >??:[S4OB3HNLQZ)J
ML6GIIMQ$\D]L4*,S(?F4\C[IXZGL#U-KX>1W&G>#;J&]LKRWF2\NI?+DMW#,
MKRLRE1CG((Z5V]% 'C]CINI0?#GP%8R:7J NM/U>WFNHOLKEHD1G+,>.F&'3
MKGCO70R6[/X^\37-UI]TVFW&C1P>8\31QRE?,+KO. .&')('O7?U3U;2[76M
M)NM,O59K:ZC,4@5BI*GT(Z4 >4Z#J-O'9^&(]>T[Q'#;:,%>W>;2F6*-BFQ3
M+*I(954X!PH[FO2_%=G/J/@[6[*U0R7%QI\\42#^)FC8 ?F:J67A62#;'>^(
M=7U*U7&+>[>+:<=-Q1%9_H20>X-=%0!YA.+Z[TOX?_\ $GU.(Z?>0M<J]JV8
MU2!D9B!G W''/)ZXQS4>L:#J>M:K\0K>TM9XVU"VLQ92S0LL<SPJ2R[B,=<#
MGKGTKU.B@#A?"US;ZM?6DO\ P@DFCWML&-Q<75DD0B)4@K"_5LGN!C;G/8&?
MQ_::HIT+7-*LY+]](OO/FLXOORQ,C(VP=V ;@5V=% '#ZUKNN:CX1U'4-&\/
MWL,@$2QQ7=LHN9!O'F,L1)Y5?NANI[8 S1T.*XM_B7<:DND:PFGW.C1H+FZ1
MF8NLCL=V26!P1A<9] !7HU% 'C=IHNL0_#CP],NASW5UHVJS75SI<\.UIHG>
M8':&&&;;("/\>*VM5CCU?P-XBETGP?<Z9)=6#VT:R6 BN;B0@X&Q<D*..6[G
MVR?2J* //KJ&ZD\1_#^X2PO3%913BZ?[,^(=T&Q=W''S<?KTKFUM]9T[X7:_
MX*N-#U2?4HQ<K;SP6S21722.SAPXXS\W*GGV->RT4 ><7<VL7.K+8W6BZI]@
MDTA!;"V0+OGY#+,X8;0.,*3M.3G)P*R=+M=2BT+X<13:-J43Z9<?Z4K6K$QJ
M(F3<0,X&YN_/?&.:]=HH *\]N-"NX/B1+96NS^Q=7":E>QYY26!E' ])"8L^
MNQJ] ==Z,NXKD$94X(^E8_A[PY%H$4G^GW^HW,H"O=7\WFRE1G:N<  #<>W<
MT <?J\,NA_$#4K_4/"UQKNE:K%"8I;6T6X>VDC78493R%(P<]/UQ9N3J-GJN
MAV8\/7-IHDEM,6@TF(!HIF<%8W9"-B[>25(!;J2!7H-% 'C-IIVJV_P_T339
M-#U*.XLO$:W$D8MRW[I;EI"PQG("D<]^V:]E5@RAAG!&>1@_E2T4 >:M;7GV
MSXE-_9U]MU"!%LS]F?\ ?D6WED+QS\W'Z].:9):WO]F?#=/[.OB^G/";P"U?
M, 6W,9W<?WCC]>E>FT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!D7GB"&WO9K*VM+N_N;>,23QVJJ3$ISMW%F49.
M"0HR<=NE4+7QUI-Y::)=PI=&VUF8P6DIC !<%N&&<C.PGI6-I\^I^&O'GB"&
MXT74+VUU>>.ZM+NUCWH"(U0QR'("8VC!/&*Y?0[>[_X5=X U*WLKF[CT[4OM
M%Q%;1F201YF4L%'+8+#@<T >FQ>*=.:_UFSF,EL^CQI+=M, %5&#,&!!.1A2
M:BB\6V1UJVTF[MKNQN;N)YK4W2*JSJHRVTAC@@<E6P<=JX>_T;6/$6H^/8X-
M+O+0:K86@LY;E BNT:L=IYXR2!CG&><'(K9\.7<6JS6TC> 7TO4+5&-Q/=6*
M1K&VT@B%QR^XX&1QMSGL" =#9^*+>^^R/!8WS07D336L^Q-DRA=PQ\V02,$!
M@#^1QS5OXRM==^'>JZIKVG:A;:?FXCD\@9;RUD9, HV00%Y/ SWQ57PMI-WI
M?B+2WT&/5;/1KE)'U'2;^%Q%9MLR/*9QP=YQA201D]*I6]CJD/PB\1>'Y-'U
M 7P:\CC40$B8R2NR;,?>&&'/0>M 'H#:Y9646G6EO%<7%Q=0>9;VL>#(8U R
MS%F  &5!+'DD#DUGW/Q T2T\.W^M3"[$6GRF"[MQ 3-!("!M91P.HYSM.>M8
M@MK_ $OQCH/B0V5Y-ITFC#3+E(X':2V<,'#F,#<02-IP#C [5C^)O#VHW?A[
MQ_J-M87;2:]);I9VBPMYC+$JJ7*XRNX[CS@X SUQ0!WUGXML+SQ#_8OD7L%R
M\+3P/<0%$N$4@,4)Y.,CJ!USTIOC'7I/#^@^=;!6OKJ>*SLU<9!FD8*I/J!D
MMCOBLG4A/=?$SPS?Q65X;2&SNDEF-LX6-I-FT,2.,[3].])\3[:1]%TC45!,
M6E:S:7T^.T2OM8_@&S]!0!N3ZE:>'?[.TP_:;N^O6=88U(,L[*NYW)8A1@<\
MD#H!V%16WC'3+O24OXEGR]V;$6S*%E^T!BICP3C((/.<8&<U1\77.IPZWH<<
M-C?3Z3(THO);",M,C;1Y:Y'S(A.<L,=!R!UY/2M'#>&M6TG7/#>JBTF\03R@
MQHQDA1BS)+&4)8[2%R1GKWZ4 >F:;J:ZD+D?9KBVDMIO)DCG4 AMJMQ@D$88
M<@U3U'Q+;:?->Q+:W=VUC )[H6RJQB0[B,@L"20K'"Y/'N*S? MOK%G;ZE:Z
MC=W=[917(73[J^C*7$D6Q<[P0"<-D D G&>F*Q/&6DM>:O?:AID>L:=X@MK=
M19WME"[Q7@QD12  H0&R/FQC(.>#@ [!/$5K)XAET,0W O4LQ>JI5=LD9;:"
M#GKGC!Q5:T\8Z7>:)'JD?GB.6Y:TBA9/WLDP8KL SUR#WQ@$D@ FN?D.JZ9\
M1-.UB^TJ[N1=:$ME*UC#YBQW(EWE3_=4Y.&) ]ZYJRTOQ%9>&-+U*'1+Q[K1
M]>N;R6Q90'GAD:0$QC/)"OQTSVH Z3QEXBMM7\#^+[.'[;9:EI5J6FA9_+DC
M+(60[D8AE(]"?>M?0_%MC+=:7HLD%[%<7-F)+:::$K%<;%&_8QY)&<\@9'(S
M69XEO[[Q+\/_ !!]FT+4;?[19M!;PW%L5N)I""/N#)51P,GWZ  F.[BN9?%/
M@"Y2QO3#9PW N7^RN!"7A"*&XXRPQ^O2@#J_$?B*Q\+:+-JNHK.;:+ ;R8BY
M&2 /8<D<D@55M/%]E=Z[)HZVE_%=_9VN8//@\M;E 0"8R3ZD<''7/2L_XHVM
MU?\ P\U2RLK6>ZNIQ&L<4$9=F(D4GITX!ZU#?K/<?%#P_?Q6=X;2.PN(I)C;
M.%1G*%021Q]T_3O0!?/CO21X67Q%Y5W_ &>9_(<^6-T;>9Y7(STW\<9J6[\8
MV%KKMQHJ6FH7.H06XN3#!;$ET+;1M)P#R#STXZYXKSFYL]8B^&&I^&$T#5);
M^#4S)E8#Y<B&\$@9&Z-E3VZ8.< 5V, N/^%LW.I/87L=FVB1P>:UNQ7S!*SE
M,@$$[2.GTZT 3+\2]$;2;755@U$Z?+((I;G[*0EJY?9ME)/!W<'&<<>HK)NM
M7&A?%C5F,.IWROH\,BVEJKSMN,K@E5)PHPH]!^)K$FTW4G^"NKZ2NE:@=0FO
MY'CM_LK[V5KKS >G3;S^G6NI=YM/^)T^LS6-^VG7FD10130VDDN)%D=BK*H+
M*<,.H H VK#QEI&J:):ZI8R2S)=2F"& )B5I1G,>TXPPVDG.  "<XYJG/\0=
M'M-/UBYNX;Z"72&5;VT:'=+'N&5/RDJ5(Z-G'O7&W7A;5]+T^WUY=&^WL->N
M=4N-(PKOY$ZE, =&=1AL#N3Z5?U^!=7^'WB)](\(7&FR7MLL$49L!%<W#Y_B
M1,D*.Q;WZ#&0#N=&U^#6Y+I8+2^A2 IB6YMS&DP89#1D_>%4$O\ 1C\0+B#%
MVNK1:8'D9RZP^1YG4 G:3NS\P'8C-;>G2>;IML^R1,Q+E9$*,..A!Y%<A-%=
M#XLW-\MA<R6O]@?9EE,#>6\HF9]F[&/ND>W;K0!O:=XEM]3ELA%9WB0WT)GM
M;AT7RY4 !SPQ(R&! 8 ^W!J[JNJVNCV8N+MFP\BQ1HB[GED8X5%'<D_X]!7!
M>%=)NM)\1Z:=!75;70[B*1[_ $O4(G$=D^W*^4SCKN.,*2,9/I6M\0K+4G70
M=7TZTEOO[)U)+J>TAY>2/:RL4'=ANR!]: *.G:BS_&/4/.CO;../0EDDANY<
MJI\[EUPS*!M Z'L<\YKH%\9Z>+_3[::WO+=-3S]AN)8P([@XR .<J2.0&"YK
MD[ZUOO$_C35)+;3-2MK/4/##V$=U<VYB5)6D<\AL$=>F,^V""9?"3_:4TW3K
M[P"UEJ]B4$]Y/91B!"G!DCEZL3CC;T)]!F@#9\/>-O[3M]<O-1L9["UTZ]E@
MWR;2%$>U2IVDDN6). #U !-:$?BZR_M=M*NK2^L[W[.;F**:(,9XP<$IL+9(
M[KP?:N&DT+6KOPQXUT2#3)TO9=9EU&U>= (+A?.CE10Q/.X*1Z#OBN@\.WUI
MJ$Z7J>!KC1Y[:)C/-<Z>J.I(QLA*C<^3W Q@>IH EM_B;HMSI;:I%9ZNVGBU
MDNC="Q8Q[4;#+N'&[OZ8ZD$$59'Q TD7EA!):ZE$NH1&2TF:U.R<A=Q1<9);
M'3C![$US>CV-_#\ ;C2)=.O4U+^SKFV^RM;OO,C[]H QR#N'/2K-Y!=/-\/'
M73[XBQ;==8M9/W(\@Q_-QQ\QQ^O2@#?A\6Z7JNE:V)K?4+8Z<ICOK:2$K.BL
MF00$)."IR"#^55K3Q=H.C:#X:CA34/LFI0QI8YB>5L;-RACSEL#IDD^E9<<-
MTGB/XA3FPOO*O;:!;5_LKXF*P,C!>.?F('Z].:SX+.^CT'X:PMIM^)--EB-X
MOV5\PA8&0[N/[Q'\Z .TT[QCIE_#JKRK<V#Z41]LBO(]CQ@KN5L G((Y&*?;
M^*K.378=&N;6[L;RXA:>V6Z10)T7[VTJQY'4J<$>E<1K&@ZIK6I_$*WM+2>-
M]0ALC9230LL<[PJ2R[B,=0%YZY]*T=+\OQ);-%#X)DT+4!;2QRW=W9)%Y#O&
M5Q"X^9LD]0,;0<\D"@"I\0/$46I>&+.YT^/41;/J=ND-]$VR&7]\H88#9*D!
ML%EVGL>1GO\ 7(Q+H.H(7D3-N_S1R,C#Y3T92"*\JG;6)?A=IWAJ3PWJRZKI
MD]I%*B6Q,;K%*GSI)]U@0N>#QWXYKUF^22ZTBYC2,B26!E5&(!!*G@]J //_
M  5X[T^P\*>%K'4H]13[5;PP+J$MNWV=IB.$,A[D]^F<\\&NRTWQ+:ZIK.IZ
M3%;W4=UINSSUE15'S@E=O/((!.>E<';Z3>ZS\,=$\(-IU[;WT1MH[MY[=D2W
M6)U9V#D;7R%P-I.=W89QL>-=)U"/Q-I.J:)(L=SJ(;2+SG!\EU9Q*/5H]K,/
MK0!U^D:G%K&FQ7\$4T<,N2GF@ L,XSP3P>WK7)>'KF/3_'?CY[J[D6SM?LDI
M:>9F6)?(+-@L3@=3CI7;6]O%:6L5M @CAA01QH.BJ!@#\J\TOM"U'6M2^)%G
M#;7$!U2"W2RFFA9(Y62':PW$8QNX_'(R* .RA\663:W9Z5<VMY97%]&TEF;F
M,*MP%&6"X)((!!VL%/M5>R\<Z5?3::(XKI;75)'BL;MD7RIV7.0,-N&=K8W
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MM)U:WN+NU$#>:J)(Q8A3][A@>* .X.I:1)XZMH98-0CU@:8\JJP?RUAW+N!
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MS$98@$A1^.,C(!N45@)XLM+JUL)-/@GNIKZV^U10?+&RQ\?,^\@+R0,=2>G
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M=CC]/6Z* ,CP\)6L'GDTA-*65]T=J H=5P!E]N5W$YX!.!COFN5M;\V/Q?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[FW%$D8@J/F8%E()QC(SR =9IOQ(L-2\,ZWK"6-TCZ(\B7MH2N]2G+;3G!&
M>_:J%G\6].NY_#N_1]2M[/7I##:74H3;Y@8+@J&)QD@9QCGC-<OX<\)>(=*\
M+?$339]#ECDU-IOL0BD1DDWAE4*<@X^8<D#CWXJD?"'B0:'\-+?^Q+HRZ)>F
M:_4%/W:^<K<?-\W )XH ]'U_XAV.BW>JV\%C<W[Z1 EQJ!@*@0JQX R?F;'S
M8Z8'7M4<OQ)T^+Q!H.E&PO FN1)-97;;5C96&<')R&&0,8[CUKG(M+\1^#_B
MQK.K6VB7.L:-KB*6-LZ!XI!T#!V P#NZG&".>,5H_%?P_=:_X+M[VU1(->TN
M6.[MDCD!*L2 4!XSVQQR5% ';Z;J;:A<7\7V26%;2?R!([*5E. 25P>@R!SC
MG([5Y'\89ELOB)X)_?M;6UU<@7FV0QK(@EC!WX(!&">3VKU_2+)]/TJWMI7$
MDX4M-(!@/*Q+.WXL2?QKS/XF:!K>L^/O"&H:;I-S<VFE7*RW,J%0 /,1N,D$
MG"F@#8L8= O_ .T/$/A]YS;V N+27[+<MMN!Y:L2F3M#*3@-['GI6/X0\;>'
M_#'POTV[MVU:[BNKQ[:TANV1KB64L>,@[0OX_J:]!O+"*#1-7:RM7\V^1YFB
M50"TC1A>G&"=HSGOFO$I='E\,_!G2+7Q)HM]%=VNLJZR0;6DMMS%A(H!(;@8
MVGC)'M0!ZK:>/4N?$FI^'SHUXNH:;#YUQB6(Q[2H9=I+!CG('W>"><5D2?&3
M2$\%VOBG^S-0-C<7AL@@V;U< D$C=C! />LOP/X@\*ZYXOU>2!M4'B/5K?#/
MJ%L(@8T4#;&%)   !.>3BN(E\$^,6^%,'A5/#5T;RTUDW+R>;&$=-K %/FR>
MO7CMUSP >Q^(?B#8^&_%-AH%W87LL]]&9('MU5PQ&?EQG.XD8''<4R'XA026
M&DM-I&H6NI:K<O;VNG7*".4E#\SMGH@')/Y UB>)M%U;4/C!X4URWTNXDTVR
M@87$WRCRRP; P3DXR,X%-^*/AK5[SQ#X;\2Z5IO]JKIDC+<V(8!GC;'*YZ\9
M'Y>] &K<WB?$'18?[-:>VN-,UN%+V N%>-H91YBY!P1M)((Z\=^*N:1X5N8+
M'7X+FYF2:\U6>]LYP^6@W ;"OI@@\=",@C!-:/A>SM[>RFN+?0$T47,GF& J
M@E8X^])L)&3]2<=>3@;4TT=O!)-,X2*-2[LQX4 9)- &'X+\0-XG\)V.J2HL
M=PZM'<(O1948JX'MD$CV(K7OK&VU&TDM;N(20N,$9(/U!'(/N.:X7P NHZ#X
M&T<_V3<7,FJ7SS3*C*IM8YG9@[ ]@NW(Z\UWT\OD0/+Y;R%1G9&,LWL* /*_
MAWX@U'0HM(\.^)YVGMM5M([G2;^4Y$F] S6[D_Q*6XSU'X"NHTF\TWPWI.LZ
MA.NR-=3FC 0;G8F3:D:CZD #ISVJ.#PK#XC^&6FZ#K-K-:W$%G#'DX$EO/&@
M ="#U!'4'D9%8,GA+Q1<?#H6MT\=QX@L=6&H(2P5+LQR;AST&Y>>>_7% '9Q
M^*8UUM-&O=/NK._G@:>UCD*$7(7[RHP8C<.,@XZYR1S7.Z7\1;A?!M]XCU;1
M+[[/;W4R/]F,+[$64H.K@G;@9./4CBKT]C<^)O%_AS5S875E;Z0L\LGVI0CM
M)(@01@ G..23TX&"><0^#-%NX_#6K>'=:TN6*![F[5I'9"D\<LC$;,$G[K<Y
M Q[\X -QO%,$?BBST![&[6:\MFN89R8_*95QN ._)(R. /?I61XD\0:1<>'S
M-J^BWT]@NI);*,I@RK*%5\J^=H<?7CI7-+X0\4)X;TO43Y;^)M%NH[>RW'Y7
MM48Q'=_OJQ<^H"^E=#XWT2Z/@>STC2K2>\EAN;5L)C<5CD5F8DD#) )]R: +
M<GB2^?XCOX;_ +,F-FNG"X:1'C^;?)LWG+ A1M88')STZ5RGA'Q3!X4\,ZA)
M/IM]+I\.MW4<]U$%*6ZF?:I.Y@S#D9V@X[UTL]KJ-M\4X]9CTRXGL+G1TM#*
MA4>4ZS,YW@D'[K=@<GBN6N=!UN;X4>)='71[K^T+S49IH(#MRZ/.'!SNP/E!
MZF@#OM1\4165UJ%M;V-S?2Z?;K<7*6Y3<JL&( #,-QPI/_U^*HOXHO\ _A9$
M?AY-,F:T&G?:C(KQY8M(JASE@0JX88')STX%8GB[1'UJ]NKZUTS5+#7+>!?[
M,U.R.UI#MSY4O.,!NN_ P>#UJ\MCKEK\1M-U6XL'NTFT-;&XG@90D<XE#L6!
M((7&<8!/;% %^+QW92MI\OV*[6PU"^:PMKM@NUI@6'*YW!248 X[<@9J.Y\>
MQ17FM6=OH>JW5QH^QKE(TC'RLI?<"7 (V]OO'/ X...FT_Q1J-EH=UJ7AV^G
MUJPUR.YO)C+$5:-6?B %\!,%?[O3)R<FNAL[+4HO$7CJ[ETRY6+48H!:, #Y
MI2$HP'/'S'OCUH Z >+;":RT>>R26ZEU>,2V<" !V3:&+-D@*%!&23U( R2!
M7%Z%=VT&H_$JXOM,NQ:(\7VBSR&D*?9_GP=V"#\Q&#T-0:9H^OZ#'X*UD:1<
MW/\ 9NG-INH6497SHPP7#H,X;E><'I^E^"RUB6X^(4[Z'>Q)JT*"S#F/,C"V
M$>W 8X.<>W7GB@#9@\7Z5I&E^%K6TTN_^S:K;(+&.) _EJ(MZHV6SG: .X]3
MC)JW8^-[">QUJXO[:YTQ]%.+Z&Y"EHQLWAAL+!@5/&#7-Q:7JJ0_#A3I5UG2
M4 ON%_<XMS%Z\_-Z9XI+VQN([CXC7-_I$DEEJ,$7V99G"+<E(/+*@@Y4EL =
M#R,4 =(/&<2:MI>FW&DW\4^J1F6T_P!6P*C!;=AN"H()'/!XS73UYAHMVT&K
MZ'-KVA^)5FL8Q96MU=PPF&)I=J%F,;$Y;"KN(QSVR37I] !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-CECE3?&ZN
MN2,J<C(."/SKD+77-3U#XAZQH,]A"VFVUI"<&0'<)"^68$<YP!M]O>N5\">*
M#X9^'VC"32)WTPWTMM)=JZJL1>Y=5PA.6 ) )'3WYH ];HKEM;\:V^ES:A#;
MQ07,NG1B2Y1[I86Y7=M0'.YMN#C@<CG-;>C:M:Z]HUGJMDS-;7<2RQ[A@@'L
M1ZCI0!9FNK>W:-9IXHVD.U [@%CZ#/4U!JFEV>M:7<:;J$/G6EPFR1-Q&1]1
MR/J*\\M0GB#Q5XUM?$NF02:9#]GCE,L^1;1K#YGRD '[Q+9!&"?:NA/C:.ST
M_2]3NM-E@T34'CC@NS*&:,/_ *MI4Q\JMQSDXR,@4 7K#PE;64B&;4]6OXXR
M&CBO;QI$4CD$CC=CJ-V>0#UKH*Y%_&MU)XAU/1K+PW?74^G26XF82QJ-DN3O
M&6Z #..IYZ8JMJ?Q+TW3;?\ M!DBETI+G[-),EROFK\^PN(NI0-WSG'.,<T
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M#&6"+U=OX5'N3@#W-<-X#N-2T3Q5K7A77+GS[J8+JUM+V<2<3*OH%DS@>AH
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MY?-;8I#D# #$ D@8Z].NEIU_=W5S<07=B+<Q*C)(DOF1RAL\J<#ICG('Y8)
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M9//643Q,6"OQ]TG;G:>0"/6LWQ%INI7?CGPIJ%K8R36>GO<M<RB1!M\R+8N
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MM)>SGN8WC5?-9U?(0MNV_*>W?O0!:N/%\XM=0FL=&GNSIB*;V)9 '1R@=HD
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MLY(*Y0YQDX/3M0!K:EXY&FQ7=[)I<W]FV=^EA-.[['+L57>B$?,@+@9R"<'
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M1'3>D95QO(!&5(/.?K0!LP>-TFTK4;L:9<M/9ZH=+\B,[]\NY5!R.B9<<D<
M=.U.3QGL_P"$BAN-,D^V:%&DT\-O*KK(CH74HS;>RMD$#IWKEHM%\96>B:XE
MOIX2:Z\0M?/%!>*K7%JQ7>B/QM)"]3M./2IK?P_K=MJ7C"6#P[';VNKZ;%%;
M1PW$0VNL<B[2,@;LN"3G'7D]P#:L_'WFZ3%JUYHMS9:?<6]O):SRS1XGDE(
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MUG4:?>VZ7>IV^/O2P,! WMDD?7RC0!W$#R26\;S1>5(R@M'NW;3Z9[U)110
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M:5<GS+>8R>9\T?!)53D?U_"M*#QS<"^T*.^T@V<6LS/##'),1<1$!BIDB*C
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MMMSY"+&W"Y.&)).> /X3STR =#=6L-[;M!<)OB?ATR0&'H?4'N.A[U* %
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MJ$@9Y(!/^>W6@"Q<7EK:>7]IN88?-<1Q^8X7>Y. HSU)/:IJ\AU.^OM3\!>
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MC6JZ1)/;75O/Y\4Q,<G0E1@KM![_ '@:B\/>*+RR'A/2;S21%9ZG9+';70N
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MA2R(J_,WH"5%9=WX$OO#NE^&G\(&&6[T'S5\BZ;8MVDH'FY8=&) (["O1**
M.#\3:7XH\4>!;^SGL;6WOKMX?*M$N0Z0*DBN2TF!EC@]!@<>YJWJ6AW^I^.[
M+4GLRNG#3)[*?,JAP92IX /08QG/YUV-% 'F]OX3UUOA\W@2ZBB,(_T9=364
M;3;;\YV?>$FWY<8QGG=6U::-?V7Q"O-72R_XES:7%91;95W[HV9NA/0AL#GZ
MUUU% 'E[>$-?/PGF\,_8XO[0>\,P/GKY>TW/G=>N<<=.M=&^F:FWQ*@U\61^
MPII#V;#S5W^8TBR=,XQ\N,YZ^W-=3<7$-I;R7%S-'#!$I>221@JJHZDD\ 4Y
M'26-9(V5T8!E93D$'H0: /,9/"&OR?"[4O#HLXA?W-\UPA\]?+"M<";D]<X&
M.G6KVM:!XDU/6-?8V=I<VFH:>(+"2YN,&P8QLKJ$ .2S'.X'T!/%>A44 >>1
M^'/$<*^!KQ;.R:YT6WDMKF W) P\*QA@VWG!7) '? SUJYI.BZWX7O\ Q!!8
MVD5]9:I=R7UM(9@GD32 ;UD!YV9 (*[CC/%=O10!YW9>"K[0KOP/!8Q"YM-!
MCN%N93($+M*FTE5/^T2<'''K7>7]FFH:==64A*QW$+Q,5Z@,"#C\ZL44 >4R
M>&?&3^ +;PF^GV,CZ?/;B&]^U[4FBBE5E.W:2IVJ <^G&>E;+Z;XMT#Q9J6H
M:+8V.HV&L&.6>WFNS";6=4"%@VT[D(4=L\=!W[>>[MK5X4N+B*%IW\N(2.%,
MCXSM7/4X!X'I4U '$^(_#D^O1+9:UH\.KP"U4QW,#K%+!<Y;<4)(*IC9@@D_
M+R&K-7PUXMT#4=%URQ>WUJ^BTM--U.">X,1FVMN617(/()(R1R/<\>D44 <1
MXATCQ#JUOX>D>WMY+JTU>+4;B..8!(XU##RT) +'##D@ G/3@"[XBTG4;_Q;
MX7U&UM@]MILTTMP6D53AXB@"CN1G)Z?C7544 <18Z3K^BZAXF2VL8+A=6NVN
MK6Y\\*D1:-4Q(I&[C;GY0V?:L[_A#=;\(SZ'?>%4M]1-CIPTV[M+F7R?/3=O
M#JV"%;<6//8UZ#=WMK86[7%Y<PV\"_>DF<(H_$\5'9ZII^HLRV-_:W115=A!
M,K[5;[I.#T.#CUH X[7M"\3:C_8?B")+/^VM+NWG%AYI\HQ.FQXA)CEL<[B,
M9)[8JUHVF:Z?B!?Z]?6%M:V=W80VX076^161F/0+@_>]?SKLJ* .5\6:3J.I
M:UX;N;*V$L6G7WVJ<F0*=NQDPH/4_-GL..M8NH^#-3UK4/&R2@6D&M16HLYP
MX8I) O!8#H"V#QGCTKT2B@#E=!NO&<XC&O:;8VHMD.]K6Y\PWCXP-JD 1KWY
M.<@#IFL?2?!>HS?"2;PEJ.RTO")=DT;[U#&5I4;CG@D9^E>A44 <MX>N/&5P
M8D\0:?8VBVRGS);:X\TWC8(&U2!Y:YYY.<@#@9KEY_"'B"7X=:UH0LHA>WNJ
MM>1DSKL"-<++R>N<+CIU(KU&B@#CM0TG6+KQ[9ZS;6XAMXM+FM/,=U+)*[*P
M;;GD#;SS^=<[9>%?%2IX7FGTW3Q>Z9>-+>SM>%GNR8V0RLVS/?.#D]N *]3H
MH X>QT?7]'N/$]O;64$ZZO>R75M=>> D6]%3$BD;N-N?E!S[56M/!-WX4UG0
MM2T5?MT5GI?]E7D#.$>2,-O$B9^7=OSD$C@]:]!IDDL<0!D=4!8*"QQDDX ^
MI- '.Z!X=>WU'7]5U"*,3ZU,ADMP=RI$D8C52>A)&2<<<XYQDU?!7A.Y\/Z7
M=66H7'VA%9K6T.>4LU9C&I_VOG.?;:.U=0]Y:QW26KW,*W#C*Q%P'8>H'4U)
M)+'"A>6140=68X H X/PKIWC70;2#PU-!82:9:'RX=7$_P"\\@'A?)V_?QQG
M( ]\<]?K:7DFD3I86\%S.=H\B<@)(NX;U)(/5=PZ&K7VRU^SM<?:8?(3[TF\
M;5^IZ4^*6.:)98G62-QE70Y!'J#0!YNO@>[L['Q3#HE@^GV.K:<;>'3'G4HM
MPP<-*,$JBX91@')P>!@5?DT#6'F\#.+)<:*/]+S,O_/$Q?)SSSSSCCWXKMS<
MP"/S#-'LW[-VX8W9VXSZYXQZU+0!Y5>>$_%EUID\,]E87-_'K$=[]ODNR'NH
MEF#JF-OR!5XQG QP#FNHATK55^)4FO2VB?8VTA+$E)03YBR-(2 <?+\V >OM
M76T4 <MX$TC4-$TJ^MM1@6*274+BZ39('!61RP''<9YKJ:J6>JZ=J,DL=C?V
MMT\) E6"97*$],@'BK= !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 >9PW&I:;\3?&1T/18[^X>VL7:-KA;=/NR9RV#
MECVX]<D5LV7Q%L-0T72[N*)+>[OY)8OL]Y,(A"\7^L#M@\ X P,G<O YQ(NF
M:OI/CK6=9MK!+ZUU.VMXU"3A&B>(,/F#?PG=U&2,=#6+-X'UO1K+1M2T.:UN
M=;L+JYN;B&5BD5S]H.94![8PNTGTR: .G\+>*/\ A(FU&"2U6"YL)_*D,4GF
MPR@C*O&^!N!Y[<$5GW.LZT?BI#HD<%HVF_V4UR5:=E+9E12Q&P@D8("].3EA
MG W=$DUFX@>YUJW@LY9,!+2"7S1$!W+X&6.>PP ![FLB_P!'U:/XCV>OV4%O
M/:-IK6,P>;8T7[T/N P=W (QQSW% '':%XBN_"6@>*K^VT9+G3;/Q!>-<L+@
M1%(_, _=KM.X@<X.T>A/;N-5\6Q6NHRZ=9FQ>[BMUN'^V7?V=,/G8H.UB2=I
M[<#'K7+R^$]>F\">+M&^Q1K=ZOJ%Q<V_[]=JI*P8;CV(QS@'M5^[TOQ3I'B9
M=?T.QM;V.^LXK>_T^XN?*97CSM='P1C#$$8_^L /A^(TEW;>&YK70KAO[:DD
MA\N28(T,B*Q*D$<C*]>..?:MGPUXDN=9OM7T[4-/2RU#2YDCF2*?SD970.C*
MVU3R#TQ69JNCZ_?:OX5OI88)GT^ZEN;ORY JJ'1D")G!;;NZG&<9[X%OP_I.
MHV7C3Q/J=U;+':ZF]NUNPD#']W'L.X#IGJ.OX4 7-:\30Z9J<.F1M:?;986G
M_P!+N?)C1 0HRV"223P .QZ8YQ;3XC6]UI=C-):QV=U=7\FGE;J?;"DB*6)$
MNWYE8 ;2!R6'2I?$VD^(+;Q79>)_#D5M>2I:M97=C<2^4)8MV]2KX(#!L]>Q
MJ;4+#5M5TN"'6M&L=1M[F1C>6"R*PA3:-@C9@-S C.?E^\<=!0!1\4^(_$5E
MINC-#86UK/=:W#93*URQRGF\;6"?=<+R<< ]">FAK/BK4=*CU%_['CV:=9+=
M3RS7+1Q2,0Q,<3E/G(VGDXY*\<\<\?!&LVGA&RLK,B9[#78]2M+.YN23';H^
M5A\SGD#)[@9QDXS5K5M \3ZAK&LO-:6%U;WVG""S>2Y.VP<HRR!5V_,6+9W#
M!( SCH "KKFI&\\:> =;TS3O/GO;*\EBB9EC9@T,94,W8#=SU[X!Z5+J?B5O
M$7@GQMI>JZ2+#5=+L9O/MFD$R8:%FCD1\#(.#V!&*DMO#GB"S3P/?/96\L^A
M6DEK<VL5P-S!HD0,K, I(V9()'7J:M7OA?4;K3_&%\88_P"T]>M/LD-N)!MA
M18V1-S=SEF8XSCH,XR0!D>K0Z?I/@*VN-(AO!>"WAAN)"N;:3R<[E!!.< C(
MQUK4B\637NJWMGIUG;W!L;Z.TN8C<E9U5B@:41[3\H#$]>0IK*O- UF:Q\$Q
M)9+OT:>*6[!F7HD1C(7UZY'3BHM?\)7NNZD+Q=-CLM:M[U6M-:MYE4B .#B0
M##,=F5VX(/'(R: *5K>WVC>.?B!-I&D0W;1BSF=&G$"8%N2<$*Q+'G'&.N2.
M_1CQU9SZ?HLUMY"3ZM:?;(DN[@1)'& N=S8/.74  <\]@:JVVBZO!XA\9WS6
M0,.KQ0K:XF7.4B,9W>F2<]^/?BL:V\*^*=$TOPKJ.E06LFJZ19-I]W933[4N
M8CM/RN!P05!&1_+D VK+XA176DM*]@4U'^T?[,BM5EW)-,>C))@9C*Y;=C@
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M2W.LZC-<VV9UVJDA7&X]B-IX&>HK=OM+U2Z\9^&-7%D$M=-M[B.Y+3+N!E5
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M,5>VD4A74$*0W7CIP<^U;DFBZGH_CZ]\0Z?;B]L]4MHX;NW$BI)')'D(Z[L
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M[B8_8=.AY!!V]:O/K=Y?ZWJ&E:/';&33EC^TS7);;YCC<L8"\_=P2W;(X/.
M#H**X&Q^(%[=^'_#&K/IT$:ZSJ9T^2$2DF'YY%# X^;B/T'6M4>*;Q?$'B+2
M_P"SOM#:79QW4*P,=]QO#D)@]#\F/QH ZFBN.T[Q=>R>*;;0KR&R:YN;!KK;
M!*<V\BE<Q2#G^\/FXZ'Y:HZ7X[UB[TJXUV]TFSMM&LGNUO'6Y+RJ82P&Q=H#
M E<<X.3T&.0#OZ0XP<].^:X^U\7:D=?TNSGTWS;34%;=+;1RG[&X&0)"R@%3
MTW#'/:K/Q%FO+?X>Z]+9,BNMC-N9B00NQLE<?Q>E %/2] \!7&J30:9%9/<(
M/.>TAN&,>TG[WE;MA7/<+BNTKAK/4/L">&+5K"P?7;^U,%K, <16Z1J[EFQN
MQ]WY1U)'(Y-22^/H]'D\06NOP+#<Z/;K=[H"2EU"W"E >5.[Y2#W(Y- ':T5
MR=WXGU+1-0T5=:L[9+35IUM5>W=B;:=AE$;/WP<$;ACD=*R_#VO^(7?QE=7-
MM'?G3[Z2*&UMBP=BD495$SV.>3UR3QVH ] HKDM)\5W-QXQ_X1V\6R>9M/-X
M7M9"?)8.JM$X.>1N!SQ]!67)\0KYO#-CXEM-/MIM/OK_ .QQP22M'(H,IB61
MF 8?>'*A> >IQ0!Z#68?#^FMKPUPPR?VB(O)$WGR?ZO.=NW=MQGG&.M8.I^+
M[R.XU*TTZWMWN]-C0S1N)'$DK('\I"J\<%?F/<_=KH=#U-M9T.SU%K2>S>XB
M#M;SJ5>(]U(/H: )K74;*^FN8;6ZBFDM9/*G5&!,;X!VGT."*M5P7_"97EMH
M_C+4$T:R2XT2Y=7C2<@3A8E8N6V9)P1QCMC/>K5IXMU8>(- L]0TVUBL];@=
MK=XIRTD;I&)"'&,8(ST)QZT =9=WMK80&>\N8;>$'!DFD"+^9JK;:_HU[,L-
MKJUA/*WW4BN49C] #5#QX ?A[XD!&?\ B5W/_HIJ\U\0ZE%+\#M(LY-%O [6
M%HD5]+"!#:MM3$Q=22H'7('?WH ]JJ&[NK>QM)KNZF2&WA0R22.<*B@9))]*
MYI/$%S8:WX6T9F@OH=4M)&^VHYR3%&K%AV8-NS5.7QA>/H/B^>72[2=]"EEB
M:)I2$G18@Y)RIQP<8_6@#J&UO2DDLHVU&U#WP!M4\T;IP1D%!U(QSD5:N;JW
MLK:2YNIXH((QN>65PJJ/4D\"N!\07(OKGX<7GE)$9KY)-B#A-UNYP/:K^K:]
M>ZSI?B>+2(+9[735EM)6G8YGE$>75<?="A@,G.3D8 &: .D_MS2_(L)O[0M_
M*U!@MHV\8G)&0%]<@9J])&LL;1L6"L,$JQ4_@1R/PKS?0M;DTKPA\.;;^S[>
MXBOTM[?SI'^:!O))W*NWT!&<CK6C/XN\0RZGXGL+#2+ R:((WWS73;9%:,R=
MDSN(P,< <\F@#J=&T33_  _IR:?I<#06B$E(C*[A<G)QN)QR2?QK0KD8_&PO
M;;PH+.V"7/B*,RQ><<I JQ>8^<8W'H .,]<C%6/#'B._UK4M9L;NQMX#I=R;
M9Y8IV;S6P&#!"OR@JP_B)!X]Z .AN;JWLK=[BZGB@@3[TDKA57MR3P*CLM1L
MM2A::PO+>ZB5MI>"57 /ID'KR*YKQWI&NZO:V2:1;:1>002-+<66IABEQ@85
M<#CC)//&0I[5-X"U'3]1\//]AT:/1I+>X>"\L(XU00SKC</E !XP<]P10!U%
M%%<,GC>_@U+0H=1L;>V.K7+6_P!B:3_2;488H[CH00O/ QGJ: .YHK@;CQGX
MA9_%"6>CZ?NT%\N9;ML2IY?F87"9W$>N /4UJ1>+SJ<FAVFEPI]LU6Q&HGSR
M2MO!A?F8#EB6<* ".YSQR ;]CJNGZD]PMC>P7)MW\N;R9 ^QL9VG'0^U6)IH
MK>)I9I$CC099W. ![FN%^'AN3KWC7[7'%'/_ &L XB)*G]RG(SZ]<=LU<O[]
MM1^*.G: 3_HMCI[:I*O:20N(XP?]WYF^N#V% '3KJ5D^I?V<MU$;WR1<?9]W
MS^63C=CKC/%1VVLZ;>1^9;7UO*GGM;[DD!'FJ<%/][CI6.FMS-\1;G0VTZV5
MDTL7<=T)"7D4R%0A^7Y1D$]_6H/#5Y%XP\,:E%>:=!9H;RYM)(;=LC*N07#8
M'S9YS@'/- '6U'//#;0//<2I%"@W/)(P55'J2>E<U\/-<N?$'@JRN[UM][$7
MMKAO[SQL4+?C@'\:S]'U/6K[QUXML;M[5K&R6WC1%+?*K1NXP.A)+<GV'I0!
MV-E?6NI6<5Y97$=Q;2C,<L;;E8=,@]ZL5Y)X)\2:IH/@/P67T^V;2;R6*P9_
M./G!Y&8*^W&W;GMG/TKM#XAU'4[O68=!MK68:3)Y#FX=AY\P4,T:X^[@%1N.
M>2>.,D TCX9T5O$7_"0-I\+:J(Q&+DY+!0,<=@<$C.,XXK5KA8OB18W]CX>N
M+>2"Q364E*37Y(2.2,A3$<$?,6) Y'W3UX%:-UXHNK3^S;&YMX8-5O5FD9?G
MDCB2-@"WRC+9+)CIG.<C% '4T5S_ (4U^[UVWO5O].DL[BSN6@+;'$<ZC[LD
M98 [2.W:F7>O7]UJNJ:9HEO;RW&F0H\S7#$!Y'4LD2@=R "6/3<.#S@ Z.BN
M6C\4WEU=Z3I4>GBTUB]LVO)X+EMPM(U(4YV_>)9@ ..Y.,8.3?\ Q"O+#0O$
MSOID!U?P\R_:8#.1')&XRDB':3@CG:<=",T =Y+&LT31L6"L,$HY4_@1@C\*
MI:-HFG^'].33]+@:"T0DI$97<+DY.-Q..237-W'BO7K3Q)I>F2Z19,FKPRM9
ME;I@T;QJ&(E^7 &#GY<],<]:HW/Q U2P\+^);VYTNT?4=!N/)FBCN&$4BE59
M74E<]&'RG'3K0!Z%17%?\)?K&G^*]+T[6M(M[?3]7+)9W$%P9'CD"[@DHP "
M1_=) /<]:9-XWO7\*S^+;&Q@N-%@=SY6\B>6!'*M*I^Z/NE@IZ@=03B@#N**
MXV3Q?J=WXJBT;2-/LYHKG2AJ5M=37#*I4N%&X!<@<]!G.1TYJ*P\?&X\-V5W
M<V:0ZE<W\FG>0K,T:RQE][9 R5"H6Z9Z#WH [>BN!N/'>JV6F^(Y9='6632(
M!<Q7'[R&"ZC*Y."RDAEQ@KSGUJY;>+-77Q%H=CJ&FVL5KK4$CVS13LTD;I&'
M(<;<8()Z$X]30!V5136T-PT32QAFB</&W=6]0>W&1[@D=Z\[T;Q=K%CH?BW6
M=7%O<1:?J<\ 6(N-NPQH,#!P@'S$]>IQ78:%JESJ;32&6QNK$QQO;7EDY*2Y
MW;AC)P5PO<]?PH V:*PM1UZ2/Q':>'K!(FOY[=[MWESLAA5@NX@<L2S  9'0
MG/&#B2>*K_4-$\56(@AM=;T9&6<"1BA1HRR2(<9Y'(!Z$4 =/;Z]I-WJ3:=;
MZC;27@4OY*R L5!P2!W /!QTK1KD/A_9>;X*\-7=[:V;3P:; +69%W.B-$N>
M2.">^*Z^@"*XMXKJ!H9T#Q/PR'HP]#ZCV[U*    , =!110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M <J-#U>S\?W^N6GV*2ROK.&&199&61'C+$8 4@@[NN>/0]#SJ^!_$"_#.W\,
M_P#$M^UQ7PN3)]I?RRHN/.Q_J\Y_AZ>_M7HEY?6FGP>?>W4%M""!YDT@1<^F
M33;'4[#4XVDL+VWND4[6:"57"GT.#P: ./GT+Q7I'BR_U;P\^ES6FK"-[NTO
MI'7R9E4)O1E4Y! &00.E=G9Q306<4=S/Y\X7]Y)MVAF[D#L,]!V%3T4 >=2?
M#_4;[0O%&A7=S:QV>I7\M_9W,19I4D9UD7<I  "E><$Y![8YV'T/5]>O="GU
MZ*S@&DS?:F%M,TGGSA"JD95=JC<6[G.![GK:* /.I_!OB5=$\6:797MC NIW
M\M[:SB1PY\QT9HW 'RC"LI()R&[8YO:;X>U^#QM#KTL&D6]M_9(L&M+>1SY1
M60N IV@$'/7 QZ''/;U5.HV2ZFNF&ZB%\T)G%ON&\Q@XW8],\4 8?@30]1\.
M^'CIVI?9C*+F:96MY&=2))&?'*K@C=BFQZ)JB_$J;7RMI_9\FFK9 "9O-!60
MONV[,8^;&,UU%% '!VN@>+_#^N:FFAW&E3:-J5T]YF\+B6TD<Y?:%&'7/(&1
M]1UK0AT'5H/B ^N?Z-+9_P!DK8+OG82LZN7W, F.<XZ^_M765FW/B+1+*=H+
MK6-/@F7[T<MTBL/J": .'B\#:]%X*L],W:=_:%CK(U.(>>YBD F:386V97[V
M,X/2KVH>&?$UWKNK71DTN:'4M-6U1YGDW6+;6#B-=OS*Q8$G*G@>@%=C8ZKI
MVJ!SI]_:W8CP'-O,LFW/3."<5;H \_M?">OV=MX+N?\ B7S7GA^W>WEMQ*ZI
M*K1+'E7VGD;<X*@<X[9-VZ\*:A=67BJ[8VO]K:[:_95C\QO*@C$;(@W;<DY9
MF)P.N.V:[.B@#SZX\)^)+.W\-ZGH\VGIK.DV0L+B"9W,%S#A<C<%# Y0$<?R
MY[#1H]56T:369+<WDK;C%;9,40P %4GEO4D@<GIC%:-% '"^+_"-]XI6_M;B
MRT]P65M+U#S62>R.U<GA<\.&8 -SG!QUI\7A[Q'HGC&_U'1YK"ZL-66(W:WC
MNCPRQH$WKM!# @9(XY[BNWILB++&T;9VL,'!(/YB@#R7PSH>H:U\)O#$FFM;
MM>Z9JTE^D<[%$EV7$P*E@"5R&/.#6W/X4\4W>J>);[[78V4VK:;';1/;R.6@
MD0-CG:,CYL;N#W %=II>D:?HEF+33;5+:V!+"*/.T$G)P.V3S5V@#S_3_"_B
M.#7_  _J;V^BVT>GV4MI+;02R$ -L.Y3M&<E>A QG.6JQHG@R]'@C6?#FLM;
M(M_+<LLEK*S[5F9F_B5>5)_'%=Q5.YU73[.\MK.YO;>*ZNFVP0O( \A_V5ZG
MI0!SGAFS\:P"VLM?N=+:UM %^TVI<RW0 PNX, $[$XSG&.,UJ>,-+O=;\(ZI
MI5@(/M%[;O &G<HJ[@1G(4GCTQ6Q++'!"\TKJD<:EG=C@*!R234=G>6VH64-
MY9SI/;3('CEC.593T(- '(7_ (6U:4^&-6MC:)K&AJ8S"TK&&XB= DB[]N0>
M,@[3BF:KX#/B<Z_<ZNT=O<:G8QV,*0L9! B,7#$D#<2Y!(QC"@9[UUNHZKI^
MD6XGU&]M[2)F"JTT@4,QZ 9ZGVJY0!QK:!K6N1:#;Z^MFBZ5=1W<LMO,SFYE
MC4A, J-H).XY)Z8]ZHW'A#Q&MMXQLK"^M+:+69FNK:Z5W$J.R(I1@!\H^7[P
M)//2O0** .!LM!UNP\3Z;X@NX]&L;&STN2SN(+>1RL*[E?<I*@'[I],?[7?G
M])M==@T>+6TT?0+_ $TS/J<3?VE+"OS$L'$14QHP!_ \]<FO4M2U33M)M?/U
M*\M[6%CL#3N%#$]AGJ?:LZU\%^&+*^^VVV@Z?%<!MX=(%&UO4#H#[B@#GWT?
MQ38>)KK7O#G]GO::S'%)=V6I,\;02J@4,I4'^$ $>HKMK**>&SBCN9_/G S)
M(%VAF/)P.P]!V&.M3T4 >>R^$->DTCQM9XTX/K\KO;G[0^(PT8C^;]WVQGC/
MI[U=G\.:U+JO@Z["6 714D%ROVA\N6B\OY/DYQUYQZ>]=K10!C^*]/O-7\*Z
MIIE@(/M%[:R6ZM/(45=ZE=Q(4GC/3%<U+X>\4W'P^A\)^5H]N/L"6$MW]JDE
MP@0(S+'Y2Y) . 6X]Z[VB@#A;OP=J&EMX0FT V]RWA^*2V,5Y*T7G1R1JA;<
MJM@@J#C'<U!'X1\0C2/&MI*^FO+KSR-"PD=0A>(1G=\IX&,\9S[5Z#10!P]Y
MX9UN>#P:J)8;]$E22Y#7#X?;$8\)^[YZYYQZ>]01>%_$6C7GB2UTO^S[G2M;
MEENE-Q,\<EM-(N'X"D.I.".5KMK[4+/3+1[N_NH;6VC&6EF<(H_$U-#+'/#'
M-$X>.10R,.A!&0: . C\'Z_'H?@JR/\ 9S2:#/').?/<!PD93"_(>?FSSCI5
M^W\.ZU#KGC"^V6)CUF.);9?M#Y4I%Y?S_)QGKQGTKLZ* /*[G2-5L],\'>%H
MO[(FUC3H6G,4ES)&&2-=@=)54.IRW0#GGL#73^$)-0L[V\TK4-'LK*8C[6TM
MG>-<"1F."9"X#!CC@G.0#Z5MZOX>T?7XXTU;3;6\$1S&9HPQ0^QZC\*EL--T
MW1+)H;&TM[*V7+L(D"+[L?\ $T 5-3E\11:E;_V79Z;<V+(1,+FX>&17SP00
MC KCMC-9MY::GX=\,ZG>:7)ISZO<7!NYGO-ZP%B5!&%^;A%"CN2!ZUT5C?VF
MIV,-[8W$=Q:S+NCEC;*L/4&IRH;&0#@Y&: *UM)<76EPR31FVN9859TZF)RO
M(]\'^5><VO@KQ7'IOA^"5M'-QI.I_:Y9_-D9KS(<&1SMR'^8<<Y_O#&*]0HH
M X>+PSK:2^-'*6!_MP?Z-BX?Y#Y(B^?Y..F>,^GO5&W\'>(=(F\,ZMIQT^74
MM,TQ=*O+:2=UBN(0!@J^S*D,,\K_ "Y]&HH Y3PGH>KZ5K/B&]U+[$(]3NEN
M8UMY&8IA%4@Y4?W>O?T'2H=0L&TWXHZ=X@(_T6]T]M+E;M')O$D9/^]\R_7:
M.XKL:K:A-906$TFHR01V87]ZUPP$87_:)XQ0!@#1-4'Q)E\0A;0V+:6+%5\Y
MO,W"0R;B-F,<XZ^_M4/A>PN_!_A_5I-9-L$-Y<7P-M(S_+(Q;;RJ_-SCC.:Z
MBSN;>\LH+FTE66VFC5XI$.0RD9!!],4Z2"*8H98U?8P==PSANQ'O0!S?P\T.
MYT#P796MZNR]E+W-PG]UY&+E?PR!^%0P:#K-AXR\0ZI;?89;+5HH2!)*ZR(\
M<93;@*1@\'=GCI@]NNHH \VA\$Z_#X%\,:&/[.:YTB_@N97^T.$=8G+87]WG
M)SCD<>];%AH&L^'?$&MW6E1V=U8ZO*+LQ3SM&UO<;<,<A3N1L ]B,=*[&B@#
MAK?P7+IOAS3?#WV*PU?28X91>Q79V,\SL'$B?*V.3)QD$9&#Q6<G@/7]&TSP
M]<Z)J%L^K:/Y\?DW;NT,MO*V[R=^-WR *%..W0=*]*HH S=%35_LK3:T]M]K
MD.?)M23%$HZ %L%CU).!UQCBN:O= \2Z7XUOM=\-OIT\&JQQ+>VM\[ILDC&U
M9$*@_P /!'^1V]% '&WWAG5HO$>D>)+*X@NM1MK9[2]BF)B2XB=M_P A ;:5
M;D YXX)[U1UGP1J6IZ-XL=#9IJWB$1QE6E;RH(XU"J-VW+'[Q/ Y;';)] HH
M Y"^T+6;OQ1X5U01V*Q:5'.MPIN'W,9(PGR?)SC&><9KE/&6B:GI?@SXAWUZ
MMJ(-3*3PB&9F90 B88%0/X<\$]:]:JGJ>E6.LV3V6HVZW-J_WXGSM;ZCO^-
M&!)HFH:[JFA7>J16T%OI3-<!(I3(9IBFP=5&U0"3ZDXZ8YR+'P;K6F^#]1\&
M0/:/I4_G16UXTK"2&"4DLK1[<,R[FP=P!XZ8KOH(([:!(8@1&@VJ"2<#ZFI*
M ./MO#%_I_CFUU.TCM/[+M=&&F1(T["7APP.-F,?*!U]_:L-/ 7B!/#H2&ZL
M;76;/69=5L9%=Y(FWLQ,<F5! (<@XS7IE% '%:EI'BSQ!X/U>QU(Z7#>WMJU
MM#!!*_DQ[A@NSE<D^@ XQU.:=/X=UJ;6O!][LL0FC)*MROVA\L7B\OY/DYQU
MYQZ5V=% '$:;X?\ $FC)XBBM&TR2.^U-[^V,KOEQ(Z%XY!M(4;0PR-V<C@8J
MSX7\)#0O$.J:E;VL&FVE]'&#I]M(6C\U2VZ7& %)! P!VSWP.NK.;7])75$T
MQM1MA>R$JD!D&YB.2!ZD#G'6@#&UKP]?_P#"8Z=XHT@P/<P6[V5U;3N4$T#'
M<-K '#*W/(P?:H!X7O\ [/XIOL6O]K:]&(_+\UA%$BQ>6@W;<D\EB=O?';-=
M#>:[I&GS^1>ZK8VTV,^7-<(C?D35BSU"RU"(RV5W!<Q@X+0R!P#]0: ,[PII
MUYI'A32]+OQ!Y]E:Q6Q:"0NK;$"YY4'G'3%;-%59M1LK>_MK":ZB2[N@Y@A9
M@&D"C+;1WP#0!:HJG9:KI^I27$=C>P7+6S^7,(9 _EMC.#CH?:BXU73[6_MK
M&XO8([RZ)$$#2 /)@$G:O4\ T 7**JVVHV5Y=75K;744L]HP2XC1@6B8C(##
MMD5:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH \[\/W#Z_\ %_Q1+>_.FA1P6UC$W(B\Q2SN!_>.W&>N.*/'
MD[Z#XU\'ZS8_)/>WZZ9=JO'GQ2= WKM/(],UM7/AN[T_QC-XFT0P/)>PK!?V
M<[E%FV_<D5@#AP.,$8(].M$OAZ]UWQ+IVKZVL$-OI9:2SLX9#)NE88\R1B!T
M'10.#SGM0!C/XV\47-IK]QIWAZPD&BWDL$R/>MF5$56/EX3EL$GG ' &3G&C
M'X[AU2/3ETH(LMY8+?EIXW<1(QPJE4&22P8=0!M/7@5B^&4U>>;QW::=!:%9
M]:N(UFFF*^4QC0$E0IW #!&",GCCK5J7P3K/AR[T:_\ "%Q9R2V6G+IMS;7Y
M94N(E.X,&4':X8L>G?\ , 5OB!JZZ/HMT?#OE7-]J@TR:&>5H]KG=ADR@W(0
MN=QQC/0UJ'6_$D'DP:A8:=82>3++/>O,SVJ$.%C0$[3N8'//0#H>@KZWX?\
M$>KV^@N\FG27=EJL>HW ,KQQ@(&7RX_D8GANIQDY.!G LZKHNNR^-['6;-K"
M>SCLVMS!=NX^SRELF9 %(8D?+CY3@=1DT <]J'C/5M8\+>#M6TR."T75M5@M
M[B-W+'(=OE# ?=)C.3U(./6ND&MW8^($>ARZ;9^:=(:[6Z60[F(D52GW<JN2
M3W[5SEIX%\0VG@?0-*\W37OM%U5+V,>8ZQS(KN<%MI*DA_[IQCOFN@.AZR?B
M#;^(&%@UO'I363J)G5RY<.6 V$;<KCKGG/M0!A#XB:X/"Q\22:+9)86U\UM=
MI]J9I-HF\K,?RX."0><9YX'4]-=>(+J;Q3<^'],B@%S;62W<DEQDJVYBJH ,
M'^$Y;MQP>W+R>!O$$GPTU#PUG3!=W-ZUPLGVF3RPIG$V#^[SGC'3WI^M0ZMK
M'CFY?1X=)N+C3[&.VNHY+V:VEC:0ERN^,9=<;#\P &>.2< '4>"_$<_BSPS;
MZU-8Q6:W!;RXDG,IPK%3N)1<'(/ SQCFN8U.Y:T^.]K*EG/=,?#C*4@"[O\
MCXZ_,0,?CWKI_"%Q,^D/93Z7:Z<VGR_91#9R^9#@*I!0X'][!!&00:R[S0=?
M_P"%E)XFM(-,DM8],-@(I;N1'.9-^_B)@/3'ZT :-E=W%['K&H6&D_9=31Q;
M"*\^0RA%W+N*D@9,C8(SP1]*H>%/%]_XI\CR["*!H Z:HDA8-:SJQ B''S'
M)/H,'^("M)AXKD-[,L.DPR"#99P"ZD=&D)Y>1O+!P %P #WR>1C)M/">J:)X
MLM]5T9[8VUU!Y>L17-P^ZXE!R)5PA&\9;)X!'&!0!1?QQXHN+#7KS3_#UA(N
MB7TUO.CWK9E2-58^7\G+8)/.!T R<XTE\=0ZFM@FDA%DN]/34"]Q&[B-')"J
M509))##J,;>]8GA>/5[I/'=GI\-H5N-<NHUGFE(,3-'&"2H4[@ 00,C)R..M
M6YO!>L^';[2-0\(3V<C6FG)IES:W[,J3Q(2RN&4'#@ENW>@!Q^(&K?V5H5RW
MATPW&H:E_9TT,\K1E'PQ#)N0;D(7(;C&>AJS'XVU"R'BF'5]-A^U:%;I=A;.
M5G2:-T9@,E001M()Q[XI^L^'O$6K)X?EDET^2YL=434+D&1XT 567RX_D8D8
M;J<9()P,X"_V#XAM_%/B/6+,Z<IU"V@BM=\SDJT6[[XV=#N[$XH GA\7^5HU
M[K<\]C>Z/!:?:$N[!B=[#.8]I)P?NXYYSR!BH[7Q9J?_  D>GZ?<Z9YUK?1N
M?/M8I<6CJ,[9"R@$'H&&.1TK+/PWCO;K7'-O;Z/:ZMIWV6:ULI"Z--NR)L;5
M *]!@<Y.<=]?P[;>-E$-OX@N=*\FU7'GVA<R71 PI8, $'<XSDCL* $\+^+9
M_$\=G>6AL9;2;<+B*-SY]DP!(20'J<C!.!ST!!S5SQGK]YX8T+^UK:VAG@AE
M077F,08XV8*7&.NW.2/2L:P\'WS^*-(\07=K86&I6L;KJ%Q8RL1?[DVX*[5X
MW?-DY(P!SU'8ZC80:KIEUI]TF^WNHFAD7U5A@_SH P%\43+\0CX:G6T6%[#[
M;!.KDM(-VTKCH".O7D5SGB/4+Z_F\"ZB]K"9YM69X(T<J&0PR;"21D9&&/!Q
MG')',I^'%[+X;T2"?4P=8LKA3<7JY!D@*>3)&/3,04?5<]ZWO$V@ZCJ>K>'+
MC3TLQ!I=Y]HD6:5D)&QDVJ A'\6>W2@"M8^*M4F7Q18WVFV9U'151RD4[>3.
MCQEU^8KD' (/%+I?BUKO1O"\5I9V\5]K5KY\<()$5O&J!F/') W* !C)/44V
M/PYK4>N^,+\+8&/68(8[9?M#Y0I&4^?]WP#NSQGI65_PA/B&RT3PG<:=<:>N
MN^'H3;['=S;W,3*%=2VT,"=H(XX- $7CZ^U2[^&VMIJVF"VGM=0MXHWC8%+E
M!/$5D3)RN<XP>A'6NDL/$>I_\)L_A_5;&UA$MD;VVDMYF?"JX1D?*CYOF!R.
M*H^(_#_B;Q)X-N;"XDTU=0NIH7\L2NL$"1R*^ VPEB=IR<#J/3F])HFJR_$2
MR\0%+);.+3GLY$$[&3<SJ^0-F"!MQU&<]J )?&7B.\\,V-C<VMA'=_:+Z&T=
M6EV%?,8*"HQ@GZD54?Q/JUI=0Z5J-K96^J3^=,IA>2>)($*@,0%#%B7 QQT)
MR.E6/&VAZEKVGZ?!IHM-]OJ$%VYN960$1N&P-JMR<8]JK>*- UV?6M,\1^'9
MK--4LXGMYK:[+>3<0N02NX#((900<4 <UXNUVZU_X4:T]_ILEE<VM_!;L&1@
MDH6XBQ)&6 )5@?3U%=;XB\0ZCI4]X(;:V@M;6S^T"[O7(CGD);$*8(PV%Z\]
M1P:H^)/#WB3Q'X'NM-GETX:E=S12%1(ZP0*CH^U3M+-]SJ0.6] !2:CX=\0W
M7BB^OXVTV2UO=.%JGVB1RUBV&W^6 N&#9&>5)P/3! *.H>*=7U.[\!7.EB"W
MM=9+3R0RLQ)/V=G"$C^$9].2!TK0U7QI>1+JS:39QW3Z6YC>$I*6N9%4,Z1E
M5(7&< G.3G@#DT+;P=XBM=&\&!7TQ[_P^^UXS*XC>,Q&+(;:3NYS]T#MVR;"
M:!XNT'Q'J4^@SZ3<:;JLPN9H[TR*UO.5 =D"YW*< X)'ID=2 =C97CZAI%O>
MQ0/"]Q LJPW"E&0LN=KCJ",X-<#X<\8ZE:>";G6=9\FZFEU&6UMXXF*F24SF
M-4YSM7IZX [UZ);1/#:Q123--(B!6E88+D#DGZUYVOP^U:;PC?:#/=V<)BU!
M[_3;J(LS>893*ID4@ 8R5(&>N>W(!T1\27NF>*].T/6(+?;JD<AM+FV+ >8@
MW-&RGVY#9Y]!6IKE_>Z?9Q/86)NYY;B.'KA8E8X:1_\ 949)Q^G6LG^Q-2UG
M7]&U768+6V_LI972*WF:7S)G4*6R57"@9P.22>V.9/&NC:IK6F64>ER6Q>WO
M8KB:VNF98KJ-<YC<@'@D@]"/EY% &5'X\N3IOBR2.WLKR?P^HD\R&<K%<(8O
M,R#AL$8(QSR.M26?C#5SJOAN._TRTBL==B/DM%.S212"+S/F&,8(R."<>M4I
M?"'B263QFS-I6/$%HD48620")Q"8L'Y3P,YSCG'1<\6Y?#&MO)X+<+I__$C_
M ./G_2'^?]R8OD_=\]<\X]/>@#/\6Z]>^(/AYXKNM-@MCID$-S:AI6.^8("L
MDBD<* <X!SNV_P .:[?P_P#\BWI?_7I%_P"@"N%_X0SQ+I_ASQ%X7T\Z;/I6
MH"X:SN)YW22#S0249 A#<DX.1US@]*[S1K6YLM#L;2[,7VB"!(G,))7*C&1D
M ]J .5E\;W]G>Z.+^QM[<:GJ!LA8O)BZA4EPDK=B&V XP,!AR:EA\4>(K[Q3
MJ^CV.CV!72[BV6662[8;HI%W$K\GW@#TZ#!Y-84/@CQ8NCZ19RR:/)<:;K*:
M@]TTLA>]PS_,YV_*V& Q\V<=0!SU&@Z'JNG^,?$>JW@LC:ZH;<QB&5BZ^5'L
MY4H!SUZG'O0!E3?$"Z:SMM6T_36O=.EN1$8(896G\K<5\T$+M/KM].^>*[:^
MEE@L)YH(DFE2,LL<C[%8@="<''Y&N(\/^'/&'AQ6T"VO-,?P^LK&WNW+_:H(
MF8DH%QM+#) 8GCK@]*[B]2:2QG2W5&F:,J@D8JI)'<@''Y&@#A(?'-Y%X2\(
MZE9Z+:[-9N(K7R$FV"$ON("C;@C"GG(QZ&KL/CB?3I_$L/B*TMX&T6WCNR]G
M(TBRQ.&( W '=E<>AR.E9L'@K7X/"G@_2?\ B6M-H=]%<S/]ID"R*@887]WG
M)W=^F*N:EX)OM:UOQ0]ZUK'I^LV$5HC12LTL;)NPQ4H!U;.,]J -B'4O$8U2
MQ@N-*@-K>P.[30N2+*0 %5DSC>#G&5QR.G>L1O']Z/AW_P )3_9]OYD=X;:6
MW\QL$?:/)RK8_'D5I^&K7QC$MM;>()],\FT7;YMFSM)=D# +!@ @[G&<D=AU
MYFX\#>*&\&:CX6@;2A;&^^TVUR\K[I%-R)MK*%^4CGD%LXQCO0!O:GXH\0KX
MNO/#VDZ/8SS0V"7L4D]VRJZERN#A>#\IP.1WR.E,L?%7B/4O$&IZ=!H^GI'I
M=[%#=2/>,?W3(&+)\@RP!S@@#MSVN6VB:NOQ%E\03+8BSETQ+(JD[F0,KL^[
M!3&/FQU[9]J7P_H.IZ?XC\2WM\MF;759TEC$,S,ZA8PF&!0#D#/!H R_^$_N
MY8--U.RTQKO3;R=8S%##*9XXF.%FSMVD="5[ ]34NM:]>ZWH7BI=)@MGL].2
M>TD:=CNGD6/,@7'"A<XR<Y((P!S4/AKP]XQ\/0Q^'Q>:9+H-NY$%Z2_VI8<Y
M$>W&W=C@-G@<X/2F1^%?$6D/XFT_2_[/N=*UJ2>YC>XF>.2VEE7#C:%(=<X(
MY% '0> O^2>>&_\ L&6W_HM:Q]4\;W^DS0RWEC;P02ZHM@EI+)BX>(OL$Z]B
MN>=N.G\5=!X3TV\T;PGI>EWQ@:XL[6.W9H&)4[%"Y!(![>E<1<^"/%4VD75B
M9=)EE_M=-12\EED\RY590ZK)\OR;5X&-PP  !UH Z*Y\73R>(=4T;3_L7VZP
M\LK9W+E9;I60.7C]@"1T.2ISMX-=1=S-;6<\Z0O.\<;.L4?WG(&=H]STKB/%
M/@_4O%,5U;WEKIIF#HVG:I'(R36>%7<<!<\,&( ;G(!QC-==J]G=7N@WUE9W
M;6UW-;/%%<]XW*D!N/0\T <WI_C&];Q+H^CZC;VB3:G:23M##(3)9NBJQCD!
MZ\-UXY!XK=\0:XFA6,,OE>=<7-S':6T.[:'ED;"@GG ZDG!X!X-<CIWA+Q)#
MJ?A*\ECT:W71X9X)XH))&WB15!D!*C+$KG!QUSN.>.A\:^'+CQ+H26]C=+:Z
MC:W,=Y9S.,JLT9RNX>AY'X]^E $-SXEU#0O[7FU^P1=.L;0727UL?EEZYBVD
MY#@CCG!SVJ&[\5ZCHTNB3ZQ96Z6&K3I;;H'8O:RR#*!L\.">"PVX/8TDV@Z[
MXI\.ZCIWBE[&U%U;-;K%I[,ZAC@^82P&2"!A>W.2<\1?\(YK6L:?H>G:\+)8
MM+N8KB:>"5G-TT0.S"E1M!."W)Z8&<Y !4N/&WB$P>)Y+71M/_XD$K"3S+ML
M2HL8D(7"?>(/? ''7MH3^-XGO-&M(9;6R?5; 7L#WQ(20G;B)2"/F^;)YXXP
M#GBHGA77%M?&L173MVNLYM\7#XCW1"/Y_P!W[9XSZ>].?PMJ-SX>T_1-6TK2
M=4L(=.BMI(GG8%)D!7>C>7D C'/!&.,]P"_<^*;F&73]->"*WU6>Q%W<*ZO(
MEOT&W"#+98D#IPI/H#4T_P <W5WIUE%-I$EMK-Y?26,5M-N2-C&I9I@S*"8]
M@R.,D\>]9J^"_$VAKH&HZ)J-I=ZI86']GWD=^SB.YBW;AA@"05/0XY'Y&]K?
MAKQ+J$6D:Q#=V'_"0Z;=-<)"VX6Q1TV/$#C=]W^(CKG@9X )_P#A*=7AUK7-
M)N+6R,VFZ>M]',C,%F!+?*5/*_=(ZGU]J;_PFMU_8O@_5!90^7KT\$$D>\YA
M,J,^0<<@;2.U9FEV]]?_ !)\0V^J?9XKBXT*!'6V)=(PSRC 8@%OK@?2HH/"
M'BQM"\*Z9-_9"#0+Z"4,LTC?:(XT==WW!M."/EYZYR,8(!J:KXXO(HM3N-'L
M5O%TV=H&M_+E,ERR8#A"JD*0<@9SD@]*E;Q;K-UXI&B:=I-L#+I2:C#+=SLA
M4,^W$BA<J1SP,_456M] \7:!KVIC0KC2IM(U.Z:\(O3()+25_OE0HPZD\@9'
MU'4Z$6@:M!\0!KNZUFM%TA=/!DG83.XDW[R F.>G7W]J *VE^.Y-1\/Z3,;%
M$U;4;R2P6V\PF-9(R_F-NQG: A;IDY ]ZM7'BC4=&M=6DUO3 JVDL,5I/"V(
M[TRD*H Y92&(!Z^HS7.1^ /$$/ARS6"YT^#6],U6;4;-Q([PR"1F+1O\H(!#
MXR >E;>J>'->\4^%KVTUBZM+&_E\M[4619X[>2-@ZN68 L2P&>!@#CU(!8TK
MQ-J%QXI_LB[L"]O);&>*^MX95C5@<&-]XX/<'//H*T-<U[^S+_2M+MXTEU#5
M)7C@5VPJJBEW=L<D #H.I(''45_#R>+9'5_$C:7$(5VA-/9V\YNFYBP&T=?E
M&>3UXQ4?BKP[>:GJ6B:UI<D*ZGH\[O''.Q6.:.1=LB$@$J2,8.#@CI0 EAXD
MOIO$.I>&[JWMH]6MK=;JWD5F\FXA8[=V.JD-P1S[&L;X6V\NI>!M-N=4M[2X
MV7-Q<02,N^193/+N?D<'D\CGFMRRT2\/BB\\3W<5NM\]DEC;VZ3$JD88N2S[
M>I8]AP%'7--\ Z'J7AKPG;:1J?V1I8&D(DMI6=6WR,_\2KC&['>@#!\;S?9O
MBE\/YQ;RSLO]H#9"H+']RO3)'3K5.VO$OOCA#+#;R:-(FFNDL=VGEOJ))R"H
M'#A,9SG/&.@KH/$F@:YJ'C;PYK>GQ:>]OHXN,QW%T\;2F5 G:-@,8SWS[4V?
MPMJFN>-](U_6&LK:#1UE^S6UI(TK2.X +.[*N  !@ ?C0!7D\=7Z>#O$FM?8
M;8SZ)>SVS1>8VV81$ D'&5)S[UHW?B"6/QEX<TY].MFCU*WGE2Z+YDB*(K,H
M&W@'<.<\XZ5SU_X+\2/H_B[0[1M,^Q:S=37<-S+*XD4RXRC(%P,$'YLGCL>V
MW/X?UJ?Q1X6U1A8>5I5O-%< 3.&8R(JY0;.@V]R,Y[4 8^E:U:>&]3^(VKWF
M?L]K?12,J#ECY" */<D@?C2Z^^KOXY\!OJ4%HBO=3MB%F+1-Y#90D_>_WACI
MTJ2[\ ZAJ]IXTLK^6U@@UV:.:WD@E9VB9%0+N!5>Z \'V]ZEET3QCJNI>&;S
M4HM'BETBX=YWBN9&\_,90L!L&WKG'/U% $P\6W<">-9DT>S6XT,ARJSD?: (
M?,RS;,YVX &/;/>BR\9:N=0\,_;],M(K#7H\1M%.S2Q2>5Y@W#&-IP1@$D>O
M:HW\*:XP\<<:=_Q/TVVW^D/^[_<^5\_[O\>,^GO3Y/"^N-'X*4+IV="*FY_T
MA_GQ$8OD_=^^><>GO0 :CXZNX=)\2:O864$MIH-TUM+#*Y62<H%,A##(0#=Q
MD-G';-=?IMQ-=Z;;W-Q%'%+*@<I%(9%&>1ABJD\8["O,DL=6UJ^UO4],T_0=
M4TJ[O6R);Z: 2"+"8DC4%&P4/+?>^F*](T34'U71K6^DM_L[S)EH@X< YQPP
M^\IQD'N"#0!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME4/E [EP?F)R3T&.]7I_$U_%/IFDND46JSV)N[EX[:6YCBP57"HAR06)P20
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M6ND(- N9582>8WG1I&KE1@C#8)^;IT&.]37VKZO?^.?"*V5Y!!8W]A-=B"2
MOA@B?>(<9X<@=,<]>P!Z#17!7_C35YK*]U#0;#[8EK=O EG]AG=[D1OL<K*O
MR*<AL##=.>N!8;Q'XCO?%]]H6GVVG0".PBO(I;H2,5WLPPZ@C)^7H",>IZ$
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M;22>,CJ1P.W>LZ+P'K$7P]TSPR+FQ,UE>)<F?<^UPLWF@8V\$DXZ^_M7HM%
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M+=+*(W58@\@<Y&3D\=.,9ZFM^;0]4F\<V/B$FS$5O8/:/")&+$NRL6!V] 5
MQ7453U35++1=,GU'4;A;>T@ ,DK D*"0.W/4B@#SK5]*N?#_ (3U73;Z^TR*
M37];:2%IU+P_O7WM')G&!M1AN!SSQ@XK4\./K6F>((+>]B\.W"WH*R3:=-,U
MPJHA*LWF%B8P1MZ\%QCK73W^H:'<7L&@W\EK/<7J,T=G*@?S%49)*D$8QZTT
MQ>'O!^ESW2V]AI-D@W2M%"L2_B%')H H>/\ P[>^+/"5UH=G+;P&Z*;YIB?D
M"NK\ #G.W'452\3>&-;\8Z,-$U*ZL;+3I71KHVP>26558-M4M@)D@<\UTC:Y
MIJW6FVK72B?4E9[-,',H50S$<<8!!YQ6A0!R5_X:U2'QC::[HL]E&JZ?_9TT
M5TKG;&'WJR;3R0<C!(^M8K> -9/P]O?#)U"R>2YOC<K,48!%\\38./O$D8Z#
M&>]>CT4 <S>:%J-WXWTC7MUJL-E;2P21;V+,9-N2#MQQM_'VKF6^'WB"V\(:
MOX0L=0TXZ-<^9]DDG1_.@5VW&,@<$ DX;]/3T#4]6T[1;3[7J=];V=ON"^;<
M2!%R>@R>]+IVIV&L6:WFFWD%W;,2%F@<.I(X."* .>E\.ZK+XJ\/ZN\]FZ:9
M:RP2J-R&4R!02!SC&T<9.?:LMO!.KR>$O%.C-/8B36[V>Y64,^(1*1D$;>2,
M=>,Y[5Z!10!YEKJW][XJL-/LK[1(]1TO3QYD-\TB8,AQNB="KGA,$=!D=<\=
M/X,N+PV5Q875KI42V3".-])9C;L",E0",AAW'/4=\UKZCH>D:P4.IZ797IC^
MY]IMTDV_3<#BK<$$-K D%O$D42#"1QJ%51Z #I0!D7:>)_[8D^Q3:5_9CQ@+
MYR2>;$_<\'#CVROUJ[I&EPZ-I<-C 698]S,[=7=F+,QQW+$G\:O44 <Q::%J
M5IXVUG70;1X;ZVA@CB,C!E,>[!)V]]WX>]8*> ]73X<6'A<7-B9K6Z2<W&Y]
MK!9O- V[>#GCK[^U>BT4 >?ZKX*UV_F\5)'J-BMMKUN$W2QN\L!$>SRP<@;,
MY.>V3QDU>;POK#ZKX2O9;BQ<Z)'*LP7>OFEX_+^48.,#GD\^U=E10!PR^$-6
M&D^,+,RV6[7Y99(V#OB'S(Q'@_+S@#/;-2-X3U9+SPK?6]W91W&CVDEG.'5G
M5T947<O0Y^3.#Z]>.>UHH X2S\*^*-#U;4(=$UBP30[^Y>Y9+F!GGM6<Y<18
M(4@G)&[@>AYSIVWA_4;3QQ>ZZKVTEO-81V:1O*V_Y"S!F.TYR6P?SYKJ** /
M-[#P'KVFZ/X;MX+[3WGT6\GG,<H<PSB4N<D=0R;SMZ^O%%WX URX\.>*M(.I
M6#C6[TW2R>4Z>66V%LC)_N8 ]\D]J[75O$&EZ'&7U"Z\I50R-MC9RB X+L%!
M*K_M'CWJ_!/%=6\=Q!(DL,JAXY$.592,@@]P10!S5[X?U&_\8:/K,OV,6]G:
MS6\T/F,2_F[<D';VV_CGM6=X:\*>)O#T2:&NLV<GAV"0M _E/]L$>[=Y1;.T
M#MNY..F.,=U10!PL'A;Q1HNNZDV@:OIZ:/J=RUU+%>0,\MM(_P!\Q8(!R><-
MP#VZYZ^XLWETF6QBN98G> PK<9RZDK@-GN1UJW10!YU8>!_$5NOA3S=0TI3H
M#.H$4#XE1HRA<Y/WSG..!G)R>E61X-U<^'_%^FM-9;M?N)YD<.^(1*@0@_+\
MV N>V?:N\I"0 23@#J30!PW_  B.MV&MZ7KNE75B+Z+3TTZ^MYR_E3QJ<JRL
M!E6!]N^/KJ>#_#VHZ =9-_=VL_\ :&HRWRB"-EV;\<')/]T<?J:V-+UG3M:B
MGETV[CN8X)F@D>/D"1<97/?&1TJ]0!S3:%J!^(J>(@]M]D&G&P,19M_,@??T
MQU&,?CGM68/"_B?1_$>I77AS5=/CTS5)OM%Q!?0.[02D ,\>TC.< X)Q7<44
M >=R)?6OQE@CLC%<R1^&@K_:I2ID N,;MP4\YP>G//2IKOP'J/V&&:SOK4ZD
M=9_M>Z2=&^SSL1@1X'.%&W!YY7..>.Q_LC3/[2_M+^S[3[?C;]I\E?-QZ;L9
MQ5V@#AH/".MQ2^+7DOK"7^W8P% B=/+?RA&2>3\HQTY)]12+X0U=+?P9&LMB
M3X>"B0EW_?XB\KCY?EXY[\\5W5% &!=76MQ^-;&WMY+.32)(&^T0[&\Z-L,1
M)NZ!20B@=3D^G&_110 450M]:TVZU:YTJ"\CDOK9 \T*G)C!.!GMVZ5?H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBFNZ11M)(RHB@LS,<  =230!S::]??\+%N- >VM_LRZ4+Z.
M1"?,8^9LVDG@#@_F.:R+3QGJT>N^'[#48K!9-4>6*XLX03)8NJ%U5G#%6.!@
MC"GO3O*_M7XIW=Q97&;>3PRD2W<#!@I>=RI!''0$CZ53L? OB*WMO"\<FHZ4
M#H4[%3';O^^1D9"[?-RYW9QP,Y.30 3^,O%3:;XKO+:UTA!H%S*K"3S&\Z-(
MU<J,$8;!/S=.@QWK9N/%5W_PD'@^WAM;?[%KB2N[.29(]L!D ';T&>>]5%\(
M:L-)\869FLMVORRR1L'?$/F1B/!^7YL 9[9J8^%M5-]X.N?-L\:#&Z2C>W[X
MM%Y7R_+QQSS]/>@#*TKQ)J&DR^.=7UJ]AN+/2[ME\J. JQ"Q(55#O( YQR#D
MDG-:M]XGUC03H5YJT=E)8:I<1VLJVZ,KVDD@^0[BQ#KG@G"^OM4;^!9[F?Q5
M9W=W VCZ\YE*JA\Z-S&J=<XP"H8<5+'X7U;4+'1=.UVXLY;;2IXI_.@+;[MH
MA^[W*1A.<$X+9(QQF@"'3/$'BO5_$&JV-M:Z/';Z7J*03-(TFYX2@8[2/XQG
MJ1C^=+IGBG7+_P /:W=0Z;:2:A9:M+8)&C[8PJ.JF1BQ&< LQZ9QCBM+P[H6
MH:1K?B"^N7M7BU2Y%PBQLV8R$";3D<\*#G]*P)/ FLOX=U:P6^LDGN]:.JQ\
M,T3@N',,@P"5XY(Z^E &OX<\43ZMXBUO1YI;2Z2RBAFAN[5&1)5D#9&"S="O
M4'!S4'PD_P"25Z!_UP;_ -#:I--\.Z[9^+=2UV:[T^3[=9Q1- D;J%>/=@ Y
M/R_-UP2?05?\$:#=>&/"%AHMW+#-):*4$L6<."Q.<$<=??I0!C>+?%^L>'H=
M9NQ%80P6"(]K#/EY+Y< R%=K@H!G;DJ>1D\58O\ Q+K9\8:?HNG6]@(;[3GN
MTFN"Y9"I4<@8R/FZ#KZBJ&K^!M<OSXLMH=3L?LFNJ"LDT3M-$0@41Y!QLXR.
MN,GCG-:-OX;UA/%.CZQ//8R"QT][.14WIO+%26'!P!M ]^O'2@"C9^/;P>'9
M'O;6V.LC6FT.-(BRPRS[]H?G)"[<L1R>#3(DU%/C99KJ$MK-_P 2&8QO!$T?
M_+:/(*EF[]\]^G',4OP[U*YT;4(&O[:WOVUUM<L)XPS+%*3D(X(&1U&1Z]..
M=6T\/^(9?&MEXBU*YTQ/)L'LY8+9)&SN=6R&8C^Z.W'3GK0!K:_KCZ7/IEC;
M(CWVIW/V>#S,[$PI=W8#D@*IXR,D@9'6L;7)]=;PEXSM=8M;<00Z?-]DO(/E
M6X5H6+ QEF*E3QR><\5?\9>&;GQ#:V,^FWJV6JZ;<BZLYW7<FX @JX_NL#@U
M'-H_B'4_#&K6FJWE@VH7]J]JB6RNEO &4KN&<LQ^;)Z= ..20#-TWQ$]EHGA
M;1K7BZN-'CN6E-K)<".-$C7[D?))+#N ,'V!EL_$WB2?1&DN-(CM;J+4?LLU
MS<(T, MQS]I".0VW'&W.<GK4%WX,UR*U\.WVCZC9VVN:-:"R;S59[>ZBVJ"K
M8PPY4,,=/UJQJWAGQ'JEAID\NJ64FIVM^E[)"T;BT<*I41A<EL#.X$Y^;GCC
M !1;QYJ8\-^+;R**QN;G0I#LE"ND4\?EAPVW).<''7!Z@U>MO$VN0^)_#]EJ
M4&G_ &/6[>5HA;[_ #(7CC#_ #,3A@03T P>YZFE<>!M<GM?%\#ZCI[CQ JX
M(B=/*;RPA/4\ #@=\]1TK3G\-ZI/K7A2_+V:KHL<JRIO8^:7C\OY?EXP!GGZ
M>] &?)XSUB+0O&E[]CL/M&A7#I&@+[758E?+'J3S[58M?%&NQ^(O#EKJ,&G_
M &+78)#&(-_F0ND0D^9B<,",\ #'J>IBD\&:M)I7C&S,]D#X@D=T;<_[D-&(
MR#\OS8 SVJY-X9U275/"5YYEF!H:2+*N]OWI>+ROE^7C YY^GO0!F:GX\U2'
MPYXAU^QM[0V^C7[V9M9E;S)0C*K-O#84DMD#:> /7CO+:2;[#')>"-)=FZ3R
MR=H/MGFO*+/[?JD^IZWIU[X2N;"XOGGQJ)EC=?+;:GF*K;<J%&"5ST)P:]0T
MJZEU+1;6YN[802SPJTD.20I(Y&2 <?4 T <;'XWUF\M-,U?3=->\L+R=0]HF
MGSB5(&.!()ON$@8)7&.< \9,VI>*M?TOQ7+H,UM9M)?1!M%F6)]DS@_.LIW?
M+M'S''4<CG"EOA[PIXH\/*NB0ZU9/X;B<F%FA?[8D1.?*#9VX[;N3CICC%CQ
M#X/O?$=I?R7,T$>J+,CZ3<QNW^A;""I''WB<EO[V0. !@ DU[Q!KVF^)=!T2
MSM]/G?4XI\S2ET"O&@.=HSA?FZ9).,<=:S+7X@:C81Z[8:_96PUC2[BWA3['
MO\JX%P0(F .6')Y')XXYXIFO_P!KIX]\ ^;]BDU%8K_S &98I#Y29P<$KGKT
M./>KVH^ 6UJSU^6]NQ;ZIJSP.DUOEEM3!@PA2<%L'))XSN/3B@"6#Q'XA76+
MJS?3UN;7[$UQ!??89[6-)5/,3A\YR.00?;'>LJP\<>(9-)\)ZU=VNFBPUJYA
MM)88@_FHTN=KAB<  C[N#QW]-[3-/\7O9S#7M0TR:986BA2SC>-)&(QOE)SS
MC^%0!R?;&2G@C5H_"/A?15N+(R:)>P7+2EGQ,(B2 !MX)SUYQCO0!;7QA<7?
MB>^T:VN-/M[VTO(XQ874;++/ =I:5&W '@L0 #]WGK4>I^,-4D76'T&V$[Z9
M.T"V[6$\QNG0 NHD3"IR=HSGD9. :?KW@^^\2+]GU :>?+O5N+34$+"YM4#A
M]B_+R>",[@,$<''+?^$7\3:1XCU*Z\.:KI\>FZI-]HN+>^@=V@E( 9X]I&<X
M!P3B@!M[XXN%U6'3-UII%Y<:?%=6L6J1-_I$K[LQ;@RA2I"@]3ENG'/;PF1H
M(VE4+(5!<#L<<UR6O^%[[6;&[TJY2PU'3IK98HFOF;S8)0I4R@A3D]#QMY!Y
MYXUM.T[5M.N-.M%O8)M)M;!8)/-0FXDF7 #[LXP0.??] #$^+?\ R2KQ!_UP
M'_H:UR_Q'U">]\#Z99W6D7>EV[S6S-K%QY;I98(.\>4SL"?N@X ^;J*[OQQH
M-YXG\)7VB6<L$+WB!&EF)P@# \ #GI[5F:]X8U[Q-X:'AZ\O-/L[*142YEMU
M>21T4@X7=@*3@<G- %__ (2"[_X3Z#0D-M)97&EO?1S!3N#!U4#.[# [L\ 5
MS]]X[UB#X>>(==6TL)+O2K^>TV,'$;K'($W8R3DYSC/XUKW_ (6U"W\2:1JV
M@36<8L[%M.DAO%=AY)*E2I7DL"O0]?45D2_#_6)? WB+P^VHV3R:M?S7*3&-
ME\M7DWG/J>!P  ,]30!H>(_^2I>!C_TSU'_T4E9/BC7-1\2?#CQ5?Z<;--,C
MBNK=%EC9I)D0%7<,& 7D-M&T]!GKQTFI:%J>H>+?#NM;K1$TM)UEBWL3(955
M3M.WC&W//7VK /@37[+0O$'AO3;_ $\Z-J7GM;FX1_-MC*#N3C@KD\'J,]#0
M!HP:]>V&J^"M(2"V:TU.S??*V3(IC@#<=AG(]>]9L_C/Q4=(\57]O:Z0@T"[
ME1E?S&\Z..-7(&",-@GYNG08[UKMX6U4ZOX2O6N;.0:'#+'+@,AF+QB/*CG&
M ,\DY]JK#P=JW]B>,-/,UENU^::5'#OB$21B/!^7YL 9[9]J -"7Q3/<ZWH>
ME6,<4+ZG8O?&:X0N%0!<( ",ME_7@#WI_@OQ!J7B&UU&34;>UB:SO9;+,!;#
MM&Q5FP>@/&.3WKEM9@OFUG0-#MK_ $6/4]*T[S'CO3(JL6Q&KQNA5\X1\@<
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MI0<;R!P/;)P*P[35/$Z^)-.ADM&NM,ND<7<GV7R/LC@94J2QW*3D8/(ZY[4
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ML\+OM)CC$&_S'"YR2=@P,\;N<XP7^)=;\6^&O"'B'493I[O8NK65PT9/GQ'
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MW<KE"1GL2N?QH Z"BO/?&'BW6O#UMK=\)+2/[ 8WM;,(9FN(?EW/(5.8P26
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ML#DA2V\XR1VHM=>\3:9XNG\/ZL+'4'N;"2]T^:VC, +H0#$X+-CJ,-G_ .L
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M-@%0G .2,'G/0GI0!B^&O#GB#2EMK;5O$*:A962[;9([7RGD &%,K;CNP.P
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M4F:&V4A2ZQL^"3@?=!QDD#\: ,C1?"EUIMOXB@N-221-8NIKG=!"8W@:10I
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M 4444 %%%% !1110 4444 %%%% '!^+_ !-K.AIKES'-:0+86ZSV4'E^<]T
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M1>:(?!W]HF37)%B:T3?FX$NX%)N/0@LQ'8&NRT^QATW3K:QMP1#;QK$F3DX
MQSZF@#E_%.N:OIESJ'DW%M:006!GM!Y?GRW,HW%@4!W!% 7) _BZC%9\_BW7
MKQ_!']G_ &" >(;9I)1+"S^4_D>9D$,,@$]."<=1FM'4?!VH7/B'6+^UUB."
MUU>R2UN(I+;S'CVJP!C;< H.XD@@\_I6L_ ^IVO_  B);6;:0^'HVC ^QD"8
M&+RL??XPO?GGGIQ0 +KFO2W=SH?VB/\ M'3[6)KFZMK(R(\TFXJ I;Y5 49[
MG/&,<]'X9OM4U'P[9W6M:?\ V?J3J1<6X.0K D9')X.,CGO6+K/A+57\4?\
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M:R@6 2I&4W!1@'&3@\>M &M1110 4444 %%%% !1110 4444 %%%% !1110
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MQ.UA!?(D 7<]S:O$"3D%5+#DJ5(..AH UKBW6[LI;:8_++&8W*\<$8.*XQ/
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M@83(SGJ0.IKO:3 SG'/K0 V**."%(HD"1HH5548  X %/HHH **** "BBB@
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MI:!?M!1V2,[\Y3! '&>/4UTD'A#4?^$DL=>O/$#7%[:VLEL0MHJ1N&(/W<G
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MQ, 5Y *A5PQ& . !Z5)_PB+/KFO:A/?AXM9M4M984AVE%564$-N/.'.>/RH
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M5Q''&MFN)DBVG:V2< @GISD]>U>H6L_VFS@GV[?-C5\>F1F@":BBB@ HHHH
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M 1>Y(&22>@Z54\3>$9-:U.PUC3=5ETG5[$-''<I$)5>-OO(Z' 8=QSQ73T4
M<C?^"[B\ATN===G75;"[-W]LDA5Q*Y38P,8P -O QTQW.344?@.:.T\36_\
M;DTB:\&\WS+=#Y9:,(S<8R<#CH!Z&NSHH XO4/ 4US::')9:Y+I^L:/#]G@O
MX8 P>/ !5XR<,#M!Z]:FU'P9=:EI%I:W&MR2W45]%?S74EN"99(R"H"@@(O
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MMRUTK4;>]T^0ZNQM+:U,$MJMNH69^,29))4@#IFMBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC P..,@=/4&E\,7EC%XB^+LEU ;VU;>[6T38:XC'FA@I'/?&1TS0!ZS9^,-
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MQ.0SG Z?*H[D\3:E9_\ "-_%'QM?7[K!::MH4DEI+(<+(X5 R ]VR#\O7&*
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MB?RFB=':(]'56 +*>Q (KA/BKX>6X^%-X?#EE"680/,;2,;IX8^G*\L%&#]
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MV; /&?7&:Q(=3&G:'X@F%DD\<GB]I#+);F46T+,I%RJ8^8 @X(XSZ]*]CHH
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MSW#PHTL.?]6Q4$K^!XJS10 4444 %%%% !1110 4444 %%%% !1110 4444
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M  UR3T( ')/8 9-3Q^)-&DL;J]_M*W2WM"5N6E;RS"?1PV"I]B!7EFD79LM
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M6BB@ HHHH **** $95<8901Z$5SWC+P_=^)='BL+6XAMRMS%<,\JEO\ 5N'
M 'J17144 ,B4K&,JJL1E@O3/>G;5W%MHW'C..:6B@ HHHH " 1@C@T@4*H4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M12,P498@#U)I: "BN4L?$FI77Q U#PV]M:+!96T=R;@,VYPYX7;T!Z\YKJZ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8=J>=*J;CZ#)YH LT56N]1LK QB\O+>W,IVQ^=*J;SZ#)Y-3QR)+&LD;JZ.
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M82)&[S1\+C@#'..OZ5)=>&[31?@W+XBT6T*:]-X?ACEO$=C(T95"_?' SSU
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MLBW\/V=OXEN=<2"WCNIH?)+11!6=?ER7;JQ^10/0#WK7(R,'I0!P/@<@^/\
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MI;J1P!CM@"O31X;T-=^-&T\;X1;MBV3YHAT0\?=]NE!\.:&T5O&=&T\QVQS
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M(V5T8!E93D$'H0:XSQ'J=A;>/M(MG>WM-0%C/(E]=R$1QQ%D#*JY 9S@'D\
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MZC87%R@D7E8Q$1#P>AV@-CLS-0!UD5]!9Z/;7-_J5LR&)-UV66..5B!\PYP
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ML16O7/\ @C4M1U?P?87FJJ@O6#I(\8PLNUV42+[, &'UXKH* "BBB@ HHHH
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M'!IUUKVCV0F-WJUC (&59O-N$7RRV=H;)X)P<9ZX-7T=9$5T8,K#(8'((]:
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M/&5#K+<(I4MPH()XS@X]<4 ,M]&MH-;N=6"1"YG01EHX@AVCGYCU9C@<GLH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&+2)[4+-9:#:3B\E RGFRJ4$.>A;!W$=AUZUW=[IUEJ40BOK.WNHP<A)XE<
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M>RMFO$&$N&B4R*/0-C(I4TZQCNC=)9VZW#9)F6)0YSUYQF@#FOBB"WPP\1
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M8*GD$@'@\]:@NM2TC1?'/B/2O$E]+I=G?10M8MGRX9H!$$:,'&!AMW'^T<4
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M53T*GW!!!]Q6C7"_"*-T\ Q2'(BFN[F6 '_GF96Q^!Y/XUW5 !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 PQ1DY,:D^I%*(
MHP" BX/48K@_'-[XE\.^%=<\00:R$:V;=;6HMHV14W*HW$C))R3VZXKH=,MM
M9@O8;B[U?[78/:L722!$9),J5(*@<8W\'VH VS&AQ\BD@<9%<SX8\-W6DZAK
M5S?K9R_;]0>^B,>6:$LJKMY [*.1CZ5J6WB31;NXD@@U.U>6.+SF7S /W?\
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M&V :=2^TQ \@L#@@'U/%58O&'AN>>SABURP>2])6V59U/FD$K\OKR"!ZXXH
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M,D'"@#&.2: .R:-&.612?4BG5QVD>+FMO$&L>'?$-Q;QW.FQ+=)>G$23V[8
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M$CF25TWY;<#\@&!@8)^;GI0!T]I:6]A9P6=K$L5O BQQ1J,!5 P /PJ:N?\
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MROS/N'MQC/X5W:VT"SM.L,8F88,@4;C^-/\ +0DG8N3WQ0!XKX6US3;'P7X
M2X>TA=I[M(M2N'_=V1&\$=0-[*VU=QQWP<8-&_O[+_A5WQ!MGO!)+_;SO^]
M5V#2PD,1@8S@GH,X..E>[F&,@ QH0#D#:.OK2^7&<_(O)R>.IH \\\<75GHF
MH^&-9RT&@I<2"[N;)1B-GBV12':#P.5SV!K;\'QZ!+>:MJ>@SS7:WKQM<7AD
M+1S2*",+VR!C)''([@XZAHT:,QLBE",%2."/I0B)$@2-%1%& JC % '!:1?I
MI?Q-\60:W-';_;([::QDG8*DL"(595)X^5B<C_:)KD;Z(Z1\#+J*ZD$%O-JJ
MR6$<IVD6YNU9, ]MH+?0U[3+!%/M\V))-IRN]0<'U%/9%;[R@_44 5[G-WID
MXM9%9I(F$;JV1D@@'/UKS;P]>6UA^SPDUWIS7L,&GRQSV8)4N0[*ZDCD<YR>
MW->H@!1@  >@K.T_2$TR[NS:L%M+J1IW@(^Y*WWBI]&ZD>I)[T >>:1JUE-\
M5-#G35[>]2?1)88VME AW>9&?+CQDG !)!)(QSBMNQC>7XWZM/%GR8=$@BF(
MZ>8TK,OX[0:[;RE1!Y4<895(08P![>PJGI>DQZ:;J8MYMW>2^=<SD8+M@* !
MV4*  /0=R22 <IXMN+>+XF^ Q)-$C^;>\,P!P8"!^9P/K7-K-IS:#\66\RU+
MM+<C.Y<D?9@!_P"/9Q[UZZ41CDJI/J12>5'_ ,\U_*@#RC3_ !%::#XD\,:E
MK%RL6D7?AJ*VM[QSF*.X!#.I;HI90O)_NU)XI?P\FE^$O[/AM[?39?$T,R!Q
MM653O+2 -_"6/7H1@]"*]2>"&6/RY(D=.NUE!'Y4XHC8W*IQTR* /./$NH67
MAOXB6%SJ=Q+INBW6G/!#=0_+&EP9=[AB!@;AM.>Y6J<UWX:T&+0/[-1(;*]U
M6>:WU:^=C#"YB.Z1<D#Y\LJYPN<MR,9]2DACFC,<L:.AZJR@C\J5HT=0K(K*
M,$ C(&* /'-)ETJ\T?Q;8W>N36CMXD$T5\ JO$Y\HQ2L,!0I=?0 \^F0_5-2
MU]O#VMQ:C%#?2Z1J%C/=WVF+C[;;JP=OEY =5 + <8QVKU\Q1D,"BD-RV1U^
MM$44<,8CBC6-!T51@#\* /-FG\$:_%JNLV^HW>H#^QIK>]NXI6/DVQ&2IX #
M]2 1G@U;\(W>K6WBI='O[ZSUVU&GF:TU>  2K'O4".7!*G/!!'7:??'>QP0Q
M(4CB1$)R550 31%!%#N\J)(]QRVQ0,GU- '$>-[BWA\;>!1+-$C_ &^8_,P!
MP86'\R!]:PX9M.:[^*K-):DE=I)9>5^R@$?3=D?6O52B,<LJD^I%)Y4?/R+S
MUXH YWP28[[X;Z"@D#J^EP1LRMG!\H CZBN?^&$R>&/#3>%-9FBM-0TJ:5<3
M,$$T3.765,_>4[L9'0C!Q7H@4*,* !Z"HYK:"Y $\,<H4Y =0V#^- 'F+69U
MSQ9XL\60C=I4>B/IMK-CY;DX+NZ^J@C;GH>V<5F"TT_5?A=X%M=*^SMJRSV3
MV_DXWQNN#,QQR  &+'Z>U>L:Q:37NBWMG;>6)9X'B4R$A5W C)P#TSTJGX5T
M5]"\.:?I]PMNUS:6T=LTT(_U@10H)R >W3F@#SN/4-!%]XJ\-^,+^ZM9[G49
MI5MBS 7=O(1Y93 RQP N!S\HK4LXM,/Q?M[*6.([/"\<(@N&5W4^<<JV<Y;;
MUKT=H8GD21XT9T^ZQ4$K]#VI=B;MVU=WKCF@#Q'QGK&GW/ACQO:6\D.G2P:B
MOF6"#=-<,KQ SOG)"$ 8V@ ;1DG.*[!]4L8_C-:7+W,:PWOA\1VKD\3M]HSA
M/[QP<\=N>E=Z8HR6)C0EQAB5'S#WIQ52P8J"1T..E 'B]W=V3> OBHJW$!W:
MG<E0''),<8&/J0?Q%;]Y<:?'XX^' @FME4VMVJA&4#:85P..Q(X]Z]'\J/&/
M+7\J/*3^XN1TXZ4 >*3W>C3Z3XC\(7/B/2K6*XUJ20W%Y<&*>(><KO\ (1@D
M,I"MN (P>.A]I$T MA.)8Q!M#"0,-NWL<],5Q^G^&?$EE!_9\]_HM[:AF(N[
MFP9KA@S$DL-^TMR>>/I75Z?80:;IEMI\"_N+>)8D!Q]U1@?RH \B\!V_@_5/
M!.IP:O>Z>CSWMVK-)=*C!2YP1R.QR*ZOQ1<:9XST&QT^QG0:A>R^?I4^\*T1
MB8_Z2O?: ./[VX#C.1W/DQ_\\T_[Y%+L7(.T9' ..E 'DMUKEKJGP4\2:>ZQ
M1:MIMM-!J%N'W'S@?FDSU8.<MN]2?2M#4K33]3U+X?OH?V=KNVG68O;X_=V@
MB/F;L=%)VKSW.*Z_Q?H<^O\ A74=(LS!%+>Q&$RR9P@/4\#GZ5HZ9:&SL(8Y
M(H$G"*LIAZ,0,9S@$_C0!Y)H]WX?U#P_/X6\47=\-:@O9!+I@=E>>7S3(CQX
M&3N)!R#ZD\<UOZ;-IQ^(_C]I9+7<+.T5B[+D#RGWC/I]W/X5Z*88C,)C&GF@
M;0^T;L>F:7RX\D[%R>O% 'COA]5O?!/@=M-\11Z7KL%C-]D>4*\,R@H)(G!/
M^YTY&">U.D\1RQ+X1U[6X'TO3"U];74UD288IV<!90<$['VO@^C'G%>NR6T$
MJ;)(8W3^ZR@BGO'')&8W16C(P5(R"/I0!YC<6/ABYTJ6XT?6[FP^W:M'-!K&
M_?&UX$8[@&PK*0-IQP2<=0:Z/P+J.I7B:Q;ZM#:->6EYY4E[99\J[/EIAQGH
MP&U2.Q%=488C$(C&AC P$VC&/I2QQI%&(XT5$7@*HP!^% ' :#?P:;XV\9V>
MOS0P27,L=S ]RP59K7RPH"D\$+@@CL2?6L:P\-ZF?@O9-$DBZII<[:EIB2 [
MU5)&:-"#S\T9(Q_M =J]6D@BF*F6)'*'*EE!VGU%24 ><ZT;[7OACK>NV-K-
M]JU2W26&WQ^\^S*00GON7S&Q_P!-"*DT/5/!_B37-+UG3]1N;Z_M(9#EY2/L
MD;+AO-& !S@8/?D=":]!50JA5   P .U,2"&/?LB1=YRVU0-Q]3ZT <)\'X[
M"3X>:=- ENTZ2W(9T +*3,_4]1D!?P K2\6>-]'T*XCTF?6+6QO[A-QDE8?N
M(_[Y'=O[H[GV!KK%55^ZH'T%(8T8Y9%)]2* /+]?_LC5/!.D7GA=S=Z;X=UB
MUNY&B!;>L9S(03RQ ?<3W.>^:U[I$\0?%;0;RPE2>TT>QN)9IXF#)OF 5$R.
M,D MCTP>XKN@H484 #T I(XXXEVQHJ+G.%&!0!PT=W;'XYSQBXB+_P#"/(FW
M>,[A<.<?7!!Q3_$VG6>C:K=Z[IEY?0ZW?0K#]@LFC)OW483<K*V,="XQA<Y-
M=MY:;MVQ=WKBD6*-9&D6-!(^-S!1EOJ: .?\">')/"G@^QTJ>42W2AI+F0'(
M:5V+-]1DX_"NCHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** .-_MV\\0^.]0\.Z?<O9V6D0QO?7$2J9))9!E8U+ A5 !).
M,YX&.M1ZCK5[X0\5:+97EY+>Z1K$IM4><+YEM/U0;@!N5NF#R#WQQ5*S@/@[
MXG:]J%_^ZTC7XX98[QN(X9HP5,;MT7.203@'IUI?$42>-_%?AJWTN1;C3])O
M!J-Y>1'=$&0?)&K#AF)SD#H.O:@#;NOB)X2LU=Y]=M@L<YMW9=S!7&,@D X
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M2UE:(S(#<Z6JJ"$=ASM/"X8 Y&.U=WX?\1:9XHTI=2TJ=IK8N4RR,A##J""
M1V/XB@"._P#%6BZ9-/%=WPC-N4$[B-V2 O\ =\QP"J9R/O$=1ZTM]XJT+3=0
M:PN]2ACO%A,YAY9]F0,X /))&!U.>!7F'C;4HKW2_'VGB&2QNH\8M+>V)>\4
M(G[^1]IRO&!C &WDG-=#%?V=S\5]$NED7R_[ E57D4KAC(A YZ$J&(]1STH
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M%?$GBS68(_+TW4KN)K7C D*1A9)0/1F)P>^,]"#4/PFA=/!LMP01%=ZC=7$
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M;FWNII##.2PC;S7*L8R< X((.* .NF\?>';&W5M2U&*SN!:I=36[99XE;'!
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M_OE'H_)]^O0US>@7]MH=YXRTGQ&ZQ37.HSWD(F_Y>[>10$$?]\@+MVC)' H
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MZ^U_9Q7DS2SW#@);$8)C4X VKVZ]>M7;3Q%I5Y=R6D=T4N8XO.:&>)X7\O\
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MZ*Y]=7?4_%]SHUK(4@TR*.6\=>K229,<8/8;5+'ZJ/7-'6=3U.T^(_AFPCO
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M(8V$4D@R-BR8V%L@C .<@BI[;7=-N]8N=)AN"U_;*&FA\M@4!Z$DC&#V]>U
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MVX[ ., =\@8ZXYU]9M[[2/"]R(Y;/[+XCC:?2[>T98[$;Y,AL+DN203SSN.
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M)J4U@EI'8PEQ^[1B[-EU4L<MV' '>E^,[QGX=W%N2&EEN+?;$!EG E4M@=\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y
M'Q/H&K:C'?7T?B>^TO[/&6M([1E6)=JYW2@J2^3GC( &.^36,GBK5]0T;P+8
M3$VFI>(1ON98QM98HX_,D*_W2PV\]MQQSBKOBCQ58OJ4NAW=GJS6" ?:WM].
MFE6?_ID&52-O]X]Q\HZG$.LA]4O_  CXQM;&[CMM-N9DE@E@*RK!*AC,A3J
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MEVL+3,(_[Q"@X'7'K@XSBO,]*N;:Y\ >-='$+SWUUJ6I0P6RQ$M*[N0A7C!
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M#7L%BC3V3+)Y4<>XX=4V\N>0<9/&*X+3VGM_#'PTO);"_6+3I_*N@+20O&3
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MN[.6>RM["X2:3[(\L:.Q&T$A2,\&@#IM/DMK*?4;R'6+N_L[=5BFA+-<&*0
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MXY6@&E3QM,(FV!F="JEL8!(!X-;GC)]O@O6T"N[RV,\<:(A9G9HV   Y))H
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MV26QP<$9Q6IJKZ1JO@OQ1J&AZ/?+)=::]M]IG@E$MPY4A8U5_F8#UZ<\9YP
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M)/N:MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS;PQJ0\6^&%FTSQ-?Q^*(D!OK:6;:1(#^\C\EOE1>H#* 1QSD&@#U&BN!O\
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M$9RO"\-P1M/.>,9I8O'&B7%M#+;O=2M+ ]R(4M9/-6)&*,S)C*C<".>N.,T
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MW<^Y&<5J>3<V'B07GAJYNU^U:P4U'0KN(O&P\TA[B,D90<>9N!VGCOQ7J=%
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M5T=5-/L$T^!T$LDTLC^9--+C?*^ -QP .@ P    *MT %%%% !1110 4444
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M9-0C>6)E081$;:Q?GY>>.>>W45FW7Q-T&UBOI1#JDT>GSM!=M%8R'R, $L_
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MY&0"1N SVKF?"]W;ZO<V F\"S:;JEKS<7%U8K'' V,,8I/XB3P-O8Y/3G/\
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M<\D*.W4\D;;DMG<Z=X_M?%,EG<?9;[2A9W4<,;3/;RJP=20H)((++D#@@>M
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MY>)+>%7* 80C<Y*DECGKQ@4S3/%4GA[Q5X@\.:O<7%S::?:+J5I<,K2S"W.
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M+QH%#';QDJ>O3O7)^9:_8-7T&\TWQ"NASZM+.R6^E/< JLVXA9D)&PNF?NY
M)&>] 'LD$RW-O',BR*LBA@)$*, ?52 0?8\UYCI-[IX\>^,;'6_$%U!;6D]N
M+.*?69H0@:+<^W]X,C/Y5Z9:7<%]907EM()+>>-98W /S*PR#^1KS[PY<MIO
MCSQG>WFFZJEK?SVQMI!IL[B0)%M;&$/?UH VDU[3/#'A236FNM0O]'>0S)/N
M:Y:.-L 98L6*YR0>P(K7A\0VEQ<74<45RZVT22R2QQ^8F&4,%&W)9L'. #Q@
M]",Y#:EOT*XM+/0;I+667[%;0SV<F&5A\TCIC*Q#<>#C.T^HK.\#6MWX4O+[
MP?-:W<VG6Y\W3]1-LVQT89,;N!C<IZ'H1@<8Q0!:A^*/AR:+3[@?;UL;]Q%'
M>O:,(%<D@*S] 3C\.^.:V-6\4V6DK>.T%W<QV*![Q[:,.+=<;LMR,_+\V%R0
M,$CD5YCHEN_B?X"Z7X9M+2Z:\NU2(.UNXCC GW&0R$;<!03P<D\=:VI8SH/C
M#78-8\)WFLV.JSK<VEW:V8N.L:HT4F?NXV\9XY- '5S>.M%CO[2SB-U=37EI
M]LMOL]L[B:/C&TXY/S#ITYSBI++QEI5_HRZE"+@;KHV7V9X]LPN VWRBI. V
M?4XQSFL!+2:U^(GAV1=(EM;2WTF:!Q;6S&"!W9"L891MX"GIQQVK)LM-AN=$
MU^RUG1=5:UO/$L]PC16TJ2Q1MS'.F%SPRCIR,\CL0#OT\1VGV2ZGN(KFV-M<
M+:O%+'\[2L%*JH4G=G>N,$]:J)XTTI9=3@O?/L+G381<7$%R@#"(]'7:2&!Z
M<$\\5PMYI'BE_#<Z[;G78-(U>"[LA>Q>7<7UNJ?.C @%B-Q 8C+;>_%;<3:5
MJ^DZE>0^!+J"W>T,%Q'<6(@N;A689C0#YB ,G/ SMQWP =A8ZNM[?363V5W:
MSQ1I*5G5<%6) (*L0?NGC.16C7G7AQ=2\,W>J?9Y-9U;PY;V GMXKJV?[5'*
M"?W$>\*SC:.AZ<#UKMM%U6+6](MM1AAGA2923%.FV2-@2"K#L001^% &7J?C
M;2M+?4/-6YD@TQD6^GAC#);%P"-W.3P03M!QGFGW_C'3-/UM='>.\FOGMC<Q
MQP6S/YB@@84XPQY[<#!R17">,DUG6+#QIILVC:H\^W_B7I:0D031[%_>,PP)
M'R"-I)(PH ZUN0-<R_$G1=0;3=0BMET22!Y'M7PCLZ,%8@$ X4GVZ'!XH Z"
MT\9:/>>'6UL22QVZRFW:*2(B59@VSRMG7?NP,#UKGK/4);GXU"%H]0M5_L%W
M>VN9"4W><@#J S)TXX].:YEM+UK^P[B^M=*OI)-/\82:N;1H&C>YMRQP4# ;
MC@Y ]O7%=-9W<VI_%:RU:#2M42P;19+<SW%F\(60S*V"' (X4]OIF@#H_&&O
MGPWX;GOXD62Z9D@M8VZ/-(P5 ?;)R?8&FWGAR:]T^WL'U:^BAY>[FMY3'-</
M@?QCE5ZDA<=% P.*Q_BI;22>%+:^0%DTS4;:^E _YYHXW'\ 2?H*UO%7B"YT
M6RA%CIFH7T]PVT-9VK3B%>[L!P?89Y/MDT 8O@ZTOH]0\4Z!=ZC>7^E65Q$E
MG<W$Q:92T8=T\SJ2A*X/49K9\(ZW-JEOJ%E>.'O]*O'LIWP!YH&"DF!TW*03
MVSG%1>$=3CN8Y+.VT+5["" ;WGU.#RFFD<DDCDEB3DL>.H]>,_P);._B'QGJ
MV"+>[U7RHCV;R4",P]MVX?\  30!JZ]>Z3%XC\/VM\UZM[+<.;,0[UC9MC9W
MD?*1C/!Y]JJW7Q#T>V;556WU.=]+;%VL-FY,8V[BQSC"@<Y/7MFJ_C&*XD\5
M^#Y8;2ZFBM;Z26>2&W=UC4Q,H+$ @<D5E00W2W?Q'=M/OPM\ ;4_9)/W^+<1
M_+\O/S#'Z]* .SE\16(BL&MC)>2:A%YUK#;@%Y8\ E^2 % 9>20.0.I K*?X
MB:!'I5MJ+R7(AGO?L!'V=BT4^[:5?'"X/OSVS7(:>-6\-2^$->;1M2N[2/0D
MTJ^MX+9FGMG&QMWE]2,K@X]/I6OXNEO=4T;1+B/1;Z,#7;6[\A+9FE6%'!9Y
M%4':>IQUQCOD  Z2V\66MW AAL=2^TR/(D=G);^5,PC(#-AR %Y7YB0.0.IQ
M44/CG1;C3(;R%YF>6].GK:^7MF%R,YB*G ##!)R<8YS6%XRBN+#Q=I7B)M"N
M-:THV<EG<P00>;+ 697601GD],'TJ+4)[FSTW3KG2?"]QIVG7>I[[M;6Q'VM
M(RA'FF-02K,W!/+!?0G@ ZB#Q?I<VGW]VWG0FPN1:7$$J8D28E0J8!(.XNN"
M"0<]:G7Q%:)'?->0W-E]B5&F%P@Z-G;MVDALXQQGGCKQ7GUCIP6#QI9ZIX:U
M>;3KV_@E",CN[Q,(EWJP)9F7!?@DC;S@\4RYT#Q+<>&]?TJSN+S5K&W:TN=,
M;5(RDTK1R>8\#%@"ZX48)'5L>N #O(O%^F_VG<:=>I<:?=0VIO-EV@7?".KJ
M5)! [C.1Z59T_7HM0NX;86=Y 9[<W,+S(H62,%1D$$X/SKP<'GI7*Z==6&K6
MMS>V_@*YM)H+.43"]L!#(Y*G]Q&>K;CP2.,>YJ/PCIEYHWB6&VT>?5)/#4EH
M[/:ZG"ZFQDRNQ(V<!B#\WR\@;<YY% '1>.+W2;#PE>RZVUXFGD*)6L]XD'S#
M&&3E><#)(';O3]0\7:9I>MIHLD=[+?/;FXCBAMG?>H(&%./F//;ISDBLWXI6
MUS??#G5K*SM;BZNIT1(XH(FD9CO4] /0'FH;DS2_%;2=02ROC9KI,T33_9)
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M*8G55#JI^\5*#W.?J:SO%-LFI?#O66T;PI=6+WTEOY<*V!2XN"DJLS.B@D
M'&[!X/J,@'H&D:W!K0NC!;7L(MY?*)NK=HM_ (9=W52#UK2ID4BS1+(H<*PR
M Z%3^(."/QI] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 45R'BGPQ+J<&H:A/XBU33V@B9[7['=-#' %7.Y@/OG().>W Q
MUK#'B'6;W2O .D7TDEOJ&O R7LD9\M_*BB\Q@",%2WRY(P1DXQV /2STK#T#
MPXN@7.J3)>S7']I737<JR*H"R$ ';@=,*.#FL*SO+ZW\:ZWX2M[R18WL(KZR
MEE8RM;AF,<@!;)." R@]"<=.!5_LF^\,_$'0(=-UG5+RUU%;@7]M?733@*B9
M$J[ON'<5'''S <4 >AT5YSX^MOL3V]Y;^*;FS\03WD2V,+WWEP,ID *F+.TJ
M%SDD9)'7D"O1'0.C(<X88.TD'\QR* '45XM:W$R>"O&^K3>(]4M[W2M5O8K*
M9]1E8*(\>7'L9BK GY>02<UV6G_$"*UTC1(M;M+T:U?:?]J-O;VCL7*J"P48
MY/.=HZ=\4 =O16"/%EI*B_9;._NIQ;)=36\4.)((W&5WJQ&&.#\HRW!XJO/X
M^\/0:=I5^+J66UU23R[:2*!V#-S\IP.&X(V_>R,8H Z:BN;TCQQH^K2:E"3<
MV-QIJ>9=07\)@>./&=^#_#@=:EC\7V']K6VFW-O>VD]W$\UIY\.!<JHRVP D
M[@.=I ;VH WZ*XR/XE:5=6;W-AI^K7:*LYW)9L%#19W*S' 4G&0#C\*33?'\
M1\-:!J6J6%Y#)JWDQ1E(@4,LB@J =W )/!..E ':451.J1#6ETH13&<P>>7"
MC8JYQR<\'/08YY]#67K^B"Y-_J4FH:BGEV6V&&WO98$1EWL7PC#).0.>RB@#
MHJ*\]^'NF3:GX.\.:Y-JVJM?%!-.9;^:1)Q\P(9&8K[\#J!6]9^-])OI].6)
M;D6^IR/'8W;(/*G9,Y P<C[IQN SCB@#I**YEO'&F1W>JV<D%XEUI@C:>%HA
MO82'";!GY\GIMSV'4@5J7>LQ6K00BVN9KR>,RI:1!3)M&-Q.2% &0.3U.!F@
M#2HKGK/QGI6HV%K<V1FGDN;A[:.U"!91*@)=&#$!2H4DY('YC.KIFI1ZI:M/
M'%-%MD>)HYDVLK*Q4C'U'7O0!<JGJUA_:FDW=@9FA6YB:)I$ +!6&#C/&<&L
M31-4;Q%XAUB5786&DW/V&% <!YE4&5V]<%@H';!/4\2/XVTF.6R+"X%G?77V
M.VOM@\F68D@*#G=R00&QM..#0!IZ'I0T/0[+2DG>>.TA6"-Y  Q10 ,XXS@5
MH5@W_BVPL1?2>3=W-OI[;;V>WC#I;G 8@\Y; ()VAL#K6'XENTN/%W@2\LKR
M1[:[NI?]5,WE2H8'93M!VGU!QF@#NJ*X;0+@6GQ%\=?:+N46EO#8R_OYF9(0
M8Y&8C<?E'? XK:A\76#ZO9:=-#=VLNH(SV3W$6U+@*,D+R2#CG#!3[4 ;]%<
MY-XVTF![9W%Q]BN;O[%%?! 86FR0%SG=C((W8VY'6J^D^+Y-1\2Z_ITFFWD4
M&F-''O$>XDE"Y)"DGD$8 !/TS@ '5$9!!Z&N5TWP5+I,26=GXFUE-+3A+,M$
M=J_W1(4\P#_@61ZU4TGQ7X?T;P7I%[9KJ4NDW4Q@MY9<R/O:1E&\LV0"V<$\
M#CI73S:O!;ZDME*DBDV[7#2G'EQHIP2QSQU_'GT. "W!!%;6\=O @CBB4(B+
MT50, "I*Y^/QAISZG86,T5W;?VB";&:>+;'<8&<*<Y4XY 8*37,>'-<C\.V7
MC6_OWOKBSLM<E!.YIWBC$<?]XYVC/X?2@#T>HYT>2!TCD,3L,!P =OO@UGOK
MMND>EOY,[_VDX2 (%)!*%\MSP-JDY]OI4?B#Q-IWAF*TEU(S*EU<);1M'"S@
M.QP,D< ?7\,T 'A;P_'X6\/6NC07,MQ;VH*Q/* &P23@X !ZUL5@6WBRUNX$
M,-AJ7VJ1Y$CLY;?RIF$9 9L.0 O*_,2!R!U.*Y_Q7X[0_#76-9T+[1]H@$EL
MQ,>U[28$*P<'H1GW[4 =_17(V$6GZ-J(O;:'5A>7\.P:8TF[S/+QNEVLV >0
M"Q8 Y'<\O?XB:!%I,>HR27*Q&]^P2(;=M\$^X*4D[*1GN>>V: .KHKDF^(>D
M136L$]GJ\$]U-+##%+I\BL[1KN. 1SGMCDYZ5=C\6VL]E%/;Z?J4TSP?:7M!
M;[9HH\D NK$8)*M@9R<' .* -V6,2Q-&Q8!A@E6*G\".126\$5K;QP01K'%&
MH557H!6+#XOTB\TO3;^QF>\74R19Q0K^\E(SN&#C&W!R6( QR:P/ MX]UXR\
M:@F]6..ZME2&[=F:(^5EE&2<#=G&#CTXQ0!WM%<O+XKF7XA)X:73KDQ"Q-R\
MP52"3(J CGA1\V3Z]N*EN_&NE6<$MY(MR=,AG-O-J"1@P1N&VG)SNP&X+ %0
M>_!H Z.BH+F\M[.QFO;B54MH8VEDE/14 R3],#-9&G>+;#4=1M+$0W5O+>VI
MN[0SH )XAC)4@G!^8'#8//2@#<DC26-HY$5XW!5E89!!Z@BH+"RCTZT2UA>1
MH8^(U<YV+V4'J0.V<FLZS\3VE_-9B"WNC;WK.MM=;!Y4NT,QY!R.%.,@9[54
M\8>)Y?#::2L-C-<O?ZA#:;D (0,W/4C)*A@/>@#H9XC- \2RO$6&-\>-P^F:
M99VEO86D5K:Q+%!$NU$7L/\ />N!DU<Z9\5[N1H]3F2708IUL8]\SAS,P.U,
MD+PHSC _/GJ;/Q9I>H:%8ZM:/++#?-Y=M$$Q+)(-V4VGH1M;.>!M))P,T ;E
M%9&C>(K+6[B^M85F@O;"01W5K<*%DB+#*DX)!!'(()!KEO%FA>([VY\42:;J
M%[$MQI=NMDL4S*%F$CE]N#P<*N2.N^@#T"BO&OC!J-]HWBGP9'::O?VD%[<-
M%>"*\DC61%>(<@, .&;D8ZUV>AVEI?ZTNKZ'K%_-86LLMK/%)J,MQ#.=H^9=
M[-RK<=<=: .RHKC8/B5I%QJFI:8EEJ(O].*K-;-$@<EG" *-_P V2PY'&"/4
M58U7Q]INC>(K+0;NSU#^T;V'S8(HH5DW\'Y<ACSE2/3OG'- '545S&C>/M"U
MG3-4OA++9#2G9+^&\39);E<YW $^AZ$]"*=I?C;3M5OH+)+>\@N;JS^W6D<Z
M*IN8?[R?,<'IPV#SG% '2T5YV/C/X9;2/[5%MJIL5NA:S3?9?EA<@$;CGISV
MR>.G3/1ZCXQT^PUN/1XX;F]OFM#>F*U525A!QN^9AN]E7)XZ4 =#17/7'C'3
MH7TN"&*YNKW4X/M%M9PJOF&,+N+-N8*H XY/)X&:OZ#KMAXDT:WU73)3):S@
M[21AE(."I'8@@B@#2HKBM1^*/A[34N+AQ=2V%K>_8+F]A16CAF[@C=OQ[A2/
M3-7M<\>:3X?UW3](O(KQ[G4%W6Q@A\Q9/88.<].W>@#IZ*Y;0_B!H>N:7JM^
MK3V::3(Z7T=Y'L>$KG.0"?0]/2O._&_CB?4[SP7?Z*VM:=;7VHHFYW,4=W#O
M49VJQ&/]X D'IB@#VN0,T;!'V,1PV,X/TK'\+>'8_"VBKI<-W-<PI(\BM,JA
M@78NWW0.[&K&O:;-J^DO907MQ9-))$6FMY#'($6168*PY!*@C\:\GF:[3]H"
MV\,KJVL?V.UF9&MO[3N.6\ICG=OW=0.] 'M5%<HNH6O@BTM--U#4+N_N+Z\>
M.P267S)I=QR$W.0/ER!DGT[FGZ5X[TS6-,U:[M+6^:;296BO+,QKY\;+G( #
M8;H>A.<'% '3.N^-EW,NX$;EZCW%8_A[PXF@Q2%]1OM2NI0%>[OI0\A5<[5X
M   W,>G4FL[P]X_TOQ3#9RZ3;7LT=T\BAMJ#RPFW<7&[*CYA[G/3I47Q1FGM
M/AUK%[:75S;7-O#OBEMYFC93N'=2,_C0!V%%>9>$?%L7A[X.:9XEUV?4+P2#
M-S.TAF?)D90?F;IT'%;^E_$;1=4\1V>AI#?P7-[:BZM'N+?8DZ8)^4YST#=0
M!P<$\4 ==17':K\3- TB6Y\\74EI:7:V5U>11AHH)F&=K<[CCOM!QTZT[5OB
M1HFC>(9]#NXK[[=%;_:%2*#S/-7&<(%))/7C'8DX S0!U]%<M#X]TNZM](-M
M;7LUWJL+3VUBL:K-Y:@EF8,P51QW//;- ^(/A^31M*U*"X>9=5F^SV<*@+))
M+G!3#$!2#P<D#ISR,@'4T5R=C\1-"O-+UN^D:XM/[$=H[^&X0>9$P)&/E)!R
M00,$Y(JYI_BZQO8)IY[>ZL88K1;TRW03883D[@R,P/ .1G(H Z"BN8TSQYI&
MI7=G;[;FU^W6S7=E)<H%6YB7JRX)(X^;# '!SBG:'XVT_P 0&S>RM;T6MZ9/
MLUTZ+Y<FS.[HQ*G@X# $^G6@#I:*\]\/Z!XCM+KPL;[4;V:.T_M#[>)9F82[
MW_=;LGG /&>G:MO2M4>R\97WA>XD:11:I?V3N<MY18HZ$GKM8#!ZX8#M0!T]
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!PWB7Q$\FK/I,_AW7[O3(L&9[2P9TN6Z[,DCY!W_O=.F<LUB&\U>[\*^+X=
M+O(&TRZF\VSEC_?BWE4QLVP9.1A6VC)QGOQ7>44 <+;0S1>+]=\:2V-Z]NEC
M%8V<"6[>?.%8NY$9&X98@#..A/3FF:#XDGNM72:Y\+Z^NI7K+$\T]GY<%M$#
MG:&)^Z.23C+-Z< =[10!PWBN2U\8^']7\/\ ]AZ@]\0\%N;JQ=(UDZ+,LI&S
M:#\V0<D#H<XKL;:,V6G0Q22/*8(E5GP2SX&"<#DDXJQ10!YS\.='B\SQ#+J>
MB/'<RZY=7=M)>615C$Y4JRLR_7CK6EK4<[?%/PW<I9W;VT%I=1RSI;NT:,^S
M:"P&.=I^G>NTHH X2P6[\-?$'Q'<7UK=S:?K @N+:YM[=Y@K(FQHV" E3T(R
M,$=\URUQI=QX:T7PDU[!*KS^*VO3;(N]H4D$Q"87.2%P2!GG(&:]DK#U_P .
M+K]SI<SWLUO_ &;=+=Q+&JD-( 0-V0>,,>!B@#C?$7AF]\6ZSXAU'3HI;=)=
M _LR!IXVB\^8R&3HP!V@!5R1_$>N*O>&;VUU2XLY)? <VF:C9@M<7%SIZHL!
MVD-Y+@9<L>!M['GT/H%% 'G_ (*LKS_A7FJZ=+975O=R37NR.XA:(L)'=D(W
M 9R&'TIVBZ(WB/X0VOAZ^L[NPGBL(K?=<Q&-HYXU&'4'G"LH.>_:N^K&U[0#
MKIM0=6U*QBA9C)'93>6)U(P5<XSCZ8(R: ,SP"=1OM#77-91%U+4$C#!#D"-
M!M7!]&.^3_MI6YKCE-"OL1RR,8'54BC9V8E2  %!-788H[>&.&%%2*-0B(HP
M% & !3Z ..^&\5W8_#72K.:SG@OK6V*/!<1-$0X)P.1TZ<BN-C.KWR^$-0NM
M"ULW]IJ>Z^C^S%(H,I(-L:9"A,D?.!C&-S9KV.B@#S3Q79W]]JB^+]*TZ<WV
M@RB&"U>T</?QD_O!RN<<_(1T()[\+XBEFB\4Z7XID\-WNJZ1<:>;2XMA9E[B
MT??O5S$PSW*G'I],^E44 >=ZCI.DZEH]G%-X:OM(M;B[>X@ETZW,5S:2; !,
MXB!VLW(YSQMSWQO^!AK2:%+%K<TEQ)'=2);7,T7E2SP _([KV8\]1G ![UTM
M% '!>!;"6U7QGHTS&.X.LW$RMW\N=59'_4_B#5;P/J>K6&B:?X4O_#=^FI:=
MMMVN'@_T0HIP)1+T/R]AR3QQU'=OIT#:DFH)NCN0GENR?\M$R2%8=P"21W&3
M@\G-N@#SG0TO/#<7BG1M1TZ]N6NKZXO+*6&W>5+I)AD*6 (5@>#N(]>G-4X=
M O\ 08?AQITMO<W+Z9([7DL$+R)%NB9>6 (P&;'T&:]2HH \RO=%O]8UWXC6
M<-O<P_VK86\%I/+ Z1R.D4BL Q&,98#\>,U9\-3P:PUE!-X%FTS5K88N+JXL
M$CC@8+@M%)_$2>FWL<GISZ)10!YMX'U#5M(T2S\(7_AR_.HV#>2MT8,VCH&R
MLOF9QTYQ]XD?EI:&+K2_B#XN:YTZ]^SWLEO<0W*0%HV18 K?,.K;AC:,GGIC
MFNWHH \Y\)>&GU?X+IX;U.VN+.>2*:-DGB:-HG,K.C8([$JW%6M.TG7-?^'N
MJ#5X_LNN:GI[695C]S;&R+GV9B[_ $DQVKO** /.?"<\.H'3;2[\!26.KV6W
M[1<W-@BPQ,HP7CD_B)QQM]>>!FK_ (+LW>Y\807UA<QP7VK32H+BW=%FA:-%
MR-P&0<,*[>L_6]+DUC2Y+.+4;S3G9E(N+-PLBX(. 2#P<8- '(> -)U&TN[J
MSU!Q+:Z \FGZ=+NR9(V*ON;W5/+3VPPJY\1HKB>RT,6UI=7+0ZU:7,BV\#R%
M8XWRS':#C _.NHTS3H-*L([. R,J$LSRMN>1F)+,Q[DDDGZU;H \^\90W%AX
MNTKQ$^A3ZUI7V.2SN;>&W\V6 LRNL@C/)Z8/I57Q79_;/A5KL.D>&9K&342#
M!9P6>V:4Y3+R(@^4G!Z\X SSP/2Z* /.O%@GM_$NC>)O[ NM8TK[))9W5LEJ
M7F@+,K+((F&3RN#[55\16HN/#%E+I?A>XL$EUNUN_LT%CME9$=2\LB(#M/!X
M/. ._ ]/HH XKQ4LTOC7P9=0V=Y-!;3SR3R1VSL(E>$HI; XY(XZCO69KB2:
M%\0;O4[_ ,-7.M:3J=M"B2VMH+E[:6/<-I7J%8-G/K7I%% 'F5Y:76A>(?#/
MB&U\.2P:1##<VT]A86X9[02L&5_+CZDX&[;G'/7OJ^#S=2>.?&%Y)IU];VMY
M+:R6\MQ 8Q(%@53C/.<]NH[X.17<44 <5>17=I\7;;4/L%W-9W&C&S6>&/<B
M2"?<0YZ*-O.3UQQD\5SNF6&I6/PMU/P-=Z9>2ZJD=S:6[B!S#<"1F*2^;C8!
M\^3D@C!XZ5ZO10!@7-K?Z-X!>TT^)+_4+/3?*ACD&1,Z1X&1WR1T[UQ6F+>S
M>-/".J?V3KKK]BN(;J>[@*>7*PCX*$@1J,'H #VS7JE% 'E_A[3;S3M?TFY\
M/1ZK9V%W([:IHU] X@M<HQ+Q,X&T[\#"DYW>@-;_ ,1+:ZFL="N;6SN+I;'6
MK6ZGCMXS(XC4G<0HY.,CI78T4 <-;-.WQ8N-3?3[^*T?0XX?,>U?:)!*SE,@
M$9VD=#[=:Y"RTK5K/P?X?U Z!=7ITC5+N6[TR6V(DDAF>3#(C#YB P( ]?K7
MM%% '-^%397376H6/AMM'BF"*7GM%MYYR,_>4<[1D 9]^W)Z2BB@#Q[XPZ9J
M.J^+/!TUAI-_>PZ=<M+=M!:NZHI>(]0,'A6X&>E=?8ZA#8ZM!IFA:+J*6]]=
MO<7,\EA)!!;C9EOOJ.690.!U8UV5% 'BWC.SU5/'^F>.?#^AWTTMG<"SN+86
M4@DN8@IW2\C &&* ]> ?I)XOU!(_CSX+OA;W3I]@D<QK"WF@%9<_)][(ZD8S
MQP">*]EKE=4\$6^J>.--\5/?W,=YI\9CAB14\O:0P.<C)SN/>@#S.'P5KGB'
M3OB3?PV=Q:#6I5_L^&X0Q/,(Y"^2K8*[A@#..IKIOA];V]U;Z1=ZAX7UFUUK
M2;4P2W5_YVV,!"I\H,QW;O[JC R?09]0HH ^:8O#'B ?!/5='.@ZF-1FUP7$
M=O\ 9'W-'L7YNG3Y3_DUV'Q!\-#6EM-1LK76+'7]/TV&2QO;6UE83/\ /^X;
M:,HP(X)QC?S7LU% 'B6MZ7XDTWQGX4\4ZII>HZA%_9266I+I9?S89<,6($9!
MQE@>..#[5ZCX4TVQTO1%BTW2I-,M9)&E6WE8E^?XF!)VD]<9^N#D#<HH ^=?
M%^D^*/$&B^)X?^$2U"VE&J+)!#9VZI"\8)!D(4AII&X);# #ICFNN\1V&I7O
MQ)\ ZC#I.H&VLXO])?[,Q$.X8 8@$ ^OIWKURB@#PC2_">MZEI'Q0L1I]Y;2
MZK=FXL3<0M$)U$KN "P Y&!SZU6U*VUK5?#?P\LX?#>LK-HMS$+T/9NH3R]H
M)&1R"%SD<=LYXKZ HH 0'(!YY]17C]QI^HG]HJWUT:7J)TI+4PM="TDV!O*8
M==O3) STKV&B@#S_ .)LFKB?P\FF:%+?Q&]W7-U;VRS3VB@KS%NX1B"WS\8Q
MU'!K$^&-EJ/AK6_'$VIZ-JMO!/>?:("\33-(NYR ""Q=L,.03WR:];HH \8\
M%6&K>$/B5>^7HEX-!UZ);EC%:2;;&4DLL;'';)!QQR.F*[CXGP7%[\.]8L;.
MUN+FZN8?+BB@A:1F.X>@./QKKZ* /$+[2-6F_9N@T&/2=1.JKY:&T^R2;P1/
MO/&.FT9STJS%I>IGXI^ M0_LK4!9V6C);W,QM9 L4ACD7:QQQRPSZ9KV:B@#
MQGP9;ZKX0U[Q%X=UCPSJ&IV=]?M>6=S#;"6&0D_QLWRKT4\G@@^U:;:9?M^T
M+%J[Z;=_8%TWR!=?9W,0EP>-V,=#C/2O4Z* /)/'>EZGIWQ6T;Q4FF:GJ.DF
MS-G<KIID\Z$Y8YQ&0V/F!_ ^U'B2PN-)T+0+?PSX-N$LI=2\Z;; )[JT7*YD
M0/GRY&&<$GY<#.">/6Z* /$?"F@WMC<_$:#5_#.J2V.HSK)'#("S31EWR%?)
MW. X.03R.34.C>"-?BTCQAX:TNYOI_#\UC_Q+S?P/ PG)#>6 X!Q@$,0 N2/
M>O=** /)/ %A%=Z9I":IX2U>/6M'MV@,U^91"@"%?W>YB#N&!M48Y/8#-+P-
MX9O_  _\0+.7P_'JEMX>O8))M1T^_MW1;23;\JJS !SN( *Y. <DBO:** "N
M&D@>Y^,[7L2,\.FZ%Y<Q09/F22DJGUVH3^5=R>0<''O56QT^"P67RMS23/YD
MTKG+R/@#)/T  '0  # % $>CZD=7TFWOS97=D9EW?9[R/9*G.,,N3CI5ZBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \]
MU"%?^%WZ7#E_(?299WA#G8T@D #%<X)P>N*O3_$BQBM=6N4T?6)HM)N&AO2D
M*#R@JAF?EQD8/09/&<8YJ&^M;UOC#INJ)I]TVGPZ9):R7(C^59&?('J1@=0,
M<UEKINI'PY\1+;^S+P3:K<7+V2F+_7*\*HI'IR#UQ0!Z5;SQW5M%<0L'BE0.
MC#NI&0:Y_5O&5II<^J1+97EW_95NMS?- $Q$C!B/O,-QVJ3@9X'KQ6CX<22+
MPUI<4T3Q2QVL4<D<BX9650"#^(KB?%5MKVJ7WBG39]'O+RTFT_9I)A=5@W&(
MAS)EAE]YXR#C QCDD ["?Q+9JVG16L<MY<:A$9[>&' 8Q  ER6("J-RCD]2
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M8K;#E5\EF8Y=@!U)QG)[ \T:UH=Y+KL^KZ#::CI7B(7J(7B!^R7\(<#=+U7
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MX)P!@UL7GBFV@OX["TM;F_NGLS?;+?:,0YP#EV49)X _E7%C3-3;PA\0K/\
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M'@DW:>#M*MKVPN+*>UM(K=XY]NXLB!21@GC(.,\^U;] !1110 4444 %%%%
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MMQ=3&665L 99CUX 'H *PQ\0;(3Z4LNE:K%!JL>ZSN#"I65]F_R\!BP..A(
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M#VD-=S10!Y]#I.HW.L_$,?89XTU6&-+*21=JRE;?RSSV^;UQZUGO::O<>%?
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MH7BK^ZMA(L>]O=F( 'K7,>';OQ*E\D5YX3DM3<R;[W49[Z%\D#LB$G' 51T
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M9XB02OS 8ZX['BJEMH<C^/&\36VG2V(:P>"Z1V0-=R;E*9"DC*A6&X^H X%
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M39'O8L%R!EB 3UP/6K'AJY\0I>);7?A66QBF9I;N_N+Z&5I'V]=J$G)(4#H
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M=OY@9#(KY!D9@<J3V85UE !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 45YE\4_#FEV7P^\2:LEI&VI28F^U,N9%)=1A6ZJ
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M2:1(T'5G8 #\35;2[V74+$3S6DEI)YDD;0R$$@HY7.1P0=N1[$5Q6KW-U?\
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M>'!C:X60$G?@< \>M=/=V6I2_$K2=9_LR9=/@TZ:":9I8AY;.R,,C?G VG)
M/XUV-,ECCFB>*5%>-U*LK#((/4&@#R#3(KV+2HEG\(:M=:&EZ^HP16=Y;O;$
M>871D5B)"O(<*3@GMCBO7;6XCN[2&YB),4R+(A(P<$9'%<IH_A7POF2#2]0N
M;BT@.UK"/599;>/_ &3'O(Q_LGCVKL ,# Z4 ><S_#Z?4+_Q+IMTR#0;TM>6
M:]2EU*FUV]MI4L!ZR>U;>B:=J]KX%F_M2(W&NW=N7N4C91NE*!  20.%50><
M9!-=710!YBGA[7K?P5X'B729)+W0[R&2ZM!/$&*K&Z$JV[:?O ]16WIUEJ\'
MQ$UC6)](F6TN=/MX8W2:)MTB%BP W X^; ) _"NSHH Y3X;:7J&B> ].TS5+
M-K6\MO,5T9T?J[,""I(Z$5U=%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!QEIK&KW_P 1]9T2XM;-],MK2 A3,22KE\L5
M*88G &W(  ZG-<MX(\37'AGX>:/(=',FDF_EMIKD3A3'YETZJ5CP=R@D \CV
M!KKDTK5[#XC:CK$%I%<:??64,;/YP5XVC+\;2.<[ACD#UKFE\)^(%^%=MX=.
MGK_:$=^+AOWZ;-@N?.ZY]..G6@#I];\;1:=<:E;V<=E<3Z:@:>.XO1 S,5W[
M(QM;<VT@\X'S 9ZXW=%U:#7=%L]4MED2&ZB$BI(N&7/8CU'2N1DL?%>@>+M2
MU'1=,MM3TW6#'-+;S78@>UF5 A.<,&4A1G&3QQ[]M9I<I9Q+>2))<[<R,@PN
M[N /0=!GG'6@#DYO&NIO?^(;*Q\.F>?12AD$MXL8D5H_,X(4X.,8'/N1WCB^
M($LL7A^_.BR1Z/K4L5O%<M<+YB22 E<Q@?=R,9W9]J6STC5K?7_&E\^GL8M6
M6'[(!*F24A\L[N>,GGZ>_%9?_",ZZO@GP9I0T_-UH]]:SW(\Y-I2'.=ISR3G
MCI[XH Z6;Q/=7$FK#1=,2_32I##.6N/++RA0S1QC:V2 1U*C)Q[U0;XAPW)\
M-/I6F37UOKRR>1()50HR(6*D'N",'L.>N,%NDZ3K/A;6?$'V.P%_8:K=-?P$
M3*C0SN '63<?NY (*[C[5G67@K4-"?P-:VD(NH-$:>2\F#JNYI48'8"<GYG)
M^F.] $^H^.=5'A+Q5/%ID-GK.A[EEB>X\R, H'5U8*-W!SM('(ZBJ&N2W9UO
MX>:A<6$<FH&:50(9=[2 VS$9=E7')R?3WJW=>%=8U!?B!";98!KL:BS=Y5(R
ML(CPV"2,D9[\5-/I.OWE[X,NIM*2/^RI&>Y1+E6V@PF, $XR<G/ICN30!)<Z
M\WB+PQXPTS4]+2UO=,@DBG@\T3H0T.]&5MHSD'/3C%0Z-XEFT#PCX"@>P22S
MU&SM+4W9GV"&0Q+M#+M.<XP#GKP<4\:%K O_ !W/_9YVZU$BV?[Y,DK!Y7S<
M_+SSWX]^*FGT%9/A!'H>MXLY+32TC>7<&\J2%!B12/1E!'>@#I;;4Y;G7[[3
MUMD^SVD<9:X$N29'!.S;MX(&">>C+Z\9?C35;;2K+3FO-(CU*&?4;>$"0KMA
M=G 5^0>03D8'XBK7A&QO+'P[;-J;;]4N1]IO7QC,K 9'_ 1A1[**H^/-)U'6
M=+T^WTZV$TD.HV]T^9%0!(W#'J>IQQ0 VZ\6ZB/%-_X?L-!-Q=6UJERCR72Q
MHZLQ')P2OW3V)]@.:AM/B!:WNA:#?I;I!+K,KPQQW4_EI'(F[<K. ><H0..2
M1TJ2VT[4XOB/J&N-I[_8IM-BMHR)4WET9F.1NX!W8Z]:Q-&\+ZA;^!]-\/ZW
MX=@U&U66X-Y 98R0'D9T>,DCD;L=5/7!Z9 +_B?Q+X@LK#0F@TZWM9KS6H[*
M9)+EC\OF'&TA/NN$ZXR W0]K^L^++_2H]3D_L96CTNS2ZN9);@Q1R$AB4A8H
M0Y 4]=O) [\<\W@W7;7PGI=K;YNI--UU-0MK6YN<NELK';"9.06 /N.V3BI]
M:T'Q/J>IZ\)["RNX+_3A#82277RV+F)ED4*5R26.=P R, D=  /\17%MJ?B/
MX=ZM#$!]JNFD1F4;PC6[L 3^/2C29%TOXB?$"YM[02&.VL9C%'A-[>7*3STR
M?6D&@Z\;?P()-.0/HI!NUCN%. (3%P3C)YSZ>YJ[#I&K0>+/%^H_V>6M]3M8
M(K4B5,EHT=3D9X!+\>PYQTH KQ_$6[.F>']6D\.R#3M8DC@1TNE:5)9 =@"8
M *DC&2P^F*T[3QFT>IZQ8:[IZZ;)IMF+\NEQYRO;G=EL[1@@J<CGV)KGQX8U
MU/ W@[21I^;O2+ZUGN1YR;2D)YVG/).>.G?.*O:KX6O];\6Z[)/;M!INI:'_
M &8)]ZED?<YW;0>GS_F* +,/C]&UG2[.6TMVBU,,(7M;Q9GB<+N"RJ  F>F0
MS#/'O5&3XE7D>@WVMGPVXL=.O7M;QC=KN0(X0L@V_,03DC@>A/;0\,R>-DAM
MM-UO3K*&.S4+)J$-T)#=A1@!8R/E+8&2Q]<#GC G\*:_-\.?$^AC3PM[J>H3
MW$ ,Z; DDH<;CG@@#!XZX_  Z"77-:/Q3BT2*"U.G#2S=<SLK-F5%+D;#R,$
M!>^3\W8='K.KVF@Z-=ZK?N4M;6,R2$#)P.P'<GH/<USLNE:POQ"L-?@LHFM9
M-*-A<+).%:!O-#[L '=QD8'?TK4\8^'AXK\(ZEHGG>2UU%M20CA7!#*3[9 S
M0!3F\5W.FZEI-OK.F+:0:K((+>:.X\SRYB,K'(-HP2,@$%AD8]ZPK!;S6_B1
MXMT[5=/L[BQ%I9V\D;W#,$B82M\HV<ECR1QC Y-7[C2=9\3IX>AUFP6R.EWD
M5]=2B976:2)2%$>#G!8Y)8*0!C!S5G1=,U.U^(/B+5)[$I8ZC':QPR>:A(,2
MN"67/ .[C&??% %GQG9VR?#C7;40)Y$.E3B-",A=L3;<9],"O,=4NM!A^#&C
MB'3)H=7:QM5M;Y;%[80SE5_>&X9551GG.[D>N:]9\66MUJ'A/5;"R@,US=VD
MMO&N\* 70J"23T&?K7+-I/B2;X9P^$TT:W2Y.FII\EQ<72F)<1A"X"@L?4#
M[4 ;YU?4K./2+!;5;^[GLS+/>M(8[9=BKN)<*W+%N!CID]JS[7XA6EWX<T;5
M!!' ^J7;V:)<3A8XY%WYW2 '@^60..25Z9XHKX6UK2)_#5C;PQ:QH^GV!MI8
M+B?RE$XV[9B"#N  ( YVYR.:KZ+X9U>S\'PZ#K.@66HV?VZX-Q )E8O$[NZN
MN[ !!9<#(.,\@T =+=>*6TVRB;4[2*TO)[LVD$3W($;D*6W^85&$V@G.,]L9
MXI/#?BU->U34],DMXXKJP*$O;S^?#,CC(9'P,^A&.#7*)X'\0:=H-I+I$_\
MIFE:K)>:99WLV\);,FPV[.,XR"Q!R<9QGO7;Z#<:[>H]SK5A!II("QV<5P)R
M/5F< #G@ #ICDG/ !RGQBAMW\,Z7)/"D@76+3.Y-QVE^1COD=N]4M.BMM4^*
MUGJ'A"W%MIEC%-;ZU)'%Y$<LF/DC*$ EU)R3C@8Y[5T'Q$T;5->TFPM-+M!-
M)#J$%TY>544+&V2.3G)^F/>F:CH.J:?XM@\3^'K92UXHAU?3Y) GG*!\L@/(
M\Q>GN#C- $^M^.(M.FU.&SCL[B735!GCGO1 [MM#[(QM.YMI'7 R0,]<0#Q\
M]UJ.CVFFZ+/<?VM8O=V[R3+%C;MRK YQC=R?;@&JOV'Q9X?\5ZG?:-I=MJ6F
M:RR3R03W8@DM)P@1B3A@RD*.F3Q^=R?2-9?QUH.JRP+/#9V4\%S,C*H,DA4_
M*I.=HVXYYQCK0!DZYX\U63X=ZOJEC816>HV%Z=.NHY)RPA?>J%D8+\WWU(R!
MUSSC!]#MFN'MT:ZBCBG.=R12&11SV8JN>/85YK<^$-=O/!WC'31:)%=:GJS:
MA:!YEVLN^-@K$$[6_=GVY'->CV4ES+9QR7D"6\[#+1))O">V[ R: ..G\=:L
M]WKEKIGA6:\FT>55F5KM(]RE ^5X.6(/"C/N1P#>L_&G]LV.C76BZ>]Q'J=O
M)<>=.YBBMPF 5=PK8;<<8QV)SQSBZ!=ZA;>-_'BV6FM=EKN#81*B!7^SKP^X
M@A>G(R>O'K'9>#M:\/IX9TZW@M]6TJQM9$N;>2;RD%RS;_.((.Y02P P2,Y
MS0!??XC-_P (79>)HM)#6DES]FNPUS@6I\PQER0IW(&'48."..N.BO-;EM=7
M-FED9XHK)KR=XG)= #A5";?F+$-CD?=;VS@>$O#-U:^";_P_XBMK=8)IKD'R
MY=PDCD=VST^7AN._':HO".CZQ%\/+ETU%9-9O+5DM+QUP BH4MR?; #GW=J
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MW1&.Y&UH_/$ISD#' P!R?7%=OXOT^TUGP9J5KJ#FUB>V:0R,1N@91N5^.ZD
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M  2@..,Y'\.* /3EN(7F>%9HVE0 L@8%ESZCM3F=4QN8+DX&3C)]*\HU)?\
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MN*EXBHP#M[,<9'K0!V5%<-<>/-2!\1+9^&VF;0W_ '_F7JH'3R_,)&%/S8/
M_,BFZCXKU6X\0^#4TBWMVL-8@EN@)IVC9P(=P5L(VT#>#WR1VQR =W45Q<P6
MD#SW,T<,*#+R2,%51ZDG@5G^(]=@\.:-)J5R%\M9(XLN^Q07=4!9L':H+ DX
M. #UKD/B)<W&I?#/Q,M_IT$:P6RR6\L<OG1R9P0RDJ,$=* /0P0P!!!!Y!%-
M\J/SO.\M?-*[=^/FQUQGTKEK#Q3=)XCT[0[_ $@VL=]:O+9W'V@.7\L+N5T
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M0K<\-\N?3WK%@\+:_!X.\%:9_9X:YT74(;BZQ.FTI&'!VG/).X8SCH:].HH
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MFOS_ %<UMZYX:T?Q+%;QZQ8I=I;2^;$KLP ;&.Q&1@]#Q6HJJB!$4*JC  &
M!0!ROBW2-4O-9\-ZIIEO%<MIEW(\L,DWE[E>-DR#@],YJKI6DZSX7\0Z[-;6
M(U"PU:87B>7,J-!.5 =6W$90D @C)'H:[6B@#!\&^'CX6\*6>DM(LLL09Y70
M8#2.Q=L9[98@>V*Y_1M/\0Z1XQ\4:L=$$UMJTL#P@7<:NHC38=PZ<]>#78ZE
MK&FZ/$)=2O[>T0Y(::0*,#&3SV&1S[U-)>VL5H+J2YA2V*AA,T@"$'H<],4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF98)9"8959=LD>X#(R.AQ^%&CZ/KP\>WGB#4+>P@MKK3XK8Q17+2.C(S-UV
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MU\A))4_Q8QQUSQHW/C.].K^'+.PTN*:+7+22YADEN"A3:BOAAM.!\XY&>_%
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M$< 8 ')X%=[;^)]1A\8IHFK:?;6T-S9R7=K+%<%V 1@&60%0 <,#P2.V3UH
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M6)X4UZ7Q'H27UQI\UA<"1HI8) >&4XRI(&5/!!QWK;H **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>arvinassixthleaseamendme005.jpg
<TEXT>
begin 644 arvinassixthleaseamendme005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 45R/B?P]J6I17U\OB?4=+,$9:T2SD"1)M7.Z48
MR^3G()QC&.<DXJ>*-7U#1_ FG7#-:ZCXA&^ZEC&UA%''YC[?[I8;>1TW'&#C
M !Z117$V>HZA;^,-;\)P7;$_88[ZPGN&,K0JQ*."3DOAAN&3WQG&,4Q8ZOX8
M\>Z#;VVO:GJ=EJ@G6\M]0D$FS8FX2(0!M&2 0./F [T >A45YU:ZEJ'B;3O%
MFL6]_<6SZ;=3VNF)%(513 H.]U'#[GSD-GC &.M==X7UH>(O"VF:P$"&\MDE
M9!T5B.1^!S0!KT5Y1X<U<^*]+U"REU_4--\;QF99+5KAHQ"X)VA(3\C(!MYP
M3W)SS7;W_B[2=#N[?3-0FG%_) 95B2WDD:0+@';M!W')Z#)H Z"BN<L_'7A^
M^T&;68KUA;03?9Y5>)EE27(41E"-VXD@8QWJ[8^)-.OIM0@\Q[>?3@K7<5RG
MEF)64LK'/&T@$Y!QP: $U[3=5U&.V32]<?2BDFZ9DMDF,J8QM&[[I[YY^E7K
M.QAL-.AL;7='%#$(HSG)  P#D]3]:S+7Q9I5WJ=IIX>:*>]B::S\Z%D%PBC+
M%"1S@$'!P<<]*;)XPT>&ZM8I994BNY_LT%TT+>1)+R-@?&,G!P>AQP30!K65
MG%86PAA!QN9V9CDLS$LS$^I))JQ7-+JKZ3XV@T*XE9[;4[>2XLF<Y9)(R/,C
MSU(PP89Z88=, :VIZS9Z2;9+EV,UU+Y-O#&I9Y7P3@ >P))/ Q0!?HKG)O'6
M@VV@7>M37$R6EG.UM<YMW+PRJ0"C*!D')')XY'/-6+'Q9I6HZX^D0R3K=B(S
MQB6W>-9HP<%HV8 . 2.1Z\<4 ;=%>;_$OQ/"W@B_DTNZOXY(KB.%+RU#K&9!
M*JNF\=1C<,],\9SQ7=ZMJ4>CZ1=ZC+%-+';1-(T<*;G8 9P!0!=JA8:7'IMQ
M<M:MLM[B0S-!CA9&.69?3<<DCU.>,G/GVM^)YM2\-^"=>$]WI_VG5;(72 O%
M&Z.I=A@XWKP.>1Q7;:7XKTK5I-0BBDF@ET_#7,=W \#1J02'(< [2 3GVH V
MJ*PHO%VE2ZE;V#&YAGNHFFM1-;N@N%49;9D<D#G;UQVJMI_C[P_JES%#:7$[
M"0S+YK6LB1H8LEP[%0$( )P<'\QD Z:BL.W\6:5<:K:Z<6GAGO$:2T,\#1K<
M*HR=A(Y('..#CG&*CM_&FBW-Q9QQS2F*]F>WM;DQ,(II%SE5;_@+8SP<'&:
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M&IKKEB8X9+=+.1Q)MN%;>KA=K CGKUKUW6$?4/#.H1V\;M)/9R+&C*58ED(
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ML6UI'*LUYI\R1(ZE6)9#M!!Y&>.#SSS6_10!@>"KF.X\!:#.GW?[/@R,="$
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ME*1 PP"9/E^09.,G&<'&<5QFGW$]SKO@+4SI^L,8!<1W:FQDBBMI&@VB-(\
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MI_#VM6_B/P]8:Q:@B&\A64*3DJ3U4^X.1^%6K^_M=+L9;V]F6&WB&7=OK@
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MK@8..U=?61X5?=X4TE3'+&\=G$CI+&R,K! ""& (K7H **** "BBB@ HHHH
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MEZ5MT;Q1IFL^&-4>PO-=,X4*6<1.L>V1"I+,RE<DKGIU)XIEUH'B:7PWJEI
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MM6+R.DJ;,MCD#."/F[C- 'HB^)+4V7GR6]U%*;DVB6SH/->4?PJ <'@$YSC
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MM9[6Z@$BR13QE&4F1B.O7@CI784 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1UKD;;Q'>ZAX^U;P[+I<PL;:UA/F!X^=Y?
M+M\V0"%  &3U) S7+> ?%</A[P%H\=SIU^]G)?36SWRJICB=[F0+NRP8C)&2
M 0,]<\4 >KT5@:MXIATTWPAL;F^.GQB2[$#(/+!7=CYF&YMOS8'8CU&=/2M3
MM-:TJUU.QD\RUNHUEB;&,J1W'8T 7*0$'H17#^/]3NX-3\-:;'87%Q:7FHJ)
MU1H]LZA';RL,P[A6.< XZ]J9H5EX;T+QS=6.G:'>6NJOIS7A)<&-8FD7,4:[
MRJ_/DX  SG!P: .\HKBK+XE6%[IS:F-(U6+3(X[AYKN2%=D1A)!5L-G)QQCC
MD#.<XT[SQ/<6MEJ$W]B77FVMF;M%,L>R9>> X8C(QD^W3- '145A>#M7N]<\
M)Z9J-[;/#/<6L4C%MF)"R EE"DX!)Z'!]JK>,-8FL?[)TJTD,=WK%ZMJLB_>
MCCP6D<>X4$#T+ ]J .FK$UOPU%KMY;2W&HZC%;Q*R2V4$^R&Y4XXD7&6'&.H
MX)%9?Q"M4M?AGK2VDDUK]FLY'B-O*T9! SR003[YZ]ZTVUBWT;PO87=UN8.E
MO"BJ1EY'VJHR2 ,DCDF@#<HKC/%GC*^T;PCKFH6^D7$=Y8*% E:/:"P&) 0Q
MW*,].I(Q@=:=XLU2XT?PZOBM+6:VN+!D-S Y4F:W+A75MI(. Q=3G@CW((!V
M-%-C=98UD1@R, RD=P:Q[_7(AJ,VD6MG/?W20"6XCA95$:-D*"S,!N;#8'L2
M<#F@#:ZT5YE\.]>M](^'>DAK>XDFOM2N;>V@ &\L9I6PQ)P,*I))/;N:Z&;Q
M[:0:!JVJOIFH-_9%PUO?6\:HTD94 EA\P#+A@<@].W!H ZRBLE]>B5M(6.UG
MF.IG]WY90^6NS>6;YONX[C/) [BM:@ HZ5RMSX[L;;37U?['=R:+',89-0C"
ME%PVPOMW;B@;(W =L@$<UE>+M4GF\:^%]*_LR:^TVY%S-)$K1%+K;$-O#. 0
MN\GYL#.",XH [^BL[1-%LO#^F)I^G1O%:HS,D;.6V;B3M&3P!G@=JRM8\:6F
MDV]_="RNKJTTY]EY/ 4Q$< M@,P+;003@?F00 #IJ*YF\\:V<+W LK2YU 6U
M@NHS-!M $+ E2"Q&XD*Q 'IU%6O^$ILIH-*:QCENYM4@^TVL" *QBVAB[;B
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M>E+&\R1)& RNI8,I+@8P.G4YX!P<4]2\=2LWA.;1[":ZL]<EW>8&16V^6S[
M&8?-QR20!@\DF@#N.^**\SL]2;1/B/XTGM]*OKV1K6QE-O;[2P^20L268*/H
M#D]@>:[[1=6M=>T6SU6R+&VNXEECW#! (Z$>HZ4 7J*S=4UJ#3)[.U,<D]Y>
MNR6]O%C<^T;F.20 H'))/IU) JE8^*HK]]3M8["Z75--*B>P8H),,,JRDMM*
MD9.<]CWXH W\C.,\T5YQ\.+"W\0:!HGB34=/F35XQ)+_ &AO53<F0N&!VL2R
MCCAP,8&.E=!X\\17GAGPTU]96C3RM-%#N#*!'O<+NP3R>>!Z]>* +>C^&X]&
MUC5=22^N9Y=4D669)0FT,JA1MPH(X '4UN5YQJMVUM\5]%OAIMXUS-I%R/LB
M%6D+!X\#.[8..^X#WKH]/\:Z??Z$VI&"Y@D2[:Q>SD"^:+@-M\O@[<Y[YQCD
MD &@"[KV@_V[';(=5U.P6&3>WV"?RC*,8*L<'(^F#6E;V\-I;16UO&L<,*".
M-%Z*H& !^%8VD^*;;4]<O=$EMIK34K2-9FAE*L'B;@.K*2",\'H0:T=6TR+6
M-.>QG>1(I'1G\MRI(5PQ7(((SC!QV- %VBO,+?0]/?XQ7VE-%(;!-$CG6#SW
MVB0RD%NO7'%=='=P^'88-"LXKG4+F*%I5B\U=RQ;B%W.[#_='))P?0D '0T5
MQ@^)6D2:9I-_#::A+'J5V;)%2)=T4XSF-QNZ_*>F1[U*GCQ#?6%A-X>UF"^O
MHII(K>2*,,?+.",[\#.0020,'.: .NHKB?\ A9$!TB_OUT#5V.F2R1ZC"$CW
M6NP98DE\-P<_(2<>E=C:W,5Y:0W4#;X9HUDC;U4C(/Y&@"6BBN53QY8NUE+]
MBNQ87NH'38+LA=IF#,O*YW!2RL <=>P'- '545@2^*8A<W<=M8W-U%9W26EQ
M+"4_=R-M_A+ E0'&3CUQG%;] !17(Z9XKO+OQOX@TJYT^2"QTR.#]\9(]J;E
MD<N_S9PP"@ 9QCG&:E;QS916VGW]Q97<.DZA(L=O?N%V9?[C,-VY5;L2.XSC
M- '4T45R&G^(+O6/&WB#P_<Z7,MC9Q6Z;Q(F/G$C%FPV<, H &<8YQF@#K\Y
MK$UOPU%KMW:RW&HZC%;Q*R2V=O/LAN5;&1(N,L.,=1P2.]<)\._%L6C> /"U
MO=Z??FVNI/LOV\*OE+*\K[0<MN.3QN (R>O6NTU?Q=;Z7'J,D=C<WL6FC=>M
M 4'E?*'( 9@68*0Q [$=^* -Z6%)H6B;<$88.QBIQ[$<BEAACMX4AAC6.*-0
MJ(HP% X  ]*AT^_MM4TZVO[.02VUS$LL3C^)6&0?R-4M1UU;.]:QMK26]O5A
M\]X8G1=B$D DN0.2& '?!],T :U%<;'\2=(GLM%N[:TU">+5I6@A\N($QR*&
MW(XSD-\I'&1[XYHF\>'^P_$ES%HUW'J.A1EY[&X:,$ H75MRL5*E03P2>#Q0
M!V6<45P=SKME=^'/"ESXCT>\EEO+VS$# IM6Y8 I*=K\+DL<>W(Z5H7GCJ*V
MUR_T>#0]6O+RR6)Y%MXD.Y)"0&7+<@8^OMP< '65"UI"]W'=.FZ6-2J$DD+G
MJ0.@/;/7'%<WJOCNPTFTGU"6UN9=+MKC[/<7L6PK&P;8QV[MS*K?*2!U!QG%
M=2K!U#*05(R".XH 6BO/+VVB?XYV$++F%M%DN&BR=C2"7 <KT+8/6N[O[ZVT
MRPN+Z\E$5M;QF21SSA0,GZT 6**YR+QA;#Q!::-?65S8W%[$\MHTI1EE"#+K
M\C'# <X/;O4%AXZLK^XT<"RNXK762ZV-S(%VR%06Y ;*Y )&1]<4 =516!#X
MIBN9B;:QN9[47IL6N4*;4D5]C;EW;@H;C./PP0:K:OXYL=(M;J^>TNI]-LYO
M(NKN'85C8,%8A2P9@I.#@<<XS@T =11UK"N_$%O/=SZ98V<^IRI;K-.MNR@(
MCYV@LS#YF ) '89..,XGPA8-\,M+8!@#)<D!^H_?R=?>@#N**\_^,6(O K72
MNT4L=W;A948HRJTBAAN'.""<UGK=K9?%72;3PI=RW>G26DSZM;0W!FAB 7]V
MW)(1RW'!&>/6@#U"BN/TSXAV6IQ_:5TK4X-/0W N+V:-1%;F'.X.0Q/.., C
MD#KG%I?&=LFLV&FWFGWEI)J,;O9/)L(E*C<4.UB5;'(!Q^?% '345P[_ !-L
M4T636?[&U;^SK>Y:WNIRD8^SE7V$L-^6&?[N<#K6M;>+H9O$D6BW&F7]G)<0
MO/:33J@2X5,;L ,64C(.& ./2@#HLT5Q>C^(] L=+U[4;33[FS6/6&M[J.4C
M=+=L8U)&6( +.HZ@<9X%;+>)(K6&^DU&SN;/[)Y8(?:WFESA!'M)SEOEYQS0
M!MT5S \;V$&J7>G:G;7&GW%O9-?CS2CK) N=Q4HQY&.5Z^F:T--UUM0NH(6T
MZY@2XMC<PS.R,C+E1C*L?F^8''3T)H UZ*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#C(K74=.^)VJZA_9D\]C?6%NBW
M$17:C1E]P8$[LX88P#G\\<JFA:V/@_:Z(='N_P"TH]1$S087(079ESG./N^_
M6O7:* /-;FTU+0_&NK7C>$WU[3-8:*>&2)8C+;RB-49'$A&%.T'.>*] TV.6
M'3H$FAA@D"Y:* ?)&3SM'KCIGC/7 JU10!QWC.UOKK7O"LMI87%S%9:A]HN7
MC Q&GELN>2,G+=!FFM;7J_%C^UOL%R=/&B&U\\*,>;YN_;C.>G?&,\5V=% '
MG_A.PU'3OAI>:?>Z%)+=+)<DV$^W%PDDKL%!SCE6QR>#UJMHWA>^L)=9L-&.
MH1>'KK2W2*RU!C^XNFR L6[D)MSGMDC!/;TFB@#G/ B7MOX+TFRO].GL9[.U
MBMG29E)9D0*2-I/RY'&>?:LSQU:/'KOA#6\9@L-3\N<]D693&&/L&*C\:[:H
MKB"&[MY;>XC26&12DD;C(8'J"* ,'Q]:W6H>!=9L+*VDN;JZM7ABCC R688'
M)( 'O4.J6HO? ]K97NA2ZA#(D,-U9, '"C 9AR.5QD8/;CG%=+;PBW@2%7=U
M08!D8LV.V2>3]3SZU(3CK0!Y3=>%-=?P+XNT2RDOKO3Y4C_LB&_?]\,8+IEN
M=N0 N['0]N3N^/)KK4_A?>VXL9K>]U$1VD%K,5,F^1U4 [20.YZG '/>NYSS
MCO5>2R@FO8KN52\D(/E!CQ&3P6 ]2#C/ID#J<@"V=N+.QM[8-N$,:Q@^N!BN
M*2#5O#GQ(UK4ETJZU'3-;BMRLEJ5+6\L2E-K!F&%(.<]*[RB@#R?1[3Q7I7A
M/2+,Z+?I;C5;A]1AMI8UG>%WD="A#@@;F7=R#@>A-;O@C1[NRO?%-I?Z(UI8
MWUZ9XE9D9'C:-%VX4GG@Y[>YKNZSM<T:'7M--C/<WELA=7\RSG:&0$'(PPH
MY7X>Z+>:>]Y'>3BXMM*DDTW3'SD^0'W,2?7[D9_ZXUW3+O1E)(R,9%06%C;Z
M;8Q6=I'L@B&%!8L?4DD\DDY))Y))-6* /+=/T36K/X97W@.;3)I+P)-9VUV
M/(EBD8E92V?EVAN5//R\ YK6O])O+/QCX*^S65U<6.CVMQ!/<JHPNZ)$3C.3
MG;S@'%=Y10 5YE;V.J>'O$FLVD_@\:W::C>O>6=['Y7R&3EHY2_*A3GGG@\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1MM'U#2HOM%UI&HQWOV7<%,Z %64$\!L,<9H T+7Q1%-K-QHUQ8W-MJD5O\
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MC#!<.@SAN5&<'I^FC;V6L2WGQ N7T.]BCU6",68<QYD86^S;@,<')'MUR>*
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M .1\;Z3K%Q-H^M:##%=7^DW#2?8Y7""XC="CJ&/ ;&,$\4D[:UJ^@7!U'PM
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MM@#!.>2O&#H>#=)U7POJ%_H(LY7\.1OYFF7+3(3$K<M$1NW%0Q.TXSZUV=%
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M;R%8$$Y&0<UW1( ))P!WHSD9% &%=0WGB/3+VQN+273;2YMI(&$S(TK%U*Y
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M3DG/0>IKHY7:.)W6-I&49"*0"WL,D#\S3ZADN[:&9(9;B))7R41G 9L>@[T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !<@=AT&:\VT?P/=ZEHGBG2]<L);$ZAK5QJ=C<K+&S0EBIC8%6)#J1^7&>:
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M##:"1,Q(D7EIO8G;GDL<$XR ,XI+[3/$NEZKHGB'2M(%^\>FKIU_ILDZ1R
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MRUSQK;:5<7]O;QP7$VGQB2YCDNUA/*[@B YW-MP<<#D<UR0\+^(?^%2IX?\
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M<?*QSV+ 8//%9?A&^OO&_@AKC585MY)Y9S#-#+EHF$SA2O (*8 ![XJGX?\
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M7P3>B(')7"'+8/3I[]J .\HKCHO&UR=3T$3:/Y.EZY\MI<FY!E#&,R+OC"X
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MQ_M&.5+GS5: ,5;=\HVL".0,CW]0#JJ*XB'XAH]_HRFTMY+/59%BC:WNQ+-
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M;2R@J,=,DYYXH+X0U6^\1W,T^F6&G:5?Z"VF216]QN: EV/ "@,?F]A[GOZ
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MM)G"174,CGHJR F@#B/%/AN\\3PSQ:EH,$MP(%;3[VVN0LEG/CG+G:VP-@Y
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M6>4]&8[?D3C&.3\QSTYS-&\+76AZ[J6L:'I0TR":P8-I37 \F>[R"K@*2$7
M*YXSN^Z,<]]371)8VCD171AAE89!'H10!F>&M2O-7\/VM[?VL=M=/O62.-]Z
M95BNY6[J<;@?0BLSXA:1?^(/!&I:/IL*R75X@12[A$7Y@22>O0=@:Z<
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M4$<:+T50, ?E4E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M('TY/YUWX40PA8T)"+A5'L.!S7!^%M.\2^'KSQ#(^BP3QZGJDM]%MO54JK@
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M?+GVSB@!/"UFT?A6R^UL9KJZ@6>[D;K+*Z@N3^> .P  X%8/PNACMM(UR"%
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MHHMVCO 9%E,>\*RE0 IP<'=GC) Z50_X1CQ"LWC4KIUA'%K=C'#;1PW'$;"
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M#$  DGUQS50^$KV\\2:7K0TR/2]8M[O=>W]M,H2[MQG*LHY9F&W.5XYY. "
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MAJ)LA)JGDK=R$LT4)W)$.R!B 6QW)'))Z# J[0 4444 %%%% !1110 4444
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M/]V8G;M(Z$KVSU- '>T5R-IXNGU/6;VRL/L32V-^+6XLI'*W CW -,!W7!)
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MR23@G' S@]*BTKQX=7\/:#=0V:+J.LSR6\,!DRB-$7\QRV,E0(R1QDY XSD
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MZ]%M+VTOXC+9W,-Q&&*EX9 X!'49'>H[;5-/O+F6VMKZVGGBSYD44JLR<XY
M.1SQ0!:7.T;L;L<XZ9KD9= UA_BC#XE5++[!'IIL"AG;S3F3?OQLQ[8S^-=?
M5._U73]*2-]0O8+42N(X_.D"[V)P%7/4\]!0!@:UHVMS^,]-UBQ-C<6<%L\+
M6UY(RB&1F!\Y %.YL#;@XXR,C)K.\.^&/$6D>%+;P_/)I[0?:Y?M,T,SJYMW
MD9SM^7AFW8QD8&<')!'>44 <GX5\/:IX9U/4K*+[)_PC<LQFL81*QEMBW+H%
MVXV%LD#/'O1\0_#VJ>*/#8TO3/LBR-<12L]S*R !'#8&U6SG&*ZRB@#E+W1=
M7N_'.B:X(K);:RMIX9D^T,7)DV\K\F"!M[D9S6!-X!UJ[TC6X6N;.TOYM<_M
MO3IXY&D6.0;=JN"H_NG)&>OMSZ510!R?V/Q9JF@ZC%JRZ7#=3VDEM#;VTKF(
MLXP7=RN?H ..>3GBG<>#M3O?AOI6AFZM[36-+6W>UN(F,D8FA VL<J#@X.1C
MC/>NGLM>TG4;V2SL]1MI[F-!(T4<@+;#P& [K[CBM&@#C)=-\:ZUX<U*VU*\
MT[3;Z6T>"W.GO(R[SC]XS, 5Z8 '3<3DG&*FG>&/$,/B30M4DAT:TALK"2RE
MM[:1V"!BAW(2HSG;T.,9ZM7?44 <#9^"[RX\1Z3K=]:6%EJ%O$Z:E<6,K$7X
M9"N"NU>,G=D\C  SU"^&= \9>'X(O#YO-,ET*V;;!>Y?[4(<Y$>W&W=CC=G@
M<X-=K>W]IIMH]W?74-M;QC+RS.$5?J34D$\5S;QSPN)(I4#HZ]&4C((_"@#A
M]8\'W^NZC;W-U:V$%_::@)[;5K>5A,MN)-P1EVC)V?)@DCG/L>LLCJYU+41?
M)9BQ#I]A,);S"NWYO,SQG=TQVK0HH *Y;QUX1'B_3+*W28P3VM[%.LJD@A,[
M9 "/5&;\0*ZFB@#D]:\%Q:GXRT#7(W$4>GH\<\2\><@(>)?HLBAL5-XWT/4=
M?TRQMM.%KO@OX+IS<2L@VQN&P,*W)QBNFJG::KI]_=7-K:7L%Q/:D"X2*0,8
MB<X#8Z'@\4 8#Z'K$'Q ?7[7[$]K<Z?':SI+(P=&1V;Y<+A@=V,DC'7!Z'GG
M\#^('^&EYX:_XEHNY[XW*R?:7V!3<";!_=YSQCI[UZ910!RLFBZN_P 0[?Q"
M([+[+'I;V31_:&W[V=7R/DQC*XZ]\^U<])X'\02?#74_#?\ Q+1=W=Z]PLGV
MA]BJTXEP?W><C&.E=U<:_I-IJ$5A<:C;174KB-(GD )<C(7_ 'B.0.IK1H ;
M&7,:F555R/F56W 'V.!G\JYF/1-47XDS>(&2T^P/IJV(43-YN5D9]V-F/XL8
MS6XFJZ?)JCZ6E[;M?I'YKVRR R*F0-Q7J!DCKZU<H YK^Q;^Q\4:MJEM%;7E
MOJD,*213RE#&T890!\K H0W(['/7/&7!X"?3=#\/1V,L/]HZ'=27,.XE8V$A
M;S(@<$JN'(!P<;5XKN:J7VJ:?IB(^H7UM:*YPIN)EC#'VR1F@#)T?09X?$FI
M^(M0\H7MY'';QQ1,66&%,D#<0,DL23QCH.<9-+Q1X>U6X\1Z/XDT)[9K[3UD
MAEMKIRB7$+XR-P!*L",C@UKKXJ\.LP5=?TLL3@ 7D>2?SK7H \VO/!WBJ]'C
M&5+G3[.?6Q;-!Y4TC;#&JJR,=H.U@"N1SSTK2T_0=:M/&D/B&[31[.Q72!92
MV\$CD0!9"XVDJH(YZ_+CT.,GMZBN+>&[MI;:XB26"9#')&XRKJ1@@CN"* .+
MTC1;6?XDZGJ]A>"73A'%,\49#1_;65D+@COY1&?^N@-,\5>#[_Q0UQ'<6M@L
MZ7"/INJQRLMQ:("I.0%R2"&P-V#D9QC-=CINEV&CV,=EIMI#:6L?W8H4"J/7
M@=ZMT 9^N6=WJ&@:A96-V;6[GMWCAN!UC<J0&X]#Z5QNG>%/$<.L>%;Z6+1K
M:/2;>:VGA@DD;<'5 74E1DDKG!QC.<MFNZO+^STZ'SKV[@MHLXWSR!%S]32V
MMY:WT GL[F&XA/ DA<.I_$4 <SH.@:M9:WXFNKU;-;?5YEDC\F9G:,",)@@H
M!V!Z]ZP8/ WB6'P7HEE%>:=;ZSH$RR6,JEWBF #*1)D @,K8( .,=>>/2Z*
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M8([RYSY%NT@$DF 2<+U( !YHM=5T^^N[JUM+V">>U*BXCBD#&(G. V.AX/%
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MK$UCP?XEU&7Q7$LNF21:S;"."YFD?S+<>7M,04+C86R<@\9)()XJQXJLO/\
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MNW*/OC+XR$!ST'0 <\FKL.@:M#\0X=<+VLMBFDC3V9YF\YF\S?O*A-OMC/\
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M>0HYQR#R2<]J /2:*XZW\0>(!XBLK)]/%U97<4F^>.QGMQ:2J,J':3(96Z9
M!SVK!/C[Q,G@<^*FL]*^SVMXT-S;CS"\B"?ROD;.%(XZ@YYZ=* /3Z*Y"/Q%
MK%CXVAT?6([#[+>64MU ]MOW0F,KN5RQPPPW4!>G2J$7C76KRWTC5;#3'N["
M^F3S+5+"<2PP/TE\T_(V!@D 8YP#QD@'?45YY<>+?%,@\6?8[;2(SH,A(,OF
M/YJ"(2;>".2#][H/0]0V_P!<UC5/$W@.6PNX+6TU6UFN_(D@+X80!OF(==PQ
M(0!Q@\\\8 /1:**YKQOXAO\ PUHT%]86T%PSW<-NZS,1P[A>,=^>Y'XT =+1
M7$6_B7Q'9>-(O#VM6FF_\3"VDGTZ>U9PH9/O1R;N3@'.X ?3GC/TCQUX@G\'
MQ^+=2L],32_(EW00M)YS3"7RXP.H"D\'J>_?  /1Z*XZVU_Q#_PD4%@U@+NS
MN;=V%TMC/;+;2J,A9"^=RMV(P<]N:YM?B'XJ3P18^,YM,TLZ3N_TV"-G\_9Y
MA0NAS@8XX.<]>.@ /5:*X;Q5XNU;0X-8O(X["&VLH%FM$N 7>_&W=)MVN"@'
M3)4\\]*?JGBC7CXBTC2M(M=/QJFGRW44ETSGRV4*?FV]OF[9)]J .VK/DT32
MI-9369-/MFU*./RTNFC!D5>> W;J?SKEKCQ5K<B:C:V<5N=2TR-$G5+&XN(I
M[DQB1D1DQL7Y@ 6R>>G'-JT\5W^K:CINDVUF-/U&;3_[0O$O(V?[,N[8$V@J
M2Q;/.1@+GOB@#H=,UG3M:2Y?3;N.Y2VF-O*T?(60 $KGOU'2DO=:TW3KVSL[
MN\CBN;Q_+MXB?FD;V ^G6N3^&7VC_BK1=^5]H'B&X$AB!"D[(^0#R >N,FCX
MBF==3\'-:QQO<?VR/+61BJD^3)U(!('X4 =W17"6GB3Q3_;.K^&[RVTO^VH+
M(7]A+"'\BXCW;=K MN4[N,Y[YQQS9TKQ9>ZUX9T"\M/LHU#49A%/$\3;82NX
MS#&[(*[2,D\G'3- '8LP1"S'"J,DUGZ=K^D:M-+#IVHVUU)"Q6589 Q0CLV.
MA]C6C7 _#( 7?C;C_F9;K^24 =]16-X@U&_T\6?V..W2&68K=7ERP\NUC"D[
MB-RELD!1SWKC[GXA:K%X"\0:U!;6,UWH]^]F6(=(YE#( X7.1D..-W;K0!Z3
M5#5]:TW0;(WFJ7D=K;A@N]SU).  !R3]*P(_$6L67C>#1]7BL%L[VSENH'M]
M^Z$QE=RN2<,,-G( ^E<GXWUG4_$GPDNM:A%I%I=U+$T<#1L9O*^T*%<ONQN)
M .W;P#C.10!Z6-:TTZW_ &*+R,ZEY)G-N#EA&"!N/IR1U]:OUQ%VRI\:;%V(
M"CP_.23V'GQU!-XVU5O!1\:6EO:R:4I:4V3(PG:W#E2XDW;0V!NV[<=L]Z .
M^J"\O;;3K.6\O)T@MX5+222'"J/4UQEYXI\17OBJ31= @TIDDTE-1MI[MI,$
M,^T!@O/..@]<YXP34-<U/7]#\4?V:;*.VTU9K)_.C9S/*D>9,$,-B@G:"0W(
M)QV(!V5C>VVI6%O?6<HEMKB-98I " RL,@\^U6*YSX?_ /).O#7_ &#+?_T6
MM;UU<Q6=I-=3MMAAC:1V]% R3^0H EJEJ.JV6E1+)>2E-V2J(C2.V!DX502<
M#DX'%<==^-M5LO!UIXSEM[5M'E\N6:T5&\^*WD8!7#[L,P#*2NT=2,\9+-0.
MIR_&32U@O+01?V1/)$'MV8*ADBW='&6.!SQQV- ';Z=J-GJVGPW^GW,=S:3K
MNCEC.585%JVM:;H5G]KU2\CM8"P0,YZL3@  <DU8^SB"S:"Q6&W(4^6/+^12
M>^T$9&><9%>.75YJNH_ "ZO]3NHKJ2>[5QMB*-N^W\Y.X@C/0 # XYH ]JHK
MCX?$NJV/C.71]:2Q%K)ISZA#);!]T01PK(Y8_-PV=P"].E4[?QEK=TNB:C::
M8]U8:C)&);>.PG62VBD&5D\T_(X'&X #KP3C- '>44C$A20-Q X [UP=KXSU
M:/7?#]CJ,5@LFJ22Q7%G""9;%PA=0SABK' P1A?44 =[17&_\)'K^K:7>:KX
M=L[2ZAM[QK>*SERLETL<FR1A(6"IR&(!!X4>N!!;7>NS_%;5K(:A;"UM].@D
MBB>V9@@=GST<?-E1D]P ,"@#N:*\['CO53\-;7Q/Y%D+AKW[/+#L;85^T^3E
M?FR#CGG-:'BOQ1J^AKK$\:6-M;V-J)[47(,CW[!2SJH5P4"@ 9(/7/04 =+=
M:UIMEJ=GIMQ>1QWMZ6%O 3EI, DX'I@'DU=.V-&;A5&6.!7 ZW>#4O%'PXO@
MFP7,LTP7.=NZU8X_6O0* ,1?&'AQWD5-;L6:-RD@$P)1AU!]#[5IV-]::E9Q
MW=C<Q7-M)G9+$P96P2#@CW!'X5YSX&U"[LM2\<"VT:\O_P#B?W#9@>%1G:OR
M_.ZG/X=ZW-7U76M)\#V^M:-I]JSB,7=Y9O&Q;#_/*4PP^8%F.#UH [*BN4M_
M$>HWOAK5/$-FMI+8+"\VG*ZNC2HJY+.<G )#8&!Q@G&<# 'CGQ-9Z9X;U_4;
M#3?[$U4V\<ZP,_G0-*!B3).W;D_=Y(&.30!Z517":CXRU:6WU.YT&S%U]@NG
MMUM#8SR-=&,[7Q*ORH<[@,AONY/7 E?Q+XAO/&#Z%8VEC;!])CU".2[#EHRS
ME=KJ",D8/ (^O&" =M17GD/Q$F'@[2-7U!+>Q:ZOI+*\N2C206S(9%W$ @[6
M9 !DC&[D\<ZL_BFZL['3TE>TN+O4KMX;2>TC>6)HE5G\W8I9F^5>@/4]<<T
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M!&-H&?N\9[UD1^ -<A\+6^C"_L)#;ZP-1CD*.N5$QEVGKR2<=L8[T =OH_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML ? [<=+ZSQ_X$1UJ^*M%NM8BM_L9,5Q")#%<QSF-XG( '&"KH>0RL"",>E
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MO+@B$:Y/4X Q5FN$L_$/B>YGT*]@L&N;*_9/MD MM@MHW&0Z2%OF"Y&<CGJ
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M:7+:K;SFZ6&$[+:>- Q5) 2K@$E2,D\9R,XK,N/%_BU?#'B76DGTM?["U&>
MQ?97/VA(BHQ]_P"3@DY^;D]L<@'J6:I:5J]AKEE]LTVY6XM_,>/>H(^9258<
MCL0:X^XNM4N?BUI<4-^L=F^C27"P-#N S)&&[C+'CGMZ=:=JEY!\.]-TVS65
MK72KB]N&N=0$!D%MYCM(H(&< EMNXY'R]!G@ [NBLW0+J>\T:&XN+NUNVD9R
MMQ:?ZN1-[;&')ZKMSR><UI4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M27VI74=M;)@,[^IX  ZDGT'-5=!\3:-XFMI9]'OX[I(FV2!059&]&5@"/Q%
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M-\/6?VO5;G[-;9"F5D8J"3@9(!QDGO4>G^)-'U2]>RM+Z-KM$\QK=P8Y-O\
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MR\#:S#<^&+B?7;5GT&.2!%BL=BR1-&$[N</@#GI_L^JMX"OG\+>)=%;5K?\
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M"P,5W*&'..#@CGGVK:U7P7?74NCZI9ZSLU[3'D874\.Z.<2??1D!&%Z8P?E
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M$E<''Z#I6S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/[RAU&X?2MZ:"*XC\N9%=-RMM8<9!!'Z@&N7NM.37/B%IFHQ*!#H44ZO,/\
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MSC<?GXS0!U6E^)=)UB\N+*TN6^V6X#36TT+PRH#T)1P&Q[XQ6M7"#PYK-_\
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M4KC!/.=O7WZ9Y$,^N>*-9L]6N/#T<YN+&]DM+>(+;^1,T3;7\PNV\;B&^[C
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M)!%)%;>2SA\ F0[CNX' & "2<>G1T4 4M6M;N]TNXMK&^-C<2KM2Y$8<Q^I
M) SCI7/:-X4U[3)[1+CQ?/<V%NV3:)8Q0^9UQEU^;KR?7G/4UUU% '*W7@M9
M8M7LK:_-MI>L2F6]MUBRY9@!)Y;Y^4.!SD'J2,9JYXE\-+K_ (3G\/03K96T
MT0A++%OV(,8"C(QT [UO44 8VK: NMZ NFWMR1,C1RI<0IM*2QL&1PI)Z$#@
MDYYI(]#EEUFVU?4;J*>ZM()(;?R8#&J;]N]B"S$D[%'7 YXYK95E=0RD,I&0
M0<@BAF5%+,P51R23@"@#"\(V^L6VD21:SJ$FH2B=O)N98!#(\>!C<@Z<[L=\
M8SCI4?B;0-4UR2T^PZ\VFQ6[>88UM$F$CC[I;<<8'4#'7GJ!CHJ* .:MO"UU
M<Z5J6G^(]:FUJ*^B\DAX$@6-,'.T)QG)SNZ\#TI]IX8D&HZ9>ZIJ'VY]+B:.
MS_<^7@L ID?D[GVC&1@<GCGB[IWB"QU75]3TRV\[[3IIC6X$D10 N"5QGKP,
MYZ<BM&>>*VMY)YY%CAB4N[L<!5 R23Z8H P]0\.3WWB[2]=6_2,:?'+&D!@+
M;Q(%#9;<.?E&../>KVK:?=ZG"UK'J#6EK(NV4PQ_OB.X5\X7(XSM)]"#R*VG
M>*++4M473T@O(99+87<#30E4FB) W*WXC@X;GI6W0!S.OZ1=V7A"/3?"UR^E
M2V^U;86]N)<XZ(0W !/5C]3721[_ "U\P@O@;MO3/?%.HH XZZ\*>))=9N]1
MMO&3VQG^58QIL3B)!T12V3CN?4\UH3^&'F31[G^T7;5]+W&.^FCW>;O7$@=
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M2""#[\@<=ZR+?PAJ,?B6UU^X\0O/>Q6+6<@^R(L<BE@PX!R!D9/))[$5UM%
M'"K\/)E\#V_A@:RODPW0N1.;7YB1+YH&-^/O?I^=7SX0N[;Q3=:YI.LFR?4$
M1=0@-L)$F9!@.F6^1L<?Q#U!KJZRK3Q#8WOB"^T2'SOMEE&DDP>)E7#$@8)^
M]T/(X]Z *_@_PV?"?AJVT;[<]XL!;;(\83[S%B,#W)[FMVBB@ HHHH ****
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MRU*1PQA"&[D_*2 /QKEM6UW5];^&,=S/?RP7,.N)92O%&J&95N0@W#!P<8)
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M&.@% '=22)#$\LKJD: LS,<!0.I)K)N_$=K9^)M.T&2"X^TW\<DD4@0>7B,
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M@6FL6:2I;72EXUE #8R1R 3Z>M<GX<M[@_%#QH7U*\D2$6>(G*%2&B<[?NY
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M88H\2PD[7D&5)!!P2!@8STKH-0O];NAXAO=!G:X6UME@L[<!"DEQMWNRDCG
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN]B@I%@@(B]%'S,><\G)SQ0!Q@U7Q)#H_@75QK\KR:R]M:W,$EO&8OWL);>
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MJRHH"R$ ';@# PHX.>E7=6TV744M3!?2V<UM.)TDC4-N.UEVL#U4ACGOZ$4
M<!J'BN9_ T^MZ#XCFN0NJ01(9(4$D2.\2-#(K)P02QSC/(Y-;>I:_>Z5\0[B
MV>YDETR/0)M0:UV)Q(DBC(;&[IG@DCFK%YX#L;_2-9M+BXE%QJTZ7,]S"H0K
M(FW847D #8.N2><GFGVW@S9XABUN]UF]O;M;)K*42)&$F1FW$%0N .!TQ[DT
M 5=%_P"$@U?2O#OB"#6D'VL1W%]:R(ODF&1<[(\#(920 2><'.>E<F/[5MM+
M^(VJ:;J\UA)I^J7%RBQ1(PD9(8VP^X'*D#&!COR>E=?H/@%- E2"'7-2FT>"
M3S;;3)64QQ-G</FQN90>0"<9QUJ0>!HQIOB&Q.J7)CUV222Y.Q,H74(VSC@;
M0!SF@#H=*NVO](LKQU"M<01RD#H"R@_UKA=5\3W6G^*KC3=8OKW1Q+=Q#3+K
MRE-G/%A-T;-M.')W@YQC(P?7NM,LO[-TNUL?.:86\2Q"1P 6"C SCC.!6)J/
MA :K!>V-YJ,TNF7MP)Y;5XU)7#!MJ-U525R>IY."* ,/1HKM?B=XTD75+@^1
M!9LB3E#%S'(0K?+D*I)/RD=\YJOIFOZM'XD\)6SZI-?0ZK#<+>3>6HMY9$BW
MAH/E#;0<@'&T@CJ>:Z6Z\&6MUKFJZB;Z[2+5;5;:\M4*A)0JLJG.-P(#'H1[
MU0M/AZ+:309)/$&IS/HFY+4L(A^Z*;-APG]W W?>]"* .:TC5;OPUX=\<ZR;
M^YNI+?7)K=%N"C+N)AC5V. >,CC(7 Q@5U-I;^*H_$D/^D7/]D36[I<&\>!I
M(I0,J\80=^A!X[XJ9? >GLNO6UQ=74^G:U*\T]DY4(DC@!F4@;L_*",G IV@
M^$+C10HN/$6I:F($*68N]A$ (QG@#>V.,MG@GIF@#AX=?\4?\*STCQ6WB"5[
MP7JQ20&WC\F9&N3$=X"YS@C[I7  XSS71G5M3\/>.KJQO-4N-2L7T674BDL<
M:F.2-P"$VJ/E(/0Y/'6K2_#RW7P7;^%QJMW]C@G$ZR[$\PD2>: 3C&-WM6I+
MX72?Q5%KTU[(\J6361@,:^6\;$,V>,Y) [T <YIMWXMU.V\/:W922-'=&*6_
MBG>$6[02+D^6!\X9<C;D\]\UE3ZEXFFT#QQ?+XDN(I-"O;C[+LMXOF6.)'"/
ME3E>3TP>3DGH.ET+X?IH,Z0P:[J<NC0R>;;Z7*ZF.-L[@-V-Q4'D+G''.:F'
M@:,:9XAL#JER8]=EDEN6V)E"ZA&V<<#: .<T 8=R]WJ?Q%\'W/\ :%U;BZTF
M><Q1%-B'$9. RGKNY)Y]"*](KF)/!D;W.A7*:I>0W&D0-;+)&$!FB8*"K94X
M/RCD8/7&.UC0=/U*SUC6IKG4;NZL;B8/;)=8S"<MO5,=(\% ,_W2>AR0"OXI
MURXL]:\/:):RFWDU>YD1[@ $QQQQEV"Y!&X\ $@]36-<ZQK&E^*-9\.'4998
MVT=M4L;IXT,D!5MC(>,,,X()&>2.:Z?Q%X;MO$4-KYDTMM=64ZW-I=0XWPR#
MOR"""."#P14'_"+K*^H75S>R2ZC>VHLVNA&J^5$,G:B]!RQ)SG)]@  #.\ C
M6K_0],UW5-<ENQ>Z=$S6I@141R =X(&<D=1TR3T& (?&5R\OC?P/HY)^S7-[
M/=2C^\T$19 ?^!$'Z@5TGA[1E\/:#9Z1'<R7$5I&(HGE #; , '  -9WBO19
MKZ72-7LXS)?:1=_:$C!P98V!25!GN5.1[@#O0!6U[4M1L_B#X3LH+QEL;\W2
MW%OL7#E(2RG.,CD^O84>&-2U&Y\9>+M/O+QKBWL9K=;8,BKY:O%O(^4#/)[\
M\5>OM"AUO6]%UY+Z>-M-\QH(E0 -YB[6WAAGIQCC!I+'0X=!UC6M=>]GF;4F
MC>:(Q@A2B[%"!1DG&!CG)H R/ 5S(FM>,-(R3!9:LTD([()5$A4>VXL?^!4[
MXB_ZSPA_V,EK_P"@R5I^$=$ETNWU&]NTV7VJWLE[.F0?+#8"1Y'7:H4'MG-3
M^(O#B>(6TQGO)K?^S[Q+V,1*IW2)D+NR#QR>!0!S=UJFO>()_$4.BRW5O-IU
MP;2T,+0A/,6-6W2!\D@LV,#C:..:@UWQ-JVBS63>(FN],L9M/C#ZAIT:S0V]
MYDA_,RK';]W;QCKG/;7O_ @E\1SZUI>NZEI$UXJK?1VA0I<;1@-A@=K8XW"K
M]SX89FE2TU&6WM)K)+*2V>-94V+N^8;N=^'(R<@X&0: .;\0>)KK1I[&34;V
M]AT.?3HRFL:?$LL27))R\GRGY2-A7C!R<Y[=UIDAFTJSD-S'<EX$8SQG*RY4
M?,/8]?QK$7PB+6!;33M1FM['^SX].-L\:RIY:;@&&>=^'(R<@X&0:VM+TVVT
M?2;33+-2MM:0K#$&.3M48&3W/% '$^'X+C_A8_C@OJ5W)'#]E B<H5(:%FV_
M=R "QP 1[YKFO#%WJ^B> / 6HV^K2^1<7MO8RV/E)Y312NRDYQNW@X.=V/:O
M1?\ A%%B\2:GK-KJ=W ^HQQK/ H0QED4HK\KG@'IG&>N:SD^'T$?AK1M"35;
ML6^DW4=U;R;$WEHVW*&XP0"3V&: ,3QKX@UG2+'Q+?VFJL]QIS1O;06D:M%!
M'A<B<LN"S$GY020"I %:FH76LW7Q+@T6WUF:TL+C1WNBD<,99'$J+E693S@]
M\CD\="'W_P -[>_AUZU.LZA%8ZTYGGM8]FU9B "X)7=CY0=N<<5IP^%##XDM
MM<.JW4MS!8FR D1"'0L&+' 'S;@#Q@=L4 5_A_JE_J>@W2:E<FZN;+4+FR-P
MRA6E6.0J&(  SC'2LWQ=!<3?$KP7'%J5W;I*;SY8BFU2L/W@&4@G#$9.>.F*
MZ+PWX=3PW;WD,=Y-<K=7<EVQE505>0Y;& .,TFN^&8];U'2M06^N;*[TV21H
MI(-I)5UVNI# CD=^U '#M!J,GB?XD3:?J\^G/;FVF5H(T9F=;12 V\$;>.0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK-$^R0 _=; ;!]\,#^-25XY8ZI/X1\%>.-:MKBXEN+?7+FVB,\K2*I:2- [
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MECJ=CE8;RT=5DVG[RL&4JRGT(I^@^%[7P_=ZC<V]W>SRZA-Y\YN)0P+X R
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MC;ALYRO';\ZFT?PS::'J.HW=I<79%_</<R6[R9B21\%V48[D#J3CMC)K:HH
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M4 <.?A?I?]D2Z,FJZO'I#3K/%8K.FR!@X?"$INQD="2.<]>:[:-/+C5-S-M
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M4G3RX6#A_D)3<!D="2.2>N"-U?#-NOBB+Q!]LO#=QVGV,(S(4,>X,0?ESG<
M<Y_2MNB@#%T#PS:>'/M2V5Q=M#/,\PAFDW)"78LP0 #@DYYR?>G:_P"'+?Q#
M]@^TW5U#]ANTO(O(*#,J?=)W*<@9/%;%% &%#X8AM]>U+68M0O5NM0B2*7F,
MJH0$+M&S@C)]>O.:L>'- MO#&A6^CV<T\MK;@B(SE2R@G.,@#/)-:M97B37$
M\-^'[S6);6:YBM8S(\<)4-M'4_,1Q^OM0!#?>&+2]\26VN_:;RWO((#;'R)
MJRQE@VUQ@Y 89X(]\CBLYOA_I[^']6T5]0U%K35;E[FY):/<7<[GP=G )_\
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M>P03[(YPJE5)XR" <<$ ]P>:;;>!;*UDT"2/4=2+:'&T=IOD1LADV'=E.?E
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M::7^SN'C+;6ZJV4PR_49]^!6KH^C6NBV\\=N7=[B=[F>63&Z65S\S'  [ <
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M( S6G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#$$'CK63IGB+4X/#&DZ;)>2S&?Q#/I1N;BY9':)&D**90"P8[57/7'H>:
M/6J*Y?P[I6K:5KFH_:[]&T^Y59+:Q:ZDN'@8<.0[@':<@XZ ]*KZ_F[\5Q6*
M7MW._P#9[M_9MM*T 0EP!/)*K @<%0,$YR0.#0!V%%>06^JZOJ'@3X=WTFKW
MJ75YJD-M<R1RX,J'S?O=F/R+US6Q8:2\WCSQ#X>?6-8.EBTM[I8OM\N])'WA
ML29W@?*#@'&?;B@#T>BO)- \2ZE?:%X TR\O;@C5I[J.[NQ(5DD6#?L0N.06
M(7)!R<'GFK^I7%]I/B3Q)H,-Y>OI[Z ^J6[-<N9+6569,*^=VTXW8SP0<<4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUM7]A:ZGI\]A>P)/:SH8Y8G'#*>U5]=UFV\/Z//J5T&:.,JH1>KNS!54?5F
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M;*6RFE0,]M,06C/<$CBL?Q+XMBT'PX^LVUL;^!+@6[[) @5C+Y1Y/HW' [4
M1IX1TS2;Y->C&IWFH6=HT0+7;R23J/F"D,V&.1P#QG\Z9X?@.LZ[+XKNM&GT
MV9[1+.".[15GV!B[E@"< D@ 'GY2>]=55+3+F^NH)7O]/^PR+,Z)'YRR;T!P
MKY'3<.<=10!3C\-VL.O7NLQ7%TE[>1+#*PD!&U<[0 1@8R<?KFL\> =''AJ'
MP\)+P:;#,)DC\_D,'WCYL9^]SUKJ:Y_QAXH7PAHAU::QDNK=)$C=8G <%F"K
M@'@C)'>@"OJW@+1]8U>/5I);^VU 1B*6XLKM[=IT'\,A3&1^7\JNMX6TXZOI
M^I1F:&;3H3!:I&^$CC( *[<<YP.OI6O \KP*TT0BD(Y0-NQ^-24 <T? VCOI
M>L:;-]IFMM7F-Q=J\IRTI()<$?=.57IQP.*W;&SCL+..VC>:14'WYI#(['N2
MQY)JQ10!ST7@G0XXM6@:WDEMM4=Y+FWEF9HMSG+E5SA22 <CG/3%3Z?X9L["
M>UG:>[O)+.,Q6K7<N\P*0 =O R2 !N.6QQGK6U5#5M431[=;NYC/V)3B>8'_
M %(/ <C^Z.Y[=>F2 "^1D$9Q[UB:1X7LM$U/4-0M9KHSZA()+KS9-PD8# .,
M<<>F*VP01D'(-% ',:QX#T;6=;76':^M+\H(I9K&[>W,Z#HK[2,C]:N-X6T[
M^V+#4XS-#-80&WMDC<!(XS@%=N,'.!U]*/$GBG3O"T5C)J#E5O+N.T3'8L?O
M'_9'<UMT <K+\/M%FLKNUD>\*W5\-1:03E72Y_YZ(P^Z>.W'M4@\!Z.MQJ,Z
MO?";4;=;:Z<W;L9% (R<D_-AB,]0#QBNFHH YUO!FFM:Z-;^=>>7HS*UD!+_
M *LJNU<\?-A>.<\5;L_#6GV&NWNL6XG2XO6#S)YS>47"A=^S.-V !FM>B@#
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MQF6/]_)(K#:H)(QSDMD D5T2^#]/4ZSB:[_XG'_'[^]^_P#+MXX^7Y>.,<5
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MYK6M.@N/C)H+N]R"^F7+'R[F1/NM'C&UA@<\@<'OFNWT^PMM+L8K.T0I#$,
M,Q8DDY))/)))))/))JCJGAK3M7U2QU*Y$ZW5D'6)X9FCRK8W*VT_,IP.#Z4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[L=;O9K5XKAXQ$Z["& 4@$_7/%>K7^HW%MX1N=3B027,5@UPBX^\XC+ 8^M
M&M17FVBZ3<ZE8^&/$UMKL$!_=27,RAV:]#@!HI,OC)8X''RD< 8Q5>SNY])\
M3V%OXBLI6%UJ+FPUVTE+QW/F%]D,PSE<!L <C*C'3- 'HJZA'=)?K8,D]Q:.
M870M@"78KA2>W#+GTS3].DO)=.MI-0@CM[QHU,T4;[U1\<@-WKS;PKI5I#HW
MC]X!+#)'JM]&CQ3.C*!&C#!!R#GOUJJ#/<>%?A=(;V\1[F:WBF,=PZ^8I@9C
MD9P3D=>H[&@#URBO,]*\/6=SXW\6:!+-?'28X;6X2U^V2[5DD5PS9W;OX0<9
MQGG' Q4\.:@VK>#_  +'?WES>7MPLQ%B6&V\$89=TS'^%!M/?)QP30!Z??WU
MMIEC->WDJQ6\*[G=NP_Q]JL5X?JB/=_"3Q+#>Y?^S_$+06Z&5G$*BYC 52<$
M@!F SV]*[*_ N?'J>%@;=+*/2A<P6UP7996:5@YX8;BH"XSG&210!WU%8'A#
M3;K1]$.FWFK_ -J26TSHLQ!W(IY5"2225!QDGIBM^@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YW6O OAWQ!JD>IZA8EKU
M$\OSHIGB9T_NML(W#ZUIQ:+80ZA'?10LDT5O]FC"R,$2/CY53.T=!T'85?HH
M \Z\:>#;:S\ :AH_AW3+J5[VZAF:W29Y 2)D=V^=L+D ],9-=C8Z+86\XOD2
MX>Y:'REEN9G>1(SSM&XDKSC/<X&<X%4_$/B&XT35M"M$LXYH=3O!:M*92&B.
MUFR%QSPI[BN@H YQO GAY](O-*>TF:QO9S<7$1NYL22$[BQ._/) )]Q5K5/"
MVDZS'8K?0S2-8OOMIEN9$EC.,'$BL&Y'7GFMFB@#GD\#>&X[+5+-=,06VJ$M
M=Q>8^UR<9(&?E/ ^[CD ]JE;PCHSR:;(T$YDTTEK5S=RY1CP6)W?,2#@ELFM
MRB@#$N?"6CW5_=7K02QRWBA+L0W$D:W  P-ZJ0&XXR><<=*FN/#>E7.IZ?J,
MENXN=.5DM#',Z+$I ! 52%P0 .G05JT4 9FF>'].T>ZO;FRBE2:]D\VX9YY'
MWOC&[#,0#@ <>E,O_#FFZCJ46I2QRQ7T49B6XMYWA<QDY*$J1E<\X/0\BM:J
M]I?6U^)C;2K((96A<KT#K]X?@>/K0!F7?A'1+W3[*PEM&%K92B>".*>2/;(#
MD/E6!+9).3DY)/6MI0%4*,X QR<FH!?6QU$Z>)5-T(O.,8ZA"< GZD'\C5B@
M#FH/ 'AFVUY]9ATT1W;R^<P65Q$9.N_R\[-V><XZ\]:;=_#[PQ?-J)N-.9UU
M%_-N8Q<2!&DX^<*&PK\#Y@ ??FNEED2&)Y975(T4LS,<!0.I)KF]6\5M97'A
MLVEK'<6>M7*0K.TA5D#(7!"[><@>HH O0>%])MM9CU>&"5;Z.W%LLGVF0CRL
MYVE2V",\\CKSUI\7AS3(=8O-6BCF2^O$$<\HN9/F4=!C=@8R<8 QFM6B@#GO
M^$&\.?\ ",MX<;3A)I)8L+>29WVL26RK%BRG))X(ZFD@\#>'[?0KG1EM)39W
M7%P&N92\HZ ,^[<1[9Q7144 06=I#86<-I '$,*A$#R,Y '3EB2?Q-41X;TE
M=>FUL6N+^9%CE?S&VN%! )3.TD D9QG!Q6K10!S6D> /#6@ZBU]ING>1*2S*
MHF<I$6X)1"=J$@D9 '!Q5[3?#6EZ1#>Q6,4\27LK37'^E2L6D;[S9+$@GU&*
MUZ* .='@;P^-$M=&%I,-/M91-!"+N8!'!W @[L\'D#/!JX?#>F'6_P"V?+G_
M +0^S_9?.^TR_P"JSG;C=CKSTZ\]:UJ* .<_X03P\-&&D?9)OL G^T"'[9-C
MS-V[=G?G[W/7KS5N7POI$^K'5)K>26[:U-FSO<2,&A/5"I;:0>IR.M;%% ',
M6WP]\,6GV#RM/D)L'+VIDNI7,61C:"6/R8/W?N^U7%\):*ESJ5PEJZ2:EG[5
MLN)%#D@ D -A20 "5P36W10!A-X/T-M$M-(^R.+.R97M0)Y-\#+]TH^[<I'L
M?:ICX9TMK"^LY(99([]=MV[SN9)AC;AGSNQCC&<8K7HH PV\(:*R:6A@GVZ5
MC[$/M<O[G P,?-SQQSGCBM'4],LM9TZ;3]1MDN;2==LD3C@CK^!SR".E6Z*
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MN)%EA&,8$@;=C '&>P]*VM.TVTTFPBL;&$0V\0(5 2>IR22>22222>2:M44
M9.N>&]+\1QP1ZI#+,D$JS1*MQ)&%=>C?*PY&>M6K[2K+5-*ETR_MUN;.9-DD
M4I+;A[D\Y[YZYYJY10!SFE^!?#^CZ==6-G:2I#=1^5*6N96<Q_W Y;<J^P(J
M>3PAHDWAD>')+:5M)"A!;FYE^Z.B[MV[ P.,XK<HH R)?#.ES:G8:C)'.]W8
M*R6TANI?D# !N-V#D 9SG.*K2>"=!EL]5M7M9C#JS;[T&ZE/FMQSRW!X'3'3
M%=!63XFU:;0?#6HZM!;)<M9P/.8GE,88*"3S@\X'I0!I"%%MQ NY4"[!AB"!
MC'7K^-9&F>$]'T>"]@L(;B&.]D:6X NYB7=OO-DMD,<=1@UH:7=MJ&DV=ZR!
M&N($E*@Y +*#C]:MT 9VBZ'I_A[38].TN)X;2/A(FF>0*,DX&XG')-4KWP;H
MM_K7]LSQ78U'R_)%Q%?SQ,$SG:-KC R<XK>ILA<1,8E5I #M5FV@GW.#C\C0
M!A'P7H4EKJ%O/:S7,>H1+%<_:KJ69G122 &=B5P23P1SS3;;P/H%I?6]]%:2
M_:X(3 D[W4K.4)S@L6RV,#&<XP,8P*?X-\0R>*?"]MK$UJMJ\SS*85?>%V2L
MG7 S]WTK>H YP>!?#PT*+1!:3#3HI?.2 7<V%?=NSG?G[W/7KS4UYX/T6^U>
M/598)DOEC$+307,D32H.BR;6&\?[V:W:Q/%VN3^&_"VH:S;VD=TUI$93$\IC
M! Z\@'\OUH K1^ _#D6C6>DI92K8V<XN((ENI1LD!R&R&SD'GZU=O/#.F7NI
M)J+QSQ7JQ>0;BWN)(G>/KM8J1N&>>>G:M*UF-Q:0S$8,D:N0.V1FI: ,2[\)
M:)>6NGVLMHRP:=(LUK'#/)$(G7HPVL,GD\G/4^M/UGPOI.O2VD]]!)]ILV+6
M]Q#.\,L>>#AT(;![C-;%% &3HWAK2M ENY--MVB>[D\V=FE=R[^IW$\\=>_>
MF7?A;2KZXO)IXYS]N %U&MS((YP%"@,@;;T !XY'!S6S10!DKX;TM-:EUA(9
MDOI8!;M(MQ(!Y8Z*%#8 !)(P.#6?_P (!X;&G6EBME,D%G.UQ;%+N8/%(Q)8
MJX?<,Y.0#@YKIJ* .=3P-X<CM]3MX]/*0ZG_ ,?:)/(HDR #T;C( SC&>^:G
ME\)Z/.-+\R&<_P!EG-F?M4N8CC&?O<\<<YXXK3N[ZVL3 +B54,\JPQ ]7<]
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M*(;[4K*TOK/4YHS/);DW-E&C?NG1_,&Q=H!R  26ZY- 'JLA81L4"E\?*&.
M3VR><5@>"M?NO$OAM-2O((8)S<3Q-'"25&R1D')Y/W:YS1I(/$'C[6M,UHQW
MZ:?868LTN(AMD61"TLP0_P 18J">HP!ZU<^$D:0^ 88H\[([R[49.3@3OWH
MZRVU.TO+^\L[>4236959PO1&89"_7&#^(JY7D:(FB3_$[4M*L;9-1M'WVKI"
MNZ,FV5B5X]<L1WYJQJ]M!8^%/".OZ  NIO=62B>/[]XDN ZR'J^[)8YR01F@
M#T35KG4;>& :79Q75Q+,$(FE,:(N"2Q(5CVQTY)%<Q8^*_$>H^(M=T2#2-+^
MTZ0(2[/?2!9#*A=0#Y7'3!S7;UP/A3_DK?Q!^FG?^B#0!VUC/+<Z?;7%Q";>
M:6)'>$G)C8@$K^!XJQ7G-W&OB;Q]XBT&_EL"(+:#[)!>6QE/E,A+R1_.N#O)
M!8#/"\\5G2Z+"GB3X?:?/JD^JH([^WDNF=D\]4CP 0#R!R,_Q#U!H ]7HKR&
M :=I.B^-M(DENK72X]9BAMH+-@&!D$1\I-W"JS$@]L,:OZ?:F#QOXKTUX+>S
M@ET>"9K2R<K&K_O!G("_-@#) &1B@#T^J=OJ=I=:E>:?#*'N+-8S.HYV;\E0
M?? SCT(]:\@T[3K:S\&_#;6X%9=3DU"S@>Y+DNT3A@R9S]TCMTKJ_"FGZ=!\
M3/&\RV=K')%/:F-Q$H*%H,L0<<9))/KS0!Z!13(I8YHEEB=9(V&593D$>QI]
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-1\5>(](NK>WBCTIK<1-$Q8N)$+Y8G'MP!Z]: .@$,8@\A%V1A=@6/Y=HQC
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MCXK\1Z1=6]O%'I;6XB:)BQ<2(6RQ./;@#UZT 7K7PSH]EI,^E6UF(K&XW>;
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M<$,!Z9!!(]CQ5F7P]I,UY8W;6:B:P79:,C,H@4C!" $  C@XZCBM.C(SC/-
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M;)IC((6V@/L&YE7.#]W'%23>!/"\YO#+HEJWVR3S9\J?F?(.X<\$D G&,]Z
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MU:WU2:VW7UL"L,WF,#&#U P< 'N._>H-1\+:)JVI1:C>Z=%+>1+L6;)5BO\
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MM+;RH5*D#S0-S8)SCMG\*U8_"NAQ6%]8#3HFM+YS)=0R$NLKGJQ#$_,>.>O
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M>(&0*\8U*&PU?X%VWB&98KC59I[>:>\('F&4W**ZD]<#) 7H !QP*]NKFY?
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M):&\M;K3V?RW0,%96#\A@2/:JQ\=W+>&Y_%T4,#>'XKDQ[ K&:2!9/+:8-G
MYR0NWD#KDU>TYK'4=7GU.XO;8:E?0&TM+=959X81EL8!^\3EF[#"C^')X>V#
MV_[-UQI;1'[?$DNG-;C[WGFX*!,>I)!_&@#O_&7B.\\/:/;:A8VUM<QRW4$+
MM)(1M61PH8 #YNOJ/QJUXBUYM(DTRSMT1[[4[H6UN),[%^4LSMCD@*IX&,G
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M"<Q2S0JS1GU4D<?A5P7$)61A-'MC)#G<,*1U!]*(IXIXA+#*DD9Z.C @_B*
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MQI;_ %W3].U/3].N;A$NK]W6&,L,X5&=F/M\N,^I%79+F"&2..6>-'D.$5G
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M/O3K[PSH>I_9OMVD65S]EX@\V%6\L>@ST'MTK3CECFC62)U=&&593D$>QIU
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVLRX/4'Y, CG)%;M5;[3;'5(5AO[."ZB5MPCGC#KG!&<'CH3^= 'GFC6>M>
M_'&D>'(]6FU;P_JB3>3%=?-/9>6N[[W=.@].>@[\QJ.F6,GPP\=:F]M$U];:
MW>O!<,,O"1< @H>J_AC->QV.@Z5ILLDUGI\$,LB['D5/F*_W<]<>W2HAX6T
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MEVE\L1W1_:(@^T]\9Z4ZYT+2KO[-Y^GV[&U4I;MY8!A4X!"$<J, <#TH S?
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MN:(PR326ZL[H1@J21DC''TXH X.:QT_5O'_@U[F"&Z^T:-<>>6 83%1%@/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%JDSWEJ\I2>683%HB@!#'C8JX],=* /2[K5M-LIT@N]0M+>9\;(Y9E1FR<#
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M5L$@X(]P10!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?"$"1EVQ&FQ%+,6(5?X5!8@#L,"I6TG37U)=1;3[4WRC:+DPKYH'INQFKE%
M%.72=-GN);B73[22>6,Q22O"I9T_NDXR1[=*#I&FM)#(VG6A>!0L+&%<Q@=
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MI/OF&)4+?7 YJ2UM+:QMEM[2WBMX$SMBA0(JY.3@#CJ2:FHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)GL+K2+2?2C$=/DB5K?R5VILQQ@=ACM0!<HHHH **** "BBB@ HHHH ****
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M"".)"22J(%!)]A4M% $26T$801PQH(P0FU0-N>N/2DBM+:"5Y8;>&.1QAG1
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M7/R(@"_D*/LMOMV^1%MSG&P8S4M% $,UI;7$0BFMXI(U((1T# ?@:F    &
M.U%% #?+0(J;%VKC:,<#'3%))#%*09(D<CIN4&GT4 1?9K?)/D19;J=@YKGO
M$&A:I=7UC>:/<6"K;"17L;V M#*7Q\_RD$, " <'ACZUTU% '/Z-X?>VO6U&
M_ATU+MH3!LL;?RT"$@D,3RYRHZX ].23O(B1HJ(JJBC"JHP /04ZB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "L_5]3.EP0,EK)<R3S+#'&C*I+$$]6('8UH
M5B^(?];HW_82C_\ 07H /[6U?_H7+G_P*A_^*H_M;5_^A<N?_ J'_P"*K:HH
M Q?[6U?_ *%RY_\  J'_ .*H_M;5_P#H7+G_ ,"H?_BJVJ* ,7^UM7_Z%RY_
M\"H?_BJ/[6U?_H7+G_P*A_\ BJVJ* ,7^UM7_P"A<N?_  *A_P#BJ/[6U?\
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MMJ__ $+ES_X%0_\ Q5']K:O_ -"Y<_\ @5#_ /%5M44 8O\ :VK_ /0N7/\
MX%0__%4?VMJ__0N7/_@5#_\ %5M44 8O]K:O_P!"Y<_^!4/_ ,51_:VK_P#0
MN7/_ (%0_P#Q5;5% &+_ &MJ_P#T+ES_ .!4/_Q5']K:O_T+ES_X%0__ !5;
M5% &+_:VK_\ 0N7/_@5#_P#%4?VMJ_\ T+ES_P"!4/\ \56U10!B_P!K:O\
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M_P#0N7/_ (%0_P#Q5']K:O\ ]"Y<_P#@5#_\56U10!B_VMJ__0N7/_@5#_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L7Q)_J=-_["5O\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q6_Y'>/\
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M?P1:(^GFZ;S4 *O\P #=3RHXY/-:GB_Q@D?PUU'Q+X9U*WG-NH:.6,+(A.X
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRKZ5[$8T+A]J[P,!L<@5SOAC1-:L56;Q%JL6IWL*R103QQ>6=CON)8=,G"#
MZ!>^: .D "@   #@ 4M%% !6+K?_ "%_#?\ V$7_ /26XK:K%UO_ )"_AO\
M["+_ /I+<4 ;5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0VW)QO; ;/OFO+([Z.Z7X>WEM9W%G86FLN#9QVTIBLU\Y& $C M([ %B<GT
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M/+DB3:EQM3<,@>G?'8BK/A;Q'<^*_#-M?:)XK>YUI5C>^L9HXACD>8JIM#*
M,A6!(Z9S63\/O&QTKP!J&D7NDK:ZQH2E9+-80GVI0<$J!C<_4'&<G![UC>-/
M!WATM:>(?A]>&T\1-<Q^5I]H^&9F(SF/[T14'+9PH ((YH ZCQ[XE\0Z3\3O
M#&B:=K,UM8:JZK.BP0L5R^T[2R$CCUS74V]GK4^KW L_%5U<V*1202>=;VY,
M-RIC*D%(UW#!8$'WYST\Y^*'V>Z^+O@I+DQ2PQ,BW>.43,G.X]A]:];\.:!8
M^';&>UTT!;.6X:XB0$D+OP2 >XSD_0T 5/!?B@>*=&EFFB6#4+.X>SOH%.0D
MR'!Q_LG@CZX[59\2?ZG3?^PE;_\ H=<3\)()6UWQ[?@'[)<:[*L)[,59RQ'_
M 'TM=MXD_P!3IO\ V$K?_P!#H VJ*** "BBB@ KRC5/$/B%/CG8>$X==N8=*
MN[5IV5(("Z$)(V%9HSQE!US7J]>$^)X;/4_VC-/2>X9+,V#02W$,QC\MS'+@
M;P?E;)'?J10!U7A?Q?K7_"V=:\%ZA=+J=K:P^=#>>4J2)PAVOL 4_?QG Y'O
M5;PQXX_X2K6=9L+KQ')H^LP7LD%I8%(P@13A>&7,C$@[AD'TQUK'^'$\WP]\
M<ZIX/UZ%3]LD\^TU9H\&?/0._?/;)X;<.XI?$NB>"O'N@3:S>RQZ+XCCC;<^
M?*>5UR ?+/\ K%; P5R3D#.1B@#8^)?B'Q3X4^&FF:I#J1MM8$D,-ULAB='8
MJVXX93CD<8K>M4UNYCT>2U\4W<MV4MKN[M)H+;8\#,H?E8U9>-^#G^'%>:^/
MO[7_ .&?] L]<,CZTUQ&SQ2<S;!YFTL.N0NW.>_7FO4/!/A[2;*"WUO2UC1K
MW3X(K@1MD,R#(/7@\D&@#L**** "BBB@ K%T#_C\U[_L)'_T3%6U6+H'_'YK
MW_82/_HF*@#:HHHH **** .&^)WCU_!&CVJV,"7&KZC+Y-G$_P!T'C+'U RH
MQZD5?M] \20Z3O;Q7<RZN8]Q,EO#]FWX^[L"!@N?1L^_:N0^-_A;5-5M=&U_
M2+9[N?1YF>2WC&69"5.0.^"@X'8^U=G8^/\ PUJ-A'<6NI12S2*"+)#NN0W]
MSRA\V[MT_2@#C?$'B_7O#WB_P-97NI_9[:^M@=4B>*,@NJC=SMR#D]C]*[[2
M/%N@Z[IUUJ&GZE%):VC,MP[@Q^25&3N#@%>.YKSKQ[()/C%X D=-GEEFE5L'
MRBQ& Q' Y_E6'X6NK6"#XM375@VHVLEW)*+1"1]HC+R\J1SMY&6'0<T >O6/
MC'0=1U6+3+>^/VR>'SX8I8)(O.C_ +R%U <<$Y7/2J=Y\1O"6GM?K>:U% ]@
MX2Y1XW#(QS@;=N2>#TSP,]*\=T*\,_Q$^'6H>7<):_8GA5%M)$BMSM<")"PW
M.!N4%B6R3G/8=/X*M+&^^-/CIKJ"&=)@J1B50RR+D;P,\'D#- 'HMWXU\/64
MQAEU$-(+;[6ZPQ/*8X< ^8^Q3L7!!RV*?'XPT";1EU>/4HVL6E$*2A&_>2'&
M%1<98G(P #FO+==ETC1?B5XN2+6M.M9M2TM+:XCU*0PK"[H IC(4[P% )7C&
M1SZ4/%.FIX=\&> +S1]2DU31-$OC)=WMGMDP2X;>!\P&#O SG&0#0![?I>L6
M&LP2RV%P)5AE:&52K(\;KU5E8 J1Z$5>KC_ ]IH9EU76-$O+V]34Y$EGNIQM
M21P#]P;5['G QT'4''84 %%%% !6+K?_ "%_#?\ V$7_ /26XK:K%UO_ )"_
MAO\ ["+_ /I+<4 ;5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/^*I)88]*DA@,\BZC
M&5B#!2WRMQD\"N@K%\0_ZW1O^PE'_P"@O0 G]JZS_P!"W/\ ^!</_P 51_:N
ML_\ 0MS_ /@7#_\ %5MT4 8G]JZS_P!"W/\ ^!</_P 51_:NL_\ 0MS_ /@7
M#_\ %5MT4 8G]JZS_P!"W/\ ^!</_P 51_:NL_\ 0MS_ /@7#_\ %5MT4 8G
M]JZS_P!"W/\ ^!</_P 51_:NL_\ 0MS_ /@7#_\ %5MT4 8G]JZS_P!"W/\
M^!</_P 51_:NL_\ 0MS_ /@7#_\ %5MT4 8G]JZS_P!"W/\ ^!</_P 51_:N
ML_\ 0MS_ /@7#_\ %5MT4 8G]JZS_P!"W/\ ^!</_P 51_:NL?\ 0MS_ /@5
M#_\ %5MT4 8G]JZS_P!"W/\ ^!</_P 51_:NL_\ 0MS_ /@7#_\ %5MT4 8G
M]JZS_P!"W/\ ^!</_P 51_:NL_\ 0MS_ /@7#_\ %5MT4 8G]JZQ_P!"W/\
M^!4/_P 51_:NL_\ 0MS_ /@7#_\ %5MT4 8G]JZQ_P!"W/\ ^!4/_P 51_:N
ML_\ 0MS_ /@7#_\ %5MT4 8G]JZS_P!"W/\ ^!</_P 51_:NL_\ 0MS_ /@7
M#_\ %5MT4 8G]JZP?^9;G_\  J'_ .*H_M76?^A;G_\  N'_ .*K;HH Q/[5
MUG_H6Y__  +A_P#BJ/[5UG_H6Y__  +A_P#BJVZ* ,3^U=9_Z%N?_P "X?\
MXJC^U=9_Z%N?_P "X?\ XJMNB@#$_M76?^A;G_\  N'_ .*H_M76?^A;G_\
M N'_ .*K;HH Q/[5UG_H6Y__  +A_P#BJ/[5UG_H6Y__  +A_P#BJVZ* ,3^
MU=9_Z%N?_P "X?\ XJC^U=9_Z%N?_P "X?\ XJMNB@#$_M76?^A;G_\  N'_
M .*H_M76?^A;G_\  N'_ .*K;HH Q/[5UG_H6Y__  +A_P#BJR&U/5O^$P1_
M[ FW_8&'E_:8LX\P<YSBNRK%;_D=X_\ L&M_Z,6@!/[5UG_H6Y__  +A_P#B
MJRM'M]2T*2ZCL?#UPEC/*TXM?M,.V*1CEMAW<*3SM[$G&.E=A10!B?VKK/\
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MK/\ T+<__@7#_P#%4?VKK/\ T+<__@7#_P#%5MT4 8G]JZS_ -"W/_X%P_\
MQ5']JZS_ -"W/_X%P_\ Q5;=% &)_:NL_P#0MS_^!</_ ,51_:FL9S_PC<V?
M^OJ'_P"*K;HH Q/[5UG_ *%N?_P+A_\ BJ/[5UG_ *%N?_P+A_\ BJVZ* ,3
M^U=9_P"A;G_\"X?_ (JC^U=9_P"A;G_\"X?_ (JMNB@#R_4_"FI:EXCOM6NO
M#%EJ(N@@6/4TBF-N%&,1L)!A3UQCJ>M:_A+2[WPEI4UC9^')=L]S)<R!+B)$
M#/CA%W':H   R>G6NYHH Q/[5UG_ *%N?_P+A_\ BJ/[5UG_ *%N?_P+A_\
MBJVZ* ,3^U=9_P"A;G_\"X?_ (JC^U=9_P"A;G_\"X?_ (JMNB@#$_M76?\
MH6Y__ N'_P"*K/O;W4+G7O#B76DR6<8OW(D:='!/V6?C"DG_ /575UBZW_R%
M_#?_ &$7_P#26XH VJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKP ;-(S*N-S 9.!D]Z6N:\0^#] UXW%WXAA%U$D1"><Y5+9 ,LRX. >I+=>
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M8W,"\>(Y=IX;8<GVSGMD;W@Y="N=-?4_#T\+V-ZJ$I;_ "HDBC#';_"QR,C
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M+>VM7>,S2R2$%B<,5  4 9;DD],#.I]@\0?]!RU_\%__ -LH^P>(/^@Y:_\
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MI$F6)8J2,LQZ G  [G O?8/$'_0<M?\ P7__ &RC[!X@_P"@Y:_^"_\ ^V4
M)KOA+1?$DL,NJVTLSPJ50I<RQ8!Z_<89_&M'R38:5Y%A"&:"#9;Q/(<':N%4
ML<GL!DYK/^P>(/\ H.6O_@O_ /ME'V#Q!_T'+7_P7_\ VR@#!T'2=:O?%5SX
MJU*Q&F7<FDQV"VKR+)B0.SLV5)&W.W'<\\#OST'A_P 5S)X9N[S0$?5=/U'S
M;^ZEO8R]P-KKO4\X3YA\O!'0+7?_ &#Q!_T'+7_P7_\ VRC[!X@_Z#EK_P""
M_P#^V4 <O%HNM+'X^#:3*#K!8V?[Z+Y\P"/GY_EY&>>WOQ40T77K!? >HQ:/
M)<S:-9O9WEHD\2N-\2)N4EMI *>N<&NM^P>(/^@Y:_\ @O\ _ME'V#Q!_P!!
MRU_\%_\ ]LH XG^Q?&=MIGBDV=BL-S?ZNEXBPWBJTT&(PZ(_&PD*1N.#Z8JQ
M9:%K-IXFUR^@\.1VUE?Z5'#'%%<Q;ED7?\I&0-Q+ DYQU^8GBNN^P>(/^@Y:
M_P#@O_\ ME'V#Q!_T'+7_P %_P#]LH K>"=-NM/\":7I.J6?DSVUJMO-$[*X
M; P>5)!!K(^'F@SZ6;\37(N+.RGEL-+/)*6ZN689[G<=A_ZXBK^N>%-1\1::
M;#4M9A>W+J^([5HSE3D?,LH-6K/1=8T^SAM+35[.&WA4)'&NG\*!_P!M* )?
M#>LZAJZ7ZZGI)TVYM+HP>6)UF#+M#*VY>,D,..U97B>X\1S:HEI:>%VU'2$
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M_P!LH^P>(/\ H.6O_@O_ /ME &U16+]@\0?]!RU_\%__ -LH^P>(/^@Y:_\
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MBRG?F1ANW !2<YX'7)K3^P>(/^@Y:_\ @O\ _ME'V#Q!_P!!RU_\%_\ ]LH
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M;Q0,"&C .[<P4#!48R?09]#K%^P>(/\ H.6O_@O_ /ME'V#Q!_T'+7_P7_\
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M[Q_]@UO_ $8M;76L5O\ D=X_^P:W_HQ: -JBBB@ HHHH **** "BBB@ HH)
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MOV6;<T3!98V1D>,D9 96 (R.1D<BKE !15&TUC3KY;UK6\BD6RF:"Y8'B)U
M+*3TX!&:H:-XS\.>(+V6STK6+6ZN8QN:-&Y*^HS]X>XR* -VBBB@ K%UO_D+
M^&_^PB__ *2W%;58NM_\A?PW_P!A%_\ TEN* -JBBB@ HHHH **** "BBB@
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MR(?D 3.2N,@@G)W'D<8GA\/WO]M7OB"::V_M>2S%G:@(QBMT!+<\@L2QR>G
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MX@L&668YR<NSGECU..G3% '9T444 %8NM_\ (7\-_P#81?\ ]);BMJL76_\
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M3_\ Q=;=% &)_P (GI/]V]_\&$__ ,71_P (GI/]V]_\&$__ ,76W10!B?\
M")Z3_=O?_!A/_P#%T?\ ")Z3_=O?_!A/_P#%UMT4 8G_  B>D_W;W_P83_\
MQ=0S^"- N6B:XM9Y6B;?&9+R9BC>HR_!]ZZ&B@#$_P"$3TG^[>_^#"?_ .+H
M_P"$3TG^[>_^#"?_ .+K;HH Q/\ A$])_NWO_@PG_P#BZ/\ A$])_NWO_@PG
M_P#BZVZ* ,3_ (1/2?[M[_X,)_\ XNC_ (1/2?[M[_X,)_\ XNMNB@#$_P"$
M3TG^[>_^#"?_ .+H_P"$3TG^[>_^#"?_ .+K;HH Q/\ A$])_NWO_@PG_P#B
MZ/\ A$])_NWO_@PG_P#BZVZ* ,3_ (1/2?[M[_X,)_\ XNC_ (1/2?[M[_X,
M)_\ XNMNB@#$_P"$3TG^[>_^#"?_ .+J'_A"- ^U_:_LL_VG9L\[[9-OV]<;
MM^<>U=#10!B?\(GI/]V]_P#!A/\ _%T?\(GI/]V]_P#!A/\ _%UMT4 8G_")
MZ3_=O?\ P83_ /Q='_")Z3_=O?\ P83_ /Q=;=% &)_PB>D_W;W_ ,&$_P#\
M71_PB>D_W;W_ ,&$_P#\76W10!B?\(GI/]V]_P#!A/\ _%UD-X9TS_A,$AVW
M>S[ S?\ ']/G/F ==^?PKLJQ6_Y'>/\ [!K?^C%H 3_A$])_NWO_ (,)_P#X
MNC_A$])_NWO_ (,)_P#XNMNB@#$_X1/2?[M[_P"#"?\ ^+H_X1/2?[M[_P"#
M"?\ ^+K;HH Q/^$3TG^[>_\ @PG_ /BZ/^$3TG^[>_\ @PG_ /BZVZ* ,3_A
M$])_NWO_ (,)_P#XNC_A$])_NWO_ (,)_P#XNMNB@#$_X1/2?[M[_P"#"?\
M^+H_X1/2?[M[_P"#"?\ ^+K;HH Q/^$3TG^[>_\ @PG_ /BZ/^$3TG^[>_\
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M)_\ XNMNB@#$_P"$3TG^[>_^#"?_ .+H_P"$3TG^[>_^#"?_ .+K;HH Q/\
MA$])_NWO_@PG_P#BZ/\ A$])_NWO_@PG_P#BZVZ* ,3_ (1/2?[M[_X,)_\
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M7=$%\JYCV.,<9(]#C(]C4+?\CO'_ -@UO_1BT ;5%%% !1110 4444 %%%%
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M& .#COS5RD "@   #@ =J6@ K%UO_D+^&_\ L(O_ .DMQ6U6+K?_ "%_#?\
MV$7_ /26XH VJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\*65I%:VVLZ;%!$@1$6X7  _&N@HH \T?1? ,DL\A\4W8:=S)+MUV50S'J2
M^*V[F_\ !MQ]A:/7+.VFL4,=M-!=*KQH0 5YR"I '!!Z ]0#7844 <+>#P)>
M:"FBG6X(;)9?.(M]0,;N^[<69PVYB6.XDGKS4>EP>!M)O&NHO$CSS-$T0-UJ
M[S; V,E=S':>.HYKOJ* .)TZ?P?I_P!GW^)Q??9FW0?;M1\[RC@C(R>3@D G
M)&>*V_\ A,/#?_0=T_\ \"%_QK;HH Q/^$P\-_\ 0=T__P "%_QK$UJ;P7KU
M]8WEYXAA$UBYDMC#?"/RV(P2,'DX]:[:B@#BX)_ \6J1:G-K-K=WT((AGN[[
MS3%GKL#'"D^H -4];M? 6NZQ'JTVNQVM^B>4UQ8ZD8'DC_NL5(R/UKT"B@#@
M=8M_ &LQ:>KZQ;6DNG#;:7%E?>3+"N,%0RG."*=J,/P^U3P_%HMUJ=DUM$_F
MQO\ ;?WJ2Y)\P29W;\DDDGG/-=Y10!Y^UKX#D\.W.B3^($GM[H@W,LVI%YIL
M= TA.<# X&!^9JY-=>#[C5].U27Q'"]WIR,ENYO5P P ;(Z'( SGTKM** ."
M,'@%[76+:?6;:>#5W\R\22^&'?CYA@C:>!TQT%7;'4/"-G=QWDGB."\NHHS%
M%-=WBNT:'&0O0#.!D]3@9)KL** /.K33/AY8ZU)J5MK,,0DF^T/9IJ)%L9<Y
MWF+=M)SSZ ]JU-.OO!VEZOJ&J6_B"W-SJ#*UR7O%97*C:IQT&!QQ78T4 <+X
M5U'PYX?M[^-?$-N8;FZ:XCBN+\2M&"!D;B>Y!.!P,]^346KP>"-:U5M2N?$T
MD=P4$>;;5WA4*.P"L!UY^M=_10!Q$#^!(= DT8ZQ:S6LDGFLTU^7E+Y!#^86
MW;@0,'/&!Z5-#?\ A"%;UO\ A(H'NKU!'/=M>J)BH!"@,,;0,G&W'))ZG-=C
M10!YK9Z+\/K*2W,?B.9X[=U=()=:D>+Y3D H7P1QTQBNCU;7/".MZ3=:9?:U
M8/:W49CE5;H*2IZ\@\5T]% &%%XK\,PPI$FN:>$10JC[0O0?C66?%.@_\)>E
MQ_;%EY(L&3S/.7;N\P'&<]<5V-% &)_PF'AO_H.Z?_X$+_C1_P )AX;_ .@[
MI_\ X$+_ (UMT4 8G_"8>&_^@[I__@0O^-'_  F'AO\ Z#NG_P#@0O\ C6W1
M0!B?\)AX;_Z#NG_^!"_XT?\ "8>&_P#H.Z?_ .!"_P"-;=% &)_PF'AO_H.Z
M?_X$+_C1_P )AX;_ .@[I_\ X$+_ (UMT4 <[>^)/"FH6%Q976M:>]O<1-%*
MGVD#<K @C(.1P>U8=L/!\6H+=77BB.^6*1)8(KF\5A&Z+A6/=R.Q;..O7FN^
MHH \YN]-\"7NHW5])XIN4GN7WRF'6Y(P3T'"N  !P!Z5I)<^"HCH_EZ] @TG
M=]G5;_AMR[29.?G/?)[Y]37:44 <-"W@N*\N)V\2":*>8SM:S:F7@#DY)"$X
MQGG:>/:KVI:QX1U.6VGDUVSBNK5BUO<0W2J\>X88 ]"".H((Z>@KJZ* .8TS
M7/"&D6GV:SUC3T0NTCLUR&:1V.69F)R23W-7/^$P\-_]!W3_ /P(7_&MNB@#
M$_X3#PW_ -!W3_\ P(7_ !H_X3#PW_T'=/\ _ A?\:VZ* ,3_A,/#?\ T'=/
M_P# A?\ &C_A,/#?_0=T_P#\"%_QK;HH Q/^$P\-_P#0=T__ ,"%_P :/^$P
M\-_]!W3_ /P(7_&MNB@#$_X3#PW_ -!W3_\ P(7_ !K)U_Q3H-Q%8"'6+*0I
M?P.VV93A0W)//05V-% &)_PF'AO_ *#NG_\ @0O^-'_"8>&_^@[I_P#X$+_C
M6W10!B?\)AX;_P"@[I__ ($+_C1_PF'AO_H.Z?\ ^!"_XUMT4 <1/)X(GFOC
M_;EK'!J#;[VVCO%6*X;&"6'N  <$;@.<U!K$/@?6]1COKGQ(T4T<7DQBUU9H
M%1/0!& YP,_0>E=]10!YKJ5KX.?PI/HMCX@&Z:<3B=M5/F"4  ,SEMQ48''L
M/J-.>?PC<ZG]O?Q6Z2M"L4J0ZH8XY0O0E0W!]QBNWHH P(/%/A:UMX[>#6-,
MBAC4(B).H"J.  ,U4LM7\':?J&HWUOK-BL^HR+)<$W0(9E4*,#/' %=510!Q
M-I)X&LIK9HM9M##:2-+:6SW:F*W=LY*+G_:.,YVY.,5M_P#"8>&_^@[I_P#X
M$+_C6W10!B?\)AX;_P"@[I__ ($+_C1_PF'AO_H.Z?\ ^!"_XUMT4 8G_"8>
M&_\ H.Z?_P"!"_XUDZ+XIT&"[UEI=8LD$M^7C+3*-R^5&,CGD9!'X5V-% &)
M_P )AX;_ .@[I_\ X$+_ (T?\)AX;_Z#NG_^!"_XUMT4 <UJ>O\ A+5M/ELK
MO6[(PR8)\N[",""&!#*0000#D>E96GR>$;/4SJ%SXF@OKA)6DMVN+I"(2R!2
M0!@%L#&XC.#CN<]U10!QUY?>#[[7K+69?$-N+RR5UMRMXH5 X 8;>AS@=:2]
MU#PM>ZJNH?\ "6/!)Y0B:.WU/9&ZY)Y7. >>HP?>NRHH X#Q%/X3U/PK_8EG
MK5I;HK*83!?B+RV!)#,P.2,\GJ2??FK]WJ/A*\N+>[;Q%;17T,)@%U!=JDC1
MG&5/8@D ^QY&*["B@#A+]/ =_H]GI/\ ;<-M96;!X8[343#AAR"2K9)SSDGJ
M<]:71O\ A"M#NIKJU\2>9<21&+S;K5&G**2"=N]B!R!^0KNJ* .4LM7\(65Y
M->C7+*:]F4))<S72LY4=%'95[[5 &><9I;36/"5EJVH:E%X@MC/?^7YJO>AD
M&Q=HVJ3A>.N.M=510!QVG7W@_2]7U#5(/$-N;K4"K7)DO%8.57:IQT&!QQBK
M<NO>$Y]5MM2DURQ,]M')'$/M*[5#E=QQZ_*!GT)]:Z:B@#$_X3#PW_T'=/\
M_ A?\:/^$P\-_P#0=T__ ,"%_P :VZ* ,3_A,/#?_0=T_P#\"%_QJA>:[I.J
MZ[X=AT_4;6ZE2_=V2&4,0OV:<9..V2!^-=510 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9VMZO'HFG&Z:
MVN+J0L$BMK90TLSG^%02,G&3UZ GM6C6%XG\*67BJWMX[NYOK9[9S)!-9W#1
M/&Y&-P(ZG&>OJ?6@"QH&LSZW9R7$^CZAI9638(KY55VX!W *QXYQ^!K5KE/
MUQJZV^JZ3K-T;V?2KTVT=Z1@SQF-)%+?[0#@&NKH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ***JZA->PVI;3[2.ZN"0%CEF\I/J6VL0/H": +5%<A'XY\W2;.9
M;"*._N;F>U\B:Z"0QM"S+(QEVGY 5X(7)+#CTM:WXBU31M";5O[(M;B"WMC<
MW92_P%4<D1G9^\..1G:#Q0!TM%<[K7BR/2K_ $JSBM'N9+V6)9/GV?9XY'"*
M[<'DL<!>^&YXIM]K^KV&NV%C)H]J\%]=&"&6._)DV!2Q<Q^5@ *I)&[T&>:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>arvinassixthleaseamendme006.jpg
<TEXT>
begin 644 arvinassixthleaseamendme006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%S-!:7\T.E^,6O[V%H'\QK82%LX(^8CY6(]LG% '<6VO27OQ>BL;>^O?L?\
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M[ ,D9)P 1D]Z=XNOA<P>.=+-K-97*68$<%K;,S7P$/$KR;3N5?NCD8QSG.*
M/3[W7-/L)!'-,[.8O.VPPO*1'_>.P' ]SUP?2FS:_IL%K;7!FDD6YB\Z%8()
M)7=, [@B*6QR.<=QZUY]J;0W+:=J6E:]-H>MP:/$8I+F/%O>19?]TZ.!DAE)
M&.</D U!-J\FDZ]HVM^)]/OM.TV_T2&W8V9F5;.X5F8HRQG(!##&<],=C0!Z
MAIFJ6.LZ=#J&G7*7-K,,I(AX/.#]"#P0>15NL+PG:Z;;:,3I%A+9V,TSS1K+
MO#2;NLA#_,NXY.#VP>,UNT %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH Z*BN(\>^)+:/PAXB2RN+Y;BSMY%:YLU<"";9E5+KT.2N<=,\XK7L-;AL]
MTE9OM%S=RV,<OE0QF61@$7<QQVR>IZD^M '045B0^+=%N=%M=5M[OSK:ZD\F
M )&QDDDR1L"8W;A@Y&.,$G &:Y[PGJ<M]\2?%L/GWWD0PV>VVNBP\EB)"P53
MP >#QP>* .\HKA/&.IG2/'?A">2]NHK25KM9X(V=EEVPDJ/+7[S9/  )R16G
M!\0?#T^BW^J">Y6'3GV7L;VL@FMS_MQ[=P'OC'7T- '445F/KUBEOILY,Q34
M75+;;"Q+$J6&0!Q\H)R>P-4_&GB0>$_"E[K'V:2X>%,1HBDC<> 6/9<D9/\
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M%% !1110 4444 %%%% !1110 4444 %%%8GB6PL;RP+ZKJ<]CIT*EI3%=-;
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MN3=Z4L;SQ;5^8."5*G=@Y"GN*9:>+-/O](TW4;-)YQJ2EK2!% DD &3P2
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M8[O38TEEA:-=TBNVU3&-WSY)QQWXZD"HM:\6W6F^)?#VE1:3=N-2\UY"/+R
MD9.P#=][)4GG&!QG/ !U=%<_JWC"PTB&[N);>\FL[%PEY<P1ADMSP3NY#' (
M)VAL9YJ*X\<:7#JYTJ&"^N[S[(+R-+:W+"6,G *G@'/KTXZT =+17/VOC+2+
MOPY;:W$\WD7,GD10F/$S3;BGE[?[VX$>G!.<<USFEZB6^+^K&=;VSABT2.26
M&\ERJ'S3EEPS*!M ^Z<<'OF@#T.BN>C\8Z>=2TZSGM[RV&I@_8;B>,".X(&<
M#!)4D<@,%)KE_B9XBANOA[KYL(]0:.WS#]NM6V1K*K %<A@S 'Y20"N>O0X
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M"JKM50< L5+;1T! ZC%=A!*9K>.4QO&70-LD&&7(S@CU%244 %%%% !1110
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M7,<F-R\=#@FN+\10W,GQ6\)WL5C>26EE#=K<3QV[LD9D0!.0.<D=NG>N\HH
MX3Q]97D6LZ#K\.BOK5E8>?#>6,<8DD*2A,.B'[Q4H..O/XUE>)[4ZE\/M2.D
M>$[BP:\N+9H[9+()<3;)49G=4^Z, XW<\'U%>H44 <5XW2>]N_"4MK9W<R0:
MQ%=3&.W<^7$$<%F&,CEAQU]J-,6:W^)WB._EL[Q;2:RMHXIOLSE7:/?N ..<
M;A]>V:[6B@#C_A=:W5A\/-,LKVUGM;J#S%DBGC*,I,C,.O7@CI78444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]E(15A.&97^ZRD#(()]\4 >MUAV_BBVNIK806=Y);W,\EO#=*J&-W0/N_BW
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M@"<>XKH)([O2/B4^OM:7EQI.IZ:EN9(;=Y'MI48D!HP"P4ACSC@]<4 :,_Q
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M'I7?7UV+&QFNC#-/Y:EA%!&7=SV  [FN/M/"%GK/A&;^UFU-9]2B>:^B$TZ
M2.,L!%D9V] ,<A1UH Z+Q%XBL?#&A3ZQ?B=K2$ L8(S(>>G3@#W) KG-:^(3
M6GV1+'1=3?S]4M[+SIH!&CJY!W)N(W97('H>N._,2G7M3^!5[H5[I&I'6881
M9HAM7S.JN-C@X_NCG/<'/45U?CN*ZO\ 1] OK*QN[A;/6+2\FACA/FB-2=QV
M'G(STH OKJ&DS^/;6W>&_BUG^S7D57W+$L)=<@\[6;)'(SWYITWC?2X&M9'C
MN?L%U=BRAOP@,+2DE0.N[!8$;MNWWK*N(KJZ^*6GWOV&]BMCHLMN\QA;;'(\
MB,%+#(S@'O@>M4/ ]]K>C:+:>$;WPY??;[!O(6],0^QO&&RLOF9_N_PCDD=L
M\ %_0YEM/B7XU,]S(+:&VLI3YTS,L0*R%B-Q^4<9P.*V8O%]@VJV&GW%M>6C
M:BK-8RW$85+C R0,$E3CG#!37+7NBWVK^(_B!:1V]S FJZ;#;6MS)"RQNZQR
M*PW8Q@%A]>V:F\*3KJ#Z?;W7@)].U6SQ]HN[BRC6&-E&"T4@Y8MVV],\GCD
M]!D5VB=8WV.5(5L9P?7'>O.X;>VT[XHZ79Z3XDN)IVAG?5;.ZU S>8 HV$(Q
M^5]QSA0 %!X Z^@W4YMK2:<0RS&)&?RHAEWP,[5'<GH*XN_M8?&6J^'=0M=+
MOK.XT^\%S+<7EHUN\<85LQ?, 6W$KPN1@$YZ9 ,KQ_JWDZ_'#K/_  DVFZ#!
M&H&I:3(4B\QC\QE*_-M V@<=2WM7HFFQ0P:7:Q6]Q)<PK$H2>24R-(N.&+'[
MQ/7/>L74-<%W+J6BMX?U2:388E\RV_T>Y#+VEY4+S@Y(/7@UH^'=*.A>&M,T
MEI?-:SM8X#)_>*J!G]* "^UR"SOTT^*">\OWB,_V:W"[A&#C<2S*H&>!DY/.
M,X..>U_QK&_P[U?7-#$\DUO%-$1L"O:S*ISYBL1@J<9'/;J#3+FWO=#^)\VM
MR6MS<Z5J.GI;-);PM,UO+&Q(!106VL&/('7KBL6]T&_B\#^.IULKDW&O7$\E
MK9I$6DPR!%+*/NEL%CGH",X/% '3^%-&ME%OK<<5_:W,MFD,T4TN4G.%;S64
M$@OU^;.>3FEU/Q5<67CG3?#\6F7$L=Q;2SO,FSG:5 "Y8<#=DGZ8SS6UHCE]
M#L=T<L;+ BLDL91E(49!!&:YK7H+VW^)/A_58M/NKJT%G<VSO;IN\MV*%=W/
MR@[3R>* ,+0/$]OX8D\927D>J7=O;:U(7>-6G\B+RX_F9F/W1SQDG /'%=[=
M:[;PM#%;0SW]Q-#]H2&U"EC'Q\V695 .0!DY/;.#C@!9WS>%_B1;_P!FW_G:
ME<W+6:&UDS,'A5%*\=V!^E,N+:[TC5]%UN[\,76L:9-HT%A<01VGFSVDT9)#
M>6PS@[B#CTSZ9 /1-!UVP\1Z3'J6G2,T#EE(=2KHRG#*P/0@BN2^()FC\1>#
MEAO+R!+K5!!.D%U)&LB;2=I"D \BNI\.PQQ:7OAT>/28I7,B6BQ+&R@]W"\!
MCC)]. >17+_$)+J37?"4UMI]]=I8ZD+FX-O;M($CVD9R!SUZ#F@#O54(BJ,X
M48&3D_G7.3>-M,MY+%IHKI+&^G%M;:@47R))#D*,YW $@X8J%/8X(-/;7)-4
MNHM.L]-U*)9PXFNKBT>)(5VGNV,L3@ #W/:N*\(VTEII]CX9U7P&6U6Q*P_V
M@]E&UHZH<";S3U.T9P/F)].P!V%UXYTJT:Y=X[I[.UO5L;B\1%,44Q*C:?FW
M<%E!(4C)ZU;U'Q/:Z?+?(MK=W?V"(2W9ME5O)!!(R"P).!G !XKSGQ1%KNL:
M'XBMKG0]5EOXM31[5((L6YMUF0JZ8($C%023RP)["M/Q5ILU]J-_JVDVVM:3
MXDAA3[++;PL\5\-@*Q3  QG#$J=Q&.#D@< ';:GXA@TZ2XBCM+N^EMHA-<1V
MBJQB0YP3N89)VG"C)XZ5<TK5+/6]*MM3T^836ER@DBD QD'V['MBO/+R*\T/
MQI?7VL^%)M;LM7@MV$ME:K<&VF2,(Z%3R%.,@]/UQZ!HD MM'MXET^#3E +"
MTA556$$DA<+QGGG'&<T 4-4\666EW=Y:_9[J[FLK47=TMLJGR8CG!.YADG:Q
MP,GCITJ4^);*46 LHYKZ2_MC=P1P!0S0C;\YWE0!\ZC&<\].#CE/$QU>]U[7
M=-FTK49K*330NG-9KB.:0J^_SG!'()&%)QC/!)%9T.CQZEX6\+6NIZ=KNEW]
MCIB)!J5G#)YUM*JJK*P0$X;'1ASM/3(H ]+TZ^CU/3H+V%)4CF7<%E7:X]B.
MQK N?%5S%\0K?PXFF7#PM8O=/,NSD^8B@C+ [1EL]\D8%7O"!U@^%+ Z_C^T
M]A\X[0I;YCM) X#%=I([$FL;48+VT^+&G:HNGW5Q9RZ3)9>; FY8Y#,K_.<_
M*, \F@#1O/&NFV5O<WK0W<FFVLQ@N+^*,-%$P.UL\[B%/!*J0.>>#CH4=)8U
MDC971@&5E.00>A%>7:58ZGI7P[UKP5=:9>3W^+NWM)5@9H;E9BQ1S)C:O+\[
MB",5Z'H.G-H_A[3-,>3S6L[6*W+_ -XH@7/Z4 8=GXEGU7QKK7AU]-NX[:SA
M@'G*ZJ<R>82V0VX A5 QSUZ5S7P]\8VNF>!?#T&HIJ$GVJXDMC?-&7B65YG"
MJ[DYR>!D9'J16W9I=Z7\3_$%U-IUX]IJ%I:F*YBB+QCRA('!([_,,#DGTKD[
M?3=3C^#NA:6VE:@+^WU..66W^RON15N3(3TZ;3G].M 'HVK>*+72EO6^RWEV
ME@@DO&M45A N-WS989.WYL+D@8..1G4L;VVU*PM[ZSE6:VN(UEBD7HRD9!KS
MB:)]#\8ZW_:?@^YUS3]7E2ZM+JWLEG9"8U1HI V-@^48SQS^7HFEP?9M+MH?
MLD%GMC ^SP !(O\ 9&...G% &?JOB:VTO[7BTN[S[%&);O[*BMY"D9YRPR<#
M.U<G&#CD9IR>/=%6ZTZW@^UW;ZE;-<VAM[=F$J  X!]>1QV[XKF;V&30?'.M
MR:GX2N-<T[5WCGMKFUM$N&B<1K&T;AONCY00>G/UQ=>RN(/'GA*6/1WM;6UL
MKJ.5+6W)AMFDV%$RHV_PD$CC/IF@"?6?B)#!X#U+7],L;J2>TF:TD@F0(]M-
MN"_O 3T!93QG.1]1H:CJ>E2>)/#<.H6NHP:C-),;)#E44B-MWF%6V'Y0<#)/
M(X%<5?:1JE[X&^(%G!IEZ;F\UAKRUC>!D,T683E<@9/[MN.OYUT>NR7.I>+/
M!6H1:9J"P03W$D^ZV;,*O"R*7QG&21QU'?% &E#X\TRYU:73;:RU6>:"\6SF
M,=FQ6%F (9_[J<]3_+FI9O&NF6\MBTT5TEC?3BVMM0*+Y$DAR%&<[@"0<,5"
MGL<$&LOPI;7!\0>,UFM;NVCOKP26\TD#('3RE0E21V(/%8/A&VDM-/L?#.J^
M RVJV)6'^T'LHVM'5#@3>:>IVC.!\Q/IV /56 92#G!&.#BN!\ >=+XE\8B>
M\O9UM-4,%ND]U)(L:;0< ,Q'4FN^8A5).< 9X&:\W\)7D^C>(/%LU[I&KK%?
M:F9[9UL)6$B;0,\#CIWQ0!WNH:E!IL<1E#O)/((H(8QEY7()VJ/H"<G  !)(
M K%_X3O1X[35I;O[19S:2Z)=VTR#S4+X\O 4D,&R,$$BN>\5'5M7M]*\0P>'
MI[J#3-0=FTNXB FGMVC,;/L;^($DJ.N,&EOKF[/A?4=4\->#Y=.ED:%"KV$<
M=W*H<;V$?.2J_=W=\\8 R =3!XLL'N=3MKN.XL)]-@%U<QW*K\L)!.\%"P(^
M4]#GBI;7Q%!<3B.:TNK-6MFNUEN @1HP1D[E8X^\#@X.*X:UMKF'Q?KMZGAS
M5KBPO-"54%VI8SLID)1BS$@MD+M///0"H[3POJ/EZIH>A76IKX>O](GB$&J1
M.OV*=@%1(V<!BI!;(&0,=>10!VD?C&P.IZ?93V]Y:C4@38SSQ@1W! S@8)*D
MCD!@I-<M\3?$4-W\/->-A'J#109A^W6S;(UE5@I7(8,P!RI(!7/7H<2>$Y1>
MC3K*\\ O8:M9;1<7D]E&L,948+Q2=6)QQMZ9Y.!SSAM=:LOA#J_@B?0M4FU6
MW66**:&W9XKI6E+B17''\7(SGVH ]E@_X]XO]P?RKSJ[A2X^,MUIMUJ6H0Z>
M=#%WY2:E-"BR^<5+#:XQ\O;I7H5D[26,#O%)"Q09CDQN7CH<$UPDFG_;/C1/
M>W>DSS::=&6T6>:S9HC,)MV,D8Z'[W3WH S_  AX[?3/"^IWNO75W?:;;:O)
M96&H>47:>'<%1F8<$9/WCU]R*[.W\66URA":=J:7+7#P0VLUOY4LVT!BZAR!
MLP1\Q(';K@5E?$FTFG\'QV>GV,\\@O+9UAMH2V%256;@#@  U5\<6UW'K>@>
M(X=$EUJPM8YH+NR2 /*J2[")$C;J04&1UY^N #2E^(FAP:-<ZE,MY&+6[%E<
MP&#,D$I8##X.T#D<YP<\$U+_ ,)SIXU>;2FL-52^6'SX(6M"&N4SC,8SV/7=
MMQWKE_$UHVH^ KPZ3X5GT\W=Y:NEM'9!)Y DJ,SR*GW> < \\>X%;5TLS_%C
M3-06SO#9II,L+3_9GV*[NC*I..#A3].AYH -7\6>'M5^'^HZE?QZBNFH[6]W
M#'&Z7$3JV&5MI^4@XYSCGKS6]=:[;V=T+&&UNKNX2V%R\4 4LD1) 8[F&<E6
M  R3@UYO=Z=J4WPY\>6*:7J!NK_5KF:UB^RN&E1W4JPXZ8!Z]._:MOQ5ID&K
M7\-U%%K>FZI;Z>C66JV-O*226?,,BA3D A3M8#[QY% '6/XCMS%:FUM;J\GN
M;8726T"KY@B./F;<P4=<8)R3G&<&JMEXTTK4["PN=/$]T]\TB0VZ*%EW1_ZP
M,'("E>^3W&,YKC+J'6M+US2=>U_PR^LQW>D0VE]%9VRSR6MPC,VX)_=.\@XZ
M$?3.EJFBZ;J6FZ;!<^';[2(9)9;BVFTN$I<6$F%"LPB!PS@MG@C@ ],@ [?3
M-0CU2Q6ZCAFA!=XS',NUU9'*,",GNIJY7.^"5UI/#:1Z[*\URDTJQS21^7)+
M"'/ENZ_PL5P2.OKSFNBH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKG_&NOR>&_"US?VZJ]VS)!
M:JW0RR,$7/L"<GV!H Z#.**X_P 2+HVAZ%IMOJ]E=:A%)?VZ^:I^8W!=0LDA
MW _>P>_3&,<5:O/&26_B&[T*WT?4KO4+>V6Y"1*@61&) (9F '0_>Q[9H Z:
MBN<LO&NFZAH.EZI:QW#G4W,5K:[0)6D&[<I!.!MV-DDX&.O2L/Q9K4&O> /&
M-J]G=6MWIEK*LT4W&&\LLC*RG# ]?YB@#O\ K17+Z7XAM[)O#.AS6UQYVHV.
M^"8!3'^[C4L#\VX'D=N].3QOI[6FJ3R6]U =.ODL)(Y=@+RL4"A2&(P3(O)(
MQWQ0!TU%<QK.N6Q\.Z\-9T:^^RVEL?M4 *$RQ,A+%"&&1@'N#P:;%XIL-,'A
MG3XM-O$MM6B1+*0;/+CQ'N".2^0=H]#G'&: .IHK&N?$EK9R:B+B"=(;#RU>
M;"E7=\;8U .2QW+P0/O#UJ"Q\5V]SXD.@75G<65^;?[5"LK(RRQYP<,C$9!Z
M@_AD4 =!116!>>*HX9=12RT^[U :;@7;6VSY&V[BB[F&Y@I!('J!UXH WZ 0
M>AKSWQIXH^V>&M!N='CFNM/U;4;2-I8F11)$T@W1$,P(+8VD8QU!(KJM!T+3
M](%U<6%@]@;YQ--:[AM1\8X5254GOMZT 1ZKX9BUF]>2[U&^:QD1$ETX,GD2
M;6W D%=P.>N",CBMSVKF/'7B*\\-Z-;W%E9M<23WD-L6#*!&'<+G#$9)S@=L
M\DBN?O;M[/XOVEXFF7DES-X?E_T1"I<MY\?!.[8O Z[@/?.* /1Z*YO3_&FG
MZAH$.J+!<QO+<M9BS=5$WV@,5,?7;D;2<YQ@9S4^C>*+;5M7U#2'MYK34;$(
M\L$I5MR-]UU9201V]0>HH W:**\GL+NX\*_%:Z9YI/["UB\.GK$S$I;W*QI)
M'@=@^]A@=Z /6**\K^+^H7DUG#9V5S+!;VES;/=M$Y4NTD@5(\CMMWL1_N>M
M=M?>((-*U'^Q[/3I[FYBLS>-# %14B#;1RQ R2#@#TYQ0!O45R<OQ TQ+#0;
MV*TOYX-;8+;-%$"0Q4MM89SG@],U/I_C2QNDUK[?;7.E2Z-AKR.[V91&7<K@
MHS @@'H>V* .EHKS3Q%J#ZAXT\"3OI=Y:"6\=HY)F7#)Y+G!56.UN0<$?R(K
MH9_'EC S2FRNS8)J/]F/=@+M6;=L^Z3NVACMSCKVQS0!?TCPW'I&M:MJB7US
M/+JCI).DH3:&50HVX4$< #DFMNN3M?$]_/\ $/4=";395L[2UBD$H>/DNS?.
MWS9"_+@ 9/4D"G3>/+"#3H=7DM+H:'-,(EU+"^6,MM#E=VX(3P&QW!Q@YH Z
MJBN3U'QU%9:W>Z/!HFK7U[:0I.R6T2-OC9B-RY89 Q['TS5W2/%=OJUSK%M]
MAN[2?27"7"7/EJ3E=P(PYX(Y!.!0!OT53TG4!JVDVNH+;3VRW,8E6*<*'52,
MC(!(!QVS63X]16\ Z_(1\\.GSRQN#@HZQL0P/8@]Z .BHKS#0V\+7O@_0+>:
M=O[4OK6VB$D;OYOG,@);.>H.2<]<=ZZO4O&=EI'B%-'O[2ZMVDMI+F&YD\L0
MRK&,L%;=G<!V('KTH Z2BN9U+QI;Z1IVDWE_I6IP_P!I7"6\<1B5GC=\D!PK
M'G / R>W6H;#Q]87%YJMG?V-_I5WIML;R6"\C7<\ ZR+L+!AV^O% '645S=A
MXQ@O-2LK&73[RVEO[-KVT,FPB5!C(^5CM;# X/KUK+;XG6*Z5)JIT;51I]O=
MM:W=PT<8%N0^S+#?DC<?X<X'6@#N*.^*P=1\3Q65W?VUO8W-]+I]NMQ<I 4W
M*K!BH 9AN.%)_P#K\56N+[26^(6FVLVG7!U8V,KV]V?]6(LKO7[W)SM[?C0!
MT]%<M=>.;*UTZ;5A97<VC03&&6_B"E%VML9PN[<R!L@D#L2 1S3[OQG;P>(?
M[$MM,O[V\:R^VP_9U0I,FX*-K%@!UZM@<=>1D Z:BLGPYX@MO$VC1ZE:Q30@
MN\4D,X >)T8JRM@D9!'K6I)&DT;1RHKHPPRL,@B@!U%>!6ES8V_PRUB\35IX
M/$4&H3I8F&\<W#,),1H$W98$<8P1C->CKXYN-.^P:5J&BZE<Z[)I2WLL5K$A
M#L H=5RPY#$]<=,#)(! .VHKF+_QK!96-Y>)IM[/%81B2]">6&@R@<J0S#<R
MJP) SUZYXIK>.K%]4L["RL;Z^DO;#[?:O B;)H_EP 688/S#[V /6@#J:,UQ
M!^)=J-#N=5&AZLT-C,\.HJ$C!LV0X;=E\-CK\F[CDXJ_J&HZ,_C;PY#/8SRZ
MA/%<2:?>#B-%V R?Q<DC;U!ZT =116!:^*8KV6)K:QN9;.6[>S%TA0JKH65B
MPW;@N5(!QZ<8(-5-5\=V&DVDVH2VMS)I5O<?9Y[V/85C8/L)V[MQ4/\ *2!U
M!QF@#JJ*Y^Y\50Q3ZA':V5S>KIS(MTT#)\A90XP"P) 5@21^&2"!3UO4#X;\
M5:+,I(L=8N#8W$?\(G*EHI .Q.UE/KD>E '6444C$A20I8@=!WH 6BN.D^(E
MC%X9U#77TK4Q!IUTUI=0[8O-B=2%8D>9C )'?ISTYK:N]0BNKF+29+.X<7=H
M\SNK)LC48&&(;.26 &,YY]#0!KYS1GG%>6?#SQ;%I/@/PE:W>GWWV>\*VBW^
MU?*$SNVU3EMQR>-P7&>]=7;:CHH\>:O']BFM]3M["-[F\E($;P;FVX^8\ [C
MG H ZBBN9B\96TUSI2-I]]'::N2MG=E!M?Y=PW '<@8<@D?7%<=X;\20^$;#
MQ=.^F7]S96WB&Z:>6W"E;>/Y!D[F!;'HN2 .<<4 >KT4U'62-9$(96 (([@U
MR7Q17'PWUR=25FAMB\4BG#(P(Y!'(H Z^BO/=/\ ^$4N[70K.*4C4KKRS&\+
MN'$B)YI).>GR'.>N:VK_ ,<66F:]<Z1>V-[#-%:/=Q2,(]ERBG!$9WY9LG[I
M - '445Q_B/Q9J.ER>'$M]&N0=4O%BD5WB#QC:S;,;L;B%ZYP!GG-7M3\6Q:
M?'>O'I]U=_V?&)+U86C!ARN\KRPW,%(.!G@CGD4 =%17)MX_TZ2]TRULK*_O
MFU.S:\M'@C7;*HQQEF&#\P^]@#N:ELO'.FW/AZYU::&YM3:W364UI(H,PN P
M41@*2&)++C!QS0!T]%>=?:))OC5ISSZ?/92?V-.S>:ZLKC>F""K$9'(/]>M;
M<GCS3X'TR6:UN4T[4YUM[6^)0QL[9V$J&W!6QP2/KB@#JJ.HR*X7QKKT-_X0
M\46]I875Y#9VTT,]Q"RJL<HC)(&6!;9D%L=/<@BNA\(_\B7H7_8.M_\ T6M
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MFZ$DHTT/-IT6G&1BZVD87,:]@Q7@MQDXX&<9.,G2HHH **** "BBB@ HHHH
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M4,3D@_XXK$T>R\4:/\/O#6GC2KX+!>2+JMM;NBSF)G=EV-N QEES@@XXXYH
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MYT[5?%'AK0-$O-*N+*ZM+JVDOI)-OEH(>248$[MQ&!CINYQB@#<_X3>W\KQ
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M)).-HP.^>U<7X:T[6-"A;PS=>#XKR2&5UM=8*Q&!XF8E7DR=P8 _= )./QH
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MJ/G!5F<#''?!/8&N8TBPU?P_>W^AS^#TU1)+R::QU,>5Y>R1R^)BWS#:6.<
MD]ATSN:?:7UI\2=8U&6PN/L4FG6\$<Z(-KO&7+ #.1]X8H T;;QKIE[H.E:K
M:I/,=581VEJ% E=^=RD$X&W:Q)S@8/MGF=!U&&R^(_C:_OH)=/BM[&TEG\Y@
MP  D)8$$Y!'/'Y9K'TGP_P"(M'\/^"M372+B6ZT&>[6\T\,OF/%.6&Y.=K$
M@XSWJ_?Z!K'B;5O&(&EW5A;ZOI<$-M/<E !(F\X8!B1DD= <=\=* .NB\8VW
M]OV.CWMC=64VH1N]F\I0K+L&64[6)5@#G!_//%<A\2=>AUOX>W%U9V%U+8F[
MA2&^#*$)$ZJ6 W;MAPR@XYSTP<UK: VIZM$EI>^#5T2Z2)DNKQEBV[BI7]R5
M.223G/  SR>*YF;3O$R_"9_!K^&[R34K)X8DFB:/R)XTG5@ZL6!Y4="..^*
M/6[Z&.YL+B&5=T;QD,,D9&/:O+O OCBWT#X?^&8]1TS4EL)(U@?4_+'D)(S$
M#=\V[&>-V,9[UZIEIK4YC:-W3[CD94D=#@D?D:\OLO#VJZA\*K+P-<Z7<VMT
M/+@NIY=OE1QK*'9U8$[\@8 '.2,X% '<V'B>&_\ $^HZ!]AO+>ZL8TE9Y@@2
M5&R%9,,21P>PQT.#5S1M576M.6]CMIX(W=E03;<N 2-PVL1M.,CGD<UROCO2
M+Y]6T35-%G6WU.21M,D8]7MY5)8^YC*^8/\ =-=K:VT-E:0VMN@C@AC6.-!T
M50, ?D* .*B\0WFO:GXNT>[TN:*TL46%6$B8&8B^YB&W9;(P!G  SCFL[P)X
MMBTSP?X.L+K3KY8+Z&*UBORJ^49BI(3&[?S@\[<9[U?MK+5=.\5>,V;2;F6V
MU,12V]Q&R%6VP!"N-V=VX8Z8QSFL=-&UA/ O@/3SI-T;K2]1M9KR,!?W:1A@
MQSG!ZCIG- '3V^LZ%;>*O$\QL;BUO;"TAEO[J3[LD0#E2H#'H W8'FM;3==;
M4+J"%M.N8$GMC<Q3,R,C+E1C*L?F^8''3T)KFEL]2A\9^,-0&CRW%O=:;#':
MB4+LN7C63*'G@$L!S@'FF>$O#]QHOB<-HT>HV7AV6U9KC3[YB4@N-R[1%DD]
M-V<$KTY/8 [R:6."&2:5PD<:EG9C@*!R2:\Y\+:UJMK\0+BVUB1A;>)+8:CI
MR.,>24^4PX_O>7L8^X-=/XM6YO;2WTF*QN9[6]F6.]DAQB.#JX/(/S8V<<X8
MGM7.^//"D\=AI^J>'+6]NM;TV]CN+9&NY) RYPZ'S'(4%<Y^@% '7ZCKL%AJ
MEEI21/<:A>*[Q0H0,(F-S,2>!R!ZDGIUQS\OQ*T^'P[J>M/I6J"#3)S;7*E(
M]R2AMK+]_L2,GW!&:H^*KJZ;Q'X=U.QT34I+Z"WG>1;4Q&>)&VKL=&;:5)R<
M@]5X[UD:C;'4_ASXBT+2-"UF+5[F9;J:&_C1))WEEW&3(;9C]VPX(QM Q0!V
M\?BU&9HY=)U&WF>X\BUBG1$-U\F_>F6P%"@DEL8Z8SQ4=GXZTRXBU-9XI[:\
MTV>.WN+1]K.7DP(@I!(8/D8.?KBL[QOI^IW;:#K^F:4-1?397:?3)MJM+%(F
MUL9XW+@$?YS1UK2=5\1>%);C3?#L.EW,%S;W=K872QJ]RT3;BLFTE0"#@ GM
MSC/ !O#QQ:QZC?Z;=6%Y!?V=G]N$ ,;F:#."R%6P2#P02/QJG'\1[-K;1;R3
M2-4CT_5]B6]T8T*^8ZEEC*AB^3@C(7!/0GK4=C/>:EI5_*O@Y]'/V.2+9(D7
MG32L,!4VG[HYR6QGCC@UC'2-77P/X#L/[)NC=:7?V<MY& N8DB4ASG.#U&,9
MS0!UNG^,K2YN]6M+^SNM*GTR%;F=;LH1Y)!(D!1F&/E.>>*8OC6U35]/T^[L
M+NU;4D=K*20H1*5&XH0&)5B.0#].O%<_K7AS4==\5>*(EM9H+74M#6Q@NW V
M>:"YY&<X^8=O6K7A6?5)OLMMJ'@I-,O+0#[5>E8C&Q4=8MIW,6/L  3R> 0"
M4_$ZQ&E2:J=&U4:?!=M:W5PR1@6Y#[,L-^6&X_P[L#KCI5Q_$]^/B4/#JZ;,
M;1=/^TF57C^8M(%#G+ A5PPP.3GIP*X^XT+6YOA/XCT=='NO[0O-1FF@@.W+
M(\XD!SNP/E'<UU$MMJ4?Q2M=:BTNXFL;G1Q9M(&1?(<3%SO!((&T]L\\4 =I
M16?I-_=:A%<O=Z;-8-%</"B2LK&5%/$@QV-:% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5BOX8L9?
M$G]N2RWDLX"[('N6,",HP'$>=N[!//OGKS6U10 4444 %%%% !1110 4444
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MHHHH **** "BBD#J6*A@6'49Y% "T444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\=#QTSL:_P#$%-)U75M-L]/^UW.DZ>=1NA+,85,0Y(0[6W-CUP.>O7'GUQX
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M#Z5O5P=^/%>G>&!<^%?"NE6.I37*;[%F0;8L'<S,I52V<< G ]3P.[3<47>
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M@"QRJYR6([*:K^+M.UW^U]$\2Z%8I>7-BDL-QITLJQM+%+MSM8G:&4H#UP:
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MWMY48YP!U]J -.\\9M%9W.HV6DW%_IMK=?999;<[I&8.$=HXP#O56R"<CH<
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MF$NH13*%CG"LVP1GYBN%/S>XJQXNAUFX\*:C%X?D$>JM%BW8L%YR,X)X!(R
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MMLD,-T\J';*ZEE4J.<'!&[CITQ@U/:WGB;5M)O?M_AM=,86KQBW%U'*\\K#
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M[VVCN;6>*>"0;DEB<,K#U!'!%<5X>\0:Y?7/BUKZRM9X;"]>".&.Y/ 6)"$
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M%% !2.BR(R, 588(/<4M% #8XXX8EBB14C0;551@ >@%.HHH **** "BBB@
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MSC/?%<!<> M0A\+>*]+T:U>ULM66-;'39[@%;9N?,?()"ACCY03T[9X]2HH
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MU@FWABCQ[CEE'8EAT[#M4=QI?C+5H?"RWFDV,5QI%_'-<2_;?DF"QLA90%)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ J.XN(+2!Y[F:.&%!EY)&"JH]23P*DKEO'.DZWK&F6
MT&CQ:5<(DWFW-KJ88Q7"@?*A"^^&YXRH[9H W[+4K#4XVDL+VVNT0X9H)5D
M/H2#5JN3^'^H6-YHUU#;:%#H=Y:7+07UA#&JJDP Y&T ,"NTANX^E=90 444
M4 %%%% !6=+K^C6]T;6;5[".X!VF)[E X/I@G-:->*^+5!_:9\)\#_CR!_\
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MRKU;!? 'N3@?C0![917FME\2[V*3PG/J]G:I9^)MRP>06WVS978&).'!W+R
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MQ\ ?AWXER,_\2NY_]%M0!>B\2Z%/(L<.MZ;(['"JETA)/L :U*^9;77-(D^
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M"[FYWYW#D 8JWXK^(VJZ%%K]S%I<=O!I$L,<8OD9?[0WG#>4P('R]>C<<\4
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MQ]W *C<<\GIQFN:N_&NH:['X+O=$\J"UU2]>.>&<MO$B(^8V(_A#*?K@=!U
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MY)SG@#H: -^BL;PGKX\4>%=.UL0>1]KBWF+=NVG)!&>_(-;- !1110 4444
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M^K&_EE9I2]SE@<O(1DGY0 -O3O7MM07=Y:Z?:R75Y<Q6]O&,O+,X15'N3P*
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M,VNO*UO(&= "X()8;3MP#T&[Z]ZJGX9>(_[-\!VPETO?X;N3/.?M$F)OWJN
MO[OCA>_K7L%% '!?\(;J]I\7;CQ=9SV3V=Y9+:SQS,PDCP4R5 &&X0=2.OMS
MTGBS3KS6/"FJ:78"#S[VUDMPT\A15WJ5W$A2>,],5=35=/DU1]+2]MWOTC\U
M[99 9%3(&XKU R1U]:N4 >1P?"*YN_A/'X3U9[)=1LGDFL;R"1F"NS%N<J"
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MX)U^#P5X3T7_ (EK7&C:A#=3/]H<+(D;$X7]WG)W=QQCO7H\DL<,32RNL<:
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M#'3GK7>44 <M:Z%JME\0-3UF)K-M/U*W@27<[>;&T0885<8(.[J2,>AKEH_
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M(AF9G3;&$PP* <XSP:D\:Z%>Z]H]K'ISP"[M+ZWO8UN&*HYC<-M) )&?7!H
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M7:>F=OIW!X%I?%'B*\\5:QHNGZ/8-_9DMMOEENV >*4%B1\GWL=NG!Y/%5-
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M.,^X-7*\7\,>(?$?A?X4:5K4%EI]QHEH9/M,19_M+1F=@74_=&,]#G@9SVH
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M01MY(Q[9SVQSJR>&]5_X2W2M=@N;.-H=/:PNHG5G^4NK[HSQSE<<^O>NLHH
MS]+35D-[_:LUK*&N7-K]G0KM@XVA\]6ZY(XK0HHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDLL<$+S32)'$BEG
M=S@*!U))Z"GUY[XYEO-6\:>&_"\"Q/:2B6_NXYF*I,(\;%; .5W')7O@=* .
MWL-2M=3A\ZT=Y(N"LAB95<'H5) ##W&15NN9\,^);K5-6UG1-3M(K;4M)DC$
MA@<M%+'(I9'7(R. <CMZUTU !1110 4444 %8-[XT\/Z=JZZ3=W_ )6H,-RV
MQAD+N.>5 7YAP>1Z&MZO$_&LD\/[2'A:2VMQ<3#3_EB+A-W^O[GI0!ZQHWB/
M1O$"S'2=1M[LP-ME2-OFC/HRGD=#U':M2O$_AX8V^,?BF?59'TSQ#<HZ+I@4
M,@0[6WB3HYP%/0=2?I?\#>*_'OC:Q:YMYM(ABLM5\BY>2)@980%+*H&<$ GG
MON'(QR >NUEWGB/2-/UBTTF[O4AO[S_CWA96S+]#C!_.O,YOB5K=]H?BSQ)I
MSP16>AW:6]O:/%N%PH8!V=NH)!R-N,=\UG>-?$=C=^.?AIXCFD6VLI8&NW:0
M_P"K4A6(/TZ4 >XT5P<'C*6#P-JGC22\BOM-"/+8V\<81@H.U5D;^\6X/''N
M:I^&?%WB#4=4T!9[>YNK'6+ SW%Q'I\D<=C-MWJ Y7#(1\O).3SGG% 'I%%>
M1>#_ !7X^\917WV.?2(5T_51!-+-$P,L0ZJH&<'&3GOD8QBD\:>/_$WAZWUN
M[9;>REL+R-;*S95E%W;%@ID?!W+D]_E'(')H ]>HKSO4?&FJ77CGPOX<L@+&
MWU:Q-[-=; [_ '&81IN^7(V\D@]1TKG;7XJZW9?#_7O$.HBUN;BTOSIUFB6Y
MC1W'\9;<=PP<X 'W>O/ ![-17%>&]?UJ?Q9<:1>V]W<Z?]B2XAU*2P>W42Y
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M4 %%%% !1110 4444 %%%% !1110 445FZWKVG>'=/-]J<S0VX94WK&S\DX
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M$VFZG?I+!K=X;P-!"8WMY/EVX)8YP44]N]:4?AS4+Z\TFYUV^MKI]*+20B"
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MF2+M:0DD\[<@#MD\GC&W<V=K>H$NK:&= <A98PP!_&I8XHX8UCB14C4855&
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&944LQ"J!DDG
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M  ,<Y#-3UWQOI'AJ&2]$%M>?VU%9QRRQHQN;=Y %9@C%4;D@@?AB@#THLJD
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M;BUUV,1SVRVRH$8P>8'5ASG(Y[<\ 4 =MK&K6NA:3<ZG>^:+:VC,DACC9R%
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M1HW<(V=P(QMQCGC&<FD'B#Q3#I7@K5CJMM*-;>WMI[9[4!%:6$L),@AL@KG
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M-,N=0N_,^SV\9DD,<;.P4#).%!-+IM_#JNEVFHVV[R+N%)X]PP=K*&&1ZX-
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MII&L><\EHUJLAADD!#%'+#"G^[@^Q'6NMTBP;2M'L]/:X>X^S0K$)74*6"C
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MR.HRWHEN9;C=)&J;2[%B,#W/_P"JMR:)9X9(GSM=2IQZ$8H \O\ #6N7VF>
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MQ@G@8JAK'@C[?KR:[IVMWVD:DT*P7,MH$*W"#IN1@1D=CVKJFD1&16=59SA
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M;JC*00R]\>M=310!R>J> [35=$M[.?4;\7]O<"[BU19 +@38QOR!C&,#;C&
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MF.1,XX/<'L1U!]1639^%#&^F'4=3GU%=+.ZS$R*N&VE0[D#YV"D@'CJ3C/-
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MI3-<7$I!>5\ 9. !P      .E:%% &-?^'+?4/$6FZW)=W27&G+(L"1E-F)
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M,\><[9%9"IYYZ#'Y5T=8K>(XT\91>&VLYUEDLWNUN"5\ME5E4@8.<Y;N!^-
M!X<\,VGABUN;>SGNI4N+A[E_M$N\AW))QQ[_ %]2:K:IX/@U/Q';:\=5U*VO
M;6)H83 T05%;[PPR'.??-='10!S<_@RUOXKV/5-2U'45N[5K1A<2(!&C$%M@
M1% )(7G!^Z*@MO =G;ZAIFH-JVL3W>G1/#%++<*2Z-CY6 4 XVCH!G^+=73P
MSQ7"%X9%=0[(2ISAE)5A]001^%24 <BWP]TY_"]YX>;4-1-C=W!N)?GCW[B^
M\X.S@%N:M7G@RVN=>BURWU+4;'4A"()Y[9XQ]I0=!(I0J3[@ C\JZ2@D 9/
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M1*C$D,F1@E3C!& .^S867B4ZCHFJP:C$;&1!_:"SWS2K<JZC:T:[ J-DY 7
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M_-'GA=@W?)S\O'_U^:LP>%H;;6-7U2+4+Y;C541)^8RJA 53:-G& 3Z]><T
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M6T+9R"JXSP>0"2 >>O-,N/AQILHUB&WU'4[.QU?>UW96\J"$NXPSKE25)ZD
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M:Q+>7:7.F"00*A0(=Z[7W J<Y ]>.V*HMX#TF:WURWO);J\@UIQ)=QS,N-X
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MRG+$?9EQD]\#C/4XKM)O &GO#HQ@U#4;6\T>(06E] Z"818 V-E"K+@#JO\
M6A/ &GI8:Y:'4-29=;)-XS3*6.5"MCY<#('I],4 9EGJLUWKOAKPN)I;>U;0
MQ?S-$Y1IB-B*@8<@#+,<$$X';.<+7-=US3=$\?Z5'JMT)-#6&>RO1M,OERKN
M\MF(.=N"-WWL=Z[JX\'64\>D.MY>0WVDKLM;Z-D$H0C:5;*[64@#(*]O6FWO
M@K3]0T34]-GN;L_VHX>]N0R>;-@  $[<  *   , ?6@#!U*;4-$O=&T_^W+^
M>3Q%>HDDLI7%LB1EG6+ ^7=@#G.,Y'/-/TBR%A\9M4C6XN)D;1(&03R&0H/.
M<;0S9)&03R3U],5T&L^$K'7M%M=.OKB[+VDB2V]Y&X2>*1>CJP&,_ACVIFF^
M$(-/\0G79-3U&\OVM5M7>XD7:Z!B1E551GGM@>V<D@%?7Y9)/$ME9"^N6C>T
ME?\ LZQ8QS.VY0)6D##:BC(Y(!)[GBN6TSQ!XBO/AMX<U=X+W5 )I1J<=D^R
MYEB1I$5EQ@D@A"0I!/T)KM=2\*6FH^(K?7!>7UI>16YM7-K,$$T1;=L;@G&>
M<J0?>J>F>!+/1;&SM=-U35(%LY99(6\Y7P)"2R$,I!7)/;/?.0* +7@S4[/5
M_#RW=CJ4]_ TTH#W (EC^8GRW!YRH('/H#SG-<7K^M:E8P7&I6FJW5W-#KL<
M)GA;;:QQ-*J?9RA.'8 X+ '#9^8$8KT/1]&M=%MYXK8N[7$[W,\LF-TLKG+,
M< #TZ #BN<F^&>DS65Y9?VAJL=G<W?VU8$N $@EWAR4&WN1T;<!GC!YH U_&
ML]U:^"-;N[*ZEM;FWL9IHY8@N0RH6'4'T^M<B]UJNCZ%H5Z=;O+NY\02V5JP
MN)%6. M&S,8R%)4MC;DY.3GKS7=:IH\.K:#<:/-/<);W$!MY'1@9"A&TC<P/
M)'?K5"]\':9J?A*+PY?O<7%I$B)%*SA94*?<8,H&&&!SCZYYH PI;#QGIR:[
M]BNH'BGM VG6TUZTTT<X(#!7=1\I!XW$X;'8UEKXCBO?#GBV2SN]8T[4[#2V
MF.FW\C^=:RHDC>8K,3N5CM[D?*.!FNJM/!5O;Z7<6DVL:Q>33!5^VW-R'GC"
ML& 0XPO(!Z9/?.!BT/"ME+/>W%_-/?SWEG]AEDGV*?(^;* (JCDL23C- '.3
M:KJ"WGP[D%[./[17;=KN^6;_ $8ODCIG=SD5F7,9ENOBP!++$5BB<-$Y1LBT
M!ZCGM71VWP[L8#H[2ZMJ]RVD/NM#+<+\B[=H3Y5'&.,]3W)K0@\(64-YKEP]
MS=S_ -MJ%O(Y&3:0$V#;A01\O'7]: &^!+86_@70\2RR>986[_O'+;<Q+P,]
M![5T59F@:)%X>TB#38+JZN8H%"(]U(&8*  J\ #   Z?K6G0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !117*?$'6KG1= MC:RM UY?V]D]PO6%)' 9QZ'&0#V)% '5US%WXJNS<W
MZ:/H[:FFG7*6UV$G"2!F"L?+4C#[0RDY9>_I69?FY\/_ !#\.V5E<W<FGZQ'
M<0W5O-</*$:--ZR*6)*GJ#@X/'>H?AYIL$&N>+Y4>Z+1:U)&H>ZE<$>5']X%
MB&//4Y/O0!Z!17->+Y@B:5!_:%Q TU\H^RVH/FWH"L3$&#+L' 8MD#"X/6N$
MN]1U:+P+\08_M][;RZ9=O]E*W;/)"IC1M@D/S$98_3.!0![!17GACN=*\?>%
MHTU349H]8L[I;R.>Y9D8I&C*RKG"$$G[H%4[:^O=&N?$7A"XO[V;4KF59-)N
M)KF1Y&AF.T$$G/[HAB<8X&: /3Z*AM[<6UI';I)*PC0('D<NY]RQR2?<UY-!
MIVIZMX8\87I\3:S#=:5JE\+)DNV54$6"H8?Q#C&#P!T R<@'K]%>:1:E=>(;
M?3IIKR[EO)_#\=Q)I]K*UNMO(XR9WD5AC/15P2,$@=:SH]1U75/#7PVN9-7O
MHIM0G6&Z>*4KYR^4Y);'4_*.?7F@#U:2Z@BN8;9Y5$TP8QIW8+C)_#(_,5-7
MF/\ PC=MI_Q3T"S^VZI<A=*NF\ZXOY6D.)4(!8,.!G&.X SFGKJ-WX7USQ'H
M-S=WEU+?QK<Z*US=2.6\PB+R0Q.1LD*GCG:V3TH ]+HJKIUG_9^FV]H9YK@P
MQA#-/(7>0@<LQ)))/6N#TR6Y\7Z-XHOI-0O;6]M;^YM;7R+AXQ:B( )\H(!)
M/S'<#G=CI@4 >@2W4$$\$,LJK+<,4B4]7(4L<?@":R-!\1MK6J:W8O8M:OI=
MPL!+2!C)N0,#QTX([FO/K*=_%'B#X;:MJ/VB.ZOM.O&G\JXDB!*HF"H5AMSD
MGC&01G.!4DVGM=WGQ,N%O[^UDM91-";2X:'$BVJL&)7!;IT)Q[4 >M45YO9Z
M[J&NWWAO2Y6#_:_#Z:C*INWM?/E;:#\R*2<<G:,#YL]A5+6;7Q!HVAZ+9W/B
M*=KC_A);>W62WN&9EMY&!$<K,,N0#U8<C&10!ZK52?4(XS=10#S[JWB65H%8
M!L-NV\G@9VM^51:/I*:-8FU2\O;I3(T@>\G,SC<<[=QYP.U<9X<TZ"/XE^.I
M5>XW1FT90;F0J2T!)RI;#=>,YQVQ0!U?A77E\3^&+#6EMS;K>1^8(B^XJ,D=
M<#/2MBO$] CN-+^'WP_U>UU*_2>74+6T>(7#"%H9)&5D,8^4^N2,Y[]*U?&^
MH7<.E>+=2TW5+ZXN;"2,QS0S-##8%0A,0 ;$C'.6^7&&P3QB@#U>BN U"*YU
M#XJVVG/JFH16-QH<DTEO!<M&I82HN1CE3@]00??DU?\ AO=74_A^^MKJZFNC
M8ZI=V<4L[EY#&DA"[F/)..,F@#8UOQ%:Z))9VS1RW-_?.8[2S@ ,DI RQY(
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M% 'J%5=2O&T_3+J\2!IV@B:3RE8*6P,XR>*\VTO4+A?"EY8W6N7R"U\2R:=
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MK9W7VN.XN&=&:-4965#\J'DCY0*P[N?7;_0-3CBN=13Q7'K)BAC@ED">5YH
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MWR6]3\HY]>:WK"-E\<CP=+J&I2V%AI7VM3-=OYUP\DI&6D4AF"CY0,]^<X%
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M9?+&<*, !1R3P!R<]:H#P+I(T?2]*62\%GI<Z7%H@FYC=#E3G&3@D\'/7Z4
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M>M>J11F*%(R[R;1C<YY/UKG_ /A"=(5KR-/M$=C>RF>YL%EQ!*YY)*]0#CD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML]"LI;G2(6F+/>L@F V\#]V<$[AUXKH? 7C>R\>^'SJEI!);M'*89H)#DHX
M/![C!'/%>9Z%I\^J?'KQQ:0:C/8>9:%7E@52^T^4"!N! /OBK?Q-\'Z/X-^"
M=SIVE0L$CNXI?-E.Z1G+ %B?7''&.* /:-REBN1N')&>:171R=K*VTX.#G!K
MQ_Q/H$?A/X7ZIXFT5KH:W>:;;0W-T9V9BI*!V S\IP3TQ@=,8K/@!T7QG\,H
MM&B6,:AI2QWR1+@7$>P$LX'WB,LV3WH ]RK!O]6UJW\7Z9IMMHAGTFXB=KG4
M/- \A@#@;?P'UW>QKRJRTMO"GQ/\0^#X;,-8^)K<263",$0@D[_HJ@R''^PO
MK6CKMC:Z;^T%X)M[*"."%;"1 D:X&%24#\A0![!O0L5#+N'49Y%8>@ZMK6H:
MKK5OJFB'3[6TN!'93F4-]J3GYL=N@/\ P+'8UY+H)OO"_P 0=/L=>L(M0LM3
MU&2XTO7+<#S&=P1M=NI!#8*GIU&0!6=87E[HVG?&2?1]T4\%ZJ1>5QY2&:56
M*XZ84D\=,4 ?0ZNCE@K*2IP0#T-*SJBEG8*H[DX%>$0%]$UKX22:+&(IM1LP
ME]Y0Q]H1EC+%\?>QN=LGOS6+<:38W5]\7FFMD<6G[RW7^&-]TAW =,\=>V3Z
MF@#Z2KC-:\=M#XNA\):#8KJ.M.GFS^9+Y<-JF,[G8 G.". .X]:L?#*>6Y^&
MGA^6:1I)#9H"S')..!^@%>=>#DDT3]HWQ+;:I\DNHPRR6CO_ ,M%+JZA3W^4
M$?\  ".U 'IC:OKUCJVEV5_IEK+!?3-$UY:S-MB(C9\,C+GG;@')]\<9Z+>@
M<(67>1D+GG%1RW$$4L,4DB++,Q$2,<%R 2<?@":^;ENKF[^#WBGQ-?,R^(X]
M>4K='B:%@8@%5NJ@!F  Z4 ?2]0SW=M;6DEW//'';1*7>5F 55'4D^E>*:Y;
MC5_C'X!&J6X\V]TG?>1XV[V\N0E6QU&>"#VXZ5D^&X(F^%/Q*L&C5[6SNYS;
MQ,,K$0."H/3&!^5 'N^AZQ;>(-&MM5LMWV:Y4M$6&"5R0#CWQFK^Y=Q7(W 9
M(SS7S[K&FZ=;?LQV]U;V=M%=2I;R2RQQJ'=O-P&)')."1GZUT.O:!'X5^%FH
M>*=&:Z_MVZTFWAN+HS,QV$IO8#/RD GIC  QC% 'L"NKE@K*Q4X.#T-<?X+\
M;3^*=:\2:;/81VKZ+="V+I,7$OS.,\@8^Y[]:\]MR^A^)_A5_8L8B?4-.5+T
M1#'GH41F9\?>QN=LGO570=-N-8D^+NFVM\ME<76I)%',[%5W--* I(Z!ON_\
M"H ]\5T<91E8>H.:=7D/PV\1Q:;<>(+?Q+I<&A:KIMO +Z5%$<$D:EMC[1P&
M._J.&XQZ5ZM97MKJ5C#>V4Z3VTZ!XY8SE64]Q0!8HHHH Y:Y\37\'Q!M/#*V
M5LT5Q:-=_:3,P955MI7;MY/3O74UP-__ ,EUTC_L!S_^C17*SZ%I]UX8^)D\
M\3RR6-[=2VK/*Q\ETMT967)X;..>N.* /:**S]!FDN?#NF3S.7EEM(G=CU)*
M DUP.E6NE^,M,\4_V[<&'4+359XY+E7"36,<; Q&-B#L7:H.1P26/<T >G45
MY7XL6PU/_A,6MU-Y<6>D)YTM\1MLCY3NGDKC<';AB<C!"\DC%2W::Q>:7X=U
M:TL[/Q!Y.CQF\TJZ<"1_,53YL9((W_*1SV^M 'I^>,T5Y19:M8ZUJOA;2K=X
M8M&N-%9[.#5+<RK+*CJA1EW*"ZJI]>K8ZUVG@S1UT#3+O34U3[='%=R%%"%5
MM@P#>2N2?E7/'/&<=J .CK-\0:S#X>\/7^L7",\5G TQ1>K8' 'U/%<LK1:U
M\5-7TC6((Y[6UTV"2RMIU#(P=F\V3:>"<[5SV QW-<CJ,#R?"3QQ97BBYMM)
MO[F#39)QO:.-2N &//RDLN?;':@#T_2KCQ!)J++J,%BVGR6ZRQ3VY9720]8V
M4DYXYW#'TK:JEI5G:V.FP0V=M#;Q;0VR&,(N2.3@5Y;XY%I>:9XYO;(>?<60
M19+NZ<9M)412J6X W#J"3D?,QQGF@#U^BO-K[3[;5?B?H27@>:*YT.9IHS(V
MV3#1\$9QCGD=#WK.TGPPOB#P#XFT*V^1]/UJ\CTLL<^04<,B#/\ #G@CT)H
M]:JKJ1OUTRY.EK;M?",^0MR2(R_;<1SCZ5R'A/4[?QM>6.N?9%B73;7R&C*8
M\N[;'F)[; H _P"NAJY\3HED^&NODE@4LW=2K%>0..E '51&3R8_.V"7:-X0
MY7..<9[4^O--4TZVO?'7@:*<2-%<:;="5!*P5PL<> 0#TY.1WSSFL+[<?#OA
MKQ#9V\CVVD0>*TM9=C$"VM',1D"G^%?F(XZ;C0![117 >)+*S\+Z=KVM^'':
M#49=(=DL[;:(2$_Y;[ /O#<.>X%9FL6MOI_AWP?KWA]0FH27EG'YT?W[R.4
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M+'-'%Y$;L[.8H\YV)N)V+[+@52U7QE::5XTTCP[+&2VH(^9OX8GP?+4^[[9
M/]VNEH K2:?:2ZC#J#VZ-=P1O%%*1\RJQ!8#Z[1^54KKPSH][K<&LW%BLFI6
MX AN"S;HQSPO/ Y/'?)]:U@0>E&: ,6U\)Z'97D-U;V"K+ S/#EV98V;[S*I
M.U6.3D@9.:=I_A70]+GO9K/3HHY+[/VLY+>?G.=X).X\GD^I]:V,BC(SC/-
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M\ O$<D%K!%,UQ<H6CC"L56Z( R.P&,#M7N58,G@OPY);WL#:3!Y-])YMRBY
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M1QF=P%?#D-P<Y!'ZGU-9VG6"^,?"UYJ-WK%GI^J6E_,]Q>+:DW=D\<S$+O\
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M_P![:C58OM5HI^:Y3#?*%_CP<.5[A2>U=/86%MIEC%96<?E6T*A(X]Q(11T
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M&1Y<RDVP]R#)(WL8UKH_AA>WVNZ?#?:G$\=QI5O_ &20_4S(W[YO?(6'\0U
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MPWGJQSSDY-8<FD3:_P"&M:T "VNK^777D34VFC*@"8$L03ORJAH]NWM@<<T
M>QT$@ DG '4FHX((;6WCM[>)(H8U")&@PJ@= !V%<9\1[Q[6/P['+QI=QK,$
M5^3]TQG.T/\ [!8+G/';O0!V<-Q#<Q^9!-'*F<;HV##/U%"7$$CA$FC9R-VU
M6!.,XS^?%<)>:='#\6(H+.WC^Q7^CRG4[<*/+?:X$;LO3=R5SZ ^E1?"+0M+
MC\#:%K"647]I-:O$;K&7*&0_+GTX'':@#T2HOM5O]I^S^?%Y^,^5O&['KCK4
MM>*ZE<64^CZ7J>F&.*UD\5QLDMP^^ZED^T%7.>-B]0%.X[<9Q0![++<P0!C-
M/'&% +%W QGIG/K3RZ+MRZC<<+D]3[5YGI_AS0=<^)?C6"_L+:ZMV@L9%C<9
M0EHWRX'3=_M=1DX/)KF-+TZ.YT;X?0ZB#/#_ &O=6L$LA^:2U E"*3U*D <=
M",=J /9K^]8:-=W>G2V\DL43LC-\Z;E&<'!'\ZQ=%U?6-<\%:!JT4UA!=78@
MENO.1MA1OOJ@SPQS@9)KFK'2(-!\=^+;/1H5M](DT:.>>WB&(HKD[P,*.%)1
M<X%93P0O\+OAK,\:&6/4M,".1RN6&0#0!Z]-<P6^WSYHXMQVKO8+D^@S1/<P
M6J![B:.)2<!I'"C/XUY];3:5J_C+QKH_B-H?,V11PI<,%Q:-$,F,GI\Q8DCN
M1Z"E_P")-)XBT_3K%O.EM]!^6;4I-\*6A<*'V'!=VV<G*_+U/:@#M-4URPT?
M[&+R=$>\N$MX$R,NS'M[ <GV%.W7YUY<7%G_ &8UJ2(L'SS+N'S YQLVG'3.
M37CVG):WOP[^&+7*PSL-8AA8R ,0F)@%.>W X]A76O%%;?&&6;3((?-?PNS1
MB, *Y$X"].O0#Z8H [[[3!]H^S^='Y^-WE[ANQZXZTLEQ##N\V:--J[FW,!@
M>I]J\=98=0^ ::Q'G^W(3YXN@/\ 2%O1-@\]=Q;Y<>A Z5N6NB6&H_%K4H]3
MTZUF,FAVTL\+H&C:4R."Q4\$\=30!Z2K*ZAE(*D9!!R"*6N*^$S$_#72U+%A
M&]Q&N3G"K/(JC\  /PK9\97%_:>"M:N-+#?;HK*5H2GW@P4\CW'44 :Z7,$D
MSPI-&TJ??16!9?J.U<UJ>OWUSXEN/#NC7%G!>0V NS-<H9%9V<JD> PQ]TY/
M)Y&!7*:O;VO_  A/@K5O#Z(NH"[LQ:RQ#YY!)@2HQZD$;BV?0D]*UK33K _&
MO4V^QVQ9='@F!\I<B0S29?I][ISUH [>P:[;3[=M02%+PQJ9UA8E ^/F"D\X
MSTS5637+%=>71!<)_:#6S7/EY'RJ&51GZEN/7!K2K@)[6Q_X7@LD\%MDZ!Y@
M9T7[XN  V3_%T&>M &MX.\1W6L6>H-JKVD<]OJMQ81B(%%<1MM& Q))/)ZUT
ML]Q!;('N)HXD)QND8*,^G->(:CI=C+\,_'FI/;1/?6VMWKP7##+PD3@@H?X?
MPQFNKNKN"^^(^HZ5K%Y;0+)ID!L4NXE=)4._S=N[C.<9QR0!Z4 >D9R,BF2R
MI!$TLK!449))Z5B>#-/M=)\*V>GV6H3:A:V^^.*XF()90YX!'!4= ?0"M/4X
M(;G2[F*XBCEB,9)210RG R.#[T <UX;US7/$4.E:W;OIPT>\1WGMF5A- O/E
MD,"0QX&00/:NL@N(;E-\$T<J9QNC8,,_A7C%DT6G?";P,ZPQ16%Y?VD>JR*@
M >+<W^L/=2VT'/;CO76WNG);_%K3XK&WC%K?Z7.-4@5!Y;JA41LR]"<L5SZ9
M% '=)<02.$2:-G()"A@3@'!/Y\4D5S!.SK#-'(T9PX1@2I]#CI7BNCZ;:Z;\
M!T\0V-F!JT=K)&UW&"95@-P1( ?0(&^G/3FNSTK3-$N/$NDZYINN0/,]J\,4
M-C'&B30E<_.J\X4XQG&"0.] ';BY@:X:!9HS,HR8PPW ?3K1-<P6^WSYHXMQ
MVKO8+D^@S7D&DZ(WB/PGX<TMX[2YN+/5C<7.HM+&Z7,8D<NP&=[>8"!@K]>
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M =1Q0!W.J:[I^CP6LMW<(JW=Q%;P ,,R/(P48]1SD^P)J[+=6\$:R33Q1HQ
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M.U"2^M(9Y!'(^"J\Y*(1QM4Y'M@CM714 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444CNL:%W8*H
M&22< 4 1I;0QW$MPD2+-*%$C@<L%SC)[XR?SH@MH+576")(U=VD8(,99CEB?
M<DDTJ3PR2/''*CO&<.JL"5^H[4@N(&D$:S1ESG"AADXZ\>U %:#1M,M;ZXO8
M-/MHKNY&)YDB >7_ 'CU/XU47PEX=2UBM5T+3E@BE\Z.(6R!4D_O 8X;WZUJ
M)<P2S/#'-&\L?WT5P67ZCM2K/"^[;+&VT9.&!Q0!5BT;3(-1?48M/MDO77:]
MPL0$C+Z%NI%1V?A[1]/N?M%GIEK!+EF#1Q ;2WWB/3/?'6EO)+U[K3VL+JR6
MU,Q%R)06:1=IP(R#C=G'7M5QKJW2<0-/$)B,B,N-V.G2@"A=>&M#OM1.HW6D
MV<UZ8S$9WA4N4(QC/7H2/H:)/#>ARV=M9R:/8-:VKB2"$VZ;(F'=1C -2VYU
M#^VKT3SVC6/EQFWBC4B9#SN+G.""<8P.QJTES!).\"31M,G+1AP67ZCM0!+5
M*^T?3=4D@DO["VNG@;?"TT88QMZKGH?<58DNK>$,99XD"8W;G QGIGZTLUQ#
M;H'GFCB0G 9V"C/IS0!2.@Z0;V>\.F6GVJ=-DTWE+OD7T8]2/:HCX6T V,5B
M=%L/LD+^9'!]G78C>H7& ?>M565U#*P8'H0<U')<P0RI'+-&DDAPBLX!;Z#O
M0!4.A:2;_P"W_P!FVOVSR_*\_P H>9L_N[NN/:HT\-Z''I<VEII%BMA,<RVP
M@41N<YR5QC.>:J^*/$(T*/3HHS%]IU"^BLXC)RL>[)+D9&0 I[CG%6-'&N?9
M[M-5FL)7$I^R7%LC /$0"I=">&SD<'!QVH D_P"$?T;[1:W']E68FM%V6T@A
M7,*],(<?*/85&/#&@BVN;<:-8B"Z??/'Y"[96]6&/F/N:XRU\<>)IO#VOZV+
M+2YX=$O;BWEMU,D;RI#C<RL2P!QD@$'IUKM=+U^PU30+#65F6"VO84EC\]@I
M&X9P<]Z .5\0^%9Y]:A<>&-&UK1XK58+:TF80O:-DEBN5((;Y?3&WCOG;\)^
M&XM CNGAL+735NF5C96CEXHR 1G) RQSS@ < <XR>A:1$"EG4!B I)ZD]*A>
M^M(X%G>Z@6%CA9#( I/L: +%8[>%/#SPW$+:'IQBN9?.G0VR;97_ +S#')]S
M6LTB)&9'=50#)8G  ]<TD4T4\0EAE22,\AT8$'\10!3&AZ4+^*_&G6OVR%-D
M<_E#>B^@;J![5#!X9T*VUE]8@TBRCU*3.ZZ2!1(2>ISCJ>Y[UH+=6[YV3Q-A
M0YPX.%/0_3WH@N8+F+S()HY8\XW1L&'YB@"6J5QH^FW=_!?W%A;2WD'^IG>,
M%X_]UNH_"K"7-N\@C2>)I&3>%#@DKZX]/>N:\/>([N\UKQ)9ZI):1QZ;>1V\
M+H"@8-&'&=Q.3\V* -9?#>B(MVJZ39!;S_CY @7]]_O\?-^--NO"^@WNE1:7
M<Z/92V$1S%;M I2,_P"R,<?A6M7&:MXEUNY\1SZ/X7.@S3V:K]J2_NF23>1N
MPJ("<!2,D]SCL: -^X\-Z'=Z9!IMQI%C+8VY!AMW@4QQD=-JXP._YTU_"V@2
M)<H^BZ>R714SJ;=,2[1A=PQSCMFM2/?Y2>:5,FT;MO3/?'M3&N8$G6!IHUF<
M96,N Q'L.M %,Z!I!NK:Z.F6AN+5=L$ODKNB'HIZ@?2HO^$7T#[-<V_]C6'D
M7+^9/']G7;*W]YACYC[FJGB#Q"=-U71](MY(8[K5)I$$LHW+"B1L[,1D9)P
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M=#=<>U6UGA>5HDEC:10&9 P) /0D51TG7=/UL73:?<),EM.T#,K @LN-V/4
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M=<>U8>K^-(=*\<:/X?>',5\&66X/W8I6!,29Z9;8_'^[74NZ1H7D954=68X
MH R_^$8T$:6^F?V-8?8';>UM]G7RRV<YVXQG/>C4O"^@ZS';IJ6CV-TEL,0B
M:!6$8]!QP.!QTIVH^(=,TR2TBN+N+S;JY%K$@<$E^X_ <GT_$5*K7YU[_CXL
MSIAM<K$ ?/\ -W<MG.-FW Z=: ";1-*N+JVNIM.M9+BU&+>5HE+1#T4X^7\*
M2#0M(M6NF@TRTC-V"+DK"H\[/7?Q\WXU;%S ;@VXFC,X&XQ[QN ]<=:Y[P]K
MFH:AXJ\3Z5>BW\O2YH$@:%"I*R1[_FR3D\@=NE &II'A_1] BDCTC3+2Q25M
MT@MX@FX^^.M,T_PSH6E:A-?Z?I%E:W<V?,FA@56;/)Y [UH17,$TDD<4\<CQ
MG#JK@E3[CM536;C48+-5TFUBGO97")Y[%8H^"2[D G  Z#J2!QG( -"J,VC:
M9<ZC%J$]A;27L0VQW#Q R(/0-U%<SHOBW5(-9U;1O%5K:076GV8OUN;$L89;
M?)!.&Y!!4C'?G\8I/&FH6?A_2O%%Y!:C1K^2+S(D5O-MHI2!&Y?=AL97< HQ
MG@G'(!T8\+Z +2>T&C6'V:X?S)HOLZ[)&_O,,8)]S6E!!%:P)!!&L<48VHB#
M 4>@%/9U12SL%4=23@5&;FW !,\6&Z?..: (-2TK3]9LS::G96]Y;%@QBGC#
MKD=#@]ZJGPOH!\__ (DNG_Z1$L,W^CI^\C4853QRH ''3BKMY)*UI<QV4T"W
MHB;RC+RJOCY2P!SC.,UGMKUMIPT:SU.\MFU'4!L7R3A'=8R[NH)R$^4\^X'>
M@"8^'-%)M"=)LB;,8MCY*_N/]SCY?PK-TFTUR_U==1\06ME;?8_,CM(;:4R[
MMQ ,C$@8.T8 ']YL]@(M'\1W<_BSQ/IFI26D=KI9M?(D4%,B5"QW$L<GH.,5
MU5 !534=+L-7M?LNI65O=VY()BGC#J2.AP>*F:X@1]C31JY8+M+ ')Z#ZT?:
M8/M'V?SX_/QN\O>-V/7'6@"H="TEKV&];3;4W<"[(IS$-\:^@;J!4#>%?#[V
MMU:MHM@8+MM]Q']G7;*V<[F&.3GOUK2:ZMTG$#3Q"8@$1EQNQTZ42W5O#GS9
MXH\$*=[@8)Z#\: ,Y?"^@+YFW1=/7S(!;/BW0;HA_ >/N^W2E/AG0FBM8CI%
MB8[0YMU\A<0GU08^7\*TI9HK>)I9I$CC7J[L !^)H$L;1"574QD;@X/&/7-
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MV11*NY<@MM+ 'H<,.*V-0M](@\7PZ/9P01S66AE2+MLVUO:E\?+'U9CMP3D
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M% !1110 4444 %%%% !1110 4450UK58=$T:ZU&;E8$+*F<%VZ*H]R2 /<T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDV8IFWD;@1_"H^\>.00*[&3Q-HL5E!>-J5N8)PQA96W&0+]XJ!R0.^.E?/\
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M"WLX[R6\@6VEV^5+Y@VR9Z;3_%GMCK7,^"]>NM:USQ1%)J*7UI9W<<=J\:J
MJF,,1\O7!)'//%<M;2Z7X6\4>#@'FM_# LKJ&QFO&.U)W?(9F;IN3.W..&QZ
MUM>!+ZPN?&WCA;.Y@D#WL,JB)P=RF%06&.HSGF@"=/%G]D^._$-KKNLV\&E6
MUO:O;^?LB5&DWY&>K'Y1^5=5_;>E#['_ ,3*S_TW'V7]\O[_ #TV<_-^%<9
M=,B^+OB1M4-H@?2[4QFZVC<@\S?C=U'3/X9KE8;7^P_"?A>YN?\ 1=*C\6FX
MMS-\JP6CF41EL_=4Y!Y_O"@#UBZ\1Z-9PZA)-J5MC3EWW:K(&:$'.-RCD$X.
M!W[4GA[7[/Q'H5IJEI(A2>%)'0.&,190VUL=",UP,>I66H>,O'XL[F.<W&C0
M>1Y;9\W$<H)3^\.1R,BNI^'-]:7OP\T$6UQ%-Y&GV\4OEMN".(U!4^A'<=J
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M&2..W5V16.[!#' 8$MC)QC%:?AZX\+:SXG77=*U>;5+Y;$Q2W D&R*$L&"R
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP1]GBP>HV"B6TMIX!#+;Q21 Y".@*_E4U% #3&C1&(HIC(V[2.,>F*4
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M)$/574$?E3Z* (5M+985A6WB$2?=0(-J_04HMX%<.(8PPZ$*,BI:* (EMH$
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M>))6&&=4 )'N: /$I->TFZT7PI<VUS;6%I#XEC<Z:K9:T!DEW-,S$L&))/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBN7UC6+A_&FE>&;>X>U%Q;37DTZ!2Y5"%5%W @9+$DXSA>
M,9S0!U%%<KX5UN\N-=\0^'M0F^T7&D31;+DJ%:6&5-Z;@ !N'() &<#BNJH
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M[15;3]1L]6L(;[3[F.YM9ANCEC;*L/\ ]?%6: "BBB@ HHHH **** "BBB@
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M->VS^)/A@_VB(XMI]S;QQFV"C/IEN/KQ5>*XETOQ!$^@:I'J.G7FM-'=Z'=
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M7L;ZWU*SCN[23S+>091P" P]1GM[]Z\P\0W$NE:UJ^I>'=4CFG:[C74/#MV
MPNGPBAX?X@Q7;TR"5]L5ZO10!Y//J6C:5XK\3Z/XP>^@35+CSK5U><1W<+1)
M&8P(SRPVD8QDYJ\?L>@_$#PF/LTUC9'19K2VB?<[*VZ,K%GDEMHZ<]*]*HH
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MD96(^8<%B<G Y&.V1G,^TV<7A/X5@30JT5W:F0!@"F(&#Y]/F(!SW->O]**
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M*C&6!P<$>E7;O4(M#\5VVJZO!J;Z+J.DVT$=W9^=^XEC+DHZQG=SOSR#S^-
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MN!!*CQ(@VEPVT@.#DX'(P,C@U#=W"3_%K0+E$F$7]E7"%GA9=K,R%5;(^4D
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MWMW/=3"]NH_-G<LQ"S.!S[ "L/1KN,_%9+]7U.YM;C00BWMS;.BNPF+'JH"
M#V ^I/.M\+,KX0>)T>.1;^Z8I(A5@&F=E.#V((- '3W^LV6G3QV\S2/<R(SI
M!!$TLA48RVU02 ,@9Z9('6L^;QKX>@T2+6)-206$L@A64(QP^=NUAC*G/!!
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M/8$]!0!KT5A7'C+0+:ZM;9K\/-=P&XMUBB>3S8\ Y7:#NSD8 Y.>E4C\1O#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M FJ:2K9&R'[ACYZ-@(Q'J6- 'H5%9U_K5K87UM8%9)[ZY5WBMH0"[*N-S<D
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M3<43G:.!GH.GJ* /1**I:1JMGKFDVNJ:?+YMI<QB2-\8R#Z@]#VJ[0 4444
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M%=E110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !5+5=4M-&TZ2^O9"D*$#@99F8@*J@=220 /4U=K
MD_B'HVH:QX<A;2D$M[87L%_% 6VB8QMG9D\<CI[@4 :%OXHMY-;71KJSN['4
M)(3/!%<!/WZC[VQE9E)'<$@]^G-<?HT(\;:UXBCUC3;Z-K34Q':W*RQH]F(X
MXR$5E<LI)))V@@[N3Z;%Q:2^)O&7AO6(K.[M;;2$N)96NH6B8O(@01@'D]R2
M..!@G-+X'ANK;5O%)N;*ZMUO-5>YMVEB*B2,HBY![<J>#@T ;>N>([;0)].C
MNK:YD6_N5M(Y(@I59&^Z&)88SSS_ /6IEGXFM[S7]2T5;.[CNM/C264R! KJ
M^=I4[N0<'Z=\4SQGH;>(O"6H:="=MTT?F6SC@I,AW1G/;Y@*XV?PSX@N[_1=
M=\KRM0U>-[/6XU8_N;>10P ]"@3;_O-[T 3:SK$<_C?P)K,5M?K'=PWK+;'Y
MGD'E+L^0,5!.[.>.#R1VVKGQ;HVK^#==NKZQU&.ULO-M=1LV3;/'A<L/D;&-
MISD-CWIFOVEPWQ#\(7-O97#V=BMV)Y8XB4B\R-50<>X[=.^*PGL-1;1?B1"-
M-O?,U224V2^0W[X- (QCT^8=\>M '90ZY86ECI%K96US/)=6HDM;2,J9!"JK
M\S%F  &Y026Y)'4UQ_C#Q!9:[X?T+5;7[7#]F\1VUO/"^Y71UEPZ,JDACQVS
M[4LD.LZ#JGAGQ);Z/>W]LFCC3+^T@3]_"<JP8(2-WS+@^W-7O%IU76=&T68:
M/=QNNMVMT+8)NDB@C8%FDVD@-U. 3U Z@T =%H_BFVU?5[[2C97ME>VB)*T5
MW&JEXVR%==K'(R".<$=Q5W5-7@THVB2))+/=S>1;PQ[=TC[68C+$ 856/)[>
MN!7.VD%R?BU>ZA]CN5LI=(BMTN&B8(9%D=BN3[,.>G:K?C73K+5K"SLM1TRZ
MO+1[C+2V@8RVC!6*RKM^;(/'&?O=",T <_X_U)+WP_IMX8+VS>UUZUBDBD.&
MXE7.51B&!'3K[5TMCXRL+K4-2L;FUO=/GL+<74BWD87? <_O%VDY'RGK@CTK
MB;S3/$9\(VME=#4-4-OX@AFM)9829VLXW5MTO&=W#=<$C'%;&HQ:N/B%JNJ:
M9I\SLWAW[-:22Q$1O<K([JA)QZCDX';- &[IWC.RU"_TRU-G>VQU6V:ZL9)U
M3;.B@$XVL2#M93A@.#Z\5R&GPC^P/B;#YL^V*]N2C>>^Y<6Z$?-G/7WIFGVN
MK3^)O!>K2:#JYD@BN(M0GNMNX2/&HSC=\J!@V, #T%7;&SODTKXA1OIUXKZA
M<3R6:F!LS*T*HN/JP[X]: .K\$DMX"\.DDDG3+8DG_KDM<;9:ZOAOQWXY8:?
MJVI*KV;^59QF9HU\G<Q^9@ ,D\9SZ#BNT\'136_@O1+:XAE@N+>QAAECD4JR
MNJ!6'Y@\UA67VS0O'OBJ\N-,OIH-2%J]F]O#YBR&.+:RDC[AS_>P/>@#:MO%
MNFZAIFG7NF^;?#449[6&$ .X7[Y.X@+M/!R1S@=2*GT#Q'9^(H+IK9)H9K2X
M:VN;>=0)(9%Z@X)!]002#ZUYQ_PB6J^%+'PS?MHJZVEFMTFHZ?"JR,@GD$F8
M@W#%2 /?\>/0_#05[26YCT)=&AF<%+=HDCE8 ?>D"$@$]ADG YZX !-J&MP6
MNH1Z7%;W%Y?2PM-]GMBH98P<;R690HR<#G)/3H<<;\/-7@LO#NLW$ZW6)/$%
MS#!!(2TS,7 6/D_>[<G P23@$U<OH]2T#XG2ZW_9MW?Z7J-A':L]HGF/;R(Q
M(RO7:0QY'>N8_L'Q!-X>O[F/0)7N+3Q1-JR6-WL NX6+ J.2,X8D9XXXS0!Z
M!!XTTQKG5+6]CN-.NM,B6>XANE4MY3='4HS!@>G!SGC&:5/%ULNMQZ1>6%_9
M7DT#7%LDR(?M"K]X)L9OF']TX-<OJ&ES>+?"&KQ:3X6_L*>6!1%]MMXX99I%
M=7"84G"?)C+==WH.='PS>?;KB&X?P+)HL]JC&YGFM8Q@[2-L!3+/D]\ 8!'4
MB@!\?Q.TB32+'5_[/U5=,NIO(-VUNH2%O,*#?\V<$CJH.,C.#Q6MI_BVTOM?
MFT62ROK&[2W^U1_:XU19H=VTNN&)&"1D, 1GI7GZ:3JP^"EIHITF^_M)+Y7:
MW\D[@HN_-)STQLYZ^W6NCU;3[G4_B-#-';7:64NA3V377DL%221U(!R/0'Z=
M.M &NWC?3XI],\ZUO(K+5)1!97[JGDRNP)0<-N&X#@E0#61X[\007?@SQ/#9
MVM_<)9V\T,MU;,%2*8(3C.\,VTD;L @=^AQF^#X;NWM=.T'4? BQ:G8>7%)J
M36\1MF5,#S5DSN+D#( &<GG'.*<5IK>D>#_%WA2?1-0NI[C[;)975O&'CN$F
M#$9;/# DY!Y],T >C>&B3X5T<GD_8H?_ $ 5ES^.],@>1S;7C646H#39;Q43
MRTGW!<$;M^ Q"Y"XS^=:GAI)XO#&EQ7-M);3QVD4<D4F-RL% .<$CMZUYGK]
MKXBU?2-12]T'4I]2M]8CEB\O;Y MUG4J8EW?,2HY.-W7) P* .ZN_&MI;ZW?
M:-#IFJ7=_:0K.T5O #O5B1\I9@.QY.!Z9-:NA:U9^(M#M-7L"YMKI-Z;UPPY
M((([$$$'Z5S6GK=I\3=5U2?3KR*TFTN")9#"6!D1G9E^7.2 PZ<'L34_PQL[
MO3O 5A8W]I-:W4#S>9%,FTC=*[#V/##I0!KWGB&*#4)["ULKO4+NVB6:>*U"
M9B5L[<EV49.TX )/'TK,G^(6AQ:1I6J1_:[BUU.Y6UA:& DK(21M<'!!!!&.
M3QP#5*TM[[PW\0M?OKBSNKG3-92"6*>VB:4Q21IL,;*N2,C!!QCWKGI/#6IZ
M9HFB+]@N9)Y/%(UBX@A3?]FA+N<$CC(!7(&><XS0!TLOB#2-2UGPV=0T?6+6
M_ENIULEN8C%Y;JC!B^&P05!Q][J#6CJ'C33]/759!;7=S!I.!?36ZJ5A. Q'
M+ MA2"=H. ?7BJ'BNWNKCQ=X/N;>SN9H+2ZEEN)(XB1&K1,@)_$].M<OJ;/%
MK7BVQCT;Q ^FZI*(KEM-MH[A)#Y2B1E8L"C$':1@XQG@] #J[[7-#O\ 4_"L
MMU9WYGNYW?3GVLBHVQN7^8 @KG YZ@XHNOB'80/K"1Z5J]R^D,!=K#;K\J[=
MV_YF'&.?4]@:R]09-3N_ UWH^G7IT^QNG,JFW8&V18WBVN#R"&X(Y/!IL%I>
MK>?$-VT^\"ZB!]C/D-^^Q;B/CC^]ZX]>E '3R>++$OID5E#<7T^I6QN[:* *
M"T("G>2[* /F4=<\_6N4\<:S:>(_AA!K6GO<)&U[;A0Q,;*1<K&ZLH.#@AAW
M'I4>FC7+2S\(:=<Z1J;Z7%I"P7,=JH2072JB[9"2I$> >AP3UR*RDT?68_@\
M-#;0[U+Z+5-XA5 =R"[\TE<'[H7N<9[9H ]BKAOBSA/ [7&^1&AO+4@H[#@S
MH#D#KP3P<UO?\)$1XI@T9M,O5BGM_.BO63$3-U*>H8 9Y%9_Q&TR]U;P9<6V
MGVSW-PL]O,(D(#,J3([8R0,X4\4 26/CBRO=>DT5].U.SO\ R3/;QW< B^U(
M.IC);]&VD>E-'CW2V\+6?B(6UZ;"YG%N/D7?&QD\H;ANZ;AVS4$MG+XC\;:#
MK,=K<6UGI$5PQ>YA:)Y))5"! K8.  23C'3&><<2=.UV+X9IX87P]J,E]8ZF
MLCN$41R)]K\P-&Q/S94_08.2.,@'>6_BB]G^(5[X?_LN<6UK:QR^<'CY+LPW
MGYLA?EP ,GKD=*V=;UJTT'3C>WGF%/,2)$C7+.[L%51T&22.I KG(+?4+7XJ
M75^VEW36=_ID$2SKM*Q.CN65SG@@,.F<]JT/&\VL0: CZ-;S3R?:H?M"VZ@S
M"#</,,8/&_'3TZ]J )(-<M==;6=(>WN[2[L8U%Q#*P5@LBDHRM&Q&#@]#GCF
MO.5+R?!7P9<-++YHOK++"1ANW3@'=S\WXUT'A^TO-/\ &7B:\_L/48+&^LK8
MPR2XD9BBR AOF+%R6'')]<5E+I.JI\(O#&E'2[TW]G>VK3P"$[D6.4,Q],8_
M.@#UNN8G\=:9;6*ZG);W?]CF;R3J85# #NV;C\V_9NXW;<=^G-=%,@NK22,,
MR"6,KNQ@KD=>>AKR^UTC5S\*9_ =QIEP-41&LHYO+)MWC+_+,)/N@!3D@G=D
M8Q0!K^*M3GF\>:#HDFE7%YILT-S++"#$4NBJH%.&<9"[SPV.<$ X!KI;>TM?
M"'AEXK6*]N;6S1Y%B#^;+MR6*J6(R #P,] !S7/7UC<6WQ"\+/%:7DUEIUC<
M6\URL+,JEU0)DCKG8<XSBNZH Y<>.=/-IH%TMG>M!KC*EI(!'@,P)"O\_!(!
M/?TZ\5C_ !-U!+SP)XJM(XKN-["!6,ZN%0L<$*"K9/!!((QR/:L:7P)J\FA:
MWI"@QP:1<R7/AUE/)D++,O\ WR<Q@^C/6SXFTO4[KX2ZI;&RDEUK4XC++!"I
M8B5R#LSZ* %R>RB@#;TWQ;:3:S;:))97]M/-;&:VFGB"QW"IC=LYW9&0<,!Q
M570]>\.VNG^(M2MHKJTAM]3D6^-P&+/<80'8I)/.5  QST%5;^&ZN?'G@Z^B
ML;PVMK:W27$I@8")I$0*#QZJ?IWKGI?#^MW_ (;\716=E-%?OX@_M2Q2X0HM
MPB-&RC)]=AX..V<4 =I-XAM=2NK[P_<V=_8WIL&NE24JN^+.TLKQN<$'@C(/
M/I7,^ ?%]MI_@WPE8WEIJ&V^C2V2^,8\DS')"$D[LG!Y (SWZUT=CXAU'6["
MXED\.ZEIL4=NPD6[C'F/(1@)&JDEAU^8@=L=\<?#I>IQ?#SP+8-I=[]KTW4[
M2:[B$#9B2-B78]B,$=,Y[=Z /4KVX>TL9[B.WDN'B0L(8RH9\=@6('YFN5\.
M^-OMW@S3];U2SF@DO65((UV,9W=CM2,!L^V6V]"3QDUULRF6VD1>KH0,\=17
MDMCHFOIX$\),NCW:7OAJ\CDGM)"H:X0;E?R^>2 V1G&><4 >B6/B>SN]7N=(
MN(;BPU"WA%P8+K:"\1./,5E9E*YX/.0>M9LGQ TR.TTZ]^Q:BUEJ4ODV5PD2
MLLSG.T!0VX;L$C(&<56;3SK?CF#Q"UM-#IUEIDMN3<QF%IGD8$KM;!"JH.2<
M#+#&<&N-T2\AM=#T*'6="\31Z9I,PO8/]"62*$C<4+2JQ9T0,<':"< GTH ]
M'U7Q=:Z5!?7 L;V[M]/&;V6V5"(/E#'(9@20I#$*#@&LX^,I;KQKIVDV.GS7
M.G7>FM?+<Q/'^\4M&%898$* QSW.1@'%8/V6YT#Q7K<-]X-EUZRU2Z-W9WEO
M!%*5+*H:.0N1L *\'..:U);'4=.^(.AZBND-):_V.]C(+)1Y<$AD1L<D83 .
M#[=.U &+X;\46WA2R\6375IJ=U:6_B"Y\V:%?-%O'\@!9F8$@>@W$#M7H%[K
ML5O.+:UM+G4+KR1<&&UV96,D@,2[*.2" ,Y.#Z&O/7TS4I/ GC^Q&EWOVK4M
M1NY;.,P-F5) H1AZ9P>N,=ZFOK2\TGQ-:ZW/X7N-;TN]TR"UFBCMUDN+2:,M
MCY'Q\I#'./3Z9 .B_P"%D:&]CH]Y!'?3Q:M*T, B@R5D7.489X;*D8Y_+FNA
MTC4O[6TN&^^Q7ED9<_Z/>1^7*F"1\RY..F1ST(KB-7L[MKKPA-;Z!):16^IM
M=36UK "+>(HZ@OL^4M\P)"Y[]<9/HM &%!XHM[N6'[/97DMK-=/:+=H$,>]2
MRMGYMP&Y&&2O7ZC/$^'O$L'A5/&4UQ9ZG>6UMKLS2R0KYOD1>7'\S,[#('/
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M^ZTFT[0?;.*\VL+;5IO$G@S5Y=!U@R6\5Q'J$USMW"1XU&=N[Y4#!L  #T%
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M&3CIG'.,UJ4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZQHSNP55&2Q. !7G'AGQ!J<?Q!EAU61OL'B.U^W:4K9 B$?R^7C^\8]CGWH
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M3+-88R(X4)Y=R223DDL3DDDDDGDDT ><WD?B.SO/'U[H^FW)N;R6U>S9H?\
M6HD:)*4W<;@ V >O'!JUHMC>)\2CJ46B:G!876C+!]HNV#-Y@E9B9"6)S@@
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M?#_Q -,\(S:9)>6P@@@:U2.XF?N65"0JCMN/KTXSU&LZ,/$_@*?2V62&2XM
M(_,4JT4J@%"1V(< _A71T4 >62^'/$UX=!\1%#!KEZIL]516_P!3;2H!QZ%"
M@?']YFK?\9V,S7OA*.PL9Y(+#5(YY?(B++#"L;KGCTW#@<UVE% 'F6MZ+=OK
MMSJ_A^VU/2_$0O$1O+1C::A$& W2_P & F>20V1P#D4U;2ZT#Q3K=O?^#)==
MM-2NS=V=Y;P12;2X :.0N1L (X)[&O3Z* *'V%IO#YL'6*W=[7R2MN,)&2N/
ME'H.U>?^#X+RUM-/T#4? JQZG8;(GU-K>(VS(F )1)G<6(&0 ,Y/..<>GT4
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M.Y?^T9)M@P[1,O[M=V%C!/8 8QU.:Z#2[>[M_$WCNZEL+M8;TPM:MY+?OMD
M1MO_  +UZ]>E=Y10!S'P[M;FP\ :-8WEO+;W5M;K%+%*NTJP_G]173T44 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5POQ?AB?X;W\LD89H9K9D.,E3Y\8./P)'XUW5<Q\0M'OM>\
M#ZAIVG1"6[D,+QQEPN[9*CD9/ .%/6@!MGXU27Q/%H6HZ1?Z9/=1O+927.PI
M<JO+8VL=K <[3SCKBJ\WQ$TV!M.N'@?^S-0N%MH+Q94/S-G8S)G<$;'!]QD"
MDO=*N?%7B/1K^>QN-/L],CG<_:"HDDDE3RPH"DX"@L2<\G&,\UD^$;;Q+I%E
M:>&;WPQ S66(4U@21F%X5/#[?O[]O&W'7J0* /2*Y_2_%,>I:IK6G/92VMQI
M)7SA.Z88,I964@GY2!U.*Z"N*\2>%[Z\\8Z?J6G[5MKR!M/U<$_>MP=ZG'KP
MR9])/:@#13Q5).VFV]OI-R;V_M6O%@D94$<:[?OMR QW+@<^^*Y;QGJ]CXJ^
M&VE:Y;0NJ2:E:F,3* \;"X5&'&>X(K=\0PZU)XNL%&F2ZCX?-JZO!%,B*MQN
M&&E#,-R;<\<\Y."<5R<'AOQ'%\)['0#H4HOK74UE,:3Q8,:W1E+ E@,;3@=\
M]A0!VTM]IA^)%M8R:7+_ &J--DDBOFV[?)WJ&08.?O$=0.GO7(?$W7(]=^&.
MJW-IILEQIRRK'%>[E^\LH4NJ]=F05W=3Z8YKH[O3M1N?B=9:F-/N!IZZ3+:2
M7&^,;)'=6 QNW<!3R!UKCI-#\4P?">^\"GP_/<7=O^ZM[R*:(03Q^<'5N6#
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M-C($GM)L_P )W \C'8C(Y]LB71_$[V'@87]M-?WNG7OGW\ZR1Y5-CJ,Y8;F
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M;@-D?(!(SCTZ_6LSQ#X6U?4M(\<7]MILIO=>6""VM-Z!PD2[0[DL%&26.,Y
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M$L7R)$^6(._!XZ8-;%[8:C_PGVK:LVG3)ITF@_9%N"\>/,5W<C ;=C#=<=:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-^)$\0"_B>RGL;S3[@V]S;3,K%6P&!!4D$$$4 ;E%9%]KJV^KQZ1:6[7>HO
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MN]F@>X W!$5$(!RY[DL !^>*I67C;3]1T'2=2M89WDU60Q6MH0!(SKNW@\X
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M\+Q:M97E]+=V=^)HU6,2L6*2AOF 4D\@'(Z"K!M?$?A;QMJ6H6>COK6GZQ%
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M!1ZDF@#EM(T3^U;G4=3US3+FVO+BX*HCSCY8%^6,#RW(Z98YZ,[5D>$-.O\
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MZI)9H,)93:A*\"KV786Y7_9.1[4 4-,MM0B^('B#6#IEPUA>65LEM,&C_>%
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M:Q6S1R2(Y8H@4L-I(P2..<^PKH$=9$5T8,C#*LIR"/44,RHI9F"J!DDG  H
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M3>'?#@M;K:+F>XFNID0Y5&D<MM![X! _"NCHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*\0Z[
M;^'M,%[<;</-' N]]B!G8*"S<[5&<D^@[UJUD>)+>:[TK[.FEPZG#)(JW%I*
M5 DB_BQNXR.",]QU'6@"I=>*'TO3;R[U6P\DPSQP6Z02^:+II-NS82%ZLVWG
MI@GI1'XGEM_$UIH6KV*6EQ?1/)9RPS^;'*4Y=,E5(8 YQ@@COVKC7^'6I'0-
M4LM,>6RMXK^WO]&L;R?S! \7+*2"V$8YP 3CK73/I=_XA\3Z#J]_ISZ='I"S
M2>7+*CM)+(H3"["1M W')P2<<=: -KQ#K=OX=T6;4[D#RXVC3YFVJ"[J@+-_
M"N6&3V&37)?$"XGU+X<>)XM0TV!%@LA+!*DOG1R9!(925&",>G_U^M\0Q7$^
MBS0V^GPZB79%DM)BH66,L-X^;C.W=C/?%<!+X'U*U\,>+-+T:SN(-/U*!([#
M3;BY1OL\A!\Q@=Q"H<KP"3P>!0!TFE^*KB+6M(T.]TB2UCO[1GLKDS*QD,:J
M6#(/N<'(Y/X&D;QS)#+IDMSI$EO9:EJ)TZ!I)2LX?<RJ[1%1A25/.XG!!QS4
M5WI6JW'BKP=J"Z<ZV^F0W"71:6/*F2-4&!NYP5Y]O7I7-GPSXNN-/TIKS2+6
MXU:QUJ.\N;Y[Q=UW&KL1MXRJ@,/E.,8X!H WM)M;<?%WQ1&((MDVFVAE78,.
M2T@)([YJ3X2(L?PXL$10JK<70 '0#[1)5FPTW5+?XB:QK$M@WV.YL8((W25"
M2\98GC(.#NP,_CBI/AYI6H:'X0@TW4[;R+F*:=R!(K@AY7<8(/HP% $FJ>*[
MBQ\5P>'[;1IKJXN+1[F*3SD1&VE00<YP/FY)_ &JUEX]MY_#SW]S8RV]ZFHG
M2C8B0.6NM^P(K< CG.>.,GM3[[3-1?XEZ;K$=DSV%OI\UL\@D0'>[*PPI.<#
M;^M<PW@O7;G1]09+=+?48/$S:[8)+*I24;LA&*D[21D'MG'/6@#KT\3W$7B'
M^P+_ $^*WU&>V:XLBMR7AN OWEW[ 58<$C:>#GFJ_P .];U7Q#X4BU+5(H%>
M:68JT<I;I,XVX*C 4  <G(':@:3>:YXQT?7KVQDT^/2K>=8XI9$=Y)90JD_(
MS#:%4]\DGH,<I\/=*U70/#:Z/J=K%%]EFF\N5)@_G!I7<, !\HPPZ\]>!0!J
M:GK5U:ZK#IUEIQN)7MY+EIII#% BJ0,%PK?,2W3'0$UQ?B_Q7/KGP9DUS2[<
MPQ7J)'*))MKQ@S+&RC (;/S#J.#GVK>U[3]<G\96-Q'80ZEHBVC(;:6<1K#<
M;\B5U(.\;< <$CD@5S \)^)5^#)\*G38CJ(F^39<KM*BX\W<2<8R. !D^N*
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M<IME47/G%N<;1MX ZY["@#L;+Q5<R^*Y=!OM'DLYC9F]MF\]9/.C#!2"!PK
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M%*/$C+L*X/))'/0#\JV/"^K7VLZ(MUJ6GK87BR212P)*)5#*Q4X8<$<?GD4
M4;K5+5/B'9Z8VC(U\VGS2P:@Y4$(&4,@ZL 21GI^-0> ]<U?7K?5)]3@MXQ%
MJ-Q;KY4Q;;Y;;-H!4<<9W9Y/84^]TO49?B9IFKQV9:PM[":VDE\Q 0SLK A<
MYP-O/UIO@G2M5T1]9L[ZUB2VEU*YNX+A9@QE65]P^7'& 3G/X9H S/'/^C>/
M/!%[!8_:;L3W2*L>U7<?9VPNXXP,G//3FKME\0H5BUJ/7=-ETJ^TA4>>W,JR
MB1'X1D<8!R>.V"1FK/BO2M1N->\-ZQ86HNUTJXE>:W614D=9(BF5W84D9S@D
M5D:SX)O_ !*OB+4)&&GWU_;P06,;,&,(A?S%,A7(RS]AG  ZF@#3L?'45QXF
MCT.:WMVGN+=Y[:2RO%N$<K]Z-CA=CXY'4'UK+M/&]EI7@3^W+'PVUO;'4'MW
MM871=CF?RRYP.26.< &MO0+_ ,77I3^W-$M]-$"'S##=+,;I\8&P?P+WY.>@
M]37)'PKX@/PUET/^S#]N;5OM87SX]OE_:?.Z[NN.,>M '7Z=XIGN/%<^@:AI
M+V$PM/ML#F=9!)%OV'=C[K D<9/7K69)\1,:+IFMPZ0\^F:G=BTMF2X E+,Q
M5&92 %5BO][C(SWQ8GLKZ/XDQ>(9K0Q:7%HSVLLTDL8V,9%D)(W?= 4@GU]N
M:X[2(M7L-$L9[OP;-<Z1:3-J4*V^IP^3%DLX=(W"O@!B0C'CTST /7@^(1)(
M/+^7<P8CY?7)KB&^)EBLFESB*WDT[4;A8(I8KM7GCW_<=X<?*I]=Q(R,@'BN
MSD2.^L61MPCGB(/&#AA^AYKA_"=OXUT6RM?#-WIUFUG98ACUA;D?- OW1Y.,
M[]O'/'?G'(!=G\=36NO7^AW&D;-2A2-[*'[1G[<KMMS&=O 7^+/3G/ )JSK'
MBVZTK7M.T5-$FNKR_MY)8_*G4)N0#*Y/8;AR0..@)XK*\2Z!KFM,^N6D#VVN
M:9< Z1&94V&/@.'PV") 2".P"X[YAUN\OO\ A9'@NX?3)/M)LK[S;594++Q'
MG#$A3S[CCWXH DD^)WV?PUKNH76@W$.HZ'*L=[IYG0[-WW6#]"I'<#/M6M-X
MPGLCMU/2AI[W%P(;#[3=HJSKL+EV(SY8 !R#DYP!DFN=\0>#M7U30O&=Q#9@
M:EXA:".*V,J#R8XE"J7;.,GYB<$]0.>M;?BW2]<OH]$US1((QJVE3-+]BN9
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M "D90Z,C#*L,$>U+10!DZ!X9T?PO9M::/9+;0NVYOG9V8^[,23CL,\5K444
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MH.F>(;1+75+1;B)'$B?,5:-QT964AE/N"*CTKP[INC.9+6.=I2NWS;FYDN'
M] TC,0.!P..*U:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*L_#N
MFV&M7FL6\<RWUZ%%Q(UQ(P<*,+\I;:, G&!WK5HH **** "LBU\+Z-9:_=:[
M!8JNI77^MG+LQ/ ' )PO '0#-:]% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 52U;5
MK+1-/>]OYO*A4A1@%F=B<*JJ.68G@ <FKM>>>+(+C5?BIX4TUKJ2VM8;>YO4
M9%4EIE 4$!@1E0V1D'&: .XL+FXNX?-GLI+0-@K'*ZE\?[07('YFK=<?X1U3
M5F\2>)/#VJ7)O?[+D@>WO&C5'DCE4L%<* NY<8R ,UV% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MXX[>/.=K%06<[W/( Y [9J+3-*UV+Q7<ZIJ4>G3I*6BBE2=]]O;]51$*8R2
M6.[D^P '4T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
2444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>arvinassixthleaseamendme007.jpg
<TEXT>
begin 644 arvinassixthleaseamendme007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&1WP,@>E8WA.[T'4M+T30-3TO5&\0Z6\*M83M<;()8L+YP.?+50,L/K@#D9
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MT,@># R=Z%=RC'.2.G->9Z7I.H>%!X,U2^MI8=)M[N_:>':?]"6X)\DN!]T
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MA#J6BV]UK-Q8W$EV#!!"?^/HX(\MQ@_+W[=.M9_@6XOM:T]O$6J6QMKR[C2
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M5%B;3K4;R?E8IYFX9Z$C(S]: .@T75=+M/"6GW2ZS<:A:2 )#>7 +S7))('
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MR%9E7!P2#A6(P-V>>E*4DN=)^*-E;Q7\\UQ'YT)FMW#RK]G49Y4<DYP./84
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MJW6%X3M=-MM%)TBPEL[&:9YHUEWAI-W5R'^9=QR<'M@\9K=H **** "BBB@
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MWU[:SW<L4+7.]YI93(V4 8 X!#8SC '/3-;FG:I!JB3M LR-!*894FC*,K@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.OE_(#@\Y./0U2D\::A8W.HP:EHL*/9PPN/LMZ9@\LTGEQ1',:X+'ZX&#WH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
(@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>arvinassixthleaseamendme008.jpg
<TEXT>
begin 644 arvinassixthleaseamendme008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH #R"*:B[4"Y)QQD]Z=10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P!3DN=4*:E>>?;Z<DL%II;#%O)M9F>5F&T@D#:">0#Q0!Z/D>HI<UYC-?\
MB#4[OP6(-<FM1K.G.]PL<,957$ ;>N1G.6Z$XX'%=]I]C<V^C0V=Y?275PD0
MC>ZVA&<XQNP. : ,/4_&LMI)>&PT&_U2WLIQ;W,EIM+"0@'"IU8#(!],]\&M
M_2;^34M*M;V:SFLI)HP[6\XP\9/\)]Z\_P##>G7%OIOB^XMM6OX9X=1O%1RR
MN-P .XJ5P6X[U"=6\07'@[P'?PZU+%<:C<6\%UNB1A+O5F+'C/\ #T! YYH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(!
M@GGK0 M%%% !1110 4444 %%%% !11FB@ HHHH **** "BBB@ HHHH ****
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M( ZG:3M7!_N@5D:3;Z_XG\.V_B6WU:RLKL3M/)=274V8@KG="R?=V #&/QH
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M>@']IW3NG_(-/_H$E=SXNTK7;O2XX?"^H6^F79NDEFE=.'7^(< \_=^N,9H
MZBBFIG8NXY..3ZTZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK3[M"]M<Q-#*H)&588(R.G!K&3P9IHCAMY)[^>Q@96CLY[EGB4KRN<\L 0"
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MYXK5\1:#%XCT:;2KBYN8;:==DOD%0SKZ9(./PK6HH YBY\&I=0Z5')J^H_\
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M-],I>)$MR5D4=6#=,#OFI=+\4Z9JVI76FQ-+#J%J TMK<1F.0*>A /4>XR*
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MJB1WR<L26SEB>230!SD#2?#?7_LD@/\ PB>I3'[/(?NZ=,W\!/:-CT]#2R:
MVO\ P]\+16FJG3=5@AAN+"<#=\XBY!'<%2<UVUYI,&JZ))I>JA;R*:/RYMR
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M":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^)<[#&E^&[9#VDNI9"/^^5 - CM^**XI])^(%V/WOB;2K+/46FFER/H9'/\
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MZ=>*L:5I0L(V>:8W-W)S+<,H!<_3M5FTLK>Q@6&VB"(HZ=2?J>IJQ0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(2!UH 6BN
M?U[QMX<\-(3JFK6T,@&?)#;I3]$'/Z5Q.N?$W6S9K=:9HIT_3I<+#>:DI\V=
MCT$4 .YB>,'IZT >D:OJ]CH6ESZCJ-PL%I"NYY&[?3U/M7CK^,&\7:W'=2:=
M>:ND)#66A6B[HXV_AEN9/NYXR%Y S6QX>^'>J^(UBU3X@:A>7NYO,BTIY0(H
M\]"X7 +>PQCOFO3K#3;'2[=;>PM(;:%1@1PH%'Z4 <(/#/B_Q6RR>)-8_LFP
M;[VE:8>67T>7J?<#BNPT7PWI'AZV$&EV$-N@&,JN6/U8\FM6B@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXF,O]@PQ.>\$CQ#\E8"NSHH XR+X5>#XGW+IT^<YYOISC_Q^K"_#3P:LA=M
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M'IH\7PD<Z/KH_P"X9+_A71<=.*S=$FU:>UG;6+6WMYQ.ZQK!)O!B!^4D^I%
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MK&VUB8G3!Z_Q 5H8'I1@9H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;Q7D$DXZQI(I8?@#FN*C\+>-;E[BZE\;7%I<M,_EPQVD3PJF\[.",G*X]\T
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M[>+=IJ>OW_\ :&HIDQ+&GEP6X(P0B=S_ +3$GZ5TE%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444'VH 1G5%+,P
M4#DDG&*X>^^)VEM<2V'A^UNO$&HI_P L=/0LBG./FDQM ]^:B@\+ZCXKDN_^
M$S,P@CN2(K""7;;R(I.U\K\QR",@GJ*[2QTZRTNV6VL+2&V@7[L<*!5'X"@#
MAQ8_$/Q*2+^]M?#-F3_JK$>?<,/0N?E7Z@5RWB#PCI7A3XB^#+J;S]1AOIY;
M:[GU%_/:20J!&6SQU;C  XKVNO(;J"]\??%>Z2"^-G9^%60(#%O$DCYW]QCA
M2 >V!0!V?B7QYH'A",6T\HDO @\FPM5W2MGA0%'W1]<5Q6H:SXS\5WDNEVJ)
M9.,":RLY-S0*PZW$^,+_ -<T&X^HJ*^\.Q:YHFMZ)X)TVWMK*-&2?49/GEO)
MT.X1(Y.<9 !8GC.!7>>$+:W\->!;$7UK!I316RO>*6 "R8^=F;/))[DT <QX
M4T;2=#^("Z(FCVLU];:<+B34DCV"-BP4(B'.."#N+$^]=KXG\1V_AK2Q<.AF
MNIG$-I:H?GN)C]U!_4]A7DD'B:YL/'#>+!;RWMK=2W=C!9VB;IY &4HY7N&(
MZ]@!7HWAW1=4U#4D\2^)X8HM0$1CM;)#O2S0G).>[G@$CMQ0!6\!:QKFI:KX
MBMM;F222SN8T5(E 2)F0,R*>I R!DY_6NVFD$,3R,"0H).!DXKA/AK(AO/&*
MR'%T=?N&=".0F%"?@0#BN^.,<T >9Z5<ZU\3K5M0759-%\/,[)%#8R#[5-M.
M,O)SY?\ N@9K=E/@KP?*]S>W=A#>'&^>\G$EPY X^9B6/'85A^+?AQ!EM4\*
M/=Z7J+3*;H:?<&+S8S]["Y"[N0>V<5Q<^JP^$[^:QU$^'M1BE1A-J=C GV^-
M3P3(A88;D],GV- ';V/Q/\&Q:E>WLVKRXN"HB9[28(L:C&%.W&"<G(]:[2Q\
M1:1JFE2:G8ZC;7%E&"SS1R J@ R<^G'K7#Z;KEQH/BRST:YU>UFT'^Q#>J3;
M"%8(U*JO.3D8]:XWQE?>&]7\6:;:^&(+^22_+)JD&G6S1BZMP<]& !R0?G]#
MUH M>+;:Z\3^#->\<:DC+$D031+=AQ%#YB_O\=G;U["O5]3\16^A>&$U2]=,
M^4FU6D5/,<@84%B!DGWKS[QJOC?5O &KI+I>G:1I<=J2+17,]RRH0<?+A%&!
M[XQ6)<)I<*>!_$DMSJFMZ097DN[J7?,T<B)B-!&!A1OSV_AZF@#VG1KZ[O\
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M2>O%>56)GL[SP5?V@F$-Y>>7)?SRD7%^CH[9D09&WH1EB1QP* /925'4BAB
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#/+U#1YGW/HD\FSRB>IB<G ^A]>]:T7Q+L;2$?\ "0:1J^C3#[PGLWDC_"1
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPQB0!F^K=3^-:M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP7'C"_%[= IHT1_=ID_Z6P(Y_P"N8Q_P+KTP*[15"J   !V%"(L:!% 55&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]Z-<UF(I<G(M;1B"+1/PX+D<D]LX%:,GA_2YM:75Y;59+Y(Q&DKDMM .> >
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M3T*:,]'2UD8'\1+4WD^*_P#G]T;_ ,!)?_CE9#-VBL+R?%?_ #^Z-_X"2_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M64R+'YKK# \ICCY^=M@.U>#R?0^E$WB?1H?[++7\175'$=FRY83,1D8('\Z
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M*00>012T %%%% !1110 4444 %%%% !1110!Q/Q:NH+?X9ZTDTT<;S0;(PS
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_$NBIJ"V#:E;BZ:3RA&7ZO\ W,]-W^SUHO\ Q)HVEW'D7VHV]O( &8.^-@/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ JKJ-_!IFGW%[<OMA@C,CG'8#/YU:KFM;MCK>O6.F2(WV&V*WMP>TC
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MV:;$-S'J3ZGWIEQX;\07$T$K^*<O"^]6_L^/(XP13E5YI2;V8DCJZ;(BNI#
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M;_L=E;V^_&[R8E3=CIG YIL&DZ;:WDMY;V%K#=3?ZR:.%5=_JP&30!S&C7,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% "'/:EHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BB@T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %9">*=#DU(:>FI0&Y,AB"YX+CJ@;H6']W.:UCRIKPS39
M<3Z9X)U&=$T^+5VFL]67=B[,<A?RP>TF]BI.<=<9- 'NE%(.E+0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>arvinassixthleaseamendme009.jpg
<TEXT>
begin 644 arvinassixthleaseamendme009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** $(!ZTM%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)@>@I:*
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M1P-2_MEYT1[::[>)8RO5454.?7)5OPQ4OAAI$L)K&5V=[&=[<%FR2H.4R?\
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MWVXK&N_"6K7U^M]<7VCR3A-A8Z9)\P[;AY^&Q[^M:8LO%2@ :QI6!_U#)/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M -KQ!X?:VTC7-2_M/4M\5F[6J)?3(L&R+@X#?,=P)).:K>%]!DU'PUX:U?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %(!BEHH **** ,F_LM:GNV>RUB*U@(&(VM!(0>YSN%5O[,\
M2?\ 0PV__@N'_P 76_10!SYTWQ+V\0VV??3A_P#%TATWQ3GCQ%9X_P"P;_\
M;*Z&B@#FSIGB[/'B2PQ_V"O_ +;2?V9XO_Z&6P_\%1_^.UTM% ',?V7XQ_Z&
M?3O_  4'_P"/4'2_&6./%&G9_P"P0?\ X]73T4 <N-+\9X_Y&C3?_!.?_CU'
M]E^-.?\ BI],_P#!.?\ X]7444 8&GV/BB&^CDO]=L+JU&=\,6FF)FXXPQE;
M'//2M^BB@ HHHH *#THHH R[#1A;:E<ZG<SM<WLPV!R-JQQ DA%'8<Y)ZD\^
M@&I110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%)D9QWH 6B@G%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCM7TF!%DDMI%7>KN[+G&,@,.*A\$Z5%K7PXO]%U"VGA$\]VKI/"T;!9)79&
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MI6]T8IV (0RIM4_2-5R/K5_6KFVD^(,=MIEW;)>2^'KF* )(N=Y9#&/ZCVH
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M*P.!@)N4CZ]:ZC3+31X]<O;ZQUV74KJYTYEF\GR?)"*?E9_+4 -R0,]0#Z4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(!-9W^&@NH&W'.<Y!W!N1QTS74>&/$^CRZ5H.G@I8W=W8)-;Z>[$N(PO8GJ
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M[2SM))Y%D94&2(XV=C^"@FO'="72(M,'AG7=#U*XU^V<J+/?.8KDARRR@@[
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MI]0N);A@/F!$7[TG)ZGCICWH ZO4]=T_2)((KR9Q-<;O)ABB:623 R<*H)(
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MKNL:%W8*JC))Z 4+(CDA6!*]0#TKD=<OSXBT?1+2U1XTUJ2*22.4 ,MN )9
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MR"P9L9&=H./P- '3T$X&:YV_\86=JTBVMI=:D8;=;F4V>PB.-@2IRS+DD D
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ME<8-0MX5\//%#$VAZ:8X/]2IM8\1\Y^48XY]*UZ*  # Q1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% %>_^T_V==?8MOVOR7\G?TWX.W/MG%>46VD^('N/#&IR^%[Y]2L[S=J,\
M]Q&SRL8V4E/FP(\G/\('& :]?HH \RM].UA-#\<P/HEZ)=4NII;1/W9\P21J
M@_BP.1DYQQ2V=MKVAZWI>N)H5W=02:1#IMW:QF/SH)(V)# %L%3D]#[UZ910
M!R'@6TU2S?7O[2TR2S%UJDMW$7D1PRL% ^Z3_=[TV[BOQ\3+74%TRZ>RBTV2
MV:X4+M\QG1P,9SC"GG'6NQHH \?N='UNY\ ^+M*CT&^%WJ>JRW5M&VP;DDD5
MP2=V!PIR#R.*W/%-BFM7<,MYX=U='CM4>RU&P.V>"5BV8V ;(QA3SE>3G%>B
M44 <;X6T_77U&&_\0_-=VFG1V@8  /(V'E88X[1KD<95L5CQQ:H^F^/8_P"Q
M=15M2>1[0-&H,@:%8ACGCYAGGMS7I5% 'DB:/JNF?V#K$OA:3588](BTR]L'
M2,S0O&<B1 QPPR6'!Z8-:.M6VJFPT:2/PW)"(]9BOC9V42$PPH,'>0=I<YSA
M?ISC->E44 -5MT88 C(S@C!%<)HUQ>V_CWQ)?RZ+J:6EW' (93!PYB1@W?(S
MD8]:[VB@#RW1_#FJ:E\'+GPT]G/8ZBGF-&MT@"L3,94&>001@'TS6CH,5YJC
M"WD\%1:'*J/'>73Q1#)*%?W)7ELGG/ QZYKT&B@#ROPUI^IV%K:^'[GP1:C4
M+/;'_:[11FW>-2,29^\7Q_#USU(YQVGC7^V!X4O3H41EOP%VJH!8KN&[:#QN
MV[L9[XKH** /)UT"ZO==N%MO#VI6=IJNB36+7-S(KR*[-G=+ER>_ R3[5L^%
M-1\3+8:=H-WX<FMI]/$<%Q?2LGD-&G&Z/!RQ91CIQGGTKOZ* .)\(0ZCIOB?
MQ+:76EW*0W>HR7D5WA?*9&1 !G.=V5/&.*C\5+JK^++&)]+O[[0I+8ADL6"L
M;C?P)&RI";??!/7.*[JB@#QF&QU>T\"Z?I3>'-126TUY;DI'&''E+<&0E<'H
M%('(&3TSS6OKVFWVM^.]46"QOHK>^\.-IL=VT#"-9F=GY/888<^O%>GX%&*
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M);PV+&=UCE1W>5$!V\ @ \G\<5ZQ@48% &3>Z[]EDTL1Z??7*:A*(P\4!_<
MC.Z0'!4?49K6'(I<44 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD*I!(]>I[U2UO2+CQ7JVA7*:!<:;?6-]'<S7TWE@I&O+1JRL2^[@>G>O1**
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MRZC<7%Q;SIM$3I)&H').=P(QC%:-E'J'_":^&;J71[Z*&VTA[:=S&&6.1MF
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HSS15/4]/_ +3LGM?M
M5S;!\?O;63RY!@YX;M0!<R/6DR#T-<J?!L<> ?$WB$=AG4/_ *U.'@L=1XD\
M1?\ @?\ _6H -,=+WXB:[.>?L%M;V:>Q8-*WYAD_*L^U1=5^,%_= [HM&TZ.
MV'/"RS,7./\ @*C/UKCYWM/"GBCQ-;ZOKFN0,_E7=D(9P)+T% FT?+\[!E Q
M72^$? M]#HINM3UG5K;4[^1KJ[2WN%4!VZ _+R0N!^% '6:X9KM%TRTG\J6X
M!#R*1NC3N0/SQ7+6=G;2?%&UT^SMPEGX>TUFX' GG(YSU)**Q)/)R:YK6?/\
M)^-M5DNKOQ%<R7=G FF/;8=KA@6!B9MN,ACGZ'OQ76>&O M[8Z>USJ&O:DNK
M7K":^>WE3:TF, #*=  !^% '=5YYXPA2\\?:'IUQ&TEM>V[HR@9'R312'(]"
M% _&ND_X1J<?\S'K7_?V+_XW6)JG@J\U'5M(OK3Q'?,MI,QE>21"VPCD)A,9
MW!>OI0!+K-Q_PB?BQ-<F79HU] (+^54SY4J']W(V.<$$J3CLN:+SQC/K=\NE
M>"Y+*^N-OF7%\Y+VUNO8$J?F<G^$'CO6J?#-P1@^(]9(]"\7/_D.HX_"S6D9
M$7B#5((P22$,*C)[_P"KH RV\+^)M<Q%XC\0K#:*<&WT=6@$PQSO<DL,^BD5
MTFB>'=(\.V?V72;&*UB)RVP?,Y]68\L?<FJ@\.7/4>)M:_[[A_\ C=+_ ,([
M=?\ 0S:S^<'_ ,:H YVY\.>)-/\ $NH0^&3:66D:HBRS7$G)MI@2',<?0LPV
MGGC(S75>'_#MAX:TL6-BKD%B\LTAW23.>KNW<FJQ\.7G./%.M#\;?_XU3/\
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M[# &]U7@,?3J!C- ''^*=6L[#XA>1XM6XCT.:V1=.N SK DN3OWE2/FZ8)Z
M#IG-;L&IP^#/#]U?74UWJ>FR7FZ&XBE^T,D3A0N6)R0&XXSV]Z?JFH12:IJN
MF>(=)GN=&81M!+]B:>,Y7YE(4$Y!YSCOC/%<I'X7U"U^&_B>RT^UN_L$MV)]
M,L90?-2)61F #<C)5B%//XF@#O[GQ3:V?B!-%FMKL7,EN]S&RQ[ED5,;@N"2
M3R.,5B#XJ: ;:*[,.I+9-*89;IK1A%;L&VXD;^$Y[=>1G&:H?;[K5OB3X?U2
M'1M4CL4LKB$S36Q3:S%/O \J..IQGMFL'39O[1^%^K^'X;*ZGU"\N;N*&/[.
M^QMTS8??C: O4DGC'TH ]&U;Q9::7-+&MI>WK01":X^QQ;Q"AY!8Y';G R<<
MXJI>?$+0K3[ 0US.M_ T]JT%NS"4*N2%..6_V1SZXKD)["'P]XKOHM;\.W6K
MV%]'"UM>6]L9RKI$L9C8#D9VY';FKTB?9/$G@H?V)+8PVJW1E@MK9Y([42 "
M,%E!4$]\=#GM0!L:9K6BZUXTLKN ZE'J$VE&5(ID>.+R"ZG)!X+Y8#C/>K=Q
MX\TFU8R21W7]GK-Y#ZB(LVROG:06SG&[C=C;GC-9M](&^+%JRQW2Q_V1+:F=
M;=RBRM(CJ-^-N<*3UKFX$ND^%M_X+N-.NVUM4FM(XC Y2;<Y*2A\;=O(8DGC
M!H [36/B#HNB:E/I]RMXUS#;_:2D5J[;H]P&5./FZ]1P,'GBM/7]=AT/PO>Z
MW(,QVT!F"GC<<?*OXG _&N0TZ(VGQ6LHI$N98X/#ZV)N3 Y1IA(&P7QC)4$]
M:Z_Q1HB>(_"^HZ.S;!=P-&&_NMU4_@<4 87A[0)]8T*TU77;^^DU6ZB$Q,%U
M)"D&X9"HBD 8&.H)/.<U>L+R7PMX?B@UR\EO+O[3+%"_WYKK=(S( HZML(X'
M3:>PK.\->*UL-#MM-U^SO;+5;2)89(OLLDBR;1@,C(I# ]>.:J>(WU*75O"_
MB233KA+*PNIQ<0A=\D<4B;%E91R,=2!D@-]: .@@\::9<65_.L5XLNGX-U:-
M WGQ \@E.I&.<C(X-*WC+2DAT>=OM AU=HTM)?);:S.,JI./E)'K6##:'7?%
MVLZSIRN;*31EL5D*%%N)2SMD9QD %1GW]JYB35EN_"_@2SAL=2:72M3LUO0+
M*7]RT<;JP^[\Q_W<T =U+\1?#\5])9^=<-<1W*6K1K;2%A(PRHQMS@^O2CPO
MXR37M.O[R>TN;.&VEF&Z>%D41HQ7ECP6^4D@=/PJAX2FM9?''B]C&P>XN87A
M=XF7S$2%%)4D8.&R.*Q-'N5G\.7WA0I<)?76M7%M.AA=0D4DSR,=V,<PAB,'
MN* $U%O$5II.B:[HMS=2:IJ-U)<R:?-,QBFB*22B/8>%8(JJ,8YK=U?Q!!XC
M^'RZSI-Y<VS"2('RI3')$YD571P.X!(P?KZ5;\1W]E8>(_#$$LHB6*XD=Q@X
M1##(BDD< ;B ,USOC7PY?:-=R:GH49;3]4N(4U.R4<*_FH1<*!_%QAO7.: .
MVO==T_0C#8N;JYN/+WB&"-[B;RQQO8#)QGC)ZFLO7O'EC8:!9ZGIRR7\5Y.D
M,4D$3.BEG"G?@<$9(QU)XQ68UROAKXH:K?:RX@T_4[*!;6\DXC1H]VZ(MT!.
M[=SC-8=U926/@C4-3:*:.QG\21ZE&AC(,=O]H0E]O4 X+8QT- 'H%YXOTNR"
M>:+LRM#]H:%+61I(X\XWN@7*CKUQT--NO&OAZS2Q>;4X0E^GF6S#)$BX)R#C
MT']*Y#4M<M+SQG)$S7-E#/I\;6TMM:OY^I ESLW;=RJI[#!.[.<5A:7JVF1:
M)\-;>ZG6.2UG)G69"OEXB=<G(Z;R!GIGZ4 >EZ9XVT'6;Z"RL+QI;B>'[1&G
MD2+F/.-V2H&,\9SUXK4T[5;75/M!M6=A;S-!(6C9<.O4<@9^HKD?'EK)H_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M169_PD6B?;FL?[8T_P"UKG=!]I3>,=<KG-7S<0+;^>9HQ#MW>86&W;ZYZ8H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HJ"2[@BN8[9Y46:569$)Y8+C)'TR/SK'O?$5S91M<_V+>36*_,9XF0
MD+W;82&P.O )Q5*+D[(#?HJ"TNH;ZSANK=P\,R"2-AW4C(-3U(!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%MEN=3O(;2 L$$DSA5R>@R:;;:UIMYICZE;7L$UB@8M/&X9,+U.1QQ0!?HK
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *FJ7+V6D7MW&NYX('D
M5?4JI('Z5RGPHB5O -CJ,C>9>ZB7NKJ8_>DD9SR3[  ?A7:LH92I ((P0>]<
M9I/AS7O"@DL="ET^ZT<R/)!;7C/&]L6))5656W+DD@$ \XS0!D?$FS70?"6I
M-ILCVYUK4H%NF0[?+#[5=ACID*,_4UWDND6$NB/I)MHC8F'R?)VC:$QC&*R;
MWPLVO>'KW3?$%U]H:]P7, V)"0<KY8.2,$ Y.23[<"'['XQ.F#3#<:6K;?+;
M4PSF0KTW"'& ^.?OD9[=J /.+?4+O4_A'X<:_E:66#7X+<2R')D5)RH)/TX_
M"O5O&9QX'U[I_P @Z?\ ]%M6=?> ["3P/!X:L&:U2T*26LOWBDJ-N5SZ_-U^
MIIUW8>)];L3I>I1Z7;6DR^7=S6\SR/*A^\J(R )D<9);K0!C>,M!3Q')X7L!
M<RVLV)9+>YA;#12+$"K#'N.E56\2W.K>&IM*UB%+;7M.U&QCNH1TD'VJ+$J>
MJ-76:GI>JS>(M&N[*.R^QV._>)965SO7;\H"D<#GD\]..M5?%O@J'Q%>Z5J4
M#_9]1L+F&3S Q EB617:-L=1\N1Z$"@!WCFT@MOA[XJ>*-5>>PGDE8=6;RMN
M3^"@?A6EH]G!<:'HD\L:M+;VT;Q-W4F/:?T)J+QAIFH:UX6U#2=.%L);V![=
MGN)&545E(+<*<GGIQ]:N:%;WMIHMI:Z@MNMQ!$L3>0Y9&V@#(R ><=.WJ: .
M!U W?P_\5S_V;;^=I_B1R((.BPZACC/HC@9/^Z:[O0-)71M*2#?YEP[&6YF(
MP996.78_4_D,#M6+XQT'6=;OM#ETX6(CTR^2];[1*ZF0J&&T;5..&Z\_2NLC
MW^6OF*%?'S!3D ^QP,T <!XCF.I?%CPUH5P-UA';S7[1'[LDJY"9'?;U^M6O
MBM;A? UUJD3^5>Z6Z7=K,."CJP[^X)&/>M7Q+X;EU6YT_4].GCMM7TUV>VFD
M7<C!AAHW YVL/3D<&J6JZ%K7BM(;'6DLK/2ED62>&UG:9[G:<A"2BA4)QG@D
MX[4 8FL7LQ^(?@O4%L9IYY--NG:WB*!QE8SCYF X)]:ZWP],-4\_5Y]/:SO&
MD>U='QO\N.1PF<$CN3QZUF:GH&M7?CW1];@CL%L].BEA*O.XDD60 $X"8&,=
M,G/J*[  #I0!PWCW0!XAU/1+1+F6UND:>:VN8CAHI50%3[C/45E/XGFUWPRV
MG:M"EKKVGZI817MMV/\ I46)%]48<Y_"NNU6QUB?Q)I=Y:0V36EJ)/,\V=E<
M[P!P A'&,\GGVJEXI\%1:[JVDZO:LMO?V-U"\CY($\*R*YC;'7D9'H10!FZ[
M/+:?%K19X+.>[?\ LJY!B@*!L;X^?F91^M;FAWG]L:QJ=S<:9+8W-FXM%$Q&
M]D*))SM)7&6XP35'4=&U^3QW:Z_:6VG206MI):I'+=NCR;RK%B1&P&-N,<UI
MVD&OW.MQ7.HK:6EE#$P%O:W#2F61B/F<E%X !P!W.: //UBM]&TCQSX1O(!)
M;A_M-E#D#?'<G:BCTQ+QGL2*NZ)J5SX@\ :1X>N!MOC='2KY1SM2#_6Y_P!Y
M% ^L@KIM<\'C5O&VA:\) B6*NES'DCSEX:,>^UP&YJ32/!\.E^,M9UY7^6_"
M>7$"<1M@>8<=,L50Y]J .F(PN!7FW@?59-.B\01QZ1J%VIUV\.^UC0J/F''+
M"O1Y2XA<Q*K2 ':K-@$^A.#C\JY7P9HNM:%#JD6H1V3?:[V:]1H)V;!D.=A!
M08QZ_I0!G?#EQ+K'C27R9(BVL%BD@ 9?W:\''^-8'C;53/>R^*+*\C,GAN[6
M.WMO- ,RCY;GY<Y/#!0?^F9]:Z+1=#\4Z/)XDN(H-*^TZK<M=09NG*Q.0%PW
M[OD #/'7I[UKZ7X;@M?#,%K=:58R7L=OY;\AA(V,$F0KGYNI..YZT :DT5EX
M@T)HV(FLKVWQQ_$CK_@:X#PQKEQHO@75- E</K&A2_V=$#_RTWG;;M]#N4?@
M:Z/P!HNN>'- 31]7-I+';$BVE@F9SY9)(1@5'W>@/ICBFW7@F*X^(5KXD$F(
M%M\3P9XDF3B)R.^%=_Q"T 8GQ$TN+1?@G<Z=%\RVT5NFXCEB)4RWU)R?QK?O
M-3_M/4M-TF]T"_@AN)O,$T[( K1#S%P4=CG*CTXS2?$#0M4\2^%I]%TU+4&Y
M*[Y+B5D"!75N %.<XQVQ4E__ ,)=?VWV:&STZP,C*KW2WK2-&F?F*KY0RV,@
M9/'6@#EO$&FZE:^,M7\3^'@9=2L(X%FL\X6[@*DLO^_QD'VK>TW7+'Q'K_A[
M5=/<26\^G7A&1\R'?!E2.Q!XK1TJSU>'Q+JEU=VMJEE=!!&Z7!=_D! RI0#G
M/KQ[U2L/!BZ3X[FUVQE\NRN;:19;3/RI,S1DN@Z#<$Y]P* ([FX70_B?IUO'
MD0:];3>8@Z">$*0^/4H2#Z[1Z5V5<?<6ZZY\2M/N8SN@T&VF+N.GGS *%SZA
M%)([;EKL* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @M;
M2WLH/)MH8X8]Q;:BX&2<D_4GG-3T44 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%%    ,#I1110 44$@#)Z5A2>,-"CD8'4$\M7V-.$8PJW3!D V _4T
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M%&<=:9%-%.F^*1)%R1E&!&1P: 'T444 %%%% !12,ZH,LP ]2: 0PR#D>HH
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M2!6(#(3V/]/2LJ[\/:KHOBR]\1>'T@N1J*(M]832>7O9!A71\$!L$@@C!]:
M-B?PW:/XIMM?C58KF.WDMY=J_P"N1BI&3[%>/J:\]TK48='^#-]>3Z3;ZG:P
M:A<^9:S,%4K]I8 ]#G!QQ7?V<OB"ZF%U>VD-C%&IVV<<PE:5L<;GV@*!Z#/U
M[5Q1\)^)#\+=2\-&PMOMMU=2.C"Z^0(\OFY)V]1TQCWH Z^\\07)UT:%H]M!
M+>QVHN9C/(4CB0G"C@$DD@_0#/M4_ACQ$/$-K<F2V-K>6=P]K=6Y??Y<B^C8
M&0000<=ZQ)='UFQ\5KXGL=/2>2\LEMKZQ,X5E93E75R,'N"./6M?PKH<NDIJ
M-W=B-;S4[MKN9$.X1Y 54#<9P%'..I- '->-M#O;SQAI^H:%(MOK-C8S7,/
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M" =_WOD'S'(]A4$_C+78O# \8K#9R:)GS#9JC>?]G+;=^_=MW8^;;C&.,YH
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M\UZI)(D:[G8*HZDG K'U[P]%XC2S$NH7=O';3+<QBV9!F13E6)93G![=/7-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMKR\AAGNY!';QN^&D8G& ._6K]>:^(M0U6_T?PU=7^D?9M137HD^S&088J7
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M44 &!Z48'I110 8'I1110 8'I1110 48'I110 4F!Z"EHH ,48S110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRFW8Z9WMF@#K:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJA=7>R73R!-FX+F$OL$L9;TW#-2CD5YYJEKH%MXEL=/3288K9) \TD4 &7)
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M)/;<-,Q/RHP_C4YY!Z#)XQ761;A$N_&['./6L)1LKHH?1114@%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ2/HNC*-TFFV(R<9:!/\* (!XK\/'IKNF'_M\C_QIP\4Z 1G^V]-_P# N/\
MQJ8Z!HY_YA5E_P" Z?X4G]@:-_T"K+_P'3_"@5F,'B70B<#6=//?BZ3_ !IX
M\0Z*?^8O8?\ @2G^-+_8&C?] JQ_\!T_PI/^$>T7_H$6'_@,G^% "_V]H_\
MT%;'_P "$_QH_M[2/^@K9?\ @0G^-<[=:AX.L]7DTJ324:^C3S6ABTEY&*9Q
MO&U#E<\9%:6DV_A37+$7FG66F7,!)7<ENG!'4$8R"/0\T!<T/[>TC_H*67_@
M0G^-*-=TC_H*61_[>%_QJ"70-"CB=WT:P95!) M%8X]@!DUG:)9^$?$6G?VA
M8:/I\MNSO'O>P5"2I*GAESU!H&;']NZ3_P!!.S_[_K_C2C6]*/\ S$[/_O\
MK_C6&-/\&R>(6T/^Q-.^WB W!1M.4 Q@@$ABN#RP'!IND:5X+UP7@L] TMQ9
MW#6LV_3D7$B]1RO/U% '01ZOILL@CBO[5W8X"K,I)/YU=K%B\(^&H)4EA\/Z
M5%*C!D=+*-64CH00O%:_FQA_+WC?C.T'G'TH ?1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%8?C)+J3P3KB66?M+6,PCQUSL/3WK<H(R,&@#F?AY):2?#W06LL>2+.,?1@,
M-^H-9WBK4$MM4T71K";[*FK:D8[V>W;:XVIN*[ARK-A1GKC/UK0C\$6=G=3R
MZ7J&I:9%.Q>2VM)@(BQZD*P.TGU7%6+OP?I-YH\.FNDJ)#*)XITD/G)*#GS
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M<,D,D4-IMC=7VYQEB0?EY))^@JM:^"-2MM)N_#PU.#^Q+J65Y&$)%QLD8LZ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 !&: ,=*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** &A%5BP4!CU..M.HHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBD!!Z$&@!:*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ J*"VAME98(UC5G9R%&,LQR3]2234M% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)SQWH 6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ I,\XI:* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH 09R<].U+110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%( 1U.:
M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "B@G%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  3BBC&:*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** ,
M#% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (5RP.3
MQ2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C+G'/2EHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBD(R0<T +1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% "$X('/-+110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M HW.2_FXR!@9V\EA4&E>(M<GN-&U&Z>S?2M:G:&"WCA99(!L=XV+EB&RJ<C
MP2,4 =Q17+>,-0US1[675+"ZL([.UB#&WFA9Y+F3.!&K!@%S\H!P3D]*ZA3E
M03W% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)H_.B9-
M[IN!&Y#@CW%4-,T.QTEYI;9)&GG;=-/-(9))#VRQYP.PZ#L*TJ* "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%&: "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *3 SFEHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
8* "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>arvinassixthleaseamendme010.jpg
<TEXT>
begin 644 arvinassixthleaseamendme010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHI<<4  ZT8I:* "@T44 %%%%
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M*7%&* $HI<<T8H 2BEQS1D"@!**<** &T48HQ0 44N*3% !12XH(H 2BBB@
MHI<48H 2BEQ2T -Q13L9HH ;2XS1BEH **** "BBB@ HHHH **** "BBB@ H
MHHH ***44 &*,4M% !BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "DQ2T4 (:3%*11SB@!**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **7!H H 2BEQ0!0 8I*=28QTH "* *6B
M@ HQS110 $4T=:=10 T]:44G>E^M !U-)2XYI"*  \444N.* $HHHH **._]
M** "BBB@ I#2TAH 2A/]:O\ GM10G^M% %32^-)LQZ0(/_'15P54TS_D%VG_
M %Q3^0JV,8H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?_Q%(;68_P#,0NO^^8O_ (B@"Y15$V4Y_P"8G=_E%_\ $4?8YQTU*[/X1?\
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M9J#R4SP9/^_C?XTGD+_>?_OXW^- %C-&:@\A3_%)_P!_&_QI/LZ>LG_?QO\
M&@"QD4 \U6^R1>LG_?UO\:/LD6>LO_?UO\: +61ZT9JJ;.'UD_[^M_C338P'
MO+_W^?\ QH N4F:I'3;;TE_[_O\ XTATJT/\,O\ W^?_ !H O9HYJB=+M?27
M_O\ /_C3?['LCU67_O\ O_C0!?HK/&BV(_Y9O_W^?_&E_L:Q_P">)_%V/]:
M+]%9YT73^]N#]6)_K2?V)IIZVD9H T:3(K/_ +#TS_GRCI/[$TS_ )\XORH
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M6 _Y<X/^^!2_V;9#C[)!_P!^Q0!<SZFC(]:I_P!G6.<_8X/^_8_PI?[/LO\
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M444 &:*04N* "BDQ1F@!:*** "BD/K0.M "T4G>E/- "8_"EH%'>@ HHHZT
M%%%)W% "T444 %%%% !129XHY(ZT +11FB@ HI!2T %%(:6@ HHHH **** "
MBBB@ HHI,YH 6BDP?6EH **3-+0 4444 %%%% !1110 O6DXHHH 7ITHS244
M %%%% "@T$TE+Q0 9XI*** %S2444 %%&:0YH 7--H HH <#12 4M !1110
MHZ4<4E'2@!3UI*#S10 49HHH 44O>D%'04 +2$T$T9H ,TF:6DH **.U% #C
M2=N*0\T4 %%%% !1110 4M)10 49HHH ***"<4 &<49S3>IIU  <FC-(324
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M_9MA_P ^5M_WY7_"@"M_PD6B_P#09T[_ ,"H_P#&C_A(=$/36=.S_P!?4?\
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M_P \8_\ O@4?9;?&/(CQ_N"@#+/BKPZ#_P C!I/_ ('1?_%4I\6>'!][Q#I
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MGW'_ ,;KHJ* .=_X3;0,X%S<Y]["X'_M.D_X3;0<#_2KG)_Z<+C_ .(KHZ3
MH YW_A-] '6ZN/\ P N/_B*/^$WT#./M=Q^-C./_ &2NBQ[D48H YX>-] [7
M5R2/2PN#_P"R4'QQH ZW-S_X+[C_ .(KH,'I2X]30!SW_"<:#_S\W7_@ON/_
M (W2_P#";Z!T^TW7_@ON/_B*Z#'UI<4 <[_PG&@8_P"/F[_\%US_ /&Z/^$X
MT'_GXN__  77/_QNNBHS0!SW_"<:!G N;O\ \%]Q_P#&Z/\ A.- QG[3=?\
M@!<?_&ZZ&B@#GO\ A-] _P"?FZ_'3[C_ .-TG_"<:!_S\W?X:=<?_&ZZ*B@#
MG?\ A.= _P"?F[_\%US_ /&Z/^$Y\/\ _/S=_P#@NN?_ (W718HQDT <Y_PG
M.@=[FZ_\%US_ /&Z7_A.- SC[3==<9_L^X_^(KHOK2F@#G/^$Y\/_P#/U<_^
M %Q_\11_PG&@'I<W1^FGW'_QNNBH_.@#G?\ A.= _P"?B[_\%US_ /&Z/^$Y
MT#_GXN__  77/_QNNBHH YW_ (3C0?\ GO>8]?[-N?\ XW2_\)OH0ZS7H_[A
MMS_\;KH:* .>/C;1.</?D9ZC3+G_ .-TA\;:/V34R/;2[G_XW71=\T4 <X/&
MVEL,BVU<CU&E7)_]ITI\::8#C[-JY]_[*N?_ (W718I,"@#GAXSTPKDV^KCC
MH=)N?_B*!XSTP]+?5C[?V3<__$5T5% '._\ ":::1D6FL'C/_(*N?_B*7_A,
MK#.!8:W_ ."BY_\ B*Z&DP/2@#GCXQT]B!]AUKU_Y!-S_P#$4UO&-GM<IIVM
M,P'W?[)N!_[)724UB,8H S=,U=-5EF$5O=Q+$%W&YM9(<YSTW@9Z=JTLXYX%
M-+!5-0E]S8P0 <T 61TI:13D9I: $HQ2T4 (!BEHHH 0BDIU&* &TQZ>:8]
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M0 4444 %%*/6DZT %%%% "B@]:2ES^= !BDI<TE !1110 44"EH 2BEZTF*
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MU1:=K-U>ZOL>&)+*=9OLYS\Y\MPI8]L-DD>F/>M;[1MU 6S#&^(NA]<'#?\
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M H/%%'6@ HHQBB@ HHHH **** "BBB@ HHHH **** ,GPX=VE.>/^/V\Z?\
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M:* #O1110 4AZTM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !2]J2C.* "BG=:3% "44=Z* #/%&:** "BBB@!<TA.:7 I"* %%!ZT<
M4E !BE[T9I* %/2DI<T9H 2BBB@ [4444 %%%% !1110 4"BB@!2:*3%** $
MQ12XYH-  *.II*7% "9HI<"DH *7/-)1TH 6DHSFB@ I<T"C)H 6DI<BDZ4
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M(@:5>$XP(')R<?PGO0 S1AC0]/!.?]&CY]?E%7:I:-_R ]/XQ_HT?_H(J[0
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M10 4444 %%%% !1110 4444 *#0>M)2GK0 <T&C- H 2EZTE*: #O24N*3%
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M=-5_^$FT+!_XFUE@?]-EJIJWB'19M&O8EU6R+26\BJ/.7G*D4 :>D9_L6P!
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M:H:9J2Z@D@Q&'C(YBD#HZG[KJPZ@X/T((]ZOT %%%% !1110 4444 %%%%
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M %(:6B@!M1R#(J2F/TH ;9_\>4'_ %S7^53FH+/_ (\H/^N:_P JGH ****
M"BBB@# \7":/2$O(MS+97$=U+&I_UD:'+#Z8Y_"K%YJ-Q-:V;Z3Y#I><+<2D
M[8P1D':!\Q]LCFM*:2.-"TKJJ^K' KCYM*U2RMM1L=&\B\TZYWB-!/Y<EG(W
MH1P5!.0!R,#ZTT(ZK3;!--LEMT=G.2\DC_>D<G+,?<DU;J&S6=+*!;IU>X6-
M1*RC 9L<D>V:F-(8444$T %%%% '/Z0/^*O\2'C_ )=1[_ZL_P"-=!7/Z.1_
MPF'B5=N&!M3GU'E?_6-=!0 G2EI#2CB@ HHHXH **** "BBB@ HHHH ****
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M_8__ (J@+C] FCG74)8G5XVO9,$?1:V,UP&@Z_H%OK^IR_VW9!;B21S))=(
MV&&T9)Z8/'U-=-_PE?AW.!K^E'_M]C_^*H V*7-8W_"5>'O^@_I0_P"WV/\
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MQ=1F0 $J#R,]./PI&UK3U9%:[C!<X4$_>XSQZ\ _E0!HYJAJ6-UE_P!?*_\
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MNF@!VD_\@:R'/_'O'U_W15RJ>DD'1K''3[/'C_OD5<H **** "BBB@ HHHH
M**** $/2F.:<:8WN* &V?_'E!_US7^53U!9_\>4'_7-?Y5,: %HI ?6EH **
M** $-<9KP?7=:N;"RBMIIM,CBE:*XA5TE9B24.[_ &<>G)Z]<=F:Y*21_#/B
M34]2NK:66PU$Q'[1 AD,+(NW#J!D ]<C--"9K:%XAL-9A,<)$%Y"-L]I)\KQ
M,.",'J,]Q4,ULWA^8W5C&3I[MFXM4'"$GET';W'3Z=1DV&DVGB.]U2_E@DAA
M:9?L5PBM#,I"_,X) ;!..O'%7A)XATAO+FB36;(?\M(R([A1CNI^5_P.3Z4
M=)'(DL:R1L&1AE2.XIU<KX5N99-4U2*&WNXM-!1X1<1NGEN0=RC=[\\=/;OU
M)QWI#%HHHH Y_1\?\)?XE((/-J/<?NB?ZUT%<]H[9\7>)AW#6O\ Z*KH: "B
MBB@ HHHH **** "DQ2YHH J:E;R76F74$> \D3*N20,D<9QVKFFCDGU7[7)H
MZ-+$V^*V$#KAN[-)LV,?0[L#ZUV%-QS0!F6>CK;V4$+W%SN2,*=D[A<X[#/
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MR!BM3P;C_A'(\*53[1<% RE2%\]\<'D<8X- S7-C!Z2=_P#EJW^-)]@@R/\
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M_&N@KG]')/BSQ+SQOMN,]/W(KH* "BBB@ H'-%% !1110 4444 %-[TZD)H
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M5@!@7MKCVE7Z#O2_VC9=#>VP'?\ ?+_C5W06+8X%&.*J?VI88S]NMA[^:O\
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MC_2M5P/74[C_ .+KG*(1K*+_ ,PW4NO3R/\ Z]87B9#JT,=S::3J O[;F(O
M &Y!VDYSV_4CO73?\(U9;<?:-3Z?]!.X_P#BZ!X9L0 //U,_74[C_P"+H$<W
MI5[=P7:3RZ)J2DK=%@(U)S).KJ/O>@K<.N.#SHVJ^W[N/_XNKH\/6('^LO\
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M%%% !1110 444&@#*\._\@IN<_Z7=<_]MY*?J,QL':^6*UQL"2233LAP"<
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MY/3CK6G@2RH\NG/YG #R"([1G/\ >/&0#Q2C*ZT'ZE!\-XM0D'(ML=>,Y/\
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M58S4%EQ86_\ UR7^53T %%%% !1110 4444 %)BEHH 0BF2'"T\CO3'SC@T
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M TO9)]1*"9WY..M9.MMF32UWX!OE!Y_V'KA;6.Z%Q:?:)#-$]T\#.I5$) D
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M/?!'4U!X RNN>($"XC6Y.TY)]./P 'YUM1ES-ZFE.5V>@4ZD'3-+6YJ%%%%
M!11BB@ HS12XH .IH%)2T *>E-IU)CF@!*!2XHH R?#QSI1YS_I-SWS_ ,MY
M*U:RO#O_ ""./^?FY_\ 1\E:M !1110 4N*2EH RM7)_M#1,8_X_CG_P'FK4
MK*U?C4-"X/\ Q_MT_P"O>:M6@ K/U_\ Y%S5,?\ /G-V_P!@UH5F^(N?#.K8
MZ_8YO_0#0!:L!C3K4>D2?R%6*@L>-/M@.GE+_(5/0 '...M(#V(-+10 4444
M %%%% !1BBB@!"::QXIQZTUN: &VO_'K%_N#^52U%:_\>L7^Z/Y5+0 4444
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MB10Z2?9G@);!4+ASR =K G@'\,)N_05]-AD-W:Z?>B>;,<,0A1FVDYPEP!C
MS_/Z]AK1ZE:WVJP0PF59(@6>.6!XVP00#\P&1D$5S]UIDFH;K6!A',3!S*"!
MPMP.PS]#S_0:EII]W!XACOKDQ RQF,1Q2R.!C<Q.7Y'WL =JSDHVN]R7:WF=
M$H!K#\0PW,D^F&VQ\EW&S%E.!EU S@CN1Q6WDXZ_6L;Q!>R6PTZ&*,R//?0C
M;D $*X;&2>#D+6=/XD1!:E2]\3M96TDK.@*HS(6M)PLA&<!21@Y(]>]/U36K
M2ZTN6*)K@/)MV.ULZ*<,I."RX)QSBGGPS9WES'<7=G!&JC_51L6W9S]]B!P,
MY"@8SW/ ":II%A9Z5+);6D<3AT*E<\$NN3BM6Z=TD7[MRYIUG/\ V59YU*\&
M;:/@+#@?(.G[O^M6K6R%M<37!N9YI951&,H3@+NQ@*H_OFJVA7HN]+MQY+QF
M.&->3_LX_ \9QVR/6M!Y$B1G=PB+C+,< 9.!^IK.4I7L3)N]B4'DTR6"*X"K
M-$D@!R-Z@XJ'^T+3!)N80!W+@"D_M"T +&ZBVCJ=XQ4V:Z$V8MI,([1 \1BV
M+@HD+ +V  Q_+I63\-_..K:TTL4<6Z=B%7(*GC(Q[?UK7.H6;)E;F(^ZN"*S
M_A^ZOK6O,K!@UTS!ACD'&#730W9M2W9Z"*!UI*7-=!L+1110 4444 %%%% !
M116?KUU-8Z!J-W;D":&VDDC)&<,%)''>@#0I<U0T:YEO-"T^ZG(:::VCDD(&
M 6903^IJ]0 452FN)4UFSMU*B*2&9V!')*F,#_T(U=H R_#^?[*//_+S<_\
MH^2M2LOP\,:3C/\ R\7'_H]ZU* "BBB@ HHHH RM6 .H:'D9Q?DCV_T>:M6L
MK5O^0AH?_7\W_I/-6K0 5G>(>/#6JD?\^<W_ * :T:S?$/\ R+.JX_Y\YO\
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M ^96P,N222@' P!GGI0!T'XT<57-C&3G?<?^!,G_ ,533IUN<@F?!_Z>)/\
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MN4LU3=6XZSQ?]]B@WML ";F$9]9!62?#%D<@6]C^-C%_A3E\,V.T VUE_P"
M4/\ \31H+4TCJ-DO#7EN#Z&5?\:/[2L/^?ZV_P"_R_XUGCPW8C/[FVYZ_P"A
M0_\ Q% \,V0Y"0#Z6<'_ ,13T&,U[4+)]**K>VQ;SX#@3+GB9#ZUI?VI88YO
MK7_O\O\ C6;J/AY[[3UL_MA\M7C94:"+: K X V<<"K$6B>3 T$5V\439RB6
M\(4YZY&S%("W_:FG_P#/]:_]_E_QI/[3T_I]OM?^_P O^-9O_"+VA_B3_P
M[?\ ^-T#PK9]28CD<@V5O_\ &Z -+^U+#'_'_:_]_E_QH&I6'_/]:_\ ?Y?\
M:S_^$8LR,%83];.W_P#C='_",VG/$.?7[';_ /QNGH,T#J5@.M]:_P#?Y?\
M&LS3-1L%U#66:\ME#7BD$S+R/L\(SU]01^%2)X<M8Y%DC\I&4Y4K9P @]N=E
M1+X8#W5Y-=7*S^?,)$WVT+%1Y:)CYD/]SM[4:"-0ZG8?\_UK_P!_E_QH_M/3
M_P#G^M?^_P O^-5)=$\ZV%M)=N\ QB)K>!D&.F%*8J >%;/;AC&W.>;.W_\
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M5.DVDF)5"6(\O>ROY:[CP0.=H&,'//<#CBM'N4Q8TL[JY27?"1'#A69 "3R
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MJUDCJ,%7N4!4Y/'6D^'+0(\P3;YDQE?<JCYU#CN/]_\ 7BJ%QIWA1+.9TEM
MRQMM*Z@Q.<'MOYJSX&T73Y+F25[6WD"+*N'02!\NN#EL] O_ (\:UI):M%PM
MT/2L'T/Y4<CL?QK/71-)Q_R"[$#T^SI_A3AHFDCII=B/^W9/\*V-">]N_L=J
MTOEM(^0J1KP78G 'MR>O:JDU[>6*I->"W,).'$;$,@[D9^\ ,D\ X!//2H[O
M0[41+)86=G!=Q.)(G$"KR.Q(&<$9'X^U4KC3M1U!XHI7N@BL2S3F +M92C8V
M#<3M8XS@9Y/H0#I1R**0# I: "BBB@ K,\1_\BSJN1G_ $.;_P! -:=9GB/_
M )%G5?\ KSE_] - #?#/_(JZ1_UY0_\ HM:U:R_#0QX6TCG/^A0\G_<6M2@#
M-NL_\)#I_I]GN.?^!14Y[747N)G&I^7$Q'EQK OR#'<G.><^E)<_\C!8#_IW
MN/\ T**LF2[GMM4GLX3J$\DDK.%@: A QSSNY4?[Q&>U &EX=_Y!'4'_ $FY
MZ?\ 7>2M6LKPZ?\ B4?]O%Q_Z.>M6@ HHHH **** ,K5L_VCH> /^/\ /_I/
M-6K65JW_ "$-#_Z_F_\ 2>>M6@ K-\0_\BUJO&?]#FX_X :TJS/$8SX8U;_K
MRF_] - %NQ&-/M@#G$2]?H*L5!9#%C;C/2-?Y5/0 4444 %%%% !1110 F><
M4&EHH ;3'!(]JD/6HV^M !:_\>L7^Z/Y5+4-K_QZQ_[H_E4U !1110 4444
M&*3'!I:* ,:X\,Z;.6VI)"'E65UA?"LRD$''.#D=1@_G6S110 4444 )BEHH
MSB@# T3/_"1^)>1C[5#P!_T[QUOU@:(<^(O$O.?]+A_])XZWZ "BBB@ HHHH
M **** "BBB@!"*,4M% "$<4AYI324 <-XU(7Q/X9!89,LF ?9HC_ $J'1/\
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M4-O]MZIQDFS(S_WYK&M\)<=SJ?!2W"Z8P<.(@\@0'H#Y\VX8]?NYKJ1TKE?
M]R\FF-;D*$C:1UP.[3S9&>_W175?A7(BP[YI?I24HH ,4M%% %/5([B2R"VN
M?-$T+<-CY1(I;G_=!JY5+5;F6SLEEBQN,\,9R,_*TJ*?T)J[0 4444 %%%%
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M:RM?YEB6X6^6/E3^[7:90=O)R, =\'-,#I_#H_XE XQ_I%Q_Z.>M:LGPZ?\
MB4#G_EXN/_1SUK4@"BBB@ HHHH RM7Q_:&A_]?S8_P# >>M6LK5L?VCH>?\
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M1D_X2SPU&Q&XO(0,$]"C'^50Z&2USJ.3G%Q)Q_VVE_S^-:4?C%+8DU _\3*
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M5VL$QAEM]123.-A@Y)]ANIB:\L>HWKO9:H41(2P\D?+D,03\W Q2^3X6P/\
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M<X_VHJT3TH RO#HQI"@8P+B<<?\ 79ZUN]9/AL :,H'3SY\?]_GK6H ****
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M?'6F* %HHHH 1NE4=$Q_8.G =/LL7_H(J\WW36?H>?\ A'],)Z_9(O\ T 4
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MV!+;?G#J4Y_W@OUZ5:'2JNH6?VVV6(/LQ+%)G&?N2*^/QVXJSF@ I:3-!S0
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M.VM4TR[;[3<<0.1F\DQ]T]MW-<I-H1N]7DAU>_LTD6)3YRP(HR"/E!XY^?J
M"<4MWX9TN.RN)4U>S=DBDPI"GL3QEC@^X_6IY5=:BTON=<MM8A06O)\X&<WS
M]L9_BK-U*.WAUW252XD+!CQ)<L^/F3LS'MFL@>&M'!+'6[0=&X55 Q[!QS[]
M:J7&B:7;3V]JFJ6[1SI)&\B*JE02HR2&YZGKZ>]-)7W#2^YZ-YL>=I=<],$C
M-<QKGDW&N6L,CHT+I$67S" V+A ,X//!;]:SCX4TAMTAUFT^8[OE55 'H,/T
M_7BJ=SI]EI<MO#9W=O-ODMU(0!<C>QR0K#/(![=.M*$(IW3$HKH=%IL%M:>*
M;F*V39&;?< &+<_N^YSZUT61STK-L])2TOFN04W,A0A0PSR.3N8Y^Z*TORK*
M=F]#*3NRCJ*>9/8.&C!2X+?/&TF?W<@X4$$GFL_PQ_QZ(.WV:+@C_:?/ZYK1
MU,,&LG5[=?+N"Q$UP80WR.N P!.?FSCVK+\*#;8Q9)YM83ST',@_I5+X"_LF
M^LP-R\(!RJ*Y/;#%@/\ T U)D$XJM'QJ=QG _P!'AQ[_ #2U9'^>*S=B&K&/
M<D?;-6SG'V./.._^MZ5EZMQKVCG/S;K<DD_[3"M2Z.+G5SP0+*/_ -JUA>)2
M4N[9T;#)'&593R"-Q_#IFM:>Y4-SL^J^E'<5C:B9HM.U I'<QB&RD=+@W)Y<
M(2,#<>F,Y./H:VG^\1V!K.2L1:PF,G I<D]JI7B))<V*N%93,V590?\ ED](
MEG&;B1&L+86X V/L&2?I@\>^1].]%M L7_N@;NGO4)N8O/,(8LZD!@JD[3UP
M2.!^-0VT<<5_<+$BHIBC^55"\Y?G^7/M56[TRY*V8M)D01W/G3LS;3("<D9"
MGKG]!0DKCLKV-?.!TYK(\!JJZ]XBP5!:Z/ ZX'_ZS5^VN/M!D=-I@!VQOC[W
MJ>O3.1GV_$T_ \+1ZWKDA9"DTQ8*H/RD.RD>_P!T'MUK?#JS=S6EHV=Y10.E
M%=1N%**2JT>H64MP;>.[@>93@QK("V?I0!;HI!S2T %%%% '*6>G7,2VCW.G
MWSW%N(P6C>W*DH6P06;=SN.>E,U*.X@\,:C!)%=1V,>FS)BX,1.=H"[?+)Z#
M=G/M4MOXDNV3]ZMOYAM!<A54]-KDCD_[(&?>FZSJ<EWH>J 21/;/97A0QC)(
M3:H(.>?O&@#7\.9_X1C22W7[%#G_ +X%:E9GAW/_  C.D@_\^4/_ * M:?2@
M#,G /B33SW^RW//_  *&M!HT,BR% 73.UL<C/7%4+GCQ%8^@M+C/_?4-5AXD
MADC\Z&TNI;8C<LZA,,O]X L&(Q[9/84FTMQ-V)O#H_XDZ]1B:<8/_75ZU:R/
M#$J3Z#%+&X>-Y9F5AT(,KG-:^<4QBXI*-PS32QZT .HIG.<Y_"G9H R]7_Y"
M.A\9_P!.;\/]'GK5Z5E:MDZCH>.GVUO_ $GFK4% "UE^)0#X5U<, 1]BFR#_
M +AK4K*\3_\ (IZSU'^@S\C_ *YM0!?LV+64#$Y)C4D^O%35#:\VD/\ US7^
M534 %%%% !1110 4444 %%%&* &TC=*6D;I0 VU_X]8O]T?RJ6HK;_CVC_W1
M_*I: "BBB@ HHHH QO$5D;JTM[F-97FL+A;M(XCAGV@@J/JK'Z].]7K2ZMM2
ML4N+=A)!*O\ $OKU!!Z'U!JT>E8ESX>!NYKS3+ZXTZYF.Z4Q -'(?5D8$9QW
M&/QI@+X?G<3ZII[<QV=SLA.[.$90P7\,D?3%;=4-*TJ+2H9426::2:4S2RS,
M"SL<#/  ' ' %7Z0!1110 4444 8&@_\A_Q-TQ]MB_\ 2>*M^L'0LG6_$N?^
M?Z/_ -)XJWJ "BBB@ HHH% !1110 4A%+WHH S-;9Q:PQ*Q5)ITBD8,5^4]L
MCIDX7/O7/&_MYX'N;1+:VGLAMBB1E,DTHXV#:<E"<+T^;.<# SV$\$5S \,R
M!XW&&4]ZJ1Z5;1RPR,9I3"/W8EF9POO@GK[GF@!WGWFXXLU(_P"NW_UJ;Y]]
M@YLH_P#O_P#_ &-7:0T >>>-)Y3KNF-/)':/$FZ%3,H#DRQACED.2%R<8]^U
M-\-R7+:+%<>3'--,SO+(SA2[[VSP$P.2>,<<U>\7%5\6^'V.>#(./?&/UJKH
M.?M.IC'_ "]R\?\ ;63_ /5^%:4M9"EL:!DON/\ 1(3CUN"/_9*G=IA$K1PH
MS\94R$ >O.#_ "J0G(_QH XQBNM+S,R%3.T1W1(DG90Y89_WL#^5-WWF/^/>
MVX_Z>&_^-U8SQ1D]:+ 55DO,\V\&"?\ GX;_ .(I0]X#S;P$>UP?_B*B-W(-
M=:S.WROLHE4=\[\=:NX.,?C2WZ@<WIDNI/<E0P8,BM*-P3:XCB'_ #RX[\>U
M:X%_N&X *#R?/4_^TJL12(\DRJ,%'"N?4[0?Y$?E3+N\AL@K3%\-G&U2W09.
M<#I@&H4+=1MW.,"S#XJ8VAY!9DC>X Z=257\.E=LS2B,&.)&;/(9]H'XX/\
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MSGCI^(^E=LIV.K'HIR3Z5F:&A738U/8*/_'%_P#KT_:NUQ\[M<AA773&WG-
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MR%/RG'3<>3ST& *WAU532(E151<+PHP/NKD_G6EDHLNRL:I'' J*X6)HP)R
MF]",G'S;AM_7%2]3Z5B>*E5M.M 0N#?P@Y'J3415W826IKE8O-24JGF+D*Y
MROK@]JH3E+_5&AF*O;01*[H3D22,3@'U "YQTR1GH*D&AZ9CBT7/^^W/ZTT:
M#I2[C]AC.[J2S?XU<7%=1WBADTD?_"2VK%L$V<X+$\</%@?7DUI":+IYB9_W
MA5!M!TG>&^PQ[L8!RWX]_84^/0M,+H#9)U Y9CG]:;<7;4+Q+%G>Q7]J+B D
MQMTW#!J?OGI7)^';274-/>4ZC?0[9<;(9 J_=![@^M33"WM[T6<FO:MY^5
MG4X)P!_#[C_.:3@KV0<JN=*:@G$)FMS-C?YA\K)Q\VUL_P#CNZLX:22RC^VM
M5.X\8F!''OMJMIL\MSINB2SR-)*;J3<SG).(YA1R^8N5'0]J0\TN1CKQ2$<U
M!)R&DSS7&G7C2;24UJ*-2%(^4/$/?G%:&M!AJUC-$BM<1V\[0 GJY>$ ?0YQ
M]">G6LR*R22TG9-D,C:C$/,2,"0$M&<ANO&3]>]77MKFY\16UO<7I%Q9PR2Q
MR1PK\Z,54$@@C/WAP.HSW&.EM7N;-:W+7ATY&H'&"]Q&[]LNUO"6/UW$Y]ZP
M=04_\(_J$03_ $=TNI),G/[T--M_$A0?JJ].^[I5G<P7>JJEWN+78=VDB!))
MAC.>, =?2LV;199/"U^AOY5CF\Z:1#&A!.XG .W<!\H[]*2:N)-7.DO#MGL2
M.OVD_P#HMZI?#PC^UO$ &.;GKZ]:DNHKO[18AKA&S/VB[^6_O4'PXC U+7Y#
MAG:YPSX'."W^)JZ*+IGH8%+WI *6N@U"E%)1S0 ZBBB@ /%%%!Z4 8-MJ&C"
MV3R=T<20*R'RFR(\,1R!G&%:LO5#%%I>LV]K#)!;BPN$(RI21HU1!MY)&!QS
MC/X5JV^A>7;HD\*22BV%NS+.X#+M(SC'!PQ_.LK5@G]C:EY1.$L;U26=F+MN
M4.<D#HRX_'CB@#H?#^3X:THGK]CAS_WP*T:SO#^?^$;TK/7['#G_ +X%:- &
M;/\ \C'8\\BUN._^W#_A6A)NV_*0&[9K/G;'B2S7UM)S_P"/Q5H-AL#..: ,
M?PYSH<?7_6S=?^NKUL+63X9YT*$]C)*>?^NC5L#@4 %%%% !1110!E:M_P A
M'1.N?MK_ /I-/6HO2LO52/[3T,9P?MKGK_T[S5JT %97B@!O"6L@G ^P3_\
MHMJU:R/%+;?".M$''^@3_P#HMJ -*VYM(3ZHO\JEJ*V&+6($Y^0?RJ6@ HHH
MH **** "BBB@ HHI,>] "9S39/NTXTU_NT -M?\ CVC_ -T?RJ:HK88MH_\
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MS#<H6@ECE4'!:-@P!].* )3ZT#F@48H ,^M17.#;S#G!0].O2IC4-SQ:3$G
M$;<CZ4 >6>";FZ;1)$2)3MG.XJHP?E7&,L#^E;C:G,LLD1:%'C(#"0J.N#_?
M]"*Q?!7VI-&FDMH+::-YNKW+1G(11T$; ]/6MZ*SNVFGEF>*'S'#!(CYH "A
M>695YX]/YUR3Y>9MG/*UW<S)?$WE2R*4!$9(+*$*G&,_\M?>K%W/]LM);:>>
MU\MQAMDH!Q[$/D5-)H2R.^Z]NMKOO:,, K'W&/;ITJ2[7[%;R7-Q?2K$G4I
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M-A\J,!??@*?Q-02W.K#0)XS80K 89-TOG 8'S9X]JU;"XA&H:L6E0#[4F/F
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MNV6*:+RRJJ0%^4J&'![T ;^@?\B[IF?^?2+K_N"M&L_0ACP]IH/_ #Z1=_\
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M110 4444 (?I2T44 %%%% !2&EI#WH PM /_ !-O$@Y_Y"*]?^O>&M[I7/\
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M0KV*XQR3Z;OK7> 8H S-4_Y"FAGO]L<?^2\U:E96J<ZMH8["[D/_ )+RUJT
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MWUY)&"-L<CJRCC' VX%8T1S\6KCG.VR&?887_&NT P,"E!)WN#.=_P"$1L<
M^9+G'7;'_P#$TX^$=/P 'EQ_NQ__ !/M70_2D/.<^E7RQ%=G-Z-I=@E]J,$E
MK;SK"Z*C2PHQ QZXQ6M)HVER1-&=-LU#J02MLF>1CCBJND_-J^L9&,3(,D?[
M-;'''/Y4E%6V#J8VA:99V44SP*-QEDC+%4!PLC #*J*T186?F^:+2V\W=O\
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MH$\-VP &-\QX_P"NKUN"N4LI_P!C:6!C^S++'_7NG^%*-(TP$8TVS'_;!?\
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M,UU$"@9H. .#]*.V3CZUG7E[+!J.GVZ;!'<&0.2.?E (Q^=#=MP-#GKB@&C
MQUI!P">/I5(15M1BZOP6S_I /3_IE'5IB<?_ %ZK6A/VC4#_  ^>/P_<QU:)
M^E3'89Q5R3IGQ#FU.\62"P>V"+<LA,><*,%NB\@]<=*[&-TFB66)U>-P&5T(
M(8'H0?2F3W=M:D+<7$$1/02.%S^=8.GS6MCXC>QLIH9+2]B:<1Q,&$,JD!L
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M^%:Z//XUY]3XV<D_B8=Z3M0<C'I1GK69(AQD?XXK/T,8TJ$<XP/Y"K[GY20
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MC^52F@ HHHH *I:Q/-;:->SVYQ-' [IP.H!/<'^573S3)$5XF1QN5@00>X-
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MY[=*8!P!UH]>U(>1TYI1@^@/ZTF N,'GO7+ZD =2U<;@,P1@9.?^>?XCK_\
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MXIZT]E*]<]&(_I6OVK)\-9_X1ZTW')*L23_O&M;\: $9U12SD*HZDG@4*ZN
MRL&!Z$'BN!UNR;Q3X\;1+NYFCTVTM!.8HFQO<D#)R#V?'X>]9I?4O!.O3:#H
MOFWB7L"R644N&\ERQ!)[8 5B>@Z9H ])N-0M+6>"">XC26=ML2$_,Y]A5FN-
M\.^"3:ZB-;UN[>^U@_-N#?)&<8XZ;O3L .@%=E0!E:F#_;&B'L+F3\_(D_\
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MH 7.,^_Z5R^HNO\ :>JG@L(8R>GK'UKJ3C/8URVJ?\A'6%R%/DQ#<<8Y,?\
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MM@H8R&>:!I,,P+[22V?89)[5KVFN>([?Q)_9=YJ5G=^6B-(8H"@!?(VGDG/
M;\15\Z$=D=3L/^?VV_[_ "_XT?VG8\_Z9;?]_5_QKA9_$?BF;Q4FCV]WI]LD
MQE,,LL1?=Y9 *X!&#@]\YQVJGJ-_XEN_$UEX?N=3M"SN)?M%O Z%&52^W(<'
M&,9P1]X4<T>X['HQU2P!YOK;_O\ +_C2'5=/S_Q_6W_?Y?\ &N33P_K>[#:V
M=I/.'N<X_P# BIH]%UJTO%NK77/G$;1D3QR2CD@D@/(<?='0U'MJ?<+,Z7^U
M].QG[?:_]_E_QJ'2KB*YN-3DAF26/[4 'C8,/]5'W%<IK>O^)-%N8D,INH6A
MW&=+7:BR9.%;D\''J#736!O3>:GS"2+H D@_\\HZT335T(V**JXO\];?'T;_
M !I<7WK;_DU,"S5;41_Q++OIGR7Z]/NFE_TW'_+ ?G6#XOFU6W\-71MVA#N4
MC.P-NVLP# <]<&@#"\)0-;Z(L;.K-E7RJ[0 T:, ![ @?YQ6Z,5A>&ENAI2^
M:T))\L_(" %\J/ Y[[<9]\UL2"X)^0QXQ_$#U_.N"HO>9R3^)DM! JN1=G_E
MI!_WR?\ &JFJ75WI^FSW6^VRBC&\%0"3@$DGIDBH4;NQ*);R^MXA);DR23%>
M8X8FD9<CC.T';GU; J'1')TM"0R_,V0?]X_TJC%J=A9V1ACUG26VJQSYHRYZ
MEC\_))Y_&I]%%TVF1E)[4KDX(0GOSSNK1P2BS1JT6:^.:K7[#9 I9?FN(P 3
M@D[AP/7U_"IHEF6/]XT9D]5! _+-<_XHCN'@TV-VB);480"JL,'GT.?U!J81
MN[$15W8Z3/'%9%ZK:S*;6V8+# Q\ZY #?-C!C7GD\_,>W3[W0LKZXNVDMSY)
M9%.6*E@1G')! SUQV8#/'(#[:QU&R00VM[:"U48CBDMF8H/0$../KD^]-+E]
M2HJVY)9W;PR?8[PG>"%1R2<@],DCGT#=^APW4U;4$MX6@B*F>08 .,*#QDYX
M]>#CH2< $B"?1[N\PUU>0R2KGRB(2JQY]%W^GJ3[8JE#!>6^H$>;!%<9^4NC
MLLH/522W1CWY.>.P!I1BW<:47J;EA:FSL8H&(++NSCH"6+8]\9Q^%6>I[<5A
MVTU[;Q "XMDMU)1A)"<VQ[*?G^[P<-GN.W3787'DJ%DB648#,T9*^_&0?UK*
M2=Q-%&?18YKLW'VV\C;<7 1UVJ2 #@%3CH*S=4MDM=5\/1AY'"S2_,YR224)
M)/'J:Z&,3>61))$9.Q5" /P)/\ZYS7!>#7=!#36Y<S2;<1D <)G(W<U<&V[-
MCB[NQTP'''0^E &2/\*KJMZ%YEMR3V$1_P#BJ!]K'5X#]$/_ ,54*)-CD=-D
M?4-.B>=WC1=1CA,<+;?NQHN=V,\X'0BM+5E%KJM@]I$/.MK67R(EX7/F0IMP
M/4.PJA'#J @B%O/9Q1F]A^4VS,0_EH2Q(<<9QQU]ZNW&G:K-KEC+)J=L'BAF
M9&CLSP"4#<%R,X/7W/%;NU]S1[[EW0!$J7HC8/\ Z2KLQQ\Q:"%BQ^N<_C7.
MWC%/#\ELJXMVB:=F])@[#;Z=%W?5<UK:?9:E#<:A%::C;8%YF0S6A;+&*,G&
M'7 YQCVJA<:3<CP9,QU%2'5KF13;CEB=V <Y]N_''2A63U8+?<ZJ]XO].]KE
MO_1,M4?AO;O!<:L[,I$S!P%&-N)9DP>>?NU#=V^N&[L=^HZ>2+AMNVR8 'RI
M.O[TYXS_ #J#P0FL_P!K'RI+8VZPR"?(;!_?R[<#UW!_P-:44D53/3J7ZU4
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M>F?W2_X4SP]QIR^NR'K_ -<(ZU@,\5X5>O-5G%=S>-*#C=HRQ9ZGD9U+CO\
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M!:**,]Z ,#PYC^T/$>!_S%3_ .B(*WZPO#W.H^(CC_F*?^VT%;M "#K2T44
M%%(:6@ HHHH ***.M  :!TI#2CI0 AIN:=ZTE '"^)N?'6C Y^9#SCCA9N/U
MI-.P=:UL<$^?%T]/)CIWB<$^.=$'^P>N/[LM5[2[M[?7=:6:=8SYT6 W&?W*
M=/6M*7Q"EL;0 SS1P2<@55_M.R_Y^XO3[U-.J6/7[3&/J:ZTT9%K&12XX!X.
M:J'5+$#)N4Z4?VK88R+E/7DXXIW0[%K QC ]Z:>N0.!5;^U+#.TW"C\Z%U6R
M;.+A3MZC!XHYD!+;Q&.>[D./WTH=?;$:+_-34^!BLV'5+=9KWS+C"), FX'
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MBLB;1[[_ (0^7_3;81NIN3_HK[\GYL;O-QC''W>E*-DP3UW.IO6_TW3LD_\
M'RQSZ'R9:SOAB%6YUQ<8;S8]WRX[R'^M,UFYOK*XTYII[5W:Z^5([=MW*.I.
M/,^Z-W/X?BOPO$GVO7O,VY$J#A2/XI.V3^'M6M%6-*=ST@?2BDI16YH+12 T
MM !111GG% !1110 5@>-3CP9JQYR+9L8]:WZP?&A(\&ZMCK]F:@#0T;']B6&
M,X^S1XS_ +HJ]5#1@5T/3PPP1;1Y_P"^15[- "TTGCI2TGUH R?#!W>&M/.,
M9A7CTK6K*\-8_P"$<L"O0Q UJT 4=3TJQUBU-K?VR3Q'D!NJGU!'(/N*Y/\
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M_P#2>"M^L#P[C^T?$>#G_B:'_P!)X*WZ "BBDS@XH 7VHHS10 4444 %%%%
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M1D,6  P/]DUS,MY=S^*;19U&U+IT3"$;-HVE0=V#G<"3@'GTP!4(-ZCC%G9
MCM2C[XQZT@[4HY&.]9F9R%M)<I!;[;=&430/N9Y,8^S(,\1GCCKG@\=LU?AE
M*>('NYD14DMMF8F=UWA^^47!(QZ_=K7.GV1.396N0<Y\E<_RK/BL[1M9EB^S
M0F)5=@AB7 ;$/.,5NI)IFJ::'V-S$MU?LWF(KW(=2R,,CRHQD<=,@C\*S;NZ
MB7PB+=(YGGDMA$D21.6+%>G3@#J?8&M[^S+#!'V"UP?^F*_X4ITZQ)R;&U)
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MUK30O]EZB+N(#'V?422>G:51N_[Z#?6MBS>Y>TC:[B2*X(^=(W+J/H2!G\J
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M]!_2NZ(JGJ=BFI:7=6+D!;B)HB<=,@C/X4 9Z^(3:%5U>QEL0?\ EOD20?\
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M=;?]_E_QI?[2L/\ G^MO^_R_XU9!) R3FER?4_G70;&7?:Q!'&J6MU:/-(V
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M:6CI0 E,<\=13J;)]W% "6W_ ![1_P"Z*EJ*V_X]H_\ ='\JEH ****  ]*
M>*** $/2C%!Z57O;N*PL9[R?<(H(VD?:,G &3B@!(;R-S=+@C[.^UN,Y^4-D
M?G^E9]IJ]M?:Q;M8WL4]O-;N71&Y5E9<''4<,P_ 5'9W"67B":V>-XEU%%N8
M=W_/11MD4XXS@(??)I^C+;6FJZEI\(7=&4E^[R%?)VY] 5./K3L(VZ#112&%
M%%% &#X:/^E>(>,#^UG_ /145;W&*Y_PS_Q]^(@.G]K/G_OU%704 %%%% !1
M110 4G7K2TA- "T444 !&:3&*6B@!.:1N].IISVH \TOB3XPL<+C_B8)@_\
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M Z7\Z"<=LBLA[B[U.Z==.G:&UARK3X0B5^.$RIR%Y!/J<=C3_LFJ#KJ+G/\
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MXZYCQCUY%:]9'B@9\,WXR?FCQP<=2/2@#8/4TE*>II* "BBB@ HHHH ****
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M4GFKN"MLXVOQAACJ.?\ .*>6 Y)SGWK/TNPDLFN?,2V3S9 P2!-H7Y0",8&
M"./S/-:!3(QM ^E<TXQ4FHEQ=U=AGGVH''/?Z5SS>)[1VF\@PKY:DIYO!E8
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M@ HHHH ****  ]*BDZ8J0]*B<\=.E "VW_'M'_NBI:BMO^/>/_=%2T %%%%
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M$VH:;;Z6_GP6UTEU<7* [$"9PH/0DG XZ#-(#J:0\TM!YH 0T=1C%'6C&,T
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M ,[_ (1S,KQL#/)PB$<[CDY).?R%=(J70D!DN(63G(6 J2/KO(_2N>\!L/\
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MQUQ74B^3^VV?R+H?Z, 1]G;/WS_+)KE?&5SYFDW@$<Z[M3C(+QE0/]&48/\
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M>3(/N#L'P/PK6_X1^PSUO/\ P.G_ /BZ -+OFG>QK*_X1_3\\?:^O_/]/_\
M%T?\([IQ&,7>/>^G_P#BZ -3IWH'2LL^'=/*[3]LVGM]NG_^+H'AW3AC NQC
MTOIQ_P"ST 4];:;^V[,6P+3?8+TQKGJ_[K _,^HJ]I<<:L["SNH&)(_?2LX*
MYX/+'!(P?TIC>&],:5)&2Y,B JCF]F+*#C(!W]#@?E3E\/:>N-OVP8]+Z?\
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M)2^X $CYXUXSQU85=#_>5ZDS_AFL/^0^_M:J#_WV<?R-<EXU;&EWH(/.JQ@
M?]>PKHUL[G^V)E_M.ZR+=,MLAR?F?C_5_6N3\9P2)IMT7NIIQ_:<8*NJ8/\
MHP.?E0'...N*^ED]#RJ:M+<W]!O7%YJ#"&X8$IRD9/\ %)_C5[6[]FT'4A]G
MNO\ CUEY,9 ^X>_XUS.D)<1W-S]DL%WB.-_M4-P4*[BX!=%C.\'DD$$#]1?O
M]<O+OPMJ,L=A;RA+6<32Q7+;%VHV2,QC.1\P4$G!&<9S23TLRIQ;=U^9;T.X
M"_;BUO.V9Y,J(]VW$LG&:M:+?.FGL!;79'VFY/RQ$]9WXJMH\UWF]$=M Q6>
M4.&N2H#"63.,1G(]^*BTO5;JSLI?M%A!%;+=W $[W;!23.XQQ$<<G SUX[\4
MUHB9J[:7YES5;X&2PW6]SQ=J.83R-K\#U_"L[7&BO/$.@V\MDXB,DNY+B#"L
M,+V(YZ5'J6K7>HW]A906<8B-S&QN8[Q@KJT<A 5O*!&0K?, >G&#@AFIVKVO
MB'P^\6G6L+"24E;>8LS_ "J/F8HN3SU.:&RHKEW-@Z3IRZQ&%TVR"&V<D?9U
MQG<G.,>YJC>:;IXTCQ(RV%HK(LH1O(7*?Z,AXXXYS6@;BZ_MF-C9-_Q[/QYJ
MY^^GO5&^GN/['\2"2SD"D299I%^7_1T'KVZTW8B*E^1F>&+BVAT338YKJ"-A
M>[R))%4C$1QP3TR *T-;N+*]U>WM'O;58KBUECDE\]0(U#Q-G.>IVX _'M57
MPIN_L73.!N-[QC_K@?3VKI22-<3G.;8_^ABB*O&PY22E?U,KPSJ=J/[0\Z\M
M$D^V\CSUP<11 E<G)&0<&N=:XM6\.I?_ &FW#F!+(Q^:N_9YJMOP#G[P(^A!
MKM=,+-J&K!@<?;5Q[CR(?_KU1DD/_""19R/]"C&.O.T4.+:$II-LM7VH63WV
MF%;RU(%VQ8B=< >3+[^M5_AJ4:SU)HW5E-QC(/'5C_4?G6C>'&H:5CO=-V_Z
M8RU1^'1)LK[(('G]#[ECZ>XJ*ES6A:VAW HSS2"C//2LCH%'-**3.* : '44
M@I: "BBB@ KFOB ,^!=5YQ^[7_T-:Z6N:^(&?^$$U;;U\I<<9_C6@#?M.+*
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M $_VC%CZ[6JWC@\]?TKAQ;TBSHHF4=)NLL4U2898GYE#$9/N>PXH72KL$?\
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MG9UZ<UIZ3J%H]UJ4J74;Q-> JRG(($,0//U!%9DFKZ:/!D,)O;<2_9HXS&)
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M1M-1F>-+>$,QO)T;.Z0]6<$\$?G3=+^VW&G6=M9WS A 9VV*5A4Y. <<N<\
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M_P!T_AQ4E1S\V\@ZY4\?A0!F>%>/"&B]/^/"#_T6M:]8_A3GPAHN>3]@@_\
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M-RQ8=_\ <S\Q_!<G\*R/&L(E\.2,TL\444T4LIA/)C5QN!]L9S]*?XEEN?\
MA'I[BREB$"P2>:LBG:T97J".1@<B@#?!R,T5#:1B*S@C#[PD:J&_O8&,U-0
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MMIVOVM]*UO(\4-R#\L7F;MZX!W*<#/?..F/>LZD)+5C12\6\QZ, 3DZI$/\
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MOM>TUKMHHUA?<L;3[UW;)"&Q@+D$#KR..E=ZIOFN87-#P?%-%H2++ L4)<M
M/XRA_P">@ 'S<9[]>:W^?SK+T"^M+S3(_LUQ'*$R&VL#M^8XS@\5=COK6601
MQW$+.>BJXS43NY,$<]KC;?&.AY'!4@<'KYT1_D#^5=N.E<EK-];6FH0L\\8(
M: $%@"/](BSG)]#FNB_M.P'_ "^VW_?Y?\:[J/P(E[EOM1VS5,ZKIPQ_IUMS
M_P!-5_QH_M;3\?\ '[;?]_5_QK01<JEJO_'K%Z?:;?\ ]&I1_;&FYQ]NMO\
MOZ*S-8U:)HH5A$<D:RV\QE\T!<><!C/U'X4 ,\(9-M<\Y'^CX]O]&BKI#UKF
M/!DL4EI<!'1CBW)VL#_R[Q#M[@C\*VGUC3HV*O>VX8'!!D'!H NBEK._MS2S
MQ_:%MST_>"D&O:4%S_:%O_W\% &E1FLX:]I;#Y;Z ]N'I?[9TXGBZCR.O- &
MA14$MY;P(K2RJJMT)[THNX#;_:!*/*_O=O2@":DZU4.IV@Q^^'/L:#JEF,YF
M QZ@T 6\>]+5#^V-/SC[7'GTS0-:TTG'VR+/IF@"_FBJ<6J6,\JQQ7,;N3@
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M]AJQD\07[^4I\M6O5P_[H'!&.>2>E8,$=H-?N42\U%XP@$4LBN&W;$R6.!D
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M9Z?JP4:CYMNRW&)977#-_H['D #/+?K3=<UBQ;Q%X?,=U$5BGE:60.-J Q,
M"?<_RHO[HK-R3MT-@6L_]LX%_<'_ $?.=D?][_=]O2LG4(I1X?\ $3_;)6"F
M4$%$PW[M!Z<?_6K1_MS21JV_^T;3_CW*L?-'9L^ON:R=1UK3)=#\01B_M6,A
MD,:B526_=)T'UINPH<UU==B/P]<1P:;I D9E*S!R=K'Y?LI7.0,=<#ZUN?VE
M9C5GE\T[/LZ@ML;&=QXZ5SOAJYM4TK21(T0(N1D$#/\ QZD?S(K<-YI2ZR=T
MMNF;8##+MZ-[^F?UHB] G&[>A-9:E:1W%]NE*A[G<&,;#(\M!D<=./TJB]Y;
M_P#")V]ON83+!"I0Q-D$;<\8JSIM]I;7&H-YEL8S=\,,'(\N//ZYK/DOM*?P
ME;1M+:F58(5V_+G(VC'USVIW#EUV9L7&IV;WVG,LVY5N"Q8(W \IP#T]2!^-
M1_#5R^AW#,&#&X8G/N21^A%.N+O31?::1) -MRQ;C&!Y4GMZXJ#P1K5@ED;=
MKF, 1JP.X8SEAC\@*RJ&U%61WH(-&3FLX:WII/%[!_WT*<-;TT_\OT'/^V*S
M-S0'O2UB7NO6_D@65U \A)+.#O\ *15+,^ >>%P/<BHUU"2U>VD^V27EO/D$
MR1JI4!E0L, ="PX(Z9YXY -^E S2 Y%*.* #'-+1UHH 3H*YGX@\^!M3X_AC
M[_\ 35*Z?O7->/R%\$:F3_<3OC_EHM '00#$,8/90*DZ5'$<Q(1W J0&@ [5
M'<$BVE*D!@A()^E2=*BN5#6LW. 4(_2@#/\ "X \):-CI]@@_P#1:UK5D>%B
M3X2T4]<V$'_HM:U7!92 2/<4 17=Y;V%K)<W<R0P1C+R2-@ ?6N#N?B'<ZMJ
M-KIWABS#&YE9$O+P%(WV#+[5ZG QR?7I7>*A,+1S8=2""&&01[UR&I?#NT-_
M!J6@7+Z1>PR;P85!B.>#A.@R/3CVH ZBY/\ Q-+(9(_UGX\"KW%4;G']IV6/
M20?A@5S.OZW<6NK?8;#7%BG=LN)5B$5LO'WB1DD]@,GUQQ0!VE%0V;![.%Q<
M"X#(#YR@8?WXXYJ:@ K*\1_\@5^"29H0,>OFIBM6LGQ)D:))CKYL./\ OZM
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MMT_T:&NCSS0 N>]'/K12"@!>:3'O2T4 %%%&: "BBB@ H[T44 !&>M XHHH
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M\M1"EV<;[9L\HC8&)!@ ' ]A65_94Z^#[$FZM@D?D7&[[,2Q)*'D[^1CCIT
MH:NAIZMW.MNG/V[3/O'_ $EO_1,M0^"H+%;,SVCK(QAA1W63< =I8KUQU<U!
M<QZE]MTXM<61;[2=F+=QSY4G7Y_2F?#48T&?)Y-PQ/&._IVJ*FYI0.U%.Y_"
MD'/K2UF=!1U33AJ5KY1?8PSM/.""I4@X(."&(X(]>U9\/AQ!/;O(2(K=MZQ+
M/*P+;@W\38QN .,=0.<9!W\4F* "E[T'I2T (*6B@4 !KF/B$2/ >JG!/R(,
M XZR**Z>N9^(.!X'U$DD?ZKI_P!=4H Z"#_CWC'^R*E ID?^J4^PIX% !45S
MG[+-C^X?Y5+BH;KBTFQG.P]/I0!G^%OE\):*/^G"#_T6M:]9/A@#_A%-'QG'
MV&#'_?M:U<4 *<4T  U@^-[J]LO!NIW&GM(MRD.5>/[RC(#,/<#)KS#6[S4'
MU*'5K3Q!)/)=2V?V*""[_P!:^Q1('B4_+\RCC 'S4 >Q7(SJ=EST$A^O ']:
MN 8JG/@:I:'_ &9 /T_PK,@O=?:\OTCTZ&6&*Y*1-<3- =NQ2-H"-N7)/S9]
M1VH Z"BHX&E>"-IXUCE*@NBMN"GN <#/UP*DH *RO$?_ "!7_P"NT/\ Z-2M
M6LKQ%C^QFR 1Y\'4X_Y:I0!K'K24'K10 4444 %%%% !111C- !1BDY%'6@!
M*8]/ICX]* "W_P"/>/\ W14M16__ ![1_P"Z*E/% !1110 IZ4E%% ""C<-V
MWOC-+6;?17/]JZ=/ C,@,D4VW  1ESDY]U7\Z -!AD$5S;^%Y[*2:[T;5;N"
M\=M[)/)YD,I]&4CCTR.:Z*=I$AD,**\H4[5=BH)]"0#C\C6;!K4> +^WET^3
M(&+@C:2>P8'!_2@"_9FY:SB-ZL27.T>8L3%D#>Q(!Q4](K*ZAE((/0@Y!I:
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MS9W'/4P'IC_EVAKHZ $-'6EHH **** $[TM HH **** "BBB@ HHHH ****
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M?#'!T.YPP.VY=>!C')./US^-35O?4NA:VAW(Z4[KVIHZ4M9'0+_2C-)2X]Z
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MKFC'-(W3'ZT 8/A8Y75R1_S%+CO[BN@KGO"@_=:MU_Y"MSU/^T*Z&@ HHHH
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MD]A^OHSHROH9I,3706\8Z)G("C/U_?1?_6KMQ7FCMJ#>+M$:]N4DD\L;]L>
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M!X7@O7MP5B-XY1<8*C:O&.V.F/:N:C _X1^RFQ^X,5K&@Z+YPDBWGZE1C/\
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MML53FWNSJM%@F_L'3O\ 2RO^C1X'EJ<?**@UJWE_T=9+IW0^8&41CD>6V?\
M#\:QK3PUJ,^DV+07;0@VZ$@7]P<_*,'&<#KT Q27>AW5BL<MS()6VS?.;V9L
M8B9@=K9&1@_7--WMJB4H\VY/IEAH7]FV<ES9W$[;5D/F6$A&\@$\K'\PR>Y(
MJP;GP[;:K.)K*")/L\157TYEYWRY(!3Z<]\>W%O2IK=M,LX?[2?S1&B%%=>"
M%'&,9':JSV^F7VM3Q3W\S?Z/$ !=M'G#R9!VD XR.OK1LM 3U=[BS7_A00R
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MC<PR/EQN&!VYZ'M5"_B:3PMKDZWT\L6^3 (0K(,+R?ESS[8K5L_#^G7-NSM
MI*SRJ.!T61E';T%/ET>PL8X$BMT427"A\@'.YN>ON:OE=C/G5]S&\/V,<^G:
M.YDN?GD0$1W,B*/]#)X 8 '/I[BM;^P[.77'+M>L8[5=K&]G##+MGG?G' _*
MH9].5K^\<7]E#! RHL5Q;JP0"-#DMN4@<GO6+9374MA:RR'2=T@4,\ENRD#9
MN,C$$#;G*YZ;CBEMHROBU3.BTO1K>-KT))>(D=VVT+>S ?=4DGY^N2<UGG0;
M+_A%+.51=@F.W< W<VT,60Y"[\#DGM3;G3)Q<62PZI8^5=2%#Y=DI7_5N^02
MY)SM'>EFMG@N$A6ZT1VSL9S P\K@D%QO( ^7 ]R,"C;H+5[,V;C2H!J.G+YV
MH8:9LDWTW_/-O]OC\*9\+RK>')MI)Q<N#G/KGO[&L;2[2?4HY2][IUNZR\I]
MC!DC!P0#E^.#CD9]ZV_AEM'AR4(,(+E\<Y[G_/X5$S:DK71W&:3/.*0=:=WK
M,U"BD&<TM !2BDI10 5%<O!%"SW#1I$!\S2$!1]2:E(JEJC!;+<59V$D>P+U
MW;UV]C_%CG!H S[R^TRWM;BXLK^W%P(B8T2Y!5F X 3)&<XZ"L?Q'&8/ NJQ
MNRG9<*,@!0?WJ=AC%;=O>W#R!1<O*A<*2B!<98KD$@AAD8[']*H>-(%M/!.H
M%"<F2.0ENY,J'M0!U$>?+7.,XYQ3J;&24!XY%.H *JZDP33+MCT$+G_QTU:J
MKJ0SI=V"< PO_P"@F@"OX=&/#.D_]>4/?/\  *T36;X<.?#&DGH#90D#T^1:
MTZ ,GQ$EY)H5PMAI]MJ%RVT+;7./+?+#.<D#@9/X5QWACX=ZAIVJ?VG=:C_9
M[E@YL],)6,_[+%LY'MCZ&O1C2T 4IL?VQ9C)SY,O'XI33K>FKJ9TYKN,70(4
MQ\\,1D*3T#$$$#.32S*?[:LSGCR91^J?X54E\,:9--+*1=HTLPG<1WDR*9!C
M#;0V >!T':@#9HID,0@@2)6=@BA078LQQZD\D^YI] !65XA.-*7@G-W:C _Z
M[QUJUE>(BPTD%>2+JV./^V\= &K101BB@ HHHH **** "BBB@ HHHH 0U&_I
M4IZ5$_04 %O_ ,>\?^Z*EJ*W_P"/>/\ W14M !1110 444QY$B3=(ZHN<98X
M% #Z*SKK7M'L3B[U6Q@/I)<(I_(FL]O'?A=7VG6[4D<$JQ8#\0,4 6-?L[J>
M&UO+%!)=V$WGQQ$X$HVE63/;(/'N!5JQUBRO[-[F*956+(F$AVM"1U#@_=(]
MZSX_&_AB4_)KEEUQ\TFWG\:9<0>%O$Q++<6%U*PV&6VN%WGT!*GGZ'(]J -B
MQU&RU. S6%W!<Q!MI>&0. ?0X[U:/O6'I&C6FG:O>S17TUQ<R(BRI*R$H,L0
M3M ZC@9SPOUK<H 3H:6D(HH P/"F3!JO&/\ B:7/_H==!U%<[X0XM=5P /\
MB:W73_?KHJ $I:3ZTM !11WI/I0 M%%% !1110!#<7,-K%YD\BQID#+'')X
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M\\\UB^+;);+P/?PQ_=:2-@D:A0-TJ< =A5R$7S[BT$D>T@ 9D*C)8<C=EB,
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M:E;8R?WZ]NGR7/3_ #WKMNV*XC0R(]4MUQ\QF0$_]L[G_P")-=N#0 4=Z**
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M:</^W>3_ ..50VZQ_;@#7-@7^S9_X]WQC?\ ]=/I1R(7._(SU3Q=EO-N[C8
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MNG)]F9MZH(V&J3KAO+)SP/E^4-T]:.5=@YY;W,[0_#92^N[:&^,:QRELJDB
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MK9V>=;[)XT.]<.GWEY'(Y'(_"L34] T]=-NW"W/RPN50W<IC^Z<#86VX]L4
M7O#XQX<TL#./LD6,_P"X*T:SM!R?#FF$][2+_P! %7UZM]: '4444 %%%% !
M1110 5E>(?\ D%QY_P"?VT_]*(ZU:RO$1QI<9QG%[:''_;Q'0!JT444 %%%%
M !1110 4444 %%%(3B@ /6HWJ0U&_P!: %M_]1'_ +HJ2H[?_CWC_P!T5)0
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M>CVLYT33C]NN1FUB. D>!\@Z9CSW_2BZM9?[0T_-[=$EWP2D7'[MN?N?YS7
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MX8NEBF\LIDS[(P<C@A9&_P#93^==<*Y+PJ\ <K( )&\ORL@DYVOGGMP#76T
M(<9I*=2&@!I-<-\3'6/2;$NV ;H <'J4;%=R:XCXCC.GV#8!"W!SG_<:@<=R
MV1PPR.M5;^R2^M=C2-'(C!XI4^]&XZ$?RQW&15L\L<XZT<'IFL.IW6NK&)H$
M[WFH7K7Y'V^VD,04'Y47)Y3V..O7C!Z5OGZUS%M8O+<:A<6[+#?074C0N5X8
M%C\K8ZJ>_IP:W=/ODOX'8(T4T;&.:!_OQ..H/\P>X--]R8/HS%U*_NSX@CT\
M2(+=V1738#E6!!!#*0<GWQ_2;2;B2QF_LZ<M);^:T5G,Q!/&?W;>^.5]0,=N
M77FDW<FJF\@D@6,E'*G.YF7U('L._P"%6TTY)].N+:]1'%P[LZKG')R,'U&!
M@^HIW5A6E>Y+J>1I%X?^G>3G_@!J/2@#I< QD%3G=WY-47NI[>VO=+OSNN%M
M96AF[7";3SG^^,\C\1P:OZ00=+M]O3;_ %YI%7390C?^P;M8&_Y!4[[83_S[
M.3]P_P"P3T]#QZ5N'.<9QV]*BN+>*Z@>&9 \4BE60]P>M9MA<2Z?=QZ5=L&#
M9%G,>KH/X&_VU&/]X<]<T;C^%^0^>W;4K6VOK8B"^C0/"Y.1R.4;U4]_SJUI
MU]'?V[.J-'+&QCFA?[T;CJI[?0]"#FIK5HFMHF@XB*C9QCCMQ5._LIDN1J5B
MBM>*NUXR<">/.=OLW7:?7@\&C<&K:HJSRJ/'.DQE@"T?"^I\Q3_)2:]%'2O-
MX;N*]\6Z1<0LS0M#@!AM96\U<@@\@@]0>F*])[5JMCCJ?$+VYH/2C-+3(&U4
MO[K[)%&=NX22",G=C&>]6S574#;BW47&W#2*J;AGYS]W]: ,?P?G[%<D_P!^
M'_TFAKHJYWPB1]BN<#^.'_TFAKHNU "TM-!IU !1110 44=J* "BBB@ HHHH
M **** #O1WHHH 0]*04IZ4G>@!><5C>*V5/"FJ.V<+;.>.N<5L]:Q_%*[O"V
MI#CB!FY]N?Z4 >4K8ZI)X8TR[LI9F/V@^0L;L/FW..,N<<9Y"^M)IFF>,M16
M6Z6_GB95"9N)Y(V/?C*\CDC/KGZUU&AN1X:T-B5Q]L())Y.7D'^%=6<8XQ[5
MO&%SDG5:Z'E$.A>*H&OFAN26@N@THBNV+-(T:,2/E&20XY..AJ!]-\57.F7U
MW/=SK''&T<@N+B1&8#G@%?F'/MSZUZ7IA'V_6AP/],4_^2\/^%,\0C/AZ_X_
MY8L<CZ4_9JPO;-.UCCT\.>,85VIJBJ@8D(+^3 Y)_N=:A30_$XU=A+>F2X%J
M,.FHNI +_P!XQGNO3'IS7I#8)(%9PS_PD+C/6T7C_@;?XBG[-$JM)WT.4_L+
MQ6BR&347<;2 %U-U[=>8CGZ<?6L+Q41:^&=+AD,QDFM8SMDNC)QA3D*>@X]/
MY5Z3?WI0_8[<*]W(IP&/RQ+_ 'W]O0=6/3@$C@?%MM;6_A#2E3#/-$KES@LS
M$1DD_09 '8<"LYI+8UI2DWJCA+&"&ZU&&"ZNX[2"1L/<2 LJ#&<XIK8#.JR*
MX#D!AD;AV('ZTWC!]30B[CDD],9-9'2>K^!8A<:9A;F6,K!;*1&5Q_J\]2#T
MY'X5VL:^7&JEV;:,9;DGZUS_ (("GPEIY'_/),G(_NK71=ACK77!:(\ZK*\V
M8[WD%QXAETM9KQ+A81*=A7R]N1]3GGTJQ<V<B6-XJ2SS2/;R1K'(0025(':L
M.Y@A/CJ)Y)[=W<#]P0V5'EGKD;3TSUSR.*W-'"K8R* % N;@  8P!,X''TI)
MWT8YQ4;-%'78)=0>UDMH1)Y3N2LR,O#*1D?(W(Z\BN;33Y8_&5DU]'9HES&[
M!)8_,0;$ Y!6,9.[/ [5Z#M^E8FL6UO>:MID$W#GSF7"*3PHS]X$8Y%*<.I5
M.J_A>QSFG^#AJFCQS"6UC#/+TL22/WC<$B0 CCCBI)/!BVHMX_M-G(9+A/F>
MR)8XR>?WO3CD5=LM&M97BCB+"1+J621UBA!C597V\A."2%X],^E7=7@NX[K2
MXH;^<&6ZQOD1&VX1CP !FI458MRES:,R3X"#-N^W6V.2%%B0/_1F<4V'P8)Y
M;V-;BS39<JI*6!!XAC/'[SIST.>]=#_9>J#KKLH!XXM4_P :YR&SOM5LPEQ?
M;DOKR,2J;964G[.L@/\ XZ!0TNPHRD^HR_\ !+6NCWK_ &VV<F%R&-F<@=?E
M/F<'WP:N3>!'E<[;ZUCYSMBLF &/3,A]Z;<:)=Z7I^I01:B1$+7S75;15#8#
M Y.>.!5J[T_4-6L+**XU+?%?%&:-K5=HPAD]>>5%%EV'S2MHR/3_  VEKKDD
M3)IUQ_HJ,&ELB1]]^?F<\^^1P*TOA9*)/#$Q!!Q=N#CUP/Z8K.L=$O+'7KBW
M@U/RB]K&Y*6B@<LR@ 9XZ"M;X9;/^$9E9!M#7DAQG..G%9S-J3O<[6G9I!TI
M0*@U"BBB@ HHHH *JZA#-+; 6ZQF59$<"1BH.U@2,@''3T-6JK7UR]K;!XTW
M.TB1KZ LP7)]AG/X4 <^NB7L:%8[6%3O5U<:B^X$;L ?N>GS-^=0^)8KJ#P2
M\=Z1),;F$<2;^#.N 6(7/'L*TSJ($#3_ &N0Q*3E]T1. <9VXZ>V=WM5#Q7.
MUQX0F:4#?'=PH^T'&5G09 SG% &[K!=-'O7BMTN)%A<K"Z;U<X. 5[CVK!:'
MPL+':)-*^T$<.+:$R[NO^KVY_#&?QYKIKIE2VF=I6B 4DR* 2OO@@]/H:YG^
MT;B\*_9]<FMK?.6EN5AWL/\ 9C\L$?5L$?W30!M)"EQX>BBN46T5[91(B *L
M7RC( /  _3%<M?MBRO#8*-4S"PDFB:2+"!3@^9DI)C)X!'>NR);[#NA N6\O
M*[V"^8<<9(&!GZ?A7+:Q?:M]AD6^26S26.56$$'F!0$8C,F6&"<#.%ZT ='H
M@']@Z=_U[1?^@"K]4=%(;0M/(Z&VC(_[Y%7J "BBB@ HHHH ***!S0 5E>(>
M--A.,_Z=9\?]O$=:M97B#C3H>.E]9GI_T\QT :M%':B@ HHHH **** "BBB@
M HHHH ::8]2$5%("?:@!T'_'O'_NBI*CM_\ CWB_W14E !1110 4444 %%%%
M '-273>&-1F:Y _L:ZE,IN/^?:5NH?\ V">A[$\UT22)-&LD;K(C#(93D'\:
M)%61&210RL,$,,@CTK!;PQ]ED,FBZC<:;D[C#'B2$GU\MN!^&* '^#I6?PY%
M"W6VEEMN>H"2,H_0"MZN#\+OK@AO8+6_TN1A?3D_:('#2?/RXVMT)/H<5U]B
M=3P!?I9Y"\M;N_)_W6'3\: +G.:".*6@]* .;\&Y&FWY.W!U2\(Q_P!=FKI!
MS7-^#/\ D&W_ "21JEYG)S_RW:NDH **3K2T (3SUI*4_2D H *6DI10 O-%
M%% !1110 AQ2&G$4TCD4 <5X>(^V6H(Y,J=,?\\IOTKM:XKP^?\ 3+3(7_6K
M]?\ 4R_X?SKM,T +WI"*.E!ZT -/2N'^)(W:78H'"DW.>F<_(U=RPXKA_B1Q
MI^GG:[ 7#$A$+$#RVR>.WO0..Y5U2WNUU""^L%W31(R2(6P)DR"$)/0]<'U/
MI5ZSNXK^T6XA)P>"C<,C#JK#L1Z58())/OSS63>12Z?</J5JC.C#_2K=/X_]
MM1_? _,>X%8^1V6MJ/T;_7ZGD''VI\'_ ($:DO;.:.Y&HV*YN4&V6+H+B,?P
M^S#JI_ \'BM8Z?IVHV\ER8HIA+-*5DQG<I=L8]L59&@Z:<9LXLCOMIZ"LVB[
M:74-]9I<P,6B?N1@@@X(([$'((]JF(QG(-<W>Z'9Z?-_:$5FDD _X^853)(_
MOK[CN!U'N.=&#1](EB2>&U@DCD4%'4<%2.H-%D4I2VL&O6<=YHURK@AHXWDB
M=>"C!3@C_#N,BH/#UVLVG+;R+Y=S"2)$/&<DX=?]D_H<CM5E=!TT?\NL;'W7
MFH[K2]L$36)6*[M@?)9B2&'=&/=3^G44M-@M)/F-(^H&:K7UC#J%F;:8$*Q!
M!0X96'((/8BBQO$O8"X5HY4)66)_O1L.H/\ GD$&K0)P![_E2ZE:-&1X>O2]
MI'97.U+N&)6P&_UB'I(/KT([&MGCCO[UB#3S=:58RPOY-Y!&K03[?NY RI]5
M/0C\:OZ=J'V^W;S(6@N(F*30-U1A_,$8(/<&GOL3'31G/ZCMTSQU8ZC#&3&T
M8DNTC4L6&]1N ]>F?92>M>IV\T5U!'/#(LD4BAT=3D,#R"*\^G8CQSI7[J3#
M1A=X0[0?,!P2.!]TXS7H@Z#^E:QV.2I\3%/%':@BDID"\5F:U_QZP=O])BY/
M;YJTJRM>S]C@ !(^TQY&?]J@"AX/7;8W.3GYX?\ TFAKI,]JYKP< -/G Q@O
M">/^O:&NDH 6ER*3K10 ZBCK10 44=J.O(H **** "BBB@ HHS10 4444 (>
MOO2$$4OO2$YH 7MFL;Q7N_X135-GWC;/@^G'6MD'M6+XL('A35&(.!;N>!GM
M0!YG;VFM-X<L'M9V:,W(\I%N71B1(W3(*@D@\GVXIR+XOFN5CBNYB&WJF;HC
M=M8*YSM'W2<$D#V#5+86.HR:'ID@N9)+=[IE2T,:J8R'D!'S8W=#PV.N.*V/
MLXD=$M]IE?>(\64*EO+(5B&!R-IP/7TS6IBY&%!IOBHZW>06^IHA+;I3)>.V
M\K'#G+!!VD7L.GYU]8M_$L%A=V]]=S3$V[N!'>G:8Q]YR"GS ;@".#R.#6Q9
MZ7JKZS?1+J[1N'<MA ^?W=MGYR,C.5YQQMI-;LC'I5U#= O=?9Y)=WV>.0E%
MP&<.?FP-R]?F]!1;02EJ5YM.\7B&6\34&@C16D\J>_=VV@$_PH/\?>K)TO7_
M .V&471#?9=H_P")I)UW_>SY7IQMQ[YJY>:7J"6%U)!>O9VZPR$Q>5&0Z[3Q
ML'RKGU!S5TV]W_;Q0:DX86X))B0Y&\^W^<U2B0ZC\C";PQJ\TS2WGV2Y;;]Y
MKQ]PZ]S$<_3CZURNO:?%;>$](NUM8X6E0%I$D9C)D Y*D?+U[&O4FM+X*<ZF
MV,<_N5_R*X+4=(O-3\,>'K6&[C8S0@QK(A 7]V#CY02?Q':IG&Q5.HWN<%;?
M9_M,2W;RK 6S(85!;'J >*8WE!G*$E<D*&7G'OSBNG?P!JPF6'S[(RLK.%"R
MX(! /6/_ &A^=.3P)K$LDJ+-:N8VVMA9.&(#8YC]"#^-9V9OS(ZSP7J!BTI(
M9;^UA1+> HLVT'YDY(^8>@KMHG62%)%D1U89#H?E8>H]JX30=0&AVXMXM3TW
M>8(0XD:1,%4 [A?6N@7Q+!L!>:P9L<E;L@$_BO'4>O6MX2LM3CJTVW>*(KV!
M#XC%U<:I;1Q1IB-)+C'EMM'(7(QGYN_3UZ#1TU[9 8;>\M9QEI"L3@MEF)+'
MYCW)K*/BP.J26]]I8B905#S-GG\OY4]/%(WH)[S3I!*<($F89/7.<$=,T)I.
MX2C)JQO7$JQ1%VEBC P-\AX'UY%<IJZ)JWB?1X/M%G.HBN690K,%X3^ZX/TY
M[5HOXDB.1%<:>&P"&-PQY^@4?SK,6\;7/%.EXO(7*17*C[&S[OX<YW#IQ3E)
M/05.#CJRK!X*%Y%+-%<Z= IGG7 T\D\2.O)\WG&./2H+WP:]M=Z=#]JT]S-<
M;=WV C&%)PP\WD''3CZ\5U'A^SDGT:*9I;HN\DQ.'/7S7I=4T>9I[!X[FY1E
MN/E:3<X!*D>HYZU/*K%J<N:QSEWX NFM9!#>6!?^%%LS&IYY^;>Q'Y&L'3_"
M]S.EO(DEHK2RI&H:WS@F 2<G>.,=>.OIT'HW]CZGDG^T&_[\O_\ '*Q1HU]9
MVMR\=Q+)]ANDV)%;2,Q_<QH2%#]0C]O3M0XJXXS;5KG-7O@^[@M[@RSVQ:&W
MWD_9NBDM@Y\SKD$=#VJ>+P;>M#:.DUJOVCE!]FW8)0MR3)TVCTZ]JW);34;N
MPU6YDFN8HEA\O]_:/'Y@ ).!O/'.._>KUWI&I6%I%)'=W$XM64+'%:.[$?<R
M!OSP"32LAWEW,'2?#-[8:O);,MK,QA20_NMHY=@.2S<]?3H/K73_  M);PO*
MQ8L&O)",C'7'_P"NLW38-4OM:N&$L\:K @1I[22,NH8_PE_4D9S6G\+5V^%I
M/E90;IR ZD'!"D=:B1K3OK<[BE'6DH!J#0=1110 4444 %4=6:-;-6D1W_?1
M!%3&=_F+MZ]LXS[9J]6?K)VV(8,%99HBF4WY;>N!C(ZG H H#43(1L>%SN7D
M3#N2!C]UDY(.,#!P>>*S?$N5\&79E0H6O(F.[)SF=.>0/Y582UN8]Y2S(W%3
MD1RY&,XP?,XY9N!@<U5UW?\ \(3*&9Y'%Y$&\S<2A%PO'S$GCIU-,#I-:2YD
MT:]2S#&Y:!Q$$;:2V.,'C'-5$U6_^V2;]%OQ;[$V<PY#9;=G]YTQM_6KVK>:
M-(O##;I<2^4VV%TWJYQP"._TKGVM/#7]G&!6L?M 7&];2(S$CG_5A.OMMI ;
MEH)8-!MUNI7BF2V03/D,RL%&3GD$YSZUSU]J&[^U(3JMVUNMFIB_<KAV(D##
M/E^@7\ZZ:U<PZ5 T\(A985+Q1+D(<#*@+GITXJCJ.KZ?-I-[''>0&4P2 (9
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MS6,I?!FE#DWQY'_/@@'4]!MQWJG/H%A)#=/9SVSRO=QI#_Q+TVD&./D;5R
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M@5)9E"C4'''FL!T?'3'YT^\AL?-L@+V4YN.3_:$G V/_ +?'04^56(YY<W_
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M5I_#(@^%G"XP+J0#'T6HDC:F[G;#BBD'3BEJ#0*7VI*7^= "T4#-% !1110
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MB/\ W1_*GGK0 4444 %%%% !1110 4WO3J0T 4DU6REU6335G4W:)O:/V_\
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M %\#_P! :@"GX/\ ^0;-W.^//_@/%71USWA$8TV;[H/F1Y &!_J8L?IBNAH
M7%+3:49H .G-+2<TM !11WHH **** "BBB@ HHHH 2@49QFC)(H ":3-%&:
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MT>YS]]N?]=NS^./:MF[TNYN+:ZO8[V:)/(<E8C$WG'!^^50+W]_8BK2V4_\
MPD5P!=W?_'I$<[8NF^3 _P!7]?SJE%$.<EU_ YBY\.:K _E?VB+N60,Q1GN
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MP/MDO&.GW:SD;4^IV0IWO3<9-+TJ#4*6DI10 M%(#2T %%%% !1110 4444
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M $V2@#4HHHH **** "BBB@ HHHH ,4&BD- "9J.3'7&:DJ-_I0 ZW_X]X_\
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M.X8XY4YR#TP<=JUXXW#[C,[CT('^%9GDW%[&+Z"14OX)IHHW(^61%E9=C^Q
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ME;E !UHHHH =D44WK2B@!:*** "D[TN>:,<T %-;G@?C2YH- "#BE-)WI2:
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M<'WJ4=:,<4>E '-^" ?^$>;/7[;=C_R8DKI#7.>!AGPRIYYN[H_7_2)*Z/%
M *6D XI: "C%%% "8HQ2TG>@ ]J0BEQB@T )161JVHBUE*23M;6\48DFE5-S
M')(4#@_W6R<<<5!8ZHZM#*QN);*XW"-Y%4N"JEL@)R00".><@>M &]2?Q 51
M&L6A&0MUUQ_QYS?_ !-*=6M05REWR?\ GSF_^)H Y[PJ&"6F&8 JN1G_ *=H
M>U=?7GNBZS]AMK>18)72*+<?W,HSBVAR!A#Z?Y%=H=6M@,[+SKVLYO\ XB@"
M[^-'>J/]K6IZK=C'4FSF&/\ QVIKB]BM659!,Q/010/)^>T'% $Y'%<-\1'V
M'1^&.9Y!QG'W>^*[-KR%;9;C$Q1N@6%RW_?(&[]*X3Q[J5N\NDX2Y7$DO^LM
M94ZIVRHS^% UN;!X8YZ@TA'R<&L\Z[IH<XEDQG@_9I/_ (FA=:L9V987FD92
M P2VD.W/KA>*QL=O/&VY%:VL=]I4L%P"Z&XG .>5Q,^T@]01Q@CI4EE=S1S_
M &"^/[\9,4PZ3H._LPZ$?B.#5'2-=L3ILDI><(LTSNYM9 H!D8YSMP.",^E2
M76IZ/J$!C>X8 ?.L@C="A'1E8C@__7I^1/,EK<VR,GM5'4+ 7B1E)?(N(6W0
MSA<E#W^H/0CO^59NG^*=.D+6T]]')<Q$B1XHGVL,GYN <=.?0^U7GU[2XY?*
M:Z_>;=VT1L2!G&< =*5FBN:+1)I]^;H20S)Y%[#Q/#G@>C*>ZGL?P/-7B>,=
MJYW4=3TV1HKF&[:"]C.V"5[>3:Q/\#?+\RGT]>1S5BS\4:?<VHEF:2"1<B1&
MA<[".O(7&.AS[BAKJ)36S9J75M%=VSV\ZAXG&",X^A![$'D53L9YK>[33;YR
M\A_X]YS_ ,O"CKG_ &QW]>OKAB^(M+:(2).[*P&"()""#Z';4-WJ6E:E8.&E
MN&CC)/FQ6\A:)EYR"%X8?_KX--)A*2W3-#2_FTBR8G)-O'DYZG:*?=VL-[:O
M!<*'1NF#@J>Q![$=0:P/#?B6TFTY;>\FC@FM8XP6?Y5=2,!LGIDY&/7ZULKK
M%@Q(%P 1G[Z,O3ZCFE9@IQ:(-/NIHKAM,OSNNHUW138P+B,'[P]&'1A^/0UJ
M+][K6+?WNE:A#Y:WNV>%]T4T:EO*<#@@XQTX(],@TVR\46,R>5<RI#>(2KQA
M&PW^TG&2IZBFXO<%)+1LO:E92S%+JS*)?P*?*9R=K@]4?'53^AY^L]C>17L'
MF(&1E.R2-^&C<=5/^>:K-KNFHA9[G  R6$;8QZYQ69<ZK81ZI:7MI<N9K@B*
M6,HX66,<[B,=5['WQT/!;H)R2=TSHO[5N+0W:P6:3^1;_:7+3;#M&[@?*<GY
M?:G:I#>7TVFQ7XMXK=[L![:%FDWD([89R%!7Y>5V\]R:R(]1M;N;68[8S2RR
M:>L2B.!V(8^9@'"\=>IXK2OM8:YOK():2HL-RCD2JP=MT<H VJK'^'/-:16A
MS5'>3L:=WJIM=7L]/2W5S/R7+L-@&?1",\< D=#V%8FL7+CQ <6=R0/L?W=G
M($[\\MT/./Z=].PU72]7VW,MNL4\:(X^U1 , PR"A/)'7D5D7^IQ76O"2VBN
MKE0MLQ$5LY(\N9F;@CT9?\XID'.WMQ>1Z=&]O;3I<+#9%&PN,BXE(/!)YS@<
M>O:LKP[-=IK6D3MY\T)9$""4'HDX48)'0AB.F,GKD5O_ &6YGAMX;C3-52,1
M6B2,MJ05,<LCMC@] R_6J&EZ4=*U"POY[;5HXX7B,GF0L8PS"5#VY +QXZGE
MJ N=%\/[EKK[4CQA3;6UG""H_A$9(SR>1G'X"NGU?3Y+Y+<1);,4FW$SJ6"C
M:1D $<\C]>E<SHNKV.B61DNFE'E:=;QNJV\F2\:-O_A [CD]:VY?$9\EO)TW
M48GZ>9<VCK&O^TQ )Q_GCK0%S/UJ"]ETG3-/:!9[[[7%.T<+[@(HI59CF0Y.
M 0/4FNQMITNK6&XBSY<J+(N1@X(R/YUSD<8=?.N!>&VGY=TMG>6X]!A%)CC]
M!P3^)+=!]JABLEF$<PBP J+;ON Z ; -WZ4 60*,5G#6;8#'DW^/^P?<?_$4
MHUFV/'DW_P#X+Y__ (B@#0Q1BJ/]KVQ_Y8W_ /X 3_\ Q%)_:]MR?*OO_ "?
M_P"(H B\0)OT6;<S*JM&[L!G:JNI)Q[ $_A6=X;MH=)L$T=6=A;Y\HN0?,BS
M\K CANN#TY_#.U!J$%Q+Y:QW2DCK):2QC\V4"N>U1;;29W^2\%D&\TO%;2'[
M&QY+HP4KLZY&3C)XP2* +3:+.=5>\6\7RS.LH@:W0A2%"G#8W9..N>A(QTQG
MW0/_  DC$<A;B =.G[J8_P C5R_U+6+2U@\BP@NY7/+HTI1EQ]X;(W(SQP?S
M-<E<Q^+;O4Y+[S19DNK)%%I\\H7:I4'+1 YPQ]N: N-BGO8WTB.&U$L68'=V
M;;AOLI 4G!QP2<^P]:JZ:]^L-E_H4; >1_RVZXL7']W^[@_I2PZ3XL@6$)?.
M%C*[5_LJ4XVQE%_Y9_W3446B>)X%C5;USY17 .E2X^6(Q#_EG_<)'UYZT 7K
M6YOX5LIA:+\BV[+MN 22+.3'\)ZCGO\ K6B+[4=3\&/J%T";BUFD9T1"I"^6
MR$XV@\!]V1UQ^%9%E9>*M/NK.9&6YCMW5O*DLIXP=D9C R(B0<$__7KM+G4+
MF[\.7[/8212"TDWAE=0"4.<;U4L/PH C\4NRV5M+&[!@TS*ZG!'^BS<@_E6-
MX4MYW\/0&*=51DB9@\>_+&"(YZ^O-%S'?:I;VL6D6TR6SAY%CNX71(P\3K\K
M%1@?/PO(Z8P*BT[6;/PK%_8NI,4NX(XMVQ<J1Y*+D$X[J:N&YE5NXZ#5\,MJ
M-_J<LU_-&3<X(2&(?\LH^0VTL..P('M5;5O""6NC3[=1N&7")M:&$YRXP VS
M*C.. 0*N6OC'2(9KQG:0>=<;U(0'(V*N>#_LU'JGC32+W2Y(86E+,4/S( ,!
MP3GGT%:>Y8Q_>I^1-+X*CDD#MJ=WNW9^6.)!U]%0#]*I)X2!UJX@_M.8*EI#
M\PMX >7DP.(\#&,Y&#SU/&-+_A.]$R<RR\'!!CQC(SZU27QGHZ:W<7!>;;);
M1(/W?.5:0GOQ]]:/<$O:BW/@Z.*PN,:C/@1/N+Q1/D;?]I#COR,&L]KZ^MI?
M#M].]O(SV^Y(V;R H:)N&8Y&1GKWQ6[<^+-*GTZ01R,6F4QH@9#(6;Y0-@;=
MG)':LFS-[_:'ANS.G:E:SP6WEDR0JN\I$5;;DXQSWQ2ER]"X<[7O$4OC*2VU
M:XD6SM)0\,0*I>ESD&3H4C8'KTXQBHKKQY<RV,\;Z1"@>%@0UT^2"O./W77V
MX^O>K\OB".QUJZ2]NKZV=HH@%EMD5FP7YP1T'3(_I4=_XNL6LYXAJ5X9&B=4
M3R8\$[3[=Z.;S!P6GNEVV\271CB06]@2%49_M%,DXQTQUJA>>++B#5;65;:S
MD(AE4JETS[06C/.Q&YX'&._M4J^,=-AMU4ZM?@(@'RP1GH.GW3Z5"WBS3I-2
MM[D:K?,J0R)GR8@<L4('W>GRD_A2<O,%#6]AJ>/;YW .DQ*O."TLN#^41/Z?
ME573/&MW::9&@TN.4!G*[99!@%V//[K''MDXK47QEI;<C6-0"Y(_X]X?7U*U
M!9^)K*PLTMI-5NQ, 6*QK!(!N9CU .?6CF?<?(K6Y2G<>,+J^GT[S-.A@V7:
MOA[E@<A&X)*!0.3SDU?35%U#Q3;2S*$$=JXQ:WP/\6>6#)CZ9HN]=M[V32_L
MM_=7#?;%81QI"TG"/R$7YL_AWI\]],?$\$CZ;JMZ4M&_=RV>&&6Z@;>G/ZBB
M[[@H]D/L]/TNXM,S6=_,6EE<'^TB%SYC'('GCGWQ[^].GT_2HVL42PU*-%N.
M%&I'C$<G3%QA3[C'<=\4VVUW1=.@-I>V<D-Q&Q\R.6VVD;B6 .<=B*9<>*/#
MLES:>7&F(YB\A,0'R['7\?F*T]+"7,GLRX=*T;S#(VG:@9,\O_:1W?G]HSZ5
M6M=-TJ8WRO97\B&Y)*?VD2#\B9W#[1R<]^>U2-XK\,@I^ZCR3A<0*>U16OB;
MP]&;EID38\Q=-T:X"[5'KZ@T:"]ZVS%O=*TJ*Q=4T_441Y8RP_M$E3EUZ@7!
MR??\?>K,FC:).YDETF_E<9^9]0+'&<]3/TS4.H>(- "-!&D D,D9+1K&PQO!
M/S!L= >]3_\ "3>&_(CGV6YCD&0%6,M^*@Y'T(HT#WK;,C\JT@NK](+?45)L
MXS\U^')YEXRTQ./;GOZ\['PWB:+PT\;(\9^T,0K>A5"/S!!_&L6.^L=3.H75
MCI5U<V[6ZPI)'9%D\Q3(6Y'&?F7FM;P9KD#VEQ%Y=R4C$!5DM)6)_<HISA3W
M7\:B1K33ZG:T50_M:W/_ "QOO_ "?_XBC^V+4?\ +*]_\ 9__B*@U+]%8=]K
MD7G) C7=NHC:>67[(X8(I484,G))<= < 'VJ.PU)I#;W,$ES-8S3&#=/M))R
M1N7'S8#+@Y['/:@#H**** "BESZ49H 044M'% "4444 %97B;_D5-9S_ ,^,
M_P#Z+:M6LKQ/QX3UDYQ_H,_;_IFU &E#DP1Y&#M&1^%/ID0Q"@R3A1R>]/H
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M^?-(#F_ N1X94=OM=UCV_?R5TO>N<\##_BEX\]3<W)SZ_OY*Z(B@!:*0&EH
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M=-&>/*G/_H'^- %C^S+'./L=MCN/*7_"GC3K,=+2 #_KDO\ A5GDTN* *O\
M9UER/LEO@]1Y2_X4X6-H,_Z-#S_TS%6:* *_V&U&#]FAR._EBD%C:?\ /K!_
MW['^%6:* *S6%F1@VD'/_3)?\*QVT/2O^$A1O[-M-QMV<GR5Y;<O/3K70UGD
M?\3]>/\ EU/_ *&* '_V5IY&&L+4\_\ /%?\*3^R-/SG[!:_]^5_PJ[2T 4_
M[*T_(/V&UR.A\E>/TI/[(T[_ *!]ITQ_J5Z?E5VB@"F-*T\9Q86HSU_<+_A2
M?V3IQ&/L%KC_ *XK_A5VB@#.GT'2+F(Q3:99O&V,@PKZY]*A\-6-I9Z':O:V
MZ0F:%'DVKC<=HY-:]9^AG.@Z>>.;:,\?[HH T*.^:** *MW9BX:*6.0Q7$))
M20#/!ZJ1W!X].@JK;:08[U;RYD@>5<E1!!Y2[B"-QRS$M@D9ST)K4I2*  48
MI*7J: #I2<4ZD(H ..E(1110 4444 %97B;_ )%36/\ KQG_ /1;5JUE>)SC
MPIK!_P"G&?\ ]%M0!J+]Q<]<>N:6E[TE !1110 4444 %%%% !67KHS;V?\
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M2&@ (I/8T$YHH YSP+_R*L YQY]QC_O_ "5TE<[X'_Y%:W]?.N/_ $?)71T
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MWSK*HB,JKL*SQ^9&ZY!PRY'((X/:FV>DB"[-PXA7!)2*&/:JD@ L>3EL#&>
M 3QR:TZ* "BBB@ I>_%)0* %S2]*;WIU !2&CFB@ P*2E'6@\4 )112]>* $
MK*\2Y_X1;5L'!^Q3?^@&M6LKQ.2OA75V&.+.;KT^X: -4\\\_C12M]X_6DH
M***.] !10>M+B@!**** "LK7?]38C@YOH,9_WQ6K65KG^KT_ !_TZ'@_6@#5
MHHHH **** "BBB@ HHHH *0TM% "<XJ-^E28XICC- !;C_1X_P#=%24RW/\
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MBBB@ K*U[ CT\G'_ !_0]3_M5JUEZV?ET\?]/L7\S0!J4444 %%%% !1110
M4444 'X444<4 )GFF/R!3CUID@X&#0 ZW_X]H_\ =%/IEO\ \>T?^Z/Y4^@
MHHHH **** "BBB@ HHHH **** $I111C- '.^",?\(K: # $DX'_ '^>NBKG
M? __ "*=F2,9>8_^1GKHJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MI,\TM% !WHQ110 44GUI>U !WHHHH **** "BBB@ HHHH *0TM&: #'-%%%
M!1110 4444 %%%% !1110 4444 %%':B@ HHHH **** "BBB@ HHHH ****
M"BC-% !112\&@! **44E !111TH **** %I*** "BEZBDH **** "BBB@ HH
MHH *44<4?6@!**44=* #\*0]:7/%)0 4444 %%%% !1110 4O6DHS0 O0TA-
M+UI* %[4E&** "LKQ,0/"VJDYP+27./]PUJUD^)SCPOJAQG_ $63_P!!- &N
M?O-]:2E;[Q^M)0 4444 %+WI**  ]:*#UHH *R]; (T\GJ+V(C]?_KUJ5E:W
MDMI@'_/]'V_V6H U:*** "BBB@ HHHH **** "BBB@ -125(>M1R<4 .M_\
MCVC_ -T4^F6__'M'_NBGT %%%% !1110 4444 %%%%  #FB@4=Z "@<XHI&Z
M<T <[X&P/"%B <@-*,^O[U^:Z.N<\"#_ (HW3_\ MI_Z,>NCH **** "BBB@
M HHHH **** "BBB@ HI2*2@ HHHH **** "BBD- !^M(,THH/% !UI>])GFC
MB@!:*3FE!H **** "BBB@!,\TM&.:0&@ .>G:EHHH **** %-':DHH ****
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M@ HHI>U !TZ4M(*.] !0*6B@ I#2TA-  ,4&C\*0B@ HI<TG>@!11Q0/I2T
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M@[3ER2 C#)_WVKH ,5S_ ((P?!NFGGF,GG_>-=!U% !10** #%%%% !1110
M4444 %% I<4 )11BB@ I:2CO0 N:2BB@ HHHH #TI.U+29YH  :6DQBEH 3
MI:0"EH **** "BBB@ HHH- !12=J,T +11G-% !0.M%':@!3BDXHHH ****
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MBBB@!:.E)2]: #-&>:2B@!?I0*2ESQ0 &DHHH **** %!HZ4E*: $HI>:2@
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M:RSW$$KK<S2M(TIYW9.=K#HP'0=P.F*NZ?#<0:?;Q74WG7"1*LDO]]@.3^=
M%BLO6!F?2N<8O0?_ "&X_K6I69JZYGTKGI>C_P!%R4 :=%%% !1110 4444
M%%%% !2*P905.0>A%+2*NU0 3@>IS0 M1R4_FF24 %M_Q[Q_[H_E4IZT44 )
M1110 4444 %%%% !1110 4444 '>D/;ZT44 <]X$&/!&E# _U1Z?[QKHJ**
M"BBB@ [T444  HHHH * ,T44 !&**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ H)Q110 4F:**  ]:4444 %%%% !1110 9X
MHHHH 7%)110 M'2BB@!#1110 4444 %%%% !2BBB@!* <444 %%%% !1110
M4444 %';-%%  *7/M110 E%%% !1110 4444 %)GG%%% "T444 %%%% !2XH
MHH 2BBB@ I<T44 )UI1THHH 2BBB@!<T"BB@ )I*** %Q61XG('AG4"03^Y;
MH<=J** -<]32=*** "BBB@"M>V%O?HJS*P93E)(W*.A]58<C^M)9Z?#8[V1Y
MI)'P'DFE:1CCH,D\#D\#CD^M%% %JBBB@!?:LK67V7&D^]Z!_P"0Y*** -2E
@QS110 8H]J** $HHHH **** "BBB@ J)P1WHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>bayer_arvinasxamendmentx001.jpg
<TEXT>
begin 644 bayer_arvinasxamendmentx001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *Y&[.L:GXWU#3;77;G3K:TL+:=4@@A?<\CS D
MET8](UX!%==7.W_AJ\GU^?5]/UR?3Y;BVBMY5C@CD!$;.5(W@X/[QJ ,O2?&
M5],O]EMI[:EK5O+<13_9RL492%]GF98\%LKA>><] ,U9A\=1Z@GF:3I%]?K%
M;K<72IL5X0Q8;-I/S2 HWRCTZ\BI(O!4>G_99M(U.YM+V))8Y;EU65K@2/O=
MG!&"V_Y@1C&2,8XJ*'P(FGQ&+2=8O;%)K=;>[9-K/, 6.\,1\DAWM\P]>G H
M OCQ7;&V$_V>;:=4_LS!QG?OV;OIG\:Y>TU[5XM8@CU76;G3]0DO?+-A>V*I
M92QER L4P3)<K@J2YRW! SQN'P3_ *:&75[I;)=174EM=BG]Z&#'+D;BI.3C
MU/6FKX)D\F+3Y==O)=%BF25+%XT)PCAU0RXW% P'O@8S0 RQ\822K]GM+&]U
M2Z5[F24 Q1F.)+B2(=P"24(4=2%R2#U@'Q'BDTZ34(-%O9;2"Q@U"ZD#QCRH
MI4WC@MEF !R!Z=>F:VH^&]0T6Y5]$AU.1Y8[A9+BSDMPS>9,\H1EEP% ,C;7
M4DC)R.E7=*\!I;^$+C2+JZ<2WND0:=<-& 0ACB,9*YZ_>/6@#4\:ZE=:3X*U
M;4;&8Q7,%N7CD"!MI]<$$'\JQ+/7UL+?4=2FUS7]2BL+*6ZDM[S21:JRH,G#
MF!,MZ#=^'%=1KVCQZ[H%YI,DSPI<Q>69$ )7W&:R[GPSJ>H:=?:?J/B2XN;6
M\M9;9T^RQ(0'4KN!49R,T 0GQNMO<-#J&D7=F0(),NZ-B&63RPYVDXVMC<.P
M.>:-0\>65E=O:);F2;[5);1&29(DD,:*TC;F( "EPGJ6XQWK1O\ PQ::C<W<
MMR[LEUIW]GR1\8V9)W ^OS5GGP/ FGZ5%;WLB7FG>;MNI8DE\XRG,I=2,'<V
M&XP00* ,V+X@Q3:@+N(3263V:A+- AD:Z-R8-@;.#\PQG=MQSTYK0F\;M;W"
MV$VBW8U4W,=O]D61#GS$D='#YQL_=.">HVGCU'\!6LL:^9J-VUPD**EQA RR
M+-YRR 8P,-_#C&!BJ>J>#M2DOK"^@U*:;4FU&*6YO-D:B**.&95"H>"NZ0Y'
M).\_@ 6)_B%:0M':-9LFIF66*6UFN(XA$8PA8F1FVD$2(1CD[AP,''0Z'K%M
MK^C6^IV>X0S@X#8RI!*LIP2,@@C@D<5@-X$C$T=]'J,G]J^9+)-=RP)()O,V
M!@4(P !''MQR-O4Y.>CTK3QI>F060GEG\I<&67&YR3DDX '4] ,"@#@]%U;7
M_$5SHML==GLO/TVXNII(+>$EW2=47.]" ,-VQ70^']7U1[J_TJ^3[=<:??"V
MDNX@L8,30K*DC+GK\P4A>_.,=*\'@>2P;3WTS6[BTEL[62U#^1')O1Y!(<A@
M0#D"M72_#YTF("#4;AYI;HW5[/*J,]VQ7;AN % PN-H& @'K0!/KJ7[V*FRO
M6LU1M]Q+%!YTWEA22(UVL"Y.T<@\9P"<5PZ>)?$.H:7I0M7U%F>>\6XGL[&-
MY@D3[8Q(CC;&Y!!*G!X. .E=UJ^FS:C';FVU">QN+>7S8Y(N5;@J5=#PRD$\
M>N",$5D0^$;BR59K'7KR"^>666YF9%=+AI-N2T?W01M4*1T QSDY ,[3M7O?
M$]_%IVF:[<0VEO817,]\EO&+B9Y'D4+M="J;?*;=\N<\<8-+>'Q+'JVAZ+/K
MQA>X:[+W=K!%OEC0(8]RNA56^8YVC'\A>C\%)IZV<FC:G<V-W;P&W><HDOVA
M"Q<^8I&"=[,P(Q@L>QQ49\$21O97-KKEY%J%O+/-)=O&DC3/*%#$J1M PH
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M3UDNF2,9C\R'RVV-R"0%'!!P,XKK8_"#0PS31ZU??VK-<)<R7YVY<JI549
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR P8;0 !V.<]L<^LZ'\/6\/>,+K7M/U41I>0K'<V?V<E)64#]X27SN)!.?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP=J@QJ!G !R>F16AI5GJ$=YJ[:A!9B"\N/-C$4K2';Y21X8% /X">_7%;-%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M )  R>G/2N7M/%/B*^U_7=&M](TPW.DK"6+7KA93*A8 'R^.F.: .UHKF?\
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MNTD+1SL<_NSD#:_' R<_E6R^HW__  DCZ8D%OY(M?M E9VW9W;=NW'XYS^%
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M6VN$N[6&XCSLE0.N>N",T 2T444 %%%% !1110 4444 %%%% !1110 4444
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M*/$7E/#9:QJ/FV:NI4O$HP),'H&SD?2NMC\.:'#()(]&TY'!R&6U0$'\JTZ
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MIEAIY<V5C;6Q?[WDQ*F[ZX'- 'GWQ(OM,U#X(W5UI,L3:=(EK]G,7"JHFC
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MR*9%X9U:".>.&_T*-)P1,J:)@2 ]=P$W/XT <1JJW$7A_P 7Z1K>BZ>FI1Z
MTZ7M@H\BYB0.$;81E'!)_IP*]+\,"Q7PY8C3Q;B'R$)$ 7;N*@GIWYK,MO#>
ML644D5KJ&B01RC$B1:)M#CI@@3<UM:-83:9IR6DTEHVPG8+2U^SQJOH$W-[]
M^] &A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5D^([ZXLM'D%D5^WW+"VM-W3S7X!/LO+'V4UK5S%Y:MKGB
MQ(;B*_@L]/AWP31EXEEF?*L0P_NH,>_F-UQ0 G@'7Y]<\(037^1J5FSV=^F,
ML)XCM;('<X#?\"IA^(OAX6JW9DNQ:?:3:R7+6D@CAD#;,2,1\GS<<^HSC-96
MD:?=>%_B5J26MG?SZ)JL$<TUPRM((KM<@\GDAEQDC/./3C&N-*U23X8:[IJZ
M7>F]N=8DN(8/).YHVNA*&]/N@G].M '?Z?XJTS4=5N=-0W$-S!"+@K<V[P[X
MLX\Q=P&5SQFHX_%^E/?VEHQN(VO8VDLW>!@MR%&3L..3CD#@D<C-<]K>E7FL
M>.;DPP7,=K=^&Y[!;MHF"I+(X90>,CCG].O%1>$UDD33K74? QL=2TU0)[Z2
MWC,0*K@M"P)9F;'0#C)R3CD VK;XA^'[M+*6*2[-O>7)M8YVM)%C67>4"LQ&
M%)(X!YY&<9IWBOQ!;V^CZU;6TEX;JTM&DFELT)-L2I*DD=#QG R0.< <UQL6
ME:HOPTT_3CI=Z+V+7!<O#Y)W",79EW>GW#G]*T%AU;1[GQGI\ND7UY%K#RWE
MC=6\896WPA/+?)&PKM&,]: -;0/%]E9^'/"]IJ,UW-J5]I,4ZX@DE:8B)2YW
M '<V3R.3SDU8/Q&\/C3C?LUZ((IC!=,;.3_1'#;2)N/DY]?K6#H]AJ4.H_#T
MW&EWD(TW2I;:[+1Y$3M%$J@E2>I0_3OBJ=[I6IS^ O'EA'IEX;K4M2N);2(P
MD&5'V;6'H/E/7&._44 >@ZGXAL]+,PD2XG>"'SYDMHC(8H^?F;'^Z<#J<' .
M#5%_'.A"XM((9KBYDO+4W=L+>VDD\Z/C[N!R>1P.G.<8KF;Z"YTSQA=:C=>%
M;G6]+U6U@"&&!'EMI44J49'(PI!!ST!J[!IUQ:>.]!N$T<V=E;:7<0NEK#^Z
M@=W1E0;1@\*<D<9^M %O4?B!91:'I6IZ=;W-U'J&H1V0'DL#$QDV.'4\AAA@
M!W..U5/$5IXIO)M<ETF^O+>.:RLC8J!@QR>:QEP.QV 9_P!ZL)=(U9?"J$:5
M>-+;>*_[2: 1X=X/M!?<H.,_*<XZUZM"[2PI(\;1,R@F-L97V.,C/TH P-4U
M5]"\2Z4DLC-8:O*UKASGRI]I9"I]&"L".F=I&.<]%7&>.;5]3U?P?I\ )E76
M4OFQ_#%"C%B?;+*/JPK<T773J]QJ,#Z?=V4ME<&$K<*!YB_PNN">#B@!VJ>(
M+/2C,LB7$[P1>?,EM$9&CCY^9@/]UL#J<' .#7-^(O%D<UWX7M].>ZFT_5YB
M[SVBOF2(1.X5&7!!R%)Q@@ U4UBUN=(\=7]_=>&)M>TO5((51K:%)9+>2,%2
MI5B/E8$'.<9J?4["X@U;P4;?16M[>PN)99X;.',=JCQ.JCY1@G+ ';[GI0!0
MA,TGBV;PA)J/B![)+ SQ3^8ZSQO),P!,@P65 N 6R.N<UU-OXHTRR&FV5Q=7
M,JW#BSAU"6+$=S,!C&X#&YBIP< $]*HQP7)^*UW>FTNELI-'CM%N?*.PRB5V
M(S]&'/3WK \(Z=<65I8^'-5\$B6_T^5575'@B:V=$;Y9@Y.[?MZ #.?3G !V
M5WXPTBRE4322B W0LS=",F%9R<;"WUX)Z \$@U2LO&$6H:GXALI;2]MX-+81
MM*L#%C\@8M\N2.&&!C/>L;PL^MZ#!-X6NO#]U</%>2R6NH84VSQ/*9 [L3D,
M"Q^4#/ QZU<TZWO]/\3>,_.TVZ:"^=+BWN$4,C@0*F!@YW;E(QCWH NZ9XGT
M>QT7P[&EUJ%U!J:K%97-PC2/,Q&1O?'#$ GG'2MF?7;&VFO(YVDC%FJ-*YC)
M7Y^%52/O,3QM'/(XY&>,M/#5]?\ P9T[2C#):ZS86T<EN)%VM%<Q?,GYD8SZ
M$U9UO1-9U/P 9H[2-];DN8-4ELI&^61T='\@D\<(JI[[10!TVG>(K'4=4N=+
M4307]NBRO;W$91C&W <=BN01D'@\'%2:CKEIIMY;V3K+->7"/)%;P)N=E3&Y
MNP &1U/.>,UC>%F@OKUM1B\(/HCB#R9);JWCCF<Y!V+M))08)).,G&.]-\1/
MJ8\5:7&NG7EQI+V\HDEL<+*)B5VJSY!2,@$\$9(&>!0!IV_BK2[VPT^[L7DN
MEU!6:VCB3YW"_>.#C&WH<XYXZUHZ??0ZE8QW=N)!%)G D0HPP2""#R#D'@UY
M=H_AZ23P5H&EZSI6LZ?<V3W1CO[+/G6DGF94C9DE6#$<@YQTQS7?^$5U=?#%
MHNNL'U$;Q(^P(77>=C,HX#%=I(]2: &7GC#2;$32S23?8[>;[/<7BQ$PPR9
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M$V ?+4 O))@\$JJG';)&>*S_  +;W-K+XD%U:7%O]IUF>ZA,L9421,%"L/\
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M+ES#JCP1/;21ERRRLQ.0P!^[@G([9X .GN?B'H%JE^[M>LFGS^3=LEE*1 <
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M$:1[<GZLZBMS0-=.N0W;/IUW82VMRUN\-TH#< ,&&">"K T :]%%% !1110
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M3[(Q\]%C1]I^?Y>&//.2>V.>BBUZZUOQ)/H^GS+9K:6,-U/*8P[%Y<[$ /&
M%))ZG( Q0!N:3J]CKNG)J&FSB>U=G59 I7)5BK<$ ]015ZN*^% D'P^M1*5,
MGVJ[WE!@9^TR9Q[5?UG6[W_A(X]!TY)1*;,W<LL2([*-^Q0 [ =<Y//0#OD
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M9M;<>IS@=*]'8$HP5MI(X..E &#_ ,(5H'_/G+_X%2__ !5'_"%:!_SYR_\
M@5+_ /%5S"^,M:_X0*WULO;?:QJ_V*0>2=CQ_:O)SC/!QSUZU9N]:\37&O\
MBS3K.]L+>/2K:"XMW:U9V.])&VD;\'.T#=Z#@<Y !N_\(5H'_/G+_P"!4O\
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M[1CR\%#YCYYSSG- '<T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"TUS-'#$O5Y'"J/Q-9VJ>)=)TC2X]1N;V'[--(D4+K(")69MH"G//7\ ">U
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MQ5&95+D D*,9/MS7*0:WXDM?&%AI6JV6GO9ZC#-)$]FSE[<QA21(6X8'<!N
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MZYTQ=>NX].>_%]! L*9A?S1*1N(RPW9QGIGG/%:J^%98]5UV_74B7U>WCMY
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M0*""[D<XR !R3T%5O%/B:;1GT_3K.YTE=6O23&-1G,$15<;B,9.22H"_7TH
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M^FYQCZ*U=30 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUR6W35C+=%(KE@'> 1?Z.4!ZCCC'0DGJ:]%\)317'@[1989$DC-C" R'(X0
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MER$%U!/&UNHSD'/'>J?A-;SPQXQO?#R:V^J>'8;#[6LMU('>P;?@1M)Z%<D
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M4;:<Y(XP&'')R> >36;X.\"ZYX3U'4-,.G:/>Z1-=FYM]0F;,T*G&5V;3N.
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M.R:^-V&\V)$7[R.P "N!S@9!&<$U@:CX+U'6;CQM#.8[:#6TM_LDRR;F1HD
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MD(8$C8N#NP!SR/09/%5-=\=VFCOJ(BCAN3I@!NHS=)'(?E#E8U/WV"D'' Y
M!)R!F>*?"-]K[2YM(AJ4"QC3-:AF\J6!@HW%\<E=VXX&[.<8'6IQI7BO0?%&
MI7.C0Z?J&G:LZ32+=3M"UM.$5&;A6W*0JG Y^G< ["QO(=1T^VOK9BT%S$LL
M9(P2K $<?0UR>K(8_BUX;99)L36-YO0RL4ROE8(4G /)Y KL+=)([>))I?-E
M5 'DV[=QQR<=L^E<YJ>DZC<^/M$U>&",V5C;W$,K&7#DR[,$+CH-G//>@"/Q
M1X6\/WOVO7=>6YF2UMRV%NI8ECC0%C@(P!)Y.3ST':N9OK"\\+^ O#4\EH]W
M9V<XGU33C(6>42AOE&X_O"CN,*>NT=Q7<^(].N-6L8+"(+Y$MU$;LDX_<JV]
MA[[MH7Z,:A\0:5>7>I:)J-IME_LVY>62U=MHE#1LF0>FY=V1GCKR.M %#P%<
M0:C8ZAJVGS1_V3?77F65M&P(MT"*K @?<+,&8IVSZDUUM<4FEW_AJV\3:WI=
MI9Q7%_+'<1V4\VR)"H"N[L!@,W).,]!SS76V,\EUI]M<30-!++$KO"W6-B 2
MI^G2@#D]?0Q_%'P>ZR3 2QWP=/-8H=L:X.W. >3R!WI?B+IVBR>'+[4-9@O+
MGR;=A (1(WDO@X=0GW3G&6/3'I5S6=)U&\\;^'=4MX(VM-.6Y$Q:7#'S451M
M&.<8YR16A>7>MQZDT%KI-M<6;1 I</>;"'YR&38>.G(S]* ,RQLM/UCP'I7]
MHWLFKV:6<;2RQ;V%V0@!8JOS-SD[3WZC(XR/A]<+_P (1JW_  C]P;QHKRY%
ME9W+,IM>?W<+[_F&.#STW=\5M:;INH^$O#VDZ3I-A#J$4.Y;@M/Y!7)+%D!!
M!&XG@D8&.M%KI.I:3%KNJV=K:2ZOJ4Z3_96F*Q#:BH%W[<Y(4DG'4XZ<T <W
MX"AT^S\2SV>I:)>Z7XH%L97:XOGN8[J,D!I(VSMSNQD!01G'K2W]GH>C_$WP
MZEM<W5EJ4S2FYN)A+MO@4($9<C8S%B&'IMP,':*ZNVT^]O\ 6+;6M2M(+6XM
M+:6&WMTF\PYD*%BS;1_<4  'J3["G/IVK>)AI:ZSIEM8"QO8[UC'<^<6>,DJ
M$^48!.,D]LC!SD '5,JNI5E#*PP01D$5XYX>F\.VFE>,7UBSNY!;:W>HDMO:
M3.\4:D;521%^3';YACVKV-B0I(7<0. .]<-X8TOQ+X>@UQ?[,L9I-0U2XOXL
MWI55$A!"M\A/&.<9H C\)>);C3?AQX?N->O8;K4;W,44AN4(D.79=\F<<(OS
M'GD8Y/!?+\3;6#2M4NFTZ66;3+J*WN$MIED3$I 1T?C<ISV&<@@BLRS^'FM:
M#X5TH:5>6DFN:=J$FH!'W+;R>8&5XE[JNUL ^OIGC5\0Z7XI\2^#KFUN+.QM
M[V>>W>.U6Y+)$L<JR$M)M!+-MQ@# X]Z *?B*XN;_6_"%U?:1)IUQ'KQAC$L
MB.SQ^3(0V4) !]/45IIK]A8ZUXQN8=#G6]TV&"6\D5DW72^6Y0CYL !0>ISS
MTJUXGTK4M5U#PW<VEO&5T^_%W<!Y0"%\MUVKQR?G]AQ6?/X>UA]5\;7"6\)C
MUFSB@M,S<[DC9"7XX&6SQG@4 6]-\;M>ZAH4$^CW%K;ZW;F6TG>56RPC$A4J
M.0-N<$]<=!76UPD/AS6$D\"DV\.-#B*7?[[J3!Y7R<<\\\XXKH/#NIZGJ/\
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M6P\>^'IIY;JRM]':[M9)FW/$)(Y 8V8\L,J2"><9Y- '4GQ;:+-X>C-K=?\
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MTLL43?P.Q52V"#@GGWXH Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV73Y"LTJ-_RS..-A/=N%ZY%/\#>')O#7A]H;R02:A>7$E[>,&+#S9#D@$\D
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ML[.V\// B,&=8"94*QE^1NV@\9_.NE_X16+_ *#&M_\ @P>C_A%8O^@QK?\
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MQL=7  !'4KZU5UWPGJ/BO[#;:SJ%JFG6URES)!:V[!IV3[H+LQVKGJ ,GU%
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MA9;N(RQW,).[YP""&W9;([DT =%X8U:]UK0H;S4=,FTZ\+,DMO*K#!4D;EW
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M @B5"&C\I6 ).<'.XGH,4F@^%8="UG6+Z*=GCO[@S0PD<6^X R!?]YQN/T%
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M$K!=JDX&=JCBJWAJSBU.W\,>)+?Q%;)*R@3>1"WF7K,GSQRDR'<P.3T^7!/
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M[P\2ED&UHF'&U@N<8'.: .OHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]J=T$CC)B/<KZ&KM% &;#X?TFWN_M,5C$DOFM/QG:)6SN<+T#')^;&>34/\
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MDEW["O#=F(!QZC&:T(_%D;XB;2M0AO'DD6*UG5(WD1-N9 2VW9\ZC).<G&*
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M^;(&?5N!73:3IVK6/Q UR^EL%-CJ<-JPN%F4B-HT964C[Q.2,'&,9Y[5UM%
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M!11P ",#UP,9JO;?#S3;9=,0ZCJTT.ES>;91277$/RE=H( )7!QR20.,XXH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[K46@G5!A7 CD)5@1N#!EQM]>U=7HVOZ=K\,\FGRNWV>4PS1RPO$\;@ X9'
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MY=Z5XZL1!<V<VHZA=-;23P/&&62)45P2!D9!]^*@\(^7??V3:W_A'4K;5]-
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MOA_4;>Y\2Z/<ZPFKQ7]M:&QMFN-'EM8F9]NXLY+ L=@ &0.O<BO2J .>7Q7
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M+8!&#QDYYP-*?Q%XAT6YN[S4K!KC18-/ENI9Q$L+12QC=M WMN5@#CN#U)H
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MY5O#]N0?;SY:PO!VNR:5X%\,Z=:B/[9JNI7=O$\@)6-1-,[L0",X"X R.2*
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MH92IS@C'!P:6B@"*WMXK6!88$"1KD@#U)R23W))))/4FI:** "BBB@ HHHH
M**** "J&LZ1:Z[I4VG7AE$,NT[H9"CJRL&5@PZ$$ _A5^B@#%T_PZ;26.2[U
MC4]3,1W1+>O'A#ZX1%W'W;.*VJ** "BBB@ HHHH **** "BBB@#/UK1[77M*
MET^[:98G*L'AD*.C*P965AT(8 _A573_  \;.:.6[U?4M3:(YB%X\>$.,9PB
M*"<'JV:VJ* "BBB@#'O_  [!J.MV^HW%]J!C@51]A6<BV=E;<KLF.6!QW[#C
MBMBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5V9FB"G[B9;C'( '7K7244 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!3?5=/35(],:]@%
M_(A=;;>/,*CJ=O7'O5RN,UE5'Q8\*L  38W^3CK_ *FNSH *JZAJ5EI5K]IO
M[F.WAW!-\AP-Q. /J:M5')!%,T;2(&,;;TSV;!&?R)H PV\<>&%\[=K=H/(
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MN4X!YR1V8'N>>E;*-OC5L8W &@#CCX1\1"\N[B+QM<Q-=/N?9I\!('95+ D
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M;V8@\K.59@Q.[/7*CM5:R\)NFJZ5J6I7Z7MUI<#PP3+;^7(X90I,C;CNX'0
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M(>'M-&LP:OY<QOX(3;QRM<RG$9()4@M@Y(!Y':J'_"">'!HTFD"QD%A)*)3
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOH!<7ZE[6+?\\JA2V0.N, G-:%>=7'_(9^&'^Y+_ .D9KT1MVQMF-V.,],T
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M]>ET=H;Z.U&G7Z7N&MS)YA0, OWEP,,?7M5+5/"$^M2QIJ-];S6\%^M[;O\
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MG4IQ<P&R%F\L<?EEE"!0P!+8/&>O6MZF++&\CQJZEX\;U!Y7/3- '-:#X?\
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M1:Y%?"Z@U)+0YB49 B";_N[25(S@Y)(R<UM^']?M_$5G<7-O!/"(+J6U=)P
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M#1TTH&[^QI=_;%3[0V1+OW[L]?O<XZ9JX/#5DNJWNIK+="[O8%@G<2]47.T
M=!C)Y'K0!R6CZU>ZYH?A%[K4+B2YO-/>:>RM/W<MPP"CS#("NQ5))/(R6 YZ
M5B)=7VO>&/A]>:A?7374FM-!*Z2E-X7SU!., MA%YQZ^M=U#X!T.W73! +R(
MZ;&T-NT5VZ,(FP3&S @LN0.#1'X!T&+2+?3(H[J.WMKO[9;E+J0/#)EC\C9R
MH^9N!QR>_- &)--KWB6Y\1VFDWHM+G3+D6MH[7C1F(B-&#N@1A(&+'[QQ@8
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ML(2,V_ELWG;N=^\'C'3&/>O'M%?3;S0/A?/?M:3HDLT$\D^U@H$$FU&)Z=L
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M&M%9O+M8Y+J2)&VC>P;Y,^Q/;->/Q6FDCX8>/X5@LUN8[K4_D5%#J%=MG'4
M<8_"M>\O[1?%6C6&M7L%KIT^A(;1[I$:%YLXD7Y_EW;-GX9'?D ],>6.-0TD
MBHI. 6. 33@00"""#W%>7+HLEI8:+#X6U*VU@V,%T(K+5<,EY;LZ[O+<# VD
M!5;!&&].O;>#;VVU#P;I%S9VDEI;-;(L=O(<F,*-NW/<<<'N.: +\#Z@=5NT
MG^R?80D9M_+9O-SSOW@\ =,8]ZM+-&[!5D0L5W !ADCU^E>;36EH?%7Q)B:&
M+RY-+M7D7 P6\N8Y/OT.:SM(T^QL!\*[^U@CBN[F$1SSJ/GE4V9.UFZL 0,
M],#&* /7"P49) 'O2;TR!N7)Z#-4==T:U\0:'>Z5>(K07431G(SM)'##W!Y'
MTKR.'49[>#P]XIN-/57\-/\ V3JY6'+.23$Q7U"$1N,?\]"!T(H ]J\Q,9WK
MUQU[^E4Y);UM3M/L[6;:<\;^<S,?-+<;-F."/O9S[5Y]XFT&T@MO!PN[2!+J
M[U])+K: ,M*DK.F1U&<+[A15V?1=+T;XF^%;/3K*"V@_L^_7RHU &,QG'TRS
M?F: .K&L?VKI.H3:!-:S7,#20QO.Q\DRKP=Q7G:#P2/0UI))B&,S/&)"F6VG
MY<XYQGM7CB6FE#X3^.HE@LQ<Q76I9554.H65MGN .,5OW6F:??\ Q#\*I=6L
M,Z3:)/YB.H*R &+ 8=&')X.10!Z.)$:,2!U*$9W \8]<T1R)*@>-U=#T93D&
MO'82EIX DBCN8(;*Q\621K:RR!(YH5NC^XR> ._/''/%=/X=ATJT\0^)?%3W
M&G6]G,L17$\3&!53$CLR$JNXXXSSMR>30!WM,,T0D\LR('QG;N&<?2D@GANK
M>.XMY4EAE4/'(C!E92,@@CJ#7FET9]*\1?;98+/6=%N];51.@VWEA<EP@!_O
MH" .Q"GTH ]-\Q,9WKCUS222QQ*&DD5 3@%CCFO%]7?3[;P#\3+&4VT<HU6=
MXH&VALF.(J57\"<CT-="=2T:[\<:KIWB2>T^QSZ5;_V<URZB)HB'$Q1CQNW8
MSCG"CTH ZB\U^[M?'6GZ(88!9W5G-<&8L=X,908] /F]_P *Z%65U#(P92,@
M@Y!KS1]-TJY\;>#[!8VN]-31[I8ENB7\U T04L#]X$#//MQ6Q\,E2'P_J5I"
M MO:ZQ>P01KTC03-A1Z 9H [2BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *BN;:"\MWM[J".>"08>.5 RL/0@\&I:K7^H6FEV,M[>SK!;Q
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MNL[7Q3I^A"*XDDN[=[@31P.Z!05 P5!!SNY/0=\9% &_'&D,:QQHJ(HPJJ,
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M6L;8SR*4>4PKN92,$$XR1BJEEXET?4-)DU.VO5:TCD,+LR,K+(#MV%" P;)
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MFKE% %&;1M+N+F6YFTVSDGF3RY97@4LZ_P!UB1DC@<&G7>DZ;?K"MYI]I<B
MYB$T*OY9]5R./PJY10!5DTVPFNENI;*VDN%&%E:)2X'L<9IUI86=@KK9VD%N
MKG<PAC"!CZG YJQ10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7-^.I[FW\*SR6NFC4'$L.Z+R//*+YBYD$?\3*/F ]0#VKI** /*/LXE
MO_'IN[+6I+#4-'A99YH6C>94CE#X+ !6RPPI _W<5/X>U6QNM>T"XU>;4(;Z
MPLVL[=9=(GMD=W"ABSL""3L  XY)ZY 'H.M:3;Z[I%QIMT\R0S 9>&0HZD$$
M$$=P0#5*P\/3P21MJ&NZCJBQ,&CCNA"JJPZ$^6BEB/\ :)YP<9&: .)T[2=2
MU#X6^)M-M+2X@U">]O)8H[B%X3*&F+KC<!D,N!GWJ416_C'2KW[!H.L6>L_V
M=<6_VC53,OV9Y(ROEJTA.[+$?=XP,G!P#Z;10!YUX7N;+5)M+DNO#>LP:MIB
M-YSWXF*6IV;7\MF)#;N@"]0<]JP[>TNU^%&@V;:9J N8=:CFD@-E+O1!=M(6
M*[<XV'.:]AHH \VUS3K[5_%WBFWLH+F,WWAL6D%PT#I&TVZ4[=Y&,X9>_>IO
M#%W8ZK<Z;/<^&]:M]5TV-O.DOUG*6AV;7\LL2'W< !>HY[5Z'10!X]86MW%\
M-O!MJVF:@MS:ZY#-/#]BEWQ(L[LS,-N0-I!S[UUWAU9[3X@^+8YK.[5+V:WG
M@F,#>4Z"!5)WXVY# C&<^V,UV=% '&^*UG@\:>$=26SNI[:WDNHY6MX6E*&2
M+"9"C@$C&3P.Y%8EI%=Z=HGC/P_J-A=SW=[=7<UH4@9TNTG'R88#:""=I!(V
MX!Z<UZ;10!E>'K*;1?"FEV-W(99K.RBBE=06W,J ''<]*\SLK6[B^&GA*U;3
M-06YMM=BGFA^Q2[XT6Y9RQ&W(&T@Y]Z]AHH \YT\7&CGQGI>J6-W.=1NY[NS
M>.W>1;F.6,*(P0" R[=I!Q@8/3FH-)TG4?#>M>!X[VVNKG[-HTMC-+!$TJQS
M$Q$*Q'"CY2 QP..M>FT4 <G\2+.YO?!DT=K;2W,B7-M*8HD+L42=&;"CDX4$
MX'-8OB'1[GQ=K<]]I"2PJFA7=D+F6)HO-EF V(-P!(7!)/0$COG'HU% 'G?A
M2:TU>YTG[3X;UB#5].4B5]0\[R[5MFUC&SL5;=P %[')QBM/XA1S"VT"^CMI
MYX;#68+FX$$32.L0#J6"J"3@L.@-=C10!Y-J?VJ]/Q*DBTK4]NHZ="EGNLI,
MS-Y#+@#&<Y9>#@C/('-:[B3_ (2KP).ME>^3;6%RD[BTDQ"6CC"AOE^4DJ>#
MZ5Z%10!Y7IVDZG>_"#6=-L[.YAU)KNYF2&>)X&E'V@R*!N ^\N!GWJ_:7=IJ
M]K=ZK8>$]5DU2VT^9"FKK+]XJ?\ 1QYA._<>#CC'7D@5Z+10!Y1I;W$OBGPW
MJ!TS5I8O[(N+>826+PQQ2'RSY03:!&HP0#CG'!8T:9I&K)%)H^A7=_)H][I-
MS''%J5NR3:3(4 1!(P!*DD#:<X"9KU>B@#R_[-=:]X,\*Z&EA=VFJZ==69N%
MD@9!;>1C>X<C:00IVX)SN'OB&\M[F3P[\3(5TZ^,M]/(;5?L<F9P8$0%/E^;
MY@>E>K44 >7:I->74EY8G2=0C6;0$2WEMK%]]W)M?,<DFW*!21A25SN/7(%&
MD>?9WW@/4KO3[^*UMM$DLYG:TD)BE*Q !E )7.QAD@#CW%>HT4 >2ZWHM['X
M+\6W$.GW?_$XU>&YM;2*W=I-BR19<H!E2VQFP1G&,\\5T?C>"^M+C2/%6B0K
M)J%M(+1H9,IY\,Y"!6SS\LA1O;!KMZQF\/)+XB.KSZC?S*-K16+RC[/$X7;O
M5<9S@GJ2,G/7& "[I5@FEZ7;62.7\E K2-U=NK,?<G)/N:XO6/#=Y<>,M0L(
MH7_L7Q':*=0E4X\IXL*V/>1&1?7@GM7H%% '&^!+?5;?1VN-?C=;NS3^ST.T
ML9(H68>:!URYYXZA5KDM/L[ZV^&G@@R:9J ?3=9BFNX1:2&6- TN6\O&XCYU
MZ ]:]?HH X" R?\ "<^++N2PODAN-+MDB=K23#LHDW*"!@D;EX&:Q= M[N+_
M (5@DVG7Z&QMITNM]G*/(8P; '.WY<MQS7K-% 'D%Q9:J=/U^ZM-,U&7[-XI
M&I?9ECDADN;<(BL8CQDY!(P>J_2M:]6PU3PCXIU#2="U:.XN]*EMO-NX9C/<
M.48+&J-EB 3UZ<\9YQZ310!YG;S7>B^)O#6M7=C?R:6^@C3W,=K([VL^Y6)>
M,#< VT+G'4"K?A+4GT;3_$5U<Z5JNV?Q!,\4:V3[W25U"N 0,KUSZ8KT&B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-8^S_P#"+?$^Q\ZT=898YHHK;Y8T8Q1[BJY./F.#[^F<4 >X;ASR..OM7/\
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M^U:Q;AK9H5,9YSRN,=>:JP>)=(NK%+R"\$L3S&W"HC-)YHSE-@&[< "2N,@
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MGBDB;2;$QR3>>Z&W3#2?WR,<M[]:MVUK;V< @M8(X(@20D:!5!/)X'O5"_\
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M;!4(5DRVQ0<%R, $]<5'X%M[GPMJ%]X1O89I@@6>TU!87,<L94#RF<Y 9,8
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M#CXC^,9##,D4XLS%(T3*DA6,JVUB,'!P#BNBU^01^'M1)5V)MI%"HA9B2I
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M-D#<!N[<C(YZUV=% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,G(&3R3G@?J*I:YIOB#3_&*>(M$T^WU.&YLTM+RRFG$++L9F216((XWL"/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M< 22>V!CG+[;PMK+^(M(UG5->@N9]/@E@*PV/E"97VY)R[8;Y><<>@'?KJ*
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MP%GW;@PYXP3T''M0!STNAM8_$WPY;2:OJMY_H-[)YEQ<DMP\9 ^4 8^;'3D
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M:&.X@D@FC62*12CHPR&4C!!'<5C:;X3TS3#:+#]HDBL239PSS-(EMD$?(#Z
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M ,8^)8K?Q9/;6FE!/#\A8B0R,9HQ$LA48QAL$\]/8]: /0F940LS!549))P
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M-TEK26>XNHK.:'[&R+NPQD^^" 0" .1TYH Z>\U2PT^6VBO+R""6ZD$4"2.
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MSP;Y&E>(-,U.[CO+76;J>XD6.$Q%!*,,N2S9QV/%6#XPLUT\:HUEJ TDKO\
MMYA'E[/[^W/F!>^[9C'/3FM^*6.>%)H9%DBD4,CH<A@>00>XH Y6T\(WC6FB
MV.K:E%>6FCS)- 4@*22M&"(S(=Q'RYR<#D@'CD&K+X%O9O#WB?26U: #7;J6
MX,@M#^YWJJE<;_FX4<\5U9OF&L+I_P!CNBI@,WVK8/)!# ;-V<[N<XQTJY0!
MS4GAJ]F\2Z'J[ZA!C3+:6!HEMS^]\P*"0=_R_<&.#WJYXJT)O$OAF]TA+MK1
MKE0!,%W;2&#<CC(.,$=P35V&^:75+JR-G=1K B.+AT BEW9X0YY(QSQW%7*
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M[81CC+ '/7\.*\^TC0+_ .Q16]K'XQTO5%7)5KT&RBE/)(#,P:/<3P,DCWH
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M'VNZC5K&[;8DF%!4Q=![Y.?7BNETC0+719K^6VDG9K^X-S/YK@AI" "PXXX
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M P]$QQCKD],:=EX3;4M#^Q:O=ZM);K>+=6R7=PK7$>W:5#NN<X<%@,GJ,^@
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M7+3D1'@QKN/RK[#KQGH*BT7P-I>@QNEG<ZBR^68H%GNWE%LAZB(-D+]<9]Z
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MB-+,5X!]7.#QUXH [JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "H+RQM-0@\B]M8+F'(/ES1AUSZX-3T4 036-I<6GV2>U@EML!?)>,,F
M!T&T\56CT'1XFA:/2;!# <Q%;9!Y9_V>./PK0HH S_["T?9,G]E6.V<YF7[.
MF)#_ +7'/XTEUH&C7MO!;W>DV$\-N<PQRVR,L7^Z",#\*T:* *CZ7I\MVMW)
M86KW*KM69H5+@>@.,XJ+^P='-E+9?V38_9)CF6#[.FQSZLN,'\:T** ,U/#N
MB1PO"FC:>L3JJN@M4"L!T!&.0.U2C1M+$T$PTVS$L VPOY"YC'HIQQ^%7:*
M*4>C:7##<0Q:;9QQ7&?/18%"R_[PQS^-1IX?T6+3QI\>D6"60;?]F6V01[O7
M;C&?>M&B@"FFE:<EVEVFGVJW*+L680J'5?0-C('M38]%TJ*.*./3+)(X9OM$
M:K H"2_WP,<-R>>M7J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7O&Y>>AR.>* .@HK(M_$$%W'I\EO97\D=[-)#N^SD>04W!O-!P4&5(^N*UZ
M"BBFQR)*@>-U=&&0RG(- #J**H66LV&H:EJ&GVTZR7.GNB7*#^ LNY?T_D:
M+]%%% !1110 445E:9K]IJNJ:II\$<Z3Z;(D<_FIM!++N&WN1C'YT :M%%%
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M7@<K;745W'L;'[R-MRY]LCI3AI<8UQM5^TW7F&V%OY'G'R<;MV[9TW=L^G%
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M.VB5%&-LDKCS"W3/"-'WZL?2JBV5OX&MY1I.DZOJG]I7CR/%%*)?+=\DD[V
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M$'&,+(!TQQSGMZ"I+WP+I&H:+#IMP]ZSP3"YCOOM+?:EF''F>9UW8X], #&
M, &-X@EUWP[IT!.O-.SZY;1P_(N\6TLBJ8Y,CYOXL-P?>C6+_47\0>+M+&HW
M,=K#HB74(C*JT3GS<E6QGG8/IVQ6[/X,TVZ\/2:1<37LJR2K,UW)<%K@RJ05
M?>>XVC'88QBBU\&:9;:C=7[S7MS<7=H+2X:>X+"1!NZ@8&?F/L.P% '+Z/J-
M[8>&/ FCVUS*[ZK9*[/)(J,JI;JWEHVTXSD=B< \]Q+/J?B70_L>CZE?0F75
M-76VM+E7#RPVS*S$-E "_P A53@]<G)%;4WP^T:X\.6FBR2WYCLG5[2Y^TL)
M[<J,+L?^' XQT_'FIKCP-I-WH0TNZDOIR)EN1>RW+-<K,OW9!)U# <#'&.,4
M 9.A6KV?Q;UZ-KJ:X4Z5:LAF(+(-\ORYQR,Y///-=Q*C21.B2-$S @.@!*^X
MR"/S%8FF>%+/3-;EUC[7?W-]+;K;R27$^X,JDD94 #/)[8_'-;DBEXV579"1
M@,N,CW&<B@#RNT\0>(+KP+X(O_[8E2\U'5$M;N3RHR)59I>HV\8V#I@?6NG\
M*W>H1^*O$^BW>HSW\%BUM)!+<!/, EC)9254 @%>..]30^ ],M](TK3(KJ^6
MVTJY%U:CS%)60$D$G;R!N;@^OTQIV.@6VGZ[J.KQSW#W.H",3AV4J=@(3  X
MP"1[]\T 0>,]=D\,^#M5UF&(2S6L!>-6Z;CP,^V2"?:L34KW4_#VK>&734Y[
MZUU6X%E=)*%.7:,LLJ8 VX*G(Z8/3O78WEG;ZA93V=W"LUM.ACEC<9#*1@@U
MDZ?X4L]/:RS=7ETM@I2R6Y=6%N"-ORX4$G;P"VX@9YY- ' 2ZSXB@\(:KKQ\
M073S:7KCVR1&*()-$+E8MLF%R?E)Z;<?7FNAOK[7M?U7Q'I^CW7V6?3&2"V8
M3!-LC1+('=2C;E);&.F%/?FM)_ >F2:%>Z.]U?&SO;HWDP\Q=QD+AR0=O +
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M$L5W TA\F7";,E.F=O'I[9H R;.T\3G6+*<:HG]EW-NZ7!>=9',A7*20CRP
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MW69-V2.<+GM6A?6%O8_$'PR-#BBAM-0MKI+^*V 6.6!4!1R%XR&90&Z_-C-
M'?9'K1D9QFO$-+TZTM_A_P"$=8B0C4$\0)$MR7)<1M>.C("3PI!.1T.<]:Z#
M5#-I7B.34KNSM=7T:XU>$"\A.V[T^<.B*A!'S1[@!@8.&/K0!Z#'J<-X^H06
M$D<US9MY4BEL*LA4,%)'3@C/IFHHM4-K!I<.KM!!J5\1&(87+*90A=@I."0
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M<\Q_UO5@-^W9ZG!..ISW'@VRATWPQ:V5OJ<NI00%TCNI.2RACP#W ^Z#Z 4
M;Q('4T5Y=XY?3[VY\7HOEO=V.C*97O7!2#*R,GD+P0['&6R,$)U/%'V:UUKQ
M5X%:[/VI;K1;C[0#(2LI"0\,,X/);([]Z /4>HR*P++7[BY\;:CH,EM$D-K:
M17,<R2%BX=F7D8&,;??ZUYO!>C2]"@TMG\G0QXPGL)P6^2.W#L5B)[(6P#VQ
MP>#75:':6%A\7]=ALHH(%?2K5VCB 4;M\F>!TXP?QSWH [+4M2M-)L9+V]F6
M*!, L>Y)P /4DD ?6LLZ_<KX^7P\]K$+9M-:]6<2$L2)%3:5Q@?>/<_A6/\
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MVL%K;I]V*&,(H^@'%07.B:5>WJWMUIEG/=K&8EGE@5G"'.5#$9QR>/<U?HH
MSDT#1HS:%-)L5-F-ML1;H#"/1./E_"IK72]/L9YI[2QMK>:<[I9(HE1I#ZL0
M.?QJW10!!=V=KJ%K):WEO%<6\@P\4R!U8>X/!J.#2M/M;1[6"QMX[>3[\2Q
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MM']R&",(J_0#BK%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%92ZT)=:?2O[-U-, C[6;?$'W<\/G\/K0
M!JT5P?A)_P"Q!XQ8C4-0\C6.@S-.^8(/SQG\ *['3+_^TK%+K[+=6NXD>5=1
M^7(,''(H MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !2,-RD9(R,9'44M% &#H7A6#0+V\NH=1U&X:
M\8R3+<RJRL^%&_ 4<X0#Z5O444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
40 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>bayer_arvinasxamendmentx002.jpg
<TEXT>
begin 644 bayer_arvinasxamendmentx002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"Q<^8I&"=[,P(Q@L>QQ49\$21O97-KKEY%J%O+/-)=O&DC3/*%#$J1M PH
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M3UDNF2,9C\R'RVV-R"0%'!!P,XKK8_"#0PS31ZU??VK-<)<R7YVY<JI549
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 45236-/DUB32$NXVU".+SW@4Y94SC)].35V@ HHHH **** "BBB@
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M9)/:JFF:M8:S:M=:==1W,"R-$9(^1N4X(]\&@"Y1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1M;
MQ-<QW#1@S1HR(_<*Q!(_':OY5PGPNMX;GP?=)-&'5=8NI #V99RRG\" ?PKO
M7#F-A&RJ^/E+#(!]QD9_.L#PCX:F\+:7/8M?K=K)<27 ?R/+*L[%B/O'(R:
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MCX:E\+V-W:O?K=K<74MUN$'EE6D.6'WCD9Z4 8GB#7M:\,Z=>HL]H1INEI-
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M@?3BH=0\'WY\3W&N:'X@ETJ2]1$OH?LRSI-L&%8!C\K <9Y' XH P6EUV_\
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M[N$M3;VWD1>7&B.0S, 68DMA><]!]<IX2\/2^%M"ATEM0:\@M\I 6B"%$R2
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M."Q##)(QZ'\:TI/#$]U<W>H7M]#)J4UBUA%+';%(X8V.6(0N223C/S?PCWR
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M4M<.?)D%JKAEYZAORZ#O6AJ<]MK *3-]JO8O#:3SB[<"" ."?-5<9,I(Z@@
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MA\P?*4"C 7#9/4DFNX\<W5K9^"]1EOKF[MX"BQM):,%ERS!0%)X&20,GH":
M.BHKRB2/[/KGC73O*M+>-M"CG%G:MF..7;+@C@?/A5.0!T'IFI[:X1[OX5MY
MP::>T82'?\TB_8R>?4;O7O0!U?B7Q8FC^%]8UC3XHK]M+8I-&92@W  L,@')
M&X<?49%='&V^)'QC< :\7FLK&T^%WQ$^SV\$4HU&_B78H4A%D7"_09''N*Z*
M>V.@_$&U?28Y#/=Z%=2RQM(S?:)8VC*%LGD\D9]#B@#TBBO(6<R?"[P]XHTR
M1G\1&>U+7"G]Y<RO*J2Q.>K+EF&T\#:,8Q6SHN@6&I_$'Q8;S[1+]AO[2:V!
MNI (G\A6R,-ZD\'B@#N=.EOY893J%M#;R"9UC6*7S T8/RL3@8)'..U7*\NT
M*YTG3_ NJWFM>9<6MCKEX8X68R-,PE=$CP>7)R  >^#VJK=VEUX4\(W.LWS1
MV6H:I=V[WL4(/EV%H945D55(X"MAF&"2QYX!H ];K!U'7Y[#Q?HNB_9(VAU)
M)V^T>:=R&)0Q&W'?<.<^O%<-XC5_"VB^(-:T/6;<O<:>A^QZ;!LBB'F*IN%
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MH **** "BBB@ HHHH **** "BBB@#SFUNY[3XQ^)F@TVYO2VFVF5@:)2/O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&3( &Z=P.] $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFDNJ38&2"H\N,'T!+L?^ UJ76MW-[<O8:#$D\R';->2#]Q!ZC(^^X_NC\2*
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M5/E'EC)9V<C"@!6)^E8UW\8--CMXQ9Z9>7=XL44UW;#Y/LRR!-H+$89B9%
MZG/2O"/1/1Z*Y35/B#H^E>+;'PW(EU+>W4B1%HH\QPLXRH=L\$CG SQS75T
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M'XM\*VVNQVKVJ3;_ -R[;BNUBO7OTH WZ*Y/3?B)H6IZG;6,<DD33Z<=1#S
M*JQ@X(8YX('/TYK1U;Q7I.D>'%UV6X\ZRE53 ;<;VG+?=5 .I/:@#;HKD;3Q
M]9ZAHWAS5+6SG-OK=W]E02$*T1^<$D#.>4/?O6Y:Z_IMYKE]HT%RKW]DB//$
M.JAN1]?_ *XH TJ*P(/%5L^L>(;*XC-O%HD<4DUPS95E>,N3C'& #6GI.JV>
MMZ3;:G82^;:W*"2-\8R/<=CVH N5GZIK-II#V"7;,#?72VL.!GYV!(S[<5H5
MYM\7H[EM/TZYM@X.FM+J6]1PK0J-N?Q:@#TFBN2U?XB:-H_B73=!E2YFN[Z2
M*/=#'N2$R'";VSQGTZXYJY#XNM#?>)(;J,V\.A%#-.S9#JT0DR!CC&2,<T =
M#162WB"TD\*/XAM#]HM/LC7<>#MWJ%+8]CQCVJ*U\3V=Q_84;HZ7.LVYN(8A
MSM4(';<?09 SZF@#;HKE/#&MZOKGB+Q TRVT6D6-R;*VC',QD3[[MZ Y&!Z$
M?CU= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% ''^)-8U>R\;>&M(L;J&
M*VU;[2)3)!O9/*C#C:<CK[TEMXHO;#QQ<^'-7EM)H5T[^T$O(D,7E('VE906
M(]PP('M63X[?3Y/B-X*6^=/LT!O6N"S8$>Z(!"Q'W<GIGK4.C6L=O\6!+X52
M1M&N+-CJ\N&:$RC_ %>QVZMTR%.,4 =XFOZ/)I:ZFFIVC6#,%%RLRF,DG&-V
M<=>/K4]MJ5E>7-S;6UU#-/:L$GC1P6B)&0&';(KA-$TN\L/%-SX2\@_V):7
MU>VD_A$;L2L'MMF#./9*[/3K_3+K4]4M[)0+NVE5+PB$IERH*Y8@;OEQR,T
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MD)&\-&N220=HY)J#PK\0M673=67Q-!;R7MC8+JBFT<8,+KD1MUVN",>X(/U
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MH#D;E 7!/.#GCFO1J* .7^(ME?ZAX"U2UTN.22^D6,0K&,G(D4Y_#&?PK/\
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MA";;+AE:8\B4=<@%NP^;J&:GH^O::?$-_*T,T=[9JDMS#&2ZKO?<0F[)VQ'
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M7/\ T,^N?]]P_P#QJM^B@# _X1JY_P"AGUS_ +[A_P#C5'_"-7/_ $,^N?\
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M<'@8KHHY%E7<A)&2.01R#@_RIU% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 9FI:1-J$ZRQZQJ-D%7;Y=JT84\GD[D8YY]>U4_P#A&KG_ *&?
M7/\ ON'_ .-5OT4 8'_"-7/_ $,^N?\ ?</_ ,:H_P"$:N?^AGUS_ON'_P"-
M5OT4 065LUI:1P/<S7+)G,TY!=N<\X 'Z5/110 4444 %%%% !1110 4444
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M %ZBLF\\3Z'I^H#3[O5;6&[.W]RT@W#=]W/IGMGK6M0 4444 %%%% !1110
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M"ZMO%WBNZFA9(+NXMV@<]) MNBDCZ$$5Q7ACPU>V2:-I>M'Q&]QIE]YZ+%#
M;1GW-^]\P)NVD.206W<D8KUFB@#R6YTW64\-7_AW^P+R>\.N"\:] 7RI(S=K
M*) V<EMG!&,@ ^E2:KX;O3K'B>TU-O$+:?K$XE0Z7#!*DL?EJNQBZ,Z,I4@<
M@8P1@YKU:B@#S?\ X1N[D\4_;'TUVC/B.&Z,LB@DPI8; Y/M)D?6J5I;>)[+
M0='T9[+5(;3^R!&181PL[7.2#'*TF0B!=IR,=3SQBO5:* /-O#^AWLDWP_>]
MTJ5/[)TRX@N//C'[F8)"H/X[6P1VJ.#PS?/8:';7&F%HX/%5S>21NH*I"6N"
MCX],LA'U%>FT4 <UX8T^YL=;\4RS6[10W6I+- 2,"1?(B4L/^!*1^%;]W<?9
M+26X\F:;RUW>7"NYV^@[FIJ* .(TY-7DN_%^O6.FRQS7D,2:?!>KY;2O%$P!
M92<JI9L<XZ'I69X>CUF3QSIFJW]IK<D;Z9+:S37L$*".8O&^ L>"J?*V"<]N
M37I5% 'F6C>&;VR\+>!8!IAAN;/5?M%XH0!HP8YP6;ZEE_,53>RUQ;(Z"GA^
M^9H_$POGNSM$/D&\$H93G+':>1CC!SZ'UFB@#SO78-4LO$=Y>^&+?68M3N9H
MO.B>!'L;O 5=[,3E,*,9!!^7H:]$HHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX$T+Q.,'!RC@,.1W%6*@L[=K6TC@>YFN608,TVW>_N=H _("N&\>V3:AXO\
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M0A^AYX'-/\&KXCGUKQ!]KU]+BWM=6,31-:GYAY,380ESY:_-T /.3WH W(]
M\+6_B%9$LM/35FW72)QYF2<-*J>N3RP'4]:GF\)Z!<:F=1FTFUDNS()3(R9R
MXZ,1T+# YQGBLBWDO[?XFQV5W<6]U'-ID]Q&_P!D5)(@)HP$#CDKAOS K)O_
M !/X@.E^)/$5I=VT-IHEW- E@\&[STA(#EGSD,WS;<<#C.: /1J*\XUCQ!XF
MGO/%#Z7?VEG::/917D:RVOF22$PF38>0 #MY/)]/?O=,NFO]*L[QE"M/ DI4
M= 64''ZT 6J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S/$6E2:YX>O])C
MN5MOML#V[RM%YFU74J<#(YP:BL=&N++PG#HGVR-Y(;06J7'D$# 0*"5W=<#U
MK8HH XR'P+/;Z9X8MX-8$=SH!*Q3_901(AC,9!4MP=IZYZ]J?<^!(]1N/$W]
MH7WFVVO)$KQQP['A,:[496W')& >G4?A7844 <WHF@Z[8Q,-5\3R:E+'$8[9
M_LBQ!"1C>X!.]O<X'7CG-;.F6]W:Z9;07][]MNXXPLMSY0C\UN[;1P/H*MT4
M %%%% &%?^#M#U'4I-0FMIHKN50LLMK=2VYE Z!_+9=WXYK1M]*LK2_FOH(
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MTV(JMG:L6< $;ADDGYLYX '0T44 %9&L^&[#7+FTN;IKJ.>T#B&6VN7A90X
M890@\[16O10!AGP?H9T,Z/\ 8B+0R^?D2OYGFYSYGF9W[\\[LYJUINBP:;%-
M&+F]NA, '-Y<O-P,\ ,< <GIU[UI44 8^E^%M&T?P^VA6=D@TUPZO#(2X</G
M<"3DG@X^F!2:3X9L]&E5K:ZU%XXT\N*&>^EECC7T"L2.,<9SBMFB@"E;Z5:6
MNJ7NI11D75ZL:SL6)#",$+QT'WC65:>"-$LKV"XABN-EM*T]M:O<NT$$ASED
MC)V@\G''&3C%=%10!Q>C^ +:":[GU5Y)FEU6>_2".ZD\AMTI>,M'PI8<=L9
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M!!'IBL33/!^E:5>V]U%]KF>U0QVJW-T\JVRD8(C#$XXXSUQQG%;]% '%^$?
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M%\):)+X<\*:?I,\ZSRVT>UG4$+DDG"Y_A&<#V K:HHH **** "BBB@ HHHH
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M)&?>-]S=H" BCLB%N3W;@=":Z:'0])MM4EU.#3+.._E!$ERD*B1L]<MC)[5
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MQK8HH Q_^$5T/_H'1?F?\:/^$5T/_H'1?F?\:V** ,?_ (170_\ H'1?F?\
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M .@=%^9_QK8HH Q_^$5T/_H'1?F?\:/^$5T/_H'1?F?\:V** ,?_ (170_\
MH'1?F?\ &C_A%=#_ .@=%^9_QK8HH Q_^$5T/_H'1?F?\:/^$5T/_H'1?F?\
M:V** ,?_ (170_\ H'1?F?\ &C_A%=#_ .@=%^9_QK8HH Q_^$5T/_H'1?F?
M\:/^$5T/_H'1?F?\:V** ,?_ (170_\ H'1?F?\ &C_A%=#_ .@=%^9_QK8H
MH Q_^$5T/_H'1?F?\:/^$5T/_H'1?F?\:V** ,?_ (170_\ H'1?F?\ &C_A
M%=#_ .@=%^9_QK8HH Q_^$5T/_H'1?F?\:/^$5T/_H'1?F?\:V** ,?_ (17
M0_\ H'1?F?\ &C_A%=#_ .@=%^9_QK8HH Q_^$5T/_H'1?F?\:/^$5T/_H'1
M?F?\:V** (K:VAL[=+>WC$<2#"J.U2T44 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 45E:]KD>AV22>2]Q=3R"&VMH_O32'H!Z#N3V K)&E^,KW]]<>(K
M?3BW(M[2R64(/0N_)/X"K4+J[=B'.SLE<ZNFNZ1H7=E51U9C@"N7_P"$?\5?
M]#K+_P""V&J6OZ%KI\(ZM;W6J2ZV\RQ^7;BTCC/#@MC;UR.Q]*'%)7YE^/\
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M?Q8T ;=%9^EZ)8Z,CK9I*-^-S2SO*QQ[N2:T* "BBB@ HHHH **** "BBB@
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MX<M)=0U%0M_<J%$?4Q)UP?<GK]!7?64:%&2D[RD<U-NI45E9(Z:1/[4U]%9
MUGIQWDG^*X(X_P"^5.?JX[BMFJ=U'=Q6X&F1VJR%RS";*KSDD_+WR<^_-5%L
M]8NT:+4+RVBA88862,KL.XW,3C\!GW%>*>@.L76[UR^NXN84CCM@_9G1G+8]
M0-P&?7<.U6(]*M8M:N-656^USP1V[G=QL0L1Q]7-6H88[>%(845(T4*JJ,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ><2P0'XL:K?ZE
MHUW<:>^FPV\<S:9+,AD5V+ 80]B.>E2^#?#]P-9\4E]/EL?"VH;([33;A=H/
MRD2L(_\ EFK$GCC/H,5Z%5#6-,_MC3)++[=>V6\J?/LI?+E7!!X;!ZXP?8T
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MSUU;_P '%W_\=H WZ*P/^$.TK_GKJW_@XN__ ([1_P (=I7_ #UU;_P<7?\
M\=H WZ*P/^$.TK_GKJW_ (.+O_X[1_PAVE?\]=6_\'%W_P#': -^BL#_ (0[
M2O\ GKJW_@XN_P#X[1_PAVE?\]=6_P#!Q=__ !V@#?HJ"SM(K"TCMH3*8TS@
MRS/*W7/+.2QZ]S4] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '(+XX%IX\/A;5[2.T:>-7LKM)2\<['/[LY4;7X.!DY_*MHZE>?\).-,
M^S0?9C;?:/.\T[_O;=NW;C\<U@ZOX=L/%6J^(-+O<@&WM'CE0X>"0&7:ZGLP
M/^'>N=TS7-1M[G7;/Q8EQ'>:-HLBW%Y:\&YAR2LT1[,0#]&'X  ]45U8D*P)
M!P<'I1O4D ,,GH,UY'I T^/QGHL"'3X;6[\.R(8(9 2R[HM@D88#L<DYP.IQ
MGK6;INDV \ _#G45@"WTVHVUN]TK$2M&XD#)O!SM([9Q0![<&#?=(.#C@T@=
M6SM8'!P<'I7D&K_\4U<?$*'18?LEM#!IT[0VJ;1&K%A,ZJ,8)C!)(QTS70:5
MIOAF;5YM2M=:LY[:[TQXKJVLU2.W:#_GI(%/! ) )P<$CL< 'H(((!!R#WK&
M\6:U)X=\*ZCJ\,*326L6]8W) 8Y Y(^M7=)AL+?1[*'2S&=/C@1;8Q/O7RP!
MMPV3D8QSFJ'B[1IO$/A/4M)MI8XIKJ+8CR9V@Y!YQSVH J6NOZI:>)+/1=<L
MK1&OXY'M+FSE9D9HP"R,K*"IP<@Y(.#TJ+2?'$>MW%L++1-6:TFN)+9KQHD$
M<;H7!S\VXCY#\P!&2!G/ EM=#U:]\1VFLZ[/9 V$4B6EM9ABH:0 ,[.V"3@8
M  &,GK5SPGHLWA_P[#IL\J2R)+/(6CSC#RNXZ^S 4 ;5%9L$6KC7[J2>XM6T
MEHE%O$J$2K)_$6/0CTK2H Y7Q!XP;1/$6G6"V@EM79/M]P6Q]E65_+A/_ G!
M!] *=K/C:#2=7N=+BTC4]0N[>U6[D6UC0J(B6&=S, "-AXZG(QGG%'4/A\FM
MC7)-2U*[6?4W(VVT[+&L:C;$"O<@ ,?<FK6G>&]42_O;_4+JWDN;O2+>QD,>
M[!E3S-S\CH3(/UH GD\9VD@TQ=-L;S4I]1M!?106X166# ^=B[*!]X #.2:Q
M= \:?8/ 6EZIJRWUW->ZA-:((X]\I8S2A 5R.@0+^5267A#6]%DT*ZTNZT][
MJST>/2KI;D/L(7!$B;>200>#C(/45)8^"KZV\.>'].EO())]-U8W\L@! D4R
M2M@#L?W@]N#0!I'Q@D&ER7=]H^I6=P+Q;*&RE5#+/(P4J$*L5((;KNP-K9Q@
MU/8>)Q?V^HA=*ODU#3W6.?3SY9ERP#*5(?800<YW=CG&*A\:>%QXJTJV@4V_
MG6EVEW$ES'OBD9004<==I#,..G![5D/X-OG\-ZC865EHNC7%S)"^VP+[)@C9
M9)6"JVUAE>!P">M '0Z'XB76+N_LI+"YL;VP*":"X*,<."58,C,"" >_:M#4
MKIK'2[N[50S00/*%/0E5)Q^E<QX3\+7WA_7M3O7@TBWM=0AAS;Z>C1B%X]PP
M!C# ALEN#GMWKI]3M6OM*O+1&"O/ \2LW0%E(Y_.@#FK;QO'=+X3$7V6276L
M>?&DN3!^X:4X'U7'-7F\5&#7+33KW1M0M([V9X+:ZE,121U5FQA7+*"%)&0/
MPK-M/ L=D/"3P16,4^C8^U2QQ;6G_P!':(X(&3\S \UCVGP_UJVU#3+UVT:>
M[T^^:Y:]='^TWBMO4B1\';@/]T;@2!T H Z*;QU90W3XL+U].BO!82ZDH3R4
MF+!-N"V\@.0I8+@&HM5\?VFEKJDZZ5J-W8Z6_E7=W;K&423 )0!G#-C<,D#
M)Z]<9-O\/#I^JW3Q:3X?U"WGO7NTN+U&$\.]]Y7A2'P<X.5[>E8/BRTO;:#Q
M+X;TK4;>8:M=F<6GV25KD22[2R@_<V9^8OV&1[@ [W5_&5OI=U>P0Z;?7_\
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M 4E>"6&=0KQ2(=K*V"1P1V)%:58_A_2)='34EED1_M6H3W:[,\*[9 /O6Q0
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MVM[/<I#%,DZK P7+J<J22">#4FNZ!;>(M#DTB_GN/L\NWS&C959]I##)QQR
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M_+B/=MP,?[9S^%4M \,1^'1Y-IJ=_)8HK+#93-&T4(+9^4A _'(&6/!K=HH
M*S]%T>VT'2TT^T,AA2220&0Y.7=G/;U8UH44 9]EH]M8:IJ>H0F0S:C)'),&
M.0"B!!CCCA16?=>$X9-6N=2L=4U'3)[O;]J%FZ;9BHP&(=&PV !E<'@5T%%
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MKLE4*)@<;][B/@ 9'05L:+I4^D^'/(DN8UU*?=-<7)7<IN)#DMC(R Q  ST
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MN;M 0%4=D0MR>[<#@'(!O7/BK1[/5ETRYN9(KEI%A4O;R",R, 57S-NS<<C
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M?IFEVD^"OF6\$<;8/49 !I__  C6@_\ 0$TW_P !4_PH_P"$:T'_ * FF_\
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M_@*G^% &A]H@_P">T?\ WT*/M$'_ #VC_P"^A6?_ ,(UH/\ T!--_P# 5/\
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M:[B1Y5U'Y<@P<<B@"W1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %5[^S34=.N;*226-+B)HF>)]KJ&&
M"5/8\]:L44 <]H/A*#P\85M=4U22WAC\N.VFG#1*.V%"CI70T44 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832570000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Aug. 04, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ARVINAS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-2566120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5 Science Park<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">395 Winchester Ave<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New Haven<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">535-1456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ARVN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,485,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001655759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832633088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 90.6<span></span>
</td>
<td class="nump">$ 81.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">948.2<span></span>
</td>
<td class="nump">1,124.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,056.7<span></span>
</td>
<td class="nump">1,240.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, equipment and leasehold improvements, net</a></td>
<td class="nump">13.2<span></span>
</td>
<td class="nump">13.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right of use assets</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_CollaborationContractAssetAndOtherAssets', window );">Collaboration contract asset and other assets</a></td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,083.5<span></span>
</td>
<td class="nump">1,268.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">74.8<span></span>
</td>
<td class="nump">74.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">230.1<span></span>
</td>
<td class="nump">218.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long term debt</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">306.9<span></span>
</td>
<td class="nump">295.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue</a></td>
<td class="nump">310.5<span></span>
</td>
<td class="nump">405.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term debt</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">619.9<span></span>
</td>
<td class="nump">703.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 53.4 and 53.2 shares issued and outstanding as of June&#160;30, 2023 and December&#160;31, 2022, respectively</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,113.9)<span></span>
</td>
<td class="num">(965.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,589.6<span></span>
</td>
<td class="nump">1,549.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(12.2)<span></span>
</td>
<td class="num">(19.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">463.6<span></span>
</td>
<td class="nump">564.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,083.5<span></span>
</td>
<td class="nump">$ 1,268.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_CollaborationContractAssetAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration contract asset and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_CollaborationContractAssetAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832446992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832700752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 54.5<span></span>
</td>
<td class="nump">$ 33.8<span></span>
</td>
<td class="nump">$ 87.0<span></span>
</td>
<td class="nump">$ 60.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">103.4<span></span>
</td>
<td class="nump">75.3<span></span>
</td>
<td class="nump">198.6<span></span>
</td>
<td class="nump">139.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">25.7<span></span>
</td>
<td class="nump">24.3<span></span>
</td>
<td class="nump">50.7<span></span>
</td>
<td class="nump">44.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">129.1<span></span>
</td>
<td class="nump">99.6<span></span>
</td>
<td class="nump">249.3<span></span>
</td>
<td class="nump">183.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(74.6)<span></span>
</td>
<td class="num">(65.8)<span></span>
</td>
<td class="num">(162.3)<span></span>
</td>
<td class="num">(123.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expenses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income, net</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Net loss before income taxes and loss from equity method investment</a></td>
<td class="num">(65.6)<span></span>
</td>
<td class="num">(64.1)<span></span>
</td>
<td class="num">(146.8)<span></span>
</td>
<td class="num">(120.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investment</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (66.6)<span></span>
</td>
<td class="num">$ (70.0)<span></span>
</td>
<td class="num">$ (148.5)<span></span>
</td>
<td class="num">$ (133.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share, basic (in dollars per share)</a></td>
<td class="num">$ (1.25)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (2.78)<span></span>
</td>
<td class="num">$ (2.51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share, diluted (in dollars per share)</a></td>
<td class="num">$ (1.25)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (2.78)<span></span>
</td>
<td class="num">$ (2.51)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.2<span></span>
</td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.2<span></span>
</td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (66.6)<span></span>
</td>
<td class="num">$ (70.0)<span></span>
</td>
<td class="num">$ (148.5)<span></span>
</td>
<td class="num">$ (133.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on available-for-sale securities</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="num">(17.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (66.2)<span></span>
</td>
<td class="num">$ (73.3)<span></span>
</td>
<td class="num">$ (141.5)<span></span>
</td>
<td class="num">$ (150.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028831660320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 781.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (682.9)<span></span>
</td>
<td class="nump">$ 1,469.2<span></span>
</td>
<td class="num">$ (4.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">36.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(133.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(133.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under equity incentive plans</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on available-for-sale securities</a></td>
<td class="num">(17.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17.4)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">670.6<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">(816.3)<span></span>
</td>
<td class="nump">1,508.8<span></span>
</td>
<td class="num">(22.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">723.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">(746.3)<span></span>
</td>
<td class="nump">1,488.3<span></span>
</td>
<td class="num">(18.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(70.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under equity incentive plans</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on available-for-sale securities</a></td>
<td class="num">(3.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">$ 670.6<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">(816.3)<span></span>
</td>
<td class="nump">1,508.8<span></span>
</td>
<td class="num">(22.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">53.2<span></span>
</td>
<td class="nump">53.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 564.9<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">(965.4)<span></span>
</td>
<td class="nump">1,549.4<span></span>
</td>
<td class="num">(19.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">38.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(148.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(148.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under equity incentive plans</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on available-for-sale securities</a></td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">$ 463.6<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">(1,113.9)<span></span>
</td>
<td class="nump">1,589.6<span></span>
</td>
<td class="num">(12.2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">511.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">(1,047.3)<span></span>
</td>
<td class="nump">1,570.8<span></span>
</td>
<td class="num">(12.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">18.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(66.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under equity incentive plans</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on available-for-sale securities</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">$ 463.6<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (1,113.9)<span></span>
</td>
<td class="nump">$ 1,589.6<span></span>
</td>
<td class="num">$ (12.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832594784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (148.5)<span></span>
</td>
<td class="num">$ (133.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Net accretion of bond discounts/premiums</a></td>
<td class="num">(7.0)<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleGainLoss', window );">Loss on sale of marketable securities</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of collaboration contract asset</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">36.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">13.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">13.1<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(12.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(83.1)<span></span>
</td>
<td class="num">(52.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(179.9)<span></span>
</td>
<td class="num">(135.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(492.3)<span></span>
</td>
<td class="num">(469.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ProceedsFromMaturitiesOfMarketableSecurities', window );">Maturities of marketable securities</a></td>
<td class="nump">638.9<span></span>
</td>
<td class="nump">555.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ProceedsFromSaleOfMarketableSecurities', window );">Sales of marketable securities</a></td>
<td class="nump">42.3<span></span>
</td>
<td class="nump">34.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, equipment and leasehold improvements</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">187.2<span></span>
</td>
<td class="nump">117.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares', window );">Proceeds from exercise of stock options and issuance of ESPP shares</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of the period</a></td>
<td class="nump">86.8<span></span>
</td>
<td class="nump">112.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of the period</a></td>
<td class="nump">96.1<span></span>
</td>
<td class="nump">97.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property, equipment and leasehold improvements unpaid at period end</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for taxes</a></td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Exercise Of Stock Options And Issuance Of Employee Stock Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ProceedsFromMaturitiesOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from maturities of marketable securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ProceedsFromMaturitiesOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ProceedsFromSaleOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of marketable securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ProceedsFromSaleOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833338560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Nature of Business and Basis of Presentation</a></td>
<td class="text">Nature of Business and Basis of Presentation<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arvinas, Inc. and its subsidiaries (&#8220;Arvinas&#8221; or the "Company&#8221;) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements include the accounts of Arvinas, Inc. and its subsidiaries. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission (&#8220;SEC&#8221;) rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December&#160;31, 2022 has been derived from the Company's audited consolidated financial statements as of that date. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December&#160;31, 2022, forming part of Arvinas&#8217; 2022 Annual Report on Form 10-K filed with the SEC on February&#160;23, 2023. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed in the Company's 2022 Annual Report on Form 10-K, the Company revised the accounting for its investment in Oerth Bio LLC ("Oerth Bio"). Accordingly, Arvinas recorded an adjustment to the unaudited condensed consolidated financial statements for the three and six months ended June&#160;30, 2022 that were previously included in the Company's Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2022. See Note 12,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Equity Method Investments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further details.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amount of assets, liabilities, revenue and expenses. These estimates include assumptions and judgments based on historical experience, current conditions, future expectations and other factors the Company considers reasonable. These estimates are reviewed on an ongoing basis and revised as necessary. Actual results could differ from these estimates.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to a number of risks similar to other biotechnology companies in the early stage, including, but not limited to, the need to obtain adequate additional funding, possible failure of preclinical testing or clinical trials, the need to obtain marketing approval for its product candidates, competitors developing new technological innovations, the need to successfully commercialize and gain market acceptance of the Company&#8217;s products and protection of proprietary technology. If the Company does not successfully obtain regulatory approval, it will be unable to generate revenue from product sales or achieve profitability. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, the Company has not generated any revenue from product sales and expects to incur additional operating losses and negative operating cash flows for the foreseeable future. The Company has financed its operations primarily through sales of equity interests, proceeds from collaborations, grant funding and debt financing. The Company had cash, cash equivalents, restricted cash and marketable securities of approximately $1.0 billion as of June&#160;30, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832498288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Pronouncements and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Accounting Pronouncements and Significant Accounting Policies</a></td>
<td class="text">Accounting Pronouncements and Significant Accounting Policies<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reviews</span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">new accounting standards as issued. As of June&#160;30, 2023, the Company has not identified any new standards that it believes will have a material impact on the Company&#8217;s financial statements.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to the Company&#8217;s significant accounting policies during the six months ended June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, Cash Equivalents and Restricted Cash </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the total amounts shown in the consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">93.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash represents a letter of credit collateralized by a certificate of deposit in the same amount as required under the terms of the Company's laboratory and office space lease entered into in May 2021 and amended in August 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833395056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Collaboration and License Agreements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsAbstract', window );"><strong>Research Collaboration And License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Research Collaboration and License Agreements</a></td>
<td class="text">Research Collaboration and License Agreements  <div style="margin-top:6pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vepdegestrant (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ARV-471) Collaboration Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company entered into a Collaboration Agreement with Pfizer Inc. (&#8220;Pfizer&#8221;) (the &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vepdegestrant (</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARV-471) Collaboration Agreement&#8221;) pursuant to which the Company granted Pfizer worldwide co-exclusive rights to develop and commercialize products containing the Company&#8217;s proprietary compound ARV-471 (the &#8220;Licensed Products&#8221;). Under the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vepdegestrant (</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARV-471) Collaboration Agreement, the Company received an upfront, non-refundable payment of $650.0 million. In addition, the Company is eligible to receive up to an additional $1.4 billion in contingent payments based on specific regulatory and sales-based milestones for the Licensed Products. Of the total contingent payments, $400.0 million in regulatory milestones are related to marketing approvals and $1.0 billion are related to sales-based milestones. There were no regulatory or sales-based milestone payments received through </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and Pfizer share equally all development costs, including costs of conducting clinical trials, for the Licensed Products, subject to certain exceptions. Except for certain regions described below, the parties will also share equally all profits and losses in commercialization and medical affairs activities for the Licensed Products in all other countries, subject to certain exceptions. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will be the marketing authorization holder in the United States and, subject to marketing approval, book sales in the United States, while Pfizer will hold marketing authorizations outside the United States. The parties will determine which, if any, regions within the world will be solely commercialized by one party, and in such region the parties will adjust their share of profits and losses for the Licensed Products based on the role each party will be performing.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a direct result of the Company&#8217;s entry into the Vepdegestrant (ARV-471) Collaboration Agreement, the Company incurred direct and incremental costs to obtain the contract, paid to a financial advisor, totaling $12.9 million. In accordance with ASC 340, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recognized an asset of $12.9 million in collaboration contract asset and other assets in the condensed consolidated balance sheet at inception of the agreement, which is being amortized as general and administrative expense over the total estimated period of performance under the Vepdegestrant (ARV-471) Collaboration Agreement.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bayer Collaboration Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, the Company and Bayer AG entered into a Collaboration and License Agreement (the &#8220;Bayer Collaboration Agreement&#8221;) setting forth the Company&#8217;s collaboration with Bayer AG to identify or optimize proteolysis targeting chimeras ("PROTAC&#174; targeted protein degraders") that mediate the degradation of target proteins. Under the terms of the Bayer Collaboration Agreement, the Company received an upfront, non-refundable payment of $17.5 million in exchange for the use of the Company&#8217;s technology license. Bayer AG was committed to fund an additional $12.0 million through 2023, all of which was received as of June&#160;30, 2023, including $1.5&#160;million and $3.0&#160;million in the six months ended June&#160;30, 2023 and 2022, respectively. These payments are being recognized over the total estimated period of performance.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also eligible to receive up to $197.5&#160;million in development milestone payments and up to $490.0&#160;million in sales-based milestone payments for all designated targets. In addition, the Company is eligible to receive, on net sales of PROTAC targeted protein degrader-related products, mid-single digit to low-double digit tiered royalties, which may be subject to reductions. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no development or sales-based milestone payments or royalties received through June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pfizer Research Collaboration Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Company entered into a Research Collaboration and License Agreement with Pfizer (the &#8220;Pfizer Research Collaboration Agreement&#8221;). Under the terms of the Pfizer Research Collaboration Agreement, the Company received an upfront, non-refundable payment and certain additional payments totaling $28.0 million in 2018 in exchange for use of the Company&#8217;s technology license and to fund Pfizer-related research as defined within the Pfizer Research Collaboration Agreement. These payments are being recognized as revenue over the total estimated period of performance. The Company is eligible to receive up to an additional $37.5&#160;million in non-refundable option payments if Pfizer exercises its options for all targets under the Pfizer Research Collaboration Agreement. The Company is also entitled to receive up to $225.0&#160;million in development milestone payments and up to $550.0&#160;million in sales-based milestone payments for all designated targets under the Pfizer Research Collaboration Agreement, as well as tiered royalties based on sales. During the six months ended June&#160;30, 2023 and 2022, the Company received payments totaling $1.0 million and $3.5 million which were included in accounts receivable as of December 31, 2022 and 2021, respectively, for additional targets and services which are being recognized as revenue over the total period of performance. There were no sales-based milestone payments or royalties received through June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restated Genentech Agreement</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, the Company entered into an Amended and Restated Option, License, and Collaboration Agreement (the &#8220;Restated Genentech Agreement&#8221;) with Genentech, Inc. and F. Hoffman-La Roche Ltd. (together "Genentech"), amending a previous Genentech agreement entered into in September 2015. Under the Restated Genentech Agreement, the Company received additional upfront, non-refundable payments of $34.5 million (in addition to $11.0 million received under the previous agreement in 2015) to fund Genentech-related research. Upfront non-refundable payments were recognized as revenue over the performance period. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is eligible to receive up to $44.0&#160;million per target in development milestone payments, $52.5&#160;million in regulatory milestone payments and $60.0&#160;million in commercial milestone payments based on sales as well as tiered royalties based on sales. There were no development, regulatory or commercial milestone payments or royalties received through June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company's contract balances for the six months ended June&#160;30, 2023 and 2022 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Accounts receivable related to collaborations</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Payments received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(15.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Accounts payable related to collaborations</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Payments made</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Contract assets: Collaboration contract asset</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Contract liabilities: Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">623.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">740.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue recognized from balances held at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(84.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(55.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions to collaboration agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">540.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">688.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2023, the Company recorded cumulative catch-up adjustments from contract modifications totaling zero and $(8.2) million, respectively, relating to performance obligations which were satisfied in prior periods. During the three and six months ended June&#160;30, 2022, the Company recorded no cumulative catch-up adjustments.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amount of the transaction price allocated to performance obligations that were unsatisfied as of June&#160;30, 2023 was $540.6 million, which is expected to be recognized in the following periods:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">110.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">90.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">55.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">540.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ResearchCollaborationAndLicenseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research Collaboration And License Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ResearchCollaborationAndLicenseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028835727152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Marketable Securities and Fair Value Measurements</a></td>
<td class="text">Marketable Securities and Fair Value Measurements The Company&#8217;s marketable securities consist of corporate bonds and government securities which are adjusted to fair value as of each balance sheet date based on quoted prices, which are considered Level 2 inputs. <div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s available-for-sale marketable securities measured at fair value on a recurring basis. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Valuation</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Hierarchy</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amortized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross </span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">888.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12.1)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">876.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">71.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">71.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">960.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">948.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Valuation</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Hierarchy</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amortized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,008.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(18.5)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">989.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">135.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">134.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,143.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(19.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,124.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not intend to sell any investments prior to recovery of their amortized cost basis for any investment in an unrealized loss position. As such, the Company has classified these losses as temporary in nature.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of accounts receivable and accounts payable and accrued liabilities approximate their </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair values due to the short-term nature of these assets and liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833380704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment and Leasehold Improvements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Equipment and Leasehold Improvements</a></td>
<td class="text">Property, Equipment and Leasehold Improvements <div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment and leasehold improvements consist of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total property, equipment and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">30.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(18.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Property, equipment and leasehold improvements, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense totaled $1.2 million and $1.5 million for the three months ended June&#160;30, 2023 and 2022, respectively, and $2.4 million and $3.0 million for the six months ended June&#160;30, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832499584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Right-of-Use Assets and Liabilities</a></td>
<td class="text">Right-of-Use Assets and Liabilities<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities in the condensed consolidated balance sheets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As the Company&#8217;s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the present value of lease payments, which ranges from 3.0% - 7.5%. Lease expense is recognized on a straight-line basis over the lease term. The Company considers options to extend or terminate leases in recognizing ROU assets and lease liabilities when it is reasonably certain that such options will be exercised.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into a lease arrangement, which was amended in August 2022, for approximately 160,000 square feet of laboratory and office space, expected to be occupied in 2025. In connection with the signing of the lease and the related amendment, and at the Company&#8217;s election to increase the landlord&#8217;s contribution to the tenant improvement allowance, the Company initially issued a letter of credit totaling $4.5&#160;million, which was subsequently increased to $5.5 million, collateralized by a certificate of deposit in the same amount, which is presented as restricted cash in the consolidated balance sheets. Once occupied, the base rent will range from $7.7 million to $8.8 million annually over a ten-year lease term.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for its corporate office, laboratories and certain equipment, which expire no later than January 2026. The leases have a weighted average remaining term of 1.8 years.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease cost</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.5&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.5&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.1&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="3" style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Supplemental non-cash information:</span></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Right-of-use assets obtained in exchange for new lease obligations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities as of June&#160;30, 2023, were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833385296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text">Accounts Payable and Accrued Liabilities <div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts payable</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">51.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Employee expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Professional fees and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833320960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt obligations consisted of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2018 Assistance Agreement Debt</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: current installments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company entered into an additional assistance agreement with the State of Connecticut (the "2018 Assistance Agreement") to provide funding for the expansion and renovation of laboratory and office space. The Company borrowed $2.0 million under the 2018 Assistance Agreement in September 2018, of which $1.0 million was forgiven upon meeting certain employment conditions. Borrowings under the agreement bear an interest rate of 3.25% per annum, with interest-only payments required for the first 60 months, and mature in September 2028. The 2018 Assistance Agreement requires that the Company be located in the State of Connecticut through September 2028, with a default penalty of repayment of the full original funding amount of $2.0 million plus liquidated damages of 7.5% of the total amount of funding received.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with an assistance agreement with the State of Connecticut entered into in 2014 under which all the borrowings by the Company were forgiven, the Company is required to be located in the State of Connecticut through January 2024, with a default penalty of repayment of the full original funding amount of $2.5 million plus liquidated damages of 7.5%. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Minimum future principal payments on long-term debt for the years ending December&#160;31 are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2023 and 2022, interest expense was immaterial.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833317168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity</a></td>
<td class="text">Equity<div style="margin-top:6pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Distribution Agreements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company entered into an Equity Distribution Agreement with Piper Sandler &amp; Company (&#8220;Piper Sandler&#8221;) and Cantor Fitzgerald &amp; Co. (&#8220;Cantor&#8221;), as agents, pursuant to which the Company may offer and sell from time to time, through the agents, up to $300.0 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the common stock registered under the Company's universal shelf registration statement pursuant to one or more &#8220;at-the-market" offerings. During the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> June&#160;30, 2023, no shares were issued under this agreement.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the Company adopted the 2018 Employee Stock Purchase Plan (the &#8220;2018 ESPP&#8221;), with the first offering period under the 2018 ESPP commencing on January 1, 2020, by initially providing participating employees with the opportunity to purchase an aggregate of 311,850 shares of the Company&#8217;s common stock. The number of shares of the Company&#8217;s common stock reserved for issuance under the 2018 ESPP increased, pursuant to the terms of the 2018 ESPP, by additional shares equal to 1% of the Company&#8217;s then-outstanding common stock, effective as of January 1 of each year. As of June&#160;30, 2023, 2,495,756 shares remained available for purchase. During the six months ended June&#160;30, 2023 and 2022, the Company issued 23,206 and 5,749 shares of common stock, respectively, of common stock under the 2018 ESPP.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Share Plan</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Fourth Amendment to the Company&#8217;s Incentive Share Plan (the &#8220;Incentive Plan&#8221;) adopted in March 2018, the Company was authorized to issue up to an aggregate of 6,199,477 incentive units pursuant to the terms of the Incentive Plan. Generally, incentive units were granted at no less than fair value as determined by the board of managers and had vesting periods ranging from <span style="-sec-ix-hidden:f-528">one</span> to four years. The Incentive Plan was terminated in September 2018. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Stock Incentive Plan</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, the Company&#8217;s board of directors adopted, and the Company&#8217;s stockholders approved, the 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), which became effective upon the effectiveness of the registration statement on Form S-1 for the Company&#8217;s initial public offering. The number of shares of common stock initially available for issuance under the 2018 Plan equaled the sum of (1) 4,067,007 shares of common stock; plus (2) the number of shares of common stock (up to 1,277,181 shares) issued in respect of incentive units granted under the Incentive Plan that were subject to vesting immediately prior to the effectiveness of the registration statement that expire, terminate or are otherwise surrendered, cancelled, forfeited or repurchased by the Company at their original issuance price pursuant to a contractual repurchase right; plus (3) an annual increase on the first day of each fiscal year beginning with the fiscal year ended December 31, 2019 and continuing to, and including, the fiscal year ending December 31, 2028, equal to the lesser of 4,989,593 shares of the Company&#8217;s common stock, 4% of the number of shares of the Company&#8217;s common stock outstanding on the first day of the year or an amount determined by the Company&#8217;s board of directors. As of June&#160;30, 2023, 1,987,423 shares remained available for issuance under the 2018 Plan. Shares of common stock subject to outstanding equity awards that expire or are terminated, surrendered, or canceled without having been fully exercised or are forfeited in whole or in part are available for future grants of awards.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Expense</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2023 and 2022, the Company recognized compensation expense of $18.3 million and $20.0 million, respectively, related to the issuance of incentive awards, including $0.3 million and $0.1 million, respectively, related to the 2018 ESPP. During the six months ended June&#160;30, 2023 and 2022, the Company recognized compensation expense of $38.2 million and $36.6 million, respectively, relating to the issuance of incentive awards, including $0.5 million and $0.3 million, respectively, related to the 2018 ESPP.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, there was $83.8 million of total unrecognized compensation expense that is expected to be amortized over a weighted average period of approximately 1.8 years.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the stock options granted during the six months ended June&#160;30, 2023 and 2022 was determined using the Black-Scholes option pricing model with the following assumptions:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">72.3 - 74.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">73.2 - 76.0%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.5 - 7.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.5 - 7.0</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.4% - 4.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.5% - 3.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercise price</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$23.23 - $36.27</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$36.79 - $78.91</span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the Company&#8217;s common stock has not been trading for a sufficient period of time, the Company calculates volatility of its common stock by utilizing a weighted average of a collection of peer company volatilities and its own common stock volatility. The expected term is calculated utilizing the simplified method. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the stock option activity under the 2018 Plan during the six months ended June&#160;30, 2023 is presented below. These amounts include stock options granted to employees and directors.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions, <br/>except weighted average exercise price)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Options </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Remaining Contractual</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Term (Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Outstanding as of December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,814,634&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">49.06&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,653,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(71,321)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(212,677)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">56.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Outstanding as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,183,808&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">46.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Vested and exercisable as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,417,474&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Vested and expected to vest as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,825,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">45.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value per share of options granted during the six months ended June&#160;30, 2023 and 2022 was $22.79 and $41.41, respectively. The total intrinsic value of options exercised during the six months ended June&#160;30, 2023 and 2022 was $0.6 million and $7.1 million, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units (RSUs)</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU activity under the 2018 Plan during the six months ended June&#160;30, 2023 is presented below. These amounts include RSUs granted to employees. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Grant Date</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Fair Value Per</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Share</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unvested RSUs as of December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">489,216&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">51.37&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">778,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(94,688)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(28,658)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unvested RSUs as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,144,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span id="ifd63f0d1bf8c4ee6838c66e23863a083_5558"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RSUs vested during the six months ended June&#160;30, 2023 and 2022 was $4.2 million and $0.7 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833336048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2023, the Company recognized income tax benefit of $0.3 million resulting in an effective tax rate of 0.4%, as compared to income tax expense of $3.4 million resulting in an effective tax rate of (5.4)% in the same period for 2022. The primary reconciling items between the federal statutory rate of 21.0% for the three months ended June&#160;30, 2023 and the Company&#8217;s overall effective tax rate of 0.4% was the effect of expected benefits from state net operating loss carryback claims offset by equity compensation and the valuation allowance recorded against the full amount of its net deferred tax assets. The primary reconciling items between the federal statutory rate of 21.0% for the three months ended June&#160;30, 2022 and the Company&#8217;s overall effective tax rate of (5.4)% was the effect of equity compensation, deferred state income taxes and the valuation allowance recorded against the full amount of its net deferred tax assets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2023, the Company recognized income tax expense of $0.7 million resulting in an effective tax rate of 0.4%, as compared to income tax expense of $7.9 million resulting in an effective tax rate of (6.5)% in the same period for 2022. The primary reconciling items between the federal statutory rate of 21.0% for the six months ended June&#160;30, 2023 and the Company&#8217;s overall effective tax rate of 0.4% was the effect of expected benefits from state net operating loss carryback claims offset by equity compensation and the valuation allowance recorded against the full amount of its net deferred tax assets. The primary reconciling items between the federal statutory rate of 21.0% for the six months ended June&#160;30, 2022 and the Company&#8217;s overall effective tax rate of (6.5)% was the effect of equity compensation, generation of tax credits, deferred state income taxes and the valuation allowance recorded against the full amount of its net deferred tax assets.</span></div>A valuation allowance is established when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The realization of deferred tax assets depends on the generation of future taxable income during the period in which related temporary differences become deductible. The Company continues to establish a full valuation allowance against its net deferred tax assets since it is more likely than not that benefits will not be realized, including those benefits created in the current year. This assessment is based on the Company's historical cumulative losses which provide strong objective evidence that cannot be overcome with projections of income, as well as the fact the Company expects continuing losses in the future.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833317168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share <div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted loss per common share was calculated as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars and shares in millions, except per share amounts)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net loss</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(66.6)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(70.0)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(148.5)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(133.4)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average number of common shares outstanding</span><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;- basic and diluted</span></div></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53.4&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53.4&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net loss per common share </span><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">-  basic and diluted</span></div></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.25)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.32)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.78)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.51)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:34.7pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reported net losses for each of the three and six months ended June&#160;30, 2023 and 2022, and therefore excluded all stock options and restricted stock units from the calculation of diluted net loss per common share as their inclusion would have had an anti-dilutive effect, as summarized below:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three and Six Months Ended<br/>June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(shares in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833336048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Equity Method Investments</a></td>
<td class="text">Equity Method Investments<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Company and Bayer CropScience LP (&#8220;Bayer LP&#8221;) formed Oerth Bio, a joint venture to research, develop and commercialize PROTAC targeted protein degraders for applications in the field of agriculture. The Company and Bayer LP each held an initial ownership interest in Oerth Bio of 50%. A 15% ownership interest of Oerth Bio was reserved for the future grants of incentive units to employees and service providers and, as a result, the Company's ownership interest totaled 45.5% and 47.5% as of June&#160;30, 2023 and 2022, respectively, as a result of vested incentive units.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the preparation of the Company's consolidated financial statements for the yea</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r ended December 31, 2022, the Company identified a prior period error related to the accounting of its investment in Oerth Bio in 2019. Previously, the Company disclosed that revenue of $24.7&#160;million was deferred and would be recognized if and when Oerth Bio recognized revenue associated with the license. The Company has determined that the consideration received for the amounts associated with the deferred revenue should have been constrained, because at the time Bayer LP had contributed only a portion of its full cash commitment to Oerth Bio, and Bayer LP had the right to all the cash contributed, but not yet spent, upon liquidation of Oerth Bio. The constrained revenue should have been recognized upon both cash being contributed by Bayer LP and the related cash spent by Oerth Bio on research and development activities. As such, for each period presented, the revenue recognized is accompanied by corresponding equity method losses of the same amount. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company ev</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aluated the error</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nd determined that the related impact did not materially misstate the previously issued unaudited condensed consoli</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dated financial statements for the three and six months ended June&#160;30, 2022. Although the Company concluded that the error was not material to its previously issued unaudited condensed consolidated financial statements, the Company has</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> determined it is appropriate to adjust its previously issued unaudited condensed consolidated financial statements for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended June&#160;30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to correct</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the error and improve comparability</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following illustrates the effect of the correction of the immaterial error for the period presented. There was no impact to the balance sheets, net loss per common share, statements of cash flows or changes in stockholders&#8217; equity.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:23.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.898%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as previously reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as adjusted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as previously reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as adjusted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from equity method investment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share - basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss of Oerth Bio for the three months ended June&#160;30, 2023 and 2022 totaled $2.8 million</span><span style="color:#ff0000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $5.3 million, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized equity method losses of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended June&#160;30, 2023 and 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. Net loss of Oerth Bio for the six months ended June&#160;30, 2023 and 2022 totaled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.2 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $10.2 million, respectively. The Company recognized equity method losses of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.4 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $4.8 million for the six</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended June&#160;30, 2023 and 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company&#8217;s </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">carrying value of t</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he investment was zero.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provides Oerth Bio with compensated research, development and administrative services through a separate agreement. The services rendered by the Company during the three and six months ended June&#160;30, 2023 and 2022 were immaterial.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 323<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481543/323-740-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 323<br> -Publisher FASB<br> -URI https://asc.fasb.org//323/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832553824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may be subject to legal proceedings, claims and disputes that arise in the&#160;ordinary&#160;course&#160;of business. The Company accrues a liability for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount, which could differ materially. Legal fees and other costs associated with such actions are expensed as incurred.&#160;The Company's accrual for such matters totaled $10.0&#160;million as of June&#160;30, 2023, primarily related to a contract dispute that is in early stages. Due to the early stage of the dispute, the means of resolution are unknown and could involve contract modification and, or payment of consideration.&#160;An estimate of the possible range of loss associated with the dispute cannot be made at this time and the Company has accrued its best estimate as of June&#160;30, 2023.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical and Preclinical Development and Licensing Arrangements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into contracts in the normal course of business with various third parties who support its clinical trials, preclinical research studies, and other services related to its development activities. The scope of the services under these agreements can generally be modified at any time, and the agreement can be terminated by either party after a period of notice and receipt of written notice.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, under licensing and related arrangements to which the Company is a party, the Company may be obligated to make milestone payments to third parties. The payment obligations under these arrangements are contingent upon future events, such as achievement of specified milestones or generation of product sales, and the amount, timing and likelihood of such payments are not known.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">FMI Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company entered into a Master In Vitro Diagnostics Agreement (the "FMI Agreement") with Foundation Medicine, Inc. ("Foundation Medicine") for the development and commercialization of one or more of Foundation Medicine&#8217;s companion in vitro diagnostic assays for use with one or more of the Company's therapeutic products.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FMI Agreement does not have a fixed duration, and the Company may terminate the FMI Agreement for convenience by providing adequate written notice to Foundation Medicine, subject to payment of applicable termination fees. Either party may terminate the FMI Agreement in its entirety for an uncured material breach by the other party, upon the bankruptcy or insolvency of the other party or by the mutual written agreement of both parties. Additionally, Foundation Medicine may terminate the FMI Agreement with respect to an applicable program, (a) if a reasonably necessary third party license is not secured by Foundation Medicine or if the Company does not consent to payments for such license, (b) if Foundation Medicine reasonably determines that further development of the applicable assay is not technically feasible or (c) following a certain number of years after the first commercial launch of the applicable assay for use with the applicable therapeutic product. Certain license and other rights and certain obligations of Foundation Medicine survive termination of the FMI Agreement. If the FMI Agreement is terminated in its entirety or with respect to any program, the Company has certain payment obligations remaining to Foundation Medicine and may also be required to pay a termination fee, if applicable.  </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bavdegalutamide</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In exchange for the development of FoundationOne&#174; Liquid CDx as a companion diagnostic for use with bavdegalutamide for androgen receptor protein (&#8220;AR&#8221;) metastatic castration-resistant prostate cancer (&#8220;mCRPC&#8221;) in the United States and European Union, pursuant to the terms of the FMI Agreement, the Company is subject to success-based milestone payments of up to low to mid tens of millions of dollars, in addition to certain validation fees per sample and related pass-through costs.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ARV-766</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In exchange for the development of FoundationOne&#174; Liquid CDx as a companion diagnostic for use with ARV-766 for AR mCRPC in the United States and European Union, pursuant to the terms of the FMI Agreement, the Company is subject to success-based milestone payments of up to low tens of millions of dollars in addition to certain validation fees per sample and related pass-through costs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832699104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (66.6)<span></span>
</td>
<td class="num">$ (70.0)<span></span>
</td>
<td class="num">$ (148.5)<span></span>
</td>
<td class="num">$ (133.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028827794176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832607104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Pronouncements and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The accompanying unaudited condensed consolidated financial statements include the accounts of Arvinas, Inc. and its subsidiaries. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission (&#8220;SEC&#8221;) rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December&#160;31, 2022 has been derived from the Company's audited consolidated financial statements as of that date. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December&#160;31, 2022, forming part of Arvinas&#8217; 2022 Annual Report on Form 10-K filed with the SEC on February&#160;23, 2023.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amount of assets, liabilities, revenue and expenses. These estimates include assumptions and judgments based on historical experience, current conditions, future expectations and other factors the Company considers reasonable. These estimates are reviewed on an ongoing basis and revised as necessary. Actual results could differ from these estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Risks and Uncertainties</a></td>
<td class="text">Risks and UncertaintiesThe Company is subject to a number of risks similar to other biotechnology companies in the early stage, including, but not limited to, the need to obtain adequate additional funding, possible failure of preclinical testing or clinical trials, the need to obtain marketing approval for its product candidates, competitors developing new technological innovations, the need to successfully commercialize and gain market acceptance of the Company&#8217;s products and protection of proprietary technology. If the Company does not successfully obtain regulatory approval, it will be unable to generate revenue from product sales or achieve profitability.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reviews</span><span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">new accounting standards as issued. As of June&#160;30, 2023, the Company has not identified any new standards that it believes will have a material impact on the Company&#8217;s financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text">Cash, Cash Equivalents and Restricted CashRestricted cash represents a letter of credit collateralized by a certificate of deposit in the same amount as required under the terms of the Company's laboratory and office space lease entered into in May 2021 and amended in August 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833314704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Pronouncements and Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the total amounts shown in the consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">93.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Restrictions on Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the total amounts shown in the consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">93.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833326528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Collaboration and License Agreements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsAbstract', window );"><strong>Research Collaboration And License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Contract Balances</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company's contract balances for the six months ended June&#160;30, 2023 and 2022 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Accounts receivable related to collaborations</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Payments received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(15.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Accounts payable related to collaborations</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Payments made</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Contract assets: Collaboration contract asset</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Contract liabilities: Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">623.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">740.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue recognized from balances held at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(84.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(55.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions to collaboration agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">540.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">688.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Schedule of Transaction Price Allocated to Performance Obligations</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amount of the transaction price allocated to performance obligations that were unsatisfied as of June&#160;30, 2023 was $540.6 million, which is expected to be recognized in the following periods:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">110.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">90.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">55.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">540.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ResearchCollaborationAndLicenseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research Collaboration And License Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ResearchCollaborationAndLicenseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833499952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Marketable Securities</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s available-for-sale marketable securities measured at fair value on a recurring basis. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Valuation</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Hierarchy</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amortized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross </span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">888.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12.1)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">876.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">71.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">71.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">960.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">948.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Valuation</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Hierarchy</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amortized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Gross</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Unrealized</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,008.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(18.5)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">989.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Government securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">135.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">134.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,143.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(19.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,124.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028834236640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment and Leasehold Improvements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Equipment and Leasehold Improvements</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment and leasehold improvements consist of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total property, equipment and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">30.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(18.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Property, equipment and leasehold improvements, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028838066912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Components of Lease Expense</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease cost</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.5&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.5&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.1&#160;</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Schedule of Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="3" style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Supplemental non-cash information:</span></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Right-of-use assets obtained in exchange for new lease obligations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities as of June&#160;30, 2023, were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental cash flow information related to leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028834287584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Components of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts payable</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">51.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Employee expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Professional fees and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028838067664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt obligations consisted of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2018 Assistance Agreement Debt</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: current installments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Minimum Future Payments on Long-Term Debt</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Minimum future principal payments on long-term debt for the years ending December&#160;31 are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-8<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028834606240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used to Determine Fair Value of Stock Options Granted</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the stock options granted during the six months ended June&#160;30, 2023 and 2022 was determined using the Black-Scholes option pricing model with the following assumptions:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">72.3 - 74.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">73.2 - 76.0%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.5 - 7.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.5 - 7.0</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.4% - 4.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.5% - 3.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercise price</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$23.23 - $36.27</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$36.79 - $78.91</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the stock option activity under the 2018 Plan during the six months ended June&#160;30, 2023 is presented below. These amounts include stock options granted to employees and directors.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions, <br/>except weighted average exercise price)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Options </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Remaining Contractual</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Term (Years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Outstanding as of December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,814,634&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">49.06&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,653,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(71,321)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(212,677)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">56.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Outstanding as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,183,808&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">46.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Vested and exercisable as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,417,474&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Vested and expected to vest as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,825,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">45.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of Restricted Stock Grant Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU activity under the 2018 Plan during the six months ended June&#160;30, 2023 is presented below. These amounts include RSUs granted to employees. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Grant Date</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Fair Value Per</span></div><div style="margin-top:0.75pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Share</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unvested RSUs as of December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">489,216&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">51.37&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">778,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(94,688)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(28,658)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unvested RSUs as of June&#160;30, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,144,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832481568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Loss per Common Share</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted loss per common share was calculated as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">For the Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars and shares in millions, except per share amounts)</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net loss</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(66.6)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(70.0)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(148.5)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(133.4)</span></td><td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average number of common shares outstanding</span><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;- basic and diluted</span></div></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53.4&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53.4&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net loss per common share </span><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">-  basic and diluted</span></div></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.25)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.32)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.78)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.51)</span></td><td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Securities Excluded From Computation of Diluted Net Loss Per Common Share</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:34.7pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reported net losses for each of the three and six months ended June&#160;30, 2023 and 2022, and therefore excluded all stock options and restricted stock units from the calculation of diluted net loss per common share as their inclusion would have had an anti-dilutive effect, as summarized below:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three and Six Months Ended<br/>June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(shares in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028833491264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Schedule of Correction of the Immaterial Error for the Period</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following illustrates the effect of the correction of the immaterial error for the period presented. There was no impact to the balance sheets, net loss per common share, statements of cash flows or changes in stockholders&#8217; equity.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:23.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.898%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%">(dollars in millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as previously reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as adjusted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as previously reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">as adjusted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from equity method investment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share - basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028836491328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Nature of Business and Basis of Presentation (Details)<br> $ in Billions</strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities', window );">Cash, cash equivalents, restricted cash and marketable securities</a></td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash and Marketable Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028827026240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounting Pronouncements and Significant Accounting Policies - Cash Reconciliation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 90.6<span></span>
</td>
<td class="nump">$ 81.3<span></span>
</td>
<td class="nump">$ 93.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 96.1<span></span>
</td>
<td class="nump">$ 86.8<span></span>
</td>
<td class="nump">$ 97.7<span></span>
</td>
<td class="nump">$ 112.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028826233968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Collaboration and License Agreements - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="nump">$ 11,700,000<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="nump">$ 11,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,700,000<span></span>
</td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_CollaborationContractAssetAndOtherAssets', window );">Collaboration contract asset and other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract', window );">Revenue adjustments arising from contract modifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(8,200,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_PfizerIncorporationMember', window );">Pfizer, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">$ 28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_PfizerIncorporationMember', window );">Pfizer, Inc. | Regulatory and Sales-Based Milestones | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_PfizerIncorporationMember', window );">Pfizer, Inc. | Collaboration Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract', window );">Collaboration agreement direct and incremental costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_CollaborationContractAssetAndOtherAssets', window );">Collaboration contract asset and other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_PfizerIncorporationMember', window );">Pfizer, Inc. | Regulatory Milestone Related to Marketing Approvals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_PfizerIncorporationMember', window );">Pfizer, Inc. | Sales-Based Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_PfizerIncorporationMember', window );">Pfizer, Inc. | Development Milestone Payments | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_PfizerIncorporationMember', window );">Pfizer, Inc. | Sales Based Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_PfizerIncorporationMember', window );">Pfizer, Inc. | Sales Based Milestone Payments | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_PfizerIncorporationMember', window );">Pfizer, Inc. | Option Payments To License Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_BayerAGMember', window );">Bayer Collaboration Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_BayerAGMember', window );">Bayer Collaboration Agreement | Research Funding Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_BayerAGMember', window );">Bayer Collaboration Agreement | Research Funding Payments | Scenario Forecast | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_BayerAGMember', window );">Bayer Collaboration Agreement | Development Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_BayerAGMember', window );">Bayer Collaboration Agreement | Development Milestone Payments | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_BayerAGMember', window );">Bayer Collaboration Agreement | Sales Based Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_BayerAGMember', window );">Bayer Collaboration Agreement | Sales Based Milestone Payments | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 490,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember', window );">Genentech, Inc. and F. Hoffman-La Roche Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Payments received</a></td>
<td class="nump">$ 34,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement', window );">Additional upfront non-refundable amount received under previous agreement</a></td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember', window );">Genentech, Inc. and F. Hoffman-La Roche Ltd. | Regulatory Milestone Related to Marketing Approvals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember', window );">Genentech, Inc. and F. Hoffman-La Roche Ltd. | Development Milestone Payments | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember', window );">Genentech, Inc. and F. Hoffman-La Roche Ltd. | Commercial Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems', window );"><strong>Research Collaboration And License Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract revenue receivable if milestones achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional upfront non-refundable amount received under previous agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_CollaborationContractAssetAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration contract asset and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_CollaborationContractAssetAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_DirectAndIncrementalCostsIncurredToObtainTheContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Direct and incremental costs incurred to obtain the contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_DirectAndIncrementalCostsIncurredToObtainTheContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ResearchCollaborationAndLicenseAgreementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research collaboration and license agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ResearchCollaborationAndLicenseAgreementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from contract modification which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from collaborators during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=arvn_PfizerIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=arvn_PfizerIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=arvn_RegulatoryAndSalesBasedMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=arvn_RegulatoryAndSalesBasedMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=arvn_CollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=arvn_CollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=arvn_RegulatoryMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=arvn_RegulatoryMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=arvn_SalesBasedMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=arvn_SalesBasedMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=arvn_DevelopmentMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=arvn_DevelopmentMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=arvn_SalesBasedMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=arvn_SalesBasedMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=arvn_OptionPaymentsToLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=arvn_OptionPaymentsToLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=arvn_BayerAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=arvn_BayerAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=arvn_ResearchFundingPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=arvn_ResearchFundingPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=arvn_CommercialMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=arvn_CommercialMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028831076064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Collaboration and License Agreements - Summary of Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward', window );"><strong>Accounts receivable related to collaborations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Beginning balance</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions', window );">Additions</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived', window );">Payments received</a></td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(15.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Ending balance</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward', window );"><strong>Accounts payable related to collaborations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_AccountsPayableContractBalancesCurrent', window );">Beginning balance</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_AccountsPayableContractBalancesCurrentAdditions', window );">Additions</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_AccountsPayableContractBalancesCurrentPayments', window );">Payments made</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_AccountsPayableContractBalancesCurrent', window );">Ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward', window );"><strong>Contract assets: Collaboration contract asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Beginning balance</a></td>
<td class="nump">10.7<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements', window );">Additions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_CapitalizedContractCostAmortizationDuringPeriod', window );">Amortization</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Ending balance</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">11.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ChangeInContractWithCustomerLiabilityRollForward', window );"><strong>Contract liabilities: Deferred revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">623.7<span></span>
</td>
<td class="nump">740.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized from balances held at the beginning of the period</a></td>
<td class="num">(84.6)<span></span>
</td>
<td class="num">(55.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements', window );">Additions to collaboration agreements</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">$ 540.6<span></span>
</td>
<td class="nump">$ 688.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_AccountsPayableContractBalancesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Payable, Contract Balances, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_AccountsPayableContractBalancesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_AccountsPayableContractBalancesCurrentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Payable, Contract Balances, Current Additions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_AccountsPayableContractBalancesCurrentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_AccountsPayableContractBalancesCurrentPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Payable, Contract Balances, Current Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_AccountsPayableContractBalancesCurrentPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, After Allowance For Credit Loss, Current, Additions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, After Allowance For Credit Loss, Current, Payments Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_CapitalizedContractCostAmortizationDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Contract Cost, Amortization During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_CapitalizedContractCostAmortizationDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Accounts Payable, after Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Accounts Receivable, after Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Collaboration Contract Asset And Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ChangeInContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ChangeInContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Assets, Increase (Decrease) For Additions To Collaboration Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Increase (Decrease) For Additions To Collaboration Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028825141024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Research Collaboration and License Agreements - Transaction Price Allocated to Performance Obligations (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation</a></td>
<td class="nump">$ 540.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-07-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-07-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation</a></td>
<td class="nump">$ 110.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation</a></td>
<td class="nump">$ 200.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation</a></td>
<td class="nump">$ 90.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation</a></td>
<td class="nump">$ 55.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2027-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation</a></td>
<td class="nump">$ 34.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2028-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2028-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation</a></td>
<td class="nump">$ 10.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2029-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2029-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation</a></td>
<td class="nump">$ 38.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-07-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-07-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2027-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2028-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2028-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2029-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2029-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028831063552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements - Summary of Available-for-Sale Marketable Securities (Details) - Level 2 - Fair Value, Measurements, Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 960.4<span></span>
</td>
<td class="nump">$ 1,143.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(12.2)<span></span>
</td>
<td class="num">(19.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">948.2<span></span>
</td>
<td class="nump">1,124.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">888.8<span></span>
</td>
<td class="nump">1,008.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(12.1)<span></span>
</td>
<td class="num">(18.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">876.7<span></span>
</td>
<td class="nump">989.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">71.6<span></span>
</td>
<td class="nump">135.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 71.5<span></span>
</td>
<td class="nump">$ 134.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028827633792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Equipment and Leasehold Improvements - Schedule of Property, Equipment and Leasehold Improvements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, equipment and leasehold improvements</a></td>
<td class="nump">$ 32.0<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(18.8)<span></span>
</td>
<td class="num">(16.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, equipment and leasehold improvements, net</a></td>
<td class="nump">13.2<span></span>
</td>
<td class="nump">13.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=arvn_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, equipment and leasehold improvements</a></td>
<td class="nump">18.0<span></span>
</td>
<td class="nump">17.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, equipment and leasehold improvements</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, equipment and leasehold improvements</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=arvn_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=arvn_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028836825872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Equipment and Leasehold Improvements - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832509888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Liabilities - Additional Information (Details)<br> ft&#178; in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LandSubjectToGroundLeases', window );">Lease for laboratory and office space | ft&#178;</a></td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_BaseLeaseRentPeriod', window );">Base rent lease term (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, weighted average remaining lease term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PledgingPurposeAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Asset Pledged as Collateral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecurities', window );">Letter of credit for collateralized by certificate of deposit</a></td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 5.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_PercentageOfIncrementalBorrowingForLeasePayments', window );">Percentage of incremental borrowing for lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Base rent</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_PercentageOfIncrementalBorrowingForLeasePayments', window );">Percentage of incremental borrowing for lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Base rent</a></td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_BaseLeaseRentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Base lease rent period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_BaseLeaseRentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_PercentageOfIncrementalBorrowingForLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of incremental borrowing for lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_PercentageOfIncrementalBorrowingForLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandSubjectToGroundLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of land subject to a ground lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandSubjectToGroundLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PledgingPurposeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PledgingPurposeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PledgedStatusAxis=us-gaap_AssetPledgedAsCollateralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PledgedStatusAxis=us-gaap_AssetPledgedAsCollateralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028827030048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Liabilities - Components of Lease Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028826160096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Liabilities - Schedule of Supplemental Cash Flow Information Related to Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract', window );"><strong>Supplemental non-cash information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new lease obligations</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for amounts included in the measurement of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_SupplementalNonCashInformationRelatedToLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental non-cash information related to leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_SupplementalNonCashInformationRelatedToLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028825127248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Right-of-Use Assets and Liabilities - Schedule of Maturities of Operating Lease Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028827594256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 6.7<span></span>
</td>
<td class="nump">$ 5.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_AccruedResearchAndDevelopmentExpenseCurrent', window );">Research and development expenses</a></td>
<td class="nump">51.6<span></span>
</td>
<td class="nump">35.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee expenses</a></td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees and other</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 74.8<span></span>
</td>
<td class="nump">$ 74.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_AccruedResearchAndDevelopmentExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expense current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_AccruedResearchAndDevelopmentExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028831019840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Long Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current installments</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=arvn_TwoThousandAndEighteenAssistanceAgreementMember', window );">2018 Assistance Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=arvn_TwoThousandAndEighteenAssistanceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=arvn_TwoThousandAndEighteenAssistanceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028827744288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=arvn_TwoThousandAndEighteenAssistanceAgreementMember', window );">2018 Assistance Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument bearing interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=arvn_TwoThousandAndEighteenAssistanceAgreementMember', window );">2018 Assistance Agreement | State of Connecticut</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_DebtInstrumentLoanForgiveness', window );">Loan forgiveness</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument bearing interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_DebtInstrumentInterestPaymentsTerm', window );">Debt instrument interest payments term (in months)</a></td>
<td class="text">60 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_PercentageOfLiquidatedDamages', window );">Percentage of liquidated damages</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=arvn_TwoThousandAndFourteenAssistanceAgreementMember', window );">2014 Assistance Agreement | State of Connecticut</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_PercentageOfLiquidatedDamages', window );">Percentage of liquidated damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_DebtInstrumentInterestPaymentsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument interest payments term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_DebtInstrumentInterestPaymentsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_DebtInstrumentLoanForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument loan forgiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_DebtInstrumentLoanForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_PercentageOfLiquidatedDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of liquidated damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_PercentageOfLiquidatedDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=arvn_TwoThousandAndEighteenAssistanceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=arvn_TwoThousandAndEighteenAssistanceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=arvn_TwoThousandAndFourteenAssistanceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=arvn_TwoThousandAndFourteenAssistanceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028834516624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Minimum Future Payments on Long-Term Debt (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_LongTermDebtMaturityYearSix', window );">2028</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_LongTermDebtMaturityYearSix">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, Year Six</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_LongTermDebtMaturityYearSix</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028826535312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2020</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value of options (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.79<span></span>
</td>
<td class="nump">$ 41.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of RSUs vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=arvn_StockIncentivePlanMember', window );">Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Incentive units authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,199,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=arvn_StockIncentivePlanMember', window );">Incentive Plan | Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">$ 36.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=arvn_StockIncentivePlanMember', window );">Incentive Plan | Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.3<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation expense not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation expense not yet recognized, period of recognition (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=arvn_StockIncentivePlanMember', window );">Incentive Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based award, vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=arvn_StockIncentivePlanMember', window );">Incentive Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,277,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based award, vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=arvn_TwoThousandEighteenStockIncentivePlanMember', window );">2018 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,067,007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock, shares remained available for purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,987,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,987,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Annual increase in reserved shares as percentage of outstanding common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=arvn_TwoThousandEighteenStockIncentivePlanMember', window );">2018 Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod', window );">Annual increase in reserved shares of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,989,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">2018 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock', window );">Common stock reserved for issuance represented as percentage on outstanding common stock</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock, shares remained available for purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,495,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,495,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,206<span></span>
</td>
<td class="nump">5,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">2018 ESPP | Incentive Plan | Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common | Equity Distribution Agreement | At-the-Market Offering | Piper Sandler and Cantor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_MaximumAggregateOfferingPriceOfCommonStock', window );">Common stock aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued and sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in capital shares reserved for future issuance represented as percentage on outstanding common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_MaximumAggregateOfferingPriceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum aggregate offering price of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_MaximumAggregateOfferingPriceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The addition or reduction in the number of reserved shares that could potentially be issued under the option plan attributable to reasons other than grants, exercises, forfeitures, and expirations during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=arvn_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=arvn_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=arvn_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=arvn_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=arvn_TwoThousandEighteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=arvn_TwoThousandEighteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=arvn_EquityDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=arvn_EquityDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=arvn_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=arvn_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=arvn_PiperSandlerAndCantorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=arvn_PiperSandlerAndCantorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832541024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Schedule of Assumptions Used to Determine Fair Value of and Stock Options Granted (Details) - Stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">72.30%<span></span>
</td>
<td class="nump">73.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">74.20%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 23.23<span></span>
</td>
<td class="nump">$ 36.79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 36.27<span></span>
</td>
<td class="nump">$ 78.91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028827587696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Summary of Stock Option Activity (Details) - 2018 Plan - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">6,814,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">1,653,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(71,321)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(212,677)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">8,183,808<span></span>
</td>
<td class="nump">6,814,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Vested and exercisable, ending balance (in shares)</a></td>
<td class="nump">4,417,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">7,825,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 49.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">33.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">18.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">56.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">46.05<span></span>
</td>
<td class="nump">$ 49.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Vested and exercisable (in dollars per share)</a></td>
<td class="nump">41.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and expected to vest (in dollars per share)</a></td>
<td class="nump">$ 45.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Term (Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding (in years)</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Vested and exercisable (in years)</a></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest (in Years)</a></td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 13.8<span></span>
</td>
<td class="nump">$ 34.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Vested and exercisable</a></td>
<td class="nump">13.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest</a></td>
<td class="nump">$ 13.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_AggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_AggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=arvn_TwoThousandEighteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=arvn_TwoThousandEighteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832439328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Summary of Restricted Stock (Details) - 2018 Plan - Restricted stock units - Employees<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">489,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">778,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(94,688)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(28,658)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">1,144,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 51.37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">33.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">44.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">44.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 40.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=arvn_TwoThousandEighteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=arvn_TwoThousandEighteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028832652144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">$ (0.3)<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate, percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="num">(5.40%)<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="num">(6.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory rate, percentage</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028831669936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Basic and Diluted Loss per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (66.6)<span></span>
</td>
<td class="num">$ (70.0)<span></span>
</td>
<td class="num">$ (148.5)<span></span>
</td>
<td class="num">$ (133.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding, basic (in shares)</a></td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.2<span></span>
</td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares outstanding, diluted (in shares)</a></td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.2<span></span>
</td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">53.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (in dollars per share)</a></td>
<td class="num">$ (1.25)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (2.78)<span></span>
</td>
<td class="num">$ (2.51)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (1.25)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (2.78)<span></span>
</td>
<td class="num">$ (2.51)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028834588336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Securities Excluded From Computation of Diluted Net Loss Per Common Share (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of diluted net loss per common share (in shares)</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of diluted net loss per common share (in shares)</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of diluted net loss per common share (in shares)</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028826892368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments- Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule Of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 540,600,000<span></span>
</td>
<td class="nump">$ 688,000,000.0<span></span>
</td>
<td class="nump">$ 540,600,000<span></span>
</td>
<td class="nump">$ 688,000,000.0<span></span>
</td>
<td class="nump">$ 623,700,000<span></span>
</td>
<td class="nump">$ 740,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">66,600,000<span></span>
</td>
<td class="nump">70,000,000.0<span></span>
</td>
<td class="nump">148,500,000<span></span>
</td>
<td class="nump">133,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investment</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=arvn_OerthBioLimitedLiabilityCorporationMember', window );">Oerth</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule Of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage', window );">Future grant of incentive units to service providers percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investment</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=arvn_OerthBioLimitedLiabilityCorporationMember', window );">Oerth</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule Of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="nump">$ 10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_BayerCropScienceLPMember', window );">Bayer LP | Oerth</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule Of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest in joint venture (percentage)</a></td>
<td class="nump">45.50%<span></span>
</td>
<td class="nump">47.50%<span></span>
</td>
<td class="nump">45.50%<span></span>
</td>
<td class="nump">47.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future grant of incentive units to service providers, percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=arvn_OerthBioLimitedLiabilityCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=arvn_OerthBioLimitedLiabilityCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=arvn_OerthBioLimitedLiabilityCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=arvn_OerthBioLimitedLiabilityCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=arvn_BayerCropScienceLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=arvn_BayerCropScienceLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028826889856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investments - Schedule of Correction of Immaterial Error for the Period (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 54.5<span></span>
</td>
<td class="nump">$ 33.8<span></span>
</td>
<td class="nump">$ 87.0<span></span>
</td>
<td class="nump">$ 60.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(74.6)<span></span>
</td>
<td class="num">(65.8)<span></span>
</td>
<td class="num">(162.3)<span></span>
</td>
<td class="num">(123.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investment</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (66.6)<span></span>
</td>
<td class="num">$ (70.0)<span></span>
</td>
<td class="num">$ (148.5)<span></span>
</td>
<td class="num">$ (133.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share, basic (in dollars per share)</a></td>
<td class="num">$ (1.25)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (2.78)<span></span>
</td>
<td class="num">$ (2.51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share, diluted (in dollars per share)</a></td>
<td class="num">$ (1.25)<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="num">$ (2.78)<span></span>
</td>
<td class="num">$ (2.51)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (66.2)<span></span>
</td>
<td class="num">$ (73.3)<span></span>
</td>
<td class="num">$ (141.5)<span></span>
</td>
<td class="num">$ (150.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">as previously reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(128.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (70.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (133.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.51)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (73.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140028838335712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 04, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=arvn_FoundationMedicineIncMember', window );">Foundation Medicine, Inc. | Maximum | Success-Based Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arvn_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer', window );">Milestone payments (up to low)</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arvn_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments And Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arvn_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479428/808-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=arvn_FoundationMedicineIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=arvn_FoundationMedicineIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=arvn_SuccessBasedMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=arvn_SuccessBasedMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>arvn-20230630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:arvn="http://www.arvinas.com/20230630"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="arvn-20230630.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <instant>2023-08-04</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:CollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:RegulatoryAndSalesBasedMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:RegulatoryMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SalesBasedMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:RegulatoryMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SalesBasedMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:CollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:CollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:ResearchFundingPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:ResearchFundingPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:ResearchFundingPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:DevelopmentMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SalesBasedMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SalesBasedMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerAGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:DevelopmentMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:OptionPaymentsToLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:DevelopmentMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SalesBasedMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PfizerIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:GenentechIncorporationAndFHoffmanLaRocheLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-01</startDate>
            <endDate>2017-11-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:GenentechIncorporationAndFHoffmanLaRocheLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:DevelopmentMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:GenentechIncorporationAndFHoffmanLaRocheLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:RegulatoryMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:GenentechIncorporationAndFHoffmanLaRocheLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:CommercialMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:GenentechIncorporationAndFHoffmanLaRocheLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:CommercialMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-07-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2027-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2028-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2029-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">arvn:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">arvn:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PledgingPurposeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PledgingPurposeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndEighteenAssistanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndEighteenAssistanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndEighteenAssistanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndEighteenAssistanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndEighteenAssistanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndFourteenAssistanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arvn:TwoThousandAndFourteenAssistanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PiperSandlerAndCantorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arvn:AtTheMarketOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:EquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:PiperSandlerAndCantorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arvn:AtTheMarketOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:EquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-01</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arvn:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arvn:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arvn:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerCropScienceLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerCropScienceLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:BayerCropScienceLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">arvn:OerthBioLimitedLiabilityCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001655759</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">arvn:FoundationMedicineIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">arvn:SuccessBasedMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-04</startDate>
            <endDate>2022-06-04</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-26">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-27">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-28">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-29">0001655759</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-30">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-78" id="f-397">P6M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-79" id="f-398">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-80" id="f-399">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-81" id="f-400">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-82" id="f-401">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-83" id="f-402">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-84" id="f-403" xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-120" id="f-528">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38672</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">ARVINAS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">47-2566120</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">5 Science Park</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-10">395 Winchester Ave</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">New Haven</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">06511</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">203</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">535-1456</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">ARVN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-19">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-20">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-21">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-22">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-24">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-25" unitRef="shares">53485023</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-31" unitRef="usd">90600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-5" id="f-32" unitRef="usd">81300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-3" decimals="-5" id="f-33" unitRef="usd">5500000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-4" decimals="-5" id="f-34" unitRef="usd">5500000</us-gaap:RestrictedCashCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-3" decimals="-5" id="f-35" unitRef="usd">948200000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-4" decimals="-5" id="f-36" unitRef="usd">1124000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-5" id="f-37" unitRef="usd">100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-5" id="f-38" unitRef="usd">1000000.0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-3" decimals="-5" id="f-39" unitRef="usd">4700000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-4" decimals="-5" id="f-40" unitRef="usd">7000000.0</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-5" id="f-41" unitRef="usd">7600000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-5" id="f-42" unitRef="usd">21400000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-5" id="f-43" unitRef="usd">1056700000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-5" id="f-44" unitRef="usd">1240200000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-5" id="f-45" unitRef="usd">13200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-5" id="f-46" unitRef="usd">13400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-5" id="f-47" unitRef="usd">3500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-48" unitRef="usd">4400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <arvn:CollaborationContractAssetAndOtherAssets contextRef="c-3" decimals="-5" id="f-49" unitRef="usd">10100000</arvn:CollaborationContractAssetAndOtherAssets>
    <arvn:CollaborationContractAssetAndOtherAssets contextRef="c-4" decimals="-5" id="f-50" unitRef="usd">10800000</arvn:CollaborationContractAssetAndOtherAssets>
    <us-gaap:Assets contextRef="c-3" decimals="-5" id="f-51" unitRef="usd">1083500000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-5" id="f-52" unitRef="usd">1268800000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-53" unitRef="usd">74800000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-54" unitRef="usd">74700000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-5" id="f-55" unitRef="usd">230100000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-5" id="f-56" unitRef="usd">218600000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-3" decimals="-5" id="f-57" unitRef="usd">100000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="-5" id="f-58" unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-5" id="f-59" unitRef="usd">1900000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-5" id="f-60" unitRef="usd">1800000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-61" unitRef="usd">306900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-62" unitRef="usd">295100000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-63" unitRef="usd">310500000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-64" unitRef="usd">405100000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-3" decimals="-5" id="f-65" unitRef="usd">900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-5" id="f-66" unitRef="usd">1000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-67" unitRef="usd">1600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-68" unitRef="usd">2700000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-5" id="f-69" unitRef="usd">619900000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-5" id="f-70" unitRef="usd">703900000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-71" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-72" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-73"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-74"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="-5" id="f-75" unitRef="shares">53400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="-5" id="f-76" unitRef="shares">53400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-5" id="f-77" unitRef="shares">53200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-5" id="f-78" unitRef="shares">53200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-5" id="f-79" unitRef="usd">100000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-5" id="f-80" unitRef="usd">100000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-81" unitRef="usd">-1113900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-5" id="f-82" unitRef="usd">-965400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-5" id="f-83" unitRef="usd">1589600000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-5" id="f-84" unitRef="usd">1549400000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-5" id="f-85" unitRef="usd">-12200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-5" id="f-86" unitRef="usd">-19200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-5" id="f-87" unitRef="usd">463600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-5" id="f-88" unitRef="usd">564900000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-5" id="f-89" unitRef="usd">1083500000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-5" id="f-90" unitRef="usd">1268800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c-5" decimals="-5" id="f-91" unitRef="usd">54500000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-6" decimals="-5" id="f-92" unitRef="usd">33800000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-1" decimals="-5" id="f-93" unitRef="usd">87000000.0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-7" decimals="-5" id="f-94" unitRef="usd">60300000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-5" id="f-95" unitRef="usd">103400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-5" id="f-96" unitRef="usd">75300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-97" unitRef="usd">198600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-5" id="f-98" unitRef="usd">139200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-5" decimals="-5" id="f-99" unitRef="usd">25700000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-6" decimals="-5" id="f-100" unitRef="usd">24300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-5" id="f-101" unitRef="usd">50700000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-7" decimals="-5" id="f-102" unitRef="usd">44500000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-5" decimals="-5" id="f-103" unitRef="usd">129100000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-6" decimals="-5" id="f-104" unitRef="usd">99600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-5" id="f-105" unitRef="usd">249300000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-7" decimals="-5" id="f-106" unitRef="usd">183700000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-107" unitRef="usd">-74600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-5" id="f-108" unitRef="usd">-65800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-109" unitRef="usd">-162300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-5" id="f-110" unitRef="usd">-123400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-111" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-5" id="f-112" unitRef="usd">-100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-113" unitRef="usd">-1100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-5" id="f-114" unitRef="usd">-200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InvestmentIncomeInterest contextRef="c-5" decimals="-5" id="f-115" unitRef="usd">9000000.0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-6" decimals="-5" id="f-116" unitRef="usd">1800000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-5" id="f-117" unitRef="usd">16600000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-7" decimals="-5" id="f-118" unitRef="usd">2900000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-119" unitRef="usd">9000000.0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-6" decimals="-5" id="f-120" unitRef="usd">1700000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-121" unitRef="usd">15500000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-7" decimals="-5" id="f-122" unitRef="usd">2700000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-5" id="f-123" unitRef="usd">-65600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-6" decimals="-5" id="f-124" unitRef="usd">-64100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-5" id="f-125" unitRef="usd">-146800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-7" decimals="-5" id="f-126" unitRef="usd">-120700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-127" unitRef="usd">-300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-128" unitRef="usd">3400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-129" unitRef="usd">-700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-130" unitRef="usd">7900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-5" id="f-131" unitRef="usd">-1300000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-6" decimals="-5" id="f-132" unitRef="usd">-2500000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-5" id="f-133" unitRef="usd">-2400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-7" decimals="-5" id="f-134" unitRef="usd">-4800000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-135" unitRef="usd">-66600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-136" unitRef="usd">-70000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-137" unitRef="usd">-148500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-138" unitRef="usd">-133400000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-139"
      unitRef="usdPerShare">-1.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-140"
      unitRef="usdPerShare">-1.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-141"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-142"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-143"
      unitRef="usdPerShare">-2.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-144"
      unitRef="usdPerShare">-2.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-145"
      unitRef="usdPerShare">-2.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-146"
      unitRef="usdPerShare">-2.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-147" unitRef="shares">53400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-148" unitRef="shares">53400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-5" id="f-149" unitRef="shares">53200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-150" unitRef="shares">53200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-151" unitRef="shares">53400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-152" unitRef="shares">53400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-5" id="f-153" unitRef="shares">53100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-5" id="f-154" unitRef="shares">53100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-155" unitRef="usd">-66600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-156" unitRef="usd">-70000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-157" unitRef="usd">-148500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-158" unitRef="usd">-133400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-159" unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-5" id="f-160" unitRef="usd">-3300000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-161" unitRef="usd">7000000.0</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-5" id="f-162" unitRef="usd">-17400000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-5" id="f-163" unitRef="usd">-66200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-5" id="f-164" unitRef="usd">-73300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-5" id="f-165" unitRef="usd">-141500000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-5" id="f-166" unitRef="usd">-150800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="-5" id="f-167" unitRef="shares">53400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-5" id="f-168" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-5" id="f-169" unitRef="usd">-1047300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-5" id="f-170" unitRef="usd">1570800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-5" id="f-171" unitRef="usd">-12600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-5" id="f-172" unitRef="usd">511000000.0</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-13" decimals="-5" id="f-173" unitRef="usd">18300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-5" id="f-174" unitRef="usd">18300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-14" decimals="-5" id="f-175" unitRef="usd">-66600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-176" unitRef="usd">-66600000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-13" decimals="-5" id="f-177" unitRef="usd">500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-5" decimals="-5" id="f-178" unitRef="usd">500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-15" decimals="-5" id="f-179" unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-180" unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-16" decimals="-5" id="f-181" unitRef="shares">53400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-5" id="f-182" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-5" id="f-183" unitRef="usd">-1113900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-5" id="f-184" unitRef="usd">1589600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-5" id="f-185" unitRef="usd">-12200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-5" id="f-186" unitRef="usd">463600000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-20" decimals="-5" id="f-187" unitRef="shares">53100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-5" id="f-188" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-5" id="f-189" unitRef="usd">-746300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-5" id="f-190" unitRef="usd">1488300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-5" id="f-191" unitRef="usd">-18700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-5" id="f-192" unitRef="usd">723300000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-25" decimals="-5" id="f-193" unitRef="usd">20000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-5" id="f-194" unitRef="usd">20000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-26" decimals="-5" id="f-195" unitRef="usd">-70000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-196" unitRef="usd">-70000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-27" decimals="-5" id="f-197" unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-27" decimals="-5" id="f-198" unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-25" decimals="-5" id="f-199" unitRef="usd">500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-6" decimals="-5" id="f-200" unitRef="usd">600000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-28" decimals="-5" id="f-201" unitRef="usd">-3300000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-5" id="f-202" unitRef="usd">-3300000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-29" decimals="-5" id="f-203" unitRef="shares">53200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-5" id="f-204" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-5" id="f-205" unitRef="usd">-816300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-5" id="f-206" unitRef="usd">1508800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-5" id="f-207" unitRef="usd">-22000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-5" id="f-208" unitRef="usd">670600000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-34" decimals="-5" id="f-209" unitRef="shares">53200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-5" id="f-210" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-5" id="f-211" unitRef="usd">-965400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-5" id="f-212" unitRef="usd">1549400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-5" id="f-213" unitRef="usd">-19200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-5" id="f-214" unitRef="usd">564900000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-38" decimals="-5" id="f-215" unitRef="usd">38200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-5" id="f-216" unitRef="usd">38200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-39" decimals="-5" id="f-217" unitRef="usd">-148500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-218" unitRef="usd">-148500000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-40" decimals="-5" id="f-219" unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-38" decimals="-5" id="f-220" unitRef="usd">2000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-5" id="f-221" unitRef="usd">2000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-41" decimals="-5" id="f-222" unitRef="usd">7000000.0</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-223" unitRef="usd">7000000.0</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-16" decimals="-5" id="f-224" unitRef="shares">53400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-5" id="f-225" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-5" id="f-226" unitRef="usd">-1113900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-5" id="f-227" unitRef="usd">1589600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-5" id="f-228" unitRef="usd">-12200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-5" id="f-229" unitRef="usd">463600000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-42" decimals="-5" id="f-230" unitRef="shares">53000000.0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-5" id="f-231" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-5" id="f-232" unitRef="usd">-682900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-5" id="f-233" unitRef="usd">1469200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-5" id="f-234" unitRef="usd">-4600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-5" id="f-235" unitRef="usd">781700000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-47" decimals="-5" id="f-236" unitRef="usd">36600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-7" decimals="-5" id="f-237" unitRef="usd">36600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-48" decimals="-5" id="f-238" unitRef="usd">-133400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-239" unitRef="usd">-133400000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-49" decimals="-5" id="f-240" unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-49" decimals="-5" id="f-241" unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-47" decimals="-5" id="f-242" unitRef="usd">3000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-7" decimals="-5" id="f-243" unitRef="usd">3100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-50" decimals="-5" id="f-244" unitRef="usd">-17400000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-5" id="f-245" unitRef="usd">-17400000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-29" decimals="-5" id="f-246" unitRef="shares">53200000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-5" id="f-247" unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-5" id="f-248" unitRef="usd">-816300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-5" id="f-249" unitRef="usd">1508800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-5" id="f-250" unitRef="usd">-22000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-5" id="f-251" unitRef="usd">670600000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-252" unitRef="usd">-148500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-253" unitRef="usd">-133400000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-5" id="f-254" unitRef="usd">2400000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-7" decimals="-5" id="f-255" unitRef="usd">3000000.0</us-gaap:DepreciationAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-1" decimals="-5" id="f-256" unitRef="usd">7000000.0</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-7" decimals="-5" id="f-257" unitRef="usd">-5800000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:DebtSecuritiesAvailableForSaleGainLoss contextRef="c-1" decimals="-5" id="f-258" unitRef="usd">-900000</us-gaap:DebtSecuritiesAvailableForSaleGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleGainLoss contextRef="c-7" decimals="-5" id="f-259" unitRef="usd">-100000</us-gaap:DebtSecuritiesAvailableForSaleGainLoss>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-5" id="f-260" unitRef="usd">900000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-7" decimals="-5" id="f-261" unitRef="usd">1000000.0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:CapitalizedContractCostAmortization contextRef="c-1" decimals="-5" id="f-262" unitRef="usd">1500000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization contextRef="c-7" decimals="-5" id="f-263" unitRef="usd">800000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-264" unitRef="usd">38200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-5" id="f-265" unitRef="usd">36600000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-5" id="f-266" unitRef="usd">-900000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-7" decimals="-5" id="f-267" unitRef="usd">-13600000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c-1" decimals="-5" id="f-268" unitRef="usd">-2400000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c-7" decimals="-5" id="f-269" unitRef="usd">-4000000.0</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-5" id="f-270" unitRef="usd">-13100000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-7" decimals="-5" id="f-271" unitRef="usd">1000000.0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-5" id="f-272" unitRef="usd">-600000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-7" decimals="-5" id="f-273" unitRef="usd">-12700000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-5" id="f-274" unitRef="usd">-1000000.0</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-7" decimals="-5" id="f-275" unitRef="usd">-1000000.0</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-5" id="f-276" unitRef="usd">-83100000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-7" decimals="-5" id="f-277" unitRef="usd">-52500000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-278" unitRef="usd">-179900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-5" id="f-279" unitRef="usd">-135700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-1" decimals="-5" id="f-280" unitRef="usd">492300000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-7" decimals="-5" id="f-281" unitRef="usd">469100000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <arvn:ProceedsFromMaturitiesOfMarketableSecurities contextRef="c-1" decimals="-5" id="f-282" unitRef="usd">638900000</arvn:ProceedsFromMaturitiesOfMarketableSecurities>
    <arvn:ProceedsFromMaturitiesOfMarketableSecurities contextRef="c-7" decimals="-5" id="f-283" unitRef="usd">555900000</arvn:ProceedsFromMaturitiesOfMarketableSecurities>
    <arvn:ProceedsFromSaleOfMarketableSecurities contextRef="c-1" decimals="-5" id="f-284" unitRef="usd">42300000</arvn:ProceedsFromSaleOfMarketableSecurities>
    <arvn:ProceedsFromSaleOfMarketableSecurities contextRef="c-7" decimals="-5" id="f-285" unitRef="usd">34300000</arvn:ProceedsFromSaleOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-5" id="f-286" unitRef="usd">1700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-5" id="f-287" unitRef="usd">3500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-5" id="f-288" unitRef="usd">187200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-5" id="f-289" unitRef="usd">117600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <arvn:ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares contextRef="c-1" decimals="-5" id="f-290" unitRef="usd">2000000.0</arvn:ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares>
    <arvn:ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares contextRef="c-7" decimals="-5" id="f-291" unitRef="usd">3000000.0</arvn:ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-5" id="f-292" unitRef="usd">2000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-5" id="f-293" unitRef="usd">3000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-5" id="f-294" unitRef="usd">9300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-5" id="f-295" unitRef="usd">-15100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-5" id="f-296" unitRef="usd">86800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-46" decimals="-5" id="f-297" unitRef="usd">112800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-298" unitRef="usd">96100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-33" decimals="-5" id="f-299" unitRef="usd">97700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-5" id="f-300" unitRef="usd">400000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-7" decimals="-5" id="f-301" unitRef="usd">500000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-5" id="f-302" unitRef="usd">9000000.0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-7" decimals="-5" id="f-303" unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c-1" id="f-304">Nature of Business and Basis of Presentation&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Arvinas, Inc. and its subsidiaries (&#x201c;Arvinas&#x201d; or the "Company&#x201d;) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements include the accounts of Arvinas, Inc. and its subsidiaries. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended (&#x201c;Exchange Act&#x201d;). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission (&#x201c;SEC&#x201d;) rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December&#160;31, 2022 has been derived from the Company's audited consolidated financial statements as of that date. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December&#160;31, 2022, forming part of Arvinas&#x2019; 2022 Annual Report on Form 10-K filed with the SEC on February&#160;23, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously disclosed in the Company's 2022 Annual Report on Form 10-K, the Company revised the accounting for its investment in Oerth Bio LLC ("Oerth Bio"). Accordingly, Arvinas recorded an adjustment to the unaudited condensed consolidated financial statements for the three and six months ended June&#160;30, 2022 that were previously included in the Company's Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2022. See Note 12,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Equity Method Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amount of assets, liabilities, revenue and expenses. These estimates include assumptions and judgments based on historical experience, current conditions, future expectations and other factors the Company considers reasonable. These estimates are reviewed on an ongoing basis and revised as necessary. Actual results could differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to a number of risks similar to other biotechnology companies in the early stage, including, but not limited to, the need to obtain adequate additional funding, possible failure of preclinical testing or clinical trials, the need to obtain marketing approval for its product candidates, competitors developing new technological innovations, the need to successfully commercialize and gain market acceptance of the Company&#x2019;s products and protection of proprietary technology. If the Company does not successfully obtain regulatory approval, it will be unable to generate revenue from product sales or achieve profitability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To date, the Company has not generated any revenue from product sales and expects to incur additional operating losses and negative operating cash flows for the foreseeable future. The Company has financed its operations primarily through sales of equity interests, proceeds from collaborations, grant funding and debt financing. The Company had cash, cash equivalents, restricted cash and marketable securities of approximately $1.0 billion as of June&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-305">The accompanying unaudited condensed consolidated financial statements include the accounts of Arvinas, Inc. and its subsidiaries. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended (&#x201c;Exchange Act&#x201d;). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission (&#x201c;SEC&#x201d;) rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December&#160;31, 2022 has been derived from the Company's audited consolidated financial statements as of that date. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December&#160;31, 2022, forming part of Arvinas&#x2019; 2022 Annual Report on Form 10-K filed with the SEC on February&#160;23, 2023.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-306">The preparation of the Company&#x2019;s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amount of assets, liabilities, revenue and expenses. These estimates include assumptions and judgments based on historical experience, current conditions, future expectations and other factors the Company considers reasonable. These estimates are reviewed on an ongoing basis and revised as necessary. Actual results could differ from these estimates.</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-307">Risks and UncertaintiesThe Company is subject to a number of risks similar to other biotechnology companies in the early stage, including, but not limited to, the need to obtain adequate additional funding, possible failure of preclinical testing or clinical trials, the need to obtain marketing approval for its product candidates, competitors developing new technological innovations, the need to successfully commercialize and gain market acceptance of the Company&#x2019;s products and protection of proprietary technology. If the Company does not successfully obtain regulatory approval, it will be unable to generate revenue from product sales or achieve profitability.</us-gaap:ConcentrationRiskCreditRisk>
    <arvn:CashCashEquivalentsRestrictedCashAndMarketableSecurities contextRef="c-3" decimals="-8" id="f-308" unitRef="usd">1000000000</arvn:CashCashEquivalentsRestrictedCashAndMarketableSecurities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-309">Accounting Pronouncements and Significant Accounting Policies&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reviews&lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;new accounting standards as issued. As of June&#160;30, 2023, the Company has not identified any new standards that it believes will have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no changes to the Company&#x2019;s significant accounting policies during the six months ended June&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the total amounts shown in the consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash represents a letter of credit collateralized by a certificate of deposit in the same amount as required under the terms of the Company's laboratory and office space lease entered into in May 2021 and amended in August 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-310">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reviews&lt;/span&gt;&lt;span style="color:#252525;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;new accounting standards as issued. As of June&#160;30, 2023, the Company has not identified any new standards that it believes will have a material impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-311">Cash, Cash Equivalents and Restricted CashRestricted cash represents a letter of credit collateralized by a certificate of deposit in the same amount as required under the terms of the Company's laboratory and office space lease entered into in May 2021 and amended in August 2022.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-312">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the total amounts shown in the consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="c-1" id="f-313">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the total amounts shown in the consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-314" unitRef="usd">90600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-33" decimals="-5" id="f-315" unitRef="usd">93200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-3" decimals="-5" id="f-316" unitRef="usd">5500000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-33" decimals="-5" id="f-317" unitRef="usd">4500000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-5" id="f-318" unitRef="usd">96100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-33" decimals="-5" id="f-319" unitRef="usd">97700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-320">Research Collaboration and License Agreements  &lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vepdegestrant (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ARV-471) Collaboration Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company entered into a Collaboration Agreement with Pfizer Inc. (&#x201c;Pfizer&#x201d;) (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vepdegestrant (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ARV-471) Collaboration Agreement&#x201d;) pursuant to which the Company granted Pfizer worldwide co-exclusive rights to develop and commercialize products containing the Company&#x2019;s proprietary compound ARV-471 (the &#x201c;Licensed Products&#x201d;). Under the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vepdegestrant (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ARV-471) Collaboration Agreement, the Company received an upfront, non-refundable payment of $650.0 million. In addition, the Company is eligible to receive up to an additional $1.4 billion in contingent payments based on specific regulatory and sales-based milestones for the Licensed Products. Of the total contingent payments, $400.0 million in regulatory milestones are related to marketing approvals and $1.0 billion are related to sales-based milestones. There were no regulatory or sales-based milestone payments received through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and Pfizer share equally all development costs, including costs of conducting clinical trials, for the Licensed Products, subject to certain exceptions. Except for certain regions described below, the parties will also share equally all profits and losses in commercialization and medical affairs activities for the Licensed Products in all other countries, subject to certain exceptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will be the marketing authorization holder in the United States and, subject to marketing approval, book sales in the United States, while Pfizer will hold marketing authorizations outside the United States. The parties will determine which, if any, regions within the world will be solely commercialized by one party, and in such region the parties will adjust their share of profits and losses for the Licensed Products based on the role each party will be performing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a direct result of the Company&#x2019;s entry into the Vepdegestrant (ARV-471) Collaboration Agreement, the Company incurred direct and incremental costs to obtain the contract, paid to a financial advisor, totaling $12.9 million. In accordance with ASC 340, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company recognized an asset of $12.9 million in collaboration contract asset and other assets in the condensed consolidated balance sheet at inception of the agreement, which is being amortized as general and administrative expense over the total estimated period of performance under the Vepdegestrant (ARV-471) Collaboration Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bayer Collaboration Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2019, the Company and Bayer AG entered into a Collaboration and License Agreement (the &#x201c;Bayer Collaboration Agreement&#x201d;) setting forth the Company&#x2019;s collaboration with Bayer AG to identify or optimize proteolysis targeting chimeras ("PROTAC&#xae; targeted protein degraders") that mediate the degradation of target proteins. Under the terms of the Bayer Collaboration Agreement, the Company received an upfront, non-refundable payment of $17.5 million in exchange for the use of the Company&#x2019;s technology license. Bayer AG was committed to fund an additional $12.0 million through 2023, all of which was received as of June&#160;30, 2023, including $1.5&#160;million and $3.0&#160;million in the six months ended June&#160;30, 2023 and 2022, respectively. These payments are being recognized over the total estimated period of performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also eligible to receive up to $197.5&#160;million in development milestone payments and up to $490.0&#160;million in sales-based milestone payments for all designated targets. In addition, the Company is eligible to receive, on net sales of PROTAC targeted protein degrader-related products, mid-single digit to low-double digit tiered royalties, which may be subject to reductions. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no development or sales-based milestone payments or royalties received through June&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pfizer Research Collaboration Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the Company entered into a Research Collaboration and License Agreement with Pfizer (the &#x201c;Pfizer Research Collaboration Agreement&#x201d;). Under the terms of the Pfizer Research Collaboration Agreement, the Company received an upfront, non-refundable payment and certain additional payments totaling $28.0 million in 2018 in exchange for use of the Company&#x2019;s technology license and to fund Pfizer-related research as defined within the Pfizer Research Collaboration Agreement. These payments are being recognized as revenue over the total estimated period of performance. The Company is eligible to receive up to an additional $37.5&#160;million in non-refundable option payments if Pfizer exercises its options for all targets under the Pfizer Research Collaboration Agreement. The Company is also entitled to receive up to $225.0&#160;million in development milestone payments and up to $550.0&#160;million in sales-based milestone payments for all designated targets under the Pfizer Research Collaboration Agreement, as well as tiered royalties based on sales. During the six months ended June&#160;30, 2023 and 2022, the Company received payments totaling $1.0 million and $3.5 million which were included in accounts receivable as of December 31, 2022 and 2021, respectively, for additional targets and services which are being recognized as revenue over the total period of performance. There were no sales-based milestone payments or royalties received through June&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restated Genentech Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2017, the Company entered into an Amended and Restated Option, License, and Collaboration Agreement (the &#x201c;Restated Genentech Agreement&#x201d;) with Genentech, Inc. and F. Hoffman-La Roche Ltd. (together "Genentech"), amending a previous Genentech agreement entered into in September 2015. Under the Restated Genentech Agreement, the Company received additional upfront, non-refundable payments of $34.5 million (in addition to $11.0 million received under the previous agreement in 2015) to fund Genentech-related research. Upfront non-refundable payments were recognized as revenue over the performance period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is eligible to receive up to $44.0&#160;million per target in development milestone payments, $52.5&#160;million in regulatory milestone payments and $60.0&#160;million in commercial milestone payments based on sales as well as tiered royalties based on sales. There were no development, regulatory or commercial milestone payments or royalties received through June&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the Company's contract balances for the six months ended June&#160;30, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Accounts receivable related to collaborations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Payments received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Accounts payable related to collaborations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Contract assets: Collaboration contract asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Contract liabilities: Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;623.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;740.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revenue recognized from balances held at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(84.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(55.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Additions to collaboration agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;540.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;688.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June&#160;30, 2023, the Company recorded cumulative catch-up adjustments from contract modifications totaling zero and $(8.2) million, respectively, relating to performance obligations which were satisfied in prior periods. During the three and six months ended June&#160;30, 2022, the Company recorded no cumulative catch-up adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate amount of the transaction price allocated to performance obligations that were unsatisfied as of June&#160;30, 2023 was $540.6 million, which is expected to be recognized in the following periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;110.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;90.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;55.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;34.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;540.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-51" decimals="-5" id="f-321" unitRef="usd">650000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-52" decimals="-8" id="f-322" unitRef="usd">1400000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-53" decimals="-5" id="f-323" unitRef="usd">400000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-54" decimals="-8" id="f-324" unitRef="usd">1000000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ProceedsFromCollaborators contextRef="c-55" decimals="INF" id="f-325" unitRef="usd">0</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ProceedsFromCollaborators contextRef="c-56" decimals="INF" id="f-326" unitRef="usd">0</us-gaap:ProceedsFromCollaborators>
    <arvn:DirectAndIncrementalCostsIncurredToObtainTheContract contextRef="c-57" decimals="-5" id="f-327" unitRef="usd">12900000</arvn:DirectAndIncrementalCostsIncurredToObtainTheContract>
    <arvn:CollaborationContractAssetAndOtherAssets contextRef="c-58" decimals="-5" id="f-328" unitRef="usd">12900000</arvn:CollaborationContractAssetAndOtherAssets>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-59" decimals="-5" id="f-329" unitRef="usd">17500000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-60" decimals="-5" id="f-330" unitRef="usd">12000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ProceedsFromCollaborators contextRef="c-61" decimals="-5" id="f-331" unitRef="usd">1500000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ProceedsFromCollaborators contextRef="c-62" decimals="-5" id="f-332" unitRef="usd">3000000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-63" decimals="-5" id="f-333" unitRef="usd">197500000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-64" decimals="-5" id="f-334" unitRef="usd">490000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ProceedsFromCollaborators contextRef="c-65" decimals="INF" id="f-335" unitRef="usd">0</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ProceedsFromCollaborators contextRef="c-66" decimals="INF" id="f-336" unitRef="usd">0</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ProceedsFromCollaborators contextRef="c-67" decimals="-5" id="f-337" unitRef="usd">28000000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-68" decimals="-5" id="f-338" unitRef="usd">37500000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-69" decimals="-5" id="f-339" unitRef="usd">225000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-70" decimals="-5" id="f-340" unitRef="usd">550000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ProceedsFromCollaborators contextRef="c-71" decimals="-5" id="f-341" unitRef="usd">1000000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ProceedsFromCollaborators contextRef="c-72" decimals="-5" id="f-342" unitRef="usd">3500000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ProceedsFromCollaborators contextRef="c-56" decimals="INF" id="f-343" unitRef="usd">0</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ProceedsFromCollaborators contextRef="c-73" decimals="-5" id="f-344" unitRef="usd">34500000</us-gaap:ProceedsFromCollaborators>
    <arvn:AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement contextRef="c-73" decimals="-5" id="f-345" unitRef="usd">11000000</arvn:AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-74" decimals="-5" id="f-346" unitRef="usd">44000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-75" decimals="-5" id="f-347" unitRef="usd">52500000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-76" decimals="-5" id="f-348" unitRef="usd">60000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ProceedsFromCollaborators contextRef="c-77" decimals="INF" id="f-349" unitRef="usd">0</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c-1" id="f-350">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the Company's contract balances for the six months ended June&#160;30, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Accounts receivable related to collaborations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Payments received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Accounts payable related to collaborations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Payments made&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Contract assets: Collaboration contract asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Contract liabilities: Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;623.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;740.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revenue recognized from balances held at the beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(84.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(55.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Additions to collaboration agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;540.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;688.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-5" id="f-351" unitRef="usd">1000000.0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-46" decimals="-5" id="f-352" unitRef="usd">15000000.0</us-gaap:AccountsReceivableNetCurrent>
    <arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions contextRef="c-1" decimals="-5" id="f-353" unitRef="usd">1600000</arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions>
    <arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions contextRef="c-7" decimals="-5" id="f-354" unitRef="usd">1400000</arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions>
    <arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived contextRef="c-1" decimals="-5" id="f-355" unitRef="usd">2500000</arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived>
    <arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived contextRef="c-7" decimals="-5" id="f-356" unitRef="usd">15000000.0</arvn:AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-5" id="f-357" unitRef="usd">100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-33" decimals="-5" id="f-358" unitRef="usd">1400000</us-gaap:AccountsReceivableNetCurrent>
    <arvn:AccountsPayableContractBalancesCurrent contextRef="c-4" decimals="-5" id="f-359" unitRef="usd">5000000.0</arvn:AccountsPayableContractBalancesCurrent>
    <arvn:AccountsPayableContractBalancesCurrent contextRef="c-46" decimals="-5" id="f-360" unitRef="usd">0</arvn:AccountsPayableContractBalancesCurrent>
    <arvn:AccountsPayableContractBalancesCurrentAdditions contextRef="c-1" decimals="-5" id="f-361" unitRef="usd">1700000</arvn:AccountsPayableContractBalancesCurrentAdditions>
    <arvn:AccountsPayableContractBalancesCurrentAdditions contextRef="c-7" decimals="-5" id="f-362" unitRef="usd">0</arvn:AccountsPayableContractBalancesCurrentAdditions>
    <arvn:AccountsPayableContractBalancesCurrentPayments contextRef="c-1" decimals="-5" id="f-363" unitRef="usd">6700000</arvn:AccountsPayableContractBalancesCurrentPayments>
    <arvn:AccountsPayableContractBalancesCurrentPayments contextRef="c-7" decimals="-5" id="f-364" unitRef="usd">0</arvn:AccountsPayableContractBalancesCurrentPayments>
    <arvn:AccountsPayableContractBalancesCurrent contextRef="c-3" decimals="-5" id="f-365" unitRef="usd">0</arvn:AccountsPayableContractBalancesCurrent>
    <arvn:AccountsPayableContractBalancesCurrent contextRef="c-33" decimals="-5" id="f-366" unitRef="usd">0</arvn:AccountsPayableContractBalancesCurrent>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-4" decimals="-5" id="f-367" unitRef="usd">10700000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-46" decimals="-5" id="f-368" unitRef="usd">12500000</us-gaap:ContractWithCustomerAssetNet>
    <arvn:ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements contextRef="c-1" decimals="-5" id="f-369" unitRef="usd">0</arvn:ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements>
    <arvn:ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements contextRef="c-7" decimals="-5" id="f-370" unitRef="usd">0</arvn:ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements>
    <arvn:CapitalizedContractCostAmortizationDuringPeriod contextRef="c-1" decimals="-5" id="f-371" unitRef="usd">1500000</arvn:CapitalizedContractCostAmortizationDuringPeriod>
    <arvn:CapitalizedContractCostAmortizationDuringPeriod contextRef="c-7" decimals="-5" id="f-372" unitRef="usd">800000</arvn:CapitalizedContractCostAmortizationDuringPeriod>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-3" decimals="-5" id="f-373" unitRef="usd">9200000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-33" decimals="-5" id="f-374" unitRef="usd">11700000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability contextRef="c-4" decimals="-5" id="f-375" unitRef="usd">623700000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-46" decimals="-5" id="f-376" unitRef="usd">740500000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="-5" id="f-377" unitRef="usd">-84600000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-7" decimals="-5" id="f-378" unitRef="usd">-55500000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <arvn:ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements contextRef="c-1" decimals="-5" id="f-379" unitRef="usd">1500000</arvn:ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements>
    <arvn:ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements contextRef="c-7" decimals="-5" id="f-380" unitRef="usd">3000000.0</arvn:ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements>
    <us-gaap:ContractWithCustomerLiability contextRef="c-3" decimals="-5" id="f-381" unitRef="usd">540600000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-33" decimals="-5" id="f-382" unitRef="usd">688000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract contextRef="c-5" decimals="-5" id="f-383" unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract contextRef="c-1" decimals="-5" id="f-384" unitRef="usd">-8200000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract contextRef="c-7" decimals="-5" id="f-385" unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract contextRef="c-6" decimals="-5" id="f-386" unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock contextRef="c-1" id="f-387">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate amount of the transaction price allocated to performance obligations that were unsatisfied as of June&#160;30, 2023 was $540.6 million, which is expected to be recognized in the following periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;110.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;90.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;55.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;34.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;540.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-3" decimals="-5" id="f-388" unitRef="usd">540600000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-78" decimals="-5" id="f-389" unitRef="usd">110200000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-79" decimals="-5" id="f-390" unitRef="usd">200900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-80" decimals="-5" id="f-391" unitRef="usd">90200000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-81" decimals="-5" id="f-392" unitRef="usd">55300000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-82" decimals="-5" id="f-393" unitRef="usd">34700000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-83" decimals="-5" id="f-394" unitRef="usd">10800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-84" decimals="-5" id="f-395" unitRef="usd">38500000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-3" decimals="-5" id="f-396" unitRef="usd">540600000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-404">Marketable Securities and Fair Value Measurements The Company&#x2019;s marketable securities consist of corporate bonds and government securities which are adjusted to fair value as of each balance sheet date based on quoted prices, which are considered Level 2 inputs. &lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s available-for-sale marketable securities measured at fair value on a recurring basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Valuation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Hierarchy&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gross &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;888.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(12.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;876.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;71.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;71.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;960.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;948.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Valuation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Hierarchy&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,008.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(18.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;989.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;135.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;134.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,143.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,124.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not intend to sell any investments prior to recovery of their amortized cost basis for any investment in an unrealized loss position. As such, the Company has classified these losses as temporary in nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of accounts receivable and accounts payable and accrued liabilities approximate their &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;fair values due to the short-term nature of these assets and liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="c-1" id="f-405">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s available-for-sale marketable securities measured at fair value on a recurring basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Valuation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Hierarchy&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gross &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;888.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(12.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;876.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;71.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;71.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;960.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;948.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Valuation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Hierarchy&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,008.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(18.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;989.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;135.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;134.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,143.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,124.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-85" decimals="-5" id="f-406" unitRef="usd">888800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-85" decimals="-5" id="f-407" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-85" decimals="-5" id="f-408" unitRef="usd">12100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-85" decimals="-5" id="f-409" unitRef="usd">876700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-86" decimals="-5" id="f-410" unitRef="usd">71600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-86" decimals="-5" id="f-411" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-86" decimals="-5" id="f-412" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-86" decimals="-5" id="f-413" unitRef="usd">71500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-87" decimals="-5" id="f-414" unitRef="usd">960400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-87" decimals="-5" id="f-415" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-87" decimals="-5" id="f-416" unitRef="usd">12200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-87" decimals="-5" id="f-417" unitRef="usd">948200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-88" decimals="-5" id="f-418" unitRef="usd">1008000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-88" decimals="-5" id="f-419" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-88" decimals="-5" id="f-420" unitRef="usd">18500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-88" decimals="-5" id="f-421" unitRef="usd">989500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-89" decimals="-5" id="f-422" unitRef="usd">135200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-89" decimals="-5" id="f-423" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-89" decimals="-5" id="f-424" unitRef="usd">700000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-89" decimals="-5" id="f-425" unitRef="usd">134500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-90" decimals="-5" id="f-426" unitRef="usd">1143200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-90" decimals="-5" id="f-427" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-90" decimals="-5" id="f-428" unitRef="usd">19200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-90" decimals="-5" id="f-429" unitRef="usd">1124000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-430">Property, Equipment and Leasehold Improvements &lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, equipment and leasehold improvements consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total property, equipment and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(18.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Property, equipment and leasehold improvements, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense totaled $1.2 million and $1.5 million for the three months ended June&#160;30, 2023 and 2022, respectively, and $2.4 million and $3.0 million for the six months ended June&#160;30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-431">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, equipment and leasehold improvements consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total property, equipment and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(18.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Property, equipment and leasehold improvements, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-91" decimals="-5" id="f-432" unitRef="usd">18000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-92" decimals="-5" id="f-433" unitRef="usd">17100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-93" decimals="-5" id="f-434" unitRef="usd">11500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-94" decimals="-5" id="f-435" unitRef="usd">10900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-95" decimals="-5" id="f-436" unitRef="usd">2500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-96" decimals="-5" id="f-437" unitRef="usd">2000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-5" id="f-438" unitRef="usd">32000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-5" id="f-439" unitRef="usd">30000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-5" id="f-440" unitRef="usd">18800000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-5" id="f-441" unitRef="usd">16600000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-5" id="f-442" unitRef="usd">13200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-5" id="f-443" unitRef="usd">13400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization contextRef="c-5" decimals="-5" id="f-444" unitRef="usd">1200000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-6" decimals="-5" id="f-445" unitRef="usd">1500000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-5" id="f-446" unitRef="usd">2400000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-7" decimals="-5" id="f-447" unitRef="usd">3000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-448">Right-of-Use Assets and Liabilities&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As the Company&#x2019;s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the present value of lease payments, which ranges from 3.0% - 7.5%. Lease expense is recognized on a straight-line basis over the lease term. The Company considers options to extend or terminate leases in recognizing ROU assets and lease liabilities when it is reasonably certain that such options will be exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the Company entered into a lease arrangement, which was amended in August 2022, for approximately 160,000 square feet of laboratory and office space, expected to be occupied in 2025. In connection with the signing of the lease and the related amendment, and at the Company&#x2019;s election to increase the landlord&#x2019;s contribution to the tenant improvement allowance, the Company initially issued a letter of credit totaling $4.5&#160;million, which was subsequently increased to $5.5 million, collateralized by a certificate of deposit in the same amount, which is presented as restricted cash in the consolidated balance sheets. Once occupied, the base rent will range from $7.7 million to $8.8 million annually over a ten-year lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for its corporate office, laboratories and certain equipment, which expire no later than January 2026. The leases have a weighted average remaining term of 1.8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.475%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.054%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Supplemental non-cash information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Right-of-use assets obtained in exchange for new lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities as of June&#160;30, 2023, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <arvn:PercentageOfIncrementalBorrowingForLeasePayments contextRef="c-97" decimals="3" id="f-449" unitRef="number">0.030</arvn:PercentageOfIncrementalBorrowingForLeasePayments>
    <arvn:PercentageOfIncrementalBorrowingForLeasePayments contextRef="c-98" decimals="3" id="f-450" unitRef="number">0.075</arvn:PercentageOfIncrementalBorrowingForLeasePayments>
    <us-gaap:LandSubjectToGroundLeases contextRef="c-99" decimals="-3" id="f-451" unitRef="sqft">160000</us-gaap:LandSubjectToGroundLeases>
    <us-gaap:DebtSecurities contextRef="c-100" decimals="-5" id="f-452" unitRef="usd">4500000</us-gaap:DebtSecurities>
    <us-gaap:DebtSecurities contextRef="c-101" decimals="-5" id="f-453" unitRef="usd">5500000</us-gaap:DebtSecurities>
    <us-gaap:LeaseCost contextRef="c-102" decimals="-5" id="f-454" unitRef="usd">7700000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-103" decimals="-5" id="f-455" unitRef="usd">8800000</us-gaap:LeaseCost>
    <arvn:BaseLeaseRentPeriod contextRef="c-104" id="f-456">P10Y</arvn:BaseLeaseRentPeriod>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-457">P1Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-458">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.475%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.054%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-5" decimals="-5" id="f-459" unitRef="usd">500000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-6" decimals="-5" id="f-460" unitRef="usd">500000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-5" id="f-461" unitRef="usd">1000000.0</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-7" decimals="-5" id="f-462" unitRef="usd">1100000</us-gaap:OperatingLeaseCost>
    <arvn:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock contextRef="c-1" id="f-463">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Supplemental non-cash information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Right-of-use assets obtained in exchange for new lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</arvn:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-5" id="f-464" unitRef="usd">1000000.0</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-7" decimals="-5" id="f-465" unitRef="usd">1000000.0</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-5" id="f-466" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-7" decimals="-5" id="f-467" unitRef="usd">2400000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-468">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities as of June&#160;30, 2023, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-5" id="f-469" unitRef="usd">1000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-5" id="f-470" unitRef="usd">2200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-5" id="f-471" unitRef="usd">500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-5" id="f-472" unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-5" id="f-473" unitRef="usd">3700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-5" id="f-474" unitRef="usd">200000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-5" id="f-475" unitRef="usd">3500000</us-gaap:OperatingLeaseLiability>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-476">Accounts Payable and Accrued Liabilities &lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Employee expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Professional fees and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-477">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Employee expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Professional fees and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-5" id="f-478" unitRef="usd">6700000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-5" id="f-479" unitRef="usd">5700000</us-gaap:AccountsPayableCurrent>
    <arvn:AccruedResearchAndDevelopmentExpenseCurrent contextRef="c-3" decimals="-5" id="f-480" unitRef="usd">51600000</arvn:AccruedResearchAndDevelopmentExpenseCurrent>
    <arvn:AccruedResearchAndDevelopmentExpenseCurrent contextRef="c-4" decimals="-5" id="f-481" unitRef="usd">35900000</arvn:AccruedResearchAndDevelopmentExpenseCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-482" unitRef="usd">12600000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-483" unitRef="usd">18700000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-3" decimals="-5" id="f-484" unitRef="usd">2900000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-5" id="f-485" unitRef="usd">4100000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-3" decimals="-5" id="f-486" unitRef="usd">1000000.0</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-4" decimals="-5" id="f-487" unitRef="usd">10300000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-3" decimals="-5" id="f-488" unitRef="usd">74800000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-489" unitRef="usd">74700000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-490">Long-Term Debt&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt obligations consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.475%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.054%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2018 Assistance Agreement Debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;09/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: current installments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2018, the Company entered into an additional assistance agreement with the State of Connecticut (the "2018 Assistance Agreement") to provide funding for the expansion and renovation of laboratory and office space. The Company borrowed $2.0 million under the 2018 Assistance Agreement in September 2018, of which $1.0 million was forgiven upon meeting certain employment conditions. Borrowings under the agreement bear an interest rate of 3.25% per annum, with interest-only payments required for the first 60 months, and mature in September 2028. The 2018 Assistance Agreement requires that the Company be located in the State of Connecticut through September 2028, with a default penalty of repayment of the full original funding amount of $2.0 million plus liquidated damages of 7.5% of the total amount of funding received.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with an assistance agreement with the State of Connecticut entered into in 2014 under which all the borrowings by the Company were forgiven, the Company is required to be located in the State of Connecticut through January 2024, with a default penalty of repayment of the full original funding amount of $2.5 million plus liquidated damages of 7.5%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Minimum future principal payments on long-term debt for the years ending December&#160;31 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June&#160;30, 2023 and 2022, interest expense was immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c-1" id="f-491">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt obligations consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.475%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.054%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2018 Assistance Agreement Debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;09/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: current installments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-105"
      decimals="INF"
      id="f-492"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt contextRef="c-105" decimals="-5" id="f-493" unitRef="usd">1000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-106" decimals="-5" id="f-494" unitRef="usd">1000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent contextRef="c-3" decimals="-5" id="f-495" unitRef="usd">100000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="-5" id="f-496" unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-3" decimals="-5" id="f-497" unitRef="usd">900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-5" id="f-498" unitRef="usd">1000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-107" decimals="-5" id="f-499" unitRef="usd">2000000</us-gaap:DebtInstrumentFaceAmount>
    <arvn:DebtInstrumentLoanForgiveness contextRef="c-108" decimals="-5" id="f-500" unitRef="usd">1000000</arvn:DebtInstrumentLoanForgiveness>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-109"
      decimals="INF"
      id="f-501"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <arvn:DebtInstrumentInterestPaymentsTerm contextRef="c-108" id="f-502">P60M</arvn:DebtInstrumentInterestPaymentsTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-107" decimals="-5" id="f-503" unitRef="usd">2000000</us-gaap:DebtInstrumentFaceAmount>
    <arvn:PercentageOfLiquidatedDamages
      contextRef="c-108"
      decimals="INF"
      id="f-504"
      unitRef="number">0.075</arvn:PercentageOfLiquidatedDamages>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-110" decimals="-5" id="f-505" unitRef="usd">2500000</us-gaap:DebtInstrumentFaceAmount>
    <arvn:PercentageOfLiquidatedDamages
      contextRef="c-111"
      decimals="INF"
      id="f-506"
      unitRef="number">0.075</arvn:PercentageOfLiquidatedDamages>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-507">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Minimum future principal payments on long-term debt for the years ending December&#160;31 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-3" decimals="-5" id="f-508" unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-3" decimals="-5" id="f-509" unitRef="usd">200000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c-3" decimals="-5" id="f-510" unitRef="usd">200000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="c-3" decimals="-5" id="f-511" unitRef="usd">200000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="c-3" decimals="-5" id="f-512" unitRef="usd">200000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <arvn:LongTermDebtMaturityYearSix contextRef="c-3" decimals="-5" id="f-513" unitRef="usd">200000</arvn:LongTermDebtMaturityYearSix>
    <us-gaap:LongTermDebt contextRef="c-3" decimals="-5" id="f-514" unitRef="usd">1000000.0</us-gaap:LongTermDebt>
    <us-gaap:InterestExpense contextRef="c-5" decimals="-5" id="f-515" unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-6" decimals="-5" id="f-516" unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-5" id="f-517" unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-7" decimals="-5" id="f-518" unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-519">Equity&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Distribution Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, the Company entered into an Equity Distribution Agreement with Piper Sandler &amp;amp; Company (&#x201c;Piper Sandler&#x201d;) and Cantor Fitzgerald &amp;amp; Co. (&#x201c;Cantor&#x201d;), as agents, pursuant to which the Company may offer and sell from time to time, through the agents, up to $300.0 million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of the common stock registered under the Company's universal shelf registration statement pursuant to one or more &#x201c;at-the-market" offerings. During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ended&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; June&#160;30, 2023, no shares were issued under this agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2018 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2018, the Company adopted the 2018 Employee Stock Purchase Plan (the &#x201c;2018 ESPP&#x201d;), with the first offering period under the 2018 ESPP commencing on January 1, 2020, by initially providing participating employees with the opportunity to purchase an aggregate of 311,850 shares of the Company&#x2019;s common stock. The number of shares of the Company&#x2019;s common stock reserved for issuance under the 2018 ESPP increased, pursuant to the terms of the 2018 ESPP, by additional shares equal to 1% of the Company&#x2019;s then-outstanding common stock, effective as of January 1 of each year. As of June&#160;30, 2023, 2,495,756 shares remained available for purchase. During the six months ended June&#160;30, 2023 and 2022, the Company issued 23,206 and 5,749 shares of common stock, respectively, of common stock under the 2018 ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Incentive Share Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the Fourth Amendment to the Company&#x2019;s Incentive Share Plan (the &#x201c;Incentive Plan&#x201d;) adopted in March 2018, the Company was authorized to issue up to an aggregate of 6,199,477 incentive units pursuant to the terms of the Incentive Plan. Generally, incentive units were granted at no less than fair value as determined by the board of managers and had vesting periods ranging from &lt;span style="-sec-ix-hidden:f-528"&gt;one&lt;/span&gt; to four years. The Incentive Plan was terminated in September 2018. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2018 Stock Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2018, the Company&#x2019;s board of directors adopted, and the Company&#x2019;s stockholders approved, the 2018 Stock Incentive Plan (the &#x201c;2018 Plan&#x201d;), which became effective upon the effectiveness of the registration statement on Form S-1 for the Company&#x2019;s initial public offering. The number of shares of common stock initially available for issuance under the 2018 Plan equaled the sum of (1) 4,067,007 shares of common stock; plus (2) the number of shares of common stock (up to 1,277,181 shares) issued in respect of incentive units granted under the Incentive Plan that were subject to vesting immediately prior to the effectiveness of the registration statement that expire, terminate or are otherwise surrendered, cancelled, forfeited or repurchased by the Company at their original issuance price pursuant to a contractual repurchase right; plus (3) an annual increase on the first day of each fiscal year beginning with the fiscal year ended December 31, 2019 and continuing to, and including, the fiscal year ending December 31, 2028, equal to the lesser of 4,989,593 shares of the Company&#x2019;s common stock, 4% of the number of shares of the Company&#x2019;s common stock outstanding on the first day of the year or an amount determined by the Company&#x2019;s board of directors. As of June&#160;30, 2023, 1,987,423 shares remained available for issuance under the 2018 Plan. Shares of common stock subject to outstanding equity awards that expire or are terminated, surrendered, or canceled without having been fully exercised or are forfeited in whole or in part are available for future grants of awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2023 and 2022, the Company recognized compensation expense of $18.3 million and $20.0 million, respectively, related to the issuance of incentive awards, including $0.3 million and $0.1 million, respectively, related to the 2018 ESPP. During the six months ended June&#160;30, 2023 and 2022, the Company recognized compensation expense of $38.2 million and $36.6 million, respectively, relating to the issuance of incentive awards, including $0.5 million and $0.3 million, respectively, related to the 2018 ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, there was $83.8 million of total unrecognized compensation expense that is expected to be amortized over a weighted average period of approximately 1.8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the stock options granted during the six months ended June&#160;30, 2023 and 2022 was determined using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;72.3 - 74.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;73.2 - 76.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.5 - 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.5 - 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.4% - 4.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.5% - 3.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$23.23 - $36.27&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$36.79 - $78.91&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Given the Company&#x2019;s common stock has not been trading for a sufficient period of time, the Company calculates volatility of its common stock by utilizing a weighted average of a collection of peer company volatilities and its own common stock volatility. The expected term is calculated utilizing the simplified method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the stock option activity under the 2018 Plan during the six months ended June&#160;30, 2023 is presented below. These amounts include stock options granted to employees and directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.054%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions, &lt;br/&gt;except weighted average exercise price)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Remaining Contractual&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Term (Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Outstanding as of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,814,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;49.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;34.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,653,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;33.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(71,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(212,677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;56.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Outstanding as of June&#160;30, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,183,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;46.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Vested and exercisable as of June&#160;30, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,417,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;41.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Vested and expected to vest as of June&#160;30, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,825,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;45.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant date fair value per share of options granted during the six months ended June&#160;30, 2023 and 2022 was $22.79 and $41.41, respectively. The total intrinsic value of options exercised during the six months ended June&#160;30, 2023 and 2022 was $0.6 million and $7.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Units (RSUs)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSU activity under the 2018 Plan during the six months ended June&#160;30, 2023 is presented below. These amounts include RSUs granted to employees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Fair Value Per&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Unvested RSUs as of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;489,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;51.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;778,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;33.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(94,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(28,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Unvested RSUs as of June&#160;30, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,144,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span id="ifd63f0d1bf8c4ee6838c66e23863a083_5558"&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of RSUs vested during the six months ended June&#160;30, 2023 and 2022 was $4.2 million and $0.7 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <arvn:MaximumAggregateOfferingPriceOfCommonStock contextRef="c-112" decimals="-5" id="f-520" unitRef="usd">300000000</arvn:MaximumAggregateOfferingPriceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-113"
      decimals="INF"
      id="f-521"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-114"
      decimals="INF"
      id="f-522"
      unitRef="shares">311850</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <arvn:IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock contextRef="c-115" decimals="2" id="f-523" unitRef="number">0.01</arvn:IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-116"
      decimals="INF"
      id="f-524"
      unitRef="shares">2495756</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="c-117"
      decimals="INF"
      id="f-525"
      unitRef="shares">23206</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="c-118"
      decimals="INF"
      id="f-526"
      unitRef="shares">5749</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-119"
      decimals="INF"
      id="f-527"
      unitRef="shares">6199477</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-121" id="f-529">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-122"
      decimals="INF"
      id="f-530"
      unitRef="shares">4067007</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-123"
      decimals="INF"
      id="f-531"
      unitRef="shares">1277181</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod
      contextRef="c-124"
      decimals="INF"
      id="f-532"
      unitRef="shares">4989593</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum contextRef="c-125" decimals="2" id="f-533" unitRef="number">0.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-126"
      decimals="INF"
      id="f-534"
      unitRef="shares">1987423</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-127" decimals="-5" id="f-535" unitRef="usd">18300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-128" decimals="-5" id="f-536" unitRef="usd">20000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-129" decimals="-5" id="f-537" unitRef="usd">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-130" decimals="-5" id="f-538" unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-131" decimals="-5" id="f-539" unitRef="usd">38200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-132" decimals="-5" id="f-540" unitRef="usd">36600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-133" decimals="-5" id="f-541" unitRef="usd">500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-134" decimals="-5" id="f-542" unitRef="usd">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-135" decimals="-5" id="f-543" unitRef="usd">83800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-136" id="f-544">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-545">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the stock options granted during the six months ended June&#160;30, 2023 and 2022 was determined using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.022%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;June 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;72.3 - 74.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;73.2 - 76.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.5 - 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.5 - 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.4% - 4.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.5% - 3.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$23.23 - $36.27&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$36.79 - $78.91&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-137" decimals="3" id="f-546" unitRef="number">0.723</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-137" decimals="3" id="f-547" unitRef="number">0.742</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-138" decimals="3" id="f-548" unitRef="number">0.732</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-138" decimals="3" id="f-549" unitRef="number">0.760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-139" id="f-550">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-140" id="f-551">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-141" id="f-552">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-142" id="f-553">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-137" decimals="3" id="f-554" unitRef="number">0.034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-137" decimals="3" id="f-555" unitRef="number">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-138" decimals="3" id="f-556" unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-138" decimals="3" id="f-557" unitRef="number">0.033</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-137" decimals="2" id="f-558" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-138" decimals="2" id="f-559" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="c-143"
      decimals="2"
      id="f-560"
      unitRef="usdPerShare">23.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="c-144"
      decimals="2"
      id="f-561"
      unitRef="usdPerShare">36.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="c-145"
      decimals="2"
      id="f-562"
      unitRef="usdPerShare">36.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="c-146"
      decimals="2"
      id="f-563"
      unitRef="usdPerShare">78.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-564">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the stock option activity under the 2018 Plan during the six months ended June&#160;30, 2023 is presented below. These amounts include stock options granted to employees and directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.054%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions, &lt;br/&gt;except weighted average exercise price)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Remaining Contractual&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Term (Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Outstanding as of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,814,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;49.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;34.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,653,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;33.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(71,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(212,677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;56.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Outstanding as of June&#160;30, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,183,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;46.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Vested and exercisable as of June&#160;30, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,417,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;41.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Vested and expected to vest as of June&#160;30, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,825,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;45.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-147"
      decimals="INF"
      id="f-565"
      unitRef="shares">6814634</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-147"
      decimals="2"
      id="f-566"
      unitRef="usdPerShare">49.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-148" id="f-567">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-147" decimals="-5" id="f-568" unitRef="usd">34500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-149"
      decimals="INF"
      id="f-569"
      unitRef="shares">1653172</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-149"
      decimals="2"
      id="f-570"
      unitRef="usdPerShare">33.67</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-149"
      decimals="INF"
      id="f-571"
      unitRef="shares">71321</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-149"
      decimals="2"
      id="f-572"
      unitRef="usdPerShare">18.90</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-149"
      decimals="INF"
      id="f-573"
      unitRef="shares">212677</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-149"
      decimals="2"
      id="f-574"
      unitRef="usdPerShare">56.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-126"
      decimals="INF"
      id="f-575"
      unitRef="shares">8183808</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-126"
      decimals="2"
      id="f-576"
      unitRef="usdPerShare">46.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-149" id="f-577">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-126" decimals="-5" id="f-578" unitRef="usd">13800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-126"
      decimals="INF"
      id="f-579"
      unitRef="shares">4417474</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-126"
      decimals="2"
      id="f-580"
      unitRef="usdPerShare">41.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-149" id="f-581">P6Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-126" decimals="-5" id="f-582" unitRef="usd">13800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c-126"
      decimals="INF"
      id="f-583"
      unitRef="shares">7825850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-126"
      decimals="2"
      id="f-584"
      unitRef="usdPerShare">45.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-149" id="f-585">P7Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-126" decimals="-5" id="f-586" unitRef="usd">13800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-587"
      unitRef="usdPerShare">22.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-7"
      decimals="2"
      id="f-588"
      unitRef="usdPerShare">41.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-5" id="f-589" unitRef="usd">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-7" decimals="-5" id="f-590" unitRef="usd">7100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="c-1" id="f-591">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSU activity under the 2018 Plan during the six months ended June&#160;30, 2023 is presented below. These amounts include RSUs granted to employees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Fair Value Per&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.75pt;text-align:center"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Unvested RSUs as of December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;489,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;51.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;778,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;33.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(94,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(28,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Unvested RSUs as of June&#160;30, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,144,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-150"
      decimals="INF"
      id="f-592"
      unitRef="shares">489216</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-150"
      decimals="2"
      id="f-593"
      unitRef="usdPerShare">51.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-151"
      decimals="INF"
      id="f-594"
      unitRef="shares">778612</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-151"
      decimals="2"
      id="f-595"
      unitRef="usdPerShare">33.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-151"
      decimals="INF"
      id="f-596"
      unitRef="shares">94688</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-151"
      decimals="2"
      id="f-597"
      unitRef="usdPerShare">44.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-151"
      decimals="INF"
      id="f-598"
      unitRef="shares">28658</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-151"
      decimals="2"
      id="f-599"
      unitRef="usdPerShare">44.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-152"
      decimals="INF"
      id="f-600"
      unitRef="shares">1144482</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-152"
      decimals="2"
      id="f-601"
      unitRef="usdPerShare">40.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-153" decimals="-5" id="f-602" unitRef="usd">4200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-154" decimals="-5" id="f-603" unitRef="usd">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-604">Income Taxes &lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended June&#160;30, 2023, the Company recognized income tax benefit of $0.3 million resulting in an effective tax rate of 0.4%, as compared to income tax expense of $3.4 million resulting in an effective tax rate of (5.4)% in the same period for 2022. The primary reconciling items between the federal statutory rate of 21.0% for the three months ended June&#160;30, 2023 and the Company&#x2019;s overall effective tax rate of 0.4% was the effect of expected benefits from state net operating loss carryback claims offset by equity compensation and the valuation allowance recorded against the full amount of its net deferred tax assets. The primary reconciling items between the federal statutory rate of 21.0% for the three months ended June&#160;30, 2022 and the Company&#x2019;s overall effective tax rate of (5.4)% was the effect of equity compensation, deferred state income taxes and the valuation allowance recorded against the full amount of its net deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended June&#160;30, 2023, the Company recognized income tax expense of $0.7 million resulting in an effective tax rate of 0.4%, as compared to income tax expense of $7.9 million resulting in an effective tax rate of (6.5)% in the same period for 2022. The primary reconciling items between the federal statutory rate of 21.0% for the six months ended June&#160;30, 2023 and the Company&#x2019;s overall effective tax rate of 0.4% was the effect of expected benefits from state net operating loss carryback claims offset by equity compensation and the valuation allowance recorded against the full amount of its net deferred tax assets. The primary reconciling items between the federal statutory rate of 21.0% for the six months ended June&#160;30, 2022 and the Company&#x2019;s overall effective tax rate of (6.5)% was the effect of equity compensation, generation of tax credits, deferred state income taxes and the valuation allowance recorded against the full amount of its net deferred tax assets.&lt;/span&gt;&lt;/div&gt;A valuation allowance is established when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The realization of deferred tax assets depends on the generation of future taxable income during the period in which related temporary differences become deductible. The Company continues to establish a full valuation allowance against its net deferred tax assets since it is more likely than not that benefits will not be realized, including those benefits created in the current year. This assessment is based on the Company's historical cumulative losses which provide strong objective evidence that cannot be overcome with projections of income, as well as the fact the Company expects continuing losses in the future.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-605" unitRef="usd">-300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-5" decimals="3" id="f-606" unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-5" id="f-607" unitRef="usd">3400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-6" decimals="3" id="f-608" unitRef="number">0.054</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-5" decimals="INF" id="f-609" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-5" decimals="3" id="f-610" unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-6" decimals="INF" id="f-611" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-6" decimals="3" id="f-612" unitRef="number">0.054</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-613" unitRef="usd">-700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-614" unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-615" unitRef="usd">7900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-7" decimals="3" id="f-616" unitRef="number">0.065</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="INF" id="f-617" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-618" unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-7" decimals="INF" id="f-619" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-7" decimals="3" id="f-620" unitRef="number">0.065</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-621">Net Loss Per Share &lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted loss per common share was calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.475%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.054%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;For the Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;For the Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars and shares in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(66.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(70.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(148.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(133.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;- basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Net loss per common share &lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;-  basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1.25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2.78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:34.7pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reported net losses for each of the three and six months ended June&#160;30, 2023 and 2022, and therefore excluded all stock options and restricted stock units from the calculation of diluted net loss per common share as their inclusion would have had an anti-dilutive effect, as summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three and Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(shares in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-622">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted loss per common share was calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.475%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.054%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;For the Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;For the Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars and shares in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(66.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(70.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(148.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(133.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;- basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Net loss per common share &lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;-  basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1.25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2.78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#CFF0FC;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#CFF0FC;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-623" unitRef="usd">-66600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-624" unitRef="usd">-70000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-625" unitRef="usd">-148500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-626" unitRef="usd">-133400000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-5" id="f-627" unitRef="shares">53400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-5" id="f-628" unitRef="shares">53400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-5" id="f-629" unitRef="shares">53200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-5" id="f-630" unitRef="shares">53200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-631" unitRef="shares">53400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-632" unitRef="shares">53400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-5" id="f-633" unitRef="shares">53100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-5" id="f-634" unitRef="shares">53100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-635"
      unitRef="usdPerShare">-1.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-636"
      unitRef="usdPerShare">-1.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-637"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-638"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-639"
      unitRef="usdPerShare">-2.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-640"
      unitRef="usdPerShare">-2.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-641"
      unitRef="usdPerShare">-2.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-642"
      unitRef="usdPerShare">-2.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-643">&lt;div style="margin-top:12pt;text-indent:34.7pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reported net losses for each of the three and six months ended June&#160;30, 2023 and 2022, and therefore excluded all stock options and restricted stock units from the calculation of diluted net loss per common share as their inclusion would have had an anti-dilutive effect, as summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three and Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(shares in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-155"
      decimals="-5"
      id="f-644"
      unitRef="shares">8200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-156"
      decimals="-5"
      id="f-645"
      unitRef="shares">8200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-157"
      decimals="-5"
      id="f-646"
      unitRef="shares">6500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-158"
      decimals="-5"
      id="f-647"
      unitRef="shares">6500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-159"
      decimals="-5"
      id="f-648"
      unitRef="shares">1100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-160"
      decimals="-5"
      id="f-649"
      unitRef="shares">1100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-161"
      decimals="-5"
      id="f-650"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-162"
      decimals="-5"
      id="f-651"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-5" decimals="-5" id="f-652" unitRef="shares">9300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-5" id="f-653" unitRef="shares">9300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-6" decimals="-5" id="f-654" unitRef="shares">6800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-7" decimals="-5" id="f-655" unitRef="shares">6800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="c-1" id="f-656">Equity Method Investments&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2019, the Company and Bayer CropScience LP (&#x201c;Bayer LP&#x201d;) formed Oerth Bio, a joint venture to research, develop and commercialize PROTAC targeted protein degraders for applications in the field of agriculture. The Company and Bayer LP each held an initial ownership interest in Oerth Bio of 50%. A 15% ownership interest of Oerth Bio was reserved for the future grants of incentive units to employees and service providers and, as a result, the Company's ownership interest totaled 45.5% and 47.5% as of June&#160;30, 2023 and 2022, respectively, as a result of vested incentive units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the preparation of the Company's consolidated financial statements for the yea&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r ended December 31, 2022, the Company identified a prior period error related to the accounting of its investment in Oerth Bio in 2019. Previously, the Company disclosed that revenue of $24.7&#160;million was deferred and would be recognized if and when Oerth Bio recognized revenue associated with the license. The Company has determined that the consideration received for the amounts associated with the deferred revenue should have been constrained, because at the time Bayer LP had contributed only a portion of its full cash commitment to Oerth Bio, and Bayer LP had the right to all the cash contributed, but not yet spent, upon liquidation of Oerth Bio. The constrained revenue should have been recognized upon both cash being contributed by Bayer LP and the related cash spent by Oerth Bio on research and development activities. As such, for each period presented, the revenue recognized is accompanied by corresponding equity method losses of the same amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company ev&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;aluated the error&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; a&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nd determined that the related impact did not materially misstate the previously issued unaudited condensed consoli&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;dated financial statements for the three and six months ended June&#160;30, 2022. Although the Company concluded that the error was not material to its previously issued unaudited condensed consolidated financial statements, the Company has&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; determined it is appropriate to adjust its previously issued unaudited condensed consolidated financial statements for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and six months ended June&#160;30, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to correct&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the error and improve comparability&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following illustrates the effect of the correction of the immaterial error for the period presented. There was no impact to the balance sheets, net loss per common share, statements of cash flows or changes in stockholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.937%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.887%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.887%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.887%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.887%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.887%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.898%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per common share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss of Oerth Bio for the three months ended June&#160;30, 2023 and 2022 totaled $2.8 million&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $5.3 million, respectively. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized equity method losses of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.3 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2.5 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended June&#160;30, 2023 and 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively. Net loss of Oerth Bio for the six months ended June&#160;30, 2023 and 2022 totaled &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.2 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $10.2 million, respectively. The Company recognized equity method losses of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2.4 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $4.8 million for the six&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; months ended June&#160;30, 2023 and 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;carrying value of t&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he investment was zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also provides Oerth Bio with compensated research, development and administrative services through a separate agreement. The services rendered by the Company during the three and six months ended June&#160;30, 2023 and 2022 were immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-163"
      decimals="INF"
      id="f-657"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <arvn:FutureGrantOfIncentiveUnitsToServiceProvidersPercentage contextRef="c-164" decimals="2" id="f-658" unitRef="number">0.15</arvn:FutureGrantOfIncentiveUnitsToServiceProvidersPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-165" decimals="3" id="f-659" unitRef="number">0.455</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-166" decimals="3" id="f-660" unitRef="number">0.475</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ContractWithCustomerLiability contextRef="c-167" decimals="-5" id="f-661" unitRef="usd">24700000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="c-1" id="f-662">&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following illustrates the effect of the correction of the immaterial error for the period presented. There was no impact to the balance sheets, net loss per common share, statements of cash flows or changes in stockholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.937%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.887%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.887%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.887%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.887%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.887%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.898%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:114%"&gt;(dollars in millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as previously reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;as adjusted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per common share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:Revenues contextRef="c-168" decimals="-5" id="f-663" unitRef="usd">31300000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-169" decimals="-5" id="f-664" unitRef="usd">2500000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-6" decimals="-5" id="f-665" unitRef="usd">33800000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-170" decimals="-5" id="f-666" unitRef="usd">55500000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-171" decimals="-5" id="f-667" unitRef="usd">4800000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-7" decimals="-5" id="f-668" unitRef="usd">60300000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss contextRef="c-168" decimals="-5" id="f-669" unitRef="usd">-68300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-169" decimals="-5" id="f-670" unitRef="usd">2500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-5" id="f-671" unitRef="usd">-65800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-170" decimals="-5" id="f-672" unitRef="usd">-128200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-171" decimals="-5" id="f-673" unitRef="usd">4800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-5" id="f-674" unitRef="usd">-123400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-168" decimals="-5" id="f-675" unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-169" decimals="-5" id="f-676" unitRef="usd">-2500000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-6" decimals="-5" id="f-677" unitRef="usd">-2500000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-170" decimals="-5" id="f-678" unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-171" decimals="-5" id="f-679" unitRef="usd">-4800000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-7" decimals="-5" id="f-680" unitRef="usd">-4800000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss contextRef="c-168" decimals="-5" id="f-681" unitRef="usd">-70000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-169" decimals="-5" id="f-682" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-5" id="f-683" unitRef="usd">-70000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-170" decimals="-5" id="f-684" unitRef="usd">-133400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-171" decimals="-5" id="f-685" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-686" unitRef="usd">-133400000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-168"
      decimals="2"
      id="f-687"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-168"
      decimals="2"
      id="f-688"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-169"
      decimals="2"
      id="f-689"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-169"
      decimals="2"
      id="f-690"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-691"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-692"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-170"
      decimals="2"
      id="f-693"
      unitRef="usdPerShare">-2.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-170"
      decimals="2"
      id="f-694"
      unitRef="usdPerShare">-2.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-171"
      decimals="2"
      id="f-695"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-171"
      decimals="2"
      id="f-696"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-697"
      unitRef="usdPerShare">-2.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-698"
      unitRef="usdPerShare">-2.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-168" decimals="-5" id="f-699" unitRef="usd">-73300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-169" decimals="-5" id="f-700" unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-5" id="f-701" unitRef="usd">-73300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-170" decimals="-5" id="f-702" unitRef="usd">-150800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-171" decimals="-5" id="f-703" unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-5" id="f-704" unitRef="usd">-150800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-172" decimals="-5" id="f-705" unitRef="usd">-2800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-173" decimals="-5" id="f-706" unitRef="usd">-5300000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-174" decimals="-5" id="f-707" unitRef="usd">-1300000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-175" decimals="-5" id="f-708" unitRef="usd">-2500000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss contextRef="c-176" decimals="-5" id="f-709" unitRef="usd">-5200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-177" decimals="-5" id="f-710" unitRef="usd">-10200000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-178" decimals="-5" id="f-711" unitRef="usd">-2400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-179" decimals="-5" id="f-712" unitRef="usd">-4800000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-180" decimals="INF" id="f-713" unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-181" decimals="INF" id="f-714" unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-715">Commitments and Contingencies&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may be subject to legal proceedings, claims and disputes that arise in the&#160;ordinary&#160;course&#160;of business. The Company accrues a liability for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount, which could differ materially. Legal fees and other costs associated with such actions are expensed as incurred.&#160;The Company's accrual for such matters totaled $10.0&#160;million as of June&#160;30, 2023, primarily related to a contract dispute that is in early stages. Due to the early stage of the dispute, the means of resolution are unknown and could involve contract modification and, or payment of consideration.&#160;An estimate of the possible range of loss associated with the dispute cannot be made at this time and the Company has accrued its best estimate as of June&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Clinical and Preclinical Development and Licensing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company enters into contracts in the normal course of business with various third parties who support its clinical trials, preclinical research studies, and other services related to its development activities. The scope of the services under these agreements can generally be modified at any time, and the agreement can be terminated by either party after a period of notice and receipt of written notice.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In addition, under licensing and related arrangements to which the Company is a party, the Company may be obligated to make milestone payments to third parties. The payment obligations under these arrangements are contingent upon future events, such as achievement of specified milestones or generation of product sales, and the amount, timing and likelihood of such payments are not known.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;FMI Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company entered into a Master In Vitro Diagnostics Agreement (the "FMI Agreement") with Foundation Medicine, Inc. ("Foundation Medicine") for the development and commercialization of one or more of Foundation Medicine&#x2019;s companion in vitro diagnostic assays for use with one or more of the Company's therapeutic products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The FMI Agreement does not have a fixed duration, and the Company may terminate the FMI Agreement for convenience by providing adequate written notice to Foundation Medicine, subject to payment of applicable termination fees. Either party may terminate the FMI Agreement in its entirety for an uncured material breach by the other party, upon the bankruptcy or insolvency of the other party or by the mutual written agreement of both parties. Additionally, Foundation Medicine may terminate the FMI Agreement with respect to an applicable program, (a) if a reasonably necessary third party license is not secured by Foundation Medicine or if the Company does not consent to payments for such license, (b) if Foundation Medicine reasonably determines that further development of the applicable assay is not technically feasible or (c) following a certain number of years after the first commercial launch of the applicable assay for use with the applicable therapeutic product. Certain license and other rights and certain obligations of Foundation Medicine survive termination of the FMI Agreement. If the FMI Agreement is terminated in its entirety or with respect to any program, the Company has certain payment obligations remaining to Foundation Medicine and may also be required to pay a termination fee, if applicable.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bavdegalutamide&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In exchange for the development of FoundationOne&#xae; Liquid CDx as a companion diagnostic for use with bavdegalutamide for androgen receptor protein (&#x201c;AR&#x201d;) metastatic castration-resistant prostate cancer (&#x201c;mCRPC&#x201d;) in the United States and European Union, pursuant to the terms of the FMI Agreement, the Company is subject to success-based milestone payments of up to low to mid tens of millions of dollars, in addition to certain validation fees per sample and related pass-through costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ARV-766&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In exchange for the development of FoundationOne&#xae; Liquid CDx as a companion diagnostic for use with ARV-766 for AR mCRPC in the United States and European Union, pursuant to the terms of the FMI Agreement, the Company is subject to success-based milestone payments of up to low tens of millions of dollars in addition to certain validation fees per sample and related pass-through costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-3" decimals="-5" id="f-716" unitRef="usd">10000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer contextRef="c-182" decimals="-6" id="f-717" unitRef="usd">10000000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-5" id="f-718">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-5" id="f-719">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-5" id="f-720">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-5" id="f-721">false</ecd:Rule10b51ArrAdoptedFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>84
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MBDFR9E'&R8_6*1A%LH)Y-]_T&ROA&$:*5D:*XE8'3'X0)@LR?8UG(C*Q'Q
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M([GFS)O(Q'GW;#P=DA.%.ZND8X4Q&?LEI@>):5#BQRP3#70O%-Z,05^#5I_
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M95J/(!O;];O)%( X;/7&KQ; ME'5G?=;,EXR@BG=1J*JS7!I]K2.6-TE9 6
MQII 6X.NND($<C7KG2"UVK3-<O/M]V6%+@1E_=+8 RC<G0YK&.5VZ0,HMY$=
M;?JU]+3-VO,\:T"2,VVC-?;];Z3^3-N_C6=6ES'@V';G>J& <$Z_ JGUIVT6
MH%6MD/H+R;1/6%I\8+I27PJC#;J(4A2R."99@<E?PM.@:$DMW\U4P-W-;P_.
MP=W80#A9'K4Z .,\NR<VM3BUS>K4$)LPBH_JB]X+HK-X9G1@G!X=" =%!\;U
M10?7VA4;==CR4_ZU6,: G*1TW]%6A#AB1\&%7&SDKJ:92L5;,$)E>ZU=F+Z%
MA5'=Z#S+5P"C^B)3*TAL5I OB4PSD4RQT?4?%!L0I<7F.;X"&-47FUIQ8FS<
M\=0?,=FV\\F[7';-'S>Q4="^=!LTJ+?UH-Z"H;RU!ZJ6R]@LETW+86GZHN6P
MM#$OAY!C:#D$<?W+(:ZE,W:?L2'?M/)210'\!(J-,OS%N3BDM_6@WH*AO+5'
MI1;DV"S(/Z89)7'TKZR3.R(+Y84:DDND3D1/)(K)0TS'<J<SYB2FB-/-,8M$
M!']$PY# UNHHJ-6['PU+5'.KV%7JD"-[UINFM53'9JF^TA(4Y.J#TQ1WV0*P
M&4 7@-FNK<]-".=9FD"?-HY7$YKM\G-M+N?>,17%V5CUM#H[?YV?&'>>W]G7
M*QMXOK:O@^)DO'9?'-2_(]DN2CF*Z58V)3=8<IBRXNR[N!'LD!_N/C A6))?
M[BD)::8 \OV6,7&^40U4_P-A^1]02P,$%     @ ,X$(5Y+&2]X."   >4,
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MQPXJD@_<)'^*453O0]XUI\WK\XE[ +4MF79-<4$U" 3N7?DJV^UBPSDD-B_
M8BXS80H_?&N;D*#Y.1#T!_OKY[-NS<^E[= CM7?P[B'C?[ VRE*S*26JB+W.
M!JO#;/OZYK;9*M1!Y$$UE 3NH<20H4$),46*O-A;9*%E7D^W)KZVB-= -ZP=
M."54/)IS.(G,%C@_I2F?EF=]-^:$J_'\UK^\RT_L*C7Y >(#$=!%)$1D RJ]
MP11:MLC/Y/(;Q7?F6&O-E>*)N=Q2$E&A!>#[#>?J[4;_0'DRNO@/4$L#!!0
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M(8XDA.H)@)FR,P,3Q\H&6D:8*U)KPCS J "5!=35R;*Y$NDS.K]R-"ZU6F6
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M1A,'3YN@8CGQE4S5^0#5X)6[4X.+US]-#I/3%P >=  /7K+^?]/RHM&G(?^
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MI<GH:#Z(Q\KV(=B*[VD+&W#KXV&.:[9R- '?E]:&]H$<=!?WBW\ 4$L#!!0
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MX>QLGJ9J(ZV!)7MB*X' 9 :TJ3>8P1?.5EQPR]%, DO1'"9(6^9%PQR_P#R
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M7[2\@.87QOCN@S?H;].S?P%02P,$%     @ ,X$(5P$ @?K!"@  ?QX  !D
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M4O$_2MM'04!9R!1';#3RQV71,M(6--FCHZ\BG1&[GNU7S?!VU=\:$]_5NKC
M-+UR-VZW9>ZS.14>?[KZ3' >9@ \^O^3GNPXR/6^U?Z!IH8H["T%_!T%W/+O
MDKX,F(!_+JXMZ(SLN[@8X0@4^ 2MJ>^&<4^_.)X[,W]'OA; QPL0=SXG=D5@
M:S!B'E9,NZ'9_* !8__XCA^!-G-2$WF4"';0&?<>1D0K[E?Q$NWWCQYX?A@O
MA[XZG0X^"N9"K\VG3ZI^"*3]/M@_[;^NGMN/BKOI]M/L1ZYQ**YP%EUA*<R8
M3NQYN[NI56D^,2Y57:O<7&X$!Q1I L972M7=#2GHOSF?_0=02P,$%     @
M,X$(5_BVA:2) P  5PP  !D   !X;"]W;W)K<VAE971S+W-H965T,38N>&UL
M[5=M;]LV$/XK![4I-B"09,EY66H;2-(5ZX "0=MM'X9]H*633(0O*DG%]G[]
MCJ2L>%CJIAVR?MD'VR)U]_">YWB'\VRMS:U=(3K82*'L/%DYUUUDF:U6*)E-
M=8>*WC3:2.9H:=K,=@99'9RDR(H\/\TDXRI9S,+>C5G,=.\$5WACP/92,K.]
M0J'7\V22[#;>\7;E_$:VF'6LQ??H?NEN#*VR$:7F$I7E6H'!9IY<3BZNIMX^
M&/S*<6WWGL$S66I]ZQ=OZGF2^X!08.4\ J.?.[Q&(3P0A?%QP$S&([WC_O,.
M_77@3ER6S.*U%K_QVJWFR7D"-3:L%^Z=7O^$ Y\3CU=I8<,WK*-M6290]=9I
M.3A3!)*K^,LV@PY[#N?Y)QR*P:$(<<>#0I2OF&.+F=%K,-Z:T/Q#H!J\*3BN
M?%+>.T-O.?FYQ1M5:8GP@6W0SC)'B'X_JP;OJ^A=?,+[%-YJY586?E0UUG_W
MSRB2,9QB%\Y5<1#PYUZE4.;'4.1%>0"O'.F5 :_\+#UXQ6TEM.T-PN^72^L,
M78@_'J(<$:</(_HBN; =JW">4!58-'>8+%X\FYSF+P_$.QWCG1Y"_VPZ'N\-
M=&G!K9 ^!A%DS!/Z/ &IC*/*Q\'J6LN.J2W56:5;Q?\D*Q[1'&FW1(4-=Z ;
M>)ZG)5U$(6)56KK]7+5D#$P!-@V&,@M>ACGT+GDZ/3H&9J'RAQB"=GH?'3?4
M8FPP?5ZFTR]$_^XDG7Y_Y$T\#\L(M$/#=0W4LCS#(H4/]*8SW+>=P%!57 1<
MA](2.[=&C/X-UFB8 .N8ZYWV]L,YQ23-CP+F8U2E>.M]85\\.R\F9R\MZ#N/
M+PY(!6N2RKM&$[_M%:H<G3$DPD)CM Q!(BAJW=2D"<)3HBM.0C-CMDM6W4(E
M&">*NFDLF2VW@!][[K8A%20ZBZUQB/6.B7[8$=2MF:HPR&4\/=92B[<NJM03
M R9UKT)X/B ?!75#-"&_1(E9.M%^ ^V+K]1^N$@/J/]/R8[ON<8DW%]G*KTG
MU7-7UY9O_F55[]==GIX]856?I3]\:56?IB?_?54?UO3_FGZZFCZH_%=7=+Q$
MCZSHEO)@HE1DXG$JXDTZ?+MB?VBBR/:&/8FF#2.MKT+"BW/?N#M.S9=Q6+PW
MCR/W6V9:"@L$-N1*+> D 1/'V+APN@NCXU([&D3#XXHF?S3>@-XW6KO=PA\P
M_I=8_ 502P,$%     @ ,X$(5XD-1S1\ P  "P@  !D   !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&ULC551;]LV$/XK!ZT8&B"59,EVO,PV$&<MVJ$M@GA;
M'X8]T-+9(D*1&DG%Z7Y][RA;M1O'V(/IHWCWW7?'N^-T:^R#JQ ]/-5*NUE4
M>=]<)XDK*JR%BTV#FD[6QM;"T]9N$M=8%&4PJE62I>DXJ874T7P:OMW9^=2T
M7DF-=Q9<6]?"?EV@,MM9-(CV'^[EIO+\(9E/&['!)?H_FSM+NZ1'*66-VDFC
MP>)Z%MT,KA=#U@\*?TG<N@,9.)*5,0^\^5#.HI0)H<+",X*@OT>\1:48B&C\
MN\.,>I=L>"COT=^%V"F6E7!X:]076?IJ%DTB*'$M6N7OS?8][N(9,5YAE LK
M;#O=/(V@:)TW]<Z8&-12=__B:9>' X/)2P;9SB +O#M'@>5OPHOYU)HM6-8F
M-!9"J,&:R$G-E[+TEDXEV?GY9[KWC\8YN$,+RTI8G":></DT*788BPXC>P%C
M#)^,]I6#M[K$\M@^(3X]J6Q/:I&=!?R]U3'DZ25D:9:?P<O[(/. E[^ ]U98
M+?7F($CX^V;EO*6:^.=4O!W<\#0<]\FU:T2!LX@:P:%]Q&C^\T^#<?KK&;+#
MGNSP'/K_O)&S&*<9/@>&A7"R *%+**5J/9:@6*$AA<+4-76-"WI;X: 0JFB5
M8"7:K8VB?G;70+T!OD+XH[*(1X70'RWET_'!ZY*LA77!<_#@0&HJ;Z6H4]TE
MX%.!C0\\.@*B-JWV[B)4!"_9@<2!!=ZOX/5X'(\O6+A*XS0(@^$D'G52GL?#
M"_@2.I7#>$1+@P=T6Z_(DUD?!>V 9ICS1)%*!]YP[_^0JQ'!\9+UTN [EV<Y
M/(7 I.)LQR[.LR!D\=5D)XP&%Y18A%M3-T)_I2G8&,N&>N<&^28LH"@JYL_9
M]N$B0F8I[W67=PQYI[["OJ^""N?O,DAD2O/0$%%*OFI972@%-("*!S -C]#N
MOB@SWLJ"672'K9:>:%A3!__[.N&92Y3VH>H7$T/51';24@F0XS#MMZ95)51T
M0;00$9K>VLLW 8N&..!Z35/]DDV[UT3^1RY6_,3\6)%,^7D!/B^ZP]):'@4]
MH0L>QR.X/QWX@&X]C7/XA7[C> *G1D!R,*!KM)OP#%%+<5%WL[K_VK]T-]V
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MCJ<%>+YTX&CS@P[H/AU?_1M02P,$%     @ ,X$(5V@T9G=_ @  P@<  !D
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M=WE:-7>&X_'FYO69::IV P*WI$JM3!G7S6VF>;&J]C>(5%FZCWBQI L@:G>
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M+U"[#;2>*V4W T?0_8&F_P!02P,$%     @ ,X$(5T[I45F= P  1@D  !D
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MM7.@_4PINS=<@.Y?,O\+4$L#!!0    ( #.!"%?L C!A"P,  "8'   9
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M6*L5:*=-:$[PJ7IK"HY+1\JCU73*R<Y.;Y7,/CZASN$*YQ:.GMA<H#D>AY;
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MD&G4.:4JZVHJ5PNK"C\)Y\K27/7BDAXRU$Z!SA=*V6;A'+1/X_0W4$L#!!0
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M-?\PT(4$CJ^M]8]&&.+]+ZCX#U!+ P04    "  S@0A71A)Q[-$"  !6"0
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M^#R+PE7J3J"W#R!I&(EWZ T*$_0IC")]?^A)Q4$C\>89WOL#7E*"]X]MXJ+
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M7!00,66>7%GF7UY O7(!V4%53"QBV@B"FR$@8NTDJO(\&25<V5Y4$5#F^U1
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MHB= 9$?N;*#X-CVUSKG29^#T<@-D"<($Z.]7G*NW@3D(%S]\C/\%4$L#!!0
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MQOM2];C%*RU($X#?-T+HQX&Y-+67Y/@K4$L#!!0    ( #.!"%<CSF7YN (
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M:.Y !??#(.CY!67"2Q,GNU9I(E>&,P'7BNA545#U>P1<;@9>U]L);MAB::S
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M]9,#7 >H[RO&Y*&C[]'JMRG\#U!+ P04    "  S@0A7Y**Y)=H"  "K"0
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MTQG@YI/%TZ#H:+'-;]>ET'A7Y\T-OJ9 F@ <7PFAGSKFPJ[>9^%O4$L#!!0
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MKD@6F!/18246ZLV,\9Q(->1S5Y0<26J<\LP-/"]R<T(+)QZ:N3L>#]E29K3
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MW#*#K&XFZHF@"UTMIU3(VJN'<]E_ 5,&<C^C5&PFRD';T85_ %!+ P04
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MS8;5":>+<NO:,^6<IN7AG(01846 ^'Y**=^<% TT6SZ'_P%02P,$%     @
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MK-_9;UWDU3&(C(]!Y%'T9.\81"9'(++[:M^:AXN,WF8AP_HDM''<VCIL-=X
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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MUJ=8]LW,K:QWKV+M7B/[] M02P,$%     @ ,X$(5Q,G[+KO 0  I2(  !H
M  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<\W:NT[K0!2%X5>)_ !,]BW
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MW7L^&WX@N7H%4$L! A0#%     @ ,X$(5P=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  S@0A7LM&A
MH>T    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    "  S@0A7F5R<(Q &  "<)P  $P              @ '+ 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( #.!"%?@_-+2[04  +H?
M   8              " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    "  S@0A7BN6$?P@&   [&0  &               @($O#@
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ ,X$(5P2$=]63
M @  OP8  !@              ("!;10  'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    ( #.!"%<64M)(B@8  (T@   8              "
M@387  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    "  S@0A7
MDL9+W@X(  !Y0P  &               @('V'0  >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&UL4$L! A0#%     @ ,X$(5[E@18&W!@  )1T  !@
M     ("!.B8  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (
M #.!"%=JP+OF-P@   44   8              " @2<M  !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6Q02P$"% ,4    "  S@0A7#^.DO>0#  !X"0  &
M            @(&4-0  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#
M%     @ ,X$(5^R9'B)*"P  @B0  !@              ("!KCD  'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( #.!"%<P51"M0 0  #L*
M   9              " @2Y%  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M4$L! A0#%     @ ,X$(5[,&L-(  P  ?P<  !D              ("!I4D
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    "  S@0A706R9
M=F8&  #$#P  &0              @('<3   >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;%!+ 0(4 Q0    ( #.!"%>S7](2M0(  %T&   9
M  " @7E3  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @
M,X$(5U!\2;.P!   60L  !D              ("!958  'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6Q02P$"% ,4    "  S@0A7 0"!^L$*  !_'@  &0
M            @(%,6P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4
M Q0    ( #.!"%?XMH6DB0,  %<,   9              " @41F  !X;"]W
M;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ ,X$(5XD-1S1\ P
M"P@  !D              ("!!&H  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q02P$"% ,4    "  S@0A7IY6DT+ '  "9%   &0              @(&W
M;0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( #.!"%<%
M4R%*<@@  $86   9              " @9YU  !X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L! A0#%     @ ,X$(5V@T9G=_ @  P@<  !D
M     ("!1WX  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #.!"%<!-EXG30,  +P'   9              "
M@=22  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ ,X$(
M5^6,__#* @  C08  !D              ("!6)8  'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"% ,4    "  S@0A73NE169T#  !&"0  &0
M        @(%9F0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0
M   ( #.!"%<QP; 5S@(  %<&   9              " @2V=  !X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ ,X$(5^P",&$+ P  )@<
M !D              ("!,J   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q0
M2P$"% ,4    "  S@0A7F3_\.-\$   2#   &0              @(%THP
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( #.!"%=M")S8
MN@,  .L(   9              " @8JH  !X;"]W;W)K<VAE971S+W-H965T
M,S$N>&UL4$L! A0#%     @ ,X$(5V$8M&.J P  9P@  !D
M ("!>ZP  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  S
M@0A7LTLI144"  ".!   &0              @(%<L   >&PO=V]R:W-H965T
M<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( #.!"%=&$G'LT0(  %8)   9
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M  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ ,X$(5^T
MHJ_Z P  !!$  !D              ("!YLX  'AL+W=O<FMS:&5E=',O<VAE
M970S."YX;6Q02P$"% ,4    "  S@0A7((V,$6L#   P#P  &0
M    @($7TP  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (
M #.!"%<CSF7YN (   <(   9              " @;G6  !X;"]W;W)K<VAE
M971S+W-H965T-# N>&UL4$L! A0#%     @ ,X$(5UA,T91!!   2!(  !D
M             ("!J-D  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"
M% ,4    "  S@0A7!_3_ J8"  #9!P  &0              @($@W@  >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( #.!"%=0Z-TY^@(
M /@'   9              " @?W@  !X;"]W;W)K<VAE971S+W-H965T-#,N
M>&UL4$L! A0#%     @ ,X$(5RH8)$^C @  \P8  !D              ("!
M+N0  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    "  S@0A7
M9K"?TO@"  !""0  &0              @($(YP  >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;%!+ 0(4 Q0    ( #.!"%?DHKDEV@(  *L)   9
M      " @3?J  !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%
M  @ ,X$(5T,X$W,^!0  6"T  !D              ("!2.T  'AL+W=O<FMS
M:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    "  S@0A7M)>GS6L"  "W!@
M&0              @(&]\@  >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+
M 0(4 Q0    ( #.!"%>E(PZ_P L  $R3   9              " @5_U  !X
M;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ ,X$(5W!0I>SL
M P  )1   !D              ("!5@$! 'AL+W=O<FMS:&5E=',O<VAE970U
M,"YX;6Q02P$"% ,4    "  S@0A7:,(((/0$   ]&0  &0
M@(%Y!0$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( #.!
M"%>]$9[01@,  ,P*   9              " @:0* 0!X;"]W;W)K<VAE971S
M+W-H965T-3(N>&UL4$L! A0#%     @ ,X$(5Z>;O[CW @  W0D  !D
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M=#4W+GAM;%!+ 0(4 Q0    ( #.!"%>0+:)0E0(  #$(   9
M  " @9XD 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @
M,X$(5YI06!%$ P  RA0   T              ( !:B<! 'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    "  S@0A7EXJ[',     3 @  "P              @ '9
M*@$ 7W)E;',O+G)E;'-02P$"% ,4    "  S@0A7S?H3@<,$  #*)@  #P
M            @ '"*P$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ,X$(
M5Q,G[+KO 0  I2(  !H              ( !LC ! 'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ ,X$(5V(CYQC8 0  2"(  !,
M         ( !V3(! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $( 0@ %
)$@  XC0!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>182</ContextCount>
  <ElementCount>260</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>52</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Nature of Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/NatureofBusinessandBasisofPresentation</Role>
      <ShortName>Nature of Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Accounting Pronouncements and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPolicies</Role>
      <ShortName>Accounting Pronouncements and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Research Collaboration and License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreements</Role>
      <ShortName>Research Collaboration and License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Marketable Securities and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurements</Role>
      <ShortName>Marketable Securities and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Property, Equipment and Leasehold Improvements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovements</Role>
      <ShortName>Property, Equipment and Leasehold Improvements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Right-of-Use Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/RightofUseAssetsandLiabilities</Role>
      <ShortName>Right-of-Use Assets and Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/AccountsPayableandAccruedLiabilities</Role>
      <ShortName>Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Equity Method Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/EquityMethodInvestments</Role>
      <ShortName>Equity Method Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9954701 - Disclosure - Accounting Pronouncements and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Accounting Pronouncements and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9954702 - Disclosure - Accounting Pronouncements and Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesTables</Role>
      <ShortName>Accounting Pronouncements and Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9954703 - Disclosure - Research Collaboration and License Agreements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTables</Role>
      <ShortName>Research Collaboration and License Agreements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954704 - Disclosure - Marketable Securities and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsTables</Role>
      <ShortName>Marketable Securities and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954705 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsTables</Role>
      <ShortName>Property, Equipment and Leasehold Improvements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954706 - Disclosure - Right-of-Use Assets and Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesTables</Role>
      <ShortName>Right-of-Use Assets and Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/RightofUseAssetsandLiabilities</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954707 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesTables</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/AccountsPayableandAccruedLiabilities</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954708 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/LongTermDebt</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954709 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/Equity</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954710 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/NetLossPerShare</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954711 - Disclosure - Equity Method Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/EquityMethodInvestmentsTables</Role>
      <ShortName>Equity Method Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/EquityMethodInvestments</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954712 - Disclosure - Nature of Business and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/NatureofBusinessandBasisofPresentationDetails</Role>
      <ShortName>Nature of Business and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/NatureofBusinessandBasisofPresentation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954713 - Disclosure - Accounting Pronouncements and Significant Accounting Policies - Cash Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails</Role>
      <ShortName>Accounting Pronouncements and Significant Accounting Policies - Cash Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954714 - Disclosure - Research Collaboration and License Agreements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails</Role>
      <ShortName>Research Collaboration and License Agreements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954715 - Disclosure - Research Collaboration and License Agreements - Summary of Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails</Role>
      <ShortName>Research Collaboration and License Agreements - Summary of Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954716 - Disclosure - Research Collaboration and License Agreements - Transaction Price Allocated to Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails</Role>
      <ShortName>Research Collaboration and License Agreements - Transaction Price Allocated to Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954717 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Available-for-Sale Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities and Fair Value Measurements - Summary of Available-for-Sale Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954718 - Disclosure - Property, Equipment and Leasehold Improvements - Schedule of Property, Equipment and Leasehold Improvements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails</Role>
      <ShortName>Property, Equipment and Leasehold Improvements - Schedule of Property, Equipment and Leasehold Improvements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954719 - Disclosure - Property, Equipment and Leasehold Improvements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsAdditionalInformationDetails</Role>
      <ShortName>Property, Equipment and Leasehold Improvements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954720 - Disclosure - Right-of-Use Assets and Liabilities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails</Role>
      <ShortName>Right-of-Use Assets and Liabilities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954721 - Disclosure - Right-of-Use Assets and Liabilities - Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesComponentsofLeaseExpenseDetails</Role>
      <ShortName>Right-of-Use Assets and Liabilities - Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954722 - Disclosure - Right-of-Use Assets and Liabilities - Schedule of Supplemental Cash Flow Information Related to Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails</Role>
      <ShortName>Right-of-Use Assets and Liabilities - Schedule of Supplemental Cash Flow Information Related to Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954723 - Disclosure - Right-of-Use Assets and Liabilities - Schedule of Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Right-of-Use Assets and Liabilities - Schedule of Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954724 - Disclosure - Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954725 - Disclosure - Long-Term Debt - Schedule of Long Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Long Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954726 - Disclosure - Long-Term Debt - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails</Role>
      <ShortName>Long-Term Debt - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954727 - Disclosure - Long-Term Debt - Schedule of Minimum Future Payments on Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Minimum Future Payments on Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954728 - Disclosure - Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/EquityAdditionalInformationDetails</Role>
      <ShortName>Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954729 - Disclosure - Equity - Schedule of Assumptions Used to Determine Fair Value of and Stock Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails</Role>
      <ShortName>Equity - Schedule of Assumptions Used to Determine Fair Value of and Stock Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954730 - Disclosure - Equity - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails</Role>
      <ShortName>Equity - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954731 - Disclosure - Equity - Summary of Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails</Role>
      <ShortName>Equity - Summary of Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954732 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/IncomeTaxes</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954733 - Disclosure - Net Loss Per Share - Basic and Diluted Loss per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/NetLossPerShareBasicandDilutedLossperCommonShareDetails</Role>
      <ShortName>Net Loss Per Share - Basic and Diluted Loss per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954734 - Disclosure - Net Loss Per Share - Securities Excluded From Computation of Diluted Net Loss Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails</Role>
      <ShortName>Net Loss Per Share - Securities Excluded From Computation of Diluted Net Loss Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954735 - Disclosure - Equity Method Investments- Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails</Role>
      <ShortName>Equity Method Investments- Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954736 - Disclosure - Equity Method Investments - Schedule of Correction of Immaterial Error for the Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails</Role>
      <ShortName>Equity Method Investments - Schedule of Correction of Immaterial Error for the Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="arvn-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954737 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arvinas.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arvinas.com/role/CommitmentsandContingencies</ParentRole>
      <Position>58</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 7 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  arvn-20230630.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Not-Referenced] WARN: 1 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 -  arvn-20230630.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="arvn-20230630.htm">arvn-20230630.htm</File>
    <File>arvinassixthleaseamendme.htm</File>
    <File>arvn-20230630.xsd</File>
    <File>arvn-20230630_cal.xml</File>
    <File>arvn-20230630_def.xml</File>
    <File>arvn-20230630_lab.xml</File>
    <File>arvn-20230630_pre.xml</File>
    <File>arvn-20230630x10qex311.htm</File>
    <File>arvn-20230630x10qex312.htm</File>
    <File>arvn-20230630x10qex321.htm</File>
    <File>arvn-20230630x10qex322.htm</File>
    <File>bayer_arvinasxamendmentx.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="643">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>90
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "arvn-20230630.htm": {
   "axisCustom": 0,
   "axisStandard": 24,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 643,
    "http://xbrl.sec.gov/dei/2023": 30,
    "http://xbrl.sec.gov/ecd/2023": 4
   },
   "contextCount": 182,
   "dts": {
    "calculationLink": {
     "local": [
      "arvn-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "arvn-20230630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "arvn-20230630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "arvn-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "arvn-20230630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "arvn-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    }
   },
   "elementCount": 512,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2023": 8,
    "http://xbrl.sec.gov/dei/2023": 5,
    "total": 13
   },
   "keyCustom": 26,
   "keyStandard": 234,
   "memberCustom": 25,
   "memberStandard": 24,
   "nsprefix": "arvn",
   "nsuri": "http://www.arvinas.com/20230630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.arvinas.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Marketable Securities and Fair Value Measurements",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurements",
     "shortName": "Marketable Securities and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Property, Equipment and Leasehold Improvements",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovements",
     "shortName": "Property, Equipment and Leasehold Improvements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Right-of-Use Assets and Liabilities",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.arvinas.com/role/RightofUseAssetsandLiabilities",
     "shortName": "Right-of-Use Assets and Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Accounts Payable and Accrued Liabilities",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilities",
     "shortName": "Accounts Payable and Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Long-Term Debt",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.arvinas.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Equity",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.arvinas.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.arvinas.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Net Loss Per Share",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.arvinas.com/role/NetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Equity Method Investments",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.arvinas.com/role/EquityMethodInvestments",
     "shortName": "Equity Method Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.arvinas.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets (unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "shortName": "Pay vs Performance Disclosure",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "shortName": "Insider Trading Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954701 - Disclosure - Accounting Pronouncements and Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "22",
     "role": "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesPolicies",
     "shortName": "Accounting Pronouncements and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954702 - Disclosure - Accounting Pronouncements and Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesTables",
     "shortName": "Accounting Pronouncements and Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954703 - Disclosure - Research Collaboration and License Agreements (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTables",
     "shortName": "Research Collaboration and License Agreements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954704 - Disclosure - Marketable Securities and Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsTables",
     "shortName": "Marketable Securities and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954705 - Disclosure - Property, Equipment and Leasehold Improvements (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsTables",
     "shortName": "Property, Equipment and Leasehold Improvements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954706 - Disclosure - Right-of-Use Assets and Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesTables",
     "shortName": "Right-of-Use Assets and Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954707 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesTables",
     "shortName": "Accounts Payable and Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954708 - Disclosure - Long-Term Debt (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.arvinas.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954709 - Disclosure - Equity (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.arvinas.com/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954710 - Disclosure - Net Loss Per Share (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.arvinas.com/role/NetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954711 - Disclosure - Equity Method Investments (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.arvinas.com/role/EquityMethodInvestmentsTables",
     "shortName": "Equity Method Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "arvn:CashCashEquivalentsRestrictedCashAndMarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954712 - Disclosure - Nature of Business and Basis of Presentation (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.arvinas.com/role/NatureofBusinessandBasisofPresentationDetails",
     "shortName": "Nature of Business and Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "arvn:CashCashEquivalentsRestrictedCashAndMarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954713 - Disclosure - Accounting Pronouncements and Significant Accounting Policies - Cash Reconciliation (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails",
     "shortName": "Accounting Pronouncements and Significant Accounting Policies - Cash Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-33",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954714 - Disclosure - Research Collaboration and License Agreements - Additional Information (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails",
     "shortName": "Research Collaboration and License Agreements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954715 - Disclosure - Research Collaboration and License Agreements - Summary of Contract Balances (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails",
     "shortName": "Research Collaboration and License Agreements - Summary of Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-46",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954716 - Disclosure - Research Collaboration and License Agreements - Transaction Price Allocated to Performance Obligations (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails",
     "shortName": "Research Collaboration and License Agreements - Transaction Price Allocated to Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-87",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954717 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Available-for-Sale Marketable Securities (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails",
     "shortName": "Marketable Securities and Fair Value Measurements - Summary of Available-for-Sale Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-87",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954718 - Disclosure - Property, Equipment and Leasehold Improvements - Schedule of Property, Equipment and Leasehold Improvements (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails",
     "shortName": "Property, Equipment and Leasehold Improvements - Schedule of Property, Equipment and Leasehold Improvements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954719 - Disclosure - Property, Equipment and Leasehold Improvements - Additional Information (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsAdditionalInformationDetails",
     "shortName": "Property, Equipment and Leasehold Improvements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-99",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LandSubjectToGroundLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "sqft",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954720 - Disclosure - Right-of-Use Assets and Liabilities - Additional Information (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails",
     "shortName": "Right-of-Use Assets and Liabilities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-99",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LandSubjectToGroundLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "sqft",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954721 - Disclosure - Right-of-Use Assets and Liabilities - Components of Lease Expense (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesComponentsofLeaseExpenseDetails",
     "shortName": "Right-of-Use Assets and Liabilities - Components of Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "arvn:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954722 - Disclosure - Right-of-Use Assets and Liabilities - Schedule of Supplemental Cash Flow Information Related to Leases (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails",
     "shortName": "Right-of-Use Assets and Liabilities - Schedule of Supplemental Cash Flow Information Related to Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "arvn:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954723 - Disclosure - Right-of-Use Assets and Liabilities - Schedule of Maturities of Operating Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails",
     "shortName": "Right-of-Use Assets and Liabilities - Schedule of Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954724 - Disclosure - Accounts Payable and Accrued Liabilities (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails",
     "shortName": "Accounts Payable and Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954725 - Disclosure - Long-Term Debt - Schedule of Long Term Debt (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Long Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-105",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954726 - Disclosure - Long-Term Debt - Additional Information (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails",
     "shortName": "Long-Term Debt - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954727 - Disclosure - Long-Term Debt - Schedule of Minimum Future Payments on Long-Term Debt (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Minimum Future Payments on Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954728 - Disclosure - Equity - Additional Information (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
     "shortName": "Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-42",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited",
     "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-42",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-137",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954729 - Disclosure - Equity - Schedule of Assumptions Used to Determine Fair Value of and Stock Options Granted (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails",
     "shortName": "Equity - Schedule of Assumptions Used to Determine Fair Value of and Stock Options Granted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-137",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-147",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954730 - Disclosure - Equity - Summary of Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails",
     "shortName": "Equity - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-149",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-150",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954731 - Disclosure - Equity - Summary of Restricted Stock (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails",
     "shortName": "Equity - Summary of Restricted Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-150",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954732 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.arvinas.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954733 - Disclosure - Net Loss Per Share - Basic and Diluted Loss per Common Share (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.arvinas.com/role/NetLossPerShareBasicandDilutedLossperCommonShareDetails",
     "shortName": "Net Loss Per Share - Basic and Diluted Loss per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954734 - Disclosure - Net Loss Per Share - Securities Excluded From Computation of Diluted Net Loss Per Common Share (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails",
     "shortName": "Net Loss Per Share - Securities Excluded From Computation of Diluted Net Loss Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954735 - Disclosure - Equity Method Investments- Additional Information (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails",
     "shortName": "Equity Method Investments- Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-164",
      "decimals": "2",
      "lang": "en-US",
      "name": "arvn:FutureGrantOfIncentiveUnitsToServiceProvidersPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954736 - Disclosure - Equity Method Investments - Schedule of Correction of Immaterial Error for the Period (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails",
     "shortName": "Equity Method Investments - Schedule of Correction of Immaterial Error for the Period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-168",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954737 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.arvinas.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - Nature of Business and Basis of Presentation",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.arvinas.com/role/NatureofBusinessandBasisofPresentation",
     "shortName": "Nature of Business and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Accounting Pronouncements and Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPolicies",
     "shortName": "Accounting Pronouncements and Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Research Collaboration and License Agreements",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreements",
     "shortName": "Research Collaboration and License Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "arvn-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 52,
   "tag": {
    "arvn_AccountsPayableContractBalancesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Payable, Contract Balances, Current",
        "label": "Accounts Payable, Contract Balances, Current",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccountsPayableContractBalancesCurrent",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_AccountsPayableContractBalancesCurrentAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Payable, Contract Balances, Current Additions",
        "label": "Accounts Payable, Contract Balances, Current Additions",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AccountsPayableContractBalancesCurrentAdditions",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_AccountsPayableContractBalancesCurrentPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Payable, Contract Balances, Current Payments",
        "label": "Accounts Payable, Contract Balances, Current Payments",
        "negatedTerseLabel": "Payments made"
       }
      }
     },
     "localname": "AccountsPayableContractBalancesCurrentPayments",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, After Allowance For Credit Loss, Current, Additions",
        "label": "Accounts Receivable, After Allowance For Credit Loss, Current, Additions",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, After Allowance For Credit Loss, Current, Payments Received",
        "label": "Accounts Receivable, After Allowance For Credit Loss, Current, Payments Received",
        "negatedTerseLabel": "Payments received"
       }
      }
     },
     "localname": "AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_AccruedResearchAndDevelopmentExpenseCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expense current.",
        "label": "Accrued Research And Development Expense Current",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpenseCurrent",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional upfront non-refundable amount received under previous agreement.",
        "label": "Additional Upfront Non Refundable Amount Received Under Previous Agreement",
        "terseLabel": "Additional upfront non-refundable amount received under previous agreement"
       }
      }
     },
     "localname": "AdditionalUpfrontNonRefundableAmountReceivedUnderPreviousAgreement",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_AggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value",
        "label": "Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValueAbstract",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "arvn_AtTheMarketOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At the market offering.",
        "label": "At The Market Offering [Member]",
        "terseLabel": "At-the-Market Offering"
       }
      }
     },
     "localname": "AtTheMarketOfferingMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_BaseLeaseRentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Base lease rent period.",
        "label": "Base Lease Rent Period",
        "terseLabel": "Base rent lease term (in years)"
       }
      }
     },
     "localname": "BaseLeaseRentPeriod",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "arvn_BayerAGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bayer AG.",
        "label": "Bayer A G [Member]",
        "terseLabel": "Bayer Collaboration Agreement"
       }
      }
     },
     "localname": "BayerAGMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_BayerCropScienceLPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bayer CropScience LP.",
        "label": "Bayer Crop Science L P [Member]",
        "terseLabel": "Bayer LP"
       }
      }
     },
     "localname": "BayerCropScienceLPMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_CapitalizedContractCostAmortizationDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized Contract Cost, Amortization During Period",
        "label": "Capitalized Contract Cost, Amortization During Period",
        "negatedLabel": "Amortization"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationDuringPeriod",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_CashCashEquivalentsRestrictedCashAndMarketableSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Restricted Cash and Marketable Securities",
        "label": "Cash, Cash Equivalents, Restricted Cash and Marketable Securities",
        "terseLabel": "Cash, cash equivalents, restricted cash and marketable securities"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndMarketableSecurities",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/NatureofBusinessandBasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid for amounts included in the measurement of lease liabilities.",
        "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "arvn_ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Accounts Payable, after Allowance for Credit Loss",
        "label": "Change in Accounts Payable, after Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts payable related to collaborations"
       }
      }
     },
     "localname": "ChangeInAccountsPayableAfterAllowanceForCreditLossRollForward",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "arvn_ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Accounts Receivable, after Allowance for Credit Loss",
        "label": "Change in Accounts Receivable, after Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts receivable related to collaborations"
       }
      }
     },
     "localname": "ChangeInAccountsReceivableAfterAllowanceForCreditLossRollForward",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "arvn_ChangeInCollaborationContractAssetAndOtherAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Collaboration Contract Asset And Other Assets",
        "label": "Change in Collaboration Contract Asset And Other Assets [Roll Forward]",
        "terseLabel": "Contract assets: Collaboration contract asset"
       }
      }
     },
     "localname": "ChangeInCollaborationContractAssetAndOtherAssetsRollForward",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "arvn_ChangeInContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract with Customer, Liability",
        "label": "Change in Contract with Customer, Liability [Roll Forward]",
        "terseLabel": "Contract liabilities: Deferred revenue"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityRollForward",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "arvn_CollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration agreement.",
        "label": "Collaboration Agreement [Member]",
        "terseLabel": "Collaboration Agreement"
       }
      }
     },
     "localname": "CollaborationAgreementMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_CollaborationContractAssetAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration contract asset and other assets.",
        "label": "Collaboration Contract Asset And Other Assets",
        "terseLabel": "Collaboration contract asset and other assets"
       }
      }
     },
     "localname": "CollaborationContractAssetAndOtherAssets",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_CommercialMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial milestones.",
        "label": "Commercial Milestones [Member]",
        "terseLabel": "Commercial Milestones"
       }
      }
     },
     "localname": "CommercialMilestonesMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies [Line Items]",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "arvn_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "arvn_ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Assets, Increase (Decrease) For Additions To Collaboration Agreements",
        "label": "Contract With Customer, Assets, Increase (Decrease) For Additions To Collaboration Agreements",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "ContractWithCustomerAssetsIncreaseDecreaseForAdditionsToCollaborationAgreements",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Increase (Decrease) For Additions To Collaboration Agreements",
        "label": "Contract With Customer, Liability, Increase (Decrease) For Additions To Collaboration Agreements",
        "terseLabel": "Additions to collaboration agreements"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_DebtInstrumentInterestPaymentsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument interest payments term.",
        "label": "Debt Instrument Interest Payments Term",
        "terseLabel": "Debt instrument interest payments term (in months)"
       }
      }
     },
     "localname": "DebtInstrumentInterestPaymentsTerm",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "arvn_DebtInstrumentLoanForgiveness": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument loan forgiveness.",
        "label": "Debt Instrument Loan Forgiveness",
        "terseLabel": "Loan forgiveness"
       }
      }
     },
     "localname": "DebtInstrumentLoanForgiveness",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_DevelopmentMilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development milestone payments.",
        "label": "Development Milestone Payments [Member]",
        "terseLabel": "Development Milestone Payments"
       }
      }
     },
     "localname": "DevelopmentMilestonePaymentsMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_DirectAndIncrementalCostsIncurredToObtainTheContract": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Direct and incremental costs incurred to obtain the contract.",
        "label": "Direct And Incremental Costs Incurred To Obtain The Contract",
        "terseLabel": "Collaboration agreement direct and incremental costs incurred"
       }
      }
     },
     "localname": "DirectAndIncrementalCostsIncurredToObtainTheContract",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees.",
        "label": "Employees [Member]",
        "terseLabel": "Employees"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_EquityDistributionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity distribution agreement.",
        "label": "Equity Distribution Agreement [Member]",
        "terseLabel": "Equity Distribution Agreement"
       }
      }
     },
     "localname": "EquityDistributionAgreementMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_FoundationMedicineIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foundation Medicine, Inc.",
        "label": "Foundation Medicine, Inc. [Member]",
        "terseLabel": "Foundation Medicine, Inc."
       }
      }
     },
     "localname": "FoundationMedicineIncMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_FutureGrantOfIncentiveUnitsToServiceProvidersPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future grant of incentive units to service providers, percentage.",
        "label": "Future Grant Of Incentive Units To Service Providers Percentage",
        "terseLabel": "Future grant of incentive units to service providers percentage"
       }
      }
     },
     "localname": "FutureGrantOfIncentiveUnitsToServiceProvidersPercentage",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "arvn_GenentechIncorporationAndFHoffmanLaRocheLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Genentech, Incorporation. and F. Hoffman-La Roche Limited.",
        "label": "Genentech Incorporation And F Hoffman La Roche Limited [Member]",
        "terseLabel": "Genentech, Inc. and F. Hoffman-La Roche Ltd."
       }
      }
     },
     "localname": "GenentechIncorporationAndFHoffmanLaRocheLimitedMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_IncomeStatementAndStatementOfComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Statement And Statement Of Comprehensive Income",
        "label": "Income Statement And Statement Of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAndStatementOfComprehensiveIncomeAbstract",
     "nsuri": "http://www.arvinas.com/20230630",
     "xbrltype": "stringItemType"
    },
    "arvn_IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in capital shares reserved for future issuance represented as percentage on outstanding common stock.",
        "label": "Increase In Capital Shares Reserved For Future Issuance Represented As Percentage On Outstanding Common Stock",
        "terseLabel": "Common stock reserved for issuance represented as percentage on outstanding common stock"
       }
      }
     },
     "localname": "IncreaseInCapitalSharesReservedForFutureIssuanceRepresentedAsPercentageOnOutstandingCommonStock",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "arvn_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment.",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_LongTermDebtMaturityYearSix": {
     "auth_ref": [],
     "calculation": {
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, Year Six",
        "label": "Long-Term Debt, Maturity, Year Six",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "LongTermDebtMaturityYearSix",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_MaximumAggregateOfferingPriceOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum aggregate offering price of common stock.",
        "label": "Maximum Aggregate Offering Price Of Common Stock",
        "terseLabel": "Common stock aggregate offering price"
       }
      }
     },
     "localname": "MaximumAggregateOfferingPriceOfCommonStock",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_OerthBioLimitedLiabilityCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oerth Bio LLC.",
        "label": "Oerth Bio Limited Liability Corporation [Member]",
        "terseLabel": "Oerth"
       }
      }
     },
     "localname": "OerthBioLimitedLiabilityCorporationMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_OptionPaymentsToLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option payments to license agreement.",
        "label": "Option Payments To License Agreement [Member]",
        "terseLabel": "Option Payments To License Agreement"
       }
      }
     },
     "localname": "OptionPaymentsToLicenseAgreementMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_PercentageOfIncrementalBorrowingForLeasePayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of incremental borrowing for lease payments.",
        "label": "Percentage Of Incremental Borrowing For Lease Payments",
        "terseLabel": "Percentage of incremental borrowing for lease payments"
       }
      }
     },
     "localname": "PercentageOfIncrementalBorrowingForLeasePayments",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "arvn_PercentageOfLiquidatedDamages": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of liquidated damages.",
        "label": "Percentage Of Liquidated Damages",
        "terseLabel": "Percentage of liquidated damages"
       }
      }
     },
     "localname": "PercentageOfLiquidatedDamages",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "arvn_PfizerIncorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfizer, Incorporation.",
        "label": "Pfizer Incorporation [Member]",
        "terseLabel": "Pfizer, Inc."
       }
      }
     },
     "localname": "PfizerIncorporationMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_PiperSandlerAndCantorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Piper sandler and cantor.",
        "label": "Piper Sandler And Cantor [Member]",
        "terseLabel": "Piper Sandler and Cantor"
       }
      }
     },
     "localname": "PiperSandlerAndCantorMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares": {
     "auth_ref": [],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Exercise Of Stock Options And Issuance Of Employee Stock Shares",
        "label": "Proceeds From Exercise Of Stock Options And Issuance Of Employee Stock Shares",
        "terseLabel": "Proceeds from exercise of stock options and issuance of ESPP shares"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfStockOptionsAndIssuanceOfEmployeeStockShares",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_ProceedsFromMaturitiesOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from maturities of marketable securities.",
        "label": "Proceeds From Maturities Of Marketable Securities",
        "terseLabel": "Maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesOfMarketableSecurities",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_ProceedsFromSaleOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of marketable securities.",
        "label": "Proceeds From Sale Of Marketable Securities",
        "terseLabel": "Sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfMarketableSecurities",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "arvn_RegulatoryAndSalesBasedMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory and sales-based milestones.",
        "label": "Regulatory And Sales Based Milestones [Member]",
        "terseLabel": "Regulatory and Sales-Based Milestones"
       }
      }
     },
     "localname": "RegulatoryAndSalesBasedMilestonesMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_RegulatoryMilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory milestone payments.",
        "label": "Regulatory Milestone Payments [Member]",
        "terseLabel": "Regulatory Milestone Related to Marketing Approvals"
       }
      }
     },
     "localname": "RegulatoryMilestonePaymentsMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_ResearchCollaborationAndLicenseAgreementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research Collaboration And License Agreements",
        "label": "Research Collaboration And License Agreements [Abstract]"
       }
      }
     },
     "localname": "ResearchCollaborationAndLicenseAgreementsAbstract",
     "nsuri": "http://www.arvinas.com/20230630",
     "xbrltype": "stringItemType"
    },
    "arvn_ResearchCollaborationAndLicenseAgreementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research collaboration and license agreements.",
        "label": "Research Collaboration And License Agreements [Line Items]",
        "terseLabel": "Research Collaboration And License Agreements [Line Items]"
       }
      }
     },
     "localname": "ResearchCollaborationAndLicenseAgreementsLineItems",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "arvn_ResearchCollaborationAndLicenseAgreementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research collaboration and license agreements.",
        "label": "Research Collaboration And License Agreements [Table]",
        "terseLabel": "Research Collaboration And License Agreements [Table]"
       }
      }
     },
     "localname": "ResearchCollaborationAndLicenseAgreementsTable",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "arvn_ResearchFundingPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research funding payments.",
        "label": "Research Funding Payments [Member]",
        "terseLabel": "Research Funding Payments"
       }
      }
     },
     "localname": "ResearchFundingPaymentsMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_SalesBasedMilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-based milestone payments.",
        "label": "Sales Based Milestone Payments [Member]",
        "terseLabel": "Sales Based Milestone Payments"
       }
      }
     },
     "localname": "SalesBasedMilestonePaymentsMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_SalesBasedMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-based milestones.",
        "label": "Sales Based Milestones [Member]",
        "terseLabel": "Sales-Based Milestones"
       }
      }
     },
     "localname": "SalesBasedMilestonesMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental cash flow information related to leases.",
        "label": "Schedule Of Supplemental Cash Flow Information Related To Leases [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Cash Flow Information Related to Leases"
       }
      }
     },
     "localname": "ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "arvn_StockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock incentive plan.",
        "label": "Stock Incentive Plan [Member]",
        "terseLabel": "Incentive Plan"
       }
      }
     },
     "localname": "StockIncentivePlanMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_SuccessBasedMilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Success-Based Milestone Payments",
        "label": "Success-Based Milestone Payments [Member]",
        "terseLabel": "Success-Based Milestone Payments"
       }
      }
     },
     "localname": "SuccessBasedMilestonePaymentsMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_SupplementalNonCashInformationRelatedToLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental non-cash information related to leases.",
        "label": "Supplemental Non Cash Information Related To Leases [Abstract]",
        "terseLabel": "Supplemental non-cash information:"
       }
      }
     },
     "localname": "SupplementalNonCashInformationRelatedToLeasesAbstract",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "arvn_TwoThousandAndEighteenAssistanceAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and eighteen assistance agreement.",
        "label": "Two Thousand And Eighteen Assistance Agreement [Member]",
        "terseLabel": "2018 Assistance Agreement"
       }
      }
     },
     "localname": "TwoThousandAndEighteenAssistanceAgreementMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_TwoThousandAndFourteenAssistanceAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and fourteen assistance agreement.",
        "label": "Two Thousand And Fourteen Assistance Agreement [Member]",
        "terseLabel": "2014 Assistance Agreement"
       }
      }
     },
     "localname": "TwoThousandAndFourteenAssistanceAgreementMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "arvn_TwoThousandEighteenStockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand eighteen stock incentive plan.",
        "label": "Two Thousand Eighteen Stock Incentive Plan [Member]",
        "terseLabel": "2018 Plan",
        "verboseLabel": "2018 Plan"
       }
      }
     },
     "localname": "TwoThousandEighteenStockIncentivePlanMember",
     "nsuri": "http://www.arvinas.com/20230630",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails",
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.arvinas.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "localname": "Additional402vDisclosureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToCompAmt": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "localname": "AdjToCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AdjToCompAxis": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "localname": "AdjToCompAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "localname": "AdjToPeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AggtErrCompAmt": {
     "auth_ref": [
      "r620",
      "r631",
      "r641",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "AggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "auth_ref": [
      "r623",
      "r634",
      "r644",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AllAdjToCompMember": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "localname": "AllAdjToCompMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllExecutiveCategoriesMember": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "localname": "AllExecutiveCategoriesMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllIndividualsMember": {
     "auth_ref": [
      "r627",
      "r635",
      "r645",
      "r662",
      "r670",
      "r674",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "localname": "AllIndividualsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllTradingArrangementsMember": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "localname": "AllTradingArrangementsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AwardExrcPrice": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "localname": "AwardExrcPrice",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "perShareItemType"
    },
    "ecd_AwardGrantDateFairValue": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "localname": "AwardGrantDateFairValue",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AwardTmgDiscLineItems": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "localname": "AwardTmgDiscLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgMethodTextBlock": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "localname": "AwardTmgMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "localname": "AwardTmgMnpiDiscTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "localname": "AwardTmgPredtrmndFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "localname": "AwardUndrlygSecuritiesAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "localname": "ChangedPeerGroupFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CoSelectedMeasureAmt": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "localname": "CoSelectedMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_CoSelectedMeasureName": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "localname": "CoSelectedMeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "auth_ref": [
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "auth_ref": [
      "r620",
      "r631",
      "r641",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "localname": "ErrCompAnalysisTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompRecoveryTable": {
     "auth_ref": [
      "r617",
      "r628",
      "r638",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "localname": "ErrCompRecoveryTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ExecutiveCategoryAxis": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "localname": "ExecutiveCategoryAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "auth_ref": [
      "r624",
      "r635",
      "r645",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "auth_ref": [
      "r624",
      "r635",
      "r645",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "auth_ref": [
      "r624",
      "r635",
      "r645",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "auth_ref": [
      "r624",
      "r635",
      "r645",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ForgoneRecoveryIndName": {
     "auth_ref": [
      "r624",
      "r635",
      "r645",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "ForgoneRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_IndividualAxis": {
     "auth_ref": [
      "r627",
      "r635",
      "r645",
      "r662",
      "r670",
      "r674",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "localname": "IndividualAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTradingArrLineItems": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "localname": "InsiderTradingArrLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "auth_ref": [
      "r616",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "localname": "InsiderTradingPoliciesProcLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "auth_ref": [
      "r616",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "auth_ref": [
      "r616",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_MeasureAxis": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "localname": "MeasureAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureName": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "MeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "localname": "MnpiDiscTimedForCompValFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonNeosMember": {
     "auth_ref": [
      "r624",
      "r635",
      "r645",
      "r662",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "localname": "NonNeosMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoMember": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "localname": "NonPeoNeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "NonRule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "NonRule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_OtherPerfMeasureAmt": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "localname": "OtherPerfMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "auth_ref": [
      "r622",
      "r633",
      "r643",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "OutstandingAggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "auth_ref": [
      "r625",
      "r636",
      "r646",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "localname": "OutstandingRecoveryCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryIndName": {
     "auth_ref": [
      "r625",
      "r636",
      "r646",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "OutstandingRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "localname": "PayVsPerformanceDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "localname": "PeerGroupIssuersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "localname": "PeoActuallyPaidCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoMember": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "localname": "PeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_PeoName": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "localname": "PeoName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_PeoTotalCompAmt": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "localname": "PeoTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PvpTable": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "localname": "PvpTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PvpTableTextBlock": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "localname": "PvpTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "auth_ref": [
      "r617",
      "r628",
      "r638",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDateAxis": {
     "auth_ref": [
      "r618",
      "r629",
      "r639",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "localname": "RestatementDateAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDeterminationDate": {
     "auth_ref": [
      "r619",
      "r630",
      "r640",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "localname": "RestatementDeterminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "dateItemType"
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "auth_ref": [
      "r626",
      "r637",
      "r647",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "Rule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "Rule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "auth_ref": [
      "r621",
      "r632",
      "r642",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TabularListTableTextBlock": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "localname": "TabularListTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TotalShareholderRtnAmt": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "localname": "TotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TradingArrAxis": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "localname": "TradingArrAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TradingArrByIndTable": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "localname": "TradingArrByIndTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrAdoptionDate": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "localname": "TrdArrAdoptionDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrDuration": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "localname": "TrdArrDuration",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "durationItemType"
    },
    "ecd_TrdArrIndName": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "localname": "TrdArrIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrIndTitle": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "localname": "TrdArrIndTitle",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "sharesItemType"
    },
    "ecd_TrdArrTerminationDate": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "localname": "TrdArrTerminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "localname": "UndrlygSecurityMktPriceChngPct",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "pureItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r150",
      "r151",
      "r276",
      "r300",
      "r419",
      "r575",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails",
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails",
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [
      "r236",
      "r237",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r262",
      "r315",
      "r452",
      "r477",
      "r498",
      "r499",
      "r550",
      "r552",
      "r554",
      "r555",
      "r557",
      "r571",
      "r572",
      "r581",
      "r588",
      "r594",
      "r601",
      "r752",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails",
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails",
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r262",
      "r315",
      "r452",
      "r477",
      "r498",
      "r499",
      "r550",
      "r552",
      "r554",
      "r555",
      "r557",
      "r571",
      "r572",
      "r581",
      "r588",
      "r594",
      "r601",
      "r752",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails",
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r262",
      "r308",
      "r315",
      "r344",
      "r345",
      "r346",
      "r427",
      "r452",
      "r477",
      "r498",
      "r499",
      "r550",
      "r552",
      "r554",
      "r555",
      "r557",
      "r571",
      "r572",
      "r581",
      "r588",
      "r594",
      "r601",
      "r604",
      "r748",
      "r752",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails",
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails",
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r262",
      "r308",
      "r315",
      "r344",
      "r345",
      "r346",
      "r427",
      "r452",
      "r477",
      "r498",
      "r499",
      "r550",
      "r552",
      "r554",
      "r555",
      "r557",
      "r571",
      "r572",
      "r581",
      "r588",
      "r594",
      "r601",
      "r604",
      "r748",
      "r752",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails",
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails",
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r150",
      "r151",
      "r276",
      "r300",
      "r419",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails",
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails",
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r121",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r180",
      "r243",
      "r244",
      "r365",
      "r384",
      "r385",
      "r386",
      "r387",
      "r405",
      "r417",
      "r418",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r121",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r180",
      "r243",
      "r244",
      "r365",
      "r384",
      "r385",
      "r386",
      "r387",
      "r405",
      "r417",
      "r418",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r164",
      "r165",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Error Correction, Adjustment [Member]",
        "terseLabel": "adjustments"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r316",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Scenario Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r121",
      "r153",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r167",
      "r180",
      "r365",
      "r384",
      "r385",
      "r386",
      "r405",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r693",
      "r695",
      "r696",
      "r697",
      "r723",
      "r746",
      "r747",
      "r783",
      "r788",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "as previously reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r168",
      "r316",
      "r689",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r236",
      "r237",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r199",
      "r200",
      "r495",
      "r496",
      "r497",
      "r551",
      "r553",
      "r556",
      "r558",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r573",
      "r590",
      "r604",
      "r754",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r199",
      "r200",
      "r495",
      "r496",
      "r497",
      "r551",
      "r553",
      "r556",
      "r558",
      "r560",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r573",
      "r590",
      "r604",
      "r754",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r168",
      "r316",
      "r689",
      "r690",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r726",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONNECTICUT",
        "terseLabel": "State of Connecticut"
       }
      }
     },
     "localname": "CT",
     "nsuri": "http://xbrl.sec.gov/stpr/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities",
        "totalLabel": "Total accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails",
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r15",
      "r599"
     ],
     "calculation": {
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r202",
      "r203"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Net accretion of bond discounts/premiums"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r62",
      "r97"
     ],
     "calculation": {
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional fees and other"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r44",
      "r127",
      "r468"
     ],
     "calculation": {
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r26",
      "r27",
      "r70",
      "r131",
      "r465",
      "r483",
      "r487"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r1",
      "r8",
      "r27",
      "r378",
      "r381",
      "r418",
      "r478",
      "r479",
      "r709",
      "r710",
      "r711",
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r65",
      "r599",
      "r806"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r493",
      "r720",
      "r721",
      "r722",
      "r782",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r50",
      "r51",
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r348",
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of diluted net loss per common share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails",
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetPledgedAsCollateralMember": {
     "auth_ref": [
      "r373",
      "r501",
      "r597",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset pledged as collateral.",
        "label": "Asset Pledged as Collateral [Member]",
        "terseLabel": "Asset Pledged as Collateral"
       }
      }
     },
     "localname": "AssetPledgedAsCollateralMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r95",
      "r128",
      "r148",
      "r182",
      "r192",
      "r196",
      "r240",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r373",
      "r375",
      "r395",
      "r462",
      "r521",
      "r599",
      "r611",
      "r750",
      "r751",
      "r791"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r123",
      "r132",
      "r148",
      "r240",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r373",
      "r375",
      "r395",
      "r599",
      "r750",
      "r751",
      "r791"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r209"
     ],
     "calculation": {
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r206",
      "r251",
      "r461"
     ],
     "calculation": {
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r207",
      "r251",
      "r455",
      "r727"
     ],
     "calculation": {
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails",
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r60",
      "r81",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Nature of Business and Basis of Presentation"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/NatureofBusinessandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r33",
      "r34",
      "r35"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property, equipment and leasehold improvements unpaid at period end"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r255"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Amortization of collaboration contract asset"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r30",
      "r125",
      "r574"
     ],
     "calculation": {
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails",
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r31",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r30",
      "r78",
      "r145"
     ],
     "calculation": {
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of the period",
        "totalLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails",
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r0",
      "r78"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r105",
      "r107",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Research Collaboration and License Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r23",
      "r56",
      "r463",
      "r508"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r86",
      "r256",
      "r257",
      "r561",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock reserved for issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r602",
      "r603",
      "r604",
      "r606",
      "r607",
      "r608",
      "r609",
      "r720",
      "r721",
      "r782",
      "r805",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited",
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r9",
      "r64",
      "r509",
      "r527",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r64",
      "r464",
      "r599"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value; 53.4 and 53.2 shares issued and outstanding as of June\u00a030, 2023 and December\u00a031, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r28",
      "r134",
      "r136",
      "r142",
      "r456",
      "r473"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Comprehensive loss",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r58",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Contract Balances"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r303",
      "r305",
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Contract revenue receivable if milestones achieved"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r303",
      "r304",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Contract with customer, liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails",
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract": {
     "auth_ref": [
      "r589"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from contract modification which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Modification of Contract",
        "terseLabel": "Revenue adjustments arising from contract modifications"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r303",
      "r304",
      "r306"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r303",
      "r304",
      "r306"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized from balances held at the beginning of the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsSummaryofContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r87",
      "r147",
      "r272",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r288",
      "r295",
      "r296",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r14",
      "r61",
      "r62",
      "r96",
      "r98",
      "r152",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r279",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r404",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r53",
      "r55",
      "r273",
      "r404",
      "r584",
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r21",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument bearing interest rate",
        "verboseLabel": "Interest Rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [
      "r152",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r279",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r297",
      "r404",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r22",
      "r152",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r279",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r404",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r22",
      "r45",
      "r46",
      "r52",
      "r53",
      "r55",
      "r57",
      "r88",
      "r89",
      "r152",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r279",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r297",
      "r404",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecurities": {
     "auth_ref": [
      "r204",
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities",
        "terseLabel": "Letter of credit for collateralized by certificate of deposit"
       }
      }
     },
     "localname": "DebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleGainLoss": {
     "auth_ref": [
      "r712",
      "r713"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Gain (Loss)",
        "negatedTerseLabel": "Loss on sale of marketable securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Marketable Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r4",
      "r43"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r317",
      "r321",
      "r349",
      "r350",
      "r352",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r143",
      "r158",
      "r159",
      "r161",
      "r162",
      "r164",
      "r170",
      "r172",
      "r174",
      "r175",
      "r176",
      "r180",
      "r386",
      "r387",
      "r457",
      "r474",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per common share, basic (in dollars per share)",
        "verboseLabel": "Net loss per common share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails",
      "http://www.arvinas.com/role/NetLossPerShareBasicandDilutedLossperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r143",
      "r158",
      "r159",
      "r161",
      "r162",
      "r164",
      "r172",
      "r174",
      "r175",
      "r176",
      "r180",
      "r386",
      "r387",
      "r457",
      "r474",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per common share, diluted (in dollars per share)",
        "verboseLabel": "Net loss per common share - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails",
      "http://www.arvinas.com/role/NetLossPerShareBasicandDilutedLossperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r169",
      "r177",
      "r178",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/NetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "negatedTerseLabel": "Effective tax rate, percentage"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r149",
      "r360",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal statutory rate, percentage"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation expense not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation expense not yet recognized, period of recognition (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "2018 ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails",
      "http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r9",
      "r120",
      "r137",
      "r138",
      "r139",
      "r153",
      "r154",
      "r155",
      "r157",
      "r165",
      "r167",
      "r181",
      "r242",
      "r245",
      "r302",
      "r353",
      "r354",
      "r355",
      "r364",
      "r365",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r385",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r418",
      "r478",
      "r479",
      "r480",
      "r493",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited",
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest in joint venture (percentage)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r189",
      "r235",
      "r706",
      "r744"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r238",
      "r241",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r164",
      "r165",
      "r166",
      "r167",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [
      "r389",
      "r390",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r389",
      "r390",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r286",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r390",
      "r424",
      "r425",
      "r426",
      "r584",
      "r585",
      "r591",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r389",
      "r390",
      "r391",
      "r392",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Marketable Securities and Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r286",
      "r309",
      "r314",
      "r390",
      "r425",
      "r584",
      "r585",
      "r591",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r286",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r424",
      "r425",
      "r426",
      "r584",
      "r585",
      "r591",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r388",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r253",
      "r254",
      "r297",
      "r301",
      "r383",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r472",
      "r582",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r740",
      "r741",
      "r742",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r73",
      "r531"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r318",
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [
      "r318",
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r182",
      "r191",
      "r195",
      "r197",
      "r475",
      "r580"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Net loss before income taxes and loss from equity method investment"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r4",
      "r71",
      "r100",
      "r187",
      "r235",
      "r470"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Loss from equity method investment",
        "terseLabel": "Loss from equity method investment"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r149",
      "r358",
      "r361",
      "r362",
      "r363",
      "r366",
      "r369",
      "r370",
      "r371",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r103",
      "r117",
      "r166",
      "r167",
      "r188",
      "r359",
      "r367",
      "r476"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax benefit (expense)",
        "terseLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.arvinas.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r453",
      "r714"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r694",
      "r714"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r54",
      "r102",
      "r140",
      "r186",
      "r403",
      "r532",
      "r610",
      "r807"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r74",
      "r185"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income, net"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandSubjectToGroundLeases": {
     "auth_ref": [
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of land subject to a ground lease.",
        "label": "Land Subject to Ground Leases",
        "terseLabel": "Lease for laboratory and office space"
       }
      }
     },
     "localname": "LandSubjectToGroundLeases",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r411",
      "r598"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Base rent"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Components of Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee Lease Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee Lease Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r787"
     ],
     "calculation": {
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Right-of-Use Assets and Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r18",
      "r148",
      "r240",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r374",
      "r375",
      "r376",
      "r395",
      "r507",
      "r579",
      "r611",
      "r750",
      "r791",
      "r792"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r69",
      "r99",
      "r467",
      "r599",
      "r718",
      "r745",
      "r784"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r20",
      "r124",
      "r148",
      "r240",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r374",
      "r375",
      "r376",
      "r395",
      "r599",
      "r750",
      "r791",
      "r792"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r14",
      "r98",
      "r285",
      "r299",
      "r584",
      "r585",
      "r802"
     ],
     "calculation": {
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.",
        "label": "Long-Term Debt, Current Maturities",
        "negatedLabel": "Less: current installments",
        "terseLabel": "Current portion of long term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r6",
      "r152",
      "r290"
     ],
     "calculation": {
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r6",
      "r152",
      "r290"
     ],
     "calculation": {
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r6",
      "r152",
      "r290"
     ],
     "calculation": {
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r6",
      "r152",
      "r290"
     ],
     "calculation": {
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r6",
      "r152",
      "r290"
     ],
     "calculation": {
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtScheduleofMinimumFuturePaymentsonLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Total long-term debt",
        "verboseLabel": "Long term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.arvinas.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r258",
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss contingency"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r707"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r78",
      "r79",
      "r80"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r72",
      "r80",
      "r101",
      "r122",
      "r133",
      "r135",
      "r139",
      "r148",
      "r156",
      "r158",
      "r159",
      "r161",
      "r162",
      "r166",
      "r167",
      "r173",
      "r182",
      "r191",
      "r195",
      "r197",
      "r240",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r387",
      "r395",
      "r471",
      "r529",
      "r545",
      "r546",
      "r580",
      "r610",
      "r750"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss)",
        "negatedLabel": "Net loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited",
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails",
      "http://www.arvinas.com/role/NetLossPerShareBasicandDilutedLossperCommonShareDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Grant Activity"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office equipment"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r182",
      "r191",
      "r195",
      "r197",
      "r580"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Loss from operations",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r412",
      "r598"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r408"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r409",
      "r413"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right of use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r715"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r415",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating lease, weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r2",
      "r7",
      "r93"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized gain (loss) on available-for-sale securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited",
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expenses)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r728"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, equipment and leasehold improvements"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails",
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails",
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PledgedStatusAxis": {
     "auth_ref": [
      "r373",
      "r501",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by pledged or not pledged status of asset owned by entity.",
        "label": "Pledged Status [Axis]",
        "terseLabel": "Pledged Status [Axis]"
       }
      }
     },
     "localname": "PledgedStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PledgedStatusDomain": {
     "auth_ref": [
      "r373",
      "r501",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pledged or not pledged status of asset owned by entity.",
        "label": "Pledged Status [Domain]",
        "terseLabel": "Pledged Status [Domain]"
       }
      }
     },
     "localname": "PledgedStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PledgingPurposeAxis": {
     "auth_ref": [
      "r435",
      "r597",
      "r600",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by pledging purpose of pledged asset owned.",
        "label": "Pledging Purpose [Axis]",
        "terseLabel": "Pledging Purpose [Axis]"
       }
      }
     },
     "localname": "PledgingPurposeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PledgingPurposeDomain": {
     "auth_ref": [
      "r435",
      "r597",
      "r600",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pledging purpose of pledged asset owned.",
        "label": "Pledging Purpose [Domain]",
        "terseLabel": "Pledging Purpose [Domain]"
       }
      }
     },
     "localname": "PledgingPurposeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r708"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollaborators": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from collaborators during the current period.",
        "label": "Proceeds from Collaborators",
        "terseLabel": "Payments received"
       }
      }
     },
     "localname": "ProceedsFromCollaborators",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r84",
      "r110",
      "r115",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Equipment and Leasehold Improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r85",
      "r126",
      "r469"
     ],
     "calculation": {
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property, equipment and leasehold improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r5",
      "r459",
      "r469",
      "r599"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, equipment and leasehold improvements, net",
        "totalLabel": "Property, equipment and leasehold improvements, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Equipment and Leasehold Improvements"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r59",
      "r357",
      "r800"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r705",
      "r716"
     ],
     "calculation": {
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesCashReconciliationDetails",
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails",
      "http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r66",
      "r90",
      "r466",
      "r482",
      "r487",
      "r491",
      "r510",
      "r599"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r120",
      "r153",
      "r154",
      "r155",
      "r157",
      "r165",
      "r167",
      "r242",
      "r245",
      "r353",
      "r354",
      "r355",
      "r364",
      "r365",
      "r377",
      "r379",
      "r380",
      "r382",
      "r385",
      "r478",
      "r480",
      "r493",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer": {
     "auth_ref": [
      "r104",
      "r781"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.",
        "label": "Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer",
        "terseLabel": "Milestone payments (up to low)"
       }
      }
     },
     "localname": "RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTransactionPriceAllocatedtoPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "auth_ref": [
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]",
        "terseLabel": "Schedule of Transaction Price Allocated to Performance Obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r141",
      "r148",
      "r183",
      "r184",
      "r190",
      "r193",
      "r194",
      "r198",
      "r199",
      "r201",
      "r240",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r395",
      "r458",
      "r750"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r414",
      "r598"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for new lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/RightofUseAssetsandLiabilitiesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Components of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountsPayableandAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/NetLossPerShareSecuritiesExcludedFromComputationofDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Securities Excluded From Computation of Diluted Net Loss Per Common Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r22",
      "r45",
      "r46",
      "r52",
      "r53",
      "r55",
      "r57",
      "r88",
      "r89",
      "r584",
      "r586",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Basic and Diluted Loss per Common Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [
      "r148",
      "r236",
      "r237",
      "r239",
      "r240",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule Of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r122",
      "r148",
      "r236",
      "r237",
      "r239",
      "r240",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule Of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r164",
      "r165",
      "r166",
      "r167",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.",
        "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]",
        "terseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsScheduleofCorrectionofImmaterialErrorforthePeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "auth_ref": [
      "r36",
      "r37",
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.",
        "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]",
        "terseLabel": "Schedule of Correction of the Immaterial Error for the Period"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityMethodInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Minimum Future Payments on Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r12",
      "r94",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Restrictions on Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r318",
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails",
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails",
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r10",
      "r11",
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used to Determine Fair Value of Stock Options Granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "verboseLabel": "Share-based award, vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "verboseLabel": "Weighted Average Grant Date Fair Value Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of RSUs vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [
      "r318",
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails",
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails",
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Incentive units authorized for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Common stock, shares remained available for purchase (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Vested and exercisable, ending balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Vested and exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value of options (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod": {
     "auth_ref": [
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The addition or reduction in the number of reserved shares that could potentially be issued under the option plan attributable to reasons other than grants, exercises, forfeitures, and expirations during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Other Increases (Decreases) in Period",
        "terseLabel": "Annual increase in reserved shares of common stock (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum",
        "terseLabel": "Annual increase in reserved shares as percentage of outstanding common stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails",
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "verboseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-Based Payment Arrangement, Employee [Member]",
        "terseLabel": "Employees"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/EquitySummaryofRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityScheduleofAssumptionsUsedtoDetermineFairValueofandStockOptionsGrantedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Vested and exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and exercisable (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "verboseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest (in Years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r81",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Accounting Pronouncements and Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r9",
      "r25",
      "r120",
      "r137",
      "r138",
      "r139",
      "r153",
      "r154",
      "r155",
      "r157",
      "r165",
      "r167",
      "r181",
      "r242",
      "r245",
      "r302",
      "r353",
      "r354",
      "r355",
      "r364",
      "r365",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r385",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r418",
      "r478",
      "r479",
      "r480",
      "r493",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited",
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r181",
      "r454",
      "r489",
      "r494",
      "r500",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r509",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r528",
      "r530",
      "r531",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r547",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r181",
      "r454",
      "r489",
      "r494",
      "r500",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r509",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r528",
      "r530",
      "r531",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r547",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r9",
      "r63",
      "r64",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r9",
      "r63",
      "r64",
      "r90",
      "r490",
      "r547",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Shares issued and sold (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r9",
      "r63",
      "r64",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under equity incentive plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r9",
      "r63",
      "r64",
      "r90",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquitySummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r49",
      "r63",
      "r64",
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under equity incentive plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r64",
      "r67",
      "r68",
      "r83",
      "r511",
      "r527",
      "r548",
      "r549",
      "r599",
      "r611",
      "r718",
      "r745",
      "r784",
      "r808"
     ],
     "calculation": {
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.",
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r402",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r402",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r402",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r297",
      "r301",
      "r383",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r472",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r740",
      "r741",
      "r742",
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CommitmentsandContingenciesDetails",
      "http://www.arvinas.com/role/EquityAdditionalInformationDetails",
      "http://www.arvinas.com/role/ResearchCollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by the United States government.",
        "label": "US Government Debt Securities [Member]",
        "terseLabel": "Government securities"
       }
      }
     },
     "localname": "USGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r106",
      "r108",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/AccountingPronouncementsandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r171",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average common shares outstanding, diluted (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.arvinas.com/role/NetLossPerShareBasicandDilutedLossperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r170",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding, basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.arvinas.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.arvinas.com/role/NetLossPerShareBasicandDilutedLossperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479428/808-10-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org//323/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org//808/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org//260/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(4)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org//718/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org//740/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iv)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//842-20/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(11))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(15))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r612": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r613": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r614": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r615": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r616": {
   "Name": "Form 20-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "16",
   "Subsection": "J",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r617": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r618": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r619": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r621": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r622": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r623": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r624": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r625": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "iii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r626": {
   "Name": "Form 20-F",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r627": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r628": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r629": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r631": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r632": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r633": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r634": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r635": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r636": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r637": {
   "Name": "Form 40-F",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r638": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r639": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r641": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r642": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r643": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r644": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r645": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r646": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r647": {
   "Name": "Form N-CSR",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r648": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r649": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r651": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r652": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r653": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r654": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "vi",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r655": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r656": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r657": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r658": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r659": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r661": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r662": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r663": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r664": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r665": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r666": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r667": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r668": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r669": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r671": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r672": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r673": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r674": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r675": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r676": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r677": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r678": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r679": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "F",
   "Subparagraph": "ii",
   "Subsection": "x",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r681": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r682": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "A",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r683": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "B",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r684": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "C",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r685": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "408",
   "Subparagraph": "D",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r686": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r687": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(f)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(18))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(i)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org//235/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org//275/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org//360/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org//440/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org//470/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>91
<FILENAME>0001655759-23-000079-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001655759-23-000079-xbrl.zip
M4$L#!!0    ( #.!"%<LW>%1YQ8  *M5   <    87)V:6YA<W-I>'1H;&5A
M<V5A;65N9&UE+FAT;=T\^7/;QGJ_YZ_8YZ8OT@Q$$SQT6?&,;,G/>K4ECZ4F
M?=-V.B"X)#<& 0:'9/:O[W?L+G8!D*(<-9[6DXQ-8(_OOO9;G+V_^_CA]0]G
M[R_/+UZ?_>7@0%QD<;64:2GF,I5Y5,JIF*S%KUG^1=U'XBJ-Q<$!3+B[NOMP
M^3K*[U4:%87Z6BX2&14R@JG3I3Q[R>]_.'M)*_]P]N;FXA]B,H^S),M_?O&P
M4*5\ 8\OKGX14:+FZ<\O8MA4YN9A4:X3^?.+993/57J0R%EY&LKEJP<U+1>G
M87]\_.H%P[L)A'X_[/VVFC.TSHJK:#I5Z?R@S%:G U@1-[SZ^#=1Y/'/+QY9
M[(4H58F+%(F:RO"%('!^?H'PO! +J>:+$GX-#\<:C==G[VZN[T2A_ALFP7@-
MPRQ+RP-\>!JNRE=$DU--DMNK?[M[+\X_7EY?P/]WXNY&?+@\O[T4XO371-R]
MO[H5&X?LE0LI_OI[E96OSN>YE,A&_KDO5"&(OL!.E9:9B J1S42Y@.?_<?J7
M_Q+3:(T/_EZE,A"#_F"(7(]28+XL'Z1,Q>W;J\OKMY?BT_GG?Q$7E[]<?KCY
M1-N_O?G\Z>;S^=W5S74@(O$V2U,9ERJN2I%F*:"<Q5]$G.6K#*1)P9-%!$2>
M"U4B"#,52Q&58BQN8R53^/$IRK\$XEH^B/?1O4P#;T71/QR'H8OI!P 2Z#?5
MB 8$]/GG7ZZNSV_%S:=+ANPV$%?7;WN!F+W\\C(2Y\SG .6YAU!?R"1ZB'(I
MNB"-Q"I7::Q642)6200P J4F5:%2611=P(=%*=XE699[>'B(M/"XDVGDL"L5
MRVRJ@#H,"?$*=HIE7D;P\@,*I^4-KF+H0/C3$UY1R*\2-@2^XS*YB"89;/_W
M**VB?"T&R.SPV 7D)E>@<H J[5&3%3!%96![@,/?J1SP%.>L(K 3B)4/EP>3
M!@?_.26SPB+X$01O,&R#T5S=!616Y3 PUR2J(;J5<8;<WQ&B32#=RE4IEQ/8
M8-2&J[G'8W Q*Q8JWQVNC93*XX4(F64G#),1'G_]76CU+L,7.\&T#2@C2,.0
MS$;?8V%C"T]%NT"K)6NV(V@[0$8\'(3"%ZY9!V ]X),4OOSC8BW2D6C:V8$K
M>\W'#<X$7:1G@G0AKBU2DJ#9N)?)6N1R)G.TXD 3H)T$6P 0.N:P5MJ>$+^^
MO_P,KB%H6PC'0. FJR@OE2QP51I*J(-+ H$##P&;S*HD$;,L!QM'\^5L!C"]
M8CW::9L'52QP?:+FVMF&* PPX!9K4<@2]P$R:/ST'M<WOP;@_V"C=S>?+Q_!
M"+T?21B0+GLH3H4(>S59"RM0\+ P;D^P! ]Y:9Z)UM^UPP41:QE-I4<I6']P
M.!@=C8_ZO0'09Q^E@>QV(GHBV8,'9, -QJJVI0AY+HN2!!?6S&4T#0S! P\'
MBZUBAF</$*"9A6$>.*<\6X&#6(LDBUD3R@ZWVN5789^I+.)<3=A17'Y=J(D"
M(8<ERBA>P%/D!@#HFIU/>C]/?S0/BD4$$D-!E)CEV;(&WR?O*I=+58#H6: !
M>1=H\:92"89LX&;W>*?ZB34I5E;-*AF[16%@/!5[:E]$*Z#15[6$(2!K1\'Q
MT1!(EY;1))&B^+U"]LXDB*">/B-5GZ$O1TH[L!!OB@4PP8ZE41 @I"VBP=!;
M_%W!+N<'H4=$MB84+@"P3 R-UBN N05TV \&HY.-4!,H!1LC"_<W@MV >]#A
M!S? [8-\$HS&AV(KH4NRDT\ >!="#[T BW;83&<@M!.2A&-V_4$#E4%P.!SL
M(#)_F/8N)H#*R$4%U )5\W8%L:B#POV^BP"'"0'&?#+*$P6V MX"+O=JREIF
ME#SL]T)Q]A)3E==G+S%M^>'LT^NS]Y\A@ <UGLK7\+.11,WEP01LSI>#B01K
M+4^CY"%:%Y!-_36=%*M79AG]U_9$;?"<B=J@G:@-W$1M_$R)FA"^T8?_C-$?
M]$:]O_4\D]\4HV%PV.]WBY'8 _=>Q< B,IO->4?]<>>\_2Z3]4SRA^*GY>^?
MC@>#/@O@&RV ^"@D";0"6$?08;<:'8^VFX.&W75<P+=;@[&'0@TB1?@M5%QS
M0'&W#KL;QC@8'(ZZ,?'9V)HW.CS>SL?--EQ\.Q\//1HP9HQ7FP#*</,<TM]D
M P% (,.V,_I#O/31Z,;CR,.# =R$AL7CG9SDE!( *IRL--W4\?%FQ[K-2^V(
M2R<JQR8:8%PLD 1@ YTV'I3:M *$H_[Q=OW:(ES?KF G'E-<1,(6(AC21ZW8
MNR5<_<.C'1CRS<+5[6O#OH<( 4C0>4CTA!_J+B"J%O)KG%0%I&JB*J3Q #;T
MQ:GAT2N(Z<%O51#V!T+^7JD5)X&0#J<*'Q-U,DJ-(70M,DA&(:9'?.K<B()D
M)Z)LA>D:^-;6Y^!5T4M!NF##]QHCBN"[(E(OR>UZY897C5=NN.(\>>,^Z3+'
M 0>S;*5J[>8)39WGIQW:PR]$ASCRFP9[ZV1\&^DL[33S)[(K,_<R=Y.F:[Y@
M5#"M U%F0:]#5CH85F\*["@@PL%M,87W8HYIS0<QJ8R8PA,L(-I4T<S0VZ(,
MP)])G<*&$-T\)7NUU0(O_Q:T#N9SH)T]EC-2[*0!LP7Y0<$:*@5]PFP;6:A5
MJEKA5AEP;5&E4T0==6(M]L+1R3Z2 ;<0!3*S,!DC:^I/A8% ,+,+FS\B2?2K
M)"NIY!%GRR7@_Z! WU@;2UJE(+1A *6:5!6 'X@[JBH:*K9A"F "0'V3!%FV
MFJ?F6,6A>KP/*I)">NY&D1][1.WIE,E;\P!^Z$A^0[$ _GQTI$DS?RH3$,:\
M2^YQ26W/L*8D)GF&84L,T362(F4A!"N%I17@0I2NK77RI(E>Y"JSY K0*H)Z
ML\%'0CXH+/M@D6;*-8,F+%:^$Q8*#S8\.$ ,4J-+L*PR&E2#2EQJX)]F):LJ
M6%VMJJA!95[%)0&.M#;:II9(8LD5(Y52)@6CRUR!-J&17H/W ;X"SO=14DF6
M&:ZI8").@H.+ZM*^46@\2^.7H#HK&&U8V[)$3#<2URQ-UG[EY)25OR@E%==@
M.=<A]*G<89'39PB$8@IDU_:""05X35'I<*,'(%/!_IEJ#PH6@$?U*81V><2F
M[YDT#I\S:1RVD\;AGY$T#H68@L,LFK$$R6BQ0OZB/0%B&4;0>52*9=*XRA67
M^KZ017J)CO>+7(LX0GDW[Z,XQE.JJ;Q7: ]Q*10CW':OV-\@>N0%ION.+0J[
MBIAN89QHR= 9GX"_<'P203A1X/$CUO3P42YQJ6W^XE_3!,$NL@R+G'$$,\&7
M3@69E7RIV(1B;>-KR;X(K58<@ZY'M MI!(6(,+P^[-39.!>+\R5[&?EU!>:@
M4R?QU!3?-;T3QZX7,N:@11]_>%6:2UR5%4=< +BV2HI_9$W<82_LG?>V$A?L
MMO3)"8)@X\LW..,SF@$1+S *V#-<!O]5+OR<@<*?<I%GU7Q1PX^P[Q/KBFI2
M@!Y4;':(5V8UQ_38/Q_M#D1.%Y;/@+,0>^=I6D58V0</ 0]OWT%B?;Y:)2HF
M7XE/[$(PBA;0*QB@=9IS8.&E!P/QXR#L]?MB?!*,CD;BQ[ _"OI')[UQ7YC3
M'YU6D.T%YX"%L:')-6#Z$,?:Z>$A9.4GO9-0^$E)8]^1G7DX",:C$&8.!K#$
M82\<UH01,Y?#@ZT<QA1DVBZ,@W\O,+P@<K/T$#Q$HG_(*.=GVF8LT5'C$G&4
M@$9$N5C#$,*@UUC@9H6=';@)R*A,;2&TN5*TS*J4@LKV#($I![E"8J-6%Q^^
MYKXV?KV+OCZ^IS^ZM=VF_>;[%%*0EH"/@S C6BVX*+65&]M/9#9$63H":7AX
M2F$0?(A+,98 /;@%Q32I8^!/^ZG@-&;S!!%LW@GT8MM.B,W&J</&5'_3FC&!
ML8J4R:#US.A4)R*"ZBPOK98H(YR'F^,8/G5I6=8=Z16(X7%P?'2TH9;A9>E7
MD#LKRI&\C&K?&T0;71M G3(1ACJ/ +F12<&VPE%C]Y/V[H$Y?'B42-VL#DS!
M9_/^WS-.&SUGG#9JQVFC/R-.&XF:A\"%#AYRP'S_J!1U:)WFXK9JER]%L,(&
M""BRDVE&\1%HXHP.?[#&:W72"5 NZI%.FQ@984@200J,C2PSS-.[ZW S4WWC
ME #,I)OPQB7[?DC4P?LG)G<UB?048E0=U?A>"Q/JWRNPPFBP][#T50'L8&(P
M6%$8SG(4R.$1K5O@(;"D/!V@GV!A@=9Y@# 8-@FX;V%5Y445I3:^L]$A4X=7
M(E3% K;%&@!&K>0))M@GL482H-(6D<(:IJ;41"(B;@W(:\LXU\-NXKA:08"Z
M%N_4O,KKF/ Z*U%RP.UP%*V#@5S.,P)>L7>4]]0/@ZU@5 3;L"P=A&/\#"-3
MD0*=P(V*&=8EP:5BIZ78.QG_\_XC#,[@\;S)4\TS2B4]I@6<E,-H8A:#BN8?
M=W!DS>DTX#I9-($T6[L;)#(M@QYXDJ@":YIZ2UH6X%<91?M6/H 8&L5N#)^*
M8E"GO^SI0 H@%Z,Z "[7$0RQ].0R085&YF.'$_(AA30LYYZDB-)Q"6"GW$+H
M'A_HO!I+7%3]M0S=XQ(8#G.8@#4\FA)+';"L(@4<$+]%X >S'#TA/J?R#4Z1
M&M*>OTH*R%.G$2@SU[7BK- 5+G>D!D]B.3-7L5UNOTY8 <Z<DR1D"8:O J@4
MB4E4@#32(1CY(K8)()X02U#W)-,.WJU]DCF"-@>^IFT3827 :'/GH@]9E4RY
M/#^1)*!Z _!^&[3(J!&-WRI;M6AM59JMELZ@P>'RQHC2'.BC"V(1W>1,BG8(
M)W:/N1Z-2ITA6Z*2NC7OI\UNCU!>^)G2FZ?&YIL*H+"05E &)OJ*_;XDI%AQ
M@1^VW&<$R*:O@5^00<-/76.ZGDA[.95YG@+/M$6;E7AXHWLMP%E<[7MD/19=
MQ$"T]ZCFIH%$S#J,369*N 1M/<"."-SZG;-6(Z.B=6@-_P7$PU< \.."0 !'
M.P),BW2\U<!.=H#5PN'"*A!:G[[=(DG0ACM"RZMLA':P$[0:#GK!;_3TJU_V
M']>-1^!MD;<SL7\"O*(C1Q=[&[M/O?AFHY[512_2MOM(^SZ*2GU+Z)A(K"4%
MS>(]G8\6"Z.8IKZ.D0(=&(L]-OKV]Q)T%L_(( ::^^<MVAVI)4>C\/>^X!J6
MHZ-/L+?&8+ED\.E@"Z_POD(T?=SW\&B:5S7U4:#96XX^J2Z/R-8U/>"%+@B3
M]\9@PA;>=(Q*.SIE,$1%YP@ $ADHTR[('1I[85'NFXL@Q!_:"G\U2TJXEF<?
M&^81SROD0?D@$^QGW@M?AH-R8?UE7>(QXW\J..@CQXQQAF$AC#$T[;3A30H]
MB4#?,RT>/V=:/&ZGQ>,_(RV&N*8A9'@!(+)MY,V:#%>8O:JN-]X6J9WC^_T.
MH=U)9ELU;E/Y#1^1W=U$]TFRVR&ZSZK;@\&WZW9M;VM&=!]Z!.(Y"->DVU,)
MMU7GGTZY41?EFH3[XY1K$>X9*-<BW&.4^U7AB;4(C_N($(35A"^#/=W@E6FA
MA\<F;G3:1359*J<0!IFAH/B=>YY6F+CFOG,.+.:<*6[$R/I47":6TPUN%<^Y
M89E6VN764_1I(,-,.(%@1G2?R/1^8"4E<D_\0##JJMN,$L8"$WCJ1Z&: 1^B
MN<G2TZ(*@]\&]'1)2_VQN&5+S%)D0N=:"(E7?BDH4Z%[.T091U)76!BS$_2,
M1VPN%RYGBNY]K(V\87<?-O8,^_NNW+%0%85N2:!M')F"G2GUJ0M@&X$SL$6E
M9\^+# P%U3JHY:5Y-(\Z7B8Z"A9 +$@#C4#5VLK88PL'7A*=1VB9].M"I/)K
MB2*"/)U64M='Z83Z4WUFE3>U"0/P2DM<8R<,X8&JYKZ<AAD5(#*SS% -DX88
M9*IN5734&2NC_K$Y1*3GV'J :T33WZJBI-V,HD-X<J\[M61]].U</S ']_9"
M*VM=3US--L7Z#*^U;W@X304T6[\U!5IC\",#8$=I,@ RERK9:-VM(W%.8>MG
M6$JF_,*'214&6+=/Z7%7N8-S1H/#3 :<L>G0+O]383V>X7GWN<-VD["33>@V
MN72\ZGG"35:*2CS*+?&,MO8Z> T(C_8?M!H0+G6)$GM?W@)"<RF:30B/]B!X
MB]A5&G'K@1=&A.+' ;8$C(Z#H\-#7.S'L!^$XY/>^+C5R."V(YA6!*<3@28/
M@N%)OS<:"*<WI]6(P-.H#:$/<X9!?W#2"X^8,M\QNSE\SNSFL)W='/X9V0UP
M<="S375%K]%?U^RX5ES\ PFF^Z%1NR%7M"[1PQS[I0;2DR&6+'5#$]M&SXQ@
M^Z%**\FU3_H2 '9#YH@]'SOXTX5V++JQYS>GL:EN+Z$K'F $8L!L./8A?BRP
M%?I\@EK>]<R/L!N>\ZS1C$0IN6F; 9J;FCZ87*(WMAS,!?QCJO@2@&^+G::J
M"YTK>-#:=K!N^HI1#]*!: :&=VD=D;X*S"4JH#('?-J6ZNX&<XO+,EGS$3M#
M\+R0EZSOB'_2%ZJ)\B9PX/(U]5_[5ZKK&]6Z_WK<Z[SC_IDGWTP2-<>XC$=?
M9]R(JKO.K:BP&451% \1]?UFB!:?PFHX:X^4:X=,&VE/6J5@+P%$1"SC38W$
MX& F%(N8SP;_RGR;#>*P)][DV1<Z>.DUO3]Z2W1^U"%,8J&C/9#%MR .$$P4
MP"R()SB:0-\(&SVP!XU$@4D%2D=4[VJW@(P#6&NN@6M\Z40US31&$X*,#H"1
M"JQ>.)I)QR?=^@C6UDN]=F/:F#900)UEBC?><< B2RPSP:TL*4;5%\3PR%"'
MB139))%:@O0E64$9Y#1: JW@'_4)G3F%<PX) VKUQS[G!#O0*28)O.9TL%M9
MGLIUH8^"Z.AOOSX5FYB&93ZS!%I5B14(M&EXE:$ E/G3*+7MP850C%R&$1*D
MNQF?P$%.1WL$+#:!+=-DE'A/) C K'TIP;W87X@-=+74]RG[#83=G;)/(VPM
M'PYI?=HZV>8&4;<TM11W"&XIRPK-M+5:S2VR.FWP]=*T$).M1R-:-,)TW]3:
M>\08G'$JT:'E0ARAYF'2]LGX&_SN0)EG"3C4J]0F'T@ H)3I:(_7WL=M'&?5
ML/B4#+D[!QW>K8$I&YDY9DRI/O,FB!!H+)'@!W*(QS8!T(?HF$QQU.CF,+9+
MH^YQQE[D% .!-&49I_#8!:G.\L9=$%9XM4).[>$^?77(..G!24>K,LQOD/^X
M)]Y&*U5&"80[[&@+_Q$WOU#)PLAV?3\#T_'4]FB8!)24&/$IP %:PGAWTW1>
M:;VJ.(&@AJ,'%\"[!LJR+/0"3KAA#;@G#O9S)5T=V^#72U2:&B#&@"\=P9IU
M)T":N?<]LIQ[AK!AJ)1THT=["N/U\AJ>0DMXV,=2;H4*BD 5O29>^A#*?H5)
MI71U*<NY>!([<X-FKY8-'*:X&$8",(^_3L/6B*(5,[K,YMS^U H <$-3J"*^
M49DTKY@3MW0AB:I71I)J\,L<(K@E$H1].59%LM6:S+45%6X+R5)0#/J$B^WD
MN0=!FSK1#14(,C%1&A@V>5AF ACX8M@EDD"[&;;VH#C+59E0 FTN,&%# Y.4
M:PSZDSUM^$E",$;6Q<3"(&O$1=^SQ TU3<4L4HD>,<T$@6=O#T6$AQ91"MZB
MB4J4N4CG6R)5ZKXP<"= WB)9FYB&X@U9H_H]D[6CYTS6CMK)VM&?D:P=B0[F
M6_V99%C_ OFEC\X]I$:.E;Y#8N77D8\Z<L<K-"OF^2X3O>"8V=L"C:S'OX,]
MJK4/7,)<XI6<=Y3P]/[SNPK%\7,*Q7%;*([_5X3B.Q+LY#D)=M(FV,G_,X*!
MXWP^@O%BC<]S]O_O4:SQ%WXTE;ZABA]I_1]02P,$%     @ ,X$(5VB?Z=E(
M' $ *24. !$   !A<G9N+3(P,C,P-C,P+FAT;>R]:7?B2I8H^OW^"CVJNRIS
M+8,U,#KS<!?I=)YV=:;MLIVGNMZ77H$4&%4*B=+@H7[]W3M"8A0@@8 0CA[R
M&"2DB#W/\?G_OHX<Y9GZ@>VYOU6TFEI1_F_W\_]7K?[/E_OORE?/C$;4#95+
MGY*06LJ+'0Z5<$B5OWO^+_N9*'<."0>>/ZI6V:\NO?&;;S\-0T57=2.Y*[[H
M7QC$:M?K#;6J&H-ZM4[4=K6CMDWXV&RK@\&@WV]89T\7C;JA4:/5JE*-&-6Z
MT>I4.U:?5*UVB^JZ5K<&JG%F7;2:@T:[HY*&;IGU@3[H#'3:;QEJL]6TC$&S
MB:\=AK _V*,;7 1^^%ME&(;CB_/S 0GZ-<]_.H<OSW&IE?@F._#JNM::W/CR
M\E)[[?L.NUE75>,\OB/Y0114GP@9+S\YOC#W]%?'=G_-/?O%8#=KG4[GG%V=
M+.0UK ;4G+L9/M>>O.=SVX4[*6+H//2)&R "2 @8A)=IC2I U= FKPSLM!?"
M5K3S__GQ_<$<TA&IVFX0$M>DR:^(_^S._0R^L%T2U$QOQ':D-@TUN9F:UN1>
M!JMDG7!A'KBO83I@UVU(!VK1JYH^ 7CHK\1.YQRN3G8.%RQ[?F7Q?<US?C&Y
M-0C'?OH6\,KL'E8C#REMNM%52]2,F<W.KM1>1W(+V%FBHOG;\7*?!)/;+6JG
M;PXN3/=VX1#WZ;<*=:L_'RK .)18W<\C&A(%?UJE_XKLY]\JEYX;@D"H/KZ-
MX?DF__1;):2OX3F#P'GW__R?__,YM$.'=I&*J@FU?#[G7WX^YX_N>]9;][-E
M/RM!^.;0WRJ6'8P=\G;A>BZ%!=BO%W@C]?F?MF51E_T)UV] *OFVR=__&M[3
MP6\5LPHT[Y(1/HG:%SV06Q;*KF\.>:HHG*)^JP )7@SL5VI5!\1!$-E NX.J
MWJQTV1>?S^?>D..%B:S\9@<F<?Y!B?\-O@DF;VA5N@B*HEYP![=[UOPKVI7N
MW_3M7W#E H;>+N$5/G&N78N^_C=]FSR\4^FJ(#2:C4:KT=G^)9>1[\]!Z<JU
MOH)N2=X#8J5;!78'$9;K):UV\I98\%[<TV?J1O0>Y)OMVNX30(Q1 3#2;=^Q
MGYB N7H=4Q,TVZ,]@EMN!P_P;3 @)E[C(-;FB =E\H45^2-X^7"RY@X@MYEO
MN9V#+O<- #U=+=!)/N"VU2.NMI-[M=K15EM7U=RKU8^X6BWW:HTCKE;/O=HZ
MJ+; OG!M!W24']']+3Y9HP&J*Y=PU)=XZV%(?/H%%+AUZ8W&U W8*GH^6$9/
M%#7 E[?I+7?D#;_JO1#?8O_\08.0[V1V80U4#G?:/Y;6=CZO7'TZH""?31JD
MV 1H6%P$S&*$U2O,7KT(P1+XK1+8H[&#%@?[;NCCYN;4?^TUL! T\\_@[Y^^
M-%Y#X$4^^\0LHXL88FPKJ$Z2[RE36,DGV\+/ YOZ"GL^3;6=+Z__>UZ1+?ZX
MFWPU__0Q@V?R">PQ/T2UQ71Z5=7@_Y+?3:]-EFG-W-JLHBTT?R7YG+SD?&[?
MZ6#0!0 #-TS#>&?MJEJ?/"B^DFUGD6OS;05(U\%D9R-*@LBGW1BP[&+RB.1:
M\AF?D0XI0SA(S=+ EI"*&#O-@R)V32]^/GS-#Z6Z6%#2$QMP5RB!(&32<K(]
M<#E@6;.W,F%(0L_?$J!+O\<OOU+7 WV1]MBLY#SWB//YU6_$9T, ?"Z*R?KA
MQ613-##HV<&@%P>&EH!@R*HT"P1#>]]@B'=#G] HXQ\M>-GKV+%-._Q!1WUX
MA67#51YQG=A\(6P)?W/UKPB=<##\/!<^!KU7&_1A<AM\#Y[G0^B9O_BS/I^G
MOF("C<E*<NLH8VOI.P_R3LE!?D]#\ VH=45\]!""LL!=4TL.^)YEV>CX$.>.
MV-:U>TG&=DB<TL!_[W[*ON%OFM$H<C#O<QL.J8_W^72(3WNFUZ[IC6AI<"&>
MLU38UO;NW9P*FPM@C&I[=[)*KPQ%P-+>7:=3E-PB(&[OSM[IF/?;AZ 68+YW
MS[+T(FU/@"^[+WLD^[XP^)?=L17 OB\*%WK9?=U#"7Z].,=#+[M_>U#!7R3@
M]^[,GJ#@+Q+^I?>XCRSXB\2%<%G+XK96>B_T*(&=XZ37]+)[G@<.[!P)2V7W
M5?=J)HJ H-+[M$>/O!T)<65WA@_H@!7E]!IE=WH/[8 5!OBR>[Y'<L *@W_I
M'>#C.V"%X4*PXMHBMU;V9.WA=-H.I;H+,"^[TWM@G58<X,ONP!Y'IQ4'_[*[
MIL?7:<7AHO1>Z+%*JH[0!F64W?,\?$G5$;!4+[NO>KC(VY$05'J?]NB1MR,A
MKNS.\*&\%*TX Z%>]@SP0;V4(@%?=I?\&%Y*D? ONWM^;"^E2%R(T-FZIZV5
MWAD^5NG#$5IJZV7WE@]?^G ,+)7=33YHZ<,1$-0HNX=\? ?L2(@3UG/&&8VW
M@YFY41QA.)8)V,EQ2-_S^6BI)Y^R&S8@:..; S^$)T< 'G\,P'^[(2,Z\]*[
M@?UOZB,M^./XU7NVMM16029)0U@W>QV6[^D3<J3GO_5<ZX$X-& SPW[8\%<(
M3+Q)UV5"^#V^F+\4/_X@K_8H&DE26DE*PD8/LI'2A'KBT7.%$-&)HEK8>,4Z
M5.]+4)PHCH6-B;QC=A8@,-\0MJ(B)^]+NBB6+H0-;KU/?T$$DA VA/8^26(_
M3>H-X4)P&V#]A;Q1O_?[/N&K=8J#;U/8"-IZ0RR@Q#>'WR+7PK'=!2K;2>#N
MP:0N 4!.G?3DFV^>3TT2[,RUDUAAU _HOR(,%C[#/[CQ^2CAP@U[EA8'H&"0
M$(7EO9JE#"7ND8*/@5H![(%F28.-ITL'QTDM-$L9*?Q*GZGCC9DQN \?\BCQ
MYK+90J<2>)2$<V#"*64T\WA1JY,V0TH9P=RW^GFOQ"!<V%*$2-$L8K1V9L3
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MIH;LX[+P48+CJ:/!2LH?5^E&^7OEC@0<OS-H7')@;.82(Q.7B!C3'JSQ(K$
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M%0PD&"K?'.]%6@MEXG[$;^-=6 N2^[?@_A9VN82@[T-/62$&TJ*(T@ HDP@
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MLX=R!%"Q>.')(TZP^.6+[2S=^.)%SM*VS+0O@V'ZK7C.6$1GS[$.;.!+XBL
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MN7_P')1EN#IX&6@,&]]RMOAX]I$!*5Z+'Y<NYZVV1_"B$^:'+UX,-[ZD9SM
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MRL>L%C/.PV"29Z(-?9 !59;X'0?T(OGC4VP67-@N6QW[T:?X8;$*156P,'>
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MUFBT]K-8(]-C-V2--U8E=)9N33'*.5<<T@A-3R)_\WQF:CS8K\H/N'L8*%?
M/-;GOG_>Q9RR8JAG<X9A1O <TQ');H1QG]E"9O4#Q785>(L#<C]8\EG3?,%\
MYJV(Z)\[JGSWG:[DB5,#FIZ')0JO:B]@IYU,.V4Z<L!TY,#W1HHWIF@7@9^"
MCN,S*QFZR$(_&:8@[TQ86Y>1[6N=)S418)%@TMVP55/8=F[Q.C0_%!3$.EX,
M*MN&\IT?6M#DEH9>Z6KU=JVQ>Z2X1(%>2>(E(/&BAA,UC-V'$QVN[S)7$6Y)
M--',W%<,I_H4$&W:X+"[L8K";_%O$VV<"(,%8/X7;N"(8L#LWT!IB";-D J^
MTC%@WF:Q/(6XED)&6,_^[Q,X)B*;]-M)O\_+O%E8]ERK-P/)- E8!T<I1?[)
MR04EIY(-DPMR4DE#M-DCA:I*(64B^FC$-'W*4.T-E+X'@M&R Q.V%0;G@+^1
M'8U*/DG[$/[/PJ3Y!*:S-'\[^)H %KCA+@;MM?M,8^,DC2F:E6YKISH:V;,G
MO-1<X5@41T2M2K>Q>_'D>YZ0>OKF\?=XR@B;*P*:8$3\7S3.:RY/&9$&4*XP
MV%?:#V<Z:Y.>VV^>_P#@_IW8[JK@01L[C9;/CY:F<\DI)ZL2V)YR.J(-Z3Q]
M<WI64:,,94"I>H-J%&!O=D##=V%)%VA(WR9!N.^4!/0>7W([^!G0'@)S%MQ7
MKSC^+NT(IJ9:B B5=K1HI+,A^E $Z6B5KK9[2$*\,18EDJ&L>JX?UV R"D L
M<&DJS=%<PC0^X@Z'"E[&<+ST@G!#7*Z)*=J4!*TT04M.+1ODYY;48J"V+:I1
M4\8:3M).+O2P]A.V<#:U5F>=_MRL5[I&>_>I0M(&%HU"-LT.STPAC6+.J174
MU#WT.;79Q.#ED+A/-%@H-F%A E:@X-BD;SL[%)YD-8".^8S3UW8]D^=KL/"(
MVL\8OI.*;KLX^K5K^NC-?Z7\O]=N MS["6S3I%M3AH!.DFZR1M&WI9L6EFZ>
MK%844URR2;4SLE(F'0L3E@RT4XI/2QLUV[)6[R2I9GM1F85J.I5N7=;N'51.
MWOET3&Q+H3Q]P5T&CPE/,_)Q*+=,.18L/V.0?Z4#"@"VXL11S[48B[#$4AIW
MM%1F1NR<BY?VIW!UH!OB+\61T(I,I(BS]$\@HEXZHWD28QB3-U:SQQI<3-./
MZ%P<Z3W8TGMI9%WM0=YQB&.# X?W]RFXTSA9QUC$LDM9YG[7=T]%N\<A\E(1
M-I7JM9889%2DL6W42]%3.JDN4AQ$Y$3&OKT':_M $G:^@BMAB+1QEJVZ0.:1
MM*V/+51S$$Y#(,(Y;3.USGJPN=NC^/29NM%V>;!3-B2V%Y9)C=;?[7!X&06P
M2>JOI?QFI=M."TI(0[3$]+.]S,Q-/]A4J(LRN.>D+=#E@6Q)[_;&@26[6*/B
MG^AWW,%6.!'OSO>>;8M:7]Y^ A9F+(_>! 5IO-/&HS$[*14)N>T.D8X_*-"@
M?9>TEV/BU ZTAZ?I&(V=0@<'I+U#G]MZ$/&=-D_39BW\18R;BB&PUWF:!58%
M'F:>9OFGF-U%OCDDF.@MM#O_E",(&^KG[\@;&YGQZ/7,?T6V3W],H#IMN4X1
MH6VUTJUW])W.$Y3Q)N&H94,N=VMJT8!:FIV=/&U!@TSBE=4CTG^0,,:&G&.R
MFZ D_K-[ 68F4)\5? ,K90K:VT%6\M<KW:;1EC-,3H]J5@C,0JC&J'0;C890
M5/,.;4Z<,?.^[<U]2%&$:G9.J(/YD&9KRN+!DI-+5O&9CURPD;,N%+F\P[,O
MYGSUL8^1^?#M3*'@-XQ'K#(;VSLQ\8('=2KV".YY7CB]\82-C+TZ\7<QN.\<
MXH8]U[I*@)[&+4U,_PM2126MTN/X\;D(IH5#JLN1]#R!.FR!FW+2H_J3I.PX
M3LXH_;?4T+Y,S!8Z"F5%2NPZ@?S:E%@;T['M5F'S461.]F3(;H,NV8WL,!.K
MM0IK+Y?IV +3L?'!ZC(=6T0ZMG262.D6?(K!QR0&PAF2OE+?M ,VFS[ ^7&*
M-T9AR?N>[2"(@%_9U:N'NSLEP,E7,D*Y983R*@;V[8"-ZKOED ;?Z#J&\^W@
M:C1VO#=*V0ULSEB:CNNH.$Y"I FZ,GAYT.!E<92D%7(\E*AQS?)XLVF6T2Y!
MR_?H5FSGS7Y+(+_6K>CHA8C<+;!3HL#G>R2Z[7S9C$1G%'EXGY">[!K-H:F"
M&=2K.T;LN/%'^6#%K3\?L7<$I?P9E_68I'H&]+KQ%%)0QZ%OFR'.:H;K,G!9
MJ*A'EL/_OYI"_7X"<+P IM+\%S-WWL'J/6NYE\MT(H3CU:O))LS>DY!>#0;4
M3,MH=.J5;J>P?+%(ZD*&/@_3CG)\$L8F[D81!;9"*A[Q0JCIQ'6968><*7WZ
M9+LN.A'>0 F'5!DS.G@/Q0]Y6+"^1^61QDC8$]X4ZO0.6111#"$U#TQ).#E9
MTX4BI7=H\><1R13'AZX3QGLWDL108_^QUWV77(X8!Q8C;7!.FH5-3BV1=R*9
M33*;<6ANZP"WM5+*8<7EMA-PIM)3+P_1>.RPBG#B*)8=F(X71#[+;YM)J8IB
MNP//'[$SG8JJ33$ $9878:./P)4I65?Y'JLFMF\]4!(:LNSG ZXX<MD<>Q+&
M=B=:HA-J9DO9)JM[2DKOE)1:MC-JV5QTRPY!Y 77+CO/P/H2A3=>^ \:W@&Y
M+*LO0V4'?>]\=(EXM2:2[,M/]MD.V]V*[#4D^YW/9Q:U,*8<6I>5#S,U!A:9
M$I+7Y9J8G<..9>/BM'V5G(LW*"]@66]$'Q'[R*PW-"5;9:@Z)EQ%.BNI(%M>
M$GCY"7SS>39+!,Y=T-\J]FMX,;!?J57]-_6]-,(W*D#D;5W3/PE$_*?6"2#H
M@L_9Z(+$H8-_DE^,B/]DN\RKUQ9TO0GZG?K%L I+V/"/^)P+M+9L<SWWZ"H&
M8BC%@W2\$:SA#1/6KA>"<QUZ+%,"W&/A 4X(#)>%MPAF5.(:6>+ JN&+^<;^
M10C$KZMC"?#8"VP6SO&I0T+[F7YZL:UP",O'M<S^BE/QA3K]">G# J)P]4_V
M#MJU)E)CP:>?^1?7B$+";C4'C79')0W=,NL#?= 9Z+3?,M1FJVD9@V;S?XU6
M)?G1T$_6/29/M-KW*?E5)0/8U@5Q7LA;4#F?)S2@LEE0+T)I)2P&@X)AP6D<
MY*SG\]@=2#;JXUVP$G+D%2A#'U7!GS;C E#QR"8">0/E\SDIV=)QWCEG2UAY
M"F6N$%'M0XBH59%A)I!Z]W]<W_0>SI3KF\N:TKOYJCS\_/)P_?6Z=W]]];!2
MRHBUB9M$B%Y.!.CEK #]-A&@#Q,!JGR(7!*!=TRMC\O;S"8_ZFIE,VP.IG'2
M8:/5E-ADNXE&\%!SV0F9M\J^1 $\) B^TL#T;=9ATW.M+R2P@]O!G4\#S"+@
MMX_PD"^.9_Z:VF1U;@':;D2M'EIQ5*N;6E/O-]O-=KVAZFW5;&JF6:>F2@9-
MHU-1X"UDC.K$CT!@W>!P-R8#DF6P"#-[.WX[^_[$[(OWM<!W<"U>"KN98W3C
M<E8ALCF>CQ,8S>(1N]9PZ/G/0,0!\*EKUGB3(M!P$/4#V[*)C^,I/Z YK*N?
MXEO9)^V3@A$$L"TJE]SHB+_^J ! B6+"FY@Q"Y;%$U7Z-G"2.71A*T]O2FRF
M@ UOP3W(2,!B/,2/I@L^U0&C@N<& ,J,K8)H,( MPG76:&E1=N9#?)( )@OL
M :V&(%OA@:QD#XP\RC(,\*47/0W9<S%'Y8&E_78&3WBFCC?--L"J1M@%!O3_
M;XY:7F?BD['-GD)"^,V33RR:/+MJ$J2F)\Q@A-1V@YJ22;+IQ\9Z3L[E/!H?
M @?[O0,):+[Q?U.XM;'(?8_#!>MT(B+SF*;8%>!$ /TP?AP[2A*0M)F&:PHN
M(?6A0_(,]$FI"TBD8^+S4RKP\;[%>G5?['"8O([C&M9ACW'DX!-U@3P<YPVO
MTW'(?XO+^^FRW3&UP-?(($TFS/2S]E!3?N_U[B9\@R$Y&U6</9I9Z4SRE.T,
M'PZ$!G U>5\QL,XWN$/1U.K?V!T]="/!WM%4?.\]?8H<_O.'ZO\HS QA#YG.
M9U.2\F6E9X;X&ZUCU,\4 GP,(,)^NF31LS<FZZXIE^"X$MCWXE('GA>B&S*3
M& [ +X%;$&(Q,CFT79"F3CI^UF%E L09+$X)"N#IC>P0\3".?.SC#!%:,QO'
M54[V!')L9 <!KC[9[\/5Y00]?N0@'5US_'ICD&]<1(R("R(.%PLP<QR%6/^,
M@C"V!9"H;3Y5!V[EFU=\7 $393/W?E1<:H)>(OX;(P6B#(CMX_8GBFEFEPGT
M.&&O8*(^<1BL@B&E>,PV+N$KO&34ISX/91C:F:*KN@Y/#OB#@3Q ]%I<R.).
M8_'^%X#6E&4W,"I_%9>8\.4:[@N&7N3 2BD A3 <P]/_&;D\!L20S+@]^ZL!
MI;'O"Z*; KX'L:)ZH\17.#VG ^&,!8D8BQ,_G!$L+!S4^L0AU>.T>D_''M[D
M3KCOOV%!#CQ\LFB@'G:=]OT(L,I?IAOL949MT<HHB>;H,8Y\MKTH ":..7LJ
M]Z;4L@%89[.WXT%K-CYE1K(S38\BD0E^G%3#-#6\YQ;DS5#Y8GO*]^^7RH?*
MY',%A%&/B0CXL0,J/L8?,AQ695A '3,LET1'ME-&"5FAR<$/,@[L5V4$ !P&
M,9G]-7)I3&)JS&>,)UZ ,&>A."L*YX'X-R <T APSS((_S99PK_X72O?6E,P
M/(3.C*+I9PF='3-<I6")5_BF_*#AT+.4ZPE^@[VL;NU:&-LK@\A'@0'R#W29
M$]3*P8WY[+B?..#@"K31"*V2J;W63+/7N-Z=-825&4L?Q&&PM16'-S%1"Q2P
MH,=]RH8=!C-:%=ET1'Z!EHOM#)KL@!\?'@31*)ZQPKB+L 8LMF"?,0WR_0A%
M"NZ#L+/KSV9/&S]+SGEDSZ/\K'MN,@9TYFV)^3G[1OS%/R/KB6^M3YC= 8H:
M=+Z']I[#G@<F*.CA,X6ERF$=""X6#85W#R+FF>)M)E?S_*D>(\<!,>%!P9RP
M9#8%Z&F4:R3P7(QN+:\6;"8F5ND+7Q*0I.<^>2A6^\SKY>7U7.Z"C)Q8'RA#
MPXB9*4'DP*Y,IJ(M&_VOB5TP^ZXE728,\^042_G8Z=)S,2;%>>3>#GY=@IEJ
MA_C7E+=:BY$+K=W6]&9?)V93K[=,K:T/]);9;+0UTFE9@R5>Q,=Q9/UT8P[@
MLRSR@_SHP8;TX,E&B#!YE%"_S3R[?S(6]\!*=B.TY)"U?0:IP(;E@J4'%SD+
MI<4>;,;.C*O *@3URL(49S&+ X^<*?TH1$,2!,7(YB$*;K*XE,<KO#X31L0"
MB05,H&"2#_>$?@QX6>P98P_\"8P]@RGOQ/$GD*M)<$0)XX&;H'^FWR&8@]1W
M\?'VS&\88[ $7Q5;2/#1 H]0,8%0F/"%)^!6X78F/^)@!\L,T1=E A#V2MMU
MX6&Q/)I];Q"9*!0&$3ILL_$1+BJ?IHN*'>!DN%6:MHB7R&F9!4S,1+E@ 2C(
MR!!]GRFNP-F:>Y)B><R!#.?7%0/'YXZN!X](H /X!&/+!I^LSZP\Q 3LBGOM
M(9V(?2;3$@@&_# !<,#,H0TWX(4!2!!^Q"@7=;,T7!;#_=%COMB\W8UN'P(T
M 0E:R&_KX))H2,0C!NVP^FN6]*>G>X);$,0_<.D3RQ+.7)U4AT\-:?@O:!7*
ML,25(O<;9]?*#0K* SSQTU!A O4 L %4DV!?D)P)0;FER2(KP&Y X>.YB6T
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M\Y0J*J@:P"W([LV)&ZI1+56A+39E5$UER65P_[TZ"Z6Y.X[TZUZB*[/!]HO
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MG-%+IZD8;TJ%F\TVFSUZQ?B!A/*]N>2N\H4_*7?VDEG[R:)L5K_A4"^JMIU
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MT;TMBU:RXZ:CP=G$3>/G%1DI,SAQ(D$]R*?R["!T3CELEQU+;>9F'&)N1H%
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MQAAV)E751->(LII(QE[*5VE4V\?T&&* HQK3H^&W%\AOCQ[@V*[-A"V4M@9
MM%$] R";&SKCOQ'HIN4ST1<Z9E[(BU.QR=?*=DU\X(W#L>/P(X^:M/Z2-$ID
MB]=N]!,V=>V%[^7_Y$ =Q J@)+;)ZJEK5DGLOW,GLK4>>'OJ</:CS6:PQ3=L
M\<2>W:M?D]W13*L=!]OZB7//-9M5?"Z!*T ]MD,W^X:Z$.-3L!-VXATH<P=)
M_"_F>#0;:I,N&_8-79WU9Y-9GT_'@^YH/#(&L]'H_\97U]0G&LW)O_W*SFSK
M*"0QZ95VGH%D:]1'O,0<S<8ZTPPV&TPT5>WKVDB?J+H^Y8.>RJ:ZD=L$\?0-
ML;$%>="HM1TT:J4>U(J!?>AFS'241^2@V&5=(2L6;W:]777)[MCH@L >;LH3
M<W?LVG]0A7YC'3%]^1Z@$S;XS]+@ 9GZ_<PY!7CXG<Y\V Y.%9Q9H\B(FJYM
M;"D.=U%B@QQ:R,[WGNVQ!8[[E(T.!9;%<"OH%WQ [-J(5=6K+ZFZMWN$P;JF
M4L01$U-C<'13)VTH!EV9MZ/;1C0[#R!,NFBII/$N ,(:_A7MH']PWDSK%&JZ
M3=SZ#G1=T *1X5(ULO*'A4,F7MU]_V.]F6JI81!?;.N1-.OH!;2^*'S>,OYA
MTBLX_F%T:F&7F/X ,#O1P >\K<PY#^L#/2YCM,-HW.D/!LT @@,-("@&V8(#
M"$ITC]^OT7P=.BZC=T-PN*;!?@U;J)_F0*3H*N_CL^?/]2BHJHOVX0HH6F=_
M'"+5*@9'[Q;.!_AL\0@=(&+_A]3+A,[0=$,_O=<[)XX_[!XJCO_A3Q\TU$\6
M*.8^U6-_!8W4N9\S2]I3H?*^6R!_T@>C79NT^KT7V(#YX/A\KF&IB^ZPF^M3
M3%)Q=1ZVXC2\B]MM,KBZ'O8Z@[W[%C9->9NFO/4AU#Q)VSN9I$UZR$L+6O7J
M>CS66J->TZ>WMM3[LE+'\P7A@<)K)4EL)VDXK%\7WZ.:J,=#+9&-T_2K/507
MO!.*.G&U.XNZT=7U1&V-M'1R5=/E]O2(^+*2%.LGY)+$M9.0&U]=JVIGN+<F
M>7[=&XXMY)INKY<LY\+;W5G4:5?7?3#JAON(NL:>.[VH:^RY ](7=H?=2<Y-
M2,Z-7F#Y<!AOK$?M<%8DLJ[5PM*!+?.;UEK6('!>;IBR?Z9ARE&WBW/.>JK:
M4K6JM-Y*\:2Q31O;M$*!W3_#2.2HVP-QW:UNE/.1:NIV2 "GNI^9,1K,ND9O
M.M-TE?.1-M#TT8CW!]IHP+K:X/^&PZ%V%=81';>J1Y17Q.IW1,ZSJT@Y?KR:
MBN'@0 4%)1TM5&<00]]2)0:C+N;)=-*B9_<ZB]Y0O0C #+  )1UN*51[D5W.
M2M2UM5P/6PMMSI37CEBQD5*;B1)[W8Y2KA;CDZ7;2W[/?KXW77UANV ZI6HN
M1EU5(!. #3@T7M6,C8<S8]#K&I.NRGJ:-M., 4".J=J$J]IPO49#O$:!]U#Z
M<TZ%?W[-X_;W)?>G]7NJIFGJ0)L,U,&X/V5=HS]@T^Y4'VM\.*IOU0B8L,0E
MO;G#^38^V:)'D5R9]0R(K]L/%KS+P.(/A+?'?BI3;O&9Z2%#+L4OANO<P@5I
M!W_E8A 6R5LN?R?>5YJNATC7@WR&!V3M+SP4(B9R/P4DMJ!R.J6#Y:-8 YQW
M0DO: 1L..<@]XX?@7>%A[^!]MP+E8$M?5UP4 KOAR=K]Z&@C/%JZ@>,O+;1L
M=;P]1]3FQ*Z-"VB6OK8M+1&JNJWQU?4@XT@E;RO?=YM]7:.UZZKTED!W&F8<
MZ?4O> 127.!M6)<,,@S!10J**"Y=.285>B$%6KJYH'-[?.D"]7E/G(O?SSB8
M=Z EN1[S?,_&YRO V@RS.AL0=\'FA%SW/HKM? ]VDW@X$T(3'$'62???^H7
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MR90M:!:].^<<=9_<@MU67"? 5N-H_<UP$JT"[]7GS'H016B4?3FW%^A0Q:A
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MX'@]<;QX#MQ6+,=DB4'-DR4:-+\8-*\T^VUG-::ZF'J#^PWNG]25MI7!C\Z
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MI=_M#R@3%O[H*Y[M 9(:RE_+"8K^;HGA<1EA^<NV87MMN4X6N0S1HYTF%@5
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M(!Y<$(MN#*.DC@%X%H!N8?[@"W-N"Z2AEX8'Q5TBCR<I=%'<F-#JX^^?E)N
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MF4P^YNN)V9%LM0*A*OPJ<B<45>6H_GR(:Z+;-FM:I%3#GZ;#I2^'H0-!]U&
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MH*F;282M=7="3%X"ZT26W9XR-VZ?1_P5%O17%$6QG\C# % %$41?2)<T_6T
MPP.FUL(#!)X/?#X@SD= 2B.2P-2>W67+U8(GW"$K8'#M()1*,8+Z.'Q*DM?-
MW3_;X]'H7*STXU"9! I]>'.G$.[7&^?+Y6<D2Z)&ZX&C.W25^1P=SK=(,%-;
MI!'$7.8??NH+']7@Q+/"Z_PO .&M#[L%/2$17H)[US'$]&0[!JA(6=$E,&.
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MZUG8L8R2/&(>J#A,^C'XBFA"ZMR)S#6TA-:LJ]B%2'3  &]\;V)/06()@FE
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MNN=(E%CBP^'^.ZBB8/@!ZXJ 2"@$9&/C/+K9S^_>MV(B-P"Y*PW0OO8+T/X
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M"#)M ._5$GU>)2K(6+,8+Q23>,(@(TTA4BIP9#W@L2^E9@"GP) N(Y##5X:
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M.A-%ES\T]#P%F@$A;=+R*"ZHC4:A-\1B#[!-;@5&,<OV5)U)W@AGK0QXIO9
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MT-(P\-V&:'#CKEQ/@B$\JUPNY%^!F\]*LM-SZ_)X<'SXK^-!WXJ3*0JR)&:
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MNH>TP0LTIXLB%/F@A[M_].$4.1DAD36#?HM!,Z;8.H&W"E)N#Y%,R4#6 ^E
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MH^ODS"R*)RW7>,GLV/#]T@EBT0&&NX,ZH$(DWQ"IX.<@#&D&Y7X N7SVJ9[
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M=Z$WZ%?R+O2;UC?28)]3H;L?#/[!"]V1FH"C8L>7(@Q/C<KPO6#Q?WAW[_S
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MD(4T3*Y,&RQ^I4 =+.22'SU-^,09P:/RC.#A,'#F\)]Q/)W\]/\!4$L#!!0
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M)/_4^5&4B3'HKD7KEXWE:S89,EEE.>MI7K)EKIA0'IAH 6AN"(XY<Z\Y_(I
M?[)]J?JV&1"VHH'%8?KED4F'AZB3A9T F,HNPS!6Y[F\+Y.I+YX84P64WVAF
M 9JR;JMU2")Q\P^!G03YM\=NO(6/ R8E=8N(YOQ>?2V1YM8DD[J:Y#UP'_#$
MW0," 9/=F9JG,.IP%DO\FF8V$K*%0/5J8BW,6SO%)A\-O RRT]>_\6A\%H.Q
MF#"9I24]W8*5A'8^4.E6&E)K/J^M-?</XGX,JSYP5[Y@<AYCR3<;0;NA', V
M  #J+:P5BU;8V@N!RV!D>PU:Y?  !W-](VM)6M&H)D,T<Q*JYXYG<FWKM#&
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M4\EF)]P:7IV/S?-.Q%A\+R$9J?>].D:[]K\22])2(W/1UUE.4"PZ6YBK1X-
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MZ,,8D&N-2$E;K\$(9F,V3(M$:8$6NJXV(H[JD&3S(V.V CRF\M_#F).M5/B
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M6["$,X?Z$-X31[DG&AVQR')*BH>.>Z2='GCX7,!>K=;TK/+: <S-Q7JY1"^
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MYY;SE>$I)Z1HM+K4I'- +,78.";M.-.6Z]#-]>_VO$=,AQX47K%ZT").N;B
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MW9]Y^"#CP"2Z$8[T9(L>[LZU(-Y.)C-(KV<MQ+:L<ZN9R>_P9_NGR0"DPJD
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M<%9'PF. ["CU2M6N/G8<29]'S>D1ZHYQM/\)[:+7RN*,[3X%3-9I8'[7#*<
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MWN=K0V<1 W1!V)-7LQG=D79+ZIASE23]V*('_Z4#TJRD<UJTD:,F,D=//%5
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MZ6J(+:5(LO&E$[1VJ7HAR8,9?L-65O]VWT:Y?23!W9K9KB:^9<+&,D/8V-)
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M4%:ZSS,0(9_:+E17V9Y'P2F0IJ\+I;M<E5W(^7LS^M:*^D]H&[6EE]]@[+]
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M18Q#=S!S8[ROG?EP \"CY<#N:NXA]^T*2=G'6"/W !R8K!PC$*TGDBM./'C
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M]IVB#[+[UB\OZBOS%#;/[KQ:Z\%'GEDF2> /*;0FUF=#A$S6B&B4Y)UZ-#R
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MLZ'VHU<;MJ5KJ_OLA.-&!9X2ITM%'9(E6_/I+\!'%:M4Q0)8($7OQ!RW+9%
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MF8Z1'H^-B/S(C&8;=&-R&PB=)9HS[7U2PAL(S3[U#6W&/!#IX^HQ55;?;?K
M5>81M9W\$R_?+_&=;C!23Q-SXZN/GVZNNGN,2N0JR<Z.9Z@_ ,<(PWXRL@C?
MR*1C@ASXJH2WE$I/ YY!44Q][4X6R:2A7#>:2>?Q8790FZRFR57S9IWGDF,6
M<CL6>SSP8,Q"1QHY"*F#!1>2(,11XH2($B-SYW W<V.)3>:>QUI,,W/E")1Z
M5LGY (W, _M9C2Y (Z,]\Z(? TM6Q)%.)C46^A7=MPE./'W&:34Y[4<F^W[D
MQEO\[CO/:5HH@?[!53)KSBZ?>([OMN?P;[)59:2L\5)Y/MU%A%&88(=!D<0<
M(NXS&,=1!&."&:41B9DPOX<RK0YS8ZP_*X]]9?_SK3;5N>4SQ_F@8\N)OPJ#
M \SYCO7\CS(WAY4=)"Y BP5HP.@$8W7@  H/RV>:KS.6-D\W)]9@^G/.UQFB
M@R>>KR2*^;;ZLR3DQGNI+AY<?D\+W>WT@5?GMMQT1 1ON>SQ(5W51*0DULP>
M<0RFTSOF,Q$:F:3[P0%?E;B6]L8]0 S:$Q]J;[*]<(\RW3UPWV/FMWFVF2</
MN]R.W1:HOM20A1Y194>CF%.($/$AYAA)DS9AG'@(NY'V79]S!)D;/;R\W-+_
MS=L=E7[^F!+KD8G&%&:C&T0V,#KC?M%9W4]V^\@&2-V[25;:&^8(^)2M-EFA
MKE8T>^!MLCCF\B0,D N9AQ*(8B^ "8X]&,2,^4[D12$+%N6FO.;)+=S1GHQH
M[$C54)OSJRH9"K(JT#.M!#7;11^'5&^O:P6HD3FH*R.HA00_-V(>=SH8;Q5/
M0F%I0W>\GTFW72?5W=\<G7YA8'B$$)R6Z1.O&[W%WS]+F^LS5WJDR[J&W67Y
MGLL6\5+%:ZQ5?;6=AQ?<"Y% 80(=$05UJ"?&O@.#D#J)' ',(Z-: 19DFIO!
MU @+BE9:((>25S<2518GK)L,R^:P:4913#L88T=6M-JT5"9%!$I&L*O1!< E
M: =MH]7^2Q:S<(T MZUH# L231NA80_"%U$;%IL>QM=OLH>'=!,KHOQ9<D'@
MLG=>+)(DH8D3Q] E/(*(!#%,(L^#;IP$/L-!Y(5&QRX]?<V-7SNB5F<D.\*:
M46L?PGJ4:0FWD:EP&&3&A*8!AB6BZNMI4@+24'F?6'1>&>+[XBN<I]E-SI_2
M;%TLGS_SQRPO.6OR_?/8]2B/&4SB6$#$W 0FKB\9(XD$=@4B3D+T_5O]G<V-
M,G !'C>B@KR1U<2%=0)<'3>5/<A&9HNMB*"5T6+9<1,PSO(YG>AB0K^2GK*[
MOB/-=\P/LZY612J?O,VQNA5]DRU3Q3PW>48_&%0,UFAE1E]T(RUHQ 6MO-5B
MJ(3FK(ZO_F"[=K !3H,.>73:G^S0QT#9[B&0R6L3I_%X>=S<INL($LPQ]2#C
ML:?2[W)("!8P#@/JQ*&'$XXG2])P3$J3&3A5,H;#P4T7@+]VDH:C0ZVW$7C5
MP1N9/D>+5)I-8H53@_#:"12.RO=C)$HX!:^UA @G.QH0_+-><M<A@2N[O\T?
M5B4SN4YS^.VY[8^4E$")"=V=.7W;Q+OH[I5Z\#IM4IX/U<@T>!HEJW=E^O$8
M%A)TN,GIHH)Z5=H)#.I_TFP:5P6Y:\_LYAKRY8IUKB0KFLGYO62:C<-7\P;J
M66W/Z.-NCCNV%^RE$IU_7=<%L3=ZM,<CIM> SQL*EM$JSTVU'+S^D.R(,[>A
M.9^$K.!8\Y1JJJ(B)_2=BH[.:WP2QK*B?TMJ=AH;' Y49X%2X99YJE)F5CD8
M*ANJN%2G7&GYO%=P'H<)#['O05\0 I$3!S ._!BZ,<+$BT,_<8UN"PX18FYV
M4K=2_5:-.A%)D_B_5<0XNLA\A/0VIF/C/O*ZM!'_)>"U!AO$P==*"3!*IJES
M4+07SF0NPM213H-!.A $-;RM\ZYX9+SXE)6?^3_7:5X=^#_Q_'D[[0;<_.AO
M<6XLU[WSP*3H8)65(*^%!ZWTPZZ%G(!68Y,X"JIC;QR[ET@4H%)L\'D/4,LI
M\H:!=?9%DQ/=O,K]$SW5CUU+T7S[=0XF:F^ZM",WJ= S]:/K=2D5J#SJEW=W
M.;^3RERM)(U*VY+6!9<\YE*'!11B[E&(_#""F/@.Q#AF3DRI%W C\^[5-)D;
M>^X<<+1%*C*@%K-I3S*&?QO3G'A,,N(_T,E(Y\-YU_EPU(_E4UM4+L &%[ !
MQE:9L=D,[DQ.7(;K\4.=S)P]7+9/<,X7:. =B3Q7F9CRG%=51%2$WDV>9GE=
M3N22_>>ZR=[6,1$V40H+ZG.DBL)!Y"3RCR!(8$)\#%D<13AR XR%4:&GLZ29
MV\)8*0,ZVC31-U*?IM8/Z&@$ND:S5ES."..IMQ!.-DHC+V9C#Y#Y!0D;P-JZ
M&G&6+-->BK !VXOK$%8:'1#7W#;V.\_N<OQXGU*\K*Z&^T&$O,B-H>^S6)*M
M"FUV40 ]WY7LZSIAX&E=@>CM96XDVI7/_";^42S[B<X:0B,3F DX9O'*IY0_
M)U#Y:-O312B?4F\G-/GDP\,L+U64^UIT+,3JP_0B[,AICF' 20B1D-,](32"
M5(0!]1 -J!^;6%0'>YG;)'^3+:7,F;H!_,1WMI)J0>[^NU.X:/<E$VKH'P$]
M&^AL7$>FAO$A-;9N>B&S9+4<[F-2:Z17S7TKH__A8<2RN9)YJ-Y.(G@0A+Y*
M7ZG<H(G#("9A!!WL.P11$00<F_!+7V=SHYGM#6?3>Y.]D.H1ABV@1N:-SBWP
MT:L9Z4!BB1=ZNYJ4'G24WF<)K7>&D<5OZT)N6HKB+2]HGE:^*+G3^0T7:7$M
M;N27U89[;;_W*(J2P&$)%+[C0D0H@R1.'"A"-PJXAUP2,1,*,1=A;L3R":N"
M!BI(IM6E6F4K%=1/NTJ8$<^ X=&CHW%!'YFD-BAWI#^.^$CL-1Q!2YPV0(!)
MF6XX0/O\=T9+@TVHG.."O^7U?Z]6;7;5?Z3E_9MU44H^SC^DF*3+M'Q>1 X)
M$C]*U#8M@@@G"8R1)V!,O2@.D)MP8N0'-^Q_;GSXE@N>YYR!O*YJ;FQL&8&O
M;7^-!>GX)EDE,?BYE?T7D*XVJ:W!-RD_:!6X !L5K!IJ0["S9[L9]3ZU.3<$
MF@,6WJ!F)H[">8_3O#IUO"R*]4-[]ZP^L'R;/J6,KUB5?XL03_@A=2$/?!\B
MZB80TS"!"4>.2WT42[DFB;;1E7AN%+J)B&"-D. YY4O-:VG3C;,>]\YJ]$9F
M:PL1,DKKIA951^^+;91,JWJ5J&T&,3"FP_3:L2[:\OX8,2VF\%N+73'N>-AR
MU2Y[*2^:ND&;"W))@!#SJ ,#1"E$@E&8>(A#XA$7,<[<A"&3=>9X5W-;(!KQ
MP'(KL6;I @U8]6C=#E@C\W%'R$VUKU'JBIY&PQ+M]70T*5^=5GB?:#3>&'#1
MN2>_7'5=9A$%/L+4PQ!S50<0(4D2 6$PBIV$.7*CGE"MT&^MWF;'$YU4B)?[
MJ1";*V0F=YE/HMW/'=8Q'/T<=6+X#*Y\VX1QHJO=O7!:NL&M"TOO3>V3C4QW
M(UM7GYV;U]HO3>Q!J(M 7*TD[5??6U&%']S>XU43"+VY![E7YZJZ;:QJYFR,
MSL_9<OD^RU6K"^JZM*+XT$$J&IF$$/MA#),82Q,P9%Z"^$(V1++1/0[C:&@R
ME[MZCC>57U3=J^^#5V6B.CO8&Y[7>]V)7!<C?6 C.SI>_Z.9OUNDQ@AT0.K&
M+FVN%6V0.E 8\O G.L9N8*9?PFM[7D;2[L?PTXP[M-:\.B.+.=#@6)."_W,M
MQ7GW)/]0<7-O,U7Y<A$*A)TDY)!PKJJ\<Z0RDU(8NEZ,/<X]%!FY@([V-+>=
MW5904$D*E*C@:RVL82CL<7@U%SX;H(V]! W#RYSZ3V%ABX2/]C,M'9Y2]P4Q
MG7QA&$5TO=&\VO9T_$T?.59A<^QZ]9G3=9ZK"Y4K)IDL;_]9A9,T>W"7QZZ/
M DA='$))+SY,6(Q@D 28!=0-,0E-*,6:9'.CH-V3*MYLZCO*@58[<+T"&_VJ
MI[H:-H%;1NX4^\.N1W6O,I@C4^-V'"\ZHX3W1^G4^!A3I74L+5&K/;DFI6+K
M<.Y3M_T.!MY:Q[DJ>5[<\+RR8=^FR[6T0Q?<Y80C%$''$1%$B$4PD?\'$\%=
M$<>8QK$PNH]^N)^YT? G7H)E5A2JY!Z@V<-#UB23OP"LEKC*+\_4]9Z\?JKZ
MM6&J^6.HJV">4'@8)H0PB.+(@]AWY#]I2-P@C!T6!F;.-PNX3^,$.XH\@)-
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MU,J QU8;%>G<J&.P%1DZ:AI[O G&8F1&:8:AOL-^+<!&"5!I 6XST.@!-HJ
MFRF'P6"?.,%P3+1['#([+CK3P];^\DQ$>W>=0]N>;B]ZIO8[.]1SVS(_ZY?V
MYPW//O'L\NFNBOZEY1HOE\\W.&4&T?,GFIG;NB+%A2I\_)/\7YNA8_>HH)$?
M* 6,H^Q/@7HZ/, BGB.O#7:A-(H9T 1I4/C J;8GBR305+(;5*#[RDCQ!<6)
MXXZ*WHJK55W/<B^3Q[OODM720K*<I+I%3%R?"B>!@B8"HL"-8.R'+O0B$@F?
M>2[%GN7D6O:D-YFDT]P9K&2W="]PRL_ TIGVZPSM#$Z["]WC[AH!5>.AQN!
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MJV8TB0]5JQJS1)7ER7R@@U<N275L6O<\>6;VX;=I0>5*M):?Q2;T-2#$\YP
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MC]*'N4N_S5V/E\CQGMZF!5UFZDQQN_'1].Z?;&ANO+D5&$B)?W[Z!6R%UC\
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M[K0UVK'M]-\:9MI]YJIE6G+V167^^6.5EL7G+W\T7[+PB>-32;<1CR*(HD1
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M\]$:^Y3T+*",]B/]6 S:EQQI<K+]2;]*W7W*B2?-;ZR_6Y5RI7^?+GD=K+'
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ME"+'2U"K"H3\/_6'1D%#P_":,=0T_R8:F;&-O,Z@-+AW-*E#%VM=VE$ '6W
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MNI%Z2(K$M>AF"ZCE..DM?"-B/\V"M54 _+!5X4<@K9;M6+3BUT-1*P!N^X?
M>$FY#D%'2X&E$)-2^'5 '5/OE:U95L&E=/.\J0M=U8TJUI=;+]G/+JJDS=1
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M<>_D!P<*@%N%^Q9VL(>]4<.F(*[=$!CP_>A#,=$Z<#@%]IKT3(9&(U<+Q%5
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MZ'.C@:VPX'4G[0UX;F2UN/8[S?!K>C]F.:AC>U:NO^;;N;;; > &[#Z5/09
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MG31LMT.Z6]&2XXJ_Y\W_WJU.+^-_+99+*8J*&%^P 'L20 \R&D80J?,@3(6
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ME ]Z5#QF@;Y'K6,-U+Y<$LM#L<Q5W/BNS \)L>^+R(.<>B%$(D9RCR<I@(H
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M(H)@1H0/@R1@B8@(]5&H?=(VLK"SX_!:-%#5A6K+5DD@BA+DK8+RMSL- :[
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M<*G&I 2D. U Y ?83Y!49#*V6/,'%12KM^N')]7ZQ+/J$V]//;:GH]B3:"8
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M#B9_7O':VG;]J!HX_5_Y[W=%_L2+[>N=_#*V\G<J9_M)B?$%9DA *#! $(4
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M=FX"Y^ J4Y=O-S1;ZL&M:91T#N*$U\*S]38^#F!J;D8T@LB5D5!OTFE-@$9
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MW-,)IJUZV\G@217;[B<G[H%]T(OS>LU4-PQ5 ^L^5__4,GQ6%M&%3ZD("62
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M.%[F8X/FDN[?YZLOF*9EBOFRJD3YZ"DXE^3E$-Y5]A*BYH&V4R@Z>,NR8BV
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MO"^ HZUO&\J?U8.M?6!VWTZ/H.@.?(:CN=Z$B:_(#%VV2]=1<>\@*L-!15?
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MW)6>RGONIDNRYI1<32U+[CA!0N"<EXD9TD%3%*4U,H!)=F?I6@5[%U07GY5
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M=6!5AN?=V RHW1+X)_L#9F]FW;?/?@)3#[]\7,<3HLF%_91 X#A)JII89#0
M4M(+YV(4;+/EP([^O[MFJ >+D3C9E29K16P$F%S] E_L]=ODH2Q^+ 5'8N,L
M\0$YI9/@@*?(9D6,/0.%=3!.[DN/G8/_CR_=][^DH5=J)7UXT"A;)FPE/%+\
M.#J5N)5QL5KU6D*$B\%1PY&/V?>,Z9/Q,2#O(V,Z9IMN7Z['85 \GJV.RCB9
M75T!VM4^)S[ ;/'UITGWR^0FEV+^96+=Y#IMY4TW^]:M'MRM-9QT$:A@"IFD
MRI*&XTG#$1I0,O&93MI4VLT*Q#L.CMY3UH/%<'9VH].VLKUZ2'\^_RW O8W&
M.,,:B^0BVOS>SE"1^_5*Y+3B5!C(&3X%3-A3UMA*S]I1G*478UYED.[:QUW;
MZ*A44-XEM<YYOJUCR'F>=Y(L-68%9^ *P'#_*NK9R2^'@FX4EIS/F4F#Y<%B
MCP+@W.4'#'*!JR2QB@5"0 >I7L.969K!PT[18ZC=P"WA05W_Z"X*>X\ED<A;
MFUNE2H=TT X)HJD-''M-2N?V]%]=*_UHBY^8(S.J 0ANW\^'?T_3#%\GWS["
MS&=>?H$KH9@6W&.DB,^9V-8C2QQ'3!FAE4LF*I3.^>V]N,;CVP/1L9EW-@JK
M:A^E[V[S1=*R0-F'^'Z:MS#Y#LL4J,ON,\R^3SQ\G'7?)XF'\T=[!*: :)PH
M207/G;NRQXX9"MI %$%8[%BO@W7@ AJ/89T&N1?C3 ,:,!<8RE>8_Y@LOKZY
MG2^Z&YC=FQA7E%*K#(XHF'16)(O"(4<50R)@*V*0N4QN8:VW=T&-.Z=E-%TY
MEC2 KZ=E-HB3WD(NLP&YK9*T*M]1):/$>"LC5<K:4!A/Q]<QJ6>JE<'/<)(W
MT5/N8>TY3VP'I:[ @(K"$ 1>6Y0\;XHL6$B'/!9:)PT,NO1;S%X+JUPG]F40
M5IY%32!OUT:X=9;A('*_B)@V0FPR* T@H:-T//WC3>GZ.:>@2YXYNDJPX;S2
M0>\(V\4W75JI7[U_?W]SDZ ]F]CKM[-9-XO=;/$55JT-RJ>*#E["B&FD9<A2
M*<4T$HEE, X9+3#*/B=RP),S((/TQJGTXV4"!B^18IH9\<"C/./'Q(_9BBL7
MX;]O5TO)+WT2[_+'551*:QM\5 %))G/)(19R4%0A#\I2XSDUM'3EXM-7?5ZI
MJ<?@<$_@[R4X7#T3\7[MRYN>9"5#9.F (9@IQ$DZOBRQZ8=A8$E@C$(O9^5@
MON&3:9L)YKT(Q[LRY&\'.>O;'D^9-90DM]SJ?-N37"_C'$-*I*5S*SQ +_>D
M/W9J7ZJ>Q+[M,!A R^K)(3"U23X^SN#[I+N=7__X!-^2@0)A?46G 8!KIE&@
M/E$E4HHT9A$982V0(%FR8XLD@.Q?1Q,P&<+>;B1:5U<@WR?SY5.X1SIV0P,_
MJ-SU_HRSG'(AD8B>(NX\0R8PBQ3UP).L,6YZ!6</ZICCUU;G>J LOD;G20/1
MV;Z'_/P161^<?"F\$M0YY$@NW9<?AVJ95'PT+IKT)^UX\5=TIRRXF4NKES2M
M7I[5#> ZR2Y,;V%^9:*)/%B-K.<:<8QI^A0QH@X\!<&)4Z7#Q'=S5W837X[=
MS\IY#*!] YA9-UB9?GET>0(BNI"[4@2;+T\$L4@;2Q$!H7&R+[A0I>M6;UE&
MY?KHU9!T*D<: %6_FQ(CL,62Y.=8(5FJPAGD(GC$- $LL8(D+<U>9HU7%+T:
M\,ISK0$H;C2\"-PSSG/K8Y)KRN4>4D)X!,(13 C3,;[BF_AZT!K.A08@M+W^
M.Z%1ICUKE)]Y(LY-CC ;C(1TWC$:)-_,1:M8<'^\HNG5('4Z5QJ$UEUY>,4]
MQR8GK0B3C$BO##(F.3^@-4M*UBH62A>!.J4F_VAW[^W :PAG&@!8+C@U@Z\P
MG=^WK$NZ^$.\M+\G3R6 IEXB3YA,:ICGAHKI)(^:"T,C)3[VBLH>E>:X<SF]
M@*9>']!*<:C1W(_<O6"R(IV=AE5CSR\P]9.3>C?W&+5$AL:QBR^4=/%HVHO-
M:9]WLR2,2<#9 K<F&>1,8F1E0J#P( +5P@51^JPX:H$GO138,],J.,@< RF9
M1])CEPY\[)$U0B-OM?6.Q^2?D$-HZC53W<#6>)!XDOY?E-PMUN.R8#V-)*+
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M@Q=?Z'+^+MD,0L[<@&3NK<3AP2K\Z<?#=];VVG)YJS6F:7)RR;6=/KK,*:L
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MSUO8NJO-TJ=CAB?KP_WMS;?K[@? ,A[ZX=NC_FEEH;][GKJUN%XP^'R0U W
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M^925N=4EH.%8)+AZ >/#V0B?R%"6\!A?::9&F+:L\G(K CG$8 S74Q(9\7O
M<1=T&GPGT!@<,G/%!HY! K'46%R@6([=T1(!FDU2&:?,E/1KWG\"&BHEY,!(
MF@RK$"IH)M*FZ* I('8&DMX"35,"W1QC-\&BZ>(TO&Z\M;8>;\ 27-QY3."8
M1S! L*$X-NN%=IDGR O<2M0C\S@K!>I$E"R$*T"$2>*2 H-,^"3<9MD<@%7L
MS9.A$>-"DN* ),H,!1!U"J'AAC/.GIB;E"69FI@9)#4,I;&:XT"<7GJ[T<I@
M 5EF9LR*M:\;7.UM =?M4B3>F0HX50*G9:^21.*CB\XYXQH<#C"N,LJ XL4
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M_G%]C>9@B1V1#8VO!"-5VB^/O0GG\T=IH#(W^?HVA$6S MJM-/!S@/8X5-$
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M;F1M92YH=&U02P$"% ,4    "  S@0A7:)_IV4@< 0 I)0X $0
M    @ $A%P  87)V;BTR,#(S,#8S,"YH=&U02P$"% ,4    "  S@0A7GL/+
MO]$0   ,N   $0              @ &8,P$ 87)V;BTR,#(S,#8S,"YX<V10
M2P$"% ,4    "  S@0A770-":H88  "TZ@  %0              @ &81 $
M87)V;BTR,#(S,#8S,%]C86PN>&UL4$L! A0#%     @ ,X$(5S.U%EYM10
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M,3(N:'1M4$L! A0#%     @ ,X$(5[/2>5&@!   'A,  !H
M ( !8QT# &%R=FXM,C R,S V,S!X,3!Q97@S,C$N:'1M4$L! A0#%     @
M,X$(5PPE!UV-!   =!(  !H              ( !.R(# &%R=FXM,C R,S V
M,S!X,3!Q97@S,C(N:'1M4$L! A0#%     @ ,X$(5_;\X\A#!P  A1   !P
M             ( ! "<# &)A>65R7V%R=FEN87-X86UE;F1M96YT>"YH=&U0
52P4&      P #  ^ P  ?2X#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
